PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oliveira, PJC; Asner, GP; Knapp, DE; Almeyda, A; Galvan-Gildemeister, R; Keene, S; Raybin, RF; Smith, RC				Oliveira, Paulo J. C.; Asner, Gregory P.; Knapp, David E.; Almeyda, Angelica; Galvan-Gildemeister, Ricardo; Keene, Sam; Raybin, Rebecca F.; Smith, Richard C.			Land-use allocation protects the Peruvian Amazon	SCIENCE			English	Article							BRAZILIAN AMAZON; RAIN-FOREST; DEFORESTATION; BIODIVERSITY; CONSERVATION; DYNAMICS; BASIN; FIRE	Disturbance and deforestation have profound ecological and socioeconomic effects on tropical forests, but their diffuse patterns are difficult to detect and quantify at regional scales. We expanded the Carnegie forest damage detection system to show that, between 1999 and 2005, disturbance and deforestation rates throughout the Peruvian Amazon averaged 632 square kilometers per year and 645 square kilometers per year, respectively. However, only 1 to 2% occurred within natural protected areas, indigenous territories contained only 11% of the forest disturbances and 9% of the deforestation, and recent forest concessions effectively protected against clear-cutting. Although the region shows recent increases in disturbance and deforestation rates and leakage into forests surrounding concession areas, land-use policy and remoteness are serving to protect the Peruvian Amazon.	Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; Inst Bien Comun, Lima 18, Peru; Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Carnegie Institution for Science; Stanford University; Boston University	Asner, GP (corresponding author), Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@stanford.edu	Asner, Gregory/G-9268-2013; Zambrano, Angelica Almeyda/Q-4758-2017	Asner, Gregory/0000-0001-7893-6421; Zambrano, Angelica Almeyda/0000-0001-5081-9936; Oliveira, Paulo/0000-0002-4071-3924				Alvarez NL, 2003, AMBIO, V32, P269, DOI 10.1639/0044-7447(2003)032[0269:LNAPTD]2.0.CO;2; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2005, EARTH INTERACT, V9, DOI 10.1175/EI134.1; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; *CONAM INRENA, 2005, IM0302 CONAM INRENA, V1; Curran LM, 2006, P NATL ACAD SCI USA, V103, P12663, DOI 10.1073/pnas.0605449103; Dinerstein E., 1995, CONSERVATION ASSESSM; FAO, 2006, 147 FAO; *FAO, 2006, 201 FAO PER INF NAC; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GENTRY AH, 1992, OIKOS, V63, P19, DOI 10.2307/3545512; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Imbernon J, 1999, AMBIO, V28, P509; *INRENA, 2003, PER FOR NUM 2002; Maki S, 2001, ENVIRON CONSERV, V28, P199, DOI 10.1017/S0376892901000212; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; *SZF CDC UNALM, 2006, HAC SIST MON AMB REM, V5; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	24	237	249	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1233	1236		10.1126/science.1146324	http://dx.doi.org/10.1126/science.1146324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17690260				2022-12-28	WOS:000249126800044
J	Frazer, KA; Eskin, E; Kang, HM; Bogue, MA; Hinds, DA; Beilharz, EJ; Gupta, RV; Montgomery, J; Morenzoni, MM; Nilsen, GB; Pethiyagoda, CL; Stuve, LL; Johnson, FM; Daly, MJ; Wade, CM; Cox, DR				Frazer, Kelly A.; Eskin, Eleazar; Kang, Hyun Min; Bogue, Molly A.; Hinds, David A.; Beilharz, Erica J.; Gupta, Robert V.; Montgomery, Julie; Morenzoni, Matt M.; Nilsen, Geoffrey B.; Pethiyagoda, Charit L.; Stuve, Laura L.; Johnson, Frank M.; Daly, Mark J.; Wade, Claire M.; Cox, David R.			A sequence-based variation map of 8.27 million SNPs in inbred mouse strains	NATURE			English	Article							HAPLOTYPE DIVERSITY; GENETIC-VARIATION; PHENOME PROJECT; LABORATORY MICE; GENOME; PATTERNS; DATABASE; REVEALS; SYSTEM	A dense map of genetic variation in the laboratory mouse genome will provide insights into the evolutionary history of the species(1) and lead to an improved understanding of the relationship between inter-strain genotypic and phenotypic differences. Here we resequence the genomes of four wild-derived and eleven classical strains. We identify 8.27 million high-quality single nucleotide polymorphisms (SNPs) densely distributed across the genome, and determine the locations of the high (divergent subspecies ancestry) and low (common subspecies ancestry) SNP-rate intervals(2-6) for every pairwise combination of classical strains. Using these data, we generate a genome-wide haplotype map containing 40,898 segments, each with an average of three distinct ancestral haplotypes. For the haplotypes in the classical strains that are unequivocally assigned ancestry, the genetic contributions of the Mus musculus subspecies-M. m. domesticus, M. m. musculus, M. m. castaneus and the hybrid M. m. molossinus-are 68%, 6%, 3% and 10%, respectively; the remaining 13% of haplotypes are of unknown ancestral origin. The considerable regional redundancy of the SNP data will facilitate imputation of the majority of these genotypes in less-densely typed classical inbred strains to provide a complete view of variation in additional strains.	Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Jackson Lab, Bar Harbor, ME 04609 USA; NIEHS, Toxicol Operat Branch, Res Triangle Pk, NC 27709 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Frazer, KA (corresponding author), Perlegen Sci, 2021 Stierlin Court, Mountain View, CA 94043 USA.	frazer.kelly@scrippshealth.org	Daly, Mark J/B-2453-2017; Eskin, Eleazar/J-9187-2012	Daly, Mark J/0000-0002-0949-8752; Eskin, Eleazar/0000-0003-1149-4758; Hinds, David/0000-0002-4911-803X; Wade, Claire/0000-0003-3413-4771; Frazer, Kelly/0000-0002-6060-8902	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER; NHLBI NIH HHS [K25 HL080079] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bogue M, 2003, J APPL PHYSIOL, V95, P1335, DOI 10.1152/japplphysiol.00562.2003; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NAKAMURA M, 1962, P JPN ACAD, V38, P348, DOI 10.2183/pjab1945.38.348; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Silver L.M., 1995, MOUSE GENETICS CONCE; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	26	346	359	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1050	U8		10.1038/nature06067	http://dx.doi.org/10.1038/nature06067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17660834				2022-12-28	WOS:000249097600038
J	Hattori, M; Tanaka, Y; Fukai, S; Ishitani, R; Nureki, O				Hattori, Motoyuki; Tanaka, Yoshiki; Fukai, Shuya; Ishitani, Ryuichiro; Nureki, Osamu			Crystal structure of the MgtE Mg2+ transporter	NATURE			English	Article							RAY DIFFRACTION ANALYSIS; HUMAN SOLUTE CARRIER; MAGNESIUM TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PROTEIN; CORA; CHANNEL; CLONING; CRYSTALLIZATION; SLC41A1	The magnesium ion Mg2+ is a vital element involved in numerous physiological processes. Mg2+ has the largest hydrated radius among all cations, whereas its ionic radius is the smallest. It remains obscure how Mg2+ transporters selectively recognize and dehydrate the large, fully hydrated Mg2+ cation for transport(1). Recently the crystal structures of the CorA Mg2+ transporter(2-5) were reported(6-8). The MgtE family of Mg2+ transporters is ubiquitously distributed in all phylogenetic domains(9-11), and human homologues have been functionally characterized and suggested to be involved in magnesium homeostasis(12-14). However, the MgtE transporters have not been thoroughly characterized. Here we determine the crystal structures of the full-length Thermus thermophilus MgtE at 3.5 angstrom resolution, and of the cytosolic domain in the presence and absence of Mg2+ at 2.3 angstrom and 3.9 angstrom resolutions, respectively. The transporter adopts a homodimeric architecture, consisting of the carboxy-terminal five transmembrane domains and the amino-terminal cytosolic domains, which are composed of the superhelical N domain and tandemly repeated cystathionine-beta-synthase domains. A solvent-accessible pore nearly traverses the transmembrane domains, with one potential Mg2+ bound to the conserved Asp 432 within the pore. The transmembrane (TM)5 helices from both subunits close the pore through interactions with the 'connecting helices', which connect the cystathionine-beta-synthase and transmembrane domains. Four putative Mg2+ ions are bound at the interface between the connecting helices and the other domains, and this may lock the closed conformation of the pore. A structural comparison of the two states of the cytosolic domains showed the Mg2+-dependent movement of the connecting helices, which might reorganize the transmembrane helices to open the pore. These findings suggest a homeostasis mechanism, in which Mg2+ bound between cytosolic domains regulates Mg2+ flux by sensing the intracellular Mg2+ concentration. Whether this presumed regulation controls gating of an ion channel or opening of a secondary active transporter remains to be determined.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Kanagawa 2268501, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Kanagawa 2268501, Japan; SORST, JST, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	nureki@bio.titech.ac.jp	Fukai, Shuya/X-4838-2018; Hattori, Motoyuki/B-6069-2014; NUREKI, OSAMU/G-4960-2014	Fukai, Shuya/0000-0002-1241-1443; Hattori, Motoyuki/0000-0002-5327-5337; Tanaka, Yoshiki/0000-0001-6960-5276				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hattori M, 2007, ACTA CRYSTALLOGR F, V63, P682, DOI 10.1107/S1744309107032332; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; ISHITANI R, 2006, CUEMOL MOL VISUALIZA; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Kowal P, 2007, J BIOL CHEM, V282, P2047, DOI 10.1074/jbc.M608356200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; NELSON DL, 1971, J BIOL CHEM, V246, P3042; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; SMITH RL, 1995, J BACTERIOL, V177, P1233, DOI 10.1128/jb.177.5.1233-1238.1995; Tanaka Y, 2007, ACTA CRYSTALLOGR F, V63, P678, DOI 10.1107/S1744309107032344; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; TOWNSEND DE, 1995, J BACTERIOL, V177, P5350, DOI 10.1128/jb.177.18.5350-5354.1995; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	34	143	147	5	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1072	U13		10.1038/nature06093	http://dx.doi.org/10.1038/nature06093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17700703				2022-12-28	WOS:000249097600043
J	Cox, J; Mann, M				Cox, Juergen; Mann, Matthias			Is proteomics the new genomics?	CELL			English	Article							SITE-SPECIFIC PHOSPHORYLATION; SPECTROMETRY-BASED PROTEOMICS; PROTEIN EXPRESSION; MASS-SPECTROMETRY; YEAST; QUANTITATION; DYNAMICS; SILAC	Mass spectrometry (MS)-based proteomics has become a formidable tool for the investigation of posttranslational modifications to proteins, protein interactions, and organelles. Is it now ready to tackle comprehensive protein expression analysis?.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013; Cox, Jurgen/B-9481-2008	Mann, Matthias/0000-0003-1292-4799; Cox, Jurgen/0000-0001-8597-205X				Aebersold R, 2003, NATURE, V422, P115, DOI 10.1038/422115a; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Domon B, 2006, MOL CELL PROTEOMICS, V5, P1921, DOI 10.1074/mcp.R600012-MCP200; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Nielsen ML, 2006, MOL CELL PROTEOMICS, V5, P2384, DOI 10.1074/mcp.M600248-MCP200; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	20	319	336	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					395	398		10.1016/j.cell.2007.07.032	http://dx.doi.org/10.1016/j.cell.2007.07.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693247	Bronze			2022-12-28	WOS:000249038100005
J	Weiner, JP				Weiner, Jonathan P.			Expanding the US medical workforce: global perspectives and parallels	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIAN; SHORTAGE		Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Weiner, JP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 624 N Broadway, Baltimore, MD 21205 USA.	jweiner@jhsph.edu						Ahmad OB, 2005, BRIT MED J, V331, P43, DOI 10.1136/bmj.331.7507.43; *ASS AM MED COLL, 2006, AAMC STAT PHYS WORKF; BAICKER K, 2004, HLTH AFFAIRS MILWOOD; Bloor K, 2006, J ROY SOC MED, V99, P281, DOI 10.1258/jrsm.99.6.281; Blumenthal D, 2004, NEW ENGL J MED, V350, P1780, DOI 10.1056/NEJMhpr033066; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Council on Graduate Medical Education, 2005, PHYS WORKF POL GUID; GOODMAN DC, 2005, HLTH AFF MILWOOD; GOODMAN DC, 2004, HLTH AFFAIRS MILWOOD; Green LA, 2004, PHYS WORKFORCE US FA; Grumbach K, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.5.13; Hooker RS, 2006, MED J AUSTRALIA, V185, P4, DOI 10.5694/j.1326-5377.2006.tb00438.x; *INF CTR, NHS HOSP COMM HLTH W; *INF CTR, GEN PERS MED SERV EN; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; *ORG EC COOP DEV, 2006, STAT 2004; Sandy LG, 2003, ANN INTERN MED, V138, P262, DOI 10.7326/0003-4819-138-3-200302040-00035; Simoens S, 2006, SUPPLY PHYS SERVICES; STARFIELD B, 2005, HLTH AFF; Weiner JP, 2002, HEALTH AFFAIR, V21, P160, DOI 10.1377/hlthaff.21.1.160; WEINER JP, 2005, HLTH AFFAIRS MILWOOD	22	26	26	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					236	238		10.1136/bmj.39246.598345.94	http://dx.doi.org/10.1136/bmj.39246.598345.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201QC	17673767	Green Published			2022-12-28	WOS:000248846700026
J	Botella, H; Blom, H; Dorka, M; Ahlberg, PE; Janvier, P				Botella, Hector; Blom, Henning; Dorka, Markus; Ahlberg, Per Erik; Janvier, Philippe			Jaws and teeth of the earliest bony fishes	NATURE			English	Article							LOPHOSTEUS-SUPERBUS PANDER; ORIGIN	Extant jawed vertebrates, or gnathostomes, fall into two major monophyletic groups, namely chondrichthyans (cartilaginous fishes) and osteichthyans (bony fishes and tetrapods). Fossil representatives of the osteichthyan crown group are known from the latest Silurian period, 418 million years (Myr) ago, to the present. By contrast, stem chondrichthyans and stem osteichthyans are still largely unknown. Two extinct Palaeozoic groups, the acanthodians and placoderms, may fall into these stem groups or the common stem group of gnathostomes, but their relationships and monophyletic status are both debated. Here we report unambiguous evidence for osteichthyan characters in jaw bones referred to the late Silurian (423-416-Myr-old) fishes Andreolepis hedei and Lophosteus superbus, long known from isolated bone fragments, scales and teeth, and whose affinities to, or within, osteichthyans have been debated(1-11). The bones are a characteristic osteichthyan maxillary and dentary, but the organization of the tooth-like denticles they bear differs from the large, conical teeth of crown-group osteichthyans, indicating that they can be assigned to the stem group. Andreolepis and Lophosteus are thus not only the oldest but also the most phylogenetically basal securely identified osteichthyans known so far.	Museum Natl Hist Nat, CNRS, Dept Hist Terre, UMR 5143, F-75231 Paris 05, France; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Valencia, Dept Geol, E-46100 Valencia, Spain; Uppsala Univ, Dept Physiol & Dev Biol, S-75236 Uppsala, Sweden; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London; University of Valencia; Uppsala University; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Janvier, P (corresponding author), Museum Natl Hist Nat, CNRS, Dept Hist Terre, UMR 5143, 47 Rue Cuvier, F-75231 Paris 05, France.	janvier@mnhn.fr	Ahlberg, Per/E-8086-2013; Self, Casey J/B-6871-2011	Ahlberg, Per/0000-0001-9054-2900				Ahlberg PE, 2006, EVOL DEV, V8, P331, DOI 10.1111/j.1525-142X.2006.00106.x; Andrews M, 2005, T ROY SOC EDIN-EARTH, V96, P197, DOI 10.1017/S0263593300001309; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Clemen G, 1998, ANN ANAT, V180, P211, DOI 10.1016/S0940-9602(98)80076-9; Fraser GJ, 2006, EVOL DEV, V8, P446, DOI 10.1111/j.1525-142X.2006.00118.x; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fredholm D., 1988, Geologiska Foreningens i Stockholm Forhandlingar, V110, P157; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GROSS W, 1971, LETHAIA, V4, P131, DOI 10.1111/j.1502-3931.1971.tb01285.x; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Huysseune A, 2006, J EXP ZOOL PART B, V306B, P204, DOI 10.1002/jez.b.21091; JANVIER P, 1978, GEOLOGIA, V3, P88; Marss T., 1986, Fossilia Baltica, V1, P1; Marss Tiiu, 2001, Proceedings of the Estonian Academy of Sciences Geology, V50, P174; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; OTTO M, 1991, Palaeontologische Zeitschrift, V65, P345; Pander CH., 1856, MONOGRAPHIE FOSSILEN; Rohon JV, 1893, MEMOIRES ACAD IMPERI, V41, P1; SCHULTZE H-P, 1982, Palaeontologische Zeitschrift, V56, P95; SCHULTZE H-P, 1977, Palaeontologische Zeitschrift, V51, P152; Schultze H-P, 2004, ACTA U LATV, V674, P57; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; SMITH MM, 2001, MAJOR EVENTS EARLY V, P133; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563	28	67	72	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					583	586		10.1038/nature05989	http://dx.doi.org/10.1038/nature05989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671501				2022-12-28	WOS:000248446700041
J	Parmet, WE				Parmet, Wendy E.			Legal power and legal rights - Isolation and quarantine in the case of drug-resistant tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northeastern Univ, Sch Law, Boston, MA 02115 USA	Northeastern University	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; NEUMANN J, 2007, LOS ANGELES TIM 0607, pA12; 2005, FED REG         1130, V70, P71892	4	29	29	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					433	435		10.1056/NEJMp078133	http://dx.doi.org/10.1056/NEJMp078133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195UB	17671251				2022-12-28	WOS:000248436300001
J	Hamilton, GL; Kang, EJ; Mba, M; Toste, FD				Hamilton, Gregory L.; Kang, Eun Joo; Mba, Miriam; Toste, F. Dean			A powerful chiral counterion strategy for asymmetric transition metal catalysis	SCIENCE			English	Article							GOLD; HYDROGENATION; CYCLIZATION; COMPLEXES	Traditionally, transition metal-catalyzed enantioselective transformations rely on chiral ligands tightly bound to the metal to induce asymmetric product distributions. Here we report high enantioselectivities conferred by a chiral counterion in a metal-catalyzed reaction. Two different transformations catalyzed by cationic gold( I) complexes generated products in 90 to 99% enantiomeric excess with the use of chiral binaphthol-derived phosphate anions. Furthermore, we show that the chiral counterion can be combined additively with chiral ligands to enable an asymmetric transformation that cannot be achieved by either method alone. This concept of relaying chiral information via an ion pair should be applicable to a vast number of metal-mediated processes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Kang, Eun/AAK-7225-2020	Toste, F. Dean/0000-0001-8018-2198; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073932] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073932] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama T, 2006, ADV SYNTH CATAL, V348, P999, DOI 10.1002/adsc.200606074; Bates RW, 2002, CHEM SOC REV, V31, P12, DOI 10.1039/b103904k; Connon SJ, 2006, ANGEW CHEM INT EDIT, V45, P3909, DOI 10.1002/anie.200600529; Dorta R, 2004, J ORGANOMET CHEM, V689, P751, DOI 10.1016/j.jorganchem.2003.12.012; Gonzalez-Arellano C, 2005, CHEM COMMUN, P3451, DOI 10.1039/b505271h; Gorin DJ, 2007, NATURE, V446, P395, DOI 10.1038/nature05592; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; ITO Y, 1986, J AM CHEM SOC, V108, P6405, DOI 10.1021/ja00280a056; Jimenez-Nunez E, 2007, CHEM COMMUN, P333, DOI 10.1039/b612008c; Johansson MJ, 2005, J AM CHEM SOC, V127, P18002, DOI 10.1021/ja0552500; Lacour J, 2003, CHEM SOC REV, V32, P373, DOI 10.1039/b205251m; LaLonde RL, 2007, J AM CHEM SOC, V129, P2452, DOI 10.1021/ja068819l; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; Llewellyn DB, 2005, TETRAHEDRON-ASYMMETR, V16, P1789, DOI 10.1016/j.tetasy.2005.04.004; Llewellyn DB, 2000, ORG LETT, V2, P4165, DOI 10.1021/ol000303y; Martin NJA, 2006, J AM CHEM SOC, V128, P13368, DOI 10.1021/ja065708d; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Mulzer J., 1999, COMPREHENSIVE ASYMME, V1; Munoz MP, 2005, ORGANOMETALLICS, V24, P1293, DOI 10.1021/om0491645; O'Donnell M.J., 2000, CATALYTIC ASYMMETRIC, P727; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Zhang LM, 2006, ADV SYNTH CATAL, V348, P2271, DOI 10.1002/adsc.200600368; Zhang ZB, 2007, ANGEW CHEM INT EDIT, V46, P283, DOI 10.1002/anie.200603260	24	697	699	6	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					496	499		10.1126/science.1145229	http://dx.doi.org/10.1126/science.1145229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	194JD	17656720				2022-12-28	WOS:000248339800040
J	Weart, RB; Lee, AH; Chien, AC; Haeusser, DP; Hill, NS; Levin, PA				Weart, Richard B.; Lee, Amy H.; Chien, An-Chun; Haeusser, Daniel P.; Hill, Norbert S.; Levin, Petra Anne			A metabolic sensor governing cell size in bacteria	CELL			English	Article							CHROMOSOME SEGREGATION; DIVISION PROTEIN; FTSZ; GROWTH; REPLICATION; INITIATION; LENGTH; PHOSPHOGLUCOMUTASE; IDENTIFICATION; LOCALIZATION	Nutrient availability is one of the strongest determinants of cell size. When grown in rich media, single-celled organisms such as yeast and bacteria can be up to twice the size of their slow-growing counterparts. The ability to modulate size in a nutrient-dependent manner requires cells to: (1) detect when they have reached the appropriate mass for a given growth rate and (2) transmit this information to the division apparatus. We report the identification of a metabolic sensor that couples nutritional availability to division in Bacillus subtilis. A key component of this sensor is an effector, UgtP, which localizes to the division site in a nutrient-dependent manner and inhibits assembly of the tubulin-like cell division protein FtsZ. This sensor serves to maintain a constant ratio of FtsZ rings to cell length regardless of growth rate and ensures that cells reach the appropriate mass and complete chromosome segregation prior to cytokinesis.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	plevin@biology.wustl.edu	Lee, Amy Huei-Yi/K-3896-2019	Lee, Amy Huei-Yi/0000-0003-3250-3246; Levin, Petra/0000-0003-2071-0547; Hill, Norbert/0000-0002-4719-2893	NIGMS NIH HHS [GM64671, R01 GM064671-02, R01 GM064671, R01 GM064671-05, R01 GM064671-04, R01 GM064671-03, R01 GM064671-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; DONACHIE WD, 1989, J BACTERIOL, V171, P4633, DOI 10.1128/jb.171.9.4633-4639.1989; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; JAACKS KJ, 1989, J BACTERIOL, V171, P4121, DOI 10.1128/JB.171.8.4121-4129.1989; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Levin PA, 1998, J BACTERIOL, V180, P6048, DOI 10.1128/JB.180.22.6048-6051.1998; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	36	251	254	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					335	347		10.1016/j.cell.2007.05.043	http://dx.doi.org/10.1016/j.cell.2007.05.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662947	Green Accepted, Bronze			2022-12-28	WOS:000248588000022
J	Menter, A; Griffiths, CEM				Menter, Alan; Griffiths, Christopher E. M.			Psoriasis 2 - Current and future management of psoriasis	LANCET			English	Review							CHRONIC PLAQUE PSORIASIS; LONG-TERM SAFETY; LOW-DOSE CYCLOSPORINE; FUMARIC-ACID ESTERS; ULTRAVIOLET-B PHOTOTHERAPY; SHORT-CONTACT DITHRANOL; TO-SEVERE PSORIASIS; G G(-1) OINTMENT; DOUBLE-BLIND; BETAMETHASONE DIPROPIONATE	Management of psoriasis begins with identification of the extent of cutaneous disease. However, a holistic, contractual approach to treatment is encouraged, with particular reference to psychosocial disability and quality-of-life issues. of The presence of psoriasis on palms, soles, body folds, genitals, face, or nails, and concomitant joint disease, are also important when considering treatment options. An evidence-based approach is essential in delineating differences between the many available treatments. However, archaic approaches, especially combinational ones, are routinely used by some clinicians, with inadequate prospective or comparative evidence. Treatments currently available are: topical agents used predominantly for mild disease and for recalcitrant lesions in more severe disease; phototherapy for moderate disease; and systemic agents including photochemotherapy, oral agents, and newer injectable biological of agents, which have revolutionised the management of severe psoriasis. Other innovative treatments are undergoing clinical studies, with the aim of maintaining safe, long-term control of the condition.	Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England; Baylor Res Inst, Dallas, TX 75246 USA; SW Med Sch, Dallas, TX 75246 USA	University of Manchester; Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Griffiths, CEM (corresponding author), Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England.	christopher.griffiths@manchester.ac.uk	menter md, alan/A-8250-2009; Griffiths, Christopher E.M./P-5448-2014	Griffiths, Christopher E.M./0000-0001-5371-4427				Agarwal R, 2002, J DERMATOL, V29, P529, DOI 10.1111/j.1346-8138.2002.tb00321.x; [Anonymous], 2005, Prescrire Int, V14, P123; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Ashcroft DM, 2000, BMJ-BRIT MED J, V320, P963, DOI 10.1136/bmj.320.7240.963; Bawle EV, 1998, TERATOLOGY, V57, P51, DOI 10.1002/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9; Bissonnette R, 2006, J AM ACAD DERMATOL, V54, P472, DOI 10.1016/j.jaad.2005.10.061; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bowman PH, 2002, J AM ACAD DERMATOL, V46, P907, DOI 10.1067/mjd.2002.120453; Bruner Christine R, 2003, Dermatol Online J, V9, P2; Cameron H, 2002, BRIT J DERMATOL, V147, P973, DOI 10.1046/j.1365-2133.2002.04996.x; Campalani E, 2007, J INVEST DERMATOL, V127, P1860, DOI 10.1038/sj.jid.5700808; Carroll CL, 2005, ARCH DERMATOL, V141, P43, DOI 10.1001/archderm.141.1.43; Chalmers RJG, 2005, BRIT J DERMATOL, V152, P444, DOI 10.1111/J.1365-2133.2005.06422.X; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Clark CM, 1999, BRIT J DERMATOL, V141, P279; Cooper EJ, 2000, CLIN EXP DERMATOL, V25, P111; CORNELL RC, 1985, ARCH DERMATOL, V121, P63, DOI 10.1001/archderm.121.1.63; Coven TR, 1997, ARCH DERMATOL, V133, P1514, DOI 10.1001/archderm.133.12.1514; DIGIOVANNA JJ, 1995, ARCH DERMATOL, V131, P1263, DOI 10.1001/archderm.131.11.1263; Douglas WS, 2002, ACTA DERM-VENEREOL, V82, P131, DOI 10.1080/00015550252948194; DUHRA P, 1993, J AM ACAD DERMATOL, V28, P466, DOI 10.1016/0190-9622(93)70069-6; Duweb G, 2005, INT J TISSUE REACT, V27, P155; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Fiala Z, 2006, ARCH DERMATOL RES, V298, P243, DOI 10.1007/s00403-006-0691-z; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fortune DG, 2003, ARCH DERMATOL, V139, P752, DOI 10.1001/archderm.139.6.752; Fortune DG, 2002, BRIT J DERMATOL, V146, P458, DOI 10.1046/j.1365-2133.2002.04622.x; Gerritsen MJP, 2001, BRIT J DERMATOL, V144, P17, DOI 10.1046/j.1365-2133.2001.00035.x; Giannetti A, 1999, J EUR ACAD DERMATOL, V13, P91, DOI 10.1016/S0926-9959(99)00056-2; Goeckerman W., 1925, NW MED, V24, P229; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021; Gottlieb AB, 2005, BRIT J DERMATOL, V152, P1219, DOI 10.1111/j.1365-2133.2005.06661.x; Gottlieb AB, 2003, ARCH DERMATOL, V139, P1627, DOI 10.1001/archderm.139.12.1627; Gottlieb Alice B, 2004, J Drugs Dermatol, V3, P614; Gribetz C, 2004, J AM ACAD DERMATOL, V51, P731, DOI 10.1016/j.jaad.2004.06.010; Griffiths C E, 2000, Health Technol Assess, V4, P1; Griffiths CEM, 2004, BRIT J DERMATOL, V150, P11, DOI 10.1111/j.0366-077X.2004.05949.x; GROSSMAN RM, 1994, J AM ACAD DERMATOL, V31, P68, DOI 10.1016/S0190-9622(94)70138-5; Grundmann-Kollmann M, 2004, J AM ACAD DERMATOL, V50, P734, DOI 10.1016/S0190-9622(03)00792-8; GUPTA AK, 1995, J RHEUMATOL, V22, P894; Harries MJ, 2005, BRIT J DERMATOL, V153, P549, DOI 10.1111/j.1365-2133.2005.06728.x; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Hoefnagel JJ, 2003, BRIT J DERMATOL, V149, P363, DOI 10.1046/j.1365-2133.2003.05433.x; Hutchinson PE, 2000, DERMATOLOGY, V201, P139, DOI 10.1159/000018457; IEST J, 1989, BRIT J DERMATOL, V120, P665, DOI 10.1111/j.1365-2133.1989.tb01354.x; INGRAM JT, 1953, BRIT MED J, V2, P591, DOI 10.1136/bmj.2.4836.591; JONES EL, 1975, J INVEST DERMATOL, V65, P537, DOI 10.1111/1523-1747.ep12610346; KATZ HI, 1991, DERMATOLOGICA, V183, P269, DOI 10.1159/000247698; Kaur I, 2001, J DERMATOL, V28, P448, DOI 10.1111/j.1346-8138.2001.tb00008.x; Kokelj F, 1998, J EUR ACAD DERMATOL, V10, P143, DOI 10.1111/j.1468-3083.1998.tb00714.x; Kragballe K, 2006, BRIT J DERMATOL, V154, P1155, DOI 10.1111/j.1365-2133.2006.07236.x; KRAGBALLE K, 1991, LANCET, V337, P1229, DOI 10.1016/0140-6736(91)92906-I; KRAGBALLE K, 1991, ACTA DERM-VENEREOL, V71, P475; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P1829, DOI 10.1002/art.1780401016; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger GG, 2004, DERMATOL CLIN, V22, P407, DOI 10.1016/j.det.2004.03.014; Lahfa M, 2003, EUR J DERMATOL, V13, P261; LARSEN FG, 1993, J INVEST DERMATOL, V100, P623; LEAVELL UW, 1970, ARCH DERMATOL, V102, P144, DOI 10.1001/archderm.102.2.144; Lebwohl M, 2004, J AM ACAD DERMATOL, V51, P723, DOI 10.1016/j.jaad.2004.07.011; Lebwohl M, 2003, ARCH DERMATOL, V139, P719, DOI 10.1001/archderm.139.6.719; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P447, DOI 10.1016/S0190-9622(98)70323-8; Lebwohl M, 2001, J AM ACAD DERMATOL, V45, P544, DOI 10.1067/mjd.2001.116347; LEBWOHL M, 2004, NEW ENGL J MED, V349, P13; Lebwohl MG, 1998, J AM ACAD DERMATOL, V39, P590, DOI 10.1016/S0190-9622(98)70008-8; Leonardi CL, 2005, J AM ACAD DERMATOL, V52, P425, DOI 10.1016/j.jaad.2004.09.029; Leonardi CL, 2004, DERMATOL CLIN, V22, P427, DOI 10.1016/j.det.2004.03.015; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; LEVINE MJ, 1979, J INVEST DERMATOL, V73, P170, DOI 10.1111/1523-1747.ep12581626; Lowe NJ, 1996, J AM ACAD DERMATOL, V35, P710, DOI 10.1016/S0190-9622(96)90726-4; Mason J, 2002, BRIT J DERMATOL, V146, P351, DOI 10.1046/j.1365-2133.2000.04713.x; McGill A, 2005, FASEB J, V19, P1012, DOI 10.1096/fj.04-2664fje; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Menter A, 2005, ARCH DERMATOL, V141, P31, DOI 10.1001/archderm.141.1.31; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Miyachi Y, 2002, EUR J DERMATOL, V12, P463; Monastirli A, 2002, SKIN PHARMACOL APPL, V15, P246, DOI 10.1159/000065971; MOY RL, 1985, ARCH DERMATOL, V121, P1297, DOI 10.1001/archderm.121.10.1297; Mrowietz U, 1998, BRIT J DERMATOL, V138, P456; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Nast Alexander, 2006, J Dtsch Dermatol Ges, V4 Suppl 2, pS1, DOI 10.1111/j.1610-0387.2006.06172.x; *NIH CLIN EXC, ET EF TREATM AD PSOR; Ortonne JP, 2003, BRIT J DERMATOL, V148, P326, DOI 10.1046/j.1365-2133.2003.05228.x; Papp KA, 2003, J AM ACAD DERMATOL, V48, P48, DOI 10.1067/mjd.2003.130; PARRISH JA, 1981, J INVEST DERMATOL, V76, P359, DOI 10.1111/1523-1747.ep12520022; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; PITTELKOW MR, 1981, ARCH DERMATOL, V117, P465, DOI 10.1001/archderm.117.8.465; Queille-Roussel C, 2001, BRIT J DERMATOL, V144, P507, DOI 10.1046/j.1365-2133.2001.04076.x; Raddadi AA, 1999, BRIT J DERMATOL, V140, P1197; Raman GV, 1998, J HYPERTENS, V16, pS39; RAMSAY B, 1990, J AM ACAD DERMATOL, V23, P73, DOI 10.1016/0190-9622(90)70189-O; Ramsay CA, 2000, DERMATOLOGY, V200, P17, DOI 10.1159/000018309; RAMSAY CA, 1994, DERMATOLOGY, V189, P260, DOI 10.1159/000246851; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Reitamo S, 1998, J INVEST DERMATOL, V111, P396, DOI 10.1046/j.1523-1747.1998.00323.x; Richards HL, 2006, J EUR ACAD DERMATOL, V20, P370, DOI 10.1111/j.1468-3083.2006.01565.x; Ring J, 2001, BRIT J DERMATOL, V144, P495, DOI 10.1046/j.1365-2133.2001.04074.x; Roenigk HH, 1998, J AM ACAD DERMATOL, V38, P478, DOI 10.1016/S0190-9622(98)70508-0; Ruderisch HS, 2004, SKIN PHARMACOL PHYS, V17, P129, DOI 10.1159/000077239; Salim A, 2006, BRIT J DERMATOL, V154, P1169, DOI 10.1111/j.1365-2133.2006.07289.x; Sandhu K, 2003, J DERMATOL, V30, P458, DOI 10.1111/j.1346-8138.2003.tb00416.x; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Sarzi-Puttini P, 2002, RHEUMATOL INT, V21, P234, DOI 10.1007/s00296-001-0166-7; Scerri L, 1999, ADV EXP MED BIOL, V455, P343; Schrader P, 2002, Z RHEUMATOL, V61, P545, DOI 10.1007/s00393-002-0369-7; SCHWECKENDIEK W, 1959, Med Monatsschr, V13, P103; Smith CH, 2005, BRIT J DERMATOL, V153, P486, DOI 10.1111/j.1365-2133.2005.06893.x; SPEIGHT EL, 1994, BRIT J DERMATOL, V130, P79, DOI 10.1111/j.1365-2133.1994.tb06887.x; STERN RS, 1990, NEW ENGL J MED, V322, P1093, DOI 10.1056/NEJM199004193221601; Stern RS, 2001, J AM ACAD DERMATOL, V44, P755, DOI 10.1067/mjd.2001.114576; STERN RS, 1988, J INVEST DERMATOL, V91, P120, DOI 10.1111/1523-1747.ep12464137; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Stucker M, 2002, SKIN RES TECHNOL, V8, P133, DOI 10.1034/j.1600-0846.2002.00330.x; Swinkels OQJ, 2003, SKIN PHARMACOL APPL, V16, P12, DOI 10.1159/000068285; Swinkels OQJ, 2002, BRIT J DERMATOL, V146, P621, DOI 10.1046/j.1365-2133.2002.04698.x; Taibjee SM, 2005, BRIT J DERMATOL, V153, P960, DOI 10.1111/j.1365-2133.2005.06827.x; TANEW A, 1991, J AM ACAD DERMATOL, V25, P682, DOI 10.1016/0190-9622(91)70253-X; Tanghetti E A, 2000, Cutis, V66, P4; Torras H, 2004, J Dermatolog Treat, V15, P98, DOI 10.1080/09546630410023322; Treumer F, 2003, J INVEST DERMATOL, V121, P1383, DOI 10.1111/j.1523-1747.2003.12605.x; Turner RJ, 2000, BRIT J DERMATOL, V143, P957, DOI 10.1046/j.1365-2133.2000.03827.x; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Tzung TY, 2005, ACTA DERM-VENEREOL, V85, P236, DOI 10.1080/00015550510027405; Van de Kerkhof PCM, 1998, BRIT J DERMATOL, V138, P84; van de Kerkhof PCM, 2002, BRIT J DERMATOL, V146, P414, DOI 10.1046/j.1365-2133.2002.04567.x; Van Zander JoEllen, 2005, Expert Opin Drug Saf, V4, P129, DOI 10.1517/14740338.4.1.129; Volden G, 2001, J DERMATOL TREAT, V12, P141; Warren RB, 2005, BRIT J DERMATOL, V153, P869, DOI 10.1111/j.1365-2133.2005.06880.x; Weinstein GD, 1997, J AM ACAD DERMATOL, V37, P85, DOI 10.1016/S0190-9622(97)70216-0; Weinstein GD, 2003, J AM ACAD DERMATOL, V48, P760, DOI 10.1067/mjd.2003.103; WILSON DJ, 1988, BRIT J DERMATOL, V119, P597, DOI 10.1111/j.1365-2133.1988.tb03470.x; Winterfield L, 2004, DERMATOL CLIN, V22, P437, DOI 10.1016/j.det.2004.03.011; Woo WK, 2003, BRIT J DERMATOL, V149, P146, DOI 10.1046/j.1365-2133.2003.05380.x; Yamauchi PS, 2004, DERMATOL CLIN, V22, P449, DOI 10.1016/j.det.2003.12.002; Young HS, 2006, J INVEST DERMATOL, V126, P453, DOI 10.1038/sj.jid.5700096; Zachariae H, 1997, BRIT J DERMATOL, V136, P531, DOI 10.1046/j.1365-2133.1997.6101586.x; ZACKHEIM HS, 1994, J AM ACAD DERMATOL, V30, P452, DOI 10.1016/S0190-9622(94)70055-9; Zhou YW, 2003, J CUTAN MED SURG, V7, P193, DOI 10.1007/s10227-002-0113-6; Zonneveld IM, 1998, ARCH DERMATOL, V134, P1101, DOI 10.1001/archderm.134.9.1101	144	245	254	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					272	284		10.1016/S0140-6736(07)61129-5	http://dx.doi.org/10.1016/S0140-6736(07)61129-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658398				2022-12-28	WOS:000248347900032
J	Weatherhead, S; Robson, SC; Reynolds, NJ				Weatherhead, Sophie; Robson, Steven C.; Reynolds, Nick J.			Pregnancy plus - Eczema in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; 1ST TRIMESTER EXPOSURE; HERPES-SIMPLEX-VIRUS; ATOPIC-DERMATITIS; LIVER-TRANSPLANTATION; DOUBLE-BLIND; CORTICOSTEROIDS; AZATHIOPRINE; DERMATOSES; TACROLIMUS		Newcastle Univ, Sch Med, Inst Cellular Med, Uterine Cell Signalling Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Reynolds, NJ (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Uterine Cell Signalling Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	N.J.Reynolds@ncl.ac.uk	Weatherhead, Sophie/AAQ-3019-2021	Reynolds, Nick/0000-0002-6484-825X; Weatherhead, Sophie/0000-0002-8705-8867				Ambros-Rudolph CM, 2006, J AM ACAD DERMATOL, V54, P395, DOI 10.1016/j.jaad.2005.12.012; Armenti Vincent T, 2004, Clin Transpl, P103; Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014; Barankin B, 2004, J CUTAN MED SURG, V8, P126, DOI 10.1177/120347540400800209; Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Brown S, 2006, BMJ-BRIT MED J, V332, P584, DOI 10.1136/bmj.332.7541.584; Christopher V, 2006, LIVER TRANSPLANT, V12, P1138, DOI 10.1002/lt.20810; Czeizel AE, 1997, TERATOLOGY, V56, P335, DOI 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W; FITZSIMONS R, 1986, J ALLERGY CLIN IMMUN, V78, P349, DOI 10.1016/S0091-6749(86)80088-4; Gur C, 2004, REPROD TOXICOL, V18, P93, DOI 10.1016/j.reprotox.2003.10.007; Jain A, 1997, TRANSPLANTATION, V64, P559, DOI 10.1097/00007890-199708270-00002; Jain A, 2000, TRANSPLANTATION, V69, P172, DOI 10.1097/00007890-200001150-00029; Janssen NM, 2000, ARCH INTERN MED, V160, P610, DOI 10.1001/archinte.160.5.610; Jones SAV, 1999, BRIT J DERMATOL, V141, P71; KATZ VL, 1990, AM J OBSTET GYNECOL, V162, P396, DOI 10.1016/0002-9378(90)90394-M; KEMMETT D, 1991, BRIT J DERMATOL, V125, P59, DOI 10.1111/j.1365-2133.1991.tb06041.x; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub2; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Meggitt SJ, 2006, LANCET, V367, P839, DOI 10.1016/S0140-6736(06)68340-2; Millington GWM, 2006, CLIN EXP DERMATOL, V31, P681, DOI 10.1111/j.1365-2230.2006.02233.x; Montnemery Peter, 2003, BMC Dermatol, V3, P4, DOI 10.1186/1471-5945-3-4; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pradat P, 2003, BIRTH DEFECTS RES A, V67, P968, DOI 10.1002/bdra.10134; PRIMATESTA P, 2003, HLTH SURVEY ENGLAND; Reynolds NJ, 2001, LANCET, V357, P2012, DOI 10.1016/S0140-6736(00)05114-X; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; Sau A, 2007, BJOG-INT J OBSTET GY, V114, P498, DOI 10.1111/j.1471-0528.2006.01232.x; SOWDEN JM, 1991, LANCET, V338, P137, DOI 10.1016/0140-6736(91)90134-B; Tauscher AE, 2002, J CUTAN MED SURG, V6, P561, DOI 10.1007/s10227-001-0147-1; Tendron A, 2002, PEDIATR NEPHROL, V17, P121, DOI 10.1007/s00467-001-0776-z; Tyring SK, 2002, J INFECT DIS, V186, pS40, DOI 10.1086/342966; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P346, DOI 10.1111/j.1365-2133.2006.07686.x; Wollenberg A, 2000, ALLERGY, V55, P205, DOI 10.1034/j.1398-9995.2000.00115.x	35	27	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2007	335	7611					152	154		10.1136/bmj.39227.671227.AE	http://dx.doi.org/10.1136/bmj.39227.671227.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641349	Green Published			2022-12-28	WOS:000248428100037
J	Galizia, CG				Galizia, C. Giovanni			Brainwashing, honeybee style	SCIENCE			English	Editorial Material							BRAIN		Univ Konstanz, Dept Neurobiol, D-78457 Constance, Germany	University of Konstanz	Galizia, CG (corresponding author), Univ Konstanz, Dept Neurobiol, D-78457 Constance, Germany.	Galizia@uni-konstanz.de	Galizia, C Giovanni/A-1771-2009	Galizia, C Giovanni/0000-0001-8292-6031				Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Holldobler B., 1990, pi; Huxley A., 2007, BRAVE NEW WORLD; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288	8	2	3	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					326	327		10.1126/science.1144895	http://dx.doi.org/10.1126/science.1144895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641186	Green Submitted			2022-12-28	WOS:000248150200030
J	Manica, A; Amos, W; Balloux, F; Hanihara, T				Manica, Andrea; Amos, William; Balloux, Francois; Hanihara, Tsunehiko			The effect of ancient population bottlenecks on human phenotypic variation	NATURE			English	Article							MODERN HUMAN ORIGINS; AFRICA; DIVERSITY; MODEL; GEOGRAPHY	The origin and patterns of dispersal of anatomically modern humans are the focus of considerable debate(1-3). Global genetic analyses have argued for one single origin, placed somewhere in Africa(4-7). This scenario implies a rapid expansion, with a series of bottlenecks of small amplitude, which would have led to the observed smooth loss of genetic diversity with increasing distance from Africa. Analyses of cranial data, on the other hand, have given mixed results(8-12), and have been argued to support multiple origins of modern humans(2,9,12). Using a large data set of skull measurements and an analytical framework equivalent to that used for genetic data, we show that the loss in genetic diversity has been mirrored by a loss in phenotypic variability. We find evidence for an African origin, placed somewhere in the central/southern part of the continent, which harbours the highest intra-population diversity in phenotypic measurements. We failed to find evidence for a second origin, and we confirm these results on a large genetic data set. Distance from Africa accounts for an average 19-25% of heritable variation in craniometric measurements - a remarkably strong effect for phenotypic measurements known to be under selection.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Saga Med Sch, Dept Anat, Saga 8498501, Japan	University of Cambridge; University of Cambridge; Saga University	Manica, A (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	am315@cam.ac.uk	Balloux, Francois/D-4783-2009; Manica, Andrea/N-9013-2019; Manica, Andrea/B-5497-2008; Balloux, Francois/X-7856-2019	Balloux, Francois/0000-0003-1978-7715; Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Balloux, Francois/0000-0003-1978-7715	Biotechnology and Biological Sciences Research Council [BB/C007123/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Brauer G, 2004, ANAT REC PART A, V279A, P701, DOI 10.1002/ar.a.20064; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Carson EA, 2006, AM J PHYS ANTHROPOL, V131, P169, DOI 10.1002/ajpa.20424; Crawley MJ., 2002, STAT COMPUTING INTRO; Fowler K, 1999, EVOLUTION, V53, P1143, DOI [10.2307/2640818, 10.1111/j.1558-5646.1999.tb04528.x]; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; Hanihara T, 2001, J ANAT, V198, P137, DOI 10.1046/j.1469-7580.2001.19820137.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; LAHR MM, 1994, J HUM EVOL, V26, P23, DOI 10.1006/jhev.1994.1003; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Venables WN., 2002, MODERN APPL STAT S; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K	29	213	221	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					346	U6		10.1038/nature05951	http://dx.doi.org/10.1038/nature05951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637668	Green Accepted			2022-12-28	WOS:000248118300056
J	Foster, NE; Thomas, E; Barlas, P; Hil, JC; Young, J; Mason, E; Hay, EM				Foster, Nadine E.; Thomas, Elaine; Barlas, Panos; Hil, Jonathan C.; Young, Julie; Mason, Elizabeth; Hay, Elaine M.			Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; PLACEBO NEEDLE; HOME EXERCISE; OLDER-ADULTS; PAIN; THERAPY; RECOMMENDATIONS; HIP; PREVALENCE; MANAGEMENT	Objective To investigate the benefit of adding acupuncture to a course of advice and exercise delivered by physiotherapists for pain reduction in patients with osteoarthritis of the knee. Design Multicentre, randomised controlled trial. Setting 37 physiotherapy centres accepting primary care patients referred from general practitioners in the Midlands, United Kingdom. Participants 352 adults aged 50 or more with a clinical diagnosis of knee osteoarthritis. Interventions Advice and exercise (n=116), advice and exercise plus true acupuncture (n=117), and advice and exercise plus non-penetrating acupuncture (n=119). Main outcome measures The primary outcome was change in scores on the Western Ontario and McMaster Universities osteoarthritis index pain subscale at six months. Secondary outcomes included function, pain intensity, and unpleasantness of pain at two weeks, six weeks, six months, and 12 months. Results Follow-up rate at six months was 94%. The mean (SD) baseline pain score was 9.2 (3.8). At six months mean reductions in pain were 2.28 (3.8) for advice and exercise, 2.32 (1 for advice and exercise plus true acupuncture, and 2.53 (4.2) for advice and exercise plus non-penetrating acupuncture. Mean differences in change scores between advice and exercise alone and each acupuncture group were 0.08 (95% confidence interval -1.0 to 0.9) for advice and exercise plus true acupuncture and 0.25 (-0.8 to 1.3) for advice and exercise plus non-penetrating acupuncture. Similar nonsignificant differences were seen at other follow-up points. Compared with advice and exercise atone there were small, statistically significant improvements in pain intensity and unpleasantness at two and six weeks for true acupuncture and at all follow-up points for non-penetrating acupuncture. Conclusion The addition of acupuncture to a course of advice and exercise for osteoarthritis of the knee delivered by physiotherapists provided no additional improvement in pain scores. Small benefits in pain intensity and unpleasantness were observed in both acupuncture groups, making it unlikely that this was due to acupuncture needling effects.	Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England; Univ Keele, Sch Hlth & Rehabil, Keele ST5 5BG, Staffs, England	Keele University; Keele University	Foster, NE (corresponding author), Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England.	n.foster@keele.ac.uk	Barlas, Panos/AAF-9892-2021	Barlas, Panos/0000-0002-4734-4236; Foster, Nadine/0000-0003-4429-9756	National Institute for Health Research [PC6/CSA04/03] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ARTHR CAR, 2004, OST NAT COMPR UK REP; Bausell RB, 2005, EVAL HEALTH PROF, V28, P9, DOI 10.1177/0163278704273081; Bellamy N, 1996, WOMAC OSTEOARTHRITIS; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Campbell Anthony, 2006, Acupunct Med, V24, P118; Cibere J, 2005, ARTHRITIS RHEUM-US, V52, pS509; Derry CJ, 2006, CLIN MED, V6, P381, DOI 10.7861/clinmedicine.6-4-381; Duncan RC, 2006, RHEUMATOLOGY, V45, P757, DOI 10.1093/rheumatology/kei270; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; FOSTER NE, 1999, P CHART SOC PHYS C O, P27; FOSTER NE, 2000, RHEUMATOLOGY S1, V39, P166; Hay E, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-31; Hay EM, 2006, BRIT MED J, V333, P995, DOI 10.1136/BMJ.38977.590752.0B; House of Lords' Science and Technology Committee, 2000, 6 HOUS LORDS SCI TEC; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kleinhenz J, 1999, PAIN, V83, P235, DOI 10.1016/S0304-3959(99)00107-4; Lund Irene, 2006, Acupunct Med, V24, P13; NORMAN GR, 1994, BIOSTATISTICS BARE E, P160; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; *OFF NAT STAT, 2000, STAND OCC CLASS 2000, V2, P4; *OFF NAT STAT, 2002, NAT STAT SOC CLASS U, P4; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pham T, 2003, J RHEUMATOL, V30, P1648; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Roddy E, 2005, RHEUMATOLOGY, V44, P67, DOI 10.1093/rheumatology/keh399; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Smidt N, 2005, AUST J PHYSIOTHER, V51, P71, DOI 10.1016/S0004-9514(05)70036-2; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Thomas KJ, 2001, BRIT J GEN PRACT, V51, P25; Thomas KS, 2005, ARTHRIT RHEUM-ARTHR, V53, P388, DOI 10.1002/art.21173; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; Vickers A, 2000, BRIT MED J, V321, P683, DOI 10.1136/bmj.321.7262.683; VINCENT C, 1995, J ROY SOC MED, V88, P199; White A, 2007, RHEUMATOLOGY, V46, P384, DOI 10.1093/rheumatology/kel413; White AR, 2001, COMPLEMENT THER MED, V9, P237, DOI 10.1054/ctim.2001.0489; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2006, ARTHRITIS RHEUM-US, V54, P3485, DOI 10.1002/art.22154	44	125	137	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2007	335	7617					436	440B		10.1136/bmj.39280.509803.BE	http://dx.doi.org/10.1136/bmj.39280.509803.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208VF	17699546	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000249346600033
J	Canani, RB; Cirillo, P; Terrin, G; Cesarano, L; Spagnuolo, MI; De Vincenzo, A; Albano, F; Passariello, A; De Marco, G; Manguso, F; Guarino, A				Canani, Roberto Berni; Cirillo, Pia; Terrin, Gianluca; Cesarano, Luisa; Spagnuolo, Maria Immacolata; De Vincenzo, Anna; Albano, Fabio; Passariello, Annalisa; De Marco, Giulio; Manguso, Francesco; Guarino, Alfredo			Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSERTIVE COMMUNITY TREATMENT; INTENSIVE CASE-MANAGEMENT; SEVERE MENTAL-ILLNESS; SEVERE PSYCHOTIC ILLNESS; COST-EFFECTIVENESS; LACTOBACILLUS GG; HEALTH PROBLEMS; HOME TREATMENT; DOUBLE-BLIND; CARE	Objective To compare the efficacy of five probiotic preparations recommended to parents in the treatment of acute diarrhoea in children. Design Randomised controlled clinical trial in collaboration with family paediatricians over 12 months. Setting Primary care. Participants Children aged 3-36 months visiting a family paediatrician for acute diarrhoea. Intervention Children's parents were randomly assigned to receive written instructions to purchase a specific probiotic product: oral rehydration solution (control group); Lactobacillus rhamnosus strain GG; Saccharomyces boulardii; Bacillus clausii; mix of L delbrueckii var bulgaricus, Streptococcus thermophilus, L acidophilus, and Bificlobacterium bifidum; or Enterococcus faecium SF68. Main outcome measures Primary outcomes were duration of diarrhoea and daily number and consistency of stools. Secondary outcomes were duration of vomiting and fever and rate of admission to hospital. Safety and tolerance were also recorded. Results 571 children were allocated to intervention. Median duration of diarrhoea was significantly shorter (P<0.001) in children who received L rhamnosus strain GG (78.5 hours) and the mix of four bacterial strains (70.0 hours) than in children who received oral rehydration solution alone (115.0 hours). One day after the first probiotic administration, the daily number of stools was significantly tower (P(O.001) in children who received L rhamnosus strain GG and in thosewho received the probiotic mix than in the other groups. The remaining preparations did not affect primary outcomes. Secondary outcomes were similar in all groups. Conclusions Not all commercially available probiotic preparations are effective in children with acute in L of diarrhoea. Paediatricians should choose bacterial preparations based on effectiveness data. Trial registration number Current Controlled Trials ISRCTN56067537.	Univ Naples Federico II, Dept Paediat, Naples, Italy; Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Guarino, A (corresponding author), Univ Naples Federico II, Dept Paediat, Naples, Italy.	alfguari@unina.it	Passariello, Annalisa/N-5130-2015; Guarino, Alfredo/AAC-4812-2022; Spagnuolo, Maria Immacolata/W-6752-2019; Canani, Roberto Berni/AAC-4810-2022	Passariello, Annalisa/0000-0003-4638-0996; Guarino, Alfredo/0000-0003-0199-0336; Spagnuolo, Maria Immacolata/0000-0001-5396-4944; Canani, Roberto Berni/0000-0002-5169-9574; Terrin, Gianluca/0000-0003-3541-2876				Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Allen S.J., 2004, COCHRANE DB SYST REV, pCD003048, DOI [10.1002/14651858.CD003048.pub2, DOI 10.1002/14651858.CD003048]; AUDINI B, 1994, BRIT J PSYCHIAT, V165, P204, DOI 10.1192/bjp.165.2.204; BELLOMO G, 1980, CURR THER RES CLIN E, V28, P927; Bjorkman T, 2002, SOC PSYCH PSYCH EPID, V37, P147, DOI 10.1007/s001270200008; Bond GR, 2001, DIS MANAG HEALTH OUT, V9, P141, DOI 10.2165/00115677-200109030-00003; BOND GR, 1990, AM J COMMUN PSYCHOL, V18, P865, DOI 10.1007/BF00938068; BOND GR, 1988, HOSP COMMUNITY PSYCH, V39, P411; Burns T, 1999, LANCET, V353, P2185, DOI 10.1016/S0140-6736(98)12191-8; Burns T, 2001, Health Technol Assess, V5, P1; Burns T, 2002, BRIT J PSYCHIAT, V181, P375, DOI 10.1192/bjp.181.5.375; Burns T, 2001, PSYCHIATR SERV, V52, P631, DOI 10.1176/appi.ps.52.5.631; Burns T, 2000, BRIT J PSYCHIAT, V177, P427, DOI 10.1017/S0007125000227359; BUSH CT, 1990, HOSP COMMUNITY PSYCH, V41, P647; Caprioli A, 1996, PEDIATR INFECT DIS J, V15, P876, DOI 10.1097/00006454-199610000-00009; Catty J, 2002, PSYCHOL MED, V32, P383, DOI 10.1017/S0033291702005299; Chandler D, 1996, PSYCHIATR SERV, V47, P175; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; CURTIS JL, 1992, HOSP COMMUNITY PSYCH, V43, P895; Davidson GP, 2000, CURR OPIN PEDIATR, V12, P477, DOI 10.1097/00008480-200010000-00010; Department of Health, 1999, NAT SERV FRAM MENT H; Drago L, 2004, J CHEMOTHERAPY, V16, P463; Drake RE, 1998, AM J ORTHOPSYCHIAT, V68, P201, DOI 10.1037/h0080330; Elmer GW, 1996, JAMA-J AM MED ASSOC, V275, P870, DOI 10.1001/jama.275.11.870; Essock SM, 1998, AM J ORTHOPSYCHIAT, V68, P179, DOI 10.1037/h0080328; Farthing MJG, 2000, J GASTROEN HEPATOL, V15, pG38, DOI 10.1046/j.1440-1746.2000.02264.x; Fekete DM, 1998, PSYCHIATR REHABIL J, V21, P371, DOI 10.1037/h0095286; Fontana M, 2004, DIGEST LIVER DIS, V36, P523, DOI 10.1016/j.dld.2004.03.012; Ford R, 1997, J MENT HEALTH, V6, P181; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P486, DOI 10.1097/00005176-200005000-00004; GUARINO A, 1994, PEDIATRICS, V93, P12; Guarino A, 1997, J PEDIATR GASTR NUTR, V25, P516, DOI 10.1097/00005176-199711000-00005; Guarino A, 2001, ACTA PAEDIATR, V90, P1087, DOI 10.1080/080352501317061413; HAMPTON B, 1992, INTEGRATION SERVICES; Harrison-Read P, 2002, PSYCHOL MED, V32, P403, DOI 10.1017/S0033291702005305; HIGGINS JPT, 2005, SELECTION BIAS COCHR; Holloway F, 1991, Int J Soc Psychiatry, V37, P2, DOI 10.1177/002076409103700102; Holloway F, 1998, BRIT J PSYCHIAT, V172, P19, DOI 10.1192/bjp.172.1.19; Hu TW, 1998, BRIT J PSYCHIAT, V173, P26, DOI 10.1192/S0007125000298024; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Isolauri E, 2003, GUT, V52, P436, DOI 10.1136/gut.52.3.436; Johnston S, 1998, AUST NZ J PSYCHIAT, V32, P551, DOI 10.1046/j.1440-1614.1998.00439.x; Killaspy H, 2006, BMJ-BRIT MED J, V332, P815, DOI 10.1136/bmj.38773.518322.7C; Kuipers E, 2004, SOC PSYCH PSYCH EPID, V39, P358, DOI 10.1007/s00127-004-0754-4; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Lehman AF, 1999, BRIT J PSYCHIAT, V174, P346, DOI 10.1192/bjp.174.4.346; MAJAMAA H, 1995, J PEDIATR GASTR NUTR, V20, P333, DOI 10.1097/00005176-199504000-00012; MARSHALL M, 1995, LANCET, V345, P409, DOI 10.1016/S0140-6736(95)90399-2; Marshall M, 2000, INT REV PSYCHIATR, V12, P191, DOI 10.1080/713673750; Marshall M, 1998, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000050, DOI 10.1002/14651858.CD000050]; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; McGovern D, 1999, LANCET, V354, P1384, DOI 10.1016/S0140-6736(05)76235-8; MCGREW JH, 1994, J CONSULT CLIN PSYCH, V62, P670, DOI 10.1037/0022-006X.62.4.670; MITRA AK, 1990, GASTROENTEROLOGY, V99, P1149, DOI 10.1016/0016-5085(90)90638-H; MUIJEN M, 1994, BRIT J PSYCHIAT, V165, P211, DOI 10.1192/bjp.165.2.211; MULLERCLEMM WJ, 1996, THESIS U VICTORIA; *NASHMPD RES I, 1997, COMMUNITY SUPPORT NE, V11, P3; Oberhelman RA, 1999, J PEDIATR-US, V134, P15, DOI 10.1016/S0022-3476(99)70366-5; Petersen L, 2005, BMJ-BRIT MED J, V331, P602, DOI 10.1136/bmj.38565.415000.E01; QUINLIVAN R, 1995, PSYCHIATR SERV, V46, P365; RABEHESKETH S, 2001, GLLAMM MANUAL TECHNI; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; ROSENHECK R, 1995, SCHIZOPHRENIA BULL, V21, P129, DOI 10.1093/schbul/21.1.129; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; Salkever D, 1999, HEALTH SERV RES, V34, P577; Saxelin M, 1997, FOOD REV INT, V13, P293, DOI 10.1080/87559129709541107; Szajewska H, 2000, J PEDIATR GASTR NUTR, V30, P522, DOI 10.1097/00005176-200005000-00011; Szajewska H, 2006, J PEDIATR GASTR NUTR, V42, P454, DOI 10.1097/01.mpg.0000221913.88511.72; TANKANOW RM, 1990, DICP ANN PHARMAC, V24, P382, DOI 10.1177/106002809002400408; TEST MA, 1991, ADV NEUROPSYCHIATRY, V1, P239; TYRER P, 1995, LANCET, V345, P756, DOI 10.1016/S0140-6736(95)90640-1; Tyrer P, 1998, BRIT J PSYCHIAT, V173, P359, DOI 10.1192/bjp.173.5.359; Tyrer P, 2000, BRIT J PSYCHIAT, V176, P492, DOI 10.1192/bjp.176.5.492; Tyrer P, 2000, BRIT J PSYCHIAT, V177, P386, DOI 10.1192/bjp.177.5.386; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; WALKERSMITH JA, 1992, J PEDIATR GASTR NUTR, V14, P113, DOI 10.1097/00005176-199201000-00023; WalkerSmith JA, 1997, J PEDIATR GASTR NUTR, V24, P619, DOI 10.1097/00005176-199705000-00024; Wright D, 2004, J COMMONW LIT, V39, P7, DOI 10.1177/0021989404044733; Young J, 1998, BRIT J NUTR, V80, pS231, DOI 10.1017/S0007114500006085; Zimmerman CM, 2001, PEDIATR INFECT DIS J, V20, P14, DOI 10.1097/00006454-200101000-00004	81	201	212	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2007	335	7615					340	+		10.1136/bmj.39272.581736.55	http://dx.doi.org/10.1136/bmj.39272.581736.55			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205LS	17690340	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000249115900029
J	Hubl, D; Hauf, M; van Swam, C; Muri, R; Dierks, T; Strik, W				Hubl, Daniela; Hauf, Martinus; van Swam, Claudia; Mueri, Rene; Dierks, Thomas; Strik, Werner			Hearing dysphasic voices	LANCET			English	Editorial Material							AUDITORY HALLUCINATIONS; DRUGS		Univ Hosp Psychiat Bern, Dept Psychiat Neurophysiol, CH-3000 Bern 60, Switzerland; Univ Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; Univ Bern, Inselspital, Dept Neurol, Div Neuropsychol Rehabil, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hubl, D (corresponding author), Univ Hosp Psychiat Bern, Dept Psychiat Neurophysiol, Bolligenstr 111, CH-3000 Bern 60, Switzerland.	hubl@puk.unibe.ch	Strik, Werner Konrad/N-7807-2013; Dierks, Thomas/B-7092-2012; Müri, René M/E-9320-2012	Strik, Werner Konrad/0000-0001-7108-1993; Dierks, Thomas/0000-0002-4173-5308; Müri, René M/0000-0001-6990-4188				Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; FRITH CD, 1992, COGBNITIVE NEUROPSYC; Nicolson SE, 2006, AM J PSYCHIAT, V163, P1153, DOI 10.1176/appi.ajp.163.7.1153; Pisani F, 2002, DRUG SAFETY, V25, P91, DOI 10.2165/00002018-200225020-00004	4	8	8	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					538	538		10.1016/S0140-6736(07)61237-9	http://dx.doi.org/10.1016/S0140-6736(07)61237-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693183				2022-12-28	WOS:000248717800033
J	Mant, J; Hobbs, FDR; Fletcher, K; Roalfe, A; Fitzmaurice, D; Lip, GYH; Murray, E				Mant, Jonathan; Hobbs, F. D. Richard; Fletcher, Kate; Roalfe, Andrea; Fitzmaurice, David; Lip, Gregory Y. H.; Murray, Ellen		BAFTA	Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial	LANCET			English	Article							PRIMARY-CARE; BLEEDING COMPLICATIONS; ORAL ANTICOAGULATION; RISK; INTENSITY; PEOPLE; XIMELAGATRAN	Background Anticoagulants are more effective than antiplatelet agents at reducing stroke risk in patients with atrial fibrillation, but whether this benefit outweighs the increased risk of bleeding in elderly patients is unknown. We assessed whether warfarin reduced risk of major stroke, arterial embolism, or other intracranial haemorrhage compared with aspirin in elderly patients. Methods 973 patients aged 75 years or over (mean age 81.5 years, SD 4.2) with atrial fibrillation were recruited from primary care and randomly assigned to warfarin (target international normalised. ratio 2-3) or aspirin (75 mg per day). Follow-up was for a mean of 2.7 years (SD 1.2). The primary endpoint was fatal or disabling stroke (ischaemic or haemorrhagic), intracranial haemorrhage, or clinically significant arterial embolism. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN89345269. Findings There were 24 primary events (21 strokes, two other intracranial haemorrhages, and one systemic embolus) in people assigned to warfarin and 48 primary events (44 strokes, one other intracranial haemorrhage, and three systemic emboli) in people assigned to aspirin (yearly risk 1.8% vs 3.8%, relative risk 0.48, 95% CI 0.28-0-80, p=0.003; absolute yearly risk reduction 2%, 95% CI 0.7-3.2). Yearly risk of extracranial haemorrhage was 1.4% (warfarin) versus 1.6% (aspirin) (relative risk 0.87, 0.43-1.73; absolute risk reduction 0.2%, -0.7 to 1.2). Interpretation These data support the use of anticoagulation therapy for people aged over 75 who have atrial fibrillation, unless there are contraindications or the patient decides that the benefits are not worth the inconvenience.	Univ Birmingham, Birmingham B15 2TT, W Midlands, England; City Hosp, Univ Dept Med, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Mant, J (corresponding author), Univ Birmingham, Primary Care Clin Sci Bldg, Birmingham B15 2TT, W Midlands, England.	j.w.mant@bham.ac.uk		hobbs, richard/0000-0001-7976-7172; Mant, Jonathan/0000-0002-9531-0268	MRC [G9900264] Funding Source: UKRI; Medical Research Council [G9900264] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AGILAR MI, 2005, COCHRANE DB SYST REV, V4; AGUILAR MI, 2005, COCHRANE DB SYST REV, V2; Albers GW, 2003, LANCET, V362, P1691; Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Blackshear JL, 1996, LANCET, V348, P633; Burton C, 2006, BRIT J GEN PRACT, V56, P697; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Douketis JD, 2006, ARCH INTERN MED, V166, P853, DOI 10.1001/archinte.166.8.853; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Fleiss JL., 2003, STAT METHODS RATES P; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia-Honrubia A, 2006, INT J CARDIOL, V110, P271, DOI 10.1016/j.ijcard.2005.09.034; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; Haemostasis and Thrombosis Task Force, 1998, BRIT J HAEMATOL, V101, P374; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Hurley V, 2007, INT J CARDIOL, V117, P152, DOI 10.1016/j.ijcard.2006.04.061; Hylek EM, 2006, STROKE, V37, P1075, DOI 10.1161/01.STR.0000209239.71702.ce; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lip GYH, 2006, THROMB RES, V118, P321, DOI 10.1016/j.thromres.2005.08.007; Mant J, 2006, BMJ-BRIT MED J, V332, P635, DOI 10.1136/bmj.38758.600116.AE; Mant J, 2000, BMJ-BRIT MED J, V320, P1009; Mant J, 2004, HLTH CARE NEEDS ASSE, P141; Mant JWF, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-9; Marine JE, 1998, CHEST, V113, P1115, DOI 10.1378/chest.113.4.1115; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Meade TW, 1998, LANCET, V351, P233; Morgan SV, 2004, AGE AGEING, V33, P544, DOI 10.1093/ageing/afh211; *NAT COLL CTR CHRO, 2006, 36 NICE CLIN GUID; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PETERSEN P, 1989, LANCET, V1, P175; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Rash A, 2007, AGE AGEING, V36, P151, DOI 10.1093/ageing/afl129; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Simpson CR, 2005, STROKE, V36, P1771, DOI 10.1161/01.STR.0000173398.99163.9e; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	46	1165	1236	0	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					493	503		10.1016/S0140-6736(07)61233-1	http://dx.doi.org/10.1016/S0140-6736(07)61233-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693178				2022-12-28	WOS:000248717800028
J	Townshend, J; Hails, S; Mckean, M				Townshend, J.; Hails, S.; Mckean, M.			Management of asthma in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE INHALED FLUTICASONE; ACTING BETA(2) AGONISTS; ORAL PREDNISOLONE; DIFFICULT ASTHMA; ADRENAL CRISIS; CORTICOSTEROIDS; INFANTS; BUDESONIDE; CHILDHOOD		Royal Victoria Infirm, Paediat Resp Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Mckean, M (corresponding author), Royal Victoria Infirm, Paediat Resp Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	m.c.mckean@ncl.ac.uk						Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Bisgaard H, 2006, LANCET, V367, P286, DOI 10.1016/S0140-6736(06)68051-3; Bisgaard H, 2000, PEDIATR PULM, V29, P221, DOI 10.1002/(SICI)1099-0496(200003)29:3<221::AID-PPUL11>3.3.CO;2-G; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2003, PEDIATR PULM, V36, P391, DOI 10.1002/ppul.10381; *BRIT THOR SOC SCO, 2005, BRIT GUID MAN ASTHM; Chavasse R, 2002, COCHRANE DATABASE SY; Csonka P, 2003, J PEDIATR-US, V143, P725, DOI 10.1067/S0022-3476(03)00498-0; Dewar AL, 1999, ARCH DIS CHILD, V80, P421, DOI 10.1136/adc.80.5.421; Drake AJ, 2002, BMJ-BRIT MED J, V324, P1081, DOI 10.1136/bmj.324.7345.1081; Everard ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001279.pub2; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Masoli M, 2004, ARCH DIS CHILD, V89, P902, DOI 10.1136/adc.2003.035709; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; McKenzie SA, 2003, ARCH DIS CHILD, V88, P168, DOI 10.1136/adc.88.2.168; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; *NAT I CLIN EXC, 2002, INH DEV ROUT TREATM; *NAT I CLIN EXC, 2000, GUID US INH SYST DEV; O'Callaghan C, 2000, BRIT MED J, V320, P664, DOI 10.1136/bmj.320.7236.664; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar JR, 2006, PAEDIATR RESPIR REV, V7, P293, DOI 10.1016/j.prrv.2006.04.010; Payne DNR, 2001, J ASTHMA, V38, P189, DOI 10.1081/JAS-100000106; Payne Donald, 2004, Paediatr Respir Rev, V5, P116, DOI 10.1016/j.prrv.2004.01.006; Russell G, 2006, ARCH DIS CHILD, V91, P802, DOI 10.1136/adc.2006.098616; Russell G, 2004, ARCH DIS CHILD, V89, P893, DOI 10.1136/adc.2004.049577; Russell G, 2002, ARCH DIS CHILD, V87, P455, DOI 10.1136/adc.87.6.455; SHYAM R, 2007, ARCH DIS CHILD, V92, pA1; Skoner DP, 2000, J ALLERGY CLIN IMMUN, V105, P259, DOI 10.1016/S0091-6749(00)90074-5; SKUNK RC, 2006, NEW ENGL J MED, V354, P2689; Todd G, 2007, ARCH DIS CHILD, V92, P372; Todd GRG, 2002, ARCH DIS CHILD, V87, P457, DOI 10.1136/adc.87.6.457; Townshend J, 2007, BRIT MED J, V335, P198, DOI 10.1136/bmj.39234.651412.AE	33	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2007	335	7613					253	257		10.1136/bmj.39255.692222.AE	http://dx.doi.org/10.1136/bmj.39255.692222.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201QC	17673768	Green Published			2022-12-28	WOS:000248846700030
J	McCormick, S				McCormick, Sheila			Plant science - Reproductive dialog	SCIENCE			English	Editorial Material							SYNERGID CELL; ARABIDOPSIS; RECEPTOR		Univ Calif Berkeley, USDA, Ctr Plant Gene Express, ARS, Albany, CA 94710 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley	McCormick, S (corresponding author), Univ Calif Berkeley, USDA, Ctr Plant Gene Express, ARS, 800 Buchanan St, Albany, CA 94710 USA.	ssm@astro.umd.edu						Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Nasrallah ME, 2000, PLANT PHYSIOL, V124, P1605, DOI 10.1104/pp.124.4.1605; Palanivelu R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-7; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5	13	14	14	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					606	607		10.1126/science.1146655	http://dx.doi.org/10.1126/science.1146655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673644				2022-12-28	WOS:000248494400025
J	Laurance, W; Luizao, R				Laurance, William; Luizao, Regina			Driving a wedge into the Amazon	NATURE			English	Editorial Material							FOREST FRAGMENTS; DEFORESTATION; DECAY		Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Natl Inst Amazonian Res, Dept Ecol, BR-69011970 Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia	Laurance, W (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.		Laurance, William F/B-2709-2012	Laurance, William F/0000-0003-4430-9408				AYRES JM, 1997, ABORDAGENS INOVADORA; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Lovejoy T.E., 1986, P257; Pimm SL, 1998, NATURE, V393, P23, DOI 10.1038/29892; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397	9	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					409	410		10.1038/448409a	http://dx.doi.org/10.1038/448409a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653170				2022-12-28	WOS:000248302700024
J	Rowe, D				Rowe, Debra			Sustainability - Education for a sustainable future	SCIENCE			English	Editorial Material									US Partnership Educ Sustainable Dev, Washington, DC 20037 USA		Rowe, D (corresponding author), US Partnership Educ Sustainable Dev, Washington, DC 20037 USA.	dgrowe@oaklandcc.edu						CORTESE A, 2007, HIGH ED ASS SUST CON	1	115	117	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					323	324		10.1126/science.1143552	http://dx.doi.org/10.1126/science.1143552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191RR	17641184				2022-12-28	WOS:000248150200028
J	Stern-Ginossar, N; Elefant, N; Zimmermann, A; Wolf, DG; Saleh, N; Biton, M; Horwitz, E; Prokocimer, Z; Prichard, M; Hahn, G; Goldman-Wohl, D; Greenfield, C; Yagel, S; Hengel, H; Altuvia, Y; Margalit, H; Mandelboim, O				Stern-Ginossar, Noam; Elefant, Naama; Zimmermann, Albert; Wolf, Dana G.; Saleh, Nivin; Biton, Moshe; Horwitz, Elad; Prokocimer, Zafnat; Prichard, Mark; Hahn, Gabriele; Goldman-Wohl, Debra; Greenfield, Caryn; Yagel, Simcha; Hengel, Hartmut; Altuvia, Yael; Margalit, Hanah; Mandelboim, Ofer			Host immune system gene targeting by a viral miRNA	SCIENCE			English	Article							GLYCOPROTEIN UL16; T-CELLS; MICRORNAS; NKG2D; CYTOMEGALOVIRUSES; IDENTIFICATION; CYTOTOXICITY; STRATEGIES; RECEPTOR	Virally encoded microRNAs (miRNAs) have recently been discovered in herpesviruses. However, their biological roles are mostly unknown. We developed an algorithm for the prediction of miRNA targets and applied it to human cytomegalovirus miRNAs, resulting in the identification of the major histocompatibility complex class I-related chain B (MICB) gene as a top candidate target of hcmv-miR-UL112. MICB is a stress-induced ligand of the natural killer (NK) cell activating receptor NKG2D and is critical for the NK cell killing of virus-infected cells and tumor cells. We show that hcmv-miR-UL112 specifically down-regulates MICB expression during viral infection, leading to decreased binding of NKG2D and reduced killing by NK cells. Our results reveal a miRNA-based immunoevasion mechanism that appears to be exploited by human cytomegalovirus.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel; Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; Hadassah Univ Hosp, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel; Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Max Von Pettenkofer Inst, Dept Virol, D-80336 Munich, Germany; Hadassah Hebrew Univ, Hosp Mt Scopus, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Heinrich Heine University Dusseldorf; Hebrew University of Jerusalem; University of Alabama System; University of Alabama Birmingham; University of Munich; Hebrew University of Jerusalem; Hadassah University Medical Center	Altuvia, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, Jerusalem, Israel.	yaelal@md.huji.ac.il; hanahm@ekmd.huji.ac.il; oferm@ekmd.huji.ac.il	Margalit, Hanah/H-1651-2013	Prichard, Mark/0000-0002-2720-6661; Mandelboim, Ofer/0000-0002-9354-1855; Biton, Moshe/0000-0001-8330-1674	NIAID NIH HHS [N01 AI30049] Funding Source: Medline; PHS HHS [N01-30049] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012	18	503	582	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					376	381		10.1126/science.1140956	http://dx.doi.org/10.1126/science.1140956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641203	Green Accepted			2022-12-28	WOS:000248150200048
J	Meier, MF; Dyurgerov, MB; Rick, UK; O'Neel, S; Pfeffer, WT; Anderson, RS; Anderson, SP; Glazovsky, AF				Meier, Mark F.; Dyurgerov, Mark B.; Rick, Ursula K.; O'Neel, Shad; Pfeffer, W. Tad; Anderson, Robert S.; Anderson, Suzanne P.; Glazovsky, Andrey F.			Glaciers dominate Eustatic sea-level rise in the 21st century	SCIENCE			English	Article								Ice loss to the sea currently accounts for virtually all of the sea-level rise that is not to ocean warming, and about 60% of the ice loss is from glaciers and ice caps rather than from two ice sheets. The contribution of these smaller glaciers has accelerated over the past decade, in part due to marked thinning and retreat of marine-terminating glaciers associated with a dynamic instability that is generally not considered in mass-balance and climate modeling. This acceleration of glacier melt may cause 0.1 to 0.25 meter of additional sea-level rise by 2100.	Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Stockholm Univ, Dept Phys Geog & Quaternary Geol, SE-1061 Stockholm, Sweden; Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; Univ Colorado, Dept Geog, Boulder, CO 80309 USA; Russian Acad Sci, Inst Geog, Moscow 119107, Russia	University of Colorado System; University of Colorado Boulder; Stockholm University; University of Colorado System; University of Colorado Boulder; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences	Meier, MF (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, UCB 450, Boulder, CO 80309 USA.	mark.meier@colorado.edu	Glazovsky, Andrey/G-9060-2011; Anderson, Suzanne/F-4039-2014; Jiao, Liqing/A-8821-2011	Glazovsky, Andrey/0000-0001-6275-7517; Anderson, Suzanne/0000-0002-6796-6649; Anderson, Robert/0000-0003-2759-4833				Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Bahr DB, 1997, WATER RESOUR RES, V33, P1669, DOI 10.1029/97WR00824; Bahr DB, 2000, WATER RESOUR RES, V36, P495, DOI 10.1029/1999WR900319; Burgess DO, 2005, J GLACIOL, V51, P219, DOI 10.3189/172756505781829430; Dyurgerov M., 2005, GLACIERS CHANGING EA; GLAZOVSKY AF, 2006, GLACIATION N CENTRAL; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; IPCC, 2007, PHYS SCI BAS INT PAN; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Meier MF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023319; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; MEIER MF, 1980, 80582 US GEOL SURV, P1; O'Neel S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2005JF000292; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Raper SCB, 2006, NATURE, V439, P311, DOI 10.1038/nature04448; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; *US GEOL SURV, 1982, 1258H US GEOL SURV; *US GEOL SURV, 1982, 1258A US GEOL SURV	19	445	461	5	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1064	1067		10.1126/science.1143906	http://dx.doi.org/10.1126/science.1143906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17641167				2022-12-28	WOS:000248946700039
J	Church, JA				Church, John A.			A change in circulation?	SCIENCE			English	Editorial Material							MERIDIONAL OVERTURNING CIRCULATION; ATLANTIC; MOC		CSIRO, Marine & Atmospher Res & Antarctic Climate & Ecos, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Church, JA (corresponding author), CSIRO, Marine & Atmospher Res & Antarctic Climate & Ecos, GPO Box 1538, Hobart, Tas 7001, Australia.	john.church@csiro.au	Church, John A/A-1541-2012	Church, John A/0000-0002-7037-8194				Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; Drijfhout SS, 2007, J CLIMATE, V20, P1571, DOI 10.1175/JCLI4104.1; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Kanzow T, 2007, SCIENCE, V317, P938, DOI 10.1126/science.1141293; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Rintoul SR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028550; Solomon S., 2007, PHYS SCI BASIS WORKI	9	11	12	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					908	909		10.1126/science.1147796	http://dx.doi.org/10.1126/science.1147796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702934				2022-12-28	WOS:000248780200028
J	Bhat, MH; Molinero, V; Soignard, E; Solomon, VC; Sastry, S; Yarger, JL; Angell, CA				Bhat, M. H.; Molinero, V.; Soignard, E.; Solomon, V. C.; Sastry, S.; Yarger, J. L.; Angell, C. A.			Vitrification of a monatomic metallic liquid	NATURE			English	Article							MOLECULAR-DYNAMICS; NEUTRON-DIFFRACTION; AMORPHOUS-GERMANIUM; HIGH-PRESSURE; ALLOYS; TRANSITION; MELT; DENSITY; SILICON; PHASES	Although the majority of glasses in use in technology are complex mixtures of oxides or chalcogenides, there are numerous examples of pure substances - 'glassformers' - that also fail to crystallize during cooling. Most glassformers are organic molecular systems, but there are important inorganic examples too(1,2), such as silicon dioxide and elemental selenium ( the latter being polymeric). Bulk metallic glasses can now be made(3); but, with the exception of Zr50Cu50 ( ref. 4), they require multiple components to avoid crystallization during normal liquid cooling. Two-component 'metglasses' can often be achieved by hyperquenching, but this has not hitherto been achieved with a single- component system. Glasses form when crystal nucleation rates are slow, although the factors that create the slow nucleation conditions are not well understood. Here we apply the insights gained in a recent molecular dynamics simulation study(5) to create conditions for successful vitrification of metallic liquid germanium. Our results also provide micrographic evidence for a rare polyamorphic transition preceding crystallization of the diamond cubic phase.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Arizona State University; Arizona State University-Tempe; Utah System of Higher Education; University of Utah; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Angell, CA (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	caa@asu.edu	Yarger, Jeffery L/L-8748-2014; Sastry, Srikanth/F-7232-2014	Yarger, Jeffery L/0000-0002-7385-5400; Sastry, Srikanth/0000-0001-7399-1835; Solomon, C. Virgil/0000-0003-2990-855X				AASLAND S, 1994, NATURE, V369, P633, DOI 10.1038/369633a0; Angell CA, 1996, J NON-CRYST SOLIDS, V207, P463, DOI 10.1016/S0022-3093(96)00261-X; ANKELE J, 1995, J NON-CRYST SOLIDS, V193, P679, DOI 10.1016/0022-3093(95)00423-8; Aptekar' L. I., 1979, Soviet Physics - Doklady, V24, P993; Benmore CJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.132201; BRAZHKIN VV, 1989, PHYS SCRIPTA, V39, P338, DOI 10.1088/0031-8949/39/3/012; BRAZHKIN VV, 1995, PHYS REV B, V51, P7549, DOI 10.1103/PhysRevB.51.7549; Chathoth SM, 2004, APPL PHYS LETT, V85, P4881, DOI 10.1063/1.1825617; COHEN MH, 1961, NATURE, V189, P131, DOI 10.1038/189131b0; ETHERINGTON G, 1982, J NON-CRYST SOLIDS, V48, P265, DOI 10.1016/0022-3093(82)90165-X; GRABOW MH, 1988, SURF SCI, V194, P333, DOI 10.1016/0039-6028(88)90858-8; Johnson WL, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400053252; Koga J, 2004, J PHYS SOC JPN, V73, P388, DOI 10.1143/JPSJ.73.388; Kurita R, 2004, SCIENCE, V306, P845, DOI 10.1126/science.1103073; Leamy H.J., 1979, LASER SOLID INTERACT, P73; Li D, 1997, J MATER SCI, V32, P1437, DOI 10.1023/A:1018593615171; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; MISHIMA O, 1994, J CHEM PHYS, V100, P5910, DOI 10.1063/1.467103; Molinero V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075701; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Ponyatovsky EG, 2003, J PHYS-CONDENS MAT, V15, P6123, DOI 10.1088/0953-8984/15/36/304; PRIVALKO Y, 1980, J PHYS CHEM-US, V84, P3307; REZ D, 1994, ACTA CRYSTALLOGR A, V50, P481, DOI 10.1107/S0108767393013200; SALMON PS, 1988, J PHYS F MET PHYS, V18, P2345, DOI 10.1088/0305-4608/18/11/007; Sastry S, 2003, NAT MATER, V2, P739, DOI 10.1038/nmat994; Schnyders HS, 1996, J PHYS-CONDENS MAT, V8, P10875, DOI 10.1088/0953-8984/8/50/013; Stanley HE, 2000, PHYS CHEM CHEM PHYS, V2, P1551, DOI 10.1039/b000058m; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; Tanaka H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064202; van Ketel W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.135703; Voronin GA, 2003, J PHYS CHEM SOLIDS, V64, P2113, DOI 10.1016/S0022-3697(03)00278-6; WACHTEL E, 1991, MAT SCI ENG A-STRUCT, V133, P196, DOI 10.1016/0921-5093(91)90048-R; Wang WH, 2005, J MATER RES, V20, P2307, DOI 10.1557/JMR.2005.0302; Yu WB, 1997, PHYS REV B, V56, P12243, DOI 10.1103/PhysRevB.56.12243; ZHANG FX, 1995, APPL PHYS LETT, V67, P617, DOI 10.1063/1.115407	35	180	182	4	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					787	U3		10.1038/nature06044	http://dx.doi.org/10.1038/nature06044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700696				2022-12-28	WOS:000248754200035
J	Kruglyak, L; Stern, DL				Kruglyak, Leonid; Stern, David L.			Evolution - An embarrassment of switches	SCIENCE			English	Editorial Material							FACTOR-BINDING SITES; HUMAN GENOME		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu; dstern@princeton.edu		Stern, David/0000-0002-1847-6483				Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KACSER H, 1981, GENETICS, V97, P639; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; WHITE RJ, 2001, GENE TRANSCRIPTION M; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	15	6	6	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					758	759		10.1126/science.1146921	http://dx.doi.org/10.1126/science.1146921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690280				2022-12-28	WOS:000248624500024
J	Liu, HJ; Fergusson, MM; Castilho, RM; Liu, J; Cao, L; Chen, JH; Malide, D; Rovira, II; Schimel, D; Kuo, CJ; Gutkind, JS; Hwang, PM; Finkel, T				Liu, Hongjun; Fergusson, Maria M.; Castilho, Rogerio M.; Liu, Jie; Cao, Liu; Chen, Jichun; Malide, Daniela; Rovira, Ilsa I.; Schimel, Daniel; Kuo, Calvin J.; Gutkind, J. Silvio; Hwang, Paul M.; Finkel, Toren			Augmented Wnt signaling in a mammalian model of accelerated aging	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELL; KLOTHO; SKIN; MICE; DIFFERENTIATION; ACTIVATION; REPAIR; LEADS	The contribution of stem and progenitor cell dysfunction and depletion in normal aging remains incompletely understood. We explored this concept in the Klotho mouse model of accelerated aging. Analysis of various tissues and organs from young Klotho mice revealed a decrease in stem cell number and an increase in progenitor cell senescence. Because klotho is a secreted protein, we postulated that klotho might interact with other soluble mediators of stem cells. We found that klotho bound to various Wnt family members. In a cell culture model, the Wnt-klotho interaction resulted in the suppression of Wnt biological activity. Tissues and organs from klotho-deficient animals showed evidence of increased Wnt signaling, and ectopic expression of klotho antagonized the activity of endogenous and exogenous Wnt. Both in vitro and in vivo, continuous Wnt exposure triggered accelerated cellular senescence. Thus, klotho appears to be a secreted Wnt antagonist and Wnt proteins have an unexpected role in mammalian aging.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; Natl Inst Dent & Craniofacial Res, Oral Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Light Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; NIH, Mouse Imaging Facil, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; Stanford University	Finkel, T (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Castilho, Rogerio M/E-4987-2010	Gutkind, J. Silvio/0000-0002-5150-4482; Castilho, Rogerio M/0000-0001-5358-612X; Kuo, Calvin/0000-0002-7427-5985	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [1 R01 DK069989-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005101, Z01HL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551, Z01DE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069989] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Xiao NM, 2004, CHINESE MED J-PEKING, V117, P742; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239	22	558	594	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					803	806		10.1126/science.1143578	http://dx.doi.org/10.1126/science.1143578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690294				2022-12-28	WOS:000248624500040
J	Armitage, M; Eddleston, J; Stokes, T				Armitage, Mary; Eddleston, Jane; Stokes, Tim		Guideline Dev Grp	Recognising and responding to acute illness in adults in hospital: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH18 8BT, Dorset, England; Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; Natl Inst Hlth & Clin Excellence, Manchester M1 5AN, Lancs, England	University of Manchester; National Institute for Health & Care Excellence	Armitage, M (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH18 8BT, Dorset, England.	mary.armitage@rbch.nhs.uk	Stokes, Tim/M-9420-2018	Stokes, Tim/0000-0002-1127-1952				*DEP HLTH, 2000, COMPR CRIT CAR REV A; *NAT I HLTH CLIN E, 2007, NICE CLIN GUID, V50	2	28	28	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					258	259		10.1136/bmj.39272.679688.47	http://dx.doi.org/10.1136/bmj.39272.679688.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201QC	17673769	Green Published			2022-12-28	WOS:000248846700031
J	Dong, MQ; Venable, JD; Au, N; Xu, T; Park, SK; Cociorva, D; Johnson, JR; Dillin, A; Yates, JR				Dong, Meng-Qiu; Venable, John D.; Au, Nora; Xu, Tao; Park, Sung Kyu; Cociorva, Daniel; Johnson, Jeffrey R.; Dillin, Andrew; Yates, John R., III			Quantitative mass spectrometry identifies insulin signaling targets in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; LONGEVITY; DAF-16; CALCINEURIN; METABOLISM; DIAPAUSE; GENES; PROTEOMICS; BEHAVIOR	DAF-2, an insulin receptor-like protein, regulates metabolism, development, and aging in Caenorhabditis elegans. In a quantitative proteomic study, we identified 86 proteins that were more or less abundant in long-lived daf-2 mutant worms than in wild-type worms. Genetic studies on a subset of these proteins indicated that they act in one or more processes regulated by DAF-2, including entry into the dauer developmental stage and aging. In particular, we discovered a compensatory mechanism activated in response to reduced DAF-2 signaling, which involves the protein phosphatase calcineurin.	Scripps Res Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Scripps Research Institute; Salk Institute; University of California System; University of California San Diego	Yates, JR (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	jyates@scripps.edu	Xu, Tao/A-9353-2009		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067598, R01DK070696, R01DK074798] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823-10] Funding Source: Medline; NIDDK NIH HHS [DK074798, DK067598, DK070696] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Gems D, 1998, GENETICS, V150, P129; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Lee J, 2004, J MOL BIOL, V344, P585, DOI 10.1016/j.jmb.2004.09.050; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	21	241	263	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					660	663		10.1126/science.1139952	http://dx.doi.org/10.1126/science.1139952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673661				2022-12-28	WOS:000248494400045
J	Schiff, ND; Giacino, JT; Kalmar, K; Victor, JD; Baker, K; Gerber, M; Fritz, B; Eisenberg, B; O'Connor, J; Kobylarz, EJ; Farris, S; Machado, A; McCagg, C; Plum, F; Fins, JJ; Rezai, AR				Schiff, N. D.; Giacino, J. T.; Kalmar, K.; Victor, J. D.; Baker, K.; Gerber, M.; Fritz, B.; Eisenberg, B.; O'Connor, J.; Kobylarz, E. J.; Farris, S.; Machado, A.; McCagg, C.; Plum, F.; Fins, J. J.; Rezai, A. R.			Behavioural improvements with thalamic stimulation after severe traumatic brain injury	NATURE			English	Article							MINIMALLY CONSCIOUS STATE; INTRALAMINAR; PROJECTIONS; ACTIVATION; ATTENTION; RECOVERY; AROUSAL	Widespread loss of cerebral connectivity is assumed to underlie the failure of brain mechanisms that support communication and goal-directed behaviour following severe traumatic brain injury. Disorders of consciousness that persist for longer than 12 months after severe traumatic brain injury are generally considered to be immutable; no treatment has been shown to accelerate recovery or improve functional outcome in such cases(1,2). Recent studies have shown unexpected preservation of large-scale cerebral networks in patients in the minimally conscious state (MCS)(3,4), a condition that is characterized by intermittent evidence of awareness of self or the environment(5). These findings indicate that there might be residual functional capacity in some patients that could be supported by therapeutic interventions. We hypothesize that further recovery in some patients in the MCS is limited by chronic underactivation of potentially recruitable large-scale networks. Here, in a 6-month double-blind alternating crossover study, we show that bilateral deep brain electrical stimulation (DBS) of the central thalamus modulates behavioural responsiveness in a patient who remained in MCS for 6 yr following traumatic brain injury before the intervention. The frequency of specific cognitively mediated behaviours (primary outcome measures) and functional limb control and oral feeding (secondary outcome measures) increased during periods in which DBS was on as compared with periods in which it was off. Logistic regression modelling shows a statistical linkage between the observed functional improvements and recent stimulation history. We interpret the DBS effects as compensating for a loss of arousal regulation that is normally controlled by the frontal lobe in the intact brain. These findings provide evidence that DBS can promote significant late functional recovery from severe traumatic brain injury. Our observations, years after the injury occurred, challenge the existing practice of early treatment discontinuation for patients with only inconsistent interactive behaviours and motivate further research to develop therapeutic interventions.	Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; JFK Rehabil Inst, Edison, NJ 08818 USA; New Jersey Neurosci Inst, Edison, NJ 08818 USA; Cleveland Clin Fdn, Ctr Neurol Restorat, Cleveland, OH 44195 USA; Weill Cornell Med Coll, Div Med Eth, New York, NY 10021 USA	Cornell University; Cleveland Clinic Foundation; Cornell University	Schiff, ND (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.	nds2001@mail.med.cornell.edu	Victor, Jonathan D./D-2931-2009; Giacino, Joseph/AAF-1952-2021; Machado, Andre GG/B-7572-2014	Victor, Jonathan D./0000-0002-9293-0111; Giacino, Joseph/0000-0002-7916-9698; Machado, Andre GG/0000-0002-8132-5610; Fins, Joseph/0000-0002-7221-0053				Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2000, NEUROL RES, V22, P273; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Morel A, 2005, EUR J NEUROSCI, V21, P1007, DOI 10.1111/j.1460-9568.2005.03921.x; Munkle MC, 2000, J CHEM NEUROANAT, V19, P155, DOI 10.1016/S0891-0618(00)00060-0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Pfaff D. W., 2005, BRAIN AROUSAL INFORM; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; SCHIFF ND, 2002, SOC NEUR 31 ANN M; Schiff Nicholas D., 2002, Thalamus & Related Systems, V2, P55, DOI 10.1016/S1472-9288(02)00028-6; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352, DOI 10.1152/jn.1982.48.2.352; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wyder MT, 2004, J NEUROPHYSIOL, V91, P2628, DOI 10.1152/jn.01221.2003	23	587	651	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					600	U10		10.1038/nature06041	http://dx.doi.org/10.1038/nature06041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671503				2022-12-28	WOS:000248446700045
J	Bryant, DA; Costas, AMG; Maresca, JA; Chew, AGM; Klatt, CG; Bateson, MM; Tallon, LJ; Hostetler, J; Nelson, WC; Heidelberg, JF; Ward, DM				Bryant, Donald A.; Costas, Amaya M. Garcia; Maresca, Julia A.; Chew, Aline Gomez Maqueo; Klatt, Christian G.; Bateson, Mary M.; Tallon, Luke J.; Hostetler, Jessica; Nelson, William C.; Heidelberg, John F.; Ward, David M.			Candidatus Chloracidobacterium thermophilum: An aerobic phototrophic acidobacterium	SCIENCE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL MAT COMMUNITY; PHOTOSYNTHESIS; ENVIRONMENT; DIVERSITY; BACTERIA; GENOMICS	Only five bacterial phyla with members capable of chlorophyll (Chl)-based phototrophy are presently known. Metagenomic data from the phototrophic microbial mats of alkaline siliceous hot springs in Yellowstone National Park revealed the existence of a distinctive bacteriochlorophyll ( BChl)-synthesizing, phototrophic bacterium. A highly enriched culture of this bacterium grew photoheterotrophically, synthesized BChls a and c under oxic conditions, and had chlorosomes and type 1 reaction centers. "Candidatus Chloracidobacterium thermophilum" is a BChl-producing member of the poorly characterized phylum Acidobacteria.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ So Calif, Dept Biol, Wrigley Marine Sci Ctr, Avalon, CA 90704 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; University of Southern California	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu	Gomez Maqueo Chew, Aline/D-8631-2016; Nelson, William C/E-9263-2016; Costas, Amaya Garcia/AAE-6827-2020	Gomez Maqueo Chew, Aline/0000-0001-6075-2907; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Maresca, Julia/0000-0002-3955-1585				Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; WARD DM, 2007, HEREDITY        0606, DOI DOI 10.1038/SJ.HDY.6801011; Yim LC, 2006, FEMS MICROBIOL ECOL, V57, P80, DOI 10.1111/j.1574-6941.2006.00104.x	20	265	275	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					523	526		10.1126/science.1143236	http://dx.doi.org/10.1126/science.1143236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656724				2022-12-28	WOS:000248339800048
J	Zhang, XB; Zwiers, FW; Hegerl, GC; Lambert, FH; Gillett, NP; Solomon, S; Stott, PA; Nozawa, T				Zhang, Xuebin; Zwiers, Francis W.; Hegerl, Gabriele C.; Lambert, F. Hugo; Gillett, Nathan P.; Solomon, Susan; Stott, Peter A.; Nozawa, Toru			Detection of human influence on twentieth-century precipitation trends	NATURE			English	Article							ATTRIBUTION ANALYSIS; HYDROLOGICAL CYCLE; TEMPERATURE; SENSITIVITY; AEROSOL	Human influence on climate has been detected in surface air temperature(1-5), sea level pressure(6), free atmospheric temperature(7), tropopause height(8) and ocean heat content(9). Human-induced changes have not, however, previously been detected in precipitation at the global scale(10-12), partly because changes in precipitation in different regions cancel each other out and thereby reduce the strength of the global average signal(13-19). Models suggest that anthropogenic forcing should have caused a small increase in global mean precipitation and a latitudinal redistribution of precipitation, increasing precipitation at high latitudes, decreasing precipitation at sub-tropical latitudes(15,18,19), and possibly changing the distribution of precipitation within the tropics by shifting the position of the Intertropical Convergence Zone(20). Here we compare observed changes in land precipitation during the twentieth century averaged over latitudinal bands with changes simulated by fourteen climate models. We show that anthropogenic forcing has had a detectable influence on observed changes in average precipitation within latitudinal bands, and that these changes cannot be explained by internal climate variability or natural forcing. We estimate that anthropogenic forcing contributed significantly to observed increases in precipitation in the Northern Hemisphere mid-latitudes, drying in the Northern Hemisphere subtropics and tropics, and moistening in the Southern Hemisphere subtropics and deep tropics. The observed changes, which are larger than estimated from model simulations, may have already had significant effects on ecosystems, agriculture and human health in regions that are sensitive to changes in precipitation, such as the Sahel.	Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; Univ E Anglia, Climat Res Unit, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; Univ Reading, Met Off, Hadley Ctr, Reading Unit, Reading RG6 6BB, Berks, England; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Environment & Climate Change Canada; Duke University; University of California System; University of California Berkeley; University of East Anglia; National Oceanic Atmospheric Admin (NOAA) - USA; Met Office - UK; Hadley Centre; University of Reading; National Institute for Environmental Studies - Japan	Zwiers, FW (corresponding author), Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada.	francis.zwiers@ec.gc.ca	Zhang, Xuebin/ABD-7511-2021; Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016	Stott, Peter/0000-0003-4853-7686; Hegerl, Gabriele/0000-0002-4159-1295				Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Barnett T, 2005, J CLIMATE, V18, P1291, DOI 10.1175/JCLI3329.1; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Gillett NP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015836; Gillett NP, 2003, NATURE, V422, P292, DOI 10.1038/nature01487; Hasselmann K, 1997, CLIM DYNAM, V13, P601, DOI 10.1007/s003820050185; Hegerl GC, 2004, J CLIMATE, V17, P3683, DOI 10.1175/1520-0442(2004)017<3683:DOACIA>2.0.CO;2; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; HULME M, 1992, CLIM DYNAM, V7, P57, DOI 10.1007/BF00209609; Jones GS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016377; Kharin VV, 2005, J CLIMATE, V18, P5201, DOI 10.1175/JCLI3597.1; Lambert FH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023654; Lambert FH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019545; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015&lt;2103:TRTATI&gt;2.0.CO;2; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Soden BJ, 2000, J CLIMATE, V13, P538, DOI 10.1175/1520-0442(2000)013<0538:TSOTTH>2.0.CO;2; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Vose R.S., 1992, ORNLCDIAC53NDP041, V3912, DOI [10.3334/CDIAC/, DOI 10.3334/CDIAC]; WENTZ F, 2007, SCIENCE         0531, DOI DOI 10.1126/SCIENCE.1140746; Zhang XB, 2006, J CLIMATE, V19, P4294, DOI 10.1175/JCLI3851.1	31	713	768	21	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					461	U4		10.1038/nature06025	http://dx.doi.org/10.1038/nature06025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17646832				2022-12-28	WOS:000248302700044
J	Martin, CR; Siwy, ZS				Martin, Charles R.; Siwy, Zuzanna S.			Learning nature's way: Biosensing with synthetic nanopores	SCIENCE			English	Editorial Material							SOLID-STATE NANOPORES; SINGLE; SELECTIVITY		Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res Bionano Interface, Gainesville, FL 32611 USA; Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Irvine	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	crmartin@chem.ufl.edu	Martin, Charles/AAA-1040-2019					Apel PY, 2001, NUCL INSTRUM METH B, V184, P337, DOI 10.1016/S0168-583X(01)00722-4; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fleischer R.L., 1975, NUCL TRACKS SOLIDS; Heins EA, 2005, NANO LETT, V5, P1824, DOI 10.1021/nl050925i; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; LINES RW, 1992, ROY SOC CH, V102, P350; Nilsson J, 2006, ADV MATER, V18, P427, DOI 10.1002/adma.200501991; Siwy Z, 2005, J AM CHEM SOC, V127, P5000, DOI 10.1021/ja043910f; Spohr R, 1983, U S Patent. No., Patent No. [4369370, US4369370A]; Spohr R, 1983, German Patent DE, Patent No. [2951376 C2, 2951376]; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Sutherland TC, 2004, NANO LETT, V4, P1273, DOI 10.1021/nl049413e	16	230	234	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					331	332		10.1126/science.1146126	http://dx.doi.org/10.1126/science.1146126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641190				2022-12-28	WOS:000248150200034
J	Mattila, HR; Seeley, TD				Mattila, Heather R.; Seeley, Thomas D.			Genetic diversity in honey bee colonies enhances productivity and fitness	SCIENCE			English	Article							APIS-MELLIFERA; SOCIAL HYMENOPTERA; POLYANDRY; PERFORMANCE; PATERNITY; EVOLUTION; SURVIVAL; APIDAE; SIZE	Honey bee queens mate with many males, creating numerous patrilines within colonies that are genetically distinct. The effects of genetic diversity on colony productivity and long-term fitness are unknown. We show that swarms from genetically diverse colonies (15 patrilines per colony) founded new colonies faster than swarms from genetically uniform colonies (1 patriline per colony). Accumulated differences in foraging rates, food storage, and population growth led to impressive boosts in the fitness (i.e., drone production and winter survival) of genetically diverse colonies. These results further our understanding of the origins of polyandry in honey bees and its benefits for colony performance.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Mattila, HR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	hrm24@cornell.edu						Arnold G, 2002, ETHOLOGY, V108, P751, DOI 10.1046/j.1439-0310.2002.00809.x; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BPAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; FELL RD, 1977, J APICULT RES, V16, P170, DOI 10.1080/00218839.1977.11099883; FREE JB, 1968, ENTOMOL EXP APPL, V11, P241, DOI 10.1111/j.1570-7458.1968.tb02048.x; FUCHS S, 1994, APIDOLOGIE, V25, P155, DOI 10.1051/apido:19940204; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; LEE PC, 1987, ECOL ENTOMOL, V12, P187, DOI 10.1111/j.1365-2311.1987.tb00997.x; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; ROBINSON GE, 1989, WESTV STUD, P61; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SEELEY TD, 1978, OECOLOGIA, V32, P109, DOI 10.1007/BF00344695; SEELEY TD, 1978, INSECT SOC, V25, P323, DOI 10.1007/BF02224297; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2002, BEHAV ECOL SOCIOBIOL, V52, P143, DOI 10.1007/s00265-002-0498-7	20	335	338	4	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					362	364		10.1126/science.1143046	http://dx.doi.org/10.1126/science.1143046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641199	Green Submitted			2022-12-28	WOS:000248150200044
J	Stapnes, S				Stapnes, Steinar			Detector challenges at the LHC	NATURE			English	Review								The best way to study the existence of the Higgs boson, supersymmetry and grand unified theories, and perhaps the physics of dark matter and dark energy, is at the TeV scale. This is the energy scale that will be explored at the Large Hadron Collider. This machine will generate the energy and rate of collisions that might provide evidence of new fundamental physics. It also brings with it the formidable challenge of building detectors that can record a large variety of detailed measurements in the inhospitable environment close to the collisions points of the machine.	CERN, Dept Phys, CH-1211 Geneva, Switzerland; Univ Oslo, Dept Phys, N-0316 Oslo, Norway	European Organization for Nuclear Research (CERN); University of Geneva; University of Oslo	Stapnes, S (corresponding author), Univ Oslo, Dept Phys, POB 1048, N-0316 Oslo, Norway.	steinar.stapnes@cern.ch						Ahmad A, 2007, NUCL INSTRUM METH A, V578, P98, DOI 10.1016/j.nima.2007.04.157; *ATLAS COLL, 1999, CERNLHCC9915 CERN AT; *ATLAS COLL, 1994, CERNLHCC9443 CERN; *CERN, 1998, CERNLHCC98104; *CERN, 2000, 2000016 CERN LHCC; *CMS COLL, 1994, CERNLHCC9438 CERN; CMS Collaboration, 2006, CERNLHCC200601 CMS C, VI; ELLIS N, 1994, ANNU REV NUCL PART S, V44, P609, DOI 10.1146/annurev.ns.44.120194.003141; FOSTER I, 1998, GRID BLUEPRINT NEW C; Froidevaux D, 2006, ANNU REV NUCL PART S, V56, P375, DOI 10.1146/annurev.nucl.54.070103.181209; GIANOTTI F, 1999, CERN2000007219244 EU; *LCG PROJ, 2005, CERNLHCC2005024 LCG; *LHCB COLL, 2001, 2011011 CERN LHCC; *LHCB COLL, 2005, CERNLHCC20050012; Yao WM, 2006, J PHYS G NUCL PARTIC, V33, P1, DOI 10.1088/0954-3899/33/1/001	15	15	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					290	296		10.1038/nature06078	http://dx.doi.org/10.1038/nature06078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637659				2022-12-28	WOS:000248118300045
J	Boden, M				Boden, Margaret			Donald Michie (1923-2007) - Obituary	NATURE			English	Biographical-Item									Univ Sussex, Dept Informat, Sch Cognit & Comp Sci, Brighton BN1 9QJ, E Sussex, England	University of Sussex	Boden, M (corresponding author), Univ Sussex, Dept Informat, Sch Cognit & Comp Sci, Brighton BN1 9QJ, E Sussex, England.	m.a.boden@sussex.ac.uk							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					765	765		10.1038/448765a	http://dx.doi.org/10.1038/448765a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700692				2022-12-28	WOS:000248754200030
J	Murali, MR; Mackool, BT; Muse, VV; Zembowicz, A; Ferry, JA; Mitsuma, SF; Zembowicz, A; Robinson, DR; Axelrod, L				Murali, Mandakolathur R.; Mackool, Bonnie T.; Muse, Victorine V.; Zembowicz, Artur; Ferry, Judith A.; Mitsuma, Sheila F.; Zembowicz, Artur; Robinson, Dwight R.; Axelrod, Lloyd			A 60-year-old man with fever, odynophagia, weight loss, and rash - Systemic lupus erythematosus with cutaneous involvement, lupus nephritis, lupus lymphadenitis, and pulmonary vasculitis. Atherosclerotic coronary artery disease with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICOPATHOLOGICAL ANALYSIS; INFECTION; LYMPHADENOPATHY; MANIFESTATIONS; FINGERPRINT; COMPLEMENT; DEFICIENCY; DEPOSITS		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Murali, MR (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Barilla-LaBarca ML, 2003, CURR OPIN RHEUMATOL, V15, P55, DOI 10.1097/00002281-200301000-00010; Calabrese Leonard H., 1996, Current Opinion in Rheumatology, V8, P34, DOI 10.1097/00002281-199601000-00006; Calguneri M, 2003, J INT MED RES, V31, P345, DOI 10.1177/147323000303100415; CHAPEL TA, 1980, SEX TRANSM DIS, V7, P161, DOI 10.1097/00007435-198010000-00002; Crowson AN, 2001, J CUTAN PATHOL, V28, P1, DOI 10.1034/j.1600-0560.2001.280101.x; Fox RA, 1943, AM J PATHOL, V19, P73; Gonzalez E, 1997, J AM ACAD DERMATOL, V37, P1019; Gonzalez E, 1996, J AM ACAD DERMATOL, V35, P871, DOI 10.1016/S0190-9622(96)90108-5; Hoagland R J, 1975, Prim Care, V2, P295; Hu S, 2003, PATHOL INT, V53, P221, DOI 10.1046/j.1320-5463.2003.01458.x; Hvala A, 2000, WIEN KLIN WOCHENSCHR, V112, P711; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; KAUFMAN LD, 1989, SEMIN ARTHRITIS RHEU, V18, P189, DOI 10.1016/0049-0172(89)90061-9; Lahita R G, 1999, Curr Opin Rheumatol, V11, P352, DOI 10.1097/00002281-199909000-00005; Lapins J, 1997, AIDS PATIENT CARE ST, V11, P67, DOI 10.1089/apc.1997.11.67; LLOYD W, 1981, MEDICINE, V60, P208, DOI 10.1097/00005792-198105000-00004; Patel P, 2002, DERMATOL CLIN, V20, P373, DOI 10.1016/S0733-8635(02)00016-5; RABENECK L, 1990, JAMA-J AM MED ASSOC, V263, P2318, DOI 10.1001/jama.263.17.2318; Rea T D, 2001, J Am Board Fam Pract, V14, P234; Shapira Y, 1996, CLIN RHEUMATOL, V15, P335, DOI 10.1007/BF02230354; Su CF, 2002, NEPHRON, V90, P37, DOI 10.1159/000046312; URMAN JD, 1978, ARTHRITIS RHEUM, V21, P58, DOI 10.1002/art.1780210110; Von Feldt JM, 1995, POSTGRAD MED, V97, P83; VONFELDT JM, 1995, POSTGRAD MED, V97, P86; Walport MJ, 1998, IMMUNOBIOLOGY, V199, P265, DOI 10.1016/S0171-2985(98)80032-6; Yell JA, 1996, BRIT J DERMATOL, V135, P355, DOI 10.1046/j.1365-2133.1996.d01-1004.x	27	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					692	701		10.1056/NEJMcpc079019	http://dx.doi.org/10.1056/NEJMcpc079019			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699820				2022-12-28	WOS:000248746000011
J	Seelig, B; Szostak, JW				Seelig, Burckhard; Szostak, Jack W.			Selection and evolution of enzymes from a partially randomized non-catalytic scaffold	NATURE			English	Article							IN-VITRO SELECTION; MESSENGER-RNA; DIRECTED EVOLUTION; INDUSTRIAL BIOCATALYSIS; ACTIVE-SITE; DESIGN; PROTEINS; IDENTIFICATION; STRATEGIES; ANTIBODIES	Enzymes are exceptional catalysts that facilitate a wide variety of reactions under mild conditions, achieving high rate-enhancements with excellent chemo-, regio- and stereoselectivities. There is considerable interest in developing new enzymes for the synthesis of chemicals and pharmaceuticals(1-3) and as tools for molecular biology. Methods have been developed for modifying and improving existing enzymes through screening, selection and directed evolution(4,5). However, the design and evolution of truly novel enzymes has relied on extensive knowledge of the mechanism of the reaction(6-10). Here we show that genuinely new enzymatic activities can be created de novo without the need for prior mechanistic information by selection from a naive protein library of very high diversity, with product formation as the sole selection criterion. We used messenger RNA display, in which proteins are covalently linked to their encoding mRNA(11), to select for functional proteins from an in vitro translated protein library of > 10(12) independent sequences without the constraints imposed by any in vivo step. This technique has been used to evolve new peptides and proteins that can bind a specific ligand(12-18), from both random- sequence libraries(12,14-16) and libraries based on a known protein fold(17,18). We now describe the isolation of novel RNA ligases from a library that is based on a zinc finger scaffold(18,19), followed by in vitro directed evolution to further optimize these enzymes. The resulting ligases exhibit multiple turnover with rate enhancements of more than two- million- fold.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Simches Res Ctr 7215, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, CCIB, Simches Res Ctr 7215, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Simches Res Ctr 7215, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aharoni A, 2005, CURR OPIN CHEM BIOL, V9, P210, DOI 10.1016/j.cbpa.2005.02.002; Baggio R, 2002, J MOL RECOGNIT, V15, P126, DOI 10.1002/jmr.567; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BONNER G, 1994, J BIOL CHEM, V269, P25120; BRYANT FR, 1981, J AM CHEM SOC, V103, P696, DOI 10.1021/ja00393a047; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cesaro-Tadic S, 2003, NAT BIOTECHNOL, V21, P679, DOI 10.1038/nbt828; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cho G, 2000, J MOL BIOL, V297, P309, DOI 10.1006/jmbi.2000.3571; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cujec TP, 2002, CHEM BIOL, V9, P253, DOI 10.1016/S1074-5521(02)00098-4; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Griffiths AD, 2000, CURR OPIN BIOTECH, V11, P338, DOI 10.1016/S0958-1669(00)00109-9; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Holmbeck SMA, 1998, J MOL BIOL, V281, P271, DOI 10.1006/jmbi.1998.1908; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kurz M, 2000, Nucleic Acids Res, V28, pE83, DOI 10.1093/nar/28.18.e83; Liu RH, 2000, METHOD ENZYMOL, V318, P268; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Purtha WE, 2005, J AM CHEM SOC, V127, P13124, DOI 10.1021/ja0533702; Raffler NA, 2003, CHEM BIOL, V10, P69, DOI 10.1016/S1074-5521(02)00309-5; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; VOLCKAERT G, 1977, ANAL BIOCHEM, V83, P228, DOI 10.1016/0003-2697(77)90531-0; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; WILSON DS, 2000, CURRENT PROTOCOLS S, V51; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Xu Y, 2004, BIOORGAN MED CHEM, V12, P5247, DOI 10.1016/j.bmc.2004.03.077	37	156	166	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					828	U13		10.1038/nature06032	http://dx.doi.org/10.1038/nature06032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700701	Green Accepted			2022-12-28	WOS:000248754200045
J	Chuang, JZ; Zhao, Y; Sung, CH				Chuang, Jen-Zen; Zhao, Yu; Sung, Ching-Hwa			SARA-regulated vesicular targeting underlies formation of the Light-Sensing organelle in mammalian rods	CELL			English	Article							FYVE DOMAIN PROTEIN; PHOTORECEPTOR OUTER SEGMENT; RAB5 EFFECTOR EEA1; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; RHODOPSIN GENE; SYNTAXIN 7; LOCALIZATION; MEMBRANE; CELLS	The light-sensing organelle of the vertebrate rod photoreceptor, the outer segment (OS), is a modified cilium containing similar to 1,000 stacked disc membranes that are densely packed with visual pigment rhodopsin. The mammalian OS is renewed every ten days; new discs are assembled at the base of the OS by a poorly understood mechanism. Our results suggest that discs are formed and matured in a process that involves specific phospholipid-directed vesicular membrane targeting. Rhodopsin-laden vesicles in the OS axonemal cytoplasm fuse with nascent discs that are highly specialized with abundant phosphatidylinositol 3-phosphate (PI3P). This membrane coupling is regulated by the FYVE domain-containing protein, SARA, through its direct interaction with PI3P, rhodopsin, and SNARE protein syntaxin 3. Our model, in contrast to the previously proposed evagination model, suggests that the vesicular delivery of rhodopsin in the OS concentrates rhodopsin into discs, and this process directly participates in disc biogenesis.	Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Res Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University; Cornell University	Chuang, JZ (corresponding author), Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Res Inst, 1300 York Ave, New York, NY 10021 USA.	jzchuang@med.cornell.edu; chsung@med.cornell.edu			NATIONAL EYE INSTITUTE [R01EY011307, R01EY016805] Funding Source: NIH RePORTER; NEI NIH HHS [EY11307, R01 EY011307, R01 EY016805] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Li ZY, 1998, INVEST OPHTH VIS SCI, V39, P808; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MATSUMOTO B, 1985, INVEST OPHTH VIS SCI, V26, P628; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mendez A, 2003, J NEUROSCI, V23, P3124; MIYAGUCHI K, 1992, J NEUROCYTOL, V21, P449, DOI 10.1007/BF01191508; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stenmark H, 1999, J CELL SCI, V112, P4175; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; Wong SH, 1998, J BIOL CHEM, V273, P375, DOI 10.1074/jbc.273.1.375; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	46	113	113	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					535	547		10.1016/j.cell.2007.06.030	http://dx.doi.org/10.1016/j.cell.2007.06.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693260	Green Accepted, Bronze			2022-12-28	WOS:000249038100020
J	Auerbach, AD; Landefeld, CS; Shojania, KG				Auerbach, Andrew D.; Landefeld, C. Seth; Shojania, Kaveh G.			The tension between needing to improve care and knowing how to do it	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL EMERGENCY TEAM; PATIENT SAFETY; QUALITY IMPROVEMENT; WORK-HOURS; MORTALITY; STRATEGIES; INFECTION; OUTCOMES; ARRESTS; DEATHS		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Ottawa Hlth Res Inst, Ottawa, ON, Canada	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Ottawa; Ottawa Hospital Research Institute	Auerbach, AD (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.		Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Auerbach, Andrew/0000-0001-8440-0527	AHRQ HHS [K08 HS11416-02] Funding Source: Medline; NIA NIH HHS [K07 AG00912] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS011416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG000912] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Berwick DM, 2005, QUAL SAF HEALTH CARE, V14, P315, DOI 10.1136/qshc.2005.015669; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brennan TA, 2005, NEW ENGL J MED, V353, P1405, DOI 10.1056/NEJMsb051157; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DENRELL J, 2005, HARVARD BUSINESS APR, V114, P134; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Forster AJ, 2005, CAN MED ASSOC J, V173, P893, DOI 10.1503/cmaj.1041582; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gawande A, 2004, NEW ENGL J MED, V350, P1283, DOI 10.1056/NEJMp048025; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Goldman L, 2007, ANN INTERN MED, V147, P143, DOI 10.7326/0003-4819-147-2-200707170-00165; Han, 2006, PEDIATRICS, V117, P594, DOI 10.1542/peds.2005-2970; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Hillman K, 2005, LANCET, V365, P2091; HILLMAN K, 2005, LANCET, V366, P1164; Hofer T P, 2000, Eff Clin Pract, V3, P261; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kerridge RK, 2003, MED J AUSTRALIA, V179, P313, DOI 10.5694/j.1326-5377.2003.tb05556.x; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Mittman BS, 2004, ANN INTERN MED, V140, P897, DOI 10.7326/0003-4819-140-11-200406010-00011; Nelson EC, 1998, CLIN IMPROVEMENT ACT; Nielsen PE, 2007, OBSTET GYNECOL, V109, P48, DOI 10.1097/01.AOG.0000250900.53126.c2; Nuckols TK, 2005, J GEN INTERN MED, V20, P873, DOI 10.1111/j.1525-1497.2005.0133.x; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; Reason J., 1997, MANAGING RISK ORG AC; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Wachter RM, 2006, JT COMM J QUAL PATIE, V32, P621, DOI 10.1016/S1553-7250(06)32080-6; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	51	229	230	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					608	613		10.1056/NEJMsb070738	http://dx.doi.org/10.1056/NEJMsb070738			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687138				2022-12-28	WOS:000248584900016
J	Dyer, LA; Singer, MS; Lill, JT; Stireman, JO; Gentry, GL; Marquis, RJ; Ricklefs, RE; Greeney, HF; Wagner, DL; Morais, HC; Diniz, IR; Kursar, TA; Coley, PD				Dyer, L. A.; Singer, M. S.; Lill, J. T.; Stireman, J. O.; Gentry, G. L.; Marquis, R. J.; Ricklefs, R. E.; Greeney, H. F.; Wagner, D. L.; Morais, H. C.; Diniz, I. R.; Kursar, T. A.; Coley, P. D.			Host specificity of Lepidoptera in tropical and temperate forests	NATURE			English	Article							DIVERSITY; PLANT; DEFENSES; INSECTS	For numerous taxa, species richness is much higher in tropical than in temperate zone habitats(1). A major challenge in community ecology and evolutionary biogeography is to reveal the mechanisms underlying these differences. For herbivorous insects, one such mechanism leading to an increased number of species in a given locale could be increased ecological specialization, resulting in a greater proportion of insect species occupying narrow niches within a community. We tested this hypothesis by comparing host specialization in larval Lepidoptera (moths and butterflies) at eight different New World forest sites ranging in latitude from 15 degrees S to 55 degrees N. Here we show that larval diets of tropical Lepidoptera are more specialized than those of their temperate forest counterparts: tropical species on average feed on fewer plant species, genera and families than do temperate caterpillars. This result holds true whether calculated per lepidopteran family or for a caterpillar assemblage as a whole. As a result, there is greater turnover in caterpillar species composition (greater beta diversity) between tree species in tropical faunas than in temperate faunas. We suggest that greater specialization in tropical faunas is the result of differences in trophic interactions; for example, there are more distinct plant secondary chemical profiles from one tree species to the next in tropical forests than in temperate forests as well as more diverse and chronic pressures from natural enemy communities.	Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Yanayacu Biol Stn, Quito, Ecuador; Ctr Creat Studies, Quito, Ecuador	Tulane University; Wesleyan University; George Washington University; University System of Ohio; Wright State University Dayton; University of Missouri System; University of Missouri Saint Louis; Yanayacu Biological Station	Dyer, LA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	ldyer@tulane.edu	TATSUTA, HARUKI/F-2997-2010; Lill, John/A-7935-2009; Diniz, Ivone/J-1804-2012	Diniz, Ivone/0000-0002-4252-8810; Stireman, John/0000-0001-8792-3980				[Anonymous], 1861, ORIGIN SPECIES MEANS; [Anonymous], 1878, TROPICAL NATURE OTHE; Armbruster WS, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P260; Chase J.M., 2009, ECOLOGICAL NICHES LI; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diniz IR, 1997, BIODIVERS CONSERV, V6, P817, DOI 10.1023/B:BIOC.0000010404.17467.6c; Dyer Lee A., 2002, P67, DOI 10.1017/CBO9780511542190.004; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Gentry GL, 2002, ECOLOGY, V83, P3108, DOI 10.1890/0012-9658(2002)083[3108:OTCNON]2.0.CO;2; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Irschick D, 2005, OIKOS, V110, P404, DOI 10.1111/j.0030-1299.2005.13927.x; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Kiflawi M, 2004, ECOLOGY, V85, P2895, DOI 10.1890/03-3058; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marquis Robert J., 1994, P261; MCGUGAN BM, 1958, FOREST LEPIDOPTERA C, V1; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Price Peter W., 2002, P3; SCHULTER D, 2000, ECOLOGY ADAPTIVE RAD; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Thompson J.N., 2005, INTERSPEC INTERACT; Tilman D., 1982, Monographs in Population Biology, pi; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569	35	355	367	1	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					696	U9		10.1038/nature05884	http://dx.doi.org/10.1038/nature05884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687325				2022-12-28	WOS:000248598000045
J	Brown, RL				Brown, Rachel L.			Epilepsy onscreen: getting it wrong	LANCET			English	Editorial Material									Univ Oxford Somerville Coll, Oxford OX2 6HD, England	University of Oxford	Brown, RL (corresponding author), Univ Oxford Somerville Coll, Oxford OX2 6HD, England.	r.l.brown@some.oxon.org						BAXENDALE S, 2007, EPILEPSY BEHAV  0628; *JOHN AMB, 2007, IFIRSTAID 1 AID ADV	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					371	371		10.1016/S0140-6736(07)61174-X	http://dx.doi.org/10.1016/S0140-6736(07)61174-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679001				2022-12-28	WOS:000248590200009
J	Escobar-Restrepo, JM; Huck, N; Kessler, S; Gagliardini, V; Gheyselinck, J; Yang, WC; Grossniklaus, U				Escobar-Restrepo, Juan-Miguel; Huck, Norbert; Kessler, Sharon; Gagliardini, Valeria; Gheyselinck, Jacqueline; Yang, Wei-Cai; Grossniklaus, Ueli			The FERONIA receptor-like kinase mediates male-female interactions during pollen tube reception	SCIENCE			English	Article							SELF-INCOMPATIBILITY; INTERSPECIFIC POLLINATIONS; ARABIDOPSIS-THALIANA; MALE DETERMINANT; GENE FAMILY; GUIDANCE; FERTILIZATION; BRASSICACEAE; PROTEINS; STIGMA	In flowering plants, signaling between the male pollen tube and the synergid cells of the female gametophyte is required for fertilization. In the Arabidopsis thaliana mutant feronia ( fer), fertilization is impaired; the pollen tube fails to arrest and thus continues to grow inside the female gametophyte. FER encodes a synergid-expressed, plasma membrane-localized receptor-like kinase. We found that the FER protein accumulates asymmetrically in the synergid membrane at the filiform apparatus. Interspecific crosses using pollen from Arabidopsis lyrata and Cardamine flexuosa on A. thaliana stigmas resulted in a fer-like phenotype that correlates with sequence divergence in the extracellular domain of FER. Our findings show that the female control of pollen tube reception is based on a FER-dependent signaling pathway, which may play a role in reproductive isolation barriers.	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	University of Zurich; University of Zurich; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Yang, Wei-Cai/AAX-7879-2021; Grossniklaus, Ueli/A-2736-2012; Kessler, Sharon A/T-4784-2017; Grossniklaus, Ueli/E-9995-2016	Yang, Wei-Cai/0000-0003-0252-7079; Kessler, Sharon A/0000-0002-7964-0451; Grossniklaus, Ueli/0000-0002-0522-8974; Gagliardini, Valeria/0000-0001-9471-0764				Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; HISCOCK SJ, 1993, THEOR APPL GENET, V86, P744, DOI 10.1007/BF00222665; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; HULSKAMP M, 1995, PLANT J, V8, P703, DOI 10.1046/j.1365-313X.1995.08050703.x; Kachroo A, 2002, PLANT CELL, V14, pS227, DOI 10.1105/tpc.010440; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; KAPIL RN, 1975, PHYTOMORPHOLOGY, V25, P334; KAUL V, 1986, CAN J BOT, V64, P282, DOI 10.1139/b86-042; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Mishima M, 2003, J BIOL CHEM, V278, P36389, DOI 10.1074/jbc.M305305200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Ray S, 1997, DEVELOPMENT, V124, P2489; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; WILLIAMS EG, 1986, AUST J BOT, V34, P413, DOI 10.1071/BT9860413	30	461	480	1	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					656	660		10.1126/science.1143562	http://dx.doi.org/10.1126/science.1143562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673660				2022-12-28	WOS:000248494400044
J	Mellman, I				Mellman, Ira			Perspectives - Private lives: Reflections and challenges in understanding the cell biology of the immune system	SCIENCE			English	Editorial Material							MHC CLASS-I; DENDRITIC CELLS; LYSOSOMAL COMPARTMENTS; ENDOCYTIC COMPARTMENTS; ANTIGEN PRESENTATION; T-CELLS; MOLECULES; COMPLEX; TRANSPORT; VIVO	The immune system comprises a variety of cell types whose activities must be carefully regulated to act as a coherent unit for the purpose of host defense. To perform their autonomous functions, immune cells must rely on the same basic organizational features that apply to all cells, although immune cells often exhibit remarkable degrees of specialization and adaptation. The study of these specializations has lagged behind advances in understanding the immune response and cell biology individually. As a result, there are great opportunities, but also great challenges, for new conceptual discoveries by taking a more cell-biological approach to probing the function of the immune system.	Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Roche Holding; Genentech; Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Genentech Inc, Dept Res Oncol, 1 DNA Way,Mail Stop 212, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lord JM, 1998, J CELL BIOL, V140, P733; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	27	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					625	627		10.1126/science.1142955	http://dx.doi.org/10.1126/science.1142955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673653				2022-12-28	WOS:000248494400034
J	Goldston, D				Goldston, David			Making room for dissent	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					524	524		10.1038/448524a	http://dx.doi.org/10.1038/448524a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	195XV	17671475	Bronze			2022-12-28	WOS:000248446700013
J	Marijon, E; Ou, P; Celermajer, DS; Ferreira, B; Mocumbi, AO; Jani, D; Paquet, C; Jacob, S; Sidi, D; Jouven, X				Marijon, Eloi; Ou, Phalla; Celermajer, David S.; Ferreira, Beatriz; Mocumbi, Ana Olga; Jani, Dinesh; Paquet, Christophe; Jacob, Sophie; Sidi, Daniel; Jouven, Xavier			Prevalence of rheumatic heart disease detected by echocardiographic screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; FEVER; DIAGNOSIS; CARDITIS; CHILDREN	Background: Epidemiologic studies of the prevalence of rheumatic heart disease have used clinical screening with echocardiographic confirmation of suspected cases. We hypothesized that echocardiographic screening of all surveyed children would show a significantly higher prevalence of rheumatic heart disease. Methods: Randomly selected schoolchildren from 6 through 17 years of age in Cambodia and Mozambique were screened for rheumatic heart disease according to standard clinical and echocardiographic criteria. Results: Clinical examination detected rheumatic heart disease that was confirmed by echocardiography in 8 of 3677 children in Cambodia and 5 of 2170 children in Mozambique; the corresponding prevalence rates and 95% confidence intervals (CIs) were 2.2 cases per 1000 (95% CI, 0.7 to 3.7) for Cambodia and 2.3 cases per 1000 (95% CI, 0.3 to 4.3) for Mozambique. In contrast, echocardiographic screening detected 79 cases of rheumatic heart disease in Cambodia and 66 cases in Mozambique, corresponding to prevalence rates of 21.5 cases per 1000 (95% CI, 16.8 to 26.2) and 30.4 cases per 1000 (95% CI, 23.2 to 37.6), respectively. The mitral valve was involved in the great majority of cases (87.3% in Cambodia and 98.4% in Mozambique). Conclusions: Systematic screening with echocardiography, as compared with clinical screening, reveals a much higher prevalence of rheumatic heart disease (approximately 10 times as great). Since rheumatic heart disease frequently has devastating clinical consequences and secondary prevention may be effective after accurate identification of early cases, these results have important public health implications. N Engl J Med 2007;357:470-6.	Hop Necker Enfants Malad, Dept Pediat Cardiol, Paris, France; Hop Necker Enfants Malad, Dept Pediat Radiol, Paris, France; Maputo Heart Inst, Maputo, Mozambique; Phnom Penh Heart Ctr, Phnom Penh, Cambodia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Natl Inst Publ Hlth Surveillance, St Maurice, France; INSERM, Unite Avenir 780, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sydney; Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm)	Marijon, E (corresponding author), Univ Paris 05, Georges Pompidou Europeen Hosp, Serv Cardiol 2, 20 Rue Leblanc, F-75908 Paris 15, France.	eloi_marijon@yahoo.fr		Mocumbi, Ana/0000-0002-9564-2860; Jacob, Sophie/0000-0003-1729-305X				Anabwani GM, 1996, E AFR MED J, V73, P215; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; McDonald M, 2005, HEART, V91, P1131, DOI 10.1136/hrt.2004.057570; Meira ZMA, 2005, HEART, V91, P1019, DOI 10.1136/hrt.2004.042762; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; *SPEC WRIT GROUP C, 1993, JAMA-J AM MED ASSOC, V269, P476; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2001, LANCET, V357, P1994, DOI 10.1016/S0140-6736(00)05134-5; WHO Expert Consultation Report, 2001, RHEUM FEV RHEUM HEAR; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q	15	478	491	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					470	476		10.1056/NEJMoa065085	http://dx.doi.org/10.1056/NEJMoa065085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671255				2022-12-28	WOS:000248436300008
J	Taylor, RW; Turnbull, DM				Taylor, Robert W.; Turnbull, Douglass M.			Mitochondrial DNA transcription: Regulating the power supply	CELL			English	Editorial Material							MUTATIONS; DISEASE	In this issue of Cell, Park et al. (2007) describe the nuclear encoded protein MTERF3 as a negative regulator of mitochondrial DNA transcription initiation. This study highlights a mechanism by which mitochondrial DNA transcription (and therefore oxidative phosphorylation) may be regulated in response to alterations in the cell's physiological and metabolic demands.	Univ Newcastle, Med Sch, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; Univ Newcastle, Med Sch, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Univ Newcastle, Med Sch, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Turnbull, DM (corresponding author), Univ Newcastle, Med Sch, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk			Wellcome Trust [074454] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; PARK CB, 2007, CELL; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200	10	12	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					211	213		10.1016/j.cell.2007.07.002	http://dx.doi.org/10.1016/j.cell.2007.07.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662933	Bronze			2022-12-28	WOS:000248588000008
J	Tomari, Y; Du, T; Zamore, PD				Tomari, Yukihide; Du, Tingting; Zamore, Phillip D.			Sorting of Drosophila small silencing RNAs	CELL			English	Article							ENZYME COMPLEX; MICRORNA TARGETS; PASSENGER-STRAND; DISTINCT ROLES; INTERFERENCE; SIRNA; MELANOGASTER; CLEAVAGE; DICER-2; GENES	In Drosophila, small interfering RNAs (siRNAs), which direct RNA interference through the Argonaute protein Ago2, are produced by a biogenesis pathway distinct from microRNAs (miRNAs), which regulate endogenous mRNA expression as guides for Ago1. Here, we report that siRNAs and miRNAs are sorted into Ago1 and Ago2 by pathways independent from the processes that produce these two classes of small RNAs. Such small-RNA sorting reflects the structure of the double-stranded assembly intermediates-the miRNA/miRNA* and siRNA duplexes-from which Argonaute proteins are loaded. We find that the Dcr-2/R2D2 heterodimer acts as a gatekeeper for the assembly of Ago2 complexes, promoting the incorporation of siRNAs and disfavoring miRNAs as loading substrates for Drosophila Ago2. A separate mechanism acts in parallel to favor miRNA/miRNA* duplexes and exclude siRNAs from assembly into Ago1 complexes. Thus, in flies small-RNA duplexes are actively sorted into Argonaute-containing complexes according to their intrinsic structures.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Japan Science & Technology Agency (JST)	Tomari, Y (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	tomari@iam.u-tokyo.ac.jp; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM062862, GM62862, GM65236, R01 GM062862-09, R01 GM062862, R01 GM065236-08, R01 GM065236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R37GM062862, R01GM062862] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim JH, 2006, MOL CELL TOXICOL, V2, P29; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	47	289	299	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					299	308		10.1016/j.cell.2007.05.057	http://dx.doi.org/10.1016/j.cell.2007.05.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662944	Green Accepted, Bronze			2022-12-28	WOS:000248588000019
J	Ploegh, HL				Ploegh, Hidde L.			A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum	NATURE			English	Article							I MEMBRANE-PROTEIN; CROSS-PRESENTATION; RETRO-TRANSLOCATION; DROPLETS; DEGRADATION; DISLOCATION; MECHANISMS; PROTEASOME; TRANSPORT; INITIATE	Lipids are not encoded by a DNA template and therefore cannot be mutated, knocked out or knocked down. This by no means renders them impotent from a cell biological perspective. Here I propose a model for the involvement of lipid rearrangements in the execution of crucial steps in ( glyco) protein quality control.	MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	45	217	221	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					435	438		10.1038/nature06004	http://dx.doi.org/10.1038/nature06004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653186				2022-12-28	WOS:000248302700039
J	[Anonymous]				[Anonymous]			Nuclear test	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					387	387		10.1038/448387a	http://dx.doi.org/10.1038/448387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653146	Bronze			2022-12-28	WOS:000248302700001
J	Reinhardt, UE				Reinhardt, Uwe E.			Getting America to take the shame - Film maker Michael Moore is to be thanked for holding up mirrors to the US healthcare system	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					128	128		10.1136/bmj.39279.711748.47	http://dx.doi.org/10.1136/bmj.39279.711748.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641346	Green Published			2022-12-28	WOS:000248428100031
J	Shanafelt, TD; Kay, NE				Shanafelt, Tait D.; Kay, Neil E.			Combination therapies for previously untreated CLL	LANCET			English	Editorial Material							CHRONIC LYMPHOCYTIC-LEUKEMIA; FLUDARABINE PLUS CYCLOPHOSPHAMIDE		Mayo Clin, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Kay, NE (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	kay.neil@mayo.edu						Bellosillo B, 1999, BLOOD, V94, P2836, DOI 10.1182/blood.V94.8.2836.420k35_2836_2843; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; Flinn IW, 2007, J CLIN ONCOL, V25, P793, DOI 10.1200/JCO.2006.08.0762; Flinn IW, 2000, BLOOD, V96, P71, DOI 10.1182/blood.V96.1.71.013k21_71_75; Levy V, 2001, J CLIN EPIDEMIOL, V54, P747, DOI 10.1016/S0895-4356(00)00359-0; O'Brien SM, 2001, J CLIN ONCOL, V19, P1414, DOI 10.1200/JCO.2001.19.5.1414; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402	8	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2007	370	9583					197	198		10.1016/S0140-6736(07)61100-3	http://dx.doi.org/10.1016/S0140-6736(07)61100-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658375				2022-12-28	WOS:000248347900005
J	Irmis, RB; Nesbitt, SJ; Padian, K; Smith, ND; Turner, AH; Woody, D; Downs, A				Irmis, Randall B.; Nesbitt, Sterling J.; Padian, Kevin; Smith, Nathan D.; Turner, Alan H.; Woody, Daniel; Downs, Alex			A Late Triassic dinosauromorph assemblage from New Mexico and the rise of dinosaurs	SCIENCE			English	Article							ARGENTINA; ORIGIN	It has generally been thought that the first dinosaurs quickly replaced more archaic Late Triassic faunas, either by outcompeting them or when the more archaic faunas suddenly became extinct. Fossils from the Hayden Quarry, in the Upper Triassic Chinle Formation of New Mexico, and an analysis of other regional Upper Triassic assemblages instead imply that the transition was gradual. Some dinosaur relatives preserved in this Chinle assemblage belong to groups previously known only from the Middle and lowermost Upper Triassic outside North America. Thus, the transition may have extended for 15 to 20 million years and was probably diachronous at different paleolatitudes.	Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Ghost Ranch Conference Ctr, Ruth Hall Museum Paleontol, Abiquiu, NM 87510 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University; American Museum of Natural History (AMNH); University of Chicago; Field Museum of Natural History (Chicago); University of Colorado System; University of Colorado Boulder	Irmis, RB (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	irmis@berkeley.edu; snesbitt@ldeo.columbia.edu		Nesbitt, Sterling/0000-0002-7017-1652				ARCUCCI A, 1987, Ameghiniana, V24, P89; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; BENTON MJ, 1993, SCIENCE, V260, P769, DOI 10.1126/science.260.5109.769; BENTON MJ, 1988, PHYLOGENY CLASSIFICA, V1, pCH8; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; FRASER N, 2006, DAWN DINOSAURS; HECKERT AB, 2003, NEW MEXICO MUSEUM NA, V24, P127; Heckert Andrew B., 2005, New Mexico Geological Society Field Conference Guidebook, V56, P302; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; LITWIN RJ, 1991, REV PALAEOBOT PALYNO, V68, P269, DOI 10.1016/0034-6667(91)90028-2; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; PADIANK, 1989, DAWN AGE DINOSAURS A, P401; Parker W.G., 2006, MUS NORTH ARIZ BULL, V62, P46; Parker WG, 2005, P ROY SOC B-BIOL SCI, V272, P963, DOI 10.1098/rspb.2004.3047; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sidor CA, 2005, NATURE, V434, P886, DOI 10.1038/nature03393; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; ZEIGLER KE, 2003, NEW MEXICO MUSEUM NA, V24, P1	26	188	197	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					358	361		10.1126/science.1143325	http://dx.doi.org/10.1126/science.1143325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641198	Green Published			2022-12-28	WOS:000248150200043
J	Koller, G; Berkebile, S; Oehzelt, M; Puschnig, P; Ambrosch-Draxl, C; Netzer, FP; Ramsey, MG				Koller, G.; Berkebile, S.; Oehzelt, M.; Puschnig, P.; Ambrosch-Draxl, C.; Netzer, F. P.; Ramsey, M. G.			Intra- and intermolecular band dispersion in an organic crystal	SCIENCE			English	Article							ANGLE-RESOLVED PHOTOEMISSION; PHOTOELECTRON-SPECTROSCOPY; P-SEXIPHENYL; THIN-FILMS; POLY(P-PHENYLENE); HETEROEPITAXY; SIMULATION; OLIGOMERS	The high crystallinity of many inorganic materials allows their band structures to be determined through angle-resolved photoemission spectroscopy (ARPES). Similar studies of conjugated organic molecules of interest in optoelectronics are often hampered by difficulties in growing well-ordered and well-oriented crystals or films. We have grown crystalline films of uniaxially oriented sexiphenyl molecules and obtained ARPES data. Supported by density-functional calculations, we show that, in the direction parallel to the principal molecular axis, a quasi-one-dimensional band structure of a system of well-defined finite size develops out of individual molecular orbitals. In contrast, perpendicular to the molecules, the band structure reflects the periodicity of the molecular crystal, and continuous bands with a large dispersion were observed.	Karl Franzens Univ Graz, Inst Phys Surface & Interface Phys, A-8010 Graz, Austria; Univ Min & Met Leoben, A-8700 Leoben, Austria	University of Graz; University of Leoben	Koller, G (corresponding author), Karl Franzens Univ Graz, Inst Phys Surface & Interface Phys, A-8010 Graz, Austria.	georg.koller@uni-graz.at; michael.ramsey@uni-graz.at	Puschnig, Peter/C-9203-2011; Draxl, Claudia/O-6189-2016; Oehzelt, Martin/C-8696-2011	Puschnig, Peter/0000-0002-8057-7795; Draxl, Claudia/0000-0003-3523-6657; Oehzelt, Martin/0000-0002-9646-6889				BAKER KN, 1993, POLYMER, V34, P1571, DOI 10.1016/0032-3861(93)90313-Y; Berkebile S, 2006, SURF SCI, V600, pL313, DOI 10.1016/j.susc.2006.06.044; Crispin X, 2004, J AM CHEM SOC, V126, P11889, DOI 10.1021/ja048669j; HASEGAWA S, 1994, J CHEM PHYS, V100, P6969, DOI 10.1063/1.467013; Hoffmann R., 1988, SOLIDS SURFACES CHEM; Ivanco J, 2003, ADV MATER, V15, P1812, DOI 10.1002/adma.200304993; Koller G, 2004, ADV MATER, V16, P2159, DOI 10.1002/adma.200400276; Koller G, 2006, NANO LETT, V6, P1207, DOI 10.1021/nl060629l; MAIER JP, 1972, FARADAY DISCUSS, V54, P149, DOI 10.1039/dc9725400149; NARIOKA S, 1995, PHYS REV B, V52, P2362, DOI 10.1103/PhysRevB.52.2362; OEHZELT M, IN PRESS CHEM PHYS C; Oehzelt M, 2006, ADV MATER, V18, P2466, DOI 10.1002/adma.200600476; Puschnig P, 1999, PHYS REV B, V60, P7891, DOI 10.1103/PhysRevB.60.7891; RAMSEY MG, 1993, CHEM PHYS, V177, P349, DOI 10.1016/0301-0104(93)80017-4; Rojas C, 2001, SURF SCI, V482, P546, DOI 10.1016/S0039-6028(01)00715-4; SEKI K, 1984, CHEM PHYS LETT, V103, P343, DOI 10.1016/0009-2614(84)80317-6; SHIRLEY EL, 1995, PHYS REV B, V51, P13614, DOI 10.1103/PhysRevB.51.13614; Winter B, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216113; Yamane H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.033102; Yoshimura D, 2004, J CHEM PHYS, V120, P10753, DOI 10.1063/1.1651065; Yoshimura D, 1999, PHYS REV B, V60, P9046, DOI 10.1103/PhysRevB.60.9046	21	157	159	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					351	355		10.1126/science.1143239	http://dx.doi.org/10.1126/science.1143239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641196				2022-12-28	WOS:000248150200041
J	Lederman, L				Lederman, Leon			The God particle et al.	NATURE			English	Editorial Material								territory of the Large Hadron Collider might be populated not just by the Higgs particle but also by all manner of other exotic apparitions.	IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Illinois Institute of Technology	Lederman, L (corresponding author), IIT, Dept Biol Chem & Phys Sci, 3300 S Fed St, Chicago, IL 60616 USA.	lederman@fnal.gov							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					310	312		10.1038/nature06081	http://dx.doi.org/10.1038/nature06081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637662				2022-12-28	WOS:000248118300048
J	Hehlmann, R; Hochhous, A; Baccarani, M				Hehlmann, Ruediger; Hochhous, Andreas; Baccarani, Michele		European LeukemiaNet	Chronic myeloid leukaemia	LANCET			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; ABL TYROSINE KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; PATIENTS RECEIVING IMATINIB; ALPHA PLUS CYTARABINE; BCR-ABL; CHRONIC-PHASE; INTERFERON-ALPHA; CYTOGENETIC RESPONSE	Chronic myeloid leukaemia (CML) was the first neoplastic disease for which knowledge of the genotype led to a rationally designed therapy. As a result of its well known pathophysiology, straightforward diagnosis, well established prognostic factors, and treatment for the cause of disease, CML has been studied to an extent that far exceeds that expected from its frequency, and serves as a model disease for other cancers. Imatinib, an inhibitor of BCR-ABL tyrosine kinase, has revolutionised treatment of this disease, and is now recommended as standard treatment for chronic-phase CML. Interferon alfa is an acceptable alternative treatment in the early chronic phase for patients who do not tolerate imatinib. If imatinib treatment fails, allogeneic stem-cell transplantation, a dose increase of imatinib, or new drugs are recommended. Up to 87% of patients achieve complete cytogenetic remission, therefore we provide guidance for monitoring disease status. Many trials of new drugs and combination therapies that include imatinib are underway.	Heidelberg Univ, Med Fak Mannheim, Med Univ Klin 3, D-68305 Mannheim, Germany; Univ Bologna, S Orsola Malpighi Hosp, Inst Haematol & Med Oncol, Bologna, Italy	Ruprecht Karls University Heidelberg; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Hehlmann, R (corresponding author), Heidelberg Univ, Med Fak Mannheim, Med Univ Klin 3, D-68305 Mannheim, Germany.	Ruediger.Hehlmann@med3.lma.uni-heidelberg.de		Hochhaus, Andreas/0000-0003-0626-0834				[Anonymous], 2006, SEER CANC STAT REV 1; Ault P, 2006, J CLIN ONCOL, V24, P1204, DOI 10.1200/JCO.2005.04.6557; Baccarani M, 2003, SEMIN HEMATOL, V40, P22, DOI 10.1053/shem.2003.50004; Baccarani M, 2002, BLOOD, V99, P1527, DOI 10.1182/blood.V99.5.1527; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Bacher U, 2005, LEUKEMIA, V19, P460, DOI 10.1038/sj.leu.2403607; Berger U, 2005, LEUKEMIA, V19, P984, DOI 10.1038/sj.leu.2403756; Berger U, 2003, LEUKEMIA, V17, P1820, DOI 10.1038/sj.leu.2403042; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; BIERNAUX C, 1995, BLOOD, V86, P3118; Bocchia M, 2005, LANCET, V365, P657; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; Bornhauser M, 2006, EUR J HAEMATOL, V76, P9, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2321.x; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Bumm T, 2003, BLOOD, V101, P1941, DOI 10.1182/blood-2002-07-2053; Burchert A, 2003, BLOOD, V101, P259, DOI 10.1182/blood-2002-02-0659; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cathcart K, 2004, BLOOD, V103, P1037, DOI 10.1182/blood-2003-03-0954; Corbin AS, 2003, BLOOD, V101, P4611, DOI 10.1182/blood-2002-12-3659; Crawley C, 2005, BLOOD, V106, P2969, DOI 10.1182/blood-2004-09-3544; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger M, 2006, HAEMATOLOGICA, V91, P452; Dengler J, 2005, LEUKEMIA, V19, P1835, DOI 10.1038/sj.leu.2403848; Donato NJ, 2004, CANCER RES, V64, P672, DOI 10.1158/0008-5472.CAN-03-1484; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fourouclas N, 2006, HAEMATOL-HEMATOL J, V91, P952; Geary CG, 2000, BRIT J HAEMATOL, V110, P2, DOI 10.1046/j.1365-2141.2000.02137.x; GOLDMAN J, 2004, HEMATOL J, V98; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Gratwohl A, 2006, HAEMATOLOGICA, V91, P513; Guglielmi C, 2002, BLOOD, V100, P397, DOI 10.1182/blood.V100.2.397; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Hasford J, 2005, HAEMATOLOGICA, V90, P335; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hehlmann R, 2000, BRIT J HAEMATOL, V110, P573; Hehlmann R, 2005, ANN HEMATOL, V84, P487, DOI 10.1007/s00277-005-1039-z; Hehlmann R, 2004, LEUKEMIA, V18, P665, DOI 10.1038/sj.leu.2403317; Hehlmann R, 2003, LEUKEMIA, V17, P1529, DOI 10.1038/sj.leu.2403006; HEHLMANN R, 2007, BLOOD           0222; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; Hess G, 2005, J CLIN ONCOL, V23, P7583, DOI 10.1200/JCO.2005.01.3110; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Huntly BJP, 2003, BLOOD, V102, P2205, DOI 10.1182/blood-2002-09-2763; Huntly BJP, 2003, BLOOD, V102, P1160, DOI 10.1182/blood-2003-01-0123; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2004, BLOOD, V103, P2873, DOI 10.1182/blood-2003-11-3800; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian HM, 2006, BLOOD, V108, P1835, DOI 10.1182/blood-2006-02-004325; Kantarjian HM, 2003, CANCER, V98, P522, DOI 10.1002/cncr.11543; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kluin-Nelemans HC, 2004, BLOOD, V103, P4408, DOI 10.1182/blood-2003-10-3605; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; KREIL S, 2007, BLOOD           0424; La Rosee P, 2004, BLOOD, V103, P208, DOI 10.1182/blood-2003-04-1074; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Lipton JH, 2007, LEUKEMIA LYMPHOMA, V48, P497, DOI 10.1080/10428190601175393; Lissauer H, 1865, BERL KLIN WCHNSCHR, V20, P403; Marin D, 2005, CANCER-AM CANCER SOC, V103, P1850, DOI 10.1002/cncr.20975; Marin D, 2005, LEUKEMIA, V19, P507, DOI 10.1038/sj.leu.2403664; Maywald O, 2006, LEUKEMIA, V20, P477, DOI 10.1038/sj.leu.2404100; Merx K, 2002, LEUKEMIA, V16, P1579, DOI 10.1038/sj.leu.2402680; Michallet M, 2004, LEUKEMIA, V18, P309, DOI 10.1038/sj.leu.2403217; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Muller MC, 2003, LEUKEMIA, V17, P2392, DOI 10.1038/sj.leu.2403157; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Or R, 2003, BLOOD, V101, P441, DOI 10.1182/blood-2002-02-0535; Quintas-Cardama A, 2005, BLOOD, V105, P2281, DOI 10.1182/blood-2004-06-2208; Raiola AM, 2003, BONE MARROW TRANSPL, V31, P687, DOI 10.1038/sj.bmt.1703883; Reichert A, 2001, BLOOD, V97, P1399, DOI 10.1182/blood.V97.5.1399; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Robin M, 2005, LEUKEMIA, V19, P1613, DOI 10.1038/sj.leu.2403821; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Silver RT, 1999, BLOOD, V94, P1517; Simonsson B, 2005, ACTA HAEMATOL-BASEL, V113, P155, DOI 10.1159/000084445; Soverini S, 2005, J CLIN ONCOL, V23, P4100, DOI 10.1200/JCO.2005.05.531; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Virchow R, 1847, ARCH PATHOLOGY ANATO, VI, P563; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisser M, 2004, BONE MARROW TRANSPL, V34, P1083, DOI 10.1038/sj.bmt.1704664; Weisser M, 2006, HAEMATOLOGICA, V91, P663; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788	102	326	356	3	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					342	350		10.1016/S0140-6736(07)61165-9	http://dx.doi.org/10.1016/S0140-6736(07)61165-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662883				2022-12-28	WOS:000248426100032
J	Rona, RJ; Fear, NT; Hull, L; Greenberg, N; Earnshaw, M; Hotopf, M; Wessely, S				Rona, Roberto J.; Fear, Nicola T.; Hull, Lisa; Greenberg, Neil; Earnshaw, Mark; Hotopf, Matthew; Wessely, Simon			Mental health consequences of overstretch in the UK armed forces: first phase of a cohort study	BRITISH MEDICAL JOURNAL			English	Article							OPERATIONS TEMPO; IRAQ WAR; SOLDIERS; CARE	Objective To assess the relation between frequency and duration of deployment of UK armed forces personnel on mental health. Design First phase of a cohort study. Setting UK armed forces personnel. Participants Operational history in past three years of a randomly chosen stratified sample of 5547. regulars with experience of deployment. Main outcome measures Psychological distress (general health questionnaire-12), caseness for post-traumatic stress disorder, physical symptoms, and alcohol use (alcohol use disorders identification test). Results Personnel who were deployed for 13 months or more in the past three years were more likely to fulfil the criteria for post-traumatic stress disorder (odds ratio 1.55, 95% confidence interval 1.07 to 2.32), show caseness on the general health questionnaire (1.35, 1.10 to 1.63), and have multiple physical symptoms (1.49, 1.19 to 1.87). A significant association was found between duration of deployment and severe alcohol problems. Exposure to combat partly accounted for these associations. The associations between number of deployments in the past three years and mental disorders were less consistent than those related to duration of deployment. Post-traumatic stress disorder was also associated with a mismatch between expectations about the duration of deployment and the reality. Conclusions A clear and explicit policy on the duration of each deployment of armed forces personnel may reduce the risk of post-traumatic stress disorder. An association was found between deployment for more than a year in the past three years and mental health that might be explained by exposure to combat.	Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England; Acad Ctr Def Mental Hlth, Weston Educ Ctr, London, England	University of London; King's College London; University of London; King's College London	Rona, RJ (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England.	roberto.rona@iop.kcl.ac.uk	Fear, Nicola/A-1917-2012; Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010	Fear, Nicola/0000-0002-5792-2925; Hotopf, Matthew/0000-0002-3980-4466; greenberg, neil/0000-0003-4550-2971; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571				Adams GA, 2005, MIL PSYCHOL, V17, P229, DOI 10.1207/s15327876mp1703_6; Adler AB, 2005, J OCCUP HEALTH PSYCH, V10, P121, DOI 10.1037/1076-8998.10.2.121; BABOR TF, 2001, AUDIT ALCOHOL USE DI; Ballone E, 2000, MIL MED, V165, P911, DOI 10.1093/milmed/165.12.911; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Britt TW, 2005, MIL PSYCHOL, V17, P203, DOI 10.1207/s15327876mp1703_5; CASTRO CA, 1999, PARAMETERS       AUT, P86; *CCHS CYCL 1 2, 2003, COMPL INF REL CAN FO; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; DANDEKER C, 2006, 2006 HFM S HUM DIM M; DASILVA T, 1998, P 34 INT APPL MIL PS, P72084; Dolan CA, 2005, MIL PSYCHOL, V17, P157, DOI 10.1207/s15327876mp1703_3; FEAR NT, IN PRESS ADDICTION; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; JONES G, 2007, MORE TROOPS AFGHANIS; *NAT AUD OFF, 2006, RECR RET ARM FORC; Piertney SB, 1999, BIOL J LINN SOC, V68, P317; RITZER DR, 1999, ARMY MED DEP J; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; SUMMERS D, 2007, BLAIR PLEDGES INCREA; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; VINCENT C, 1994, MIL MED, V159, P322, DOI 10.1093/milmed/159.4.322; 2006, BBC NEWS        1222	26	95	98	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					603	607		10.1136/bmj.39274.585752.BE	http://dx.doi.org/10.1136/bmj.39274.585752.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215TR	17664192	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000249832400035
J	McConnell, JR; Edwards, R; Kok, GL; Flanner, MG; Zender, CS; Saltzman, ES; Banta, JR; Pasteris, DR; Carter, MM; Kahl, JDW				McConnell, Joseph R.; Edwards, Ross; Kok, Gregory L.; Flanner, Mark G.; Zender, Charles S.; Saltzman, Eric S.; Banta, J. Ryan; Pasteris, Daniel R.; Carter, Megan M.; Kahl, Jonathan D. W.			20th-century industrial black carbon emissions altered arctic climate forcing	SCIENCE			English	Article							ICE-CORE; SNOW; COMBUSTION; GREENLAND; RECORD; SOOT	Black carbon (BC) from biomass and fossil fuel combustion alters chemical and physical properties of the atmosphere and snow albedo, yet little is known about its emission or deposition histories. Measurements of BC, vanillic acid, and non-sea-salt sulfur in ice cores indicate that sources and concentrations of BC in Greenland precipitation varied greatly since 1788 as a result of boreal forest fires and industrial activities. Beginning about 1850, industrial emissions resulted in a sevenfold increase in ice-core BC concentrations, with most change occurring in winter. BC concentrations after about 1951 were lower but increasing. At its maximum from 1906 to 1910, estimated surface climate forcing in early summer from BC in Arctic snow was about 3 watts per square meter, which is eight times the typical preindustrial forcing value.	Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; Univ Calif Irvine, Dept Earth syst Sci, Irvine, CA 92697 USA; Droplet Measurement Technol, Boulder, CO 80301 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Wisconsin System; University of Wisconsin Milwaukee; University of California System; University of California Irvine	McConnell, JR (corresponding author), Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA.	Joe.McConnell@dri.edu	Flanner, Mark/C-6139-2011; Edwards, Ross/B-1433-2013; Zender, Charles S/D-4485-2012	Flanner, Mark/0000-0003-4012-174X; Edwards, Ross/0000-0002-9233-8775; Zender, Charles S/0000-0003-0129-8024				CHYLEK P, 1992, GEOPHYS RES LETT, V19, P1951, DOI 10.1029/92GL01904; CHYLEK P, 1995, GEOPHYS RES LETT, V22, P89, DOI 10.1029/94GL02841; CLARKE AD, 1985, ATMOS ENVIRON, V19, P2045, DOI 10.1016/0004-6981(85)90113-1; Conway H, 1996, WATER RESOUR RES, V32, P1713, DOI 10.1029/96WR00712; Fine PM, 2004, ENVIRON ENG SCI, V21, P387, DOI 10.1089/109287504323067021; FLANNER MG, 2007, J GEOPHYS RES, V112; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; HARRIS JM, 1994, J GEOPHYS RES-ATMOS, V99, P25845, DOI 10.1029/94JD02324; Holdsworth G, 1996, J GEOPHYS RES-ATMOS, V101, P23317, DOI 10.1029/96JD01158; Intergovernmental Panel on Climate Change, 2001, IPCC 3 ASS REP CLIM; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; KOCH D, 2005, J GEOPHYS RES, V110; McConnell JR, 2007, P NATL ACAD SCI USA, V104, P5743, DOI 10.1073/pnas.0607657104; McConnell JR, 1997, J GEOPHYS RES-OCEANS, V102, P26809, DOI 10.1029/96JC02194; McConnell JR, 2002, GEOPHYS RES LETT, V29, DOI [10.1029/2002GL016016, 10.1029/2002GL016016,2002]; McConnell JR, 2002, ENVIRON SCI TECHNOL, V36, P7, DOI 10.1021/es011088z; NOVAKOV T, 2003, GEOPHYS RES LETT, V30; PATRIS N, 2002, J GEOPHYS RES, V107; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; Smith SJ, 2001, GLOBAL PLANET CHANGE, V29, P99, DOI 10.1016/S0921-8181(00)00057-6; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	21	433	458	6	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1381	1384		10.1126/science.1144856	http://dx.doi.org/10.1126/science.1144856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690261	Green Published, Green Submitted			2022-12-28	WOS:000249377500043
J	Kimchi, T; Xu, J; Dulac, C				Kimchi, Tali; Xu, Jennings; Dulac, Catherine			A functional circuit underlying male sexual behaviour in the female mouse brain	NATURE			English	Article							MICE MUS-MUSCULUS; MUTANT MICE; COURTSHIP BEHAVIOR; VOMERONASAL ORGAN; PHEROMONE; DISCRIMINATION; REPRODUCTION; TRP2; VOCALIZATIONS; TRANSDUCTION	In mice, pheromone detection is mediated by the vomeronasal organ and the main olfactory epithelium. Male mice that are deficient for Trpc2, an ion channel specifically expressed in VNO neurons and essential for VNO sensory transduction, are impaired in sex discrimination and male-male aggression. We report here that Trpc2(-/-) female mice show a reduction in female-specific behaviour, including maternal aggression and lactating behaviour. Strikingly, mutant females display unique characteristics of male sexual and courtship behaviours such as mounting, pelvic thrust, solicitation, anogenital olfactory investigation, and emission of complex ultrasonic vocalizations towards male and female conspecific mice. The same behavioural phenotype is observed after VNO surgical removal in adult animals, and is not accompanied by disruption of the oestrous cycle and sex hormone levels. These findings suggest that VNO-mediated pheromone inputs act in wild-type females to repress male behaviour and activate female behaviours. Moreover, they imply that functional neuronal circuits underlying male-specific behaviours exist in the normal female mouse brain.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kimhi@fas.harvard.edu; dulac@fas.harvard.edu		Xu, Jennings/0000-0002-3068-0559; Dulac, Catherine/0000-0001-5024-5418				Afonso VM, 2006, HORM BEHAV, V49, P30, DOI 10.1016/j.yhbeh.2005.04.013; BEACH FA, 1968, PERSPECTIVES REPROD, P88; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; EDWARDS DA, 1971, HORM BEHAV, V2, P49, DOI 10.1016/0018-506X(71)90037-7; Fang JM, 1999, ANIM BEHAV, V57, P545, DOI 10.1006/anbe.1998.1025; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; MANNING A, 1974, HORM BEHAV, V5, P19, DOI 10.1016/0018-506X(74)90004-X; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; SAGOVIA S, 1993, BRAIN RES BRAIN RES, V18, P51; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	30	295	300	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1009	U1		10.1038/nature06089	http://dx.doi.org/10.1038/nature06089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17676034				2022-12-28	WOS:000249097600029
J	Stern, RS				Stern, Robert S.			Psoralen and ultraviolet a light therapy for psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; ORAL METHOXSALEN PHOTOCHEMOTHERAPY; CHRONIC PLAQUE PSORIASIS; SQUAMOUS-CELL CARCINOMA; A RADIATION PUVA; SYSTEMIC TREATMENTS; SKIN INFLAMMATION; NESTED COHORT; RISK; CYCLOSPORINE		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stern, RS (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, 330 Brookline Ave, Boston, MA 02215 USA.	rstern@bidmc.harvard.edu						Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2482; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Clark RA, 2006, J CLIN INVEST, V116, P2084, DOI 10.1172/JCI29441; *DAN MED AG, 2007, GUID CRIT SINGL REIM; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; Detmar M, 2004, J INVEST DERMATOL, V122, pXIV, DOI 10.1046/j.0022-202X.2003.22140.x; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P643; Erkin G, 2007, J CUTAN PATHOL, V34, P213, DOI 10.1111/j.1600-0560.2006.00591.x; Fortune DG, 2004, BRIT J DERMATOL, V151, P1219, DOI 10.1111/j.1365-2133.2004.06222.x; Fortune DG, 1997, BRIT J DERMATOL, V137, P755; Griffiths C E, 2000, Health Technol Assess, V4, P1; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Heydendael VMR, 2004, J INVEST DERM SYMP P, V9, P131, DOI 10.1111/j.1087-0024.2004.09115.x; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Krueger G, 2001, ARCH DERMATOL, V137, P280; Kupper TS, 2003, NEW ENGL J MED, V349, P1987, DOI 10.1056/NEJMp038164; LASKIN JD, 1986, P NATL ACAD SCI USA, V83, P8211, DOI 10.1073/pnas.83.21.8211; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Lim JL, 2005, J INVEST DERMATOL, V124, P505, DOI 10.1111/j.0022-202X.2005.23618.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Marcil I, 2001, LANCET, V358, P1042, DOI 10.1016/S0140-6736(01)06179-7; MCEVOY MT, 1987, PHARMACOL THERAPEUT, V34, P75, DOI 10.1016/0163-7258(87)90093-3; MELSKI JW, 1977, J INVEST DERMATOL, V68, P328, DOI 10.1111/1523-1747.ep12496022; MORISON WL, 1982, J AM ACAD DERMATOL, V6, P46, DOI 10.1016/S0190-9622(82)70005-2; Morison WL, 2004, PHOTODERMATOL PHOTO, V20, P315, DOI 10.1111/j.1600-0781.2004.00125.x; Myers A, 2005, RHEUMATOLOGY, V44, P773, DOI 10.1093/rheumatology/keh589; *NICE, 2006, 103 NICE, P1; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Nijsten TEC, 2003, J AM ACAD DERMATOL, V49, P644, DOI 10.1067/S0190-9622(03)01587-1; Nijsten TEC, 2003, J INVEST DERMATOL, V121, P252, DOI 10.1046/j.1523-1747.2003.12350.x; NORRIS PG, 1994, BRIT J DERMATOL, V130, P246; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Spuls PI, 1997, BRIT J DERMATOL, V137, P943, DOI 10.1046/j.1365-2133.1997.19902071.x; Stern RS, 2006, ARCH DERMATOL, V142, P1132, DOI 10.1001/archderm.142.9.1132; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805; STERN RS, 1994, J INVEST DERMATOL, V103, P534, DOI 10.1111/1523-1747.ep12395733; STERN RS, 1980, ARCH DERMATOL, V116, P1269, DOI 10.1001/archderm.116.11.1269; STERN RS, 1990, NEW ENGL J MED, V322, P1093, DOI 10.1056/NEJM199004193221601; Stern RS, 1997, NEW ENGL J MED, V336, P1041, DOI 10.1056/NEJM199704103361501; STERN RS, 1979, NEW ENGL J MED, V300, P809, DOI 10.1056/NEJM197904123001501; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; VALLAT VP, 1994, J EXP MED, V180, P283, DOI 10.1084/jem.180.1.283; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Yan KL, 2007, J INVEST DERMATOL, V127, P312, DOI 10.1038/sj.jid.5700506	49	108	114	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					682	690		10.1056/NEJMct072317	http://dx.doi.org/10.1056/NEJMct072317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699818				2022-12-28	WOS:000248746000008
J	Spoor, F; Leakey, MG; Gathogo, PN; Brown, FH; Anton, SC; McDougall, I; Kiarie, C; Manthi, FK; Leakey, LN				Spoor, F.; Leakey, M. G.; Gathogo, P. N.; Brown, F. H.; Anton, S. C.; McDougall, I.; Kiarie, C.; Manthi, F. K.; Leakey, L. N.			Implications of new early Homo fossils from Ileret, east of Lake Turkana, Kenya	NATURE			English	Article							KOOBI-FORA-FORMATION; OLDUVAI-GORGE; PLIOCENE; BASIN; PALEOANTHROPOLOGY; PLEISTOCENE; REMAINS; ERECTUS; DMANISI; SKULLS	Sites in eastern Africa have shed light on the emergence and early evolution of the genus Homo(1-6). The best known early hominin species, H. habilis and H. erectus, have often been interpreted as time-successive segments of a single anagenetic evolutionary lineage(3,7-10). The case for this was strengthened by the discovery of small early Pleistocene hominin crania from Dmanisi in Georgia that apparently provide evidence of morphological continuity between the two taxa(11,12). Here we describe two new cranial fossils from the Koobi Fora Formation, east of Lake Turkana in Kenya, that have bearing on the relationship between species of early Homo. A partial maxilla assigned to H. habilis reliably demonstrates that this species survived until later than previously recognized, making an anagenetic relationship with H. erectus unlikely. The discovery of a particularly small calvaria of H. erectus indicates that this taxon overlapped in size with H. habilis, and may have shown marked sexual dimorphism. The new fossils confirm the distinctiveness of H. habilis and H. erectus, independently of overall cranial size, and suggest that these two early taxa were living broadly sympatrically in the same lake basin for almost half a million years.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Koobi Fora Res Project, Nairobi 00502, Kenya; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; NYU, Dept Anthropol, New York, NY 10003 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Natl Museums Kenya, Div Palaeontol, Nairobi 00100, Kenya	University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utah System of Higher Education; University of Utah; New York University; Australian National University	Spoor, F (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	f.spoor@ucl.ac.uk; meaveleakey@uuplus.com	Spoor, Fred/C-1718-2008	Leakey, Louise/0000-0003-3420-6341				Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Anton SC, 2004, J HUM EVOL, V46, P337, DOI 10.1016/j.jhevol.2003.12.005; Anton Susan C., 2007, P1655, DOI 10.1007/978-3-540-33761-4_54; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; de Lumley MA, 2006, ANTHROPOLOGIE, V110, P1, DOI 10.1016/j.anthro.2006.02.001; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Gathogo PN, 2006, J AFR EARTH SCI, V45, P369, DOI 10.1016/j.jafrearsci.2006.03.006; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HOWELL FC, 1982, CAMBRIDGE HIST AFRIC, V1, P70; KIMBEL WH, 1991, J HUM EVOL, V20, P355, DOI 10.1016/0047-2484(91)90016-O; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Leakey M.D., 1971, OLDUVAI GORGE; LEAKEY MG, 1978, KOOBI FORA RES PROJE, V1; MANEGA PC, 1993, THHESIS U COLORADO; Marquez S, 2001, ANAT REC, V262, P344, DOI 10.1002/ar.1046; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Tattersall I, 2000, EVOL ANTHROPOL, V9, P2, DOI 10.1002/(SICI)1520-6505(2000)9:1<2::AID-EVAN2>3.0.CO;2-2; Tobias P.V., 1989, P141; Tobias P.V., 1991, OLDUVAI GORGE, V4; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; WALTER RC, 1991, NATURE, V354, P145, DOI 10.1038/354145a0; WOOD B, 1991, KOOBI FLORA RES PROJ, V4	28	219	227	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					688	691		10.1038/nature05986	http://dx.doi.org/10.1038/nature05986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687323				2022-12-28	WOS:000248598000043
J	McCormick, S				McCormick, Sheila			Materials science - Exploiting wrinkle formation	SCIENCE			English	Editorial Material							THIN-FILMS		Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M60 1QD, Lancs, England	University of Manchester	McCormick, S (corresponding author), Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M60 1QD, Lancs, England.	sheilamc@nature.berkeley.edu		Saiani, Aline/0000-0003-2731-3536				Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Cerda E, 2002, NATURE, V419, P579, DOI 10.1038/419579b; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Genzer J, 2006, SOFT MATTER, V2, P310, DOI 10.1039/b516741h; Huang J, 2007, SCIENCE, V317, P650, DOI 10.1126/science.1144616; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175	7	11	12	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					605	606		10.1126/science.1146680	http://dx.doi.org/10.1126/science.1146680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673643				2022-12-28	WOS:000248494400024
J	Chipman, A				Chipman, Andrea			Swiss on a roll	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					525	525		10.1038/448525a	http://dx.doi.org/10.1038/448525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671476	Bronze			2022-12-28	WOS:000248446700014
J	Ramanathan, V; Ramana, MV; Roberts, G; Kim, D; Corrigan, C; Chung, C; Winker, D				Ramanathan, Veerabhadran; Ramana, Muvva V.; Roberts, Gregory; Kim, Dohyeong; Corrigan, Craig; Chung, Chul; Winker, David			Warming trends in Asia amplified by brown cloud solar absorption	NATURE			English	Article							CLIMATE-CHANGE; MODEL; GLACIER; IMPACTS	Atmospheric brown clouds are mostly the result of biomass burning and fossil fuel consumption(1). They consist of a mixture of light-absorbing and light-scattering aerosols(1) and therefore contribute to atmospheric solar heating and surface cooling. The sum of the two climate forcing terms-the net aerosol forcing effect is thought to be negative and may have masked as much as half of the global warming attributed to the recent rapid rise in greenhouse gases(2). There is, however, at least a fourfold uncertainty(2) in the aerosol forcing effect. Atmospheric solar heating is a significant source of the uncertainty, because current estimates are largely derived from model studies. Here we use three lightweight unmanned aerial vehicles that were vertically stacked between 0.5 and 3 km over the polluted Indian Ocean. These unmanned aerial vehicles deployed miniaturized instruments measuring aerosol concentrations, soot amount and solar fluxes. During 18 flight missions the three unmanned aerial vehicles were flown with a horizontal separation of tens of metres or less and a temporal separation of less than ten seconds, which made it possible to measure the atmospheric solar heating rates directly. We found that atmospheric brown clouds enhanced lower atmospheric solar heating by about 50 per cent. Our general circulation model simulations, which take into account the recently observed widespread occurrence of vertically extended atmospheric brown clouds over the Indian Ocean and Asia(3), suggest that atmospheric brown clouds contribute as much as the recent increase in anthropogenic greenhouse gases to regional lower atmospheric warming trends. We propose that the combined warming trend of 0.25 K per decade may be sufficient to account for the observed retreat of the Himalayan glaciers(4-6).	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Clouds Chem & Climate, La Jolla, CA 92037 USA; NASA, Langley Res Ctr, Hampton, VA 23681 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Aeronautics & Space Administration (NASA); NASA Langley Research Center	Ramanathan, V (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Clouds Chem & Climate, La Jolla, CA 92037 USA.	vramanathan@ucsd.edu		Roberts, Greg/0000-0002-3636-8590				Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Chung CE, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006356; Corrigan CE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006370; CORRIGAN CE, 2006, INT AER C ST PAUL MI; Dubovik O, 2000, J GEOPHYS RES-ATMOS, V105, P9791, DOI 10.1029/2000JD900040; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Haywood J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002687; Holland GJ, 2001, B AM METEOROL SOC, V82, P889, DOI 10.1175/1520-0477(2001)082<0889:TARAAN>2.3.CO;2; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; Kulkarni AV, 2005, CURR SCI INDIA, V88, P1844; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y; Novakov T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016345; Ramana MV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007063; RAMANA MV, 2006, EOS, V87; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; RAMANATHAN V, 2006, EOS, V87; RAMANATHAN V, 2005, MALDIVES AUAV CAMPAI; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; ROBERTS GC, 2005, AM ASS AER RES C AUS; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; WINKER D, 2006, P SOC PHOTO-OPT INS, V6409, P1	25	611	637	15	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					575	U5		10.1038/nature06019	http://dx.doi.org/10.1038/nature06019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671499				2022-12-28	WOS:000248446700039
J	Mettetal, JT; van Oudenaarden, A				Mettetal, Jerome T.; van Oudenaarden, Alexander			Necessary noise	SCIENCE			English	Editorial Material							STOCHASTIC GENE-EXPRESSION; FLUCTUATING ENVIRONMENTS; DIVERSITY		MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Mettetal, JT (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019					Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	12	32	32	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					463	464		10.1126/science.1146747	http://dx.doi.org/10.1126/science.1146747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656711				2022-12-28	WOS:000248339800029
J	Harris, PD; Cokis, C				Harris, Paul D.; Cokis, Chris			Ascending aortic aneurysm in a young adult	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Royal Perth Hosp, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia	Harris, PD (corresponding author), Royal Perth Hosp, Perth, WA, Australia.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					E5	E5		10.1056/NEJMicm065440	http://dx.doi.org/10.1056/NEJMicm065440			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652644				2022-12-28	WOS:000248283500012
J	Kiel, DP; Magaziner, J; Zimmerman, S; Ball, L; Barton, BA; Brown, KM; Stone, JP; Dewkett, D; Birge, SJ				Kiel, Douglas P.; Magaziner, Jay; Zimmerman, Sheryl; Ball, Linda; Barton, Bruce A.; Brown, Kathleen M.; Stone, Judith P.; Dewkett, Dawn; Birge, Stanley J.			Efficacy of a hip protector to prevent hip fracture in nursing home residents - The HIPPRO randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; FORCE ATTENUATION PROPERTIES; FEMORAL IMPACT FORCE; FALLING CONDITIONS; ELDERLY-PEOPLE; RISK-FACTORS; WOMEN; ADHERENCE	Context Past studies of the efficacy of hip protectors to prevent hip fracture in nursing home residents have had conflicting results, possibly due to potential biases from clustered randomization designs and modest adherence to intervention. Objective To determine whether an energy-absorbing and energy-dispersing hip protector would reduce the risk of hip fracture when worn by nursing home residents. Design, Setting, and Participants Multicenter, randomized controlled clinical trial in which 37 nursing homes were randomly assigned to having residents wear a 1-sided hip protector on the left or right hip. Participants were 1042 nursing home residents ( mean [SD] aged 85 [ 7] years; 79% women) who consented and adhered to the hip protector use during a 2-week run-in period and were enrolled. Participating facilities were in greater Boston, Massachusetts, St Louis, Missouri, and Baltimore, Maryland from October 2002 to October 2004. Mean duration of participation for nursing home residents was 7.8 months. None were withdrawn because of adverse effects. Intervention(s) Undergarments with a 1-sided hip protector made of a 0.32-cm outer layer of polyethylene (2.7 kg/m(3)) backed by a hard high-density polyethylene shield (0.95 cm) that was backed by 0.9 kg/m(3) of 1.27-kg ethylene vinyl acetate foam. Each facility was visited 3 times per week to assess adherence and provide staff support. Main Outcome Measure Adjudicated hip fracture occurrences on padded vs unpadded hips. Results After a 20-month follow-up ( 676 person-years of observation), the study was terminated due to a lack of efficacy. The incidence rate of hip fracture on protected vs unprotected hips did not differ (3.1%; 95% confidence interval [CI], 1.8%4.4% vs 2.5%; 95% CI, 1.3%-3.7%; P=. 70). For the 334 nursing home residents with greater than 80% adherence to hip protector use, the incidence rate of hip fracture on protected vs unprotected hips did not differ (5.3%; 95% CI, 2.6%-8.8% vs 3.5%; 95% CI, 1.3%- 5.7%; P=. 42). Overall adherence was 73.8%. Conclusions In this clinical trial of an energy-absorbing/shunting hip protector conducted in US nursing homes, we were unable to detect a protective effect on the risk of hip fracture, despite good adherence to protocol. These results add to the increasing body of evidence that hip protectors, as currently designed, are not effective for preventing hip fracture among nursing home residents.	Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Maryland, Dept Epidemiol & Prevent Med, Div Gerontol, Baltimore, MD 21201 USA; Univ N Carolina, Sch Social Work, Chapel Hill, NC USA; Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Program Aging Disabil & Long Term Care, Chapel Hill, NC USA; Washington Univ, Sch Med, Div Geriatr & Gerontol, St Louis, MO USA; Maryland Med Res Inst, Baltimore, MD USA	Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL)	Kiel, DP (corresponding author), Hebrew SeniorLife, Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	kiel@hrca.harvard.edu		Barton, Bruce/0000-0001-7878-8895; Kiel, Douglas/0000-0001-8474-0310	NATIONAL INSTITUTE ON AGING [R01AG018461] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG018461] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Birge SJ, 2005, J AM GERIATR SOC, V53, pS113; Birks YF, 2004, OSTEOPOROSIS INT, V15, P701, DOI 10.1007/s00198-004-1599-0; Birks YF, 2003, AGE AGEING, V32, P442, DOI 10.1093/ageing/32.4.442; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Broe KE, 2000, OSTEOPOROSIS INT, V11, P765, DOI 10.1007/s001980070055; CALI CM, 1995, J AM GERIATR SOC, V43, P1336, DOI 10.1111/j.1532-5415.1995.tb06610.x; Cameron ID, 2003, INJ PREV, V9, P138, DOI 10.1136/ip.9.2.138; Cameron ID, 2001, AGE AGEING, V30, P477, DOI 10.1093/ageing/30.6.477; Chan DK, 2000, ARCH GERONTOL GERIAT, V30, P25, DOI 10.1016/S0167-4943(99)00048-5; Chandler JM, 2000, JAMA-J AM MED ASSOC, V284, P972, DOI 10.1001/jama.284.8.972; Ekman A, 1997, LANCET, V350, P563, DOI 10.1016/S0140-6736(05)63140-6; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Harada A, 2001, OSTEOPOROSIS INT, V12, P215, DOI 10.1007/s001980170132; HAYES WC, 1993, CALCIFIED TISSUE INT, V52, P192, DOI 10.1007/BF00298717; HEDLUND R, 1987, J ORTHOPAED RES, V5, P242, DOI 10.1002/jor.1100050210; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hubacher M, 2001, OSTEOPOROSIS INT, V12, P794, DOI 10.1007/s001980170057; Jantti PO, 1998, AGE AGEING, V27, P758, DOI 10.1093/ageing/27.6.758; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Kannus P, 1999, BONE, V25, P229, DOI 10.1016/S8756-3282(99)00154-4; Kaptoge S, 2005, BONE, V36, P387, DOI 10.1016/j.bone.2004.11.012; Kurrle SE, 2004, OSTEOPOROSIS INT, V15, P1, DOI 10.1007/s00198-003-1503-3; Lach H, 2002, GERONTOLOGIST, V42, P171; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; MELTON LJ, 1982, CLIN ORTHOP RELAT R, P131; Meyer G, 2003, BRIT MED J, V326, P76, DOI 10.1136/bmj.326.7380.76; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Pampallona S, 2001, DRUG INF J, V35, P1113, DOI 10.1177/009286150103500408; Parker MJ, 2006, BMJ-BRIT MED J, V332, P571, DOI 10.1136/bmj.38753.375324.7C; PARKER MJ, 2001, COCHRANE DB SYST REV; PARKER MJ, 2003, COCHRANE DB SYST REV; PARKER MJ, 2004, COCHRANE DATABASE SY; PARKKARI J, 1995, J BONE MINER RES, V10, P1437; PARKKARI J, 1994, J BONE MINER RES, V9, P1391; Robinovitch SN, 1995, J BIOMECH ENG-T ASME, V117, P409, DOI 10.1115/1.2794200; Rosner B., 2000, FUNDAMENTALS BIOSTAT; SCHNEIDER EL, 1990, JAMA-J AM MED ASSOC, V263, P2335, DOI 10.1001/jama.263.17.2335; THAL LJ, 1986, NEUROLOGY, V36, P262, DOI 10.1212/WNL.36.2.262; Thapa PB, 1996, J AM GERIATR SOC, V44, P273, DOI 10.1111/j.1532-5415.1996.tb00913.x; TINETTI ME, 1992, ANN INTERN MED, V116, P369, DOI 10.7326/0003-4819-116-5-369; *US DEP HHS, 1999, AHCPR PUBL; van Schoor NM, 2006, BONE, V39, P401, DOI 10.1016/j.bone.2006.01.156; van Schoor NM, 2003, JAMA-J AM MED ASSOC, V289, P1957, DOI 10.1001/jama.289.15.1957; Warnke A, 2004, J AM GERIATR SOC, V52, P340, DOI 10.1111/j.1532-5415.2004.52103.x; Wiener SL, 2002, CLIN ORTHOP RELAT R, P157	49	97	100	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					413	422		10.1001/jama.298.4.413	http://dx.doi.org/10.1001/jama.298.4.413			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652295				2022-12-28	WOS:000248269100020
J	Quirrenbach, A				Quirrenbach, Andreas			Seeing the surfaces of stars	SCIENCE			English	Editorial Material							RAPIDLY ROTATING STAR; VEGA		Univ Heidelberg, Landessternwarte Konigstuhl, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Quirrenbach, A (corresponding author), Univ Heidelberg, Landessternwarte Konigstuhl, D-69117 Heidelberg, Germany.	a.quirrenbach@lsw.uni-heidelberg.de						Aufdenberg JP, 2006, ASTROPHYS J, V645, P664, DOI 10.1086/504149; MacGregor KB, 2007, ASTROPHYS J, V663, P560, DOI 10.1086/518303; MALBET F, 2007, MESSENGER, V127, P37; Monnier JD, 2007, SCIENCE, V317, P342, DOI 10.1126/science.1143205; Peterson DM, 2006, NATURE, V440, P896, DOI 10.1038/nature04661; Quirrenbach A, 1997, ASTROPHYS J, V479, P477, DOI 10.1086/303854; Thompson MJ, 2004, ASTRON GEOPHYS, V45, P21, DOI 10.1046/j.1468-4004.2003.45421.x; Von Zeipel H., 1924, MON NOT R ASTRON SOC, V84, P665	8	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					325	326		10.1126/science.1145599	http://dx.doi.org/10.1126/science.1145599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641185				2022-12-28	WOS:000248150200029
J	Barker, A; Maratos, EC; Edmonds, L; Lim, E				Barker, Allanah; Maratos, Eleni C.; Edmonds, Lyn; Lim, Eric			Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials	LANCET			English	Review							THORACIC-SURGERY; AXILLARY THORACOTOMY; SURGICAL-TREATMENT; PLEURECTOMY; MANAGEMENT; VIDEOTHORACOSCOPY; THERAPY; COSTS	Background Evidence supporting similar recurrence rates between video-assisted and open surgery for the treatment of recurrent pneumothorax is questionable, because the number of randomised trials is sparse and they are underpowered to detect any meaningful difference. Our aim was to do a systematic review of randomised and non-randomised studies to compare recurrence rates between the two forms of surgical access. Methods We did a systematic literature search for studies on pneumothorax surgery in Medline, Embase, Cochrane Library, trial registers on the internet, and conference abstracts, and identified 29 studies (four randomised and 25 non-randomised) eligible for inclusion. Meta-analysis was done by combining the results of reported recurrence rates in patients undergoing video-assisted thoracoscopic surgery compared with those having open surgery. Both fixed and random effects models were applied to the results pooled for analysis. Results In studies that did the same pleurodesis through two different forms of access, the relative risk (RR) of recurrences in patients undergoing video-assisted surgery compared with open surgery was similar between non-randomised and randomised studies (RR 4.880 [95% CI 2.670-8.922] vs 3.951 [0.858-18.193]), yielding an overall RR of 4.731 (2.699-8.291; p < 0.0001). There was no evidence to suggest heterogeneity of trial results (p=0.88). The high RR of recurrence for video-assisted surgery remained robust to a random effects model (4.051 [1.996-7.465]; p < 0.0001), by including all comparative studies (3.991 [2.584-6.164]; p < 0.0001), with only high-quality studies used (4.016 [1.8468.736]; p < 0.0001), and on a simulation biased in favour of video-assisted surgery when there were no events in either group (3.559 [2.165-5.852]; p < 0.0001). Interpretation Both randomised and non-randomised trials are consistent in recurrence of pneumothoraces and show a four-fold increase when a similar pleurodesis procedure is done with a video-assisted approach compared with an open approach.	Royal Brompton Hosp, Dept Thorac Surg, London SW3 6NP, England; Papworth Hosp, Dept Cardiothorac Surg, Cambridge CB3 8RE, England; Papworth Hosp, Lib & Knowledge Serv, Cambridge CB3 8RE, England	Royal Brompton Hospital; Papworth Hospital; Papworth Hospital	Lim, E (corresponding author), Royal Brompton Hosp, Dept Thorac Surg, Sydney St, London SW3 6NP, England.	e.lim@rbht.nhs.uk		Lim, Eric/0000-0002-9078-3226				Al-Qudah A, 1999, J KOREAN MED SCI, V14, P147; Atta HM, 1997, AM SURGEON, V63, P209; Ayed AK, 2000, MED PRIN PRACT, V9, P113, DOI 10.1159/000026127; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; Baumann MH, 1997, CHEST, V112, P789, DOI 10.1378/chest.112.3.789; Ben-Nun A, 2006, WORLD J SURG, V30, P285, DOI 10.1007/s00268-005-0235-2; BERNARD A, 1993, REV MAL RESPIR, V10, P433; Cheynel N, 1994, LYON CHIR, V90, P193; COLE FH, 1995, ANN THORAC SURG, V60, P931, DOI 10.1016/0003-4975(95)00598-F; Crisci R, 1996, EUR J CARDIO-THORAC, V10, P556, DOI 10.1016/S1010-7940(96)80424-6; De Giacomo T, 1995, Minerva Chir, V50, P967; Deeks J J, 2003, Health Technol Assess, V7, piii; DEGIACOMO T, 1995, EUR J SURG, V161, P227; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dumont P, 1997, EUR J CARDIO-THORAC, V11, P27, DOI 10.1016/S1010-7940(96)01021-4; ELFELDT RJ, 1994, J CARDIOVASC SURG, V35, P229; Freixinet J, 2001, EUR RESPIR J, V18, p524s; Freixinet JL, 2004, ANN THORAC SURG, V78, P417, DOI 10.1016/j.athoracsur.2003.11.038; Gebhard FT, 1996, ARCH SURG-CHICAGO, V131, P1079; Gilliland R, 1996, MINIM INVASIV THER, V5, P69, DOI 10.3109/13645709609153287; HAZELRIGG SR, 1993, J THORAC CARDIOV SUR, V105, P389; Henry M, 2003, THORAX S2, V58, P39, DOI DOI 10.1136/TH0RAX.58.SUPPL_21I39; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horio H, 1998, SURG ENDOSC-ULTRAS, V12, P1155, DOI 10.1007/s004649900805; Hyland M J, 2001, Can Respir J, V8, P339; Ingolfsson Ingimar, 2006, Interact Cardiovasc Thorac Surg, V5, P602, DOI 10.1510/icvts.2006.129676; Inoue N, 1998, Kyobu Geka, V51, P481; JimenezMerchan R, 1997, SURG ENDOSC-ULTRAS, V11, P919, DOI 10.1007/s004649900487; Kim KH, 1996, ANN THORAC SURG, V61, P1510; Leo F, 2000, J CARDIOVASC SURG, V41, P633; LI ZJ, 2003, J JILIN U MED ED, V32, P711; Luh SP, 1996, INT SURG, V81, P336; Matsuzoe D, 1996, Nihon Kyobu Geka Gakkai Zasshi, V44, P144; Matsuzoe D, 1999, INT SURG, V84, P111; Miller JD, 2000, AM SURGEON, V66, P1014; PAGE RD, 2006, SOC CARDIOTHORACIC S; Panebianco V, 1997, G Chir, V18, P131; Passlick B, 1997, Langenbecks Arch Chir Suppl Kongressbd, V114, P1290; Passlick B, 1997, Pneumologie, V51, P1135; Passlick B, 1998, ANN THORAC SURG, V65, P324, DOI 10.1016/S0003-4975(97)01128-4; Passlick B, 2001, CHIRURG, V72, P934, DOI 10.1007/s001040170091; Qureshi R, 2002, MED FORUM MONTHLY, V13, P5; Qureshi R, 2001, J COLL PHYS SURG PAK, V11, P541; RADBERG G, 1995, SURG LAPAROSC ENDOSC, V5, P90; RAMO OJ, 1995, ANN CHIR GYNAECOL FE, V84, P272; Sawada S, 2005, CHEST, V127, P2226, DOI 10.1378/chest.127.6.2226; Sedrakyan A, 2004, BMJ-BRIT MED J, V329, P1008, DOI 10.1136/bmj.38243.440486.55; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; VanSchil P, 1997, EUR J CARDIO-THORAC, V12, P166, DOI 10.1016/S1010-7940(97)00100-0; WALLER DA, 1994, ANN THORAC SURG, V58, P372, DOI 10.1016/0003-4975(94)92210-1; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	51	98	102	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					329	335		10.1016/S0140-6736(07)61163-5	http://dx.doi.org/10.1016/S0140-6736(07)61163-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662881				2022-12-28	WOS:000248426100030
J	Bates, M; Huang, B; Dempsey, GT; Zhuang, XW				Bates, Mark; Huang, Bo; Dempsey, Graham T.; Zhuang, Xiaowei			Multicolor super-resolution imaging with photo-switchable fluorescent probes	SCIENCE			English	Article							SINGLE MOLECULES; ENERGY-TRANSFER; QUANTUM DOTS; MICROSCOPY; LOCALIZATION; CELLS; RESOLUTION; NANOSCOPY	Recent advances in far-field optical nanoscopy have enabled fluorescence imaging with a spatial resolution of 20 to 50 nanometers. Multicolor super-resolution imaging, however, remains a challenging task. Here, we introduce a family of photo-switchable fluorescent probes and demonstrate multicolor stochastic optical reconstruction microscopy (STORM). Each probe consists of a photo-switchable "reporter" fluorophore that can be cycled between fluorescent and dark states, and an "activator" that facilitates photo-activation of the reporter. Combinatorial pairing of reporters and activators allows the creation of probes with many distinct colors. Iterative, color-specific activation of sparse subsets of these probes allows their localization with nanometer accuracy, enabling the construction of a super-resolution STORM image. Using this approach, we demonstrate multicolor imaging of DNA model samples and mammalian cells with 20- to 30-nanometer resolution. This technique will facilitate direct visualization of molecular interactions at the nanometer scale.	Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Huang, Bo/D-4854-2009	Dempsey, Graham/0000-0002-9273-7506; Bates, Mark/0000-0003-0668-5277	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068518-05, R01 GM068518, GM 068518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nan XL, 2005, J PHYS CHEM B, V109, P24220, DOI 10.1021/jp056360w; Novotny B. H., 2006, PRINCIPLES NANO OPTI; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; WEBER K, 1978, P NATL ACAD SCI USA, V75, P1820, DOI 10.1073/pnas.75.4.1820; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	1037	1120	23	867	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1749	1753		10.1126/science.1146598	http://dx.doi.org/10.1126/science.1146598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17702910	Green Accepted			2022-12-28	WOS:000249585900048
J	Giraud, M; Taubert, R; Vandiedonck, C; Ke, XY; Levi-Strauss, M; Pagani, F; Baralle, FE; Eymard, B; Tranchant, C; Gajdos, P; Vincent, A; Willcox, N; Beeson, D; Kyewski, B; Garchon, HJ				Giraud, Matthieu; Taubert, Richard; Vandiedonck, Claire; Ke, Xiayi; Levi-Strauss, Matthieu; Pagani, Franco; Baralle, Francisco E.; Eymard, Bruno; Tranchant, Christine; Gajdos, Philippe; Vincent, Angela; Willcox, Nick; Beeson, David; Kyewski, Bruno; Garchon, Henri-Jean			An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus	NATURE			English	Article							AUTOIMMUNE REGULATOR AIRE; T-CELL TOLERANCE; INSULIN EXPRESSION; MYASTHENIA-GRAVIS; EPITHELIAL-CELLS; GENE-EXPRESSION; IDDM2 LOCUS; TRANSCRIPTION; MUTATION; ALLELES	Promiscuous expression of tissue-restricted auto-antigens in the thymus imposes T-cell tolerance and provides protection from autoimmune diseases(1-3). Promiscuous expression of a set of self-antigens occurs in medullary thymic epithelial cells(4,5) and is partly controlled by the autoimmune regulator (AIRE), a nuclear protein for which loss-of-function mutations cause the type 1 autoimmune polyendocrine syndrome(6,7). However, additional factors must be involved in the regulation of this promiscuous expression. Here we describe a mechanism controlling thymic transcription of a prototypic tissue-restricted human auto-antigen gene, CHRNA1. This gene encodes the alpha-subunit of the muscle acetylcholine receptor, which is the main target of pathogenic auto-antibodies in autoimmune myasthenia gravis(8,9). On re-sequencing theCHRNA1 gene, we identified a functional bi-allelic variant in the promoter that is associated with early onset of disease in two independent human populations (France and United Kingdom). We show that this variant prevents binding of interferon regulatory factor 8 (IRF8) and abrogates CHRNA1 promoter activity in thymic epithelial cells in vitro. Notably, both the CHRNA1 promoter variant and AIRE modulate CHRNA1 messenger RNA levels in human medullary thymic epithelial cells ex vivo and also in a transactivation assay. These findings reveal a critical function of AIRE and the interferon signalling pathway in regulating quantitative expression of this auto-antigen in the thymus, suggesting that together they set the threshold for self-tolerance versus autoimmunity.	INSERM, U580, F-75015 Paris, France; Univ Paris 05, F-75015 Paris, France; Univ Oxford, Weatherhall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England; German Canc Res Ctr, Tumor Immunol Program, Div Dev Immunol, D-69120 Heidelberg, Germany; Univ Manchester, CIGMR, Manchester M13 9PT, Lancs, England; Univ Manchester, ARC, Epidemiol Unit, Manchester M13 9PT, Lancs, England; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Hop La Pitie Salpetriere, Inst Myol, F-75013 Paris, France; CHRU, Hop Civil, Serv Neurol, F-67091 Strasbourg, France; Hop Raymond Poincare, Serv Reanimat, F-92380 Garches, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); University of Manchester; University of Manchester; International Center for Genetic Engineering & Biotechnology (ICGEB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Garchon, HJ (corresponding author), INSERM, U580, F-75015 Paris, France.	garchon@necker.fr	Giraud, Matthieu/E-4972-2017; Ke, Xiayi/C-7674-2009; Vincent, Angela/AAE-7310-2019	Giraud, Matthieu/0000-0002-1208-9677; tranchant, christine/0000-0002-2895-1292; Pagani, Franco/0000-0002-2678-3459; vandiedonck, claire/0000-0002-6669-6923	Medical Research Council [G117/490] Funding Source: Medline; MRC [G117/490] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FERNANDEZ E, 1994, BLOOD, V83, P3245; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Sabater L, 2005, J AUTOIMMUN, V25, P312, DOI 10.1016/j.jaut.2005.08.006; Sillanpaa N, 2004, MOL IMMUNOL, V41, P1185, DOI 10.1016/j.molimm.2004.06.004; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Taubert R, 2007, EUR J IMMUNOL, V37, P838, DOI 10.1002/eji.200636962; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916	28	145	155	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					934	U9		10.1038/nature06066	http://dx.doi.org/10.1038/nature06066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17687331				2022-12-28	WOS:000248912900048
J	Donohue, JM; Cevasco, M; Rosenthal, MB				Donohue, Julie M.; Cevasco, Marisa; Rosenthal, Meredith B.			A decade of direct-to-consumer advertising of prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTION; CHOICE	Background: Evidence suggests that direct-to-consumer advertising of prescription drugs increases pharmaceutical sales and both helps to avert underuse of medicines and leads to potential overuse. Concern about such advertising has increased recently owing to the withdrawal from the market of heavily advertised drugs found to carry serious risks. Moreover, the Food and Drug Administration (FDA) has been criticized for its weak enforcement of laws regulating such advertising. Methods: We examined industry-wide trends in spending by pharmaceutical companies on direct-to-consumer advertising and promotion to physicians during the past decade. We characterized the drugs for which such advertising is used and assessed the timing of advertising after a drug is introduced. Finally, we examined trends in the FDA's regulation of drug advertising. Results: Total spending on pharmaceutical promotion grew from $11.4 billion in 1996 to $29.9 billion in 2005. Although during that time spending on direct-to-consumer advertising increased by 330%, it made up only 14% of total promotional expenditures in 2005. Direct-to-consumer campaigns generally begin within a year after the approval of a product by the FDA. In the context of regulatory changes requiring legal review before issuing letters, the number of letters sent by the FDA to pharmaceutical manufacturers regarding violations of drug-advertising regulations fell from 142 in 1997 to only 21 in 2006. Conclusions: Spending on direct-to-consumer advertising has continued to increase in recent years in spite of the criticisms leveled against it. Our findings suggest that calls for a moratorium on such advertising for new drugs would represent a dramatic departure from current practices.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Donohue, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Crabtree Hall A613,130 DeSoto St, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu		Rosenthal, Meredith/0000-0003-3410-0184; Donohue, Julie/0000-0003-2418-6017	NCRR NIH HHS [KL2-RR024154-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Angell M., 2004, TRUTH DRUG CO; ARNOLD M, 2006, MED MARKETING ME APR, P38; BACIU A, 2006, FUTURE DRUG SAFETY P; Berndt ER, 2002, J ECON PERSPECT, V16, P45, DOI 10.1257/089533002320950975; Bradford WD, 2006, HEALTH AFFAIR, V25, P1371, DOI 10.1377/hlthaff.25.5.1371; Cassels A, 2006, BRIT MED J, V332, P1469, DOI 10.1136/bmj.332.7556.1469-a; Donohue JM, 2004, J PUBLIC POLICY MARK, V23, P115, DOI 10.1509/jppm.23.2.115.51395; Donohue JM, 2004, MED CARE, V42, P1176, DOI 10.1097/00005650-200412000-00004; DONOHUE JM, 2006, INT J PHARM MED, V20, P17; *GEN ACC OFF, 2002, FDA OV DIR TO CONS A; Gonul FF, 2001, J MARKETING, V65, P79, DOI 10.1509/jmkg.65.3.79.18329; *GOV ACC OFF, 2006, PRESCR DRUGS IMPR NE; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; Iizuka T, 2005, J ECON MANAGE STRAT, V14, P701, DOI 10.1111/j.1530-9134.2005.00079.x; Iizuka T, 2004, J IND ECON, V52, P349, DOI 10.1111/j.0022-1821.2004.00230.x; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V294, P2436; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; *PHARM RES MAN AM, 2005, PHRMA GUID PRINC DIR; Pines WL, 1999, FOOD DRUG LAW J, V54, P489; Risso JA, 1999, J LAW ECON, V42, P89; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Rosenthal MB, 2003, FRONTIERS HLTH POLIC, V6, P1; SAUL S, 2005, NY TIMES        0702, pC13; Watson Rory, 2003, BMJ, V326, P1284, DOI 10.1136/bmj.326.7402.1284-b; Wolfe SM, 2002, NEW ENGL J MED, V346, P1424; ELECT ORANGE BOOK AP	26	340	344	3	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					673	681		10.1056/NEJMsa070502	http://dx.doi.org/10.1056/NEJMsa070502			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	200EF	17699817				2022-12-28	WOS:000248746000007
J	Malathi, K; Dong, BH; Gale, M; Silverman, RH				Malathi, Krishnamurthy; Dong, Beihua; Gale, Michael, Jr.; Silverman, Robert H.			Small self-RNA generated by RNase L amplifies antiviral innate immunity	NATURE			English	Article							HEPATITIS-C VIRUS; RIG-I; INTERFERON ACTION; 2-5A-DEPENDENT RNASE; ADAPTER PROTEIN; RESPONSES; INFECTION; IDENTIFICATION; RIBONUCLEASE; EXPRESSION	Antiviral innate immunity is initiated in response to RNA molecules that are produced in virus- infected cells(1). These RNAs activate signalling cascades that activate the genes that encode alpha- and beta- interferon ( IFN). Signalling occurs through the interaction of the RNAs with either of two pathogen recognition receptors, retinoic acid- inducible gene- I ( RIG- I, also known as DDX58) and melanoma differentiation associated gene- 5 ( MDA5, also known as IFIH1), which contain amino- terminal caspase activation and recruitment domains ( CARD) and carboxy- terminal DExD/ H Box RNA helicase motifs(2-5). RIG- I and MDA5 interact with another CARD protein, interferon-beta promotor stimulator protein- 1 ( IPS- 1, also known as MAVS, VISA and Cardif), in the mitochondrial membrane, which relays the signal through the transcription factors interferon regulatory factor 3 ( IRF- 3) and nuclear factor ( NF)- kappa B to the IFN-beta gene(6-10). Although the signalling pathway is well understood, the origin of the RNA molecules that initiate these processes is not. Here we show that activation of the antiviral endoribonuclease, RNase L-11, by 2',5'- linked oligoadenylate ( 2-5A)(12) produces small RNA cleavage products from self- RNA that initiate IFN production. Accordingly, mouse embryonic fibroblasts lacking RNase L were resistant to the induction of IFN-beta expression in response to 2- 5A, dsRNA or viral infection. Single-stranded regions of RNA are cleaved 39 of UpUp and UpAp sequences by RNase L during viral infections, resulting in small, often duplex, RNAs13,14. We show that small self- RNAs produced by the action of RNase L on cellular RNA induce IFN-beta expression and that the signalling involves RIG- I, MDA5 and IPS- 1. Mice lacking RNase L produce significantly less IFN-beta during viral infections than infected wild- type mice. Furthermore, activation of RNase L with 2- 5A in vivo induced the expression of IFN-beta in wild- type but not RNase L- deficient mice. Our results indicate that RNase L has an essential role in the innate antiviral immune response that relieves the requirement for direct sensing of non- self RNA.	Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Cleveland Clinic Foundation; University of Washington; University of Washington Seattle	Silverman, RH (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	silverr@ccf.org		Gale, Michael/0000-0002-6332-7436	NATIONAL CANCER INSTITUTE [R01CA044059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089518] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA044059-24, R01 CA044059] Funding Source: Medline; NIAID NIH HHS [R15 AI089518-01, R15 AI089518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; DONG BH, 1994, J BIOL CHEM, V269, P14153; Flodstrom-Tullberg M, 2005, J IMMUNOL, V174, P1171, DOI 10.4049/jimmunol.174.3.1171; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Thakur CS, 2005, METH MOLEC MED, V116, P103; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	30	461	482	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					816	U9		10.1038/nature06042	http://dx.doi.org/10.1038/nature06042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653195	Green Accepted			2022-12-28	WOS:000248754200042
J	Hildesheim, A; Herrero, R; Wacholder, S; Rodriguez, AC; Solomon, D; Bratti, MC; Schiller, JT; Gonzalez, P; Dubin, G; Porras, C; Jimenez, SE; Lowy, DR				Hildesheim, Allan; Herrero, Rolando; Wacholder, Sholom; Rodriguez, Ana C.; Solomon, Diane; Bratti, M. Concepcion; Schiller, John T.; Gonzalez, Paula; Dubin, Gary; Porras, Carolina; Jimenez, Silvia E.; Lowy, Douglas R.		Costa Rican HPV Vaccine Tr	Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CELLULAR IMMUNE-RESPONSES; BROAD-SPECTRUM; EFFICACY; PCR; DNA; NEOPLASIA; ASSAY	Context Viruslike particle human papillomavirus (HPV) vaccines were designed to prevent HPV infection and development of cervical precancers and cancer. Women with oncogenic HPV infections might consider vaccination as therapy. Objective To determine whether vaccination against HPV types 16 and 18 increases the rate of viral clearance in women already infected with HPV. Design and Setting Phase 3, masked, community-based randomized trial conducted in 2 provinces of Costa Rica. Participants A total of 2189 women aged 18 to 25 years who were recruited between June 2004 and December 2005. Participants were positive for HPV DNA at enrollment, had at least 6 months of follow-up, and had follow-up HPV DNA results. Intervention Participants were randomly assigned to receive 3 doses of a bivalent HPV-16/18 L1 protein viruslike particle ASO4 candidate vaccine (n = 1088) or a control hepatitis A vaccine (n = 1101) over 6 months. Main Outcome Measures Presence of HPV DNA was determined in cervical specimins by a molecular hybridization assay using chemiluminescence with HPV RNA probes and by polymerase chain reaction using SPF10 primers and a line probe assay detection system before vaccination and by polymerase chain reaction after vaccination. We compared rates of type-specific viral clearance using generalized estimating equations methods at the 6-month visit (after 2 doses) and 12-month visit (after 3 doses) in the 2 study groups. Results There was no evidence of increased viral clearance at 6 or 12 months in the group who received HPV vaccine compared with the control group. Clearance rates for HPV-16/18 infections at 6 months were 33.4% (82/248) in the HPV vaccine group and 31.6% (95/298) in the control group (vaccine efficacy for viral clearance, 2.5%; 95% confidence interval, -9.8% to 13.5%). Human papillomavirus 16/ 18 clearance rates at 12 months were 48.8% (86/177) in the HPV vaccine group and 49.8% (110/220) in the control group (vaccine efficacy for viral clearance, -2.0%; 95% confidence interval, -24.3% to 16.3%). There was no evidence of a therapeutic effect for other oncogenic or nononcogenic HPV categories, among women receiving all vaccine doses, among women with single infections, or among women stratified by the following entry variables: HPV-16/18 serology, cytologic results, HPV DNA viral load, time since sexual debut, Chlamydia trachomatis or Neisseria gonorrhoeae infection, hormonal contraceptive use, or smoking. Conclusion In women positive for HPV DNA, HPV-16/18 vaccination does not accelerate clearance of the virus and should not be used to treat prevalent infections.	NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Proyecto Epidemiol Guanacaste, San Jose, Costa Rica	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Herrero, R (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd,Ste 550, Rockville, MD 20852 USA.	Rherrero@amnet.co.cr	Schiller, John/ABK-8287-2022		NCI NIH HHS [N01-CP-11005] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC009052, Z01BC009052, Z01BC010579, ZIABC010579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Emeny RT, 2002, J VIROL, V76, P7832, DOI 10.1128/JVI.76.15.7832-7842.2002; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Kirnbauer R, 1996, VIROLOGY, V219, P37, DOI 10.1006/viro.1996.0220; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Peng SW, 1998, VIROLOGY, V240, P147, DOI 10.1006/viro.1997.8912; Pinto LA, 2005, VACCINE, V23, P3555, DOI 10.1016/j.vaccine.2005.01.146; Pinto LA, 2003, J INFECT DIS, V188, P327, DOI 10.1086/376505; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Schachter J, 1999, J CLIN MICROBIOL, V37, P3668, DOI 10.1128/JCM.37.11.3668-3671.1999; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2006, CANC EPIDEMIOLOGY PR, P1044; Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8	28	447	479	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					743	753		10.1001/jama.298.7.743	http://dx.doi.org/10.1001/jama.298.7.743			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699008	Bronze			2022-12-28	WOS:000248728800019
J	Blencowe, M				Blencowe, Miles			Applied physics - How to strum a nanobar	SCIENCE			English	Editorial Material									Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	Dartmouth College	Blencowe, M (corresponding author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.	blencowe@dartmouth.edu						CADY WA, 1978, PIEZOELECTRICITY; Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373; Essinger James, 2004, JACQUARDS WEB; Knoll A, 2006, MICROELECTRON ENG, V83, P1261, DOI 10.1016/j.mee.2006.01.219; Masmanidis SC, 2007, SCIENCE, V317, P780, DOI 10.1126/science.1144793; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; SODERKVIST J, 1994, J MICROMECH MICROENG, V4, P28, DOI 10.1088/0960-1317/4/1/004; SWADE D, 2001, DIFFERENCE ENGINE; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Wong AC, 2004, J MICROELECTROMECH S, V13, P100, DOI 10.1109/JMEMS.2003.823218; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m	11	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					762	763		10.1126/science.1146803	http://dx.doi.org/10.1126/science.1146803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690283				2022-12-28	WOS:000248624500027
J	Burns, T				Burns, Tom			Is it acceptable for people to be paid to adhere to medication?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; NHS Direct, London EC1V 9PS, England		Burns, T (corresponding author), Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	tom.burns@psych.ox.ac.uk							0	22	24	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					232	233		10.1136/bmj.39286.399514.BE	http://dx.doi.org/10.1136/bmj.39286.399514.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201QC	17673764	Green Published			2022-12-28	WOS:000248846700024
J	Key, NS; Negrier, C				Key, Nigel S.; Negrier, Claude			Transfusion Medicine 3 - Coagulation factor concentrates: past,, present, and future	LANCET			English	Review							RECOMBINANT-FACTOR-VIIA; PROTHROMBIN-COMPLEX CONCENTRATE; PREVIOUSLY UNTREATED PATIENTS; ACTIVATED-FACTOR-VII; VON-WILLEBRAND-DISEASE; FRESH-FROZEN PLASMA; PROTEIN-C CONCENTRATE; CHRONIC LIVER-DISEASE; SEVERE HEMOPHILIA-A; CREUTZFELDT-JAKOB-DISEASE	Clotting factor transfusions are vital for people with diseases such as haemophilia. In the 1970s and 1980s, transfusions with pooled plasma led to a devastatingly high number of recipients becoming infected with blood-borne pathogens such as HIV and hepatitis C. This epidemic triggered the development of virus-free factor concentrates through a combination of improved donor selection and screening, effective virucidal technologies, and recombinant protein expression biotechnology. There is now a wide range of recombinant factor concentrates, and an impressive safety record with respect to pathogen transmission. However, remaining therapeutic challenges include the potential threat of transmission of prions and other pathogens, the formation of inhibitory alloantibodies, and the international disparity that exists in product availability due to differences in licensure status as well as prohibitively high costs. In the future, it is likely that bioengineered recombinant proteins that have been modified to enhance pharmacokinetic properties or reduce immumogenicity, or both, will be used increasingly in clinical practice.	Univ N Carolina, Sch Med, Chapel Hill, NC USA; Harold R Roberts Comprehens Hemophilia Diagnost &, Chapel Hill, NC USA; Hop Edouard Herriot, Ctr Natl Reference Hemophilie, Unite Hemostase Clin, Lyon, France	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; CHU Lyon	Key, NS (corresponding author), 932 Mary Ellen Jones Bldg,CB 7035, Chapel Hill, NC 27599 USA.	Nigel_Key@med.unc.edu		Negrier, Claude/0000-0003-3569-0366; Chamouard, Valerie/0000-0002-4443-1609				Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abshire T, 2004, J THROMB HAEMOST, V2, P899, DOI 10.1111/j.1538-7836.2004.00759.x; Aledort LM, 2005, AM J HEMATOL, V80, P301, DOI 10.1002/ajh.20565; Allen G, 2006, AM J HEMATOL, V81, P71, DOI 10.1002/ajh.20474; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; ARONSTAM A, 1993, ARCH DIS CHILD, V68, P521, DOI 10.1136/adc.68.4.521; Avidan MS, 2005, J THORAC CARDIOV SUR, V130, P107, DOI 10.1016/j.jtcvs.2004.10.045; Baglin TP, 2006, BRIT J HAEMATOL, V132, P277, DOI 10.1111/j.1365-2141.2005.05856.x; Baker RI, 2004, MED J AUSTRALIA, V181, P492, DOI 10.5694/j.1326-5377.2004.tb06407.x; Barrow RT, 2006, J THROMB HAEMOST, V4, P2223, DOI 10.1111/j.1538-7836.2006.02135.x; BARROWCLIFFE TW, 1973, VOX SANG, V25, P426, DOI 10.1111/j.1423-0410.1973.tb03534.x; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERNTORP E, 2007, BLOOD, V109, P546; Bijsterveld NR, 2004, BRIT J HAEMATOL, V124, P653, DOI 10.1111/j.1365-2141.2003.04811.x; Bijsterveld NR, 2002, CIRCULATION, V106, P2550, DOI 10.1161/01.CIR.0000038501.87442.02; BLATT PM, 1974, ANN INTERN MED, V81, P766, DOI 10.7326/0003-4819-81-6-766; Blumel J, 2002, TRANSFUSION, V42, P1473, DOI 10.1046/j.1537-2995.2002.00221.x; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; BOLTONMAGGS PHB, 1988, BRIT J HAEMATOL, V69, P521, DOI 10.1111/j.1365-2141.1988.tb02409.x; BOLTONMAGGS PHB, 1992, THROMB HAEMOSTASIS, V67, P314; BRAY GL, 1994, BLOOD, V83, P2428; BRINKHOUS KM, 1968, J AMER MED ASSOC, V205, P613, DOI 10.1001/jama.205.9.613; BRUNING PF, 1971, BRIT J HAEMATOL, V21, P377, DOI 10.1111/j.1365-2141.1971.tb02699.x; Budde U, 2006, SEMIN THROMB HEMOST, V32, P626, DOI 10.1055/s-2006-949668; Chandler WL, 2001, BLOOD COAGUL FIBRIN, V12, P101, DOI 10.1097/00001721-200103000-00003; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; Dao A, 2005, AM J MED, V118, P1172, DOI 10.1016/j.amjmed.2005.04.025; Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009; Di Paola J, 2001, HAEMOPHILIA, V7, P16, DOI 10.1046/j.1365-2516.2001.00100.x; DREYFUS M, 1991, NEW ENGL J MED, V325, P1565, DOI 10.1056/NEJM199111283252207; Dusel CH, 2004, BLOOD COAGUL FIBRIN, V15, P405, DOI 10.1097/01.mbc.0000114437.81125.2b; Dzik Walter H, 2006, J Intensive Care Med, V21, P54, DOI 10.1177/0885066605285223; Ehrlich HJ, 2002, HAEMOPHILIA, V8, P83, DOI 10.1046/j.1365-2516.2002.00532.x; Erber WN, 2002, TRANSFUS APHER SCI, V27, P83, DOI 10.1016/S1473-0502(02)00029-0; Evans G, 2001, BRIT J HAEMATOL, V115, P998, DOI 10.1046/j.1365-2141.2001.03214.x; Farrugia A, 2005, VOX SANG, V89, P186, DOI 10.1111/j.1423-0410.2005.00702.x; Feldman BM, 2006, J THROMB HAEMOST, V4, P1228, DOI 10.1111/j.1538-7836.2006.01953.x; Fiedler H, 1998, VOX SANG, V75, P72, DOI 10.1046/j.1423-0410.1998.75100721.x; Fischer K, 2003, HAEMOPHILIA, V9, P376, DOI 10.1046/j.1365-2516.2003.00764.x; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; GILL JC, 1983, J PEDIATR-US, V103, P18, DOI 10.1016/S0022-3476(83)80768-9; Gill JC, 2003, HAEMOPHILIA, V9, P688, DOI 10.1046/j.1351-8216.2003.00816.x; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Goudemand J, 2005, J THROMB HAEMOST, V3, P2219, DOI 10.1111/j.1538-7836.2005.01435.x; Grothaus-Pinke B, 2001, TRANSPLANTATION, V72, P1456, DOI 10.1097/00007890-200110270-00022; Grundmann C, 2005, THROMB HAEMOSTASIS, V94, P1338, DOI 10.1055/s-0037-1615589; HAMPTON KK, 1991, BLOOD COAGUL FIBRIN, V2, P637, DOI 10.1097/00001721-199110000-00008; Heindl B, 2005, ANAESTHESIST, V54, P787, DOI 10.1007/s00101-005-0865-7; Hellstern P, 1997, VOX SANG, V73, P155, DOI 10.1046/j.1423-0410.1997.7330155.x; Hemphill JC, 2006, STROKE, V37, P6, DOI 10.1161/01.STR.0000195152.46506.3e; HILGARTNER M, 1990, TRANSFUSION, V30, P626, DOI 10.1046/j.1537-2995.1990.30790385521.x; Hirsh J, 2005, BLOOD, V105, P453, DOI 10.1182/blood-2003-12-4195; KARCK M, 1994, EUR J ANAESTH, V11, P475; KASPER CK, 1972, J AMER MED ASSOC, V221, P510, DOI 10.1001/jama.1972.03200180052024; KASPER CK, 2005, WORLD FED HEMOPHIL M, V6, P1; Key NS, 2004, SEMIN HEMATOL, V41, P51, DOI 10.1053/j.seminhematol.2003.11.011; Key NS, 2004, BRIT J HAEMATOL, V127, P379, DOI 10.1111/j.1365-2141.2004.05168.x; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Kohler M, 1999, THROMB RES, V95, pS13, DOI 10.1016/S0049-3848(99)00079-1; Konkle BA, 2003, TRANSFUSION, V43, P390, DOI 10.1046/j.1537-2995.2003.00315.x; Kreuz W, 2005, TRANSFUS APHER SCI, V32, P247, DOI 10.1016/j.transci.2004.08.003; Kreuz W, 2005, THROMB HAEMOSTASIS, V93, P457, DOI 10.1160/TH03-10-0643; LECHNER K, 1995, THROMB HAEMOSTASIS, V73, P340; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Lofqvist T, 1997, J INTERN MED, V241, P395, DOI 10.1046/j.1365-2796.1997.130135000.x; Lorenz R, 2003, EUR J GASTROEN HEPAT, V15, P15, DOI 10.1097/00042737-200301000-00004; Lorenz Reinhard, 1996, Seminars in Thrombosis and Hemostasis, V22, P451, DOI 10.1055/s-2007-999045; Lovejoy AE, 2006, BLOOD, V108, P57, DOI 10.1182/blood-2005-02-0788; Ludlam CA, 2006, BRIT J HAEMATOL, V132, P13, DOI 10.1111/j.1365-2141.2005.05796.x; Ludlam CA, 2006, LANCET, V367, P252, DOI 10.1016/S0140-6736(06)68036-7; Lusher J, 2004, J THROMB HAEMOST, V2, P574, DOI 10.1111/j.1538-7933.2004.00646.x; LUSHER JM, 1980, NEW ENGL J MED, V303, P421, DOI 10.1056/NEJM198008213030803; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; LUSHER JM, 1983, BLOOD, V62, P1135; LUSHER JM, 1984, NEW ENGL J MED, V310, P464; MAKRIS M, 1990, LANCET, V335, P1117, DOI 10.1016/0140-6736(90)91124-S; Manco-Johnson MJ, 2005, BLOOD, V106, p6A; MANNUCCI PM, 1976, LANCET, V2, P542; MANNUCCI PM, 1975, J CLIN PATHOL, V28, P620, DOI 10.1136/jcp.28.8.620; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; Mannucci PM, 2002, BLOOD, V99, P450, DOI 10.1182/blood.V99.2.450; Mannucci PM, 2001, BLOOD, V97, P1915, DOI 10.1182/blood.V97.7.1915; Mariani G, 2000, BLOOD, V96, P374, DOI 10.1182/blood.V96.1.374.013k56d_374_374; Mariani G, 2006, HAEMOPHILIA, V12, P19, DOI 10.1111/j.1365-2516.2006.01180.x; Mathijssen NCJ, 2004, BRIT J HAEMATOL, V125, P494, DOI 10.1111/j.1365-2141.2004.04942.x; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mitchell L, 2003, THROMB HAEMOSTASIS, V90, P235, DOI 10.1160/TH02-11-0283; Monroe DM, 1998, BLOOD COAGUL FIBRIN, V9, pS15; *NAT HEM FDN, 2001, MED SCI ADV BOARD RE; Negrier C, 1997, THROMB HAEMOSTASIS, V77, P1113; Nugent DJ, 2006, THROMB RES, V118, pS23, DOI 10.1016/j.thromres.2006.02.009; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Parameswaran R, 2005, HAEMOPHILIA, V11, P100, DOI 10.1111/j.1365-2516.2005.01075.x; Parameswaran R, 2000, HAEMOPHILIA, V6, P705, DOI 10.1046/j.1365-2516.2000.00448.x; Peerlinck K, 1997, THROMB HAEMOSTASIS, V77, P80; Perry  DJ, 2002, BRIT J HAEMATOL, V118, P689, DOI 10.1046/j.1365-2141.2002.03545.x; Pescatore S L, 2001, Expert Opin Pharmacother, V2, P431, DOI 10.1517/14656566.2.3.431; Peyvandi F, 2006, J THROMB HAEMOST, V4, P1634, DOI 10.1111/j.1538-7836.2006.02014.x; Pipe SW, 2005, J THROMB HAEMOST, V3, P1692, DOI 10.1111/j.1538-7836.2005.01367.x; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rivard GE, 2003, HAEMOPHILIA, V9, P711, DOI 10.1046/j.1351-8216.2003.00814.x; RIVARD GE, 1995, J PEDIATR-US, V126, P646, DOI 10.1016/S0022-3476(95)70369-1; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Rosenberg PS, 1998, STAT MED, V17, P155, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;155::AID-SIM758&gt;3.0.CO;2-O; ROSENDAAL FR, 1993, BLOOD, V81, P2180; Santagostino E, 2006, J THROMB HAEMOST, V4, P367, DOI 10.1111/j.1538-7836.2006.01772.x; SANTAGOSTINO E, 1994, THROMB HAEMOSTASIS, V71, P737; Sanz-Rodriguez C, 1999, THROMB HAEMOSTASIS, V81, P887, DOI 10.1055/s-0037-1614593; Schmidt B, 1998, AM J RESP CRIT CARE, V158, P470, DOI 10.1164/ajrccm.158.2.9712116; Schneider B, 2004, THROMB HAEMOSTASIS, V92, P838, DOI 10.1160/TH04-04-0229; Shapiro AD, 2005, BLOOD, V105, P518, DOI 10.1182/blood-2004-06-2283; Siddiqui MAA, 2005, DRUGS, V65, P1161, DOI 10.2165/00003495-200565080-00008; SJAMSOEDIN LJM, 1981, NEW ENGL J MED, V305, P717, DOI 10.1056/NEJM198109243051301; Skinner MW, 2006, HAEMOPHILIA, V12, P169, DOI 10.1111/j.1365-2516.2006.01280.x; Sorensen B, 2005, HAEMOPHILIA, V11, P1, DOI 10.1111/j.1365-2516.2005.01156.x; Spira J, 2006, BLOOD, V108, P3668, DOI 10.1182/blood-2006-03-008276; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Turecek PL, 1999, VOX SANG, V77, P72, DOI 10.1159/000056722; Turecek PL, 2003, PATHOPHYSIOL HAEMO T, V33, P16, DOI 10.1159/000071637; *US FDA, 2005 SAF AL XIGR DRO; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; WEBSTER WP, 1965, AM J MED SCI, V250, P643, DOI 10.1097/00000441-196512000-00005; Yasaka M, 2005, THROMB RES, V115, P455, DOI 10.1016/j.thromres.2004.09.002; 2005, THROMB HAEMOST, V94, P8	135	142	153	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					439	448		10.1016/S0140-6736(07)61199-4	http://dx.doi.org/10.1016/S0140-6736(07)61199-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679021				2022-12-28	WOS:000248590200034
J	Mocroft, A; Phillips, A; Gatell, J; Ledergerber, B; Fisher, M; Clumeck, N; Losso, M; Lazzarin, A; Fatkenheuer, G; Lundgren, JD				Mocroft, A.; Phillips, A.; Gatell, J.; Ledergerber, B.; Fisher, M.; Clumeck, N.; Losso, M.; Lazzarin, A.; Fatkenheuer, G.; Lundgren, J. D.		EuroSIDA Study Grp	Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study	LANCET			English	Article							CELL COUNT; POSITIVE INDIVIDUALS; CLINICAL-PRACTICE; VIRUS-INFECTION; T-LYMPHOCYTES; RECOVERY; INCREASES; EUROSIDA; INTERRUPTION; PROGRESSION	Background Combination antiretroviral therapy (cART) has been shown to reduce mortality and morbidity in patients with HIV. As viral replication falls, the CD4 count increases, but whether the CD4 count returns to the level seen in HIV-negative people is unknown. We aimed to assess whether the CD4 count for patients with maximum virological suppression (viral load <50 copies per mL) continues to increase with long-term CART to reach levels seen in HIV-negative populations. Methods We compared increases in CD4 counts in 1835 antiretroviral-naive patients who started CART from EuroSIDA, a pan-European observational cohort study. Rate of increase in CD4 count (per year) occurring between pairs of consecutive viral loads below 50 copies per mL was estimated using generalised linear models, accounting for multiple measurements for individual patients. Findings The median CD4 count at starting CART was 204 cells per mu L (IQR 85-330). The greatest mean yearly increase in CD4 count of 100 cells per mu L was seen in the year after starting CART. Significant, but lower, yearly increases in CD4 count, around 50 cells per mu L, were seen even at 5 years after starting CART in patients whose current CD4 count was less than 500 cells per mu L. The only groups without significant increases in CD4 count were those where CART had been taken for more than 5 years with a current CD4 count of more than 500 cells per mu L, (current mean CD4 count 774 cells per mu L; 95% CI 764-783). Patients starting CART with low CD4 counts (<200 cells per mu L) had significant rises in CD4 counts even after 5 years of CART. Interpretation Normalisation. of CD4 counts in HIV-infected patients for all infected individuals might be achievable if viral suppression with cART can be maintained for a sufficiently long period of time.	UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Hosp Clin Barcelona, Barcelona, Spain; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; St Pierre Hosp, Brussels, Belgium; Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; Univ Milan, Osped San Raffaele, I-20127 Milan, Italy; Univ Cologne, Cologne, Germany; Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-1168 Copenhagen, Denmark	University of London; University College London; University of London; University College London; University of Barcelona; Hospital Clinic de Barcelona; University of Zurich; University Zurich Hospital; University of Brighton; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hospital Ramos Mejia; University of Buenos Aires; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cologne; University of Copenhagen	Mocroft, A (corresponding author), UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, Royal Free Campus, London NW3 2PF, England.	a.mocroft@pcps.uci.ac.uk	Mocroft, Amanda/C-1527-2008; VALLET, Yannick/F-9979-2011; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008; Ledergerber, Bruno/B-5656-2009; Mocroft, Amanda/G-8748-2011; LAZZARIN, Adriano/K-3607-2018	Phillips, Andrew N/0000-0003-2384-4807; Ledergerber, Bruno/0000-0002-6881-4401; Mocroft, Amanda/0000-0001-8316-1122; LAZZARIN, Adriano/0000-0003-2551-7754				AidsInfo, GUID US ANT AG HIV 1; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Coakley EPG, 2000, AIDS, V14, P1147, DOI 10.1097/00002030-200006160-00011; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maini MK, 1996, GENITOURIN MED, V72, P27; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Monforte AD, 2005, JAIDS-J ACQ IMM DEF, V38, P407, DOI 10.1097/01.qai.0000147529.57240.b0; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Taffe P, 2002, AIDS, V16, P747, DOI 10.1097/00002030-200203290-00010; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678	40	195	198	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					407	413		10.1016/S0140-6736(07)60948-9	http://dx.doi.org/10.1016/S0140-6736(07)60948-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17659333				2022-12-28	WOS:000248590200030
J	Huang, J; Juszkiewicz, M; de Jeu, WH; Cerda, E; Emrick, T; Menon, N; Russell, TP				Huang, Jiangshui; Juszkiewicz, Megan; de Jeu, Wim H.; Cerda, Enrique; Emrick, Todd; Menon, Narayanan; Russell, Thomas P.			Capillary wrinkling of floating thin polymer films	SCIENCE			English	Article								A freely floating polymer film, tens of nanometers in thickness, wrinkles under the capillary force exerted by a drop of water placed on its surface. The wrinkling pattern is characterized by the number and length of the wrinkles. The dependence of the number of wrinkles on the elastic properties of the film and on the capillary force exerted by the drop confirms recent theoretical predictions on the selection of a pattern with a well-defined length scale in the wrinkling instability. We combined scaling relations that were developed for the length of the wrinkles with those for the number of wrinkles to construct a metrology for measuring the elasticity and thickness of ultrathin films that relies on no more than a dish of fluid and a low-magnification microscope. We validated this method on polymer films modified by plasticizer. The relaxation of the wrinkles affords a simple method to study the viscoelastic response of ultrathin films.	Univ Massachusetts, Dept Phys, Amherst, MA USA; Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 31003 USA; FOM, Inst Atom & Mol Phys, Amsterdam, Netherlands; Univ Santiago Chile, Dept Fis, Santiago, Chile	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; AMOLF; Universidad de Santiago de Chile	Menon, N (corresponding author), Univ Massachusetts, Dept Phys, Amherst, MA USA.	menon@physics.umass.edu; russell@pse.umail.umass.edu	Huang, Jiangshui/G-5833-2010; Russell, Thomas Paul/ADL-3689-2022	Huang, Jiangshui/0000-0002-3523-2165; Russell, Thomas Paul/0000-0001-6384-5826				Bodiguel H, 2006, EUR PHYS J E, V19, P185, DOI 10.1140/epje/e2006-00021-8; Brandrup J., 1989, POLYM HDB, V3rd ed.; Cerda E, 2005, J BIOMECH, V38, P1598, DOI 10.1016/j.jbiomech.2004.07.026; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Cerda E, 2002, NATURE, V419, P579, DOI 10.1038/419579b; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Geminard JC, 2004, EUR PHYS J E, V15, P117, DOI 10.1140/epje/i2004-10041-1; Genzer J, 2006, SOFT MATTER, V2, P310, DOI 10.1039/b516741h; Landau LD, 1986, THEORY ELASTICITY CO, V7; McCrum NG, 1967, ANELASTIC DIELECTRIC; Miyake K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234648; Russell T. P., 1990, Material Science Reports, V5, P171, DOI 10.1016/S0920-2307(05)80002-7; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Timoshenko SP., 1987, THEORY ELASTICITY	14	391	394	6	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					650	653		10.1126/science.1144616	http://dx.doi.org/10.1126/science.1144616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673658				2022-12-28	WOS:000248494400042
J	Mueller, SN; Hosiawa-Meagher, KA; Konieczny, BT; Sullivan, BM; Bachmann, MF; Locksley, RM; Ahmed, R; Matloubian, M				Mueller, Scott N.; Hosiawa-Meagher, Karoline A.; Konieczny, Bogumila T.; Sullivan, Brandon M.; Bachmann, Martin F.; Locksley, Richard M.; Ahmed, Rafi; Matloubian, Mehrdad			Regulation of homeostatic chemokine expression and cell trafficking during immune responses	SCIENCE			English	Article							LYMPHOID-ORGAN CHEMOKINE; MICE LACKING EXPRESSION; DENDRITIC CELLS; MIGRATION; MOTILITY; LIGANDS; NODES; SLC	The chemokines CCL21 and CXCL13 are immune factors that dictate homing and motility of lymphocytes and dendritic cells in lymphoid tissues. However, the means by which these chemokines are regulated and how they influence cell trafficking during immune responses remain unclear. We show that CCL21 and CXCL13 are transiently down-regulated within lymphoid tissues during immune responses by a mechanism controlled by the cytokine interferon-gamma. This modulation was found to alter the localization of lymphocytes and dendritic cells within responding lymphoid tissues. As a consequence, priming of T cell responses to a second distinct pathogen after chemokine modulation became impaired. We propose that this transient chemokine modulation may help orchestrate local cellularity, thus minimizing competition for space and resources in activated lymphoid tissues.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Cytos Biotechnol AG, CH-8952 Schlieren, Switzerland	Emory University; Emory University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mueller, SN (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mueller@microbio.emory.edu	Mueller, Scott N/B-1918-2012	Mueller, Scott N/0000-0002-3838-3989	NIAID NIH HHS [AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Saeki H, 1999, J IMMUNOL, V162, P2472; Serra HM, 2004, ALLERGY, V59, P1219, DOI 10.1111/j.1398-9995.2004.00531.x; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	18	199	204	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					670	674		10.1126/science.1144830	http://dx.doi.org/10.1126/science.1144830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673664				2022-12-28	WOS:000248494400048
J	Fonseca, EB; Celik, E; Parra, M; Singh, M; Nicolaides, KH; Thornton, S; Alfirevic, Z; Smith, G; Radhakrishnan, P; Khoury, O; Divianathan, L; Kaul, A; Rao, A; Kuppusamy, R; Molina, F; Turan, S; Gajewska, K; Palanappian, V; Paramasivam, G; Atzei, A; Poggi, S; Vafaie, H; Hagan, P; Coward, H; Milovanovic, Z; Nikolopoulou, D; Tsolakidis, F; Rencoret, G; Pedraza, D; Valdes, E; Valadares, S; Damiao, R; Skentou, H				Fonseca, Eduardo B.; Celik, Ebru; Parra, Mauro; Singh, Mandeep; Nicolaides, Kypros H.; Thornton, S.; Alfirevic, Z.; Smith, G.; Radhakrishnan, P.; Khoury, O.; Divianathan, L.; Kaul, A.; Rao, A.; Kuppusamy, R.; Molina, F.; Turan, S.; Gajewska, K.; Palanappian, V.; Paramasivam, G.; Atzei, A.; Poggi, S.; Vafaie, H.; Hagan, P.; Coward, H.; Milovanovic, Z.; Nikolopoulou, D.; Tsolakidis, F.; Rencoret, G.; Pedraza, D.; Valdes, E.; Valadares, S.; Damiao, R.; Skentou, H.		Fetal Med Fdn Second Trimester Scr	Progesterone and the risk of preterm birth among women with a short cervix	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH; PREDICTION; DELIVERY; CAPROATE; AGE	Background: Previous randomized trials have shown that progesterone administration in women who previously delivered prematurely reduces the risk of recurrent premature delivery. Asymptomatic women found at midgestation to have a short cervix are at greatly increased risk for spontaneous early preterm delivery, and it is unknown whether progesterone reduces this risk in such women. Methods: Cervical length was measured by transvaginal ultrasonography at a median of 22 weeks of gestation (range, 20 to 25) in 24,620 pregnant women seen for routine prenatal care. Cervical length was 15 mm or less in 413 of the women (1.7%), and 250 (60.5%) of these 413 women were randomly assigned to receive vaginal progesterone (200 mg each night) or placebo from 24 to 34 weeks of gestation. The primary outcome was spontaneous delivery before 34 weeks. Results: Spontaneous delivery before 34 weeks of gestation was less frequent in the progesterone group than in the placebo group (19.2% vs. 34.4%; relative risk, 0.56; 95% confidence interval [CI], 0.36 to 0.86). Progesterone was associated with a nonsignificant reduction in neonatal morbidity (8.1% vs. 13.8%; relative risk, 0.59; 95% CI, 0.26 to 1.25; P=0.17). There were no serious adverse events associated with the use of progesterone. Conclusions: In women with a short cervix, treatment with progesterone reduces the rate of spontaneous early preterm delivery. (ClinicalTrials.gov number, NCT00422526.).	Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr, London SE5 8RX, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Nicolaides, KH (corresponding author), Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr, Denmark Hill, London SE5 8RX, England.	kypros@fetalmedicine.com	Thornton, Steven/A-7898-2013; Celik, ebru/X-4343-2019; Fonseca, Eduardo/A-2490-2013; Celik, Ebru/B-3860-2013; Parra-Cordero, Mauro/H-8367-2014	Celik, ebru/0000-0002-0774-4294; Celik, Ebru/0000-0002-0774-4294; Nicolaides, Kypros/0000-0003-1266-0711				ACOG Committee Opinion, 2003, OBSTET GYNECOL, V102, P1115; Brent RL, 2005, BIRTH DEFECTS RES A, V73, P906, DOI 10.1002/bdra.20184; Clement S, 2003, ULTRASOUND OBST GYN, V22, P508, DOI 10.1002/uog.893; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Friedler S, 1999, HUM REPROD, V14, P1944, DOI 10.1093/humrep/14.8.1944; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; HENDRICKX AG, 1987, TERATOLOGY, V35, P129, DOI 10.1002/tera.1420350116; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mathews T J, 2000, Natl Vital Stat Rep, V48, P1; Meis PJ, 2003, NEW ENGL J MED, V349, P1087; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; MILES RA, 1994, FERTIL STERIL, V62, P485; *OFF POP CENS SURV, 2004, NHS MAT STAT ENGL 20; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; To MS, 2006, AM J OBSTET GYNECOL, V194, P1360, DOI 10.1016/j.ajog.2005.11.001; To MS, 2006, ULTRASOUND OBST GYN, V27, P362, DOI 10.1002/uog.2773; To MS, 2001, ULTRASOUND OBST GYN, V17, P217, DOI 10.1046/j.1469-0705.2001.00369.x; VEEN S, 1991, LANCET, V338, P33, DOI 10.1016/0140-6736(91)90015-H; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	26	733	760	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					462	469		10.1056/NEJMoa067815	http://dx.doi.org/10.1056/NEJMoa067815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671254	Bronze			2022-12-28	WOS:000248436300007
J	Silverman, JG; Decker, MR; Gupta, J; Maheshwari, A; Willis, BM; Raj, A				Silverman, Jay G.; Decker, Michele R.; Gupta, Jhumka; Maheshwari, Ayonija; Willis, Brian M.; Raj, Anita			HIV prevalence and predictors of infection in sex-trafficked Nepalese girls and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; INDIA; WORKERS; MUMBAI; PROSTITUTION; EXPERIENCE; EPIDEMIC; ASIA	Context Sex trafficking of girls and women is widespread across South Asia and is recognized as both a violent gender-based crime and major human rights violation. Inadequate empirical data exist to characterize this phenomenon and its related health consequences, such as human immunodeficiency virus (HIV) infection. Objective To determine the prevalence of HIV infection among repatriated sex-trafficked Nepalese girls and women and to identify trafficking-related predictors of such infection. Design Medical and case records of 287 repatriated girls and women reporting being trafficked from Nepal for sexual exploitation and receiving rehabilitative services between January 1997 and December 2005 at a major nongovernmental organization were systematically reviewed in January 2006. Setting Major Nepalese nongovernmental organization providing shelter and care to repatriated survivors of sex trafficking. Main Outcome Measures Prevalence of and risk for HIV based on demographic characteristics and on trafficking- and prostitution-related experiences. Results Among 287 repatriated Nepalese sex-trafficked girls and women, 109 (38.0%) tested positive for HIV. Among those with complete documentation of trafficking experiences (n=225), median age at time of trafficking was 17.0 years, with 33 (14.7%) trafficked prior to age 15 years. Compared with those trafficked at 18 years or older, girls trafficked prior to age 15 years were at increased risk for HIV ( adjusted odds ratio [AOR], 3.70; 95% confidence interval [CI], 1.32-10.34), with 20 of 33 (60.6%) infected among this youngest age group. Additional factors associated with HIV positivity included being trafficked to Mumbai ( AOR, 4.85; 95% CI, 2.16-10.89) and longer duration of forced prostitution ( AOR, 1.02; 95% CI, 1.01-1.03; indicating increased risk per additional month of brothel servitude). In post hoc analyses, girls trafficked prior to age 15 years had increased odds of having been detained in multiple brothels ( odds ratio [ OR], 5.03; 95% CI, 1.96-12.93) and in brothels for a duration of 1 year or more ( OR, 2.67; 95% CI, 1.12-6.33) vs those trafficked at 18 years or older. Conclusions In this study, repatriated Nepalese sex-trafficked girls and women were found to have a high prevalence of HIV infection, with increased risk among those trafficked prior to age 15 years. Present findings demonstrate the need for greater attention to reducing and intervening in sex trafficking in South Asia, particularly among the very young.	Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; ECPAT Int, Washington, DC USA; Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Boston University	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 667 Huntington Ave, Boston, MA 02115 USA.	jsilverm@hsph.harvard.edu		Decker, Michele/0000-0002-7085-7080	NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bansal R K, 1992, Indian J Matern Child Health, V3, P108; Beyrer C, 2001, SOC SCI MED, V53, P543, DOI 10.1016/S0277-9536(00)00358-0; BEYRER C, 2003, BROWN J WORLD AFFAIR, V10, P105; *C RES SERV, 2001, TRAFF WOM CHILDR US; Chakraborty A. K., 1994, Journal of Communicable Diseases, V26, P161; Chander Anil, 2004, Nepal Med Coll J, V6, P60; Hennick M., 2004, ASIAN PAC MIGR J, V13, P305, DOI [10.1177/011719680401300302, DOI 10.1177/011719680401300302]; Hosain GMM, 2005, PUBLIC HEALTH, V119, P371, DOI 10.1016/j.puhe.2004.08.015; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Human Rights Watch, 1995, RAP PROF TRAFF NEP G; *JOINT UN PROGR HI, 2 5 MILL PEOPL LIV H; *JOINT UN PROGR HI, DEC 06 AIDS EP UPD; *JOINT UN PROGR HI, 2006, NEP COUNTR PROF; Kannangai R, 2003, JAIDS-J ACQ IMM DEF, V32, P573, DOI 10.1097/00126334-200304150-00018; Madhivanan P, 2005, SEX TRANSM DIS, V32, P685, DOI 10.1097/01.olq.0000175405.36124.3b; Nair P, 2004, REPORT TRAFFICKING W, VI; *NAT AIDS CONTROL, 2006, HIV AIDS EP SURV EST; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Raymond JG, 2004, VIOLENCE AGAINST WOM, V10, P1156, DOI 10.1177/1077801204268609; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Sharma V, 1996, Sex Marital Ther, V11, P147, DOI 10.1080/02674659608404426; Silverman JG, 2007, INT J GYNECOL OBSTET, V97, P221, DOI 10.1016/j.ijgo.2006.12.003; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Singh S, 2005, PLOS MED, V2, P705, DOI 10.1371/journal.pmed.0020216; UN, 2000, PROT PREV SUPPR PUN; *US DEP STAT, 2005, VICT TRAFF VIOL PROT; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; *WORLD BANK, 2006, HIV AIDS NEP; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	128	130	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					536	542		10.1001/jama.298.5.536	http://dx.doi.org/10.1001/jama.298.5.536			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666674	Bronze			2022-12-28	WOS:000248438100021
J	Chochinov, H				Chochinov, Harvey			Dignity and the essence of medicine: the A, B, C, and D of dignity conserving care	BRITISH MEDICAL JOURNAL			English	Editorial Material							TERMINALLY-ILL; LIFE; END; CANCER		Univ Manitoba, Dept Psychiat, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada	CancerCare Manitoba Foundation; University of Manitoba	Chochinov, H (corresponding author), Univ Manitoba, Dept Psychiat, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.	harvey.chochinov@cancercare.mb.ca		Chochinov, Harvey/0000-0003-2656-4704				Bollinger J L, 1978, Bull Am Protestant Hosp Assoc, V42, P90; Breitbart W, 2002, SUPPORT CARE CANCER, V10, P272, DOI 10.1007/s005200100289; Broyard, 1992, INTOXICATED MY ILLNE; BULTER RN, 1963, PSYCHIATRY, V26, P65; Burt RA, 2002, DEATH IS MAN TAKING; CALLAHAN D, 1993, HASTINGS CENT REP, V23, P33, DOI 10.2307/3562588; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Chochinov HM, 2006, J PALLIAT MED, V9, P666, DOI 10.1089/jpm.2006.9.666; Chochinov Harvey Max, 2005, J Palliat Med, V8 Suppl 1, pS103; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Chochinov HM, 2004, J CLIN ONCOL, V22, P1336, DOI 10.1200/JCO.2004.12.095; Chochinov HM, 2002, LANCET, V360, P2026, DOI 10.1016/S0140-6736(02)12022-8; CHOCHINOV HM, IN PRESS J PAIN SYMP; LOUHIVUORI KA, 1979, AM J EPIDEMIOL, V109, P59, DOI 10.1093/oxfordjournals.aje.a112659; Lovell M, 2006, J VASC NURS, V24, P22, DOI 10.1016/j.jvn.2005.11.001; McPherson CJ, 2007, SOC SCI MED, V64, P417, DOI 10.1016/j.socscimed.2006.09.013; Mount B, 1993, Am J Hosp Palliat Care, V10, P28, DOI 10.1177/104990919301000109; Murata Hisayuki, 2003, Palliat Support Care, V1, P15; PEABODY FW, 1927, JAMA-J AM MED ASSOC, V88, P876, DOI DOI 10.1001/JAMA.252.6.813; Remen RN, 2001, WESTERN J MED, V175, P353, DOI 10.1136/ewjm.175.5.353; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; SPIRO H, 1992, ANN INTERN MED, V116, P843, DOI 10.7326/0003-4819-116-10-843; Stienstra D, 2006, J PALLIAT CARE, V22, P166, DOI 10.1177/082585970602200307; URILLO M, 2004, PALLIAT SUPPORT CARE, V2, P65; Wilson Keith G., 2005, Cognitive Behaviour Therapy, V34, P115, DOI 10.1080/16506070510008461	26	252	254	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					184	187		10.1136/bmj.39244.650926.47	http://dx.doi.org/10.1136/bmj.39244.650926.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17656543	Green Published			2022-12-28	WOS:000248662200028
J	Deans, TL; Cantor, CR; Collins, JJ				Deans, Tara L.; Cantor, Charles R.; Collins, James J.			A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells	CELL			English	Article							DIPHTHERIA-TOXIN; TRANSGENE EXPRESSION; NOISE-PROPAGATION; TOGGLE SWITCH; APOPTOSIS; SYSTEM; MOUSE; BAX; OVEREXPRESSION; INTERFERENCE	Here, we introduce an engineered, tunable genetic switch that couples repressor proteins and an RNAi target design to effectively turn any gene off. We used the switch to regulate the expression of EGFP in mouse and human cells and found that it offers > 99% repression as well as the ability to tune gene expression. To demonstrate the system's modularity and level of gene silencing, we used the switch to tightly regulate the expression of diphtheria toxin and Cre recombinase, respectively. We also used the switch to tune the expression of a proapoptotic gene and show that a threshold expression level is required to induce apoptosis. This work establishes a system for tight, tunable control of mammalian gene expression that can be used to explore the functional role of various genes as well as to determine whether a phenotype is the result of a threshold response to changes in gene expression.	Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA	Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA.	jcollins@bu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070583] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, METAB ENG, V7, P241, DOI 10.1016/j.ymben.2005.02.005; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Malphettes L, 2006, J BIOTECHNOL, V124, P732, DOI 10.1016/j.jbiotec.2006.01.003; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng WD, 2002, MOL THER, V6, P537, DOI 10.1006/mthe.2002.0694; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	48	199	226	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					363	372		10.1016/j.cell.2007.05.045	http://dx.doi.org/10.1016/j.cell.2007.05.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662949	Bronze			2022-12-28	WOS:000248588000024
J	Hidalgo, CA; Klinger, B; Barabasi, AL; Hausmann, R				Hidalgo, C. A.; Klinger, B.; Barabasi, A.-L.; Hausmann, R.			The product space conditions the development of nations	SCIENCE			English	Article							COMPARATIVE ADVANTAGE; COMPLEX NETWORKS	Economies grow by upgrading the products they produce and export. The technology, capital, institutions, and skills needed to make newer products are more easily adapted from some products than from others. Here, we study this network of relatedness between products, or "product space," finding that more-sophisticated products are located in a densely connected core whereas less-sophisticated products occupy a less-connected periphery. Empirically, countries move through the product space by developing goods close to those they currently produce. Most countries can reach the core only by traversing empirically infrequent distances, which may help explain why poor countries have trouble developing more competitive exports and fail to converge to the income levels of rich countries.	Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Harvard Univ, Ctr Int Dev, John F Kennedy Sch Govt, Cambridge, MA 02139 USA	University of Notre Dame; University of Notre Dame; Harvard University	Hidalgo, CA (corresponding author), Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA.	chidalgo@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017; Hidalgo, Cesar A./B-5155-2009	Hidalgo, Cesar A./0000-0002-6977-9492; /0000-0002-6031-5982; Barabasi, Albert/0000-0002-4028-3522				Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; AGHION P, 1992, ECONOMETRICA, V60, P2; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BALASSA B, 1986, REV ECON STAT, V68, P315, DOI 10.2307/1925512; Caballero R, 1993, NBER MACROECON ANNU, V1993, P15; Caldarelli G., 2007, SCALE FREE NETWORKS; Dietzenbacher E, 2001, INPUT OUTPUT ANAL FR; Feenstra R., 2005, 11040 NBER; Gallup JL, 1999, INT REGIONAL SCI REV, V22, P179, DOI 10.1177/016001799761012334; GROSSMAN G, 1991, REV ECON STUD, V58, P1; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; Heckscher E., 1991, HECKSCHEROHLIN TRADE; Hirschman A., 1958, STRATEGY EC DEV; Lall S., 2000, OXFORD DEV STUDIES, V28, P337, DOI 10.1080/713688318; Leamer E.E., 1984, SOURCES COMP ADVANTA; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RODRIK D, 2002, 9305 NBER; ROMER P, 1986, J POLITICAL EC, V94, P5; Rosenstein-Rodan PN, 1943, ECON J, V53, P202, DOI 10.2307/2226317; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101	23	1098	1208	46	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					482	487		10.1126/science.1144581	http://dx.doi.org/10.1126/science.1144581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194JD	17656717	Green Submitted			2022-12-28	WOS:000248339800036
J	Myong, S; Bruno, MM; Pyle, AM; Ha, T				Myong, Sua; Bruno, Michael M.; Pyle, Anna M.; Ha, Taekjip			Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase	SCIENCE			English	Article							SINGLE-STRANDED-DNA; UVRD HELICASE; STEP-SIZE; RNA; PROTEIN; TRANSLOCATION; DOMAIN; RESOLUTION; DYNAMICS; TIME	NS3, an essential helicase for replication of hepatitis C virus, is a model enzyme for investigating helicase function. Using single-molecule fluorescence analysis, we showed that NS3 unwinds DNA in discrete steps of about three base pairs ( bp). Dwell time analysis indicated that about three hidden steps are required before a 3-bp step is taken. Taking into account the available structural data, we propose a spring-loaded mechanism in which several steps of one nucleotide per adenosine triphosphate molecule accumulate tension on the protein-DNA complex, which is relieved periodically via a burst of 3-bp unwinding. NS3 appears to shelter the displaced strand during unwinding, and, upon encountering a barrier or after unwinding > 18 bp, it snaps or slips backward rapidly and repeats unwinding many times in succession. Such repetitive unwinding behavior over a short stretch of duplex may help to keep secondary structures resolved during viral genome replication.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Yale Univ, New Haven, CT 06511 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Yale University; Howard Hughes Medical Institute	Myong, S (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	myong@uiuc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01-GM060620, R01 GM065367, R01-GM065367, R01 GM060620] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM060620] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; DIBISCEGLIE AM, 1997, HEPATOLOGY S, V26, P345; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Lavanchy D, 1999, J HEPATOL, V31, P146, DOI 10.1016/S0168-8278(99)80392-4; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Marians KJ, 1997, STRUCTURE, V5, P1129, DOI 10.1016/S0969-2126(97)00263-3; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Seeff LB, 1998, HEPATOLOGY, V28, P1710, DOI 10.1002/hep.510280636; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Yao Hang-Ping, 2002, Zhejiang Da Xue Xue Bao Yi Xue Ban, V31, P2	24	238	242	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					513	516		10.1126/science.1144130	http://dx.doi.org/10.1126/science.1144130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656723	Green Accepted			2022-12-28	WOS:000248339800045
J	Richter, S; Geldner, N; Schrader, J; Wolters, H; Stierhof, YD; Rios, G; Koncz, C; Robinson, DG; Jurgens, G				Richter, Sandra; Geldner, Niko; Schrader, Jarmo; Wolters, Hanno; Stierhof, York-Dieter; Rios, Gabino; Koncz, Csaba; Robinson, David G.; Juergens, Gerd			Functional diversification of closely related ARF-GEFs in protein secretion and recycling	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; BREFELDIN-A; AUXIN TRANSPORT; FACTORS GEA1P; PLANT-CELLS; ARABIDOPSIS; GOLGI; GNOM; LOCALIZATION; TRAFFICKING	Guanine-nucleotide exchange factors on ADP-ribosylation factor GTPases (ARF-GEFs) regulate vesicle formation in time and space by activating ARF substrates on distinct donor membranes(1). Mammalian GBF1 (ref. 2) and yeast Gea1/2 ( ref. 3) ARF-GEFs act at Golgi membranes, regulating COPI-coated vesicle formation. In contrast, their Arabidopsis thaliana homologue GNOM (GN) is required for endosomal recycling, playing an important part in development(4). This difference indicates an evolutionary divergence of trafficking pathways between animals and plants, and raised the question of how endoplasmic reticulum - Golgi transport is regulated in plants. Here we demonstrate that the closest homologue of GNOM in Arabidopsis, GNOM-LIKE1 (GNL1; NM_ 123312; At5g39500), performs this ancestral function. GNL1 localizes to and acts primarily at Golgi stacks, regulating COPI-coated vesicle formation. Surprisingly, GNOM can functionally substitute for GNL1, but not vice versa. Our results suggest that large ARF-GEFs of the GBF1 class perform a conserved role in endoplasmic reticulum - Golgi trafficking and secretion, which is done by GNL1 and GNOM in Arabidopsis, whereas GNOM has evolved to perform an additional plant-specific function of recycling from endosomes to the plasma membrane. Duplication and diversification of ARF-GEFs in plants contrasts with the evolution of entirely new classes of ARF-GEFs(5) for endosomal trafficking in animals, which illustrates the independent evolution of complex endosomal pathways in the two kingdoms.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; Max Planck Inst Pflanzenzuchtung, D-50829 Cologne, Germany; Heidelberg Univ, Dept Cell Biol, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Ruprecht Karls University Heidelberg	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Auf Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Geldner, Niko/Y-2481-2019; Rios, Gabino/F-4046-2011	Rios, Gabino/0000-0002-1398-282X; Geldner, Niko/0000-0002-2300-9644				Barzilay E, 2005, TRAFFIC, V6, P794, DOI 10.1111/j.1600-0854.2005.00317.x; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee GJ, 2004, PLANT CELL PHYSIOL, V45, P1211, DOI 10.1093/pcp/pch142; MAYER U, 1993, DEVELOPMENT, V117, P149; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Volker A, 2001, J CELL SCI, V114, P3001; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	30	181	194	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					488	U10		10.1038/nature05967	http://dx.doi.org/10.1038/nature05967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653190	Green Published			2022-12-28	WOS:000248302700050
J	Tsai, TT; Evangelista, A; Nienaber, CA; Myrmel, T; Meinhardt, G; Cooper, JV; Smith, DE; Suzuki, T; Fattori, R; Llovet, A; Froehlich, J; Hutchison, S; Distante, A; Sundt, T; Beckman, J; Januzzi, JL; Isselbacher, EM; Eagle, KA				Tsai, Thomas T.; Evangelista, Arturo; Nienaber, Christoph A.; Myrmel, Truls; Meinhardt, Gabriel; Cooper, Jeanna V.; Smith, Dean E.; Suzuki, Toru; Fattori, Rossella; Llovet, Alfredo; Froehlich, James; Hutchison, Stuart; Distante, Alessandro; Sundt, Thoralf; Beckman, Joshua; Januzzi, James L., Jr.; Isselbacher, Eric M.; Eagle, Kim A.		Int Registry Acute Aortic Dissecti	Partial thrombosis of the false lumen in patients with acute type B aortic dissection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRALUMINAL THROMBUS; MANAGEMENT; ANEURYSM; ECHOCARDIOGRAPHY; PROGNOSIS; DIAGNOSIS; THERAPY; ELASTIN; RUPTURE	Background: Patency or thrombosis of the false lumen in type B acute aortic dissection has been found to predict outcomes. The prognostic implications of partial thrombosis of the false lumen have not yet been elucidated. Methods: We examined 201 patients with type B acute aortic dissection who were enrolled in the International Registry of Acute Aortic Dissection between 1996 and 2003 and who survived to hospital discharge. Kaplan-Meier mortality curves were stratified according to the status of the false lumen (patent, partial thrombosis, or complete thrombosis) as determined during the index hospitalization. Cox proportional-hazards analysis was performed to identify independent predictors of death. Results: During the index hospitalization, 114 patients (56.7%) had a patent false lumen, 68 patients (33.8%) had partial thrombosis of the false lumen, and 19 (9.5%) had complete thrombosis of the false lumen. The mean (+/-SD) 3-year mortality rate for patients with a patent false lumen was 13.7+/-7.1%, for those with partial thrombosis was 31.6+/-12.4%, and for those with complete thrombosis was 22.6+/-22.6% (median follow-up, 2.8 years; P=0.003 by the log-rank test). Independent predictors of postdischarge mortality were partial thrombosis of the false lumen (relative risk, 2.69; 95% confidence interval [CI], 1.45 to 4.98; P=0.002), a history of aortic aneurysm (relative risk, 2.05; 95% CI, 1.07 to 3.93; P=0.03), and a history of atherosclerosis (relative risk, 1.87; 95% CI, 1.01 to 3.47; P=0.05). Conclusions: Mortality is high after discharge from the hospital among patients with type B acute aortic dissection. Partial thrombosis of the false lumen, as compared with complete patency, is a significant independent predictor of postdischarge mortality in these patients.	Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; Hosp Gen Univ Vall dHebron, Barcelona, Spain; Univ Rostock, Rostock, Germany; Univ Tromso Hosp, N-9012 Tromso, Norway; Robert Bosch Krankenhaus, Stuttgart, Germany; Univ Tokyo, Tokyo, Japan; Univ Hosp S Orsola, Bologna, Italy; Hosp Univ 12 Octubre, Madrid, Spain; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; CNR, Lecce, Italy; Mayo Clin, Rochester, MN USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Michigan System; University of Michigan; Hospital Universitari Vall d'Hebron; University of Rostock; UiT The Arctic University of Tromso; University Hospital of North Norway; Bosch; Robert Bosch Krankenhaus; University of Tokyo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Hospital Universitario 12 de Octubre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Consiglio Nazionale delle Ricerche (CNR); Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Tsai, TT (corresponding author), Univ Michigan, Ctr Cardiovasc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hsianshi@umich.edu	Fattori, Rossella/L-1017-2016; Januzzi, James/Y-2436-2019; Beckman, Joshua/A-7537-2016	Beckman, Joshua/0000-0001-8332-8439; DISTANTE, Alessandro/0000-0003-2776-0192	NHLBI NIH HHS [5T32HL007853-08] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akutsu K, 2004, EUR J CARDIO-THORAC, V26, P359, DOI 10.1016/j.ejcts.2004.03.026; Bernard Y, 2001, AM J CARDIOL, V87, P1378, DOI 10.1016/S0002-9149(01)01556-9; Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1053/ejvs.2002.1620; Chung JW, 2000, RADIOLOGY, V214, P87, DOI 10.1148/radiology.214.1.r00ja3287; Daily P O, 1970, Ann Thorac Surg, V10, P237; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DINSMORE RE, 1972, RADIOLOGY, V105, P567, DOI 10.1148/105.3.567; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; Ehrlich M, 1998, CIRCULATION, V98, pII294; Elefteriades JA, 1999, ANN THORAC SURG, V67, P2002, DOI 10.1016/S0003-4975(99)00428-2; ERBEL R, 1989, LANCET, V1, P457; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; ERGIN MA, 1994, ANN THORAC SURG, V57, P820, DOI 10.1016/0003-4975(94)90182-1; GLOWER DD, 1991, ANN SURG, V214, P31; Gysi J, 1997, EUR J CARDIO-THORAC, V11, P1163, DOI 10.1016/S1010-7940(97)00091-2; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HAVERICH A, 1985, CIRCULATION, V72, P22; Juvonen T, 1999, J THORAC CARDIOV SUR, V117, P776, DOI 10.1016/S0022-5223(99)70299-0; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Lansman SL, 1999, ANN THORAC SURG, V67, P1975, DOI 10.1016/S0003-4975(99)00419-1; Marui A, 1999, CIRCULATION, V100, P275; MASUDA Y, 1991, CIRCULATION, V84, P7; Mehta RH, 2002, J AM COLL CARDIOL, V40, P685, DOI 10.1016/S0735-1097(02)02005-3; MOHRKAHALY S, 1989, CIRCULATION, V80, P24, DOI 10.1161/01.CIR.80.1.24; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Parodi JC, 2001, J VASC SURG, V34, P909, DOI 10.1067/mva.2001.119038; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Satta J, 1998, EUR J VASC ENDOVASC, V15, P313, DOI 10.1016/S1078-5884(98)80034-8; Schor JS, 1996, ANN THORAC SURG, V61, P1339, DOI 10.1016/0003-4975(96)00105-1; Sesso HD, 2000, AM J EPIDEMIOL, V152, P107, DOI 10.1093/aje/152.2.107; Sueyoshi E, 2004, CIRCULATION, V110, pII256, DOI 10.1161/01.CIR.0000138386.48852.b6; Umana JP, 2002, J THORAC CARDIOV SUR, V124, P896, DOI 10.1067/mtc.2002.123131; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Williams DM, 1997, RADIOLOGY, V203, P37, DOI 10.1148/radiology.203.1.9122414; WOLF YG, 1994, J VASC SURG, V20, P529, DOI 10.1016/0741-5214(94)90277-1; WOLF YG, 1995, J VASC SURG, V21, P499, DOI 10.1016/S0741-5214(95)70293-8	37	467	496	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					349	359		10.1056/NEJMoa063232	http://dx.doi.org/10.1056/NEJMoa063232			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652650				2022-12-28	WOS:000248283500006
J	Jacoby, R; Steer, P				Jacoby, Robin; Steer, Peter			Practice pointer - How to assess capacity to make a will	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Warneford Hosp, Oxford OX3 7JX, England; Wilson Solicitors, Salisbury SP2 7RJ, Wilts, England	University of Oxford	Jacoby, R (corresponding author), Univ Oxford, Warneford Hosp, Oxford OX3 7JX, England.	robin.jacoby@psych.ox.ac.uk						FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Norris A, 2007, NEWSLETTER ASS CONTE, V87, P1; Shulman KI, 2005, INT J GERIATR PSYCH, V20, P63, DOI 10.1002/gps.1257	3	24	24	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					155	157		10.1136/bmj.39232.706840.AD	http://dx.doi.org/10.1136/bmj.39232.706840.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641350	Green Published			2022-12-28	WOS:000248428100038
J	Clark, RM; Schweikert, G; Toomajian, C; Ossowski, S; Zeller, G; Shinn, P; Warthmann, N; Hu, TT; Fu, G; Hinds, DA; Chen, HM; Frazer, KA; Huson, DH; Schoelkopf, B; Nordborg, M; Raetsch, G; Ecker, JR; Weigel, D				Clark, Richard M.; Schweikert, Gabriele; Toomajian, Christopher; Ossowski, Stephan; Zeller, Georg; Shinn, Paul; Warthmann, Norman; Hu, Tina T.; Fu, Glenn; Hinds, David A.; Chen, Huaming; Frazer, Kelly A.; Huson, Daniel H.; Schoelkopf, Bernhard; Nordborg, Magnus; Raetsch, Gunnar; Ecker, Joseph R.; Weigel, Detlef			Common sequence polymorphisms shaping genetic diversity in Arabidopsis thaliana	SCIENCE			English	Article							RESISTANCE GENE; GENOME; SELECTION; REVEALS; DELETIONS	The genomes of individuals from the same species vary in sequence as a result of different evolutionary processes. To examine the patterns of, and the forces shaping, sequence variation in Arabidopsis thaliana, we performed high-density array resequencing of 20 diverse strains (accessions). More than 1 million nonredundant single-nucleotide polymorphisms (SNPs) were identified at moderate false discovery rates (FDRs), and similar to 4% of the genome was identified as being highly dissimilar or deleted relative to the reference genome sequence. Patterns of polymorphism are highly nonrandom among gene families, with genes mediating interaction with the biotic environment having exceptional polymorphism levels. At the chromosomal scale, regional variation in polymorphism was readily apparent. A scan for recent selective sweeps revealed several candidate regions, including a notable example in which almost all variation was removed in a 500-kilobase window. Analyzing the polymorphisms we describe in larger sets of accessions will enable a detailed understanding of forces shaping population-wide sequence variation in A. thaliana.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; Max Planck Inst Biol Cybernet, Dept Empir Inference, D-72076 Tubingen, Germany; Univ So Calif, Los Angeles, CA 90089 USA; Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Perlegen Sci, Mountain View, CA 94043 USA	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society; University of Southern California; Eberhard Karls University of Tubingen; Salk Institute	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Rätsch, Gunnar/O-5914-2017; Zeller, Georg/M-6484-2013; Toomajian, Christopher/ABA-2615-2021; Warthmann, Norman/E-1069-2011; Schölkopf, Bernhard/A-7570-2013; Rätsch, Gunnar/B-8182-2009; Huson, Daniel H./AAC-5494-2019; Weigel, Detlef/AAR-3312-2021; Ecker, Joseph R/B-9144-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Rätsch, Gunnar/0000-0001-5486-8532; Zeller, Georg/0000-0003-1429-7485; Toomajian, Christopher/0000-0002-6763-0678; Warthmann, Norman/0000-0002-1178-8409; Schölkopf, Bernhard/0000-0002-8177-0925; Ecker, Joseph R/0000-0001-5799-5895; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963; Chen, Huaming/0000-0001-5289-7882; Frazer, Kelly/0000-0002-6060-8902; Hinds, David/0000-0002-4911-803X; Nordborg, Magnus/0000-0001-7178-9748				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HUDSON RR, 1988, GENETICS, V120, P831; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAPLAN NL, 1989, GENETICS, V123, P887; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kling J, 2005, NAT BIOTECHNOL, V23, P1333, DOI 10.1038/nbt1105-1333; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 1997, GENETICS, V146, P1501; Nordborg M, 2003, GENETICS, V163, P1201; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Scholkopf B., 2002, LEARNING KERNELS; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vapnik V., 1982, ESTIMATION DEPENDENC	34	539	556	0	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					338	342		10.1126/science.1138632	http://dx.doi.org/10.1126/science.1138632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641193				2022-12-28	WOS:000248150200037
J	Ellis, J				Ellis, John			Beyond the standard model with the LHC	NATURE			English	Review							SYMMETRIES; MASS	Whether or not the Large Hadron Collider reveals the long-awaited Higgs particle, it is likely to lead to discoveries that add to, or challenge, the standard model of particle physics. Data produced will be pored over for any evidence of supersymmetric partners for the existing denizens of the particle 'zoo' and for the curled-up extra dimensions demanded by string theory. There might also be clues as to why matter dominates over antimatter in the Universe, and as to the nature of the Universe's dark matter.	CERN, Div Theory, Dept Phys, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN); University of Geneva	Ellis, J (corresponding author), CERN, Div Theory, Dept Phys, CH-1211 Geneva 23, Switzerland.	john.ellis@cern.ch	Ellis, John/J-2222-2012	Ellis, John/0000-0002-7399-0813				Arkani-Hamed N, 1998, PHYS LETT B, V429, P263, DOI 10.1016/S0370-2693(98)00466-3; ATHANASIOU C, 2006, JHEP; *ATLAS COLL, 2007, DET PHYS PERF TECHN; Barate R, 2000, PHYS LETT B, V495, P1, DOI 10.1016/S0370-2693(00)01269-7; Battaglia M, 2004, EUR PHYS J C, V33, P273, DOI 10.1140/epjc/s2003-01575-7; BLAISING JJ, 2006, POTENTIAL LHC CONTRI; BLONDEL A, 2006, PHYS OPPORTUNITIES F; CAVALLI D, 2001, P WORKSH PHYS TEV CO; Cembranos JAR, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.036004; CHRISTENSON JH, 1964, PHYS REV LETT, V13, P138, DOI 10.1103/PhysRevLett.13.138; Csaki C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.101802; DEROECK A, CERNLHCC2006021; Ellis J, 2005, INT J MOD PHYS A, V20, P5297, DOI 10.1142/S0217751X05028806; ELLIS J, 1990, PHYS LETT B, V249, P441, DOI 10.1016/0370-2693(90)91013-2; ELLIS J, 1984, NUCL PHYS B, V238, P453, DOI 10.1016/0550-3213(84)90461-9; ELLIS J, 2007, HIGGS BOSON PROPERTI; Ellis J, 2007, ACTA PHYS POL B, V38, P1071; ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321; FARHI E, 1981, PHYS REP, V74, P279; Fayet P., 1980, Unification of the Fundamental Particle Interactions. Proceedings of the Europhysics Conference, P587; Feng JL, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.015004; FERRARA S, 1974, NUCL PHYS B, VB 77, P413, DOI 10.1016/0550-3213(74)90372-1; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; Green M.B., 1988, SUPERSTRING THEORY, V1; HARRIS CM, 2005, JHEP; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; *LHCB COLL, 2007, LARG HADR COLL BEAUT; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; SAKHAROV AD, 1967, PISMA ESKP TEOR FIZ, V5, P32, DOI DOI 10.1070/PU1991V034N05ABEH002497; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; Servant G, 2003, NUCL PHYS B, V650, P391, DOI 10.1016/S0550-3213(02)01012-X; *STRAT GROUP EUR P, 2007, CERN COUNC STRAT GRO; 't HOOFT G, 1971, NUCL PHYS B, VB 35, P167, DOI 10.1016/0550-3213(71)90139-8; *TEV EL WORK GROUP, 2007, TEV EL WORK GROUP W; *TEV EL WORK GROUP, 2007, COMB CDF DO RES MASS; THOOFT G, 1972, NUCL PHYS B, VB-44, P189, DOI 10.1016/0550-3213(72)90279-9; THOOFT G, 1994, NATURALNESS CHIRAL S, P352; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264; WESS J, 1974, PHYS LETT B, VB 49, P52, DOI 10.1016/0370-2693(74)90578-4; WITTEN E, 1981, PHYS LETT B, V105, P267, DOI 10.1016/0370-2693(81)90885-6	43	16	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					297	301		10.1038/nature06079	http://dx.doi.org/10.1038/nature06079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637660	Bronze			2022-12-28	WOS:000248118300046
J	Koshland, DE				Koshland, Daniel E.			Philosophy of science - The cha-cha-cha theory of scientific discovery	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Koshland, DE (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	blencowe@dartmouth.edu							0	38	38	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					761	762		10.1126/science.1147166	http://dx.doi.org/10.1126/science.1147166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690282				2022-12-28	WOS:000248624500026
J	Morrison, AJ; Kim, JA; Person, MD; Highland, J; Xiao, J; Wehr, TS; Hensley, S; Bao, Y; Shen, J; Collins, SR; Weissman, JS; Delrow, J; Krogan, NJ; Haber, JE; Shen, X				Morrison, Ashby J.; Kim, Jung-Ae; Person, Maria D.; Highland, Jessica; Xiao, Jing; Wehr, Tammy S.; Hensley, Sean; Bao, Yunhe; Shen, Jianjun; Collins, Sean R.; Weissman, Jonathan S.; Delrow, Jeff; Krogan, Nevan J.; Haber, James E.; Shen, Xuetong			Mec1/Tel1 phosphorylation of the INO80 Chromatin Remodeling Complex Influences DNA damage checkpoint responses	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; S-PHASE; HISTONE H2AX; REPAIR; PROTEINS; KINASE; MRC1; RECOMBINATION; RECRUITMENT	The yeast Mec1/Tel1 kinases, ATM/ATR in mammals, coordinate the DNA damage response by phosphorylating proteins involved in DNA repair and checkpoint pathways. Recently, ATP-dependent chromatin remodeling complexes, such as the INO80 complex, have also been implicated in DNA damage responses, although regulatory mechanisms that direct their function remain unknown. Here, we show that the Ies4 subunit of the INO80 complex is phosphorylated by the Mec1/Tel1 kinases during exposure to DNA-damaging agents. Mutation of Ies4's phosphorylation sites does not significantly affect DNA repair processes, but does influence DNA damage checkpoint responses. Additionally, ies4 phosphorylation mutants are linked to the function of checkpoint regulators, such as the replication checkpoint factors Tof1 and Rad53. These findings establish a chromatin remodeling complex as a functional component in the Mec1/Tel1 DNA damage signaling pathway that modulates checkpoint responses and suggest that posttranslational modification of chromatin remodeling complexes regulates their involvement in distinct processes.	Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA; Univ Texas, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; Brandeis University; Brandeis University; University of Texas System; University of Texas Austin; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Shen, X (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA.	snowshen@mac.com	Morrison, Ashby/AHE-2820-2022	Collins, Sean/0000-0002-4276-5840; Morrison, Ashby/0000-0003-1228-5093; Haber, James/0000-0002-1878-0610; Shen, Xuetong/0000-0002-4267-5298; Weissman, Jonathan/0000-0003-2445-670X	NCI NIH HHS [1K22CA100017] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline; NIGMS NIH HHS [GM20056, R01 GM061766-07, R01 GM061766-08, R01 GM061766] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA100017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R01GM061766, R37GM020056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bouazoune K, 2005, J BIOL CHEM, V280, P41912, DOI 10.1074/jbc.M507084200; Brondello JM, 1999, MOL CELL BIOL, V19, P4262; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Foss EJ, 2001, GENETICS, V157, P567; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kawashima S, 2007, BIOCHEM BIOPH RES CO, V355, P835, DOI 10.1016/j.bbrc.2007.02.036; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2005, CELL CYCLE, V4, P568; Morrison AJ, 2006, RES PRO CEL, V41, P109, DOI 10.1007/008; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wong LY, 2006, J MOL HISTOL, V37, P261, DOI 10.1007/s10735-006-9047-4; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004	54	97	106	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					499	511		10.1016/j.cell.2007.06.010	http://dx.doi.org/10.1016/j.cell.2007.06.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693258	Bronze			2022-12-28	WOS:000249038100017
J	Quinones-Hinojosa, A				Quinones-Hinojosa, Alfredo			Becoming a physician: Terra firma - A journey from migrant farm labor to neurosurgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Brain Tumor Stem Cell Lab, Baltimore, MD 21205 USA	Johns Hopkins University	Quinones-Hinojosa, A (corresponding author), Johns Hopkins Univ, Sch Med, Brain Tumor Stem Cell Lab, Baltimore, MD 21205 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					529	531		10.1056/NEJMp078105	http://dx.doi.org/10.1056/NEJMp078105			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687127				2022-12-28	WOS:000248584900002
J	[Anonymous]				[Anonymous]			Counseling about proper use of motor vehicle occupant restraints and avoidance of alcohol use while driving: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article																			0	10	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					187	193		10.7326/0003-4819-147-3-200708070-00008	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679707				2022-12-28	WOS:000248454700006
J	Gruskin, S; Mills, EJ; Tarantola, D				Gruskin, Sofia; Mills, Edward J.; Tarantola, Daniel			Health and Human Rights 1 - History, principles, and practice of health and human rights	LANCET			English	Article							PUBLIC-HEALTH; HIV; DISCRIMINATION; INSURANCE; ACCESS; ETHICS; MARKET; AIDS; CARE	Individuals and populations suffer violations of their rights that affect health and wellbeing. Health professionals have a part to play in reduction and prevention of these violations and ensuring that health-related policies and practices promote rights. This needs efforts in terms of advocacy, application of legal standards, and public-health programming. We discuss the changing views of human rights in the context of the HIV/AIDS epidemic and propose further development of the right to health by increased practice, evidence, and action.	Harvard Univ, Sch Publ Hlth, Program Int Hlth & Human Rights, Boston, MA 02115 USA; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Univ New S Wales, Initiat Hlth & Human Rights, Sydney, NSW, Australia	Harvard University; Harvard T.H. Chan School of Public Health; B.C. Centre for Excellence in HIV/AIDS; University of New South Wales Sydney	Gruskin, S (corresponding author), Harvard Univ, Sch Publ Hlth, Program Int Hlth & Human Rights, 665 Huntington Ave, Boston, MA 02115 USA.	sgruskin@hsph.harvard.edu						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 1993, WORLD C HUM RIGHTS V; Braveman P, 2003, B WORLD HEALTH ORGAN, V81, P539; Brunner E, 1999, J EPIDEMIOL COMMUN H, V53, P757, DOI 10.1136/jech.53.12.757; CAPTIER C, 2005, MED FRONTIERES; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Eide A, 1995, EC SOCIAL CULTURAL R; Farberman R, 2005, LANCET, V366, P712, DOI 10.1016/S0140-6736(05)67167-X; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; FLESHMAN M, 2001, AFRICA RECOVERY, P151; Focht-New V, 1996, Issues Ment Health Nurs, V17, P427, DOI 10.3109/01612849609009411; Freeman Michael, 2002, HUMAN RIGHTS INTERDI; Friedman SR, 2006, NEW ENGL J MED, V354, P877; Gent RN, 1999, J EPIDEMIOL COMMUN H, V53, P594, DOI 10.1136/jech.53.10.594; GERNHOLTZ L, 2002, CAN HIV AIDS POLICY, V6, P20; Gruskin S, 2004, LANCET, V363, P329, DOI 10.1016/S0140-6736(03)15399-8; Gruskin S, 2002, LANCET, V360, P1880, DOI 10.1016/S0140-6736(02)11780-6; GRUSKIN S, 2004, SANTE DROITS HOMME; GRUSKIN S, 2001, HIV AIDS PREVENTION; GRUSKIN S, 2004, TEMPLE LAW REV, V77, P313; GRUSKIN S, 2001, OXFORD TXB PUBLIC HL; Gruskin Sofia, 2004, HIV AIDS Policy Law Rev, V9, P99; Hargreaves S, 2004, LANCET, V363, P1999, DOI 10.1016/S0140-6736(04)16422-2; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hunt P, 2006, T ROY SOC TROP MED H, V100, P603, DOI 10.1016/j.trstmh.2006.03.001; Hunt Paul, 2006, 61 SESS GEN ASS DAT; *INT COUNC AIDS SE, 1999, HIV AIDS HUM RIGHTS; Kennedy PJ, 2004, HARVARD J LEGIS, V41, P363; Koniaris LG, 2005, LANCET, V365, P1412, DOI 10.1016/S0140-6736(05)66377-5; Ku L, 2001, HEALTH AFFAIR, V20, P247, DOI 10.1377/hlthaff.20.1.247; Lynch Tom, 2006, Consult Pharm, V21, P143, DOI 10.4140/TCP.n.2006.143; MANN JM, 1998, HLTH HUMAN RIGHTS, V5, P5; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Martikainen P, 1999, SOC SCI MED, V49, P499, DOI 10.1016/S0277-9536(99)00135-5; Menon-Johansson Anatole S, 2005, BMC Int Health Hum Rights, V5, P4, DOI 10.1186/1472-698X-5-4; Miles SH, 2004, LANCET, V364, P725, DOI 10.1016/S0140-6736(04)16902-X; Mills Edward J, 2005, BMC Int Health Hum Rights, V5, P7, DOI 10.1186/1472-698X-5-7; Mills Edward J, 2006, HIV AIDS Policy Law Rev, V11, P27; Mills EJ, 2005, BMJ-BRIT MED J, V331, P1485, DOI 10.1136/bmj.331.7531.1485; Parfitt T, 2004, LANCET, V363, P1291, DOI 10.1016/S0140-6736(04)16036-4; Parry J, 2006, B WORLD HEALTH ORGAN, V84, P261; *PHR, 2005, NEWSLETTER PHYS HUMA, V18; Pinfold V, 2005, INT J SOC PSYCHIATR, V51, P128, DOI 10.1177/0020764005056760; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; RITCHEY FJ, 1991, J HEALTH SOC BEHAV, V32, P33, DOI 10.2307/2136798; Shaw D, 2006, BEST PRACT RES CL OB, V20, P299, DOI 10.1016/j.bpobgyn.2006.01.013; Stockdill Brett C., 2002, ACTIVISM AIDS INTERS; Tarantola D, 2007, LANCET, V370, P202, DOI 10.1016/S0140-6736(07)61102-7; Terry Fiona, 2002, CONDEMNED REPEAT PAR; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *UNAIDS, 2005, 5 M UNAIDS REF GROUP; *UNAIDS, 2001, GLOB STRAT FRAM HIV; Verwimp P, 2004, POP STUD-J DEMOG, V58, P233, DOI 10.1080/0032472042000224422; WARRICK P, 1994, LOS ANGELES TIM 1030; *WHO, 2005, WORLD HLTH SURV RES; *WHO, 2005, ANT THER COV LOW MID; *WHO, 1987, WHO WORLD HLTH ASS 4; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928; World Health Organization, 1946, INT HLTH C NEW YORK; 2004, LANCET, V364, P637; 2005, LANCET, V365, P1597; 2005, 5 M UNAIDS REF GROUP; 2003, 2 INT WORKSH IMPL HU; 2004, AIDS POLICY LAW, V19, P5; 2004, UNAIDS WHO POLICY ST	66	134	137	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					449	455		10.1016/S0140-6736(07)61200-8	http://dx.doi.org/10.1016/S0140-6736(07)61200-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197XL	17679022				2022-12-28	WOS:000248590200035
J	Maartens, G; Boulle, A				Maartens, Gary; Boulle, Andrew			CD4T-cell responses to combination antiretroviral therapy	LANCET			English	Editorial Material							T-CELL COUNT; HIV-1-INFECTED PATIENTS; HIV-1 INFECTION; INDIVIDUALS; MORTALITY; RECOVERY; NADIR		Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Maartens, G (corresponding author), Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.	gary.maartens@uct.ac.za	Boulle, Andrew/C-1413-2008; Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Boulle, Andrew/0000-0002-7713-8062; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606				Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cole SR, 2004, STAT MED, V23, P3351, DOI 10.1002/sim.1579; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; MOCROFT A, 2007, LANCET          0719; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Olsen CH, 2005, AIDS, V19, P319; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913	12	7	8	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					366	368		10.1016/S0140-6736(07)60949-0	http://dx.doi.org/10.1016/S0140-6736(07)60949-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17659332				2022-12-28	WOS:000248590200006
J	Wang, XS; Guerin, G; Wang, H; Wang, YS; Manners, I; Winnik, MA				Wang, Xiaosong; Guerin, Gerald; Wang, Hai; Wang, Yishan; Manners, Ian; Winnik, Mitchell A.			Cylindrical block copolymer micelles and co-micelles of controlled length and architecture	SCIENCE			English	Article							WORM MICELLES; NANOTUBES	Block copolymers consist of two or more chemically different polymers connected by covalent linkages. In solution, repulsion between the blocks leads to a variety of morphologies, which are thermodynamically driven. Polyferrocenyldimethylsilane block copolymers show an unusual propensity to forming cylindrical micelles in solution. We found that the micelle structure grows epitaxially through the addition of more polymer, producing micelles with a narrow size dispersity, in a process analogous to the growth of living polymer. By adding a different block copolymer, we could form co-micelles. We were also able to selectively functionalize different parts of the micelle. Potential applications for these materials include their use in lithographic etch resists, in redox-active templates, and as catalytically active metal nanoparticle precursors.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Toronto; University of Bristol	Manners, I (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	ian.manners@bristol.ac.uk; mwinnik@chem.utoronto.ca	Wang, Hai/J-3186-2014; Wang, Xiaosong/N-8121-2013; Winnik, Mitchell A/R-8621-2018; Wang, Hai/M-3820-2016	Wang, Hai/0000-0001-9243-3935; Wang, Hai/0000-0001-9243-3935; Guerin, Gerald/0000-0003-4997-0561; Manners, Ian/0000-0002-3794-967X				Dalhaimer P, 2003, MACROMOLECULES, V36, P6873, DOI 10.1021/ma034120d; Dean JM, 2003, MACROMOLECULES, V36, P9267, DOI 10.1021/ma034807y; Greer SC, 2002, ANNU REV PHYS CHEM, V53, P173, DOI 10.1146/annurev.physchem.53.082301.111949; Greer SC, 1996, ADV CHEM PHYS, V94, P261, DOI 10.1002/9780470141533.ch4; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, P359; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Kim Y, 2005, NANOTECHNOLOGY, V16, pS484, DOI 10.1088/0957-4484/16/7/024; Massey J, 1998, J AM CHEM SOC, V120, P9533, DOI 10.1021/ja981803d; Massey JA, 2000, J AM CHEM SOC, V122, P11577, DOI 10.1021/ja002205d; O'Shaughnessy B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118301; Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h; Rodriguez-Hernandez J, 2005, PROG POLYM SCI, V30, P691, DOI 10.1016/j.progpolymsci.2005.04.002; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Wang XS, 2005, J AM CHEM SOC, V127, P8924, DOI 10.1021/ja051365s; Wang XS, 2003, J AM CHEM SOC, V125, P12686, DOI 10.1021/ja037521h; WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887; Won YY, 2003, MACROMOLECULES, V36, P953, DOI 10.1021/ma021439+; Zhulina EB, 2005, MACROMOLECULES, V38, P5330, DOI 10.1021/ma048102n	19	862	871	12	560	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					644	647		10.1126/science.1141382	http://dx.doi.org/10.1126/science.1141382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673656				2022-12-28	WOS:000248494400040
J	Yuzawa, S; Opatowsky, Y; Zhang, ZT; Mandiyan, V; Lax, I; Schlessinger, J				Yuzawa, Satoru; Opatowsky, Yarden; Zhang, Zhongtao; Mandiyan, Valsan; Lax, Irit; Schlessinger, Joseph			Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor	CELL			English	Article							C-KIT; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; BIVALENT BINDING; LIGAND-BINDING; DIMERIZATION; ADHESION; DOMAIN; PIEBALDISM; PROTEIN	Stem Cell Factor (SCF) initiates its multiple cellular responses by binding to the ectodomain of KIT, resulting in tyrosine kinase activation. We describe the crystal structure of the entire ectodomain of KIT before and after SCF stimulation. The structures show that KIT dimerization is driven by SCF binding whose sole role is to bring two KIT molecules together. Receptor dimerization is followed by conformational changes that enable lateral interactions between membrane proximal Ig-like domains D4 and D5 of two KIT molecules. Experiments with cultured cells show that KIT activation is compromised by point mutations in amino acids critical for D4-D4 interaction. Moreover, a variety of oncogenic mutations are mapped to the D5-D5 interface. Since key hallmarks of KIT structures, ligand-induced receptor dimerization, and the critical residues in the D4-D4 interface, are conserved in other receptors, the mechanism of KIT stimulation unveiled in this report may apply for other receptor activation.	New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	New York Medical College; Yale University	Schlessinger, J (corresponding author), New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA.	joseph.schlessinger@yale.edu		zhang, zhongtao/0000-0002-1910-4753; Yuzawa, Satoru/0000-0002-1031-5781	NIAMS NIH HHS [AR 051886, AR 051448, P50 AR 054086] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448, R01AR051886, P50AR054086] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BESMER P, 1986, J VIROL, V60, P194, DOI 10.1128/JVI.60.1.194-203.1986; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fleischman RA, 1996, J INVEST DERMATOL, V107, P703, DOI 10.1111/1523-1747.ep12365596; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Hsu YR, 1998, BIOCHEMISTRY-US, V37, P2251, DOI 10.1021/bi972372z; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEV S, 1992, J BIOL CHEM, V267, P15970; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Murakami T, 2005, J INVEST DERMATOL, V124, P670, DOI 10.1111/j.0022-202X.2005.23637.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILO JS, 1996, KIT J BIOL CHEM, V271, P6895; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732	35	238	262	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					323	334		10.1016/j.cell.2007.05.055	http://dx.doi.org/10.1016/j.cell.2007.05.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662946	Bronze			2022-12-28	WOS:000248588000021
J	Christakis, NA; Fowler, JH				Christakis, Nicholas A.; Fowler, James H.			The spread of obesity in a large social network over 32 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS-INDEX; SMOKING-CESSATION; FRIENDS; IMPACT	ackground: The prevalence of obesity has increased substantially over the past 30 years. We performed a quantitative analysis of the nature and extent of the person-to-person spread of obesity as a possible factor contributing to the obesity epidemic. Methods: We evaluated a densely interconnected social network of 12,067 people assessed repeatedly from 1971 to 2003 as part of the Framingham Heart Study. The body-mass index was available for all subjects. We used longitudinal statistical models to examine whether weight gain in one person was associated with weight gain in his or her friends, siblings, spouse, and neighbors. Results: Discernible clusters of obese persons (body-mass index [the weight in kilograms divided by the square of the height in meters], greater/equal 30) were present in the network at all time points, and the clusters extended to three degrees of separation. These clusters did not appear to be solely attributable to the selective formation of social ties among obese persons. A person's chances of becoming obese increased by 57% (95% confidence interval [CI], 6 to 123) if he or she had a friend who became obese in a given interval. Among pairs of adult siblings, if one sibling became obese, the chance that the other would become obese increased by 40% (95% CI, 21 to 60). If one spouse became obese, the likelihood that the other spouse would become obese increased by 37% (95% CI, 7 to 73). These effects were not seen among neighbors in the immediate geographic location. Persons of the same sex had relatively greater influence on each other than those of the opposite sex. The spread of smoking cessation did not account for the spread of obesity in the network. Conclusions: Network phenomena appear to be relevant to the biologic and behavioral trait of obesity, and obesity appears to spread through social ties. These findings have implications for clinical and public health interventions.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Mt Auburn Hosp, Dept Med, Cambridge, MA USA; Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Harvard University; Harvard Medical School; Harvard University; Mount Auburn Hospital; Harvard University; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008; 白, 纯歌/V-1853-2017; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	NATIONAL INSTITUTE ON AGING [R01AG024448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrews JA, 2002, HEALTH PSYCHOL, V21, P349, DOI 10.1037//0278-6133.21.4.349; Atwood LD, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2004, MATH VIS, P77; Beck N, 2001, ANNU REV POLIT SCI, V4, P271, DOI 10.1146/annurev.polisci.4.1.271; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; Carrington PJ, 2005, MODELS METHODS SOCIA, V28; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chang VW, 2002, SOCIOL HEALTH ILL, V24, P151, DOI 10.1111/1467-9566.00289; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; KING G, 2000, AM J POLIT SCI, V0044; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Malchodi CS, 2003, OBSTET GYNECOL, V101, P504, DOI 10.1016/S0029-7844(02)03070-3; MCKNIGHT AJ, 1986, ACCIDENT ANAL PREV, V18, P339, DOI 10.1016/0001-4575(86)90047-3; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Montgomery GH, 2003, PREV MED, V37, P242, DOI 10.1016/S0091-7435(03)00120-8; Moody J, 2005, AM J SOCIOL, V110, P1206, DOI 10.1086/421509; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; SACKETT DL, 1975, CIRCULATION, V52, P589, DOI 10.1161/01.CIR.52.4.589; Schildcrout JS, 2005, BIOSTATISTICS, V6, P633, DOI 10.1093/biostatistics/kxi033; Sobal J, 1999, SOCIAL PROB SO ISS, P231; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WECHSLER H, 1995, J STUD ALCOHOL, V56, P628, DOI 10.15288/jsa.1995.56.628; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132	42	2945	2994	21	609	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					370	379		10.1056/NEJMsa066082	http://dx.doi.org/10.1056/NEJMsa066082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652652	Green Published			2022-12-28	WOS:000248283500008
J	Oparil, S; Yarows, SA; Patel, S; Fang, H; Zhang, J; Satlin, A				Oparil, Suzanne; Yarows, Steven A.; Patel, Samir; Fang, Hui; Zhang, Jack; Satlin, Andrew			Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial	LANCET			English	Article							RENIN-ANGIOTENSIN SYSTEM; CONVERTING-ENZYME-INHIBITORS; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE EFFICACY; HEART-FAILURE; DUAL BLOCKADE; COMBINATION; CANDESARTAN; REDUCTION; LOSARTAN	Background The aim of this study was to assess dual renin system intervention with the maximum recommended doses of aliskiren and valsartan, compared with each drug alone in patients with hypertension. Methods In this double-blind study, 1797 patients with hypertension (mean sitting diastolic blood pressure 95-109 mm. Hg and 8-h daytime ambulatory diastolic blood pressure 90 mm. Hg) were randomly assigned to receive once-daily aliskiren 150 mg (n=437), valsartan 160 ring (455), a combination of aliskiren 150 mg and valsartan 160 mg (446), or placebo (459) for 4 weeks, followed by forced titration to double the dose to the maximum recommended dose for another 4 weeks. The primary endpoint was change in mean sitting diastolic blood pressure from baseline to week 8 endpoint. Analyses were done by intention to treat. This trial is registered at ClinicalTrials. gov with the number NCT00219180. Findings 196 (11%) patients discontinued study treatment before the end of the trial (63 in the placebo group, 53 in the aliskiren group, 43 in the valsartan group, and 37 in the aliskiren/valsartan group), mainly due to lack of therapeutic effect. At week 8 endpoint, the combination of aliskiren 300 mg and valsartan 320 mg lowered mean sitting diastolic blood pressure from baseline by 12.2 mm Hg, significantly more than either monotherapy (aliskiren 300 mg 9.0 mm Hg decrease, p < 0.0001; valsartan 320 mg, 9.7 mm Hg decrease, p < 0.0001), or with placebo (4.1 mm Hg decrease, p < 0.0001). Rates of adverse events and laboratory abnormalities were similar in all groups. Interpretation The combination of aliskiren and valsartan at maximum recommended doses provides significantly greater reductions in blood pressure than does monotherapy with either agent in patients with hypertension, with a tolerability profile similar to that with aliskiren and valsartan alone.	Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA; Chelsea Internal Med IHA, Chelsea, MI USA; Nova Pharmaceut Corp, E Hanover, NJ USA	University of Alabama System; University of Alabama Birmingham; Novartis	Oparil, S (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, 1034 Zeigler Res Bldg,703 19th St S, Birmingham, AL 35294 USA.	soparil@uab.edu						Azizi M, 2004, J AM SOC NEPHROL, V15, P3126, DOI 10.1097/01.ASN.0000146686.35541.29; Azizi M, 2004, CIRCULATION, V109, P2492, DOI 10.1161/01.CIR.0000131449.94713.AD; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Fisher NDL, 2005, J AM SOC NEPHROL, V16, P592, DOI 10.1681/ASN.2004100874; Fox KM, 2003, LANCET, V362, P782; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; HIRAMATSU K, 1981, J AM GERIATR SOC, V29, P25, DOI 10.1111/j.1532-5415.1981.tb02389.x; Izzo Joseph L Jr, 2004, J Clin Hypertens (Greenwich), V6, P485, DOI 10.1111/j.1524-6175.2004.03511.x; Jacobsen P, 2003, KIDNEY INT, V63, P1874, DOI 10.1046/j.1523-1755.2003.00940.x; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; Matos JPS, 2005, CLIN NEPHROL, V64, P180; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Nakao N, 2004, AM J NEPHROL, V24, P543, DOI 10.1159/000081953; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Oh BH, 2007, J AM COLL CARDIOL, V49, P1157, DOI 10.1016/j.jacc.2006.11.032; Oparil S, 2001, J Clin Hypertens (Greenwich), V3, P283, DOI 10.1111/j.1524-6175.2001.01136.x; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pool JL, 2007, AM J HYPERTENS, V20, P11, DOI 10.1016/j.amjhyper.2006.06.003; Rossing K, 2005, KIDNEY INT, V68, P1190, DOI 10.1111/j.1523-1755.2005.00511.x; Schmieder RE, 2005, J AM SOC NEPHROL, V16, P3038, DOI 10.1681/ASN.2005020138; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; VANDER AJ, 1965, P SOC EXP BIOL MED, V120, P399; Yusuf S, 2000, NEW ENGL J MED, V342, P145	27	344	363	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					221	229		10.1016/S0140-6736(07)61124-6	http://dx.doi.org/10.1016/S0140-6736(07)61124-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658393				2022-12-28	WOS:000248347900026
J	Robinson, RD; Sadtler, B; Demchenko, DO; Erdonmez, CK; Wang, LW; Alivisatos, AP				Robinson, Richard D.; Sadtler, Bryce; Demchenko, Denis O.; Erdonmez, Can K.; Wang, Lin-Wang; Alivisatos, A. Paul			Spontaneous superlattice formation in nanorods through partial cation exchange	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; SILVER CHALCOGENIDES; GROWTH; NANOWIRES; SULFIDE; CDS; NANOSTRUCTURES; CONVERSION; DIFFUSION; SURFACES	Lattice-mismatch strains are widely known to control nanoscale pattern formation in heteroepitaxy, but such effects have not been exploited in colloidal nanocrystal growth. We demonstrate a colloidal route to synthesizing CdS-Ag2S nanorod superlattices through partial cation exchange. Strain induces the spontaneous formation of periodic structures. Ab initio calculations of the interfacial energy and modeling of strain energies show that these forces drive the self-organization of the superlattices. The nanorod superlattices exhibit high stability against ripening and phase mixing. These materials are tunable near-infrared emitters with potential applications as nanometer-scale optoelectronic devices.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Computat Res Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	alivis@berkeley.edu	Robinson, Richard/AHD-5643-2022; Alivisatos, Paul/N-8863-2015; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022	Alivisatos, Paul/0000-0001-6895-9048; Robinson, Richard/0000-0002-0385-2925; Sadtler, Bryce/0000-0003-4860-501X				Achermann M, 2004, NATURE, V429, P642, DOI 10.1038/nature02571; Battaglia D, 2005, J AM CHEM SOC, V127, P10889, DOI 10.1021/ja0437297; Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Dloczik L, 2004, J SOLID STATE ELECTR, V8, P142, DOI 10.1007/s10008-003-0427-3; Dresselhaus MS, 1999, PHYS SOLID STATE+, V41, P679, DOI 10.1134/1.1130849; Dzhafarov TD, 1999, J PHYS D APPL PHYS, V32, pL5, DOI 10.1088/0022-3727/32/5/001; Ertekin E, 2005, J APPL PHYS, V97, DOI 10.1063/1.1903106; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; GUHA S, 1990, APPL PHYS LETT, V57, P2110, DOI 10.1063/1.103914; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; JUNOD P, 1977, PHILOS MAG, V36, P941, DOI 10.1080/14786437708239769; Kastner G, 2004, PHILOS MAG, V84, P3803, DOI 10.1080/1478643042000281389; Klimov VI, 2006, J PHYS CHEM B, V110, P16827, DOI 10.1021/jp0615959; KOBAYASHI M, 1990, SOLID STATE IONICS, V39, P121, DOI 10.1016/0167-2738(90)90392-5; Law M, 2004, ANNU REV MATER RES, V34, P83, DOI 10.1146/annurev.matsci.34.040203.112300; Li DY, 2003, APPL PHYS LETT, V83, P3186, DOI 10.1063/1.1619221; LOKHANDE CD, 1992, J PHYS D APPL PHYS, V25, P315, DOI 10.1088/0022-3727/25/2/029; MEWS A, 1994, J PHYS CHEM-US, V98, P924; Miller MS, 1996, J APPL PHYS, V80, P3360, DOI 10.1063/1.363248; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Mokari T, 2006, ANGEW CHEM INT EDIT, V45, P8001, DOI 10.1002/anie.200602559; Motte L, 2005, J PHYS CHEM B, V109, P21499, DOI 10.1021/jp0542322; Notzel R, 1996, SEMICOND SCI TECH, V11, P1365, DOI 10.1088/0268-1242/11/10/004; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Saunders AE, 2006, J PHYS CHEM B, V110, P25421, DOI 10.1021/jp065594s; SCHMALZRIED H, 1980, PROG SOLID STATE CH, V13, P119, DOI 10.1016/0079-6786(80)90002-3; Shchukin VA, 1999, REV MOD PHYS, V71, P1125, DOI 10.1103/RevModPhys.71.1125; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Williamson AJ, 2000, PHYS REV B, V62, P12963, DOI 10.1103/PhysRevB.62.12963; WOODBURY HH, 1964, PHYS REV, V134, pA492, DOI 10.1103/PhysRev.134.A492; Wu YY, 2002, NANO LETT, V2, P83, DOI 10.1021/nl0156888	34	606	618	6	488	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					355	358		10.1126/science.1142593	http://dx.doi.org/10.1126/science.1142593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641197	Green Submitted			2022-12-28	WOS:000248150200042
J	Taguchi, A; Wartschow, LM; White, MF				Taguchi, Akiko; Wartschow, Lynn M.; White, Morris F.			Brain IRS2 signaling coordinates life span and nutrient homeostasis	SCIENCE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; DISRUPTION; EXTENSION; LONGEVITY; GROWTH; MICE	Reduced insulin-like signaling extends the life span of Caenorhabditis elegans and Drosophila. Here, we show that, in mice, less insulin receptor substrate-2 (Irs2) signaling throughout the body or just in the brain extended life span up to 18%. At 22 months of age, brain-specific Irs2 knockout mice were overweight, hyperinsulinemic, and glucose intolerant; however, compared with control mice, they were more active and displayed greater glucose oxidation, and during meals they displayed stable superoxide dismutase-2 concentrations in the hypothalamus. Thus, less Irs2 signaling in aging brains can promote healthy metabolism, attenuate meal-induced oxidative stress, and extend the life span of overweight and insulin-resistant mice.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu	Gimenez, Luis E Diaz/D-9291-2011		NIDDK NIH HHS [DK55326, DK38712] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK038712, R01DK055326, R29DK038712, R01DK038712] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbieri M, 2003, EXP GERONTOL, V38, P137, DOI 10.1016/S0531-5565(02)00153-5; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kabil H, 2007, BIOGERONTOLOGY, V8, P201, DOI 10.1007/s10522-006-9065-3; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Miller RA, 2005, J AM GERIATR SOC, V53, pS284, DOI 10.1111/j.1532-5415.2005.53490.x; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Wang Y, 2006, PHYSIOL GENOMICS, V27, P131, DOI 10.1152/physiolgenomics.00239.2005; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	23	407	436	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					369	372		10.1126/science.1142179	http://dx.doi.org/10.1126/science.1142179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641201	Green Submitted			2022-12-28	WOS:000248150200046
J	Bianco, A; Poukkula, M; Cliffe, A; Mathieu, J; Luque, CM; Fulga, TA; Rorth, P				Bianco, Ambra; Poukkula, Minna; Cliffe, Adam; Mathieu, Juliette; Luque, Carlos M.; Fulga, Tudor A.; Rorth, Pernille			Two distinct modes of guidance signalling during collective migration of border cells	NATURE			English	Article							ZEBRAFISH LATERAL-LINE; DROSOPHILA OOGENESIS; EGF RECEPTOR; PROTEIN; MORPHOGENESIS; MICROSCOPY; PATHWAY	Although directed migration is a feature of both individual cells and cell groups, guided migration has been studied most extensively for single cells in simple environments(1,2). Collective guidance of cell groups remains poorly understood, despite its relevance for development and metastasis(3). Neural crest cells and neuronal precursors migrate as loosely organized streams of individual cells(4,5), whereas cells of the fish lateral line(6,7), Drosophila tracheal tubes and border-cell clusters(8) migrate as more coherent groups. Here we use Drosophila border cells to examine how collective guidance is performed. We report that border cells migrate in two phases using distinct mechanisms. Genetic analysis combined with live imaging shows that polarized cell behaviour is critical for the initial phase of migration, whereas dynamic collective behaviour dominates later. PDGF- and VEGF-related receptor and epidermal growth factor receptor act in both phases, but use different effector pathways in each. The myoblast city (Mbc, also known as DOCK180) and engulfment and cell motility (ELMO, also known as Ced-12) pathway is required for the early phase, in which guidance depends on subcellular localization of signalling within a leading cell. During the later phase, mitogen-activated protein kinase and phospholipase C gamma are used redundantly, and we find that the cluster makes use of the difference in signal levels between cells to guide migration. Thus, information processing at the multicellular level is used to guide collective behaviour of a cell group.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Natl Univ Singapore, Temasek Life Sci Lab TLL, Singapore 117604, Singapore	European Molecular Biology Laboratory (EMBL); National University of Singapore	Rorth, P (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	Pernille@tll.org.sg	Luque, Carlos M./Q-6043-2019; Ladoux, Benoit/A-9879-2013; Luque, Carlos/H-6810-2015; Rørth, Pernille/H-3020-2011	Luque, Carlos M./0000-0002-2993-4152; Luque, Carlos/0000-0002-2993-4152; Fulga, Tudor/0000-0002-1056-0082; Mathieu, Juliette/0000-0002-7152-4245; Poukkula, Minna Karoliina/0000-0003-4192-2899				Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Starz-Gaiano M, 2004, CURR OPIN GENET DEV, V14, P86, DOI 10.1016/j.gde.2003.12.001; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	27	211	212	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					362	U12		10.1038/nature05965	http://dx.doi.org/10.1038/nature05965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637670				2022-12-28	WOS:000248118300060
J	Harrington, DW; Munekata, MT				Harrington, Darrell W.; Munekata, Mark T.			Update in general internal medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SUSPECTED PULMONARY-EMBOLISM; PERIOPERATIVE BETA-BLOCKADE; SUSTAINED-RELEASE BUPROPION; ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; RECEPTOR PARTIAL AGONIST; HIGH-RISK PATIENTS; NONCARDIAC SURGERY; SMOKING-CESSATION		Harbor UCLA Med Ctr, Div Gen Internal, Med Director Off, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Harrington, DW (corresponding author), Harbor UCLA Med Ctr, Div Gen Internal, Med Director Off, Box 2,1000 W Carson St, Torrance, CA 90502 USA.	dharrington@ladhs.org						Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 2004, LANCET, V363, P757; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Devereaux PJ, 2006, AM HEART J, V152, P223, DOI 10.1016/j.ahj.2006.05.019; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; Feringa HHH, 2006, ARCH INTERN MED, V166, P529, DOI 10.1001/archinte.166.5.529; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Humair JP, 2006, ARCH INTERN MED, V166, P640, DOI 10.1001/archinte.166.6.640; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Juul AB, 2006, BMJ-BRIT MED J, V332, P1482, DOI 10.1136/bmj.332.7556.1482; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Knight CL, 2006, ANN INTERN MED, V145, P52, DOI 10.7326/0003-4819-145-1-200607040-00010; Leibowitz D, 2006, AM J CARDIOL, V97, P1188, DOI 10.1016/j.amjcard.2005.11.037; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Press MJ, 2006, ARCH INTERN MED, V166, P914, DOI 10.1001/archinte.166.8.914; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Thorp ML, 2006, ANN INTERN MED, V144, P700, DOI 10.7326/0003-4819-144-9-200605020-00020; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; Ward HB, 2006, ANN THORAC SURG, V82, P795, DOI 10.1016/j.athoracsur.2006.03.074; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yang H, 2006, AM HEART J, V152, P983, DOI 10.1016/j.ahj.2006.07.024; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, MMWR RECOMM REP, V50, P63	38	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					104	116		10.7326/0003-4819-147-2-200707170-00009	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00009			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17638720				2022-12-28	WOS:000248179300005
J	Kogevinas, M; Zock, JP; Jarvis, D; Kromhout, H; Lillienberg, L; Plana, E; Radon, K; Toren, K; Alliksoo, A; Benke, G; Blanc, PD; Dahlman-Hoglund, A; D'Errico, A; Hery, M; Kennedy, S; Kunzli, N; Leynaert, B; Mirabelli, MC; Muniozguren, N; Norback, D; Olivieri, M; Payo, F; Villani, S; van Sprundel, M; Urrutia, I; Wieslander, G; Sunyer, J; Anto, JM				Kogevinas, Manolis; Zock, Jan-Paul; Jarvis, Debbie; Kromhout, Hans; Lillienberg, Linnea; Plana, Estel; Radon, Katja; Toren, Kjell; Alliksoo, Ada; Benke, Geza; Blanc, Paul D.; Dahlman-Hoglund, Anna; D'Errico, Angelo; Hery, Michel; Kennedy, Susan; Kunzli, Nino; Leynaert, Benedicte; Mirabelli, Maria C.; Muniozguren, Nerea; Norback, Dan; Olivieri, Mario; Payo, Felix; Villani, Simona; van Sprundel, Marc; Urrutia, Isabel; Wieslander, Gundla; Sunyer, Jordi; Anto, Josep M.			Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II)	LANCET			English	Article							OCCUPATIONAL RESPIRATORY-DISEASES; AIRWAYS DYSFUNCTION SYNDROME; WORK-RELATED ASTHMA; REPORTED INCIDENCE; EPIDEMIOLOGY; SURVEILLANCE; LATEX	Background The role of exposure to substances in the workplace in new-onset asthma is not well characterised in population-based studies. We therefore aimed to estimate the relative and attributable risks of new-onset asthma in relation to occupations, work-related exposures, and inhalation accidents. Methods We studied prospectively 6837 participants from 13 countries who previously took part in the European Community Respiratory Health Survey (1990-95) and did not report respiratory symptoms or a history of asthma at the time of the first study. Asthma was assessed by methacholine challenge test and by questionnaire data on asthma symptoms. Exposures were defined by high-risk occupations, an asthma-specific job exposure matrix with additional expert judgment, and through self-report of acute inhalation events. Relative risks for new onset asthma were calculated with log-binomial models adjusted for age, sex, smoking, and study Centre. Findings A significant excess asthma risk was seen after exposure to substances known to cause occupational asthma (Relative risk=1.6, 95% CI 1.1-2.3, p=0.017). Risks were highest for asthma defined by bronchial hyper-reactivity in addition to symptoms (2.4,1.3-4.6, p=0.008). Of common occupations, a significant excess risk of asthma was seen for nursing (2.2,1.3-4.0, p=0.007). Asthma risk was also increased in participants who reported an acute symptomatic inhalation event such as fire, mixing cleaning products, or chemical spills (RR=3.3, 95% CI 1.0-11.1, p=0.051). The population-attributable risk for adult asthma due to occupational exposures ranged from 10% to 25%, equivalent to an incidence of new-onset occupational asthma of 250-300 cases per million people per year. Interpretation Occupational exposures account for a substantial proportion of adult asthma incidence. The increased risk of asthma after inhalation accidents suggests that workers who have such accidents should be monitored closely.	Municipal Inst Med Res, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; Univ Crete, Sch Med, Iraklion, Greece; Univ London Imperial Coll Sci Technol & Med, Resp Epidmeiol & Publ Hlth Grp, Natl Heart & Lung Inst, London, England; Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; Univ Munich, Inst Occupat & Environm Med, Unit Occupat & Environm Epidemiol & NetTeaching, Munich, Germany; Tartu Univ Clin, Lung Clin, Tartu, Estonia; Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3168, Australia; Univ Calif San Francisco, Dept Med, Div Environm & Occupat Med, San Francisco, CA USA; Serv Reg Epidemiol, Turin, Italy; Inst Natl Rech & Secur, F-54501 Vandoeuvre Les Nancy, France; Univ British Columbia, Sch Occupat & Environm Hyg, Vancouver, BC V5Z 1M9, Canada; Univ Paris 07, INSERM, French Inst Hlth & Med Res, Unit Epidemiol 700, Paris, France; Publ Hlth Dept Bizkaia, Epidemiol Unit, Galolatao, Spain; Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; Univ Verona, Dept Med & Publ Hlth, Unit Occupat Med, I-37100 Verona, Italy; Natl Inst Silicosis, Oviedo, Spain; Univ Pavia, Dept Hlth Sci, Sect Epidemiol & Med Stat, I-27100 Pavia, Italy; Univ Antwerp, Dept Epidemiol & Community Hlth, Antwerp, Belgium; Pompeu Fabra Univ, Barcelona, Spain	University of Crete; Imperial College London; Utrecht University; Sahlgrenska University Hospital; University of Munich; University of Tartu; Monash University; University of California System; University of California San Francisco; University of British Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Uppsala University; University of Verona; University of Pavia; University of Antwerp; Pompeu Fabra University	Kogevinas, M (corresponding author), Municipal Inst Med Res, Ctr Res Environm Epidemiol, Barcelona 08003, Spain.	kogevinas@imim.es	Kromhout, Hans/A-9159-2008; Reid, David W/B-3263-2011; Kuenzli, Nino/F-7195-2014; Kogevinas, Manolis/C-3918-2017; Anto, J M/H-2676-2014; Rolla, Giovanni/C-9901-2009; Jarvis, Deborah/E-6494-2011; Sánchez-Ramos, José Luis/G-1259-2011; Sunyer, Jordi/G-6909-2014; Ciccone, Giovannino/K-3136-2016; Svanes, Cecilie/N-7556-2017; Zock, Jan-Paul/P-5034-2018; HERY, Michel/AAU-1804-2021; Bono, Roberto/J-8954-2012; Corsico, Angelo Guido/AAC-8138-2019; Leynaert, Benedicte/N-5251-2018; Burgos, Felip/E-5734-2015; Jaen, Angeles/J-9780-2013; Dalmasso, Paola/F-8555-2013; Heinrich, Joachim/N-1720-2013	Kromhout, Hans/0000-0002-4233-1890; Kuenzli, Nino/0000-0001-8360-080X; Kogevinas, Manolis/0000-0002-9605-0461; Anto, J M/0000-0002-4736-8529; Rolla, Giovanni/0000-0001-5997-7172; Sánchez-Ramos, José Luis/0000-0001-7187-9989; Sunyer, Jordi/0000-0002-2602-4110; Ciccone, Giovannino/0000-0001-7644-9574; Svanes, Cecilie/0000-0001-8512-5192; Zock, Jan-Paul/0000-0002-2941-6259; Bono, Roberto/0000-0002-2471-6594; Corsico, Angelo Guido/0000-0002-8716-4694; Burgos, Felip/0000-0002-4938-4581; Cerveri, Isa/0000-0003-0337-043X; d'Errico, Angelo/0000-0003-3171-413X; Mirabelli, Maria/0000-0002-3540-0085; Jarvis, Deborah/0000-0002-1753-3896; Norback, Dan/0000-0002-5174-6668; Plana, Estel/0000-0001-8675-7503; Leynaert, Benedicte/0000-0001-5045-2492; Jaen, Angeles/0000-0002-6815-2022; Abramson, Michael/0000-0002-9954-0538; /0000-0003-2517-6515; Dalmasso, Paola/0000-0001-6081-6966; ROMANO, Canzio/0000-0001-5294-9793; Heinrich, Joachim/0000-0002-9620-1629; Grassi, Mario/0000-0001-6612-8566	NCRR NIH HHS [2 S07RR05521-28] Funding Source: Medline; NHLBI NIH HHS [1 R01 HL62633-01, R01 HL62633-01] Funding Source: Medline; NIEHS NIH HHS [5P30 ES07048] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ameille J, 2003, OCCUP ENVIRON MED, V60, P136, DOI 10.1136/oem.60.2.136; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Balmes JR, 2002, CLIN CHEST MED, V23, P727, DOI 10.1016/S0272-5231(02)00031-X; Bernstein D. I., 2006, ASTHMA WORKPLACE; Blanc PD, 1999, AM J MED, V107, P580, DOI 10.1016/S0002-9343(99)00307-1; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; CONTRERAS GR, 1994, OCCUP ENVIRON MED, V51, P710, DOI 10.1136/oem.51.10.710; Elder D, 2004, OCCUP MED-OXFORD, V54, P395, DOI 10.1093/occmed/kqh050; Garabrant DH, 2002, J ALLERGY CLIN IMMUN, V110, pS82, DOI 10.1067/mai.2002.124967; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; International Labour Organisation, 1991, INT STAND CLASS OCC; Karjalainen A, 2000, AM J IND MED, V37, P451, DOI 10.1002/(SICI)1097-0274(200005)37:5&lt;451::AID-AJIM1&gt;3.0.CO;2-U; Kennedy SM, 2000, OCCUP ENVIRON MED, V57, P635, DOI 10.1136/oem.57.9.635; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; Lemiere C, 1997, EUR RESPIR J, V10, P241, DOI 10.1183/09031936.97.10010241; McDonald JC, 2000, OCCUP ENVIRON MED, V57, P823, DOI 10.1136/oem.57.12.823; Medina-Ramon M, 2005, OCCUP ENVIRON MED, V62, P598, DOI 10.1136/oem.2004.017640; Orriols R, 2006, OCCUP ENVIRON MED, V63, P255, DOI 10.1136/oem.2005.022525; Pekkanen J, 2006, J CLIN EPIDEMIOL, V59, P281, DOI 10.1016/j.jclinepi.2005.07.013; Rosenman KD, 1997, J OCCUP ENVIRON MED, V39, P415, DOI 10.1097/00043764-199705000-00007; Rosenman KD, 2003, J OCCUP ENVIRON MED, V45, P556, DOI 10.1097/01.jom.0000058347.05741.f9; Toren K, 1996, OCCUP ENVIRON MED, V53, P757, DOI 10.1136/oem.53.11.757; VANDENPLAS O, 1995, AM J RESP CRIT CARE, V151, P54, DOI 10.1164/ajrccm.151.1.7812572; Vandenplas O, 2005, REV MAL RESPIR, V22, P421, DOI 10.1016/S0761-8425(05)85570-6; Venables KM, 1997, LANCET, V349, P1465, DOI 10.1016/S0140-6736(96)07219-4; Zock JP, 2002, EUR RESPIR J, V20, P679, DOI 10.1183/09031936.02.00279702	27	293	294	0	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					336	341		10.1016/S0140-6736(07)61164-7	http://dx.doi.org/10.1016/S0140-6736(07)61164-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662882				2022-12-28	WOS:000248426100031
J	Neuberger, J; Gimson, A				Neuberger, James; Gimson, Alexander			Selfless adults and split donor livers	LANCET			English	Editorial Material							TRANSPLANTATION; ALLOCATION; PRIORITIES; CARE		Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England; Addenbrookes Hosp, Cambridge, England	University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Neuberger, J (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.	J.M.Neuberger@bham.ac.uk	Neuberger, James/ABG-3010-2020					Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Barshes NR, 2005, AM J TRANSPLANT, V5, P2047, DOI 10.1111/j.1600-6143.2005.00946.x; Broering DC, 2001, ANN SURG, V234, P713, DOI 10.1097/00000658-200112000-00002; Burroughs AK, 2006, LANCET, V367, P225, DOI 10.1016/S0140-6736(06)68033-1; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Johri M, 2003, LIVER TRANSPLANT, V9, P878, DOI 10.1053/jlts.2003.50154; Merion RM, 2004, AM J TRANSPLANT, V4, P1792, DOI 10.1111/j.1600-6143.2004.00594.x; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pomfret EA, 2007, AM J TRANSPLANT, V7, P1376, DOI 10.1111/j.1600-6143.2007.01782.x	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					299	300		10.1016/S0140-6736(07)61139-8	http://dx.doi.org/10.1016/S0140-6736(07)61139-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662864				2022-12-28	WOS:000248426100008
J	Thorleifsson, G; Magnusson, KP; Sulem, P; Walters, GB; Gudbjartsson, DF; Stefansson, H; Jonsson, T; Jonasdottir, A; Jonasdottir, A; Stefansdottir, G; Masson, G; Hardarson, GA; Petursson, H; Arnarsson, A; Motallebipour, M; Wallerman, O; Wadelius, C; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Jonasson, F; Stefansson, K				Thorleifsson, Gudmar; Magnusson, Kristinn P.; Sulem, Patrick; Walters, G. Bragi; Gudbjartsson, Daniel F.; Stefansson, Hreinn; Jonsson, Thorlakur; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Stefansdottir, Gerdur; Masson, Gisli; Hardarson, Gudmundur A.; Petursson, Hjorvar; Arnarsson, Arsaell; Motallebipour, Mehdi; Wallerman, Ola; Wadelius, Claes; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Jonasson, Fridbert; Stefansson, Kari			Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma	SCIENCE			English	Article							OPEN-ANGLE GLAUCOMA; PSEUDOEXFOLIATION SYNDROME; LAMINA-CRIBROSA; LYSYL-OXIDASE; IDENTIFICATION; ASSOCIATION; PREVALENCE; MUTATIONS; STABILITY; ELASTOSIS	Glaucoma is a leading cause of irreversible blindness. A genome-wide search yielded multiple single-nucleotide polymorphisms (SNPs) in the 15q24.1 region associated with glaucoma. Further investigation revealed that the association is confined to exfoliation glaucoma (XFG). Two nonsynonymous SNPs in exon 1 of the gene LOXL1 explain the association, and the data suggest that they confer risk of XFG mainly through exfoliation syndrome (XFS). About 25% of the general population is homozygous for the highest-risk haplotype, and their risk of suffering from XFG is more than 100 times that of individuals carrying only low-risk haplotypes. The population-attributable risk is more than 99%. The product of LOXL1 catalyzes the formation of elastin fibers found to be a major component of the lesions in XFG.	Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; deCODE Genet Inc, IS-101 Reykjavik, Iceland; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Natl Univ Hosp Reykjavik, Dept Ophthalmol, IS-101 Reykjavik, Iceland	University of Iceland; Uppsala University; Landspitali National University Hospital	Jonasson, F (corresponding author), Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland.	fridbert@landspitali.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Magnusson, Kristinn/A-6479-2011; Walters, G. Bragi/L-4215-2013; Jonasson, Fridbert/ABA-9889-2021; Magnusson, Kristinn P Pétur/X-4907-2019	Magnusson, Kristinn/0000-0003-4528-6826; Walters, G. Bragi/0000-0002-5415-6487; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857; Wallerman, Ola/0000-0003-1037-7904; Kong, Augustine/0000-0001-8193-5438				Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hewitt AW, 2006, CLIN EXP OPHTHALMOL, V34, P472, DOI 10.1111/j.1442-9071.2006.01268.x; Jeng SM, 2007, J GLAUCOMA, V16, P117, DOI 10.1097/01.ijg.0000243470.13343.8b; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; Kirwan RP, 2005, MOL VIS, V11, P798; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ringvold A, 1999, ACTA OPHTHALMOL SCAN, V77, P371, DOI 10.1034/j.1600-0420.1999.770401.x; Ritch R, 2003, PROG RETIN EYE RES, V22, P253, DOI 10.1016/S1350-9462(02)00014-9; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Zhang HP, 2006, HUM MOL GENET, V15, P807, DOI 10.1093/hmg/ddl024	22	505	535	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1397	1400		10.1126/science.1146554	http://dx.doi.org/10.1126/science.1146554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690259				2022-12-28	WOS:000249377500048
J	Das, S				Das, Shamita			The need to study speed	SCIENCE			English	Editorial Material							SAN-FRANCISCO EARTHQUAKE; KUNLUNSHAN-EARTHQUAKE; RUPTURE; SUPERSHEAR; FAULTS; SLIP		Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Das, S (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	das@earth.ox.ac.uk			Natural Environment Research Council [NE/C518806/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Bhat HS, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004425; Bouchon M, 2003, SCIENCE, V301, P824, DOI 10.1126/science.1086832; Bouchon M, 2001, GEOPHYS RES LETT, V28, P2723, DOI 10.1029/2001GL013112; Dunham EM, 2004, B SEISMOL SOC AM, V94, pS256, DOI 10.1785/0120040616; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; KOSTROV BV, 1988, PRINCIPLES EARTHQUAK, P286; Lasserre C, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003500; MADARIAGA R, 1983, ANN GEOPHYS, V1, P17; Madariaga R, 2007, SCIENCE, V316, P842, DOI 10.1126/science.1142332; Robinson DP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004137; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1421; SONG S, 2005, EOS T AGU S, V86; Thatcher W, 1997, J GEOPHYS RES-SOL EA, V102, P5353, DOI 10.1029/96JB03486; WALD DJ, 1993, B SEISMOL SOC AM, V83, P981; Xia KW, 2005, SCIENCE, V308, P681, DOI 10.1126/science.1108193	17	45	52	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					905	906		10.1126/science.1142143	http://dx.doi.org/10.1126/science.1142143			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702932				2022-12-28	WOS:000248780200026
J	Bylaite, M; Ruzicka, T				Bylaite, Matilda; Ruzicka, Thomas			Pearly penile papules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Munich, D-80337 Munich, Germany	University of Munich	Bylaite, M (corresponding author), Univ Munich, D-80337 Munich, Germany.	matilda.bylaite@gmail.com							0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					691	691		10.1056/NEJMicm060634	http://dx.doi.org/10.1056/NEJMicm060634			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699819				2022-12-28	WOS:000248746000009
J	Goulielmakis, E; Yakovlev, VS; Cavalieri, AL; Uiberacker, M; Pervak, V; Apolonski, A; Kienberger, R; Kleineberg, U; Krausz, F				Goulielmakis, E.; Yakovlev, V. S.; Cavalieri, A. L.; Uiberacker, M.; Pervak, V.; Apolonski, A.; Kienberger, R.; Kleineberg, U.; Krausz, F.			Attosecond control and measurement: Lightwave electronics	SCIENCE			English	Review							HIGH-HARMONIC-GENERATION; EXTREME-ULTRAVIOLET; NONLINEAR OPTICS; LASER-PULSES; TIME-SCALE; DYNAMICS; MOLECULES; FIELDS; INTERFEROMETRY; LOCALIZATION	Electrons emit light, carry electric current, and bind atoms together to form molecules. Insight into and control of their atomic-scale motion are the key to understanding the functioning of biological systems, developing efficient sources of x-ray light, and speeding up electronics. Capturing and steering this electron motion require attosecond resolution and control, respectively (1 attosecond = 10(-18) seconds). A recent revolution in technology has afforded these capabilities: Controlled light waves can steer electrons inside and around atoms, marking the birth of lightwave electronics. Isolated attosecond pulses, well reproduced and fully characterized, demonstrate the power of the new technology. Controlled few-cycle light waves and synchronized attosecond pulses constitute its key tools. We review the current state of lightwave electronics and highlight some future directions.	MPQ, D-85748 Garching, Germany; Univ Munich, Dept Phys, D-85748 Garching, Germany	University of Munich	Krausz, F (corresponding author), MPQ, Hans Kopfermann Str 1, D-85748 Garching, Germany.	krausz@lmu.de	Apolonskiy, Alexander/F-2559-2013; Yakovlev, Vladislav S/C-4091-2015; Goulielmakis, Eleftherios/AAZ-1052-2020; Goulielmakis, Eleftherios/F-1693-2011	Apolonskiy, Alexander/0000-0002-0853-6104; Yakovlev, Vladislav S/0000-0002-0648-9375; Goulielmakis, Eleftherios/0000-0003-3386-0245; Kienberger, Reinhard/0000-0001-8781-3685				Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; Agostini P, 2004, REP PROG PHYS, V67, P813, DOI 10.1088/0034-4885/67/6/R01; Akozbek N, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/177; Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bandrauk AD, 2004, INT J QUANTUM CHEM, V100, P834, DOI 10.1002/qua.20252; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Brumer P., 2003, PRINCIPLES QUANTUM C; Cavalieri AL, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/242; Chang ZH, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.043802; Christov IP, 2001, PHYS REV LETT, V86, P5458, DOI 10.1103/PhysRevLett86.5458; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Iaconis C, 1999, IEEE J QUANTUM ELECT, V35, P501, DOI 10.1109/3.753654; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259; Lopez-Martens R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033001; Mauritsson J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013001; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Nisoli M, 1997, OPT LETT, V22, P522, DOI 10.1364/OL.22.000522; Oishi Y, 2006, OPT EXPRESS, V14, P7230, DOI 10.1364/OE.14.007230; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Pfeifer T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.163901; Quere F, 2005, J MOD OPTIC, V52, P339, DOI 10.1080/09500340412331307942; Remetter T, 2006, NAT PHYS, V2, P323, DOI 10.1038/nphys290; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Schafer KJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.023003; Schultze M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/243; Sekikawa T, 2004, NATURE, V432, P605, DOI 10.1038/nature03108; Sola IJ, 2006, NAT PHYS, V2, P319, DOI 10.1038/nphys281; SZIPOCS R, 1994, OPT LETT, V19, P201, DOI 10.1364/OL.19.000201; Trebino R, 1997, REV SCI INSTRUM, V68, P3277, DOI 10.1063/1.1148286; Tzallas P, 2003, NATURE, V426, P267, DOI 10.1038/nature02091; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h; Zholents AA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.224801	45	302	312	9	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					769	775		10.1126/science.1142855	http://dx.doi.org/10.1126/science.1142855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690286				2022-12-28	WOS:000248624500030
J	Insel, TR				Insel, Thomas R.			Shining light on depression	SCIENCE			English	Editorial Material							PREFRONTAL CORTEX; MAJOR DEPRESSION; HIPPOCAMPAL; DISORDERS		NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, Room 8235,6001 Execut Blvd, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov			Intramural NIH HHS [Z99 MH999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; HOUENOU J, 2007, MOL PSYCHIAT; Insel TR, 2005, JAMA-J AM MED ASSOC, V294, P2221, DOI 10.1001/jama.294.17.2221; Lopez-Figueroa AL, 2004, BIOL PSYCHIAT, V55, P225, DOI 10.1016/j.biopsych.2003.09.017; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659	15	15	17	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					757	758		10.1126/science.1147565	http://dx.doi.org/10.1126/science.1147565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690279	Green Accepted			2022-12-28	WOS:000248624500023
J	Cigolle, CT; Langa, KM; Kabeto, MU; Tian, Z; Blaum, CS				Cigolle, Christine T.; Langa, Kenneth M.; Kabeto, Mohammed U.; Tian, Zhiyi; Blaum, Caroline S.			Geriatric conditions and disability: The health and retirement study	ANNALS OF INTERNAL MEDICINE			English	Article							DWELLING OLDER-ADULTS; BODY-MASS INDEX; HEARING-LOSS; URINARY-INCONTINENCE; COGNITIVE IMPAIRMENT; FUNCTIONAL DECLINE; ALZHEIMERS-DISEASE; UNITED-STATES; COMMUNITY; FRAILTY	Background: Geriatric conditions, such as incontinence and falling, are not part of the traditional disease model of medicine and may be overlooked in the care of older adults. The prevalence of geriatric conditions and their effect on health and disability in older adults has not been investigated in population-based samples. Objective: To investigate the prevalence of geriatric conditions and their association with dependency in activities of daily living by using nationally representative data. Design: Cross-sectional analysis. Setting: Health and Retirement Study survey administered in 2000. Participants: Adults age 65 years or older (n = 11 093, representing 34.5 million older Americans) living in the community and in nursing homes. Measurements: Geriatric conditions (cognitive impairment, falls, incontinence, low body mass index, dizziness, vision impairment, hearing impairment) and dependency in activities of daily living (bathing, dressing, eating, transferring, toileting). Results: Of adults age 65 years or older, 49.9% had 1 or more geriatric conditions. Some conditions were as prevalent as common chronic diseases, such as heart disease and diabetes. The association between geriatric conditions and dependency in activities of daily living was strong and significant, even after adjustment for demographic characteristics and chronic diseases (adjusted risk ratio, 2.1 [95% CI, 1.9 to 2.4] for 1 geriatric condition, 3.6 [CI, 3.1 to 4.1] for 2 conditions, and 6.6 [CI, 5.6 to 7.6] for >= 3 conditions). Limitations: The study was cross-sectional and based on self-reported data. Because measures were limited by the survey questions, important conditions, such as delirium and frailty, were not assessed. Survival biases may influence the estimates. Conclusions: Geriatric conditions are similar in prevalence to chronic diseases in older adults and in some cases are as strongly associated with disability. The findings suggest that geriatric conditions, although not a target of current models of health care, are important to the health and function of older adults and should be addressed in their care.	Univ Michigan, Ann Arbor Vet Affairs Healthcare Syst Geriatr Res, Educ & Clin Ctr, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Ctr Practice Management & O, Ann Arbor, MI USA	Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Cigolle, CT (corresponding author), Univ Michigan, 300 N Ingalls,Room 919, Ann Arbor, MI 48109 USA.			Langa, Kenneth/0000-0002-2798-1836	NATIONAL INSTITUTE ON AGING [R01AG021493, K08AG019180, T32AG000114, F32AG027649, U01AG009740] Funding Source: NIH RePORTER; NIA NIH HHS [1F32AG027649-01, 5T32AG000114, R01:AG021493-01, U01 AG009740, K08 AG19180, U01 AG09740] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; BLAUM CS, 1995, J GERONTOL A-BIOL, V50, pM162, DOI 10.1093/gerona/50A.3.M162; Blaum CS, 2002, J GERONTOL A-BIOL, V57, pM523, DOI 10.1093/gerona/57.8.M523; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Buchner D M, 1992, Clin Geriatr Med, V8, P1; Buttar A, 2001, J GERONTOL A-BIOL, V56, pM292, DOI 10.1093/gerona/56.5.M292; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Cassel CK, 2003, GERIATRIC MED EVIDEN, V4th; Cigolle CT, 2005, J AM GERIATR SOC, V53, P2051, DOI 10.1111/j.1532-5415.2005.00496.x; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cook JA, 2006, MAYO CLIN PROC, V81, P234, DOI 10.4065/81.2.234; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Cruickshanks KJ, 2003, ARCH OTOLARYNGOL, V129, P1041, DOI 10.1001/archotol.129.10.1041; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; de Rekeneire N, 2003, J AM GERIATR SOC, V51, P841, DOI 10.1046/j.1365-2389.2003.51267.x; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Dodge HH, 2005, GERONTOLOGIST, V45, P222, DOI 10.1093/geront/45.2.222; Flacker JM, 2003, J AM GERIATR SOC, V51, P574, DOI 10.1046/j.1532-5415.2003.51174.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Gill TM, 2003, J GERONTOL A-BIOL, V58, P70; Gill TM, 1996, J GERONTOL A-BIOL, V51, pM283, DOI 10.1093/gerona/51A.6.M283; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Hardy SE, 2006, J GERONTOL A-BIOL, V61, P272, DOI 10.1093/gerona/61.3.272; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hargrave R, 2000, J GERIATR PSYCH NEUR, V13, P72, DOI 10.1177/089198870001300205; HAZZARD WR, 2003, PRINCIPLES GERIATR M; Hebert R, 1999, AM J EPIDEMIOL, V150, P501; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; HOENIG H, 2003, PRINCIPLES GERIATRIC, P285; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; Holroyd-Leduc JM, 2004, JAMA-J AM MED ASSOC, V291, P996, DOI 10.1001/jama.291.8.996; Holroyd-Leduc JM, 2004, JAMA-J AM MED ASSOC, V291, P986, DOI 10.1001/jama.291.8.986; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; KATZ S, 1989, J AM GERIATR SOC, V37, P267, DOI 10.1111/j.1532-5415.1989.tb06820.x; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Koroukian SM, 2006, J CLIN ONCOL, V24, P2304, DOI 10.1200/JCO.2005.03.1567; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mehta KM, 2002, J AM GERIATR SOC, V50, P1045, DOI 10.1046/j.1532-5415.2002.50259.x; Mitnitski AB, 2004, J GERONTOL A-BIOL, V59, P627, DOI 10.1093/gerona/59.6.M627; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Njegovan V, 2001, J GERONTOL A-BIOL, V56, pM638, DOI 10.1093/gerona/56.10.M638; Pompei P, 2006, GERIATRICS REV SYLLA; POPE AM, 1991, DISABILITY AM NATL A; Racz M, 2005, J AM GERIATR SOC, V53, pS245, DOI 10.1111/j.1532-5415.2005.53350.x; Rantanen T, 2000, J AM GERIATR SOC, V48, P613, DOI 10.1111/j.1532-5415.2000.tb04717.x; Reuben D. B., 1991, GERIATRICS REV SYLLA, P117; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Rockwood K, 2005, J AM GERIATR SOC, V53, P1069, DOI 10.1111/j.1532-5415.2005.53312.x; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Roubenoff R, 1999, J NUTR, V129, p256S, DOI 10.1093/jn/129.1.256S; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; SOLDO BJ, 1997, J GERONTOL B, V52; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Taylor DH, 2001, J GERONTOL B-PSYCHOL, V56, pS285, DOI 10.1093/geronb/56.5.S285; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tinetti ME, 2000, J AM GERIATR SOC, V48, P417, DOI 10.1111/j.1532-5415.2000.tb04700.x; Wallace JI, 1997, CLIN GERIATR MED, V13, P717; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; 2006, J UROL, V175, P601; 2001, J GERONTOL A, V56, pM146; 2004, OBSTET GYNECOL, V104, P301	75	259	267	2	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					156	164		10.7326/0003-4819-147-3-200708070-00004	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679703				2022-12-28	WOS:000248454700002
J	Williams, SB; Whitlock, EP; Edgerton, EA; Smith, PR; Bell, TL				Williams, Selvi B.; Whitlock, Evelyn P.; Edgerton, Elizabeth A.; Smith, Paula R.; Bell, Tracy L.			Counseling about proper use of motor vehicle occupant restraints and avoidance of alcohol use while driving: A systematic evidence review for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article																			0	17	17	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					194	206		10.7326/0003-4819-147-3-200708070-00009	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00009			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679708				2022-12-28	WOS:000248454700007
J	Lakhal, K; Damoisel, C				Lakhal, Karim; Damoisel, Charles			Air in the gut wall	LANCET			English	Editorial Material									Hop Bichat Claude Bernard, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Lakhal, K (corresponding author), Hop Bichat Claude Bernard, 46 Ave Henri Huchard, F-75018 Paris, France.	lakhal_karim@yahoo.fr							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					414	414		10.1016/S0140-6736(07)61196-9	http://dx.doi.org/10.1016/S0140-6736(07)61196-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679018				2022-12-28	WOS:000248590200031
J	Hedman, MM; Burns, JA; Tiscareno, MS; Porco, CC; Jones, GH; Roussos, E; Krupp, N; Paranicas, C; Kempf, S				Hedman, Matthew M.; Burns, Joseph A.; Tiscareno, Matthew S.; Porco, Carolyn C.; Jones, Geraint H.; Roussos, Elias; Krupp, Norbert; Paranicas, Chris; Kempf, Sascha			The source of Saturn's G Ring	SCIENCE			English	Article							MAGNETOSPHERE	The origin of Saturn's narrow G ring has been unclear. We show that it contains a bright arc located 167,495.6 +/- 1.3 km from Saturn's center. This longitudinally localized material is trapped in a 7: 6 corotation eccentricity resonance with the satellite Mimas. The cameras aboard the Cassini spacecraft mainly observe small ( 1 to 10 micrometers) dust grains in this region, but a sharp decrease in the flux of energetic electrons measured near this arc requires that it also contain larger (centimeter- to meter-sized) bodies whose total mass is equivalent to that of a similar to 100-meter-wide ice-rich moonlet. Collisions into these bodies may generate dust, which subsequently drifts outward to populate the rest of the G ring. Thus, the entire G ring could be derived from an arc of debris held in a resonance with Mimas.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; Space Sci Inst, Cassini Imaging Cent Lab Operat, Mountain View, CA 94043 USA; Max Planck Inst Sonnensystemforsch, D-37191 Katlenburg Lindau, Germany; UCL, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Max Planck Inst Kernphys, D-69117 Heidelberg, Germany	Cornell University; Cornell University; Max Planck Society; University of London; University College London; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Max Planck Society	Hedman, MM (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	mmhedman@astro.cornell.edu	Paranicas, Christopher/B-1470-2016; Tiscareno, Matthew/D-6963-2011; Roussos, Elias/H-2249-2011; Jones, Geraint H./C-1682-2008	Paranicas, Christopher/0000-0002-4391-8255; Jones, Geraint H./0000-0002-5859-1136; Roussos, Elias/0000-0002-5699-0678; KEMPF, SASCHA/0000-0001-5236-3004; Hedman, Matthew/0000-0002-8592-0812	Science and Technology Facilities Council [PP/D005213/1] Funding Source: researchfish; STFC [PP/D005213/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Burns J.A., 1984, IAU COLLO Q 75 PLANE, P200; Burns JA, 2001, ASTR AST LI, P641; Canup RM, 1997, ICARUS, V126, P28, DOI 10.1006/icar.1996.5634; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; de Pater I, 2004, ICARUS, V172, P446, DOI 10.1016/j.icarus.2004.07.012; GOLDREICH P, 1986, ASTRON J, V92, P490, DOI 10.1086/114178; Gurnett DA, 2007, SCIENCE, V316, P442, DOI 10.1126/science.1138562; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Lissauer JJ, 2000, ICARUS, V146, P12, DOI 10.1006/icar.2000.6386; Namouni F, 2002, NATURE, V417, P45, DOI 10.1038/417045a; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; PORCO CC, 1991, SCIENCE, V253, P995, DOI 10.1126/science.253.5023.995; ROUSSOS E, IN PRESS ICARUS; SHOWALTER MR, 1993, ICARUS, V103, P124, DOI 10.1006/icar.1993.1062; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Throop HB, 1998, ICARUS, V131, P152, DOI 10.1006/icar.1997.5851; VANALLEN JA, 1983, J GEOPHYS RES-SPACE, V88, P6911, DOI 10.1029/JA088iA09p06911	19	52	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					653	656		10.1126/science.1143964	http://dx.doi.org/10.1126/science.1143964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673659				2022-12-28	WOS:000248494400043
J	Bolton, P; Bass, J; Betancourt, T; Speelman, L; Onyango, G; Clougherty, KF; Neugebauer, R; Murray, L; Verdeli, H				Bolton, Paul; Bass, Judith; Betancourt, Theresa; Speelman, Liesbeth; Onyango, Grace; Clougherty, Kathleen F.; Neugebauer, Richard; Murray, Laura; Verdeli, Helen			Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERPERSONAL PSYCHOTHERAPY; DIFFICULTIES QUESTIONNAIRE; MENTAL-HEALTH; PRIMARY-CARE; STRENGTHS; CHILD; EFFICACY; VALIDITY; IMPACT	Context Prior qualitative work with internally displaced persons in war-affected northern Uganda showed significant mental health and psychosocial problems. Objective To assess effect of locally feasible interventions on depression, anxiety, and conduct problem symptoms among adolescent survivors of war and displacement in northern Uganda. Design, Setting, and Participants A randomized controlled trial from May 2005 through December 2005 of 314 adolescents ( aged 14-17 years) in 2 camps for internally displaced persons in northern Uganda. Interventions Locally developed screening tools assessed the effectiveness of interventions in reducing symptoms of depression and anxiety, ameliorating conduct problems, and improving function among those who met study criteria and were randomly allocated ( 105, psychotherapy-based intervention [ group interpersonal psychotherapy]; 105, activity-based intervention [ creative play]; 104, wait-control group [ individuals wait listed to receive treatment at study end]). Intervention groups met weekly for 16 weeks. Participants and controls were reassessed at end of study. Main Outcome Measures Primary measure was a decrease in score ( denoting improvement) on a depression symptom scale. Secondary measures were improvements in scores on anxiety, conduct problem symptoms, and function scales. Depression, anxiety, and conduct problems were assessed using the Acholi Psychosocial Assessment Instrument with a minimum score of 32 as the lower limit for clinically significant symptoms ( maximum scale score, 105). Results Difference in change in adjusted mean score for depression symptoms between group interpersonal psychotherapy and control groups was 9.79 points (95% confidence interval [CI], 1.66-17.93). Girls receiving group interpersonal psychotherapy showed substantial and significant improvement in depression symptoms compared with controls (12.61 points; 95% CI, 2.09-23.14). Improvement among boys was not statistically significant (5.72 points; 95% CI, - 1.86 to 13.30). Creative play showed no effect on depression severity (-2.51 points; 95% CI, - 11.42 to 6.39). There were no statistically different improvements in anxiety in either intervention group. Neither intervention improved conduct problem or function scores. Conclusions Both interventions were locally feasible. Group interpersonal psychotherapy was effective for depression symptoms among adolescent girls affected by war and displacement. Other interventions should be investigated to assist adolescent boys in this population who have symptoms of depression.	Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Dept Mental Hlth, Baltimore, MD 21205 USA; Boston Univ, Sch Publ Hlth, Appl Mental Hlth Res Grp, Ctr Int Hlth & Dev, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Dept Populat & Int Hlth, Boston, MA 02115 USA; War child Holland, Gulu, Uganda; World Vis Uganda, Kampala, Uganda; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Div Epidemiol, New York, NY USA; Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, Fac Med, New York, NY USA; Columbia Univ, Teachers Coll, New York, NY 10027 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University Teachers College	Bolton, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Dept Mental Hlth, 615 N Wolfe St,Room E8646, Baltimore, MD 21205 USA.	pbolton@jhsph.edu		Bass, Judith/0000-0002-5192-628X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], CHILD SOLD GLOB REP; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Barenbaum J, 2004, J CHILD PSYCHOL PSYC, V45, P41, DOI 10.1046/j.0021-9630.2003.00304.x; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P151; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Igreja V, 2004, BRIT J PSYCHIAT, V184, P251, DOI 10.1192/bjp.184.3.251; KALKSMAVANLITH B, 2005, STATE ART PSYCHOSOCI; KASHALA E, 2006, CO EXISTING SYMPTOMS; Lin EHB, 2000, ARCH FAM MED, V9, P1052, DOI 10.1001/archfami.9.10.1052; Lustig SL, 2004, J AM ACAD CHILD PSY, V43, P24, DOI 10.1097/00004583-200401000-00012; Mufson L, 1999, ARCH GEN PSYCHIAT, V56, P573, DOI 10.1001/archpsyc.56.6.573; Mufson Laura, 2004, American Journal of Psychotherapy, V58, P220; Omar RZ, 2000, STAT MED, V19, P2675, DOI 10.1002/1097-0258(20001015)19:19<2675::AID-SIM556>3.3.CO;2-1; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; PROSCHAN MA, 1995, AM STAT, V49, P144, DOI 10.2307/2684628; Samad L, 2005, INT J METH PSYCH RES, V14, P158, DOI 10.1002/mpr.3; Stichick T, 2001, CHILD ADOL PSYCH CL, V10, P797, DOI 10.1016/S1056-4993(18)30031-2; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; Thabet AAM, 2004, CHILD ABUSE NEGLECT, V28, P77, DOI 10.1016/j.chiabu.2002.12.002; WEISSMAN MM, 1981, ARCH GEN PSYCHIAT, V38, P51; WEISSMAN MM, 2000, COMPREHENSIVE GUIDE; Young JF, 2006, J AM ACAD CHILD PSY, V45, P904, DOI 10.1097/01.chi.0000222791.23927.5f	29	340	340	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					519	527		10.1001/jama.298.5.519	http://dx.doi.org/10.1001/jama.298.5.519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666672	Bronze			2022-12-28	WOS:000248438100019
J	Lemmon, MA; Ferguson, KM				Lemmon, Mark A.; Ferguson, Kathryn M.			A new twist in the transmembrane signaling tool-kit	CELL			English	Editorial Material							STEM-CELL FACTOR; RECEPTOR TYROSINE KINASES; BINDING; DIMERIZATION; ACTIVATION	In this issue, Schlessinger and his colleagues (Yuzawa et al., 2007) describe crystal structures of the complete extracellular region of the Kit receptor tyrosine kinase, both alone and in complex with its activating ligand, stem cell factor (SCF). The structures explain how SCF drives dimerization of the receptor. They also reveal important receptor-receptor contacts that may explain how several Kit mutations lead to cancer.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu; ferguso2@mail.med.upenn.edu		Lemmon, Mark/0000-0002-3379-5319				BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; YUZAWA S, 2007, CELL	10	12	22	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					213	215		10.1016/j.cell.2007.07.006	http://dx.doi.org/10.1016/j.cell.2007.07.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662934	Bronze			2022-12-28	WOS:000248588000009
J	Senior, AE				Senior, Alan E.			ATP synthase: Motoring to the finish line	CELL			English	Editorial Material								Protonmotive force produced by the electron transport chain is harnessed by the rotary molecular nanomotor ATP synthase to generate ATP. In this issue of Cell, Adachi et al. (2007), in a dazzling display of technical sophistication, now disentangle the coupling between the mechanical force generated by rotation of the ATP synthase subunits and the chemical reactions that occur simultaneously at the enzyme's three catalytic sites.	Univ Rochester, Ctr Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Senior, AE (corresponding author), Univ Rochester, Ctr Med, Dept Biochem & Biophys, Rochester, NY 14642 USA.	alan_senior@urmc.rochester.edu						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ADACHI K, 2007, CELL; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007	8	35	37	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					220	221		10.1016/j.cell.2007.07.004	http://dx.doi.org/10.1016/j.cell.2007.07.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662937	Bronze			2022-12-28	WOS:000248588000012
J	Matheu, A; Maraver, A; Klatt, P; Flores, I; Garcia-Cao, I; Borras, C; Flores, JM; Vina, J; Blasco, MA; Serrano, M				Matheu, Ander; Maraver, Antonio; Klatt, Peter; Flores, Ignacio; Garcia-Cao, Isabel; Borras, Consuelo; Flores, Juana M.; Vina, Jose; Blasco, Maria A.; Serrano, Manuel			Delayed ageing through damage protection by the Arf/p53 pathway	NATURE			English	Article							P53 TUMOR-SUPPRESSOR; MAMMALIAN LIFE-SPAN; ONCOGENIC RAS; DNA-DAMAGE; MICE; SENESCENCE; RESISTANT; STRESS; GROWTH; AGE	The tumour-suppressor pathway formed by the alternative reading frame protein of the Cdkn2a locus (Arf) and by p53 (also called Trp53) plays a central part in the detection and elimination of cellular damage, and this constitutes the basis of its potent cancer protection activity(1,2). Similar to cancer, ageing also results from the accumulation of damage and, therefore, we have reasoned that Arf/p53 could have anti-ageing activity by alleviating the load of age-associated damage. Here we show that genetically manipulated mice with increased, but otherwise normally regulated, levels of Arf and p53 present strong cancer resistance and have decreased levels of ageing-associated damage. These observations extend the protective role of Arf/p53 to ageing, revealing a previously unknown anti-ageing mechanism and providing a rationale for the co-evolution of cancer resistance and longevity.	Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid 28029, Spain; Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain; Univ Valencia, Dept Physiol, Valencia 46010, Spain; Univ Complutense Madrid, Dept Anim Surg & Med, E-28040 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia; Complutense University of Madrid	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid 28029, Spain.	mserrano@cnio.es	Flores, Ignacio/E-8304-2016; Vina, Jose/AAB-3069-2021; Maraver, Antonio/G-2666-2015; Serrano, Manuel/H-2634-2015; Blasco, Maria A./M-1694-2014; borras, consuelo/Y-3407-2019; matheu, ander/G-9906-2014	Flores, Ignacio/0000-0001-8789-6396; Vina, Jose/0000-0001-9709-0089; Serrano, Manuel/0000-0001-7177-9312; Blasco, Maria A./0000-0002-4211-233X; borras, consuelo/0000-0003-4606-1792; matheu, ander/0000-0002-1848-0781; Maraver, Antonio/0000-0002-5527-5680				Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; ASENSI M, 1994, METHOD ENZYMOL, V234, P367; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; INGRAM DK, 1986, EXP AGING RES, V12, P155; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2005, J BIOL CHEM, V280, P42433, DOI 10.1074/jbc.M508270200; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WEXLER H, 1979, J NATL CANCER I, V63, P1393; WONG SHY, 1987, CLIN CHEM, V33, P214; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	38	371	383	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					375	U14		10.1038/nature05949	http://dx.doi.org/10.1038/nature05949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637672				2022-12-28	WOS:000248118300063
J	Diamond, GA; Bax, L; Kaul, S				Diamond, George A.; Bax, Leon; Kaul, Sanjay			Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death	ANNALS OF INTERNAL MEDICINE			English	Article							SPARSE DATA; METAANALYSIS; OUTCOMES; TRIALS	A recent, widely publicized meta-analysis of 42 clinical trials concluded that rosiglitazone was associated with an approximately 43% increased risk for myocardial infarction and an approximately 64% increased risk for cardiovascular death. The sensitivity of these conclusions to several methodological choices was not assessed. The meta-analysis was not based on a comprehensive search for all studies that might yield evidence about rosiglitazone's cardiovascular effects. Studies were combined on the basis of a lack of statistical heterogeneity, despite substantial variability in study design and outcome assessment. The meta-analytic approach that was used required the exclusion of studies with zero events in the treatment and control groups. Alternative meta-analytic approaches that use continuity corrections show lower odds ratios that are not statistically significant. We conclude that the risk for myocardial infarction and death from cardiovascular disease for diabetic patients taking rosiglitazone is uncertain: Neither increased nor decreased risk is established.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaul, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	kaul@cshs.org						*ADV COMM BRIEF DO, 2007, CARD SAFT ROS; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; COOK DJ, 1991, AM J MED, V91, P519, DOI 10.1016/0002-9343(91)90189-5; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nathan DM, 2007, NEW ENGL J MED, V357, P64, DOI 10.1056/NEJMe078117; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105	14	225	230	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					578	581		10.7326/0003-4819-147-8-200710160-00182	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17679700				2022-12-28	WOS:000250437100008
J	Martin, DC; Seibert, M; Neill, JD; Schiminovich, D; Forster, K; Rich, RM; Welsh, BY; Madore, BF; Wheatley, JM; Morrissey, P; Barlow, TA				Martin, D. Christopher; Seibert, Mark; Neill, James D.; Schiminovich, David; Forster, Karl; Rich, R. Michael; Welsh, Barry Y.; Madore, Barry F.; Wheatley, Jonathan M.; Morrissey, Patrick; Barlow, Tom A.			A turbulent wake as a tracer of 30,000 years of Mira's mass loss history	NATURE			English	Article							ASYMPTOTIC GIANT BRANCH; STARS; EVOLUTION; DISCOVERY; EMISSION; ENVELOPE; H-2; CO	Mira is one of the first variable stars ever discovered(1) and it is the prototype ( and also the nearest example) of a class of low- to-intermediate-mass stars in the late stages of stellar evolution. These stars are relatively common and they return a large fraction of their original mass to the interstellar medium ( ISM) ( ref. 2) through a processed, dusty, molecular wind. Thus stars in Mira's stage of evolution have a direct impact on subsequent star and planet formation in their host galaxy. Previously, the only direct observation(3) of the interaction between Mira- type stellar winds and the ISM was in the infrared. Here we report the discovery of an ultraviolet- emitting bow shock and turbulent wake extending over 2 degrees on the sky, arising from Mira's large space velocity and the interaction between its wind and the ISM. The wake is visible only in the far ultraviolet and is consistent with an unusual emission mechanism whereby molecular hydrogen is excited by turbulent mixing of cool molecular gas and shock- heated gas. This wind wake is a tracer of the past 30,000 years of Mira's mass- loss history and provides an excellent laboratory for studying turbulent stellar wind - ISM interactions.	CALTECH, Dept Phys Math & Astron, Pasadena, CA 91125 USA; Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Columbia Univ, Dept Astron, New York, NY 10027 USA; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	California Institute of Technology; Carnegie Institution for Science; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Martin, DC (corresponding author), CALTECH, Dept Phys Math & Astron, 1200 E Calif Blvd,Mail Code 405-47, Pasadena, CA 91125 USA.	cmartin@srl.caltech.edu		Morrissey, Patrick/0000-0001-8177-1023; Seibert, Mark/0000-0002-1143-5515				BOWERS PF, 1988, ASTROPHYS J, V332, P299, DOI 10.1086/166655; Evans D.S, 1967, IAU S, P57; Ferland GJ, 1998, PUBL ASTRON SOC PAC, V110, P761, DOI 10.1086/316190; HARTIGAN P, 1987, ASTROPHYS J, V316, P323, DOI 10.1086/165204; Hoffleit D., 1997, Journal of the American Association of Variable Star Observers, V25, P115; Ireland MJ, 2007, ASTROPHYS J, V662, P651, DOI 10.1086/517993; Josselin E, 2000, ASTRON ASTROPHYS, V362, P255; Karovska M, 2005, ASTROPHYS J, V623, pL137, DOI 10.1086/430111; KHAKOO MA, 1987, PHYS REV A, V35, P2832, DOI 10.1103/PhysRevA.35.2832; Knapp GR, 2003, ASTRON ASTROPHYS, V403, P993, DOI 10.1051/0004-6361:20030429; Liu WH, 1996, ASTROPHYS J, V462, P502, DOI 10.1086/177168; Martin C, 1990, ASTROPHYS J, V354, P220, DOI 10.1086/168681; Prieur JL, 2002, ASTROPHYS J SUPPL S, V139, P249, DOI 10.1086/338029; Raymond JC, 1997, ASTROPHYS J, V489, P314, DOI 10.1086/304787; Ryde N, 2000, ASTROPHYS J, V545, P945, DOI 10.1086/317832; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schroder KP, 2001, ASTRON ASTROPHYS, V366, P913, DOI 10.1051/0004-6361:20000282; Speck AK, 2000, ASTROPHYS J, V545, pL145, DOI 10.1086/317881; Turon C., 1993, B INF CDS, V43, P5; Ueta T, 2006, ASTROPHYS J, V648, pL39, DOI 10.1086/507627; Wareing CJ, 2006, MON NOT R ASTRON SOC, V372, pL63, DOI 10.1111/j.1745-3933.2006.00227.x; Wareing CJ, 2007, ASTROPHYS J, V660, pL129, DOI 10.1086/518308; WOOD PR, 1990, FROM MIRAS TO PLANETARY NEBULAE : WHICH PATH FOR STELLAR EVOLUTION ?, P67	25	109	110	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					780	783		10.1038/nature06003	http://dx.doi.org/10.1038/nature06003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700694				2022-12-28	WOS:000248754200033
J	Sitges-Serra, A; Bergenfelz, A				Sitges-Serra, Antonio; Bergenfelz, Anders			Clinical update: sporadic primary hyperparathyroidism	LANCET			English	Article							MINIMALLY INVASIVE PARATHYROIDECTOMY; BILATERAL CERVICAL EXPLORATION; MENOPAUSAL WOMEN; FRACTURE; SURGERY; RISK		Hosp del Mar, Dept Surg, Barcelona, Spain; Univ Lund Hosp, S-22185 Lund, Sweden	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Lund University; Skane University Hospital	Sitges-Serra, A (corresponding author), Hosp del Mar, Dept Surg, Barcelona, Spain.	asitges@imas.imim.es						Bergenfelz A, 2005, BRIT J SURG, V92, P190, DOI 10.1002/bjs.4814; Bergenfelz A, 2002, ANN SURG, V236, P543, DOI 10.1097/00000658-200211000-00001; Bilezikian JP, 2002, J CLIN ENDOCR METAB, V87, P5353, DOI 10.1210/jc.2002-021370; Carneiro DM, 2002, WORLD J SURG, V26, P1074, DOI 10.1007/s00268-002-6675-z; Coker LH, 2005, ANN SURG, V242, P642, DOI 10.1097/01.sla.0000186337.83407.ec; Gawande AA, 2006, ARCH SURG-CHICAGO, V141, P381, DOI 10.1001/archsurg.141.4.381; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; Nilsson IL, 2005, SURGERY, V137, P632, DOI 10.1016/j.surg.2005.02.001; Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x; Russell CFJ, 2006, BRIT J SURG, V93, P418, DOI 10.1002/bjs.5250; Silverberg SJ, 2003, J CLIN ENDOCR METAB, V88, P5348, DOI 10.1210/jc.2003-031014; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Sitges-Serra A, 2004, WORLD J SURG, V28, P1148, DOI 10.1007/s00268-004-7562-6; Stalberg P, 2006, J AM COLL SURGEONS, V203, P1, DOI 10.1016/j.jamcollsurg.2006.03.022; Steiniche T, 2000, BONE, V26, P535, DOI 10.1016/S8756-3282(00)00260-X; VanderWalde LH, 2006, ARCH SURG-CHICAGO, V141, P885, DOI 10.1001/archsurg.141.9.885; Vestergaard P, 2003, WORLD J SURG, V27, P216, DOI 10.1007/s00268-002-6541-z; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910	19	34	35	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					468	470		10.1016/S0140-6736(07)61213-6	http://dx.doi.org/10.1016/S0140-6736(07)61213-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693163				2022-12-28	WOS:000248717800010
J	Kinseth, MA; Anjard, C; Fuller, D; Guizzunti, G; Loomis, WF; Malhotra, V				Kinseth, Matthew A.; Anjard, Christophe; Fuller, Danny; Guizzunti, Gianni; Loomis, William F.; Malhotra, Vivek			The golgi-associated protein GRASP is required for unconventional protein secretion during development	CELL			English	Article							DICTYOSTELIUM-DISCOIDEUM; MAMMALIAN-CELLS; TERMINAL DIFFERENTIATION; PLASMA-MEMBRANE; SPORE DIFFERENTIATION; COMPLEX; STACKING; FRAGMENTATION; CISTERNAE; PATHWAYS	During Dictyostelium development, prespore cells secrete acyl-CoA binding protein (AcbA). Upon release, AcbA is processed to generate a peptide called spore differentiation factor-2 (SDF-2), which triggers terminal differentiation of spore cells. We have found that cells lacking Golgi reassembly stacking protein (GRASP), a protein attached peripherally to the cytoplasmic surface of Golgi membranes, fail to secrete AcbA and, thus, produce inviable spores. Surprisingly, AcbA lacks a signal sequence and is not secreted via the conventional secretory pathway (endoplasmic reticulum-Golgi-cell surface). GRASP is not required for conventional protein secretion, growth, and the viability of vegetative cells. Our findings reveal a physiological role of GRASP and provide a means to understand unconventional secretion and its role in development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	vivek@biomail.ucsd.edu	Malhotra, Vivek/O-9811-2014; Anjard, Christophe/H-5012-2017	Malhotra, Vivek/0000-0001-6198-7943; Anjard, Christophe/0000-0002-6905-1493	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078175] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM78175, GM46224, GM53747] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; DEVINE KM, 1983, DEV BIOL, V99, P437, DOI 10.1016/0012-1606(83)90293-2; FARQUHAR MG, 1981, J CELL BIOL, V91, P77; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; FIEGER O, 2003, FEBS LETT, V551, P78; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HUYER G, 2006, CELL, V5, P1560; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Metcalf T, 2003, MICROBIOL-SGM, V149, P305, DOI 10.1099/mic.0.25984-0; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Shaulsky G, 1996, DEV BIOL, V174, P214, DOI 10.1006/dbio.1996.0067; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Wang N, 1999, MOL CELL BIOL, V19, P4750; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; West CM, 2003, INT REV CYTOL, V222, P237; WOOD L, 1985, J CELL BIOL, V101, P2063, DOI 10.1083/jcb.101.6.2063; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	45	177	181	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					524	534		10.1016/j.cell.2007.06.029	http://dx.doi.org/10.1016/j.cell.2007.06.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17655921	Bronze			2022-12-28	WOS:000249038100019
J	Jackson, MG; Hart, SR; Koppers, AAP; Staudigel, H; Konter, J; Blusztajn, J; Kurz, M; Russell, JA				Jackson, Matthew G.; Hart, Stanley R.; Koppers, Anthony A. P.; Staudigel, Hubert; Konter, Jasper; Blusztajn, Jerzy; Kurz, Mark; Russell, Jamie A.			The return of subducted continental crust in Samoan lavas	NATURE			English	Article							OCEANIC UPPER-MANTLE; ISOTOPIC SYSTEMATICS; ATLANTIC RIDGE; SR; ND; PB; EVOLUTION; CONSTRAINTS; ORIGIN; GEOCHEMISTRY	Substantial quantities of terrigenous sediments are known to enter the mantle at subduction zones, but little is known about their fate in the mantle(1). Subducted sediment may be entrained in buoyantly upwelling plumes and returned to the Earth's surface at hotspots(2-5), but the proportion of recycled sediment in the mantle is small, and clear examples of recycled sediment in hotspot lavas are rare(6,7). Here we report remarkably enriched Sr-87/Sr-86 and Nd-143/Nd-144 isotope signatures in Samoan lavas from three dredge locations on the underwater flanks of Savai'i island, Western Samoa. The submarine Savai'i lavas represent the most extreme Sr-87/Sr-86 isotope compositions reported for ocean island basalts to date. The data are consistent with the presence of a recycled sediment component (with a composition similar to the upper continental crust) in the Samoan mantle. Trace-element data show affinities similar to those of the upper continental crust including exceptionally low Ce/Pb and Nb/U ratios(8)-that complement the enriched Sr-87/Sr-86 and Nd-143/Nd-144 isotope signatures. The geochemical evidence from these Samoan lavas significantly redefines the composition of the EM2 (enriched mantle 2; ref. 9) mantle endmember, and points to the presence of an ancient recycled upper continental crust component in the Samoan mantle plume.	MIT, Woods Hole Oceanog Inst, Joint Program, Woods Hole, MA 02543 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University	Jackson, MG (corresponding author), MIT, Woods Hole Oceanog Inst, Joint Program, Woods Hole, MA 02543 USA.	mjackson@whoi.edu	Konter, Jasper/G-5206-2012	Konter, Jasper/0000-0002-4853-5456; Koppers, Anthony/0000-0002-8136-5372; Kurz, Mark/0000-0003-1745-2356				ALLEGRE CJ, 1985, GEOPHYS RES LETT, V12, P207, DOI 10.1029/GL012i004p00207; Bonatti E, 1996, NATURE, V380, P518, DOI 10.1038/380518a0; CHASE CG, 1981, EARTH PLANET SC LETT, V52, P277, DOI 10.1016/0012-821X(81)90182-5; COHEN RS, 1982, EARTH PLANET SC LETT, V61, P73, DOI 10.1016/0012-821X(82)90040-1; FARLEY KA, 1992, EARTH PLANET SC LETT, V111, P183, DOI 10.1016/0012-821X(92)90178-X; Frey FA, 2002, J PETROL, V43, P1207, DOI 10.1093/petrology/43.7.1207; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V87, P249, DOI 10.1016/0012-821X(88)90013-1; Hart SR, 2004, EARTH PLANET SC LETT, V227, P37, DOI 10.1016/j.epsl.2004.08.005; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; HART SR, 1988, EARTH PLANET SC LETT, V90, P273, DOI 10.1016/0012-821X(88)90131-8; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; HAWKESWORTH CJ, 1979, NATURE, V280, P28, DOI 10.1038/280028a0; HOFMANN AW, 1986, EARTH PLANET SC LETT, V79, P33, DOI 10.1016/0012-821X(86)90038-5; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Kamenetsky VS, 2001, GEOLOGY, V29, P243, DOI 10.1130/0091-7613(2001)029<0243:ROGCLI>2.0.CO;2; KOPPERS AAP, UNPUB GEOLOGY; MCCULLOCH MT, 1978, SCIENCE, V200, P1003, DOI 10.1126/science.200.4345.1003; MCDONOUGH WF, 1990, EARTH PLANET SC LETT, V101, P1, DOI 10.1016/0012-821X(90)90119-I; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; SU Y, 2003, GLOBAL MORB CHEM COM; Taylor B, 2006, EARTH PLANET SC LETT, V241, P372, DOI 10.1016/j.epsl.2005.11.049; WEAVER BL, 1991, EARTH PLANET SC LETT, V104, P381, DOI 10.1016/0012-821X(91)90217-6; White W.M., 1996, EARTH PROCESSES READ, P183, DOI [10.1029/GM095p0183, DOI 10.1029/GM095P0183]; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0; WORKMAN RK, 2004, GEOCHEM GEOPHYS GEOS, V5; WRIGHT E, 1987, EARTH PLANET SC LETT, V81, P151, DOI 10.1016/0012-821X(87)90152-X; ZINDLER A, 1982, NATURE, V298, P519, DOI 10.1038/298519a0; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	31	247	263	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					684	687		10.1038/nature06048	http://dx.doi.org/10.1038/nature06048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687322	Green Submitted			2022-12-28	WOS:000248598000042
J	Frye, RL				Frye, Robert L.			Update in cardiology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; HIGH-RISK PATIENTS; ATRIAL-FIBRILLATION; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; THERAPY; BYPASS; DISCONTINUATION; INHIBITORS; ISCHEMIA		Mayo Clin, Rochester, MN USA	Mayo Clinic	Frye, RL (corresponding author), Mayo Clin, Siebens Bldg, Room 640,200 First St SW, Rochester, MN 55905 USA.							*ANG EXTR SER OP M, 2001, J AM COLL CARDIOL, V38, P143; *BASKET LATE INV, 2006, J AM COLL CARDIOL, V48, P2584; Choudhry NK, 2006, AM J MED, V119, P607, DOI 10.1016/j.amjmed.2005.09.052; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; *DEP VET AFF ANG E, 2003, J AM COLL CARDIOL, V41, P1732; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; *INV VET AFF COOP, 2006, CIRCULATION, V114, P1251; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066	13	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					180	186		10.7326/0003-4819-147-3-200708070-00007	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679706				2022-12-28	WOS:000248454700005
J	Gibbs, DA; Martin, SL; Kupper, LL; Johnson, RE				Gibbs, Deborah A.; Martin, Sandra L.; Kupper, Lawrence L.; Johnson, Ruby E.			Child maltreatment in enlisted soldiers' families during combat-related deployments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US ARMY; MILITARY; ABUSE; NEGLECT; STRESS; SEPARATION; IMPACT; MODEL; WAR	Context Parental stress is believed to play a critical role in child maltreatment, and deployment is often stressful for military families. Objective To examine the association between combat-related deployment and rates of child maltreatment in families of enlisted soldiers in the US Army who had 1 or more substantiated reports of child maltreatment. Design and Setting Descriptive case series of substantiated incidents of parental child maltreatment in 1771 families of enlisted US Army soldiers who experienced at least 1 combat deployment between September 2001 and December 2004. Main Outcome Measures Conditional Poisson regression models were used to estimate rate ratios (RRs) that compare rates of substantiated child maltreatment incidents during periods of deployment and nondeployment. Results A total of 1858 parents in 1771 different families maltreated their children. In these families, the overall rate of child maltreatment was higher during the times when the soldier-parents were deployed compared with the times when they were not deployed ( 942 incidents and 713 626 days at risk during deployments vs 2392 incidents and 2.6 million days at risk during nondeployment; RR, 1.42 [95% confidence interval {CI}, 1.31-1.54]). During deployment, the rates of moderate or severe maltreatment also were elevated ( 638 incidents and 447 647 days at risk during deployments vs 1421 incidents and 1.6 million days at risk during nondeployment; RR, 1.61 [ 95% CI, 1.45-1.77]). The rates of child neglect were nearly twice as great during deployment ( 761 incidents and 470 657 days at risk during deployments vs 1407 incidents and 1.6 million days at risk during nondeployment; RR, 1.95[ 95% CI, 1.77-2.14]); however, the rate of physical abuse was less during deployments ( 97 incidents and 80 033 days at risk during deployments vs 451 incidents and 318 326 days at risk during nondeployment; RR, 0.76 [ 95% CI, 0.58-0.93]). Among female civilian spouses, the rate of maltreatment during deployment was more than 3 times greater ( 783 incidents and 382 480 days at risk during deployments vs 832 incidents and 1.2 million days at risk during nondeployment; RR, 3.33[ 95% CI, 2.98-3.67]), the rate of child neglect was almost 4 times greater ( 666 incidents and 303 555 days at risk during deployments vs 605 incidents and 967 362 days at risk during nondeployment; RR, 3.88 [ 95% CI, 3.43-4.34]), and the rate of physical abuse was nearly twice as great ( 73 incidents and 18 316 days at risk during deployments vs 141 incidents and 61 105 days at risk during nondeployment; RR, 1.91 [ 95% CI, 1.33-2.49]). Conclusions Among families of enlisted soldiers in the US Army with substantiated reports of child maltreatment, rates of maltreatment are greater when the soldiers are on combat-related deployments. Enhanced support services may be needed for military families during periods of increased stress.	RTI Int, Children & Families Program, Res Triangle Pk, NC 27709 USA; RTI Int, Educ Res Program, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Dept Maternal & Child Hlth, Chapel Hill, NC USA; Univ N Carolina, UNC Injury Prevent Res Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	Research Triangle Institute; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gibbs, DA (corresponding author), RTI Int, Children & Families Program, POB 12194, Res Triangle Pk, NC 27709 USA.	dag@rti.org		Johnson, Ruby E./0000-0003-2893-1635				Burke J, 1998, CHILD WELFARE, V77, P389; Coohey C, 1996, CHILD ABUSE NEGLECT, V20, P241, DOI 10.1016/S0145-2134(95)00143-3; *DEP ARM, 2006, ARM FAM ADV PROGR AR; *DEP ARM, 2002, ARM INF PAP MOB DEPL; DUBANOSKI RA, 1984, CHILD ABUSE NEGLECT, V8, P55, DOI 10.1016/0145-2134(84)90050-4; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; Goldman J., 2003, COORDINATED RESPONSE, DOI DOI 10.1080/15374410802148152; Haas DM, 2005, WOMEN HEALTH ISS, V15, P48, DOI 10.1016/j.whi.2004.12.002; HILLSON JMC, 1994, CLIN PSYCHOL REV, V14, P261, DOI 10.1016/0272-7358(94)90025-6; Jensen PS, 1996, J AM ACAD CHILD PSY, V35, P433, DOI 10.1097/00004583-199604000-00009; JENSEN PS, 1991, J NERV MENT DIS, V179, P102; JENSEN PS, 1989, J AM ACAD CHILD PSY, V28, P171, DOI 10.1097/00004583-198903000-00004; KELLEY ML, 1994, AM J ORTHOPSYCHIAT, V64, P103, DOI 10.1037/h0079499; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Lamberg L, 2004, JAMA-J AM MED ASSOC, V292, P1541, DOI 10.1001/jama.292.13.1541; McCarroll JE, 2004, MIL MED, V169, P461, DOI 10.7205/MILMED.169.6.461; McCarroll JE, 2004, CHILD MALTREATMENT, V9, P103, DOI 10.1177/1077559503261262; MCCARROLL JE, IN PRESS CHILD ABUSE; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; McNulty PAF, 2003, MIL MED, V168, P465; *N CAR CHILD ADV I, 2004, RED COLL DAM HOM FRO; National Research Council, 1993, UND CHILD AB NEGL; *OFF DEP SECR DEF, 2004, 2004 DEM PROF MIL CO; PEEBLESKLEIGER MJ, 1994, J TRAUMA STRESS, V7, P173, DOI 10.1007/BF02102943; Raiha NK, 1997, CHILD ABUSE NEGLECT, V21, P759, DOI 10.1016/S0145-2134(97)00037-9; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Rentz ED, 2006, TRAUMA VIOLENCE ABUS, V7, P93, DOI 10.1177/1524838005285916; ROSEN LN, 1993, MIL MED, V158, P465, DOI 10.1093/milmed/158.7.465; Runyan D., 2002, WORLD REPORT VIOLENC, P59; Ryan-Wenger NA, 2001, AM J ORTHOPSYCHIAT, V71, P236, DOI 10.1037/0002-9432.71.2.236; *US DEP HHS, 2007, CHILD MALTR 2005; *US FAM FAM ADV PR, 1997, CHILD AB MAN	33	174	176	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					528	535		10.1001/jama.298.5.528	http://dx.doi.org/10.1001/jama.298.5.528			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666673	Bronze			2022-12-28	WOS:000248438100020
J	Boutet, SC; Disatnik, MH; Chan, LS; Iori, K; Rando, TA				Boutet, Stephane C.; Disatnik, Marie-Helene; Chan, Lauren S.; Iori, Kevin; Rando, Thomas A.			Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors	CELL			English	Article							MULTIUBIQUITIN-CHAIN; MET RECEPTOR; UBA DOMAINS; UBIQUITIN; BINDING; SUBUNIT; CELLS; EXPRESSION; MIGRATION; KINASE	Pax3 and Pax7 play distinct but overlapping roles in developmental and postnatal myogenesis. The mechanisms involved in the differential regulation of these highly homologous proteins are unknown. We present evidence that Pax3, but not Pax7, is regulated by ubiquitination and proteasomal degradation during adult muscle stem cell activation. Intriguingly, only monoubiquitinated forms of Pax3 could be detected. Mutation of two specific lysine residues in the C-terminal region of Pax3 reduced the extent of its monoubiquitination and susceptibility to proteasomal degradation, whereas introduction of a key lysine into the C-terminal region of Pax7 rendered that protein susceptible to monoubiquitination and proteasomal degradation. Monoubiquitinated Pax3 was shuttled to the intrinsic proteasomal protein S5a by interacting specifically with the ubiquitin-binding protein Rad23B. Functionally, sustained expression of Pax3 proteins inhibited myogenic differentiation, demonstrating that Pax3 degradation is an essential step for the progression of the myogenic program. These results reveal an important mechanism of Pax3 regulation in muscle progenitors and an unrecognized role of protein monoubiquitination in mediating proteasomal degradation.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 34304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564	NIA NIH HHS [AG23806] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023806, R37AG023806] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOBER E, 1994, DEVELOPMENT, V120, P603; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yang XM, 1996, DEVELOPMENT, V122, P2163; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	43	145	148	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					349	362		10.1016/j.cell.2007.05.044	http://dx.doi.org/10.1016/j.cell.2007.05.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662948	Bronze			2022-12-28	WOS:000248588000023
J	Chen, MH; Wilson, CW; Chuang, PT				Chen, Miao-Hsueh; Wilson, Christopher W.; Chuang, Pao-Tien			SnapShot: Hedgehog signaling pathway	CELL			English	Editorial Material							MECHANISM; TRANSDUCTION; DIVERGENCE; DROSOPHILA		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Chen, MH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.			Chen, Miao-Hsueh/0000-0002-9715-3067				Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Eaton S, 2006, CURR OPIN GENET DEV, V16, P17, DOI 10.1016/j.gde.2005.12.006; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Guerrero I, 2007, TRENDS CELL BIOL, V17, P1, DOI 10.1016/j.tcb.2006.11.002; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016	17	24	28	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					386	U26	e1	10.1016/j.cell.2007.07.017	http://dx.doi.org/10.1016/j.cell.2007.07.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662951	Bronze			2022-12-28	WOS:000248588000028
J	Vergoz, V; Schreurs, HA; Mercer, AR				Vergoz, Vanina; Schreurs, Haley A.; Mercer, Alison R.			Queen pheromone blocks aversive learning in young worker bees	SCIENCE			English	Article							APIS-MELLIFERA L.; MANDIBULAR GLAND PHEROMONE; HONEY-BEES; OVARY DEVELOPMENT; DOPAMINE; BEHAVIOR; MEMORY	Queen mandibular pheromone (QMP) has profound effects on dopamine signaling in the brain of young worker honey bees. As dopamine in insects has been strongly implicated in aversive learning, we examined QMP's impact on associative olfactory learning in bees. We found that QMP blocks aversive learning in young workers, but leaves appetitive learning intact. We postulate that QMP's effects on aversive learning enhance the likelihood that young workers remain in close contact with their queen by preventing them from forming an aversion to their mother's pheromone bouquet. The results provide an interesting twist to a story of success and survival.	Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Mercer, AR (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	alison.mercer@stonebow.otago.ac.nz	Vergoz, Vanina/L-9638-2015	Mercer, Alison/0000-0001-8110-4247				Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Ledoux MN, 2001, INSECT SOC, V48, P14, DOI 10.1007/PL00001738; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Moritz RFA, 2001, ETHOLOGY, V107, P465, DOI 10.1046/j.1439-0310.2001.00681.x; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; PHAM MH, 1982, APIDOLOGIE, V13, P143, DOI 10.1051/apido:19820203; RHODES J, 2003, PUBLICATION RURAL IN; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Vaitkevieiene G, 1999, PHEROMONES, V6, P39; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Winston, 1987, BIOL HONEYBEE; WINSTON ML, 1991, ANN ENTOMOL SOC AM, V84, P234	22	79	83	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					384	386		10.1126/science.1142448	http://dx.doi.org/10.1126/science.1142448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641204				2022-12-28	WOS:000248150200050
J	Ding, RJ; Xia, K				Ding, Ronqjing; Xia, Kun			Myocardial infarction in a woman with no apparent risk factors	LANCET			English	Editorial Material							MYXOMA		Dalian Univ, Zhongsan Hosp, Dept Cardiol, Dalian, Peoples R China; Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China	Dalian University; Capital Medical University	Ding, RJ (corresponding author), Dalian Univ, Zhongsan Hosp, Dept Cardiol, Dalian, Peoples R China.	drj2003@sina.com						MARKEL ML, 1987, MEDICINE, V66, P114, DOI 10.1097/00005792-198703000-00003; Panos A, 1997, INT J CARDIOL, V62, P73, DOI 10.1016/S0167-5273(97)00178-2; PRICHARD RW, 1951, AMA ARCH PATHOL, V51, P98; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					360	360		10.1016/S0140-6736(07)61166-0	http://dx.doi.org/10.1016/S0140-6736(07)61166-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662885				2022-12-28	WOS:000248426100034
J	Miller, DM				Miller, David M.			Synapses here and not everywhere	SCIENCE			English	Editorial Material							ELEGANS; SYG-1		Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 465 21st Ave S, Nashville, TN 37232 USA.	david.miller@vanderbilt.edu						Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X	7	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					907	908		10.1126/science.1147570	http://dx.doi.org/10.1126/science.1147570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702933				2022-12-28	WOS:000248780200027
J	Frey, S; Gorlich, D				Frey, Steffen; Goerlich, Dirk			A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes	CELL			English	Article							IMPORTIN-BETA; STRUCTURAL BASIS; PROTEIN IMPORT; BINDING-SITES; TRANSPORT; NUCLEOPORINS; NTF2; IDENTIFICATION; TRANSLOCATION; ARCHITECTURE	The permeability barrier of nuclear pore complexes (NPCs) controls the exchange between nucleus and cytoplasm. It suppresses the flux of inert macromolecules >= 30 kDa but allows rapid passage of even very large cargoes, provided these are bound to appropriate nuclear transport receptors. We show here that a saturated hydrogel formed by a single nucleoporin FG-repeat domain is sufficient to reproduce the permeability properties of NPCs. Importin beta and related nuclear transport receptors entered such hydrogel > 10003 faster than a similarly sized inert macromolecule. The FG-hydrogel even reproduced import signal-dependent and importin-mediated cargo influx, allowing importin b to accelerate the gel entry of a large cognate cargo more than 20,000-fold. Intragel diffusion of the importin beta-cargo complex occurred rapidly enough to traverse an NPC within approximate to 12 ms. We extend the "selective phase model'' to explain these effects.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210; Steffen, Frey/0000-0002-5134-9961				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Burke B, 2006, SCIENCE, V314, P766, DOI 10.1126/science.1135739; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cushman I, 2006, METHODS, V39, P329, DOI 10.1016/j.ymeth.2006.06.011; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Elbaum M, 2006, SCIENCE, V314, P766, DOI 10.1126/science.1135924; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Morris K, 2003, LANCET NEUROL, V2, P587, DOI 10.1016/S1474-4422(03)00545-3; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2007, MOL BIOL CELL, V18, P886, DOI 10.1091/mbc.E06-06-0525; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	41	361	361	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					512	523		10.1016/j.cell.2007.06.024	http://dx.doi.org/10.1016/j.cell.2007.06.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693259	Bronze, Green Submitted			2022-12-28	WOS:000249038100018
J	Perfeito, L; Fernandes, L; Mota, C; Gordo, I				Perfeito, Lilia; Fernandes, Lisete; Mota, Catarina; Gordo, Isabel			Adaptive mutations in bacteria: High rate and small effects	SCIENCE			English	Article							BENEFICIAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; LANDSCAPE MODEL; POPULATIONS; ADAPTATION; EVOLUTION; SELECTION; VIRUS; SEX	Evolution by natural selection is driven by the continuous generation of adaptive mutations. We measured the genomic mutation rate that generates beneficial mutations and their effects on fitness in Escherichia coli under conditions in which the effect of competition between lineages carrying different beneficial mutations is minimized. We found a rate on the order of 10(-5) per genome per generation, which is 1000 times as high as previous estimates, and a mean selective advantage of 1%. Such a high rate of adaptive evolution has implications for the evolution of antibiotic resistance and pathogenicity.	Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade de Lisboa	Gordo, I (corresponding author), Gulbenkian Inst Sci, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	igordo@igc.gulbenkian.pt	Perfeito, Lilia/AAE-1245-2020; Perfeito, Lilia/I-1618-2013; Gordo, Isabel/D-6770-2013; Mota, Catarina/M-4281-2013; fernandes, lisete/E-6522-2016	Perfeito, Lilia/0000-0003-4844-8763; Perfeito, Lilia/0000-0003-4844-8763; Gordo, Isabel/0000-0003-1622-5143; Mota, Catarina/0000-0002-5440-9157; fernandes, lisete/0000-0002-3384-2031				Barrett RDH, 2006, GENETICS, V174, P2071, DOI 10.1534/genetics.106.062406; Barrett RDH, 2006, BIOL LETTERS, V2, P236, DOI 10.1098/rsbl.2006.0439; Bataillon T, 2000, HEREDITY, V84, P497, DOI 10.1046/j.1365-2540.2000.00727.x; Betancourt AJ, 2006, CURR OPIN GENET DEV, V16, P618, DOI 10.1016/j.gde.2006.10.006; Burch CL, 1999, GENETICS, V151, P921; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Estes S, 2003, EVOLUTION, V57, P1022, DOI 10.1111/j.0014-3820.2003.tb00313.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grimberg B, 2005, EVOLUTION, V59, P431; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Kimura M., 1983, NEUTRAL THEORY MOL E; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2003, GENETICS, V163, P1519; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schlotterer C, 2006, J EVOLUTION BIOL, V19, P1671, DOI 10.1111/j.1420-9101.2006.01108.x; Shaw RG, 2000, GENETICS, V155, P369; Zeyl C, 2005, GENETICS, V169, P1825, DOI 10.1534/genetics.104.027102	27	216	217	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					813	815		10.1126/science.1142284	http://dx.doi.org/10.1126/science.1142284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690297	Green Submitted			2022-12-28	WOS:000248624500043
J	Schuh, M; Ellenberg, J				Schuh, Melina; Ellenberg, Jan			Self-organization of MTOCs replaces Centrosome Function during Acentrosomal Spindle Assembly in Live Mouse Oocytes	CELL			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; XENOPUS EXTRACT SPINDLES; CYCLE-DEPENDENT CHANGES; NEWT LUNG-CELLS; MICROTUBULE DYNAMICS; MITOTIC SPINDLE; FLUORESCENT PROTEIN; MEIOTIC MATURATION; GAMMA-TUBULIN; CHROMOSOME CONGRESSION	Chromosome segregation in mammalian oocytes is driven by a microtubule spindle lacking centrosomes. Here, we analyze centrosome-independent spindle assembly by quantitative high-resolution confocal imaging in live maturing mouse oocytes. We show that spindle assembly proceeds by the self-organization of over 80 microtubule organizing centers (MTOCs) that form de novo from a cytoplasmic microtubule network in prophase and that functionally replace centrosomes. Initially distributed throughout the ooplasm, MTOCs congress at the center of the oocyte, where they contribute to a massive, Ran-dependent increase of the number of microtubules after nuclear envelope breakdown and to the individualization of clustered chromosomes. Through progressive MTOC clustering and activation of kinesin-5, the multipolar MTOC aggregate self- organizes into a bipolar intermediate, which then elongates and thereby establishes chromosome biorientation. Finally, a stable barrel-shaped acentrosomal metaphase spindle with oscillating chromosomes and astral-like microtubules forms that surprisingly exhibits key properties of a centrosomal spindle.	European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014	Ellenberg, Jan/0000-0001-5909-701X				Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; CALARCO PG, 1972, J CELL SCI, V10, P369; Calaro PG, 2000, MICROSC RES TECHNIQ, V49, P428, DOI 10.1002/(SICI)1097-0029(20000601)49:5<428::AID-JEMT4>3.0.CO;2-K; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Can A, 2003, MOL HUM REPROD, V9, P749, DOI 10.1093/molehr/gag093; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Combelles CMH, 2001, DEV BIOL, V239, P281, DOI 10.1006/dbio.2001.0444; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Karsenti E, 2004, BIOL CELL, V96, P237, DOI 10.1016/j.biolcel.2003.12.008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MESSINGER SM, 1991, J CELL SCI, V100, P289; Olson KR, 1999, METHOD ENZYMOL, V302, P103, DOI 10.1016/S0076-6879(99)02013-3; Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485; PALACIOS MJ, 1993, J CELL SCI, V104, P383; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; SORENSEN RA, 1973, AM J ANAT, V136, P265, DOI 10.1002/aja.1001360302; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stepanova T, 2003, J NEUROSCI, V23, P2655; Strickland L, 2004, METHOD CELL BIOL, V74, P371; VANBLERKOM J, 1991, P NATL ACAD SCI USA, V88, P5031, DOI 10.1073/pnas.88.11.5031; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; WASSARMAN PM, 1978, J CELL SCI, V29, P171; Yajima J, 2003, EMBO J, V22, P1067, DOI 10.1093/emboj/cdg102	60	367	375	3	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					484	498		10.1016/j.cell.2007.06.025	http://dx.doi.org/10.1016/j.cell.2007.06.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693257	Green Submitted, Bronze			2022-12-28	WOS:000249038100016
J	Lee, TH				Lee, Thomas H.			Pay for performance, version 2.0?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Partners Healthcare Syst, Boston, MA 02199 USA	Partners Healthcare System	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA 02199 USA.							EAGLE KA, 2004, ACC AHA 2004 GUIDELI	1	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					531	533		10.1056/NEJMp078124	http://dx.doi.org/10.1056/NEJMp078124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687128				2022-12-28	WOS:000248584900003
J	Chan, WS; Chunilal, S; Lee, A; Crowther, M; Rodger, M; Ginsberg, JS				Chan, Wee-Shian; Chunilal, Sanjeev; Lee, Agnes; Crowther, Mark; Rodger, Marc; Ginsberg, Jeffrey S.			A red blood cell agglutination D-Dimer test to exclude deep venous thrombosis in pregnancy	ANNALS OF INTERNAL MEDICINE			English	Article							VEIN THROMBOSIS; MATERNAL MORTALITY; PULMONARY-EMBOLISM; NONINVASIVE DIAGNOSIS; UNITED-STATES; THROMBOEMBOLISM; ASSAY; MANAGEMENT; TRIAL	Background: D-Dimer testing is often used with compression ultrasonography for the diagnosis of deep venous thrombosis (DVT) in nonpregnant patients. The D-dimer test is highly sensitive, and a negative result can obviate the need for further testing for DVT. This test has not been studied for DVT diagnosis in pregnancy because its specificity was deemed too poor. Objective: To determine the sensitivity and specificity and assess the utility of the SimpliRED assay (Agen Biomedical, Brisbane, Australia) for the diagnosis of DVT in pregnant women. Design: Prospective cohort study. Setting: 5 tertiary university-affiliated Canadian hospitals providing care to obstetric patients. Patients: 149 consecutive pregnant women with suspected DVT who presented to 1 of the participating centers over 5 years. Intervention: Participating women were tested with compression leg ultrasonography (single or serially on days 0, 3, and 7) and received 3 months' clinical follow-up for the presence or absence of DVT. Whole blood was tested with the SimpliRED assay at initial presentation, and results were correlated with ultrasonography and clinical findings for the presence or absence of DVT. Measurements: The sensitivity, specificity, and negative predictive value of the SimpliRED assay were calculated, along with the prevalence of false-positive SimpliRED assay results (with 95% CIs). Results: The prevalence of DVT in the cohort was 8.7% (95% CI, 5.2% to 14.4%). The sensitivity of the SimpliRED assay was 100% (CI, 77% to 100% [13 of 13 patients]), the specificity was 60% (CI, 52% to 68% [81 of 135]), and the negative predictive value was 100% (CI, 95% to 100% [81 of 81]). The SimpliRED assay was positive in 0% (CI, 0% to 60%), 24% (CI, 14% to 37%), and 51 % (CI, 40% to 61 %) of women in the first, second, and third trimesters, respectively, among pregnant patients in whom DVT was not diagnosed. Limitations: The prevalence of DVT in the cohort was low, resulting in wide CIs. The clinician's previous impression was used to determine pretest probability in the absence of a validated clinical prediction rule for pregnant women. Conclusion: The SimpliRED assay may be useful in pregnancy because a normal result excludes DVT and occurs frequently enough to be clinically helpful.	Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Ottawa, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; McMaster University; University of Ottawa	Chan, WS (corresponding author), Womens Coll Hosp, Dept Med, 76 Grenville St, Toronto, ON M5G 1B2, Canada.	wee-shian.chan@wchospital.ca	ginsberg, jeffrey s/ABC-1065-2020	Rodger, Marc/0000-0001-8166-3487; Chan, Wee-Shian/0000-0002-2513-0480				Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Chan WS, 2002, THROMB RES, V107, P85, DOI 10.1016/S0049-3848(02)00105-6; Chan WS, 1999, BLOOD, V94, p20A; Chunilal SD, 2002, ARCH INTERN MED, V162, P217, DOI 10.1001/archinte.162.2.217; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; FRANCALANCI I, 1995, THROMB RES, V78, P399, DOI 10.1016/0049-3848(95)00073-Z; FREDE TE, 1988, J ULTRAS MED, V7, P33, DOI 10.7863/jum.1988.7.1.33; GINSBERG JS, 1989, THROMB HAEMOSTASIS, V61, P189; Health Canada, 2003, CAN PER HLTH REP 200; KAUNITZ AM, 1985, OBSTET GYNECOL, V65, P605; Kearon C, 2005, ANN INTERN MED, V142, P490, DOI 10.7326/0003-4819-142-7-200504050-00007; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KIERKEGAARD A, 1983, ACTA OBSTET GYN SCAN, V62, P239, DOI 10.3109/00016348309155799; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Morse M, 2004, J THROMB HAEMOST, V2, P1202, DOI 10.1111/j.1538-7836.2004.00776.x; POLAK JF, 1988, RADIOLOGY, V166, P377, DOI 10.1148/radiology.166.2.3275978; PROIETTI AB, 1991, OBSTET GYNECOL, V77, P696; Rathbun SW, 2004, ANN INTERN MED, V141, P839, DOI 10.7326/0003-4819-141-11-200412070-00007; ROCHAT RW, 1988, OBSTET GYNECOL, V72, P91; RYLATT DB, 1983, THROMB RES, V31, P767, DOI 10.1016/0049-3848(83)90108-1; SACHS BP, 1987, NEW ENGL J MED, V316, P667, DOI 10.1056/NEJM198703123161105; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Wells PS, 2006, J THROMB THROMBOLYS, V21, P31, DOI 10.1007/s11239-006-5573-x; 1986, REPORT CONFIDENTIAL	26	93	96	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					165	170		10.7326/0003-4819-147-3-200708070-00005	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679704				2022-12-28	WOS:000248454700003
J	Robertson, G				Robertson, Geoffrey			Health and human rights series	LANCET			English	Editorial Material									Doughty St Chambers, London WC1N 2PL, England		Robertson, G (corresponding author), Doughty St Chambers, London WC1N 2PL, England.	g.robertson@doughtystreet.co.uk							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					368	369		10.1016/S0140-6736(07)61172-6	http://dx.doi.org/10.1016/S0140-6736(07)61172-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197XL	17678999				2022-12-28	WOS:000248590200007
J	Hillmyer, MA				Hillmyer, Marc A.			Materials science - Micelles made to order	SCIENCE			English	Editorial Material							BLOCK-COPOLYMER MICELLES; MULTICOMPARTMENT MICELLES; FLOW		Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hillmyer, MA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hillmyer@chem.umn.edu						Castelletto V, 2007, LANGMUIR, V23, P6896, DOI 10.1021/la700382y; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Dean JM, 2003, MACROMOLECULES, V36, P9267, DOI 10.1021/ma034807y; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gohy JF, 2005, ADV POLYM SCI, V190, P65, DOI 10.1007/12_048; HADJICHRISTIDS N, 2002, BLOCK COPOLYMERS SYN; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Li ZB, 2006, LANGMUIR, V22, P9409, DOI 10.1021/la0620051; Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073; Massey J, 1998, J AM CHEM SOC, V120, P9533, DOI 10.1021/ja981803d; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Waton G, 2007, SURFACTANT SCI SER, V140, P323; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960	16	49	49	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					604	605		10.1126/science.1144899	http://dx.doi.org/10.1126/science.1144899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673642				2022-12-28	WOS:000248494400023
J	Stuart, GL; Temple, JR; Moore, TM				Stuart, Gregory L.; Temple, Jeff R.; Moore, Todd M.			Improving batterer intervention programs through theory-based research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTIMATE PARTNER VIOLENCE; AGGRESSION; OUTCOMES; THERAPY; TIME; MEN		Brown Univ, Warren Alpert Med Sch, Providence, RI 02906 USA; Butler Hosp, Providence, RI 02906 USA; Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA	Brown University; Butler Hospital Rhode Island; University of Tennessee System; University of Tennessee Knoxville	Stuart, GL (corresponding author), Brown Univ, Warren Alpert Med Sch, 345 Blackstone Blvd, Providence, RI 02906 USA.	gregory_stuart@brown.edu	Temple, Jeff/A-7666-2009	Temple, Jeff/0000-0003-3193-0510	NIAAA NIH HHS [R01 AA014193, R01 AA016315, R01AA014193, R01AA016315] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016315, R01AA014193] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; ECKHARDT C, IN PRESS VIOLENCE VI; Fals-Stewart W, 2003, J CONSULT CLIN PSYCH, V71, P41, DOI 10.1037/0022-006X.71.1.41; Feder L., 2005, J EXPT CRIMINOLOGY, V1, P239, DOI [10.1007/s11292-005-1179-0, https://doi.org/10.1007/s11292-005-1179-0, DOI 10.1007/S11292-005-1179-0]; GOLDKAMP JS, 1996, ROLE DRUG ALCOHOL AB; Healey K., 1998, BATTERER INTERVENTIO; Holtzworth- Munroe A, 2001, J AGGRESS MALTREAT T, V5, P165, DOI DOI 10.1300/J146V05N02_10; HOLTZWORTHMUNROE A, 1994, PSYCHOL BULL, V116, P476, DOI 10.1037/0033-2909.116.3.476; Jones AS, 2001, J FAM VIOLENCE, V16, P345, DOI 10.1023/A:1012268725273; Moore TA, 2004, PSYCHOL ADDICT BEHAV, V18, P385, DOI 10.1037/0893-164X.18.4.385; Murphy CM, 1997, J INTERPERS VIOLENCE, V12, P607, DOI 10.1177/088626097012004009; O'Farrell T., 2006, BEHAV COUPLES THERAP; O'Farrell TJ, 2003, J CONSULT CLIN PSYCH, V71, P92, DOI 10.1037/0022-006X.71.1.92; Pence E., 1993, ED GROUPS MEN WHO BA; Prochaska J. O., 1984, TRANSTHEORETICAL APP; Stith SM, 2004, J MARITAL FAM THER, V30, P305, DOI 10.1111/j.1752-0606.2004.tb01242.x; Stuart GL, 2005, J INTERPERS VIOLENCE, V20, P388, DOI 10.1177/0886260504267881; Stuart GL, 2003, J INTERPERS VIOLENCE, V18, P1113, DOI 10.1177/0886260503255550; STUART GL, IN PRESS PSYCHOL ADD; Stuart Gregory L, 2003, Subst Abus, V24, P107, DOI 10.1023/A:1023736732766; Stuart RB, 2005, PROF PSYCHOL-RES PR, V36, P254, DOI 10.1037/0735-7028.36.3.254; Taft CT, 2004, J CONSULT CLIN PSYCH, V72, P349, DOI 10.1037/0022-006X.72.2.349; White House United States, 2022, FACT SHEET REAUTH VI	25	79	79	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					560	562		10.1001/jama.298.5.560	http://dx.doi.org/10.1001/jama.298.5.560			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666677				2022-12-28	WOS:000248438100024
J	Vinck, P; Pham, PN; Stover, E; Weinstein, HM				Vinck, Patrick; Pham, Phuong N.; Stover, Eric; Weinstein, Harvey M.			Exposure to war crimes and implications for peace building in northern Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENTAL-HEALTH; POSTWAR AFGHANISTAN; TRAUMA; PTSD; CONSEQUENCES; ATTITUDES; CHECKLIST; SYMPTOMS; REFUGEES; TORTURE	Context Since the late 1980s, the Lord's Resistance Army has waged war against the Ugandan People's Democratic Army and the people of northern Uganda. Ending the conflict and achieving peace have proven to be challenges. In this context, it is important to examine population-based data on exposure to war crimes to understand how survivors perceive mechanisms aimed at achieving a lasting peace. Objectives To assess the level of exposure to war-related violence and the prevalence of posttraumatic stress disorder ( PTSD) and depression symptoms in northern Uganda and to determine how these variables are associated with respondents' views about peace. Design, Setting, and Participants Multistage, stratified, random cluster survey of 2585 adults aged 18 years or older conducted in villages and camps for internally displaced persons in 4 districts of northern Uganda in April and May 2005. Main Outcome Measures Rates and patterns of exposure to trauma; symptom criteria for PTSD, assessed via the PTSD Checklist - Civilian Version with a total severity score of 44; symptoms of depression, assessed via the Johns Hopkins Depression Symptom Checklist with a cutoff of 42; and opinions and attitudes about peace. Results Among the respondents, 1774 of 2389 (74.3%) met PTSD symptom criteria and 1151 of 2585 (44.5%) met depression symptom criteria. Four patterns of exposure to trauma were distinguished: those with low exposure ( group 1; 21.4%), witnesses to war-related violence ( group 2; 17.8%), those threatened with death and/or physically injured ( group 3; 16.4%), and those abducted ( group 4; 44.3%). Respondents in groups 3 and 4, who experienced the most traumatic exposures, were more likely to have PTSD symptoms compared with group 1 ( group 3 vs group 1: odds ratio [ OR], 7.04 [95% confidence interval {CI}, 5.02-9.87]; group 4 vs group 1: OR, 6.07 [ 95% CI, 4.77-7.71]). Groups 3 and 4 were also more likely to meet depression symptom criteria ( group 3 vs group 1: OR, 5.76 [ 95% CI, 4.34-7.65]; group 4 vs group 1: OR, 4.00 [ 95% CI, 3.16-5.06]). Respondents who met the PTSD symptom criteria were more likely to identify violence as a means to achieve peace ( OR, 1.31; 95% CI, 1.05-1.65). Respondents who met the depression symptom criteria were less likely to identify nonviolence as a means to achieve peace ( OR, 0.77; 95% CI, 0.65-0.93). Conclusions Our study found high prevalence rates for symptoms of PTSD and depression in a conflict zone. Respondents reporting symptoms of PTSD and depression were more likely to favor violent over nonviolent means to end the conflict.	Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94702 USA; Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Calif Berkeley, Boalt Hall Sch Law, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Tulane University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Vinck, P (corresponding author), Univ Calif Berkeley, Human Rights Ctr, 460 Stephens Hall 2300, Berkeley, CA 94702 USA.	pvinck@berkeley.edu		Pham, Phuong/0000-0002-5696-2933				Allen T, 2006, TRIAL JUSTICE INT CR; BAINES E, 2006, WAR AFFECTED CHILDRE, P13; Biro M., 2004, MY NEIGHBOR MY ENEMY; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BREWIN CR, 2003, POST TRAUMATIC STRES; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2005, J WOMENS HEALTH, V14, P285, DOI 10.1089/jwh.2005.14.285; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; CLOGG CC, 1977, 197709 PENNS STAT U; de Jong JP, 2000, ACTA PSYCHIAT SCAND, V102, P171, DOI 10.1034/j.1600-0447.2000.102003171.x; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Keane T., 1991, PTSD CHECKLIST MILIT; Kleinman A, 1997, SOCIAL SUFFERING; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; McNally Richard J., 2003, REMEMBERING TRAUMA; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; PARLOFF MB, 1954, AM J PSYCHIAT, V111, P343, DOI 10.1176/ajp.111.5.343; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Porter M, 2001, J TRAUMA STRESS, V14, P817, DOI 10.1023/A:1013054524810; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Tabachnick B. G., 2006, USING MULTIVARIATE S; WEINE SM, 1995, AM J PSYCHIAT, V152, P536	24	144	144	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					543	554		10.1001/jama.298.5.543	http://dx.doi.org/10.1001/jama.298.5.543			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666675	Bronze			2022-12-28	WOS:000248438100022
J	Collado, M; Blasco, MA; Serrano, M				Collado, Manuel; Blasco, Maria A.; Serrano, Manuel			Cellular senescence in cancer and aging	CELL			English	Review							ONCOGENE-INDUCED SENESCENCE; GENOME-WIDE ASSOCIATION; DNA-DAMAGE RESPONSE; TELOMERE LENGTH; LIFE-SPAN; TUMOR-SUPPRESSOR; IN-VIVO; HUMAN-CELLS; P53; MICE	Cellular senescence, a state of irreversible growth arrest, can be triggered by multiple mechanisms including telomere shortening, the epigenetic derepression of the INK4a/ARF locus, and DNA damage. Together these mechanisms limit excessive or aberrant cellular proliferation, and so the state of senescence protects against the development of cancer. Recent evidence suggests that cellular senescence also may be involved in aging.	CNIO, Spanish Natl Canc Res Ctr, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), CNIO, Spanish Natl Canc Res Ctr, Madrid, Spain.	mserrano@cnio.es	Collado, Manuel/K-8140-2014; Serrano, Manuel/H-2634-2015; Blasco, Maria A./M-1694-2014	Collado, Manuel/0000-0002-0330-0880; Serrano, Manuel/0000-0001-7177-9312; Blasco, Maria A./0000-0002-4211-233X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chen S.-C., 2000, KLUW INT S ADV DATA, V21; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez-Suarez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kelland LR, 2005, EUR J CANCER, V41, P971, DOI 10.1016/j.ejca.2004.11.024; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mason PJ, 2004, CELL CYCLE, V3, P1127; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Siegl-Cachedenier I, 2007, GENE DEV, V21, P2234, DOI 10.1101/gad.430107; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; te Poele RH, 2002, CANCER RES, V62, P1876; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	114	1187	1235	9	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					223	233		10.1016/j.cell.2007.07.003	http://dx.doi.org/10.1016/j.cell.2007.07.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662938	Bronze			2022-12-28	WOS:000248588000013
J	Fuss, SH; Omura, M; Mombaerts, P				Fuss, Stefan H.; Omura, Masayo; Mombaerts, Peter			Local and cis effects of the H element on expression of odorant receptor genes in mouse	CELL			English	Article							OLFACTORY SENSORY NEURONS; AXON GUIDANCE; EPITHELIUM; GLOMERULI; CHOICE; SYSTEM; LHX2; BULB; PROJECTION; IDENTITY	From the similar to 1,200 odorant receptor (OR) genes in the mouse genome, an olfactory sensory neuron is thought to express only one gene. The mechanisms of OR gene choice are not understood. A 2.1 kilobase region (the H element) adjacent to a cluster of seven OR genes has been proposed as a trans- and pan-enhancer for OR gene expression. Here, we deleted the H element by gene targeting in mice. The deletion abolishes expression of a family of three OR genes proximal to H, and H operates in cis on these genes. Deletion of H has a graded effect on expression of a distal group of four OR genes, commensurate with genomic distance. There is no demonstrable effect on expression of OR genes located outside the cluster. Our findings are not consistent with the hypothesis of H as an essential trans-acting enhancer for genome-wide regulation of OR gene expression.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	peter@rockefeller.edu	Fuss, Stefan H/G-2065-2011	Fuss, Stefan H/0000-0002-3076-1121				Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	144	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					373	384		10.1016/j.cell.2007.06.023	http://dx.doi.org/10.1016/j.cell.2007.06.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662950	Bronze			2022-12-28	WOS:000248588000025
J	Mameli, M; Balland, B; Lujan, R; Luscher, C				Mameli, Manuel; Balland, Benedicte; Lujan, Rafael; Luescher, Christian			Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area	SCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-PERMEABLE AMPA RECEPTORS; PROTEIN-SYNTHESIS; DOPAMINE NEURONS; IN-VIVO; DEPENDENT REGULATION; PLASTICITY; POLYRIBOSOMES; REQUIREMENT; ACTIVATION	The activation of metabotropic glutamate receptors (mGluRs) leads to long-term depression (mGluR-LTD) at many synapses of the brain. The induction of mGluR-LTD is well characterized, whereas the mechanisms underlying its expression remain largely elusive. mGluR-LTD in the ventral tegmental area (VTA) efficiently reverses cocaine-induced strengthening of excitatory inputs onto dopamine neurons. We show that mGluR-LTD is expressed by an exchange of GluR2-lacking AMPA receptors for GluR2-containing receptors with a lower single-channel conductance. The synaptic insertion of GluR2 depends on de novo protein synthesis via rapid messenger RNA translation of GluR2. Regulated synthesis of GluR2 in the VTA is therefore required to reverse cocaine-induced synaptic plasticity.	Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland; Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland.	Christian.Luscher@medecine.unige.ch	Lujan, Rafael/G-2555-2015; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Lujan Miras, Rafael/0000-0003-2001-9545; Mameli, Manuel/0000-0002-0570-6964				Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hartmann J, 2004, J NEUROSCI, V24, P5119, DOI 10.1523/JNEUROSCI.4193-03.2004; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Oguro K, 1999, J NEUROSCI, V19, P9218; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	26	216	221	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					530	533		10.1126/science.1142365	http://dx.doi.org/10.1126/science.1142365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656725				2022-12-28	WOS:000248339800050
J	Annas, GJ				Annas, George J.			Cancer and the constitution - Choice at life's end	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANAND G, 2007, WALL STREET J   0315, pA1; Annas G J, 1992, Health Matrix Clevel, V2, P119; Annas George J, 2005, Stetson Law Rev, V35, P49; Annas George J, 1989, Villanova Law Rev, V34, P771; Annas GJ, 1997, NEW ENGL J MED, V337, P1098, DOI 10.1056/NEJM199710093371523; Appelbaum PS, 2006, KENNEDY INST ETHIC J, V16, P367, DOI 10.1353/ken.2006.0021; Berezikov E, 2000, GENOME BIOL, V1; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Callahan Daniel., 1998, FALSE HOPES WHY AM Q; Coetzee J., 1990, AGE IRON; CULBERT M, 1974, VITAMIN B17 FORBIDDE; *FDA, 2006, PROP RUL CHARG INV D; *FDA, 2006, FDA PROP RUL OV EXP; Groopman Jerome, 2006, New Yorker, P40; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; KATZ J, 1984, SILENT WORLD DOCTOR, P151; MILLER HI, 2006, WALL STREET J   0302, pA15; NATHAN D, 2007, CANC TREATMENT REVOL; Patterson James T., 1987, DREAD DIS CANC MODER; PRUDHOMME A, 2004, CELL GAME S WAKSALS; Robertson JA, 2006, HASTINGS CENT REP, V36, P15, DOI 10.1353/hcr.2006.0101; 2005, WALL STREET J   0329, pA14; 2005, WALL STREET J   0324, pA14	23	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					408	413		10.1056/NEJMhle070625	http://dx.doi.org/10.1056/NEJMhle070625			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652658	Green Published			2022-12-28	WOS:000248283500016
J	Einhorn, LH; Williams, SD; Chamness, A; Brames, MJ; Perkins, SM; Abonour, R				Einhorn, Lawrence H.; Williams, Stephen D.; Chamness, Amy; Brames, Mary J.; Perkins, Susan M.; Abonour, Rafat			High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 02-06, 2006	Atlanta, GA	Amer Soc Clin Oncol			LONG-TERM SURVIVAL; SALVAGE CHEMOTHERAPY; PHASE-II; PROGNOSTIC VARIABLES; TESTICULAR CANCER; 2ND-LINE THERAPY; RANDOMIZED-TRIAL; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL	Background: Metastatic testicular tumors that have not been successfully treated by means of initial chemotherapy are potentially curable with salvage chemotherapy. Methods: We conducted a retrospective review of 184 consecutive patients with metastatic testicular cancer that had progressed after they received cisplatin-containing combination chemotherapy. We gave 173 patients two consecutive courses of high-dose chemotherapy consisting of 700 mg of carboplatin per square meter of body-surface area and 750 mg of etoposide per square meter, each for 3 consecutive days, and each followed by an infusion of autologous peripheral-blood hematopoietic stem cells; the other 11 patients received a single course of this treatment. In 110 patients, cytoreduction with one or two courses of vinblastine plus ifosfamide plus cisplatin preceded the high-dose chemotherapy. Results: Of the 184 patients, 116 had complete remission of disease without relapse during a median follow-up of 48 months (range, 14 to 118). Of the 135 patients who received the treatment as second-line therapy, 94 were disease-free during follow-up; 22 of 49 patients who received treatment as third-line or later therapy were disease-free. Of 40 patients with cancer that was refractory to standard-dose platinum, 18 were disease-free. A total of 98 of 144 patients who had platinum-sensitive disease were disease-free, and 26 of 35 patients with seminoma and 90 of 149 patients with nonseminomatous germ-cell tumors were disease-free. Among the 184 patients, there were three drug-related deaths during therapy. Acute leukemia developed in three additional patients after therapy. Conclusions: Testicular tumors are potentially curable by means of high-dose chemotherapy plus hematopoietic stem-cell rescue, even when this regimen is used as third-line or later therapy or in patients with platinum-refractory disease.	Indiana Univ, Ctr Canc, Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Walther Canc Inst, Indianapolis, IN 46202 USA; Indiana Univ, Div Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Einhorn, LH (corresponding author), Indiana Univ, Ctr Canc, Sch Med, Div Hematol Oncol, 535 Barnhill Dr,Rm 473, Indianapolis, IN 46202 USA.	leinhorn@iupui.edu						Beyer J, 1997, CANCER, V79, P161, DOI 10.1002/(SICI)1097-0142(19970101)79:1<161::AID-CNCR23>3.0.CO;2-1; Beyer J, 1996, J CLIN ONCOL, V14, P2638, DOI 10.1200/JCO.1996.14.10.2638; Bhatia S, 2000, J CLIN ONCOL, V18, P3346, DOI 10.1200/JCO.2000.18.19.3346; Bosl GJ, 1997, NEW ENGL J MED, V337, P1403; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; BUCKNER CD, 1974, CANCER CHEMOTH REP 1, V58, P709; COOPER MA, 1995, J CLIN ONCOL, V13, P1167, DOI 10.1200/JCO.1995.13.5.1167; Efron B, 1998, INTRO BOOTSTRAP; Einhorn LH, 2007, J CLIN ONCOL, V25, P513, DOI 10.1200/JCO.2006.07.7271; EINHORN LH, 1990, J CLIN ONCOL, V8, P1777, DOI 10.1200/JCO.1990.8.11.1777; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Hartmann JT, 2001, J CLIN ONCOL, V19, P1641, DOI 10.1200/JCO.2001.19.6.1641; Houck W, 2004, J CLIN ONCOL, V22, P2155, DOI 10.1200/JCO.2004.11.054; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Loehrer PJ, 1998, J CLIN ONCOL, V16, P2500, DOI 10.1200/JCO.1998.16.7.2500; Lotz JP, 2005, ANN ONCOL, V16, P411, DOI 10.1093/annonc/mdi087; Mead GM, 1997, J CLIN ONCOL, V15, P594; Motzer RJ, 2000, J CLIN ONCOL, V18, P1173, DOI 10.1200/JCO.2000.18.6.1173; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413, DOI 10.1200/JCO.2000.18.12.2413; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; MURPHY BR, 1993, J CLIN ONCOL, V11, P324, DOI 10.1200/JCO.1993.11.2.324; NICHOLS CR, 1989, J CLIN ONCOL, V7, P932, DOI 10.1200/JCO.1989.7.7.932; Pico JL, 2005, ANN ONCOL, V16, P1152, DOI 10.1093/annonc/mdi228; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Rick O, 2001, J CLIN ONCOL, V19, P81, DOI 10.1200/JCO.2001.19.1.81; Rick O, 1998, EUR J CANCER, V34, P1883, DOI 10.1016/S0959-8049(98)00272-X; Rodenhuis S, 1999, ANN ONCOL, V10, P1467, DOI 10.1023/A:1008328012040; Rosti G, 2002, CANCER, V95, P309, DOI 10.1002/cncr.10672; SIEGERT W, 1994, J CLIN ONCOL, V12, P1223, DOI 10.1200/JCO.1994.12.6.1223; Vaena DA, 2003, J CLIN ONCOL, V21, P4100, DOI 10.1200/JCO.2003.06.067; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	32	334	348	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					340	348		10.1056/NEJMoa067749	http://dx.doi.org/10.1056/NEJMoa067749			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652649				2022-12-28	WOS:000248283500005
J	Wright, AA; Katz, IT				Wright, Alexi A.; Katz, Ingrid T.			Letting go of the rope - Aggressive treatment, hospice care, and open access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER; LIFE; END						Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Finn JW, 2002, P AN M AM SOC CLIN, P21; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; *NAT HOSP PALL CAR, 2006, 2005 NAT SUMM HOSP C, P4; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458	5	61	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					324	327		10.1056/NEJMp078074	http://dx.doi.org/10.1056/NEJMp078074			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652646				2022-12-28	WOS:000248283500002
J	Xavier, RJ; Podolsky, DK				Xavier, R. J.; Podolsky, D. K.			Unravelling the pathogenesis of inflammatory bowel disease	NATURE			English	Review							GENOME-WIDE ASSOCIATION; INCREASED INTESTINAL PERMEABILITY; REGULATORY T-CELLS; CROHNS-DISEASE; OLIGOMERIZATION DOMAIN-2; ILEAL MUCOSA; DOUBLE-BLIND; KEY ROLE; SUSCEPTIBILITY; INNATE	Recently, substantial advances in the understanding of the molecular pathogenesis of inflammatory bowel disease (IBD) have been made owing to three related lines of investigation. First, IBD has been found to be the most tractable of complex disorders for discovering susceptibility genes, and these have shown the importance of epithelial barrier function, and innate and adaptive immunity in disease pathogenesis. Second, efforts directed towards the identification of environmental factors implicate commensal bacteria ( or their products), rather than conventional pathogens, as drivers of dysregulated immunity and IBD. Third, murine models, which exhibit many of the features of ulcerative colitis and seem to be bacteria-driven, have helped unravel the pathogenesis/ mucosal immunopathology of IBD.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Podolsky, DK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA.	dpodolsky@partners.org						Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fort MM, 1998, J IMMUNOL, V161, P3256; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Matute JD, 2005, BLOOD CELL MOL DIS, V35, P291, DOI 10.1016/j.bcmd.2005.06.010; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mizoguchi A, 2007, J CLIN INVEST, V117, P605, DOI 10.1172/JCI30150; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2005, IMMUNOL RES, V32, P193, DOI 10.1385/IR:32:1-3:193; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; ONDERDONK AB, 1977, AM J CLIN NUTR, V30, P1819, DOI 10.1093/ajcn/30.11.1819; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Silverberg MS, 2007, EUR J HUM GENET, V15, P328, DOI 10.1038/sj.ejhg.5201756; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; YU QT, 2006, INFLAMM BOWEL DIS, V168, P1898; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	98	3009	3152	52	832	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					427	434		10.1038/nature06005	http://dx.doi.org/10.1038/nature06005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653185				2022-12-28	WOS:000248302700038
J	Saiz-Lopez, A; Mahajan, AS; Salmon, RA; Bauguitte, SJB; Jones, AE; Roscoe, HK; Plane, JMC				Saiz-Lopez, Alfonso; Mahajan, Anoop S.; Salmon, Rhian A.; Bauguitte, Stephane J. -B.; Jones, Anna E.; Roscoe, Howard K.; Plane, John M. C.			Boundary layer halogens in coastal Antarctica	SCIENCE			English	Article							POLAR SUNRISE; TROPOSPHERIC CHEMISTRY; OZONE DESTRUCTION; IODINE OXIDE; BRO; PHYTOPLANKTON; PARTICLES; DEPLETION; IO	Halogens influence the oxidizing capacity of Earth's troposphere, and iodine oxides form ultrafine aerosols, which may have an impact on climate. We report year-round measurements of boundary layer iodine oxide and bromine oxide at the near-coastal site of Halley Station, Antarctica. Surprisingly, both species are present throughout the sunlit period and exhibit similar seasonal cycles and concentrations. The springtime peak of iodine oxide ( 20 parts per trillion) is the highest concentration recorded anywhere in the atmosphere. These levels of halogens cause substantial ozone depletion, as well as the rapid oxidation of dimethyl sulfide and mercury in the Antarctic boundary layer.	Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7JT, Norfolk, England; British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Leeds; University of East Anglia; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Plane, JMC (corresponding author), Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England.	J.M.C.Plane@leeds.ac.uk	Saiz-Lopez, Alfonso/B-3759-2015; Plane, John M C/C-7444-2015; Mahajan, Anoop S/D-2714-2012	Saiz-Lopez, Alfonso/0000-0002-0060-1581; Plane, John M C/0000-0003-3648-6893; Mahajan, Anoop S/0000-0002-2909-5432	Natural Environment Research Council [NER/G/S/2001/00010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson PS, 2003, BOUND-LAY METEOROL, V107, P323, DOI 10.1023/A:1022171009297; BARRIE LA, 1988, NATURE, V334, P138, DOI 10.1038/334138a0; Calvert JG, 2004, ATMOS ENVIRON, V38, P5105, DOI 10.1016/j.atmosenv.2004.05.050; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Davison B, 1996, J GEOPHYS RES-ATMOS, V101, P22855, DOI 10.1029/96JD01166; Fleischmann OC, 2003, J PHOTOCH PHOTOBIO A, V157, P127, DOI 10.1016/S1010-6030(03)00069-8; Friess U, 2001, GEOPHYS RES LETT, V28, P1941, DOI 10.1029/2000GL012784; Gilles MK, 1997, J PHYS CHEM A, V101, P5526, DOI 10.1021/jp9709159; Goodsite ME, 2004, ENVIRON SCI TECHNOL, V38, P1772, DOI 10.1021/es034680s; HAUSMANN M, 1994, J GEOPHYS RES-ATMOS, V99, P25399, DOI 10.1029/94JD01314; Hollwedel J, 2004, ADV SPACE RES, V34, P804, DOI 10.1016/j.asr.2003.08.060; Honninger G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018982; JOBSON BT, 1994, J GEOPHYS RES-ATMOS, V99, P25355, DOI 10.1029/94JD01243; Kreher K, 1997, GEOPHYS RES LETT, V24, P3021, DOI 10.1029/97GL02997; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; PLANE JMC, 2006, ANAL TECHNIQUES ATMO, pCH3; Rankin AM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002492; Sander R, 1999, GEOPHYS RES LETT, V26, P2857, DOI 10.1029/1999GL900478; Saunders RW, 2005, ENVIRON CHEM, V2, P299, DOI 10.1071/EN05079; Sirois A, 1999, J GEOPHYS RES-ATMOS, V104, P11599, DOI 10.1029/1999JD900077; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; Spietz P, 2005, J PHOTOCH PHOTOBIO A, V176, P50, DOI 10.1016/j.jphotochem.2005.08.023; Thomas David N, 2008, SEA ICE INTRO ITS PH; Tuckermann M, 1997, TELLUS B, V49, P533, DOI 10.1034/j.1600-0889.49.issue5.9.x; von Glasow R, 2005, ENVIRON CHEM, V2, P243, DOI 10.1071/ENv2n4_ES; von Glasow R., 2003, TREATISE GEOCHEMISTR, V4, P21	27	214	217	5	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					348	351		10.1126/science.1141408	http://dx.doi.org/10.1126/science.1141408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641195				2022-12-28	WOS:000248150200040
J	Neder, I; Ofek, N; Chung, Y; Heiblum, M; Mahalu, D; Umansky, V				Neder, I.; Ofek, N.; Chung, Y.; Heiblum, M.; Mahalu, D.; Umansky, V.			Interference between two indistinguishable electrons from independent sources	NATURE			English	Article							QUANTUM SHOT-NOISE; HANBURY-BROWN	Very much like the ubiquitous quantum interference of a single particle with itself(1), quantum interference of two independent, but indistinguishable, particles is also possible. For a single particle, the interference is between the amplitudes of the particle's wave-functions, whereas the interference between two particles is a direct result of quantum exchange statistics. Such interference is observed only in the joint probability of finding the particles in two separated detectors, after they were injected from two spatially separated and independent sources. Experimental realizations of two-particle interferometers have been proposed(2,3); in these proposals it was shown that such correlations are a direct signature of quantum entanglement(4) between the spatial degrees of freedom of the two particles ('orbital entanglement'), even though they do not interact with each other. In optics, experiments using indistinguishable pairs of photons encountered difficulties in generating pairs of independent photons and synchronizing their arrival times; thus they have concentrated on detecting bunching of photons (bosons) by coincidence measurements(5,6). Similar experiments with electrons are rather scarce. Cross-correlation measurements between partitioned currents, emanating from one source(7-10), yielded similar information to that obtained from auto-correlation (shot noise) measurements(11,12). The proposal of ref. 3 is an electronic analogue to the historical Hanbury Brown and Twiss experiment with classical light(13,14). It is based on the electronic Mach-Zehnder interferometer(15) that uses edge channels in the quantum Hall effect regime(16). Here we implement such an interferometer. We partitioned two independent and mutually incoherent electron beams into two trajectories, so that the combined four trajectories enclosed an Aharonov-Bohm flux. Although individual currents and their fluctuations (shot noise measured by auto-correlation) were found to be independent of the Aharonov-Bohm flux, the cross-correlation between current fluctuations at two opposite points across the device exhibited strong Aharonov-Bohm oscillations, suggesting orbital entanglement between the two electron beams.	Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea	Weizmann Institute of Science; Pusan National University	Heiblum, M (corresponding author), Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	heiblum@wisemail.weizmann.ac.il	heiblum, moty/Q-1193-2019; Umansky, Vladimir/P-1334-2019	Umansky, Vladimir/0000-0001-5727-2064				AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Born M., 1999, PRINCIPLES OPTICS, P348; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Feynman R. P., 2010, FEYNMAN LECT PHYS, VNew; Gavish U, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.216807; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; HANBURYBROWN R, 1954, PHILOS MAG, V45, P663; Heiblum M, 2006, PHYS STATUS SOLIDI B, V243, P3604, DOI 10.1002/pssb.200642237; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Kiesel H, 2002, NATURE, V418, P392, DOI 10.1038/nature00911; KITENBAEK R, 2006, PHYS REV LETT, V96; Kumar A, 1996, PHYS REV LETT, V76, P2778, DOI 10.1103/PhysRevLett.76.2778; LESOVIK GB, 1989, JETP LETT+, V49, P592; Mandel L, 1999, REV MOD PHYS, V71, pS274, DOI 10.1103/RevModPhys.71.S274; Neder I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.036803; Neder I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016804; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; REZNIKOV M, 1995, PHYS REV LETT, V75, P3340, DOI 10.1103/PhysRevLett.75.3340; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; YURKE B, 1992, PHYS REV A, V46, P2229, DOI 10.1103/PhysRevA.46.2229	23	247	248	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					333	337		10.1038/nature05955	http://dx.doi.org/10.1038/nature05955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637665				2022-12-28	WOS:000248118300053
J	Wang, SA; Harvey, AB; Conner, SM; Zaidi, AA; Knapp, JS; Whittington, WLH; del Rio, C; Judson, FN; Holmes, KK				Wang, Susan A.; Harvey, Alesia B.; Conner, Susan M.; Zaidi, Akbar A.; Knapp, Joan S.; Whittington, William L. H.; del Rio, Carlos; Judson, Franklyn N.; Holmes, King K.			Antimicrobial resistance for Neisseria gonorrhoeae in the united states, 1988 to 2003: The spread of fluoroquinolone resistance	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; DECREASED SUSCEPTIBILITY; RISK-FACTORS; SURVEILLANCE; AZITHROMYCIN; EMERGENCE; THERAPY; HAWAII; MEN	Background: Over the past 60 years, Neisseria gonorrhoeae has acquired clinically significant resistance to sulfonamides, tetracyclines, penicillins, and ciprofloxacin. Objective: To determine U.S. trends in the prevalence of antimicrobial resistance of N. gonorrhoeae from 1988 to 2003. Design: 16-year, multisite, sentinel surveillance for gonococcal isolate susceptibility through the Gonococcal Isolate Surveillance Project (GISP). Setting: Sexually transmitted disease clinics in 37 cities. Patients: Male patients with a total of 82 064 episodes of urethral gonorrhea. Measurements: Primary outcome measures included percentage of gonococcal isolates resistant to antimicrobials used to treat gonorrhea, percentage of patients treated with specific antimicrobials for gonorrhea, and trends of these measures over time. Results: The median age of patients was 26 years, and 74.1% of patients were African American. The proportion of men treated with penicillins for gonorrhea declined from 39.5% in 1988 to 0% in 1994, while the proportion of those receiving fluoroquinolone treatment increased from 0% in 1988 to 42.0% in 2003. Penicillin resistance peaked at 19.6% in 1991, then declined to 6.5% in 2003. Tetracycline resistance peaked at 25.8% in 1997 and declined to 14.4% in 2003. The first fluoroquinolone-resistant isolate was found in 1991. Nationally, 0.4% of isolates were fluoroquinolone-resistant in 1999 and were identified in 39% of GISP cities. By 2003, 4.1 % of isolates were fluoroquinolone-resistant and were identified in 70% of GISP cities. Isolates with decreased susceptibility to ceftriaxone, cefixime, azithromycin, and spectinomycin remained rare. In 2001, 3 multidrug-resistant isolates with decreased susceptibility to cefixime were identified. Limitation: Sentinel surveillance may not fully reflect trends for all patients with gonorrhea in the United States. Conclusions: Prevalence of penicillin resistance has declined in the years since gonorrhea treatment with penicillin was discontinued. Fluoroquinolone-resistant N. gonorrhoeae infections continue to increase at a time when fluoroquinolone use has increased. Ongoing nationwide and local antimicrobial susceptibility monitoring is crucial to ensure appropriate treatment of gonorrhea.	Emory Univ, Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Sch Med, Atlanta, GA 30333 USA; Emory Ctr AIDS Res, Atlanta, GA USA; Medtronic, Memphis, TN USA; Univ Washington, Seattle, WA 98195 USA; Univ Colorado, Sch Med, Denver, CO USA	Centers for Disease Control & Prevention - USA; Emory University; Emory University; Medtronic; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Wang, SA (corresponding author), Emory Univ, Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Sch Med, Mail Stop G-37,1600 Clifton Rd, Atlanta, GA 30333 USA.	sjw8@cdc.gov	, Holmes/K-6215-2019; del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517				AKASAKA S, 2002, 13 INT PATH NEISS C; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], NEISS GON REF STRAIN; Bauer HM, 2005, CLIN INFECT DIS, V41, P795, DOI 10.1086/432801; Brackbill RM, 1999, FAM PLANN PERSPECT, V31, P10, DOI 10.2307/2991551; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P335; *CDCP, 2004, OR ALT CEF TREATM UN; *CDCP, STD SURV SYST; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P370; *CDCP, 2002, MMWR RECOMM REP, V10, P1; *CDCP, 2004, SEX TRANSM DIS SURV; *CDCP, 2003, SEX TRANSM DIS SURV; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V21, p1S; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1052; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; Dicker LW, 2004, SEX TRANSM DIS, V31, P259, DOI 10.1097/01.OLQ.0000124609.84050.F3; *EXP WORK GROUP CA, 2004, CMAJ, V171, P1345; Fox KK, 1997, J INFECT DIS, V175, P1396, DOI 10.1086/516472; Ghanem KG, 2005, INFECT DIS CLIN N AM, V19, P351, DOI 10.1016/j.idc.2005.03.005; *GRASP STEER GROUP, 2004, GON RES ANT SURV PRO; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; *I MED, 1977, HIDD EP CONFR SEX TR; *INT CTR DIARRH DI, 2003, SURV UPD HLTH SCI B, V1, P17; Iverson CJ, 2004, SEX TRANSM DIS, V31, P702, DOI 10.1097/01.olq.0000145846.45781.a4; KAMPMEIER RH, 1983, SEX TRANSM DIS, V10, P81, DOI 10.1097/00007435-198304000-00007; Macomber KE, 2005, EMERG INFECT DIS, V11, P1009, DOI 10.3201/eid1107.041359; Manhart LE, 2004, AM J EPIDEMIOL, V160, P393, DOI 10.1093/aje/kwh220; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; MCCORMACK WM, 1994, NEW ENGL J MED, V330, P115, DOI 10.1056/NEJM199401133300207; McLean CA, 2004, SEX TRANSM DIS, V31, P73, DOI 10.1097/01.OLQ.0000109514.91508.FC; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; *NAT COMM CLIN LAB, 2002, 100S12 M NAT COMM CL; Patrick D, 1995, Can Commun Dis Rep, V21, P137; Porter CA, 2004, SEX TRANSM INFECT, V80, P488, DOI 10.1136/sti.2004.011049; Roy K, 2005, EMERG INFECT DIS, V11, P1265, DOI 10.3201/eid1108.050157; Schrag SJ, 2002, EMERG INFECT DIS, V8, P496; SCHWARCZ SK, 1990, JAMA-J AM MED ASSOC, V264, P1413, DOI 10.1001/jama.264.11.1413; TAKAHASHI K, 2001, 41 INT C ANT AG CHEM; Tapsall J, 2001, WHOCDSDRS2001316; Tapsall J, 2005, COMMUN DIS INTELL, V29, P62; Tapsall JW, 1998, SEX TRANSM DIS, V25, P505, DOI 10.1097/00007435-199811000-00002; *US DEP HHS, PUBL HLTH ACT PLAN C; Wang SA, 2003, CLIN INFECT DIS, V37, P849, DOI 10.1086/377500; Whittington WLH, 2000, J INFECT DIS, V181, P1044, DOI 10.1086/315343; *WHO, STRAT CONT ANT RES; *WHO REG OFF EUR, GON INC RAT 100000 P; 1995, COMMUN DIS INTELL, V19, P495	50	40	47	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					81	88		10.7326/0003-4819-147-2-200707170-00006	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17638718				2022-12-28	WOS:000248179300002
J	Mathonnet, G; Fabian, MR; Svitkin, YV; Parsyan, A; Huck, L; Murata, T; Biffo, S; Merrick, WC; Darzynkiewicz, E; Pillai, RS; Filipowicz, W; Duchaine, TF; Sonenberg, N				Mathonnet, Geraldine; Fabian, Marc R.; Svitkin, Yuri V.; Parsyan, Armen; Huck, Laurent; Murata, Takayuki; Biffo, Stefano; Merrick, William C.; Darzynkiewicz, Edward; Pillai, Ramesh S.; Filipowicz, Witold; Duchaine, Thomas F.; Sonenberg, Nahum			MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex elF4F	SCIENCE			English	Article							MECHANISMS; CELLS; RNA	MicroRNAs (miRNAs) play an important role in gene regulatory networks in animals. Yet, the mechanistic details of their function in translation inhibition or messenger RNA (mRNA) destabilization remain controversial. To directly examine the earliest events in this process, we have developed an in vitro translation system using mouse Krebs-2 ascites cell-free extract that exhibits an authentic miRNA response. We show here that translation initiation, specifically the 5' cap recognition process, is repressed by endogenous let-7 miRNAs within the first 15 minutes of mRNA exposure to the extract when no destabilization of the transcript is observed. Our results indicate that inhibition of translation initiation is the earliest molecular event effected by miRNAs. Other mechanisms, such as mRNA degradation, may subsequently consolidate mRNA silencing.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; Ist Sci San Raffaele, Lab Mol Histol, I-20132 Milan, Italy; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Univ Warsaw, Inst Phys Expt, Dept Biophys, PL-02089 Warsaw, Poland; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	McGill University; McGill University; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Case Western Reserve University; University of Warsaw; Friedrich Miescher Institute for Biomedical Research	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	thomas.duchaine@mcgill.ca; nahum.sonenberg@mcgill.ca	Duchaine, Thomas/U-2399-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Svitkin, Yuri/0000-0003-3819-2143; Mathonnet, Geraldine/0000-0002-9898-6490; biffo, stefano/0000-0002-3780-1050; Duchaine, Thomas/0000-0002-3454-1839				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034	15	379	396	5	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1764	1767		10.1126/science.1146067	http://dx.doi.org/10.1126/science.1146067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17656684	Green Submitted			2022-12-28	WOS:000249585900052
J	Farooqi, IS; Bullmore, ET; Keogh, J; Gillard, J; O'Rahilly, S; Fletcher, PC				Farooqi, I. Sadaf; Bullmore, Edward T.; Keogh, Julia; Gillard, Jonathan; O'Rahilly, Stephen; Fletcher, Paul C.			Leptin regulates striatal regions and human eating Behavior	SCIENCE			English	Article									Univ Cambridge, Addenbrookes Hosp, Univ Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Univ Dept Med, Cambridge CB2 2QQ, England.	isf20@cam.ac.uk; pcf22@cam.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; Bullmore, Ed/C-1706-2012; O'Rahilly, Stephen/ABF-6509-2020; Fletcher, Paul/F-5380-2011	Bullmore, Ed/0000-0002-8955-8283; O'Rahilly, Stephen/0000-0003-2199-4449; Fletcher, Paul/0000-0001-8257-1517; Farooqi, Sadaf/0000-0001-7609-3504	Medical Research Council [G0001354B] Funding Source: researchfish; MRC [G9824984] Funding Source: UKRI; Medical Research Council [G0001354, G9824984] Funding Source: Medline; Wellcome Trust [064351, 068086] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026	3	412	417	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1355	1355		10.1126/science.1144599	http://dx.doi.org/10.1126/science.1144599			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690262	Green Accepted			2022-12-28	WOS:000249377500036
J	Chung, A; Perera, R; Brueggemann, AB; Elamin, AE; Harnden, A; Mayon-White, R; Smith, S; Crook, DW; Mant, D				Chung, Angela; Perera, Rafael; Brueggemann, Angela B.; Elamin, Abdel E.; Harnden, Anthony; Mayon-White, Richard; Smith, Susan; Crook, Derrick W.; Mant, David			Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; BACTERIA; ELEMENTS	Objective To assess the effect of community prescribing of an antibiotic for acute respiratory infection on the prevalence of antibiotic resistant bacteria in an individual child. Study design Observational cohort study with follow-up at two and 12 weeks. Setting General practices in Oxfordshire. Participants 119 children with acute respiratory tract infection, of whom 71 received a beta lactam antibiotic. Main outcome measures Antibiotic resistance was assessed by the geometric mean minimum inhibitory concentration (MIC) for ampicillin and presence of the ICEHin1056 resistance element in up to four isolates of Hoemophilus species recovered from throat swabs at recruitment, two weeks, and 12 weeks. Results Prescribing amoxicillin to a child in general practice more than triples the mean minimum inhibitory concentration for ampicillin (9.2 mu g/ml v 2.7 mu g/ml, P=0.005) and doubles the risk of isolation of Haemophilus isolates possessing homologues of ICEHin1056 (67% v 36%; relative risk 1.9, 95% confidence interval 1.2 to 2.9) two weeks later. Although this increase is transient (by 12 weeks ampicilin resistance had fallen close to baseline), it is in the context of recovery of the element from 35% of children with Haemophilus isolates at recruitment and from 83% (76% to 89%) at some point in the study. Conclusion The short term effect of amoxicillin prescribed in primary care is transitory in the individual child but sufficient to sustain a high level of antibiotic resistance in the population.	Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin & Lab Sci, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Mant, D (corresponding author), Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Hlth Care, Oxford OX3 7LF, England.	david.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009	Brueggemann, Angela/0000-0002-2329-1934; Perera, Rafael/0000-0003-2418-2091	Medical Research Council [G0000340, G0400039] Funding Source: Medline; MRC [G0400039, G0000340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arason VA, 2002, MICROB DRUG RESIST, V8, P187, DOI 10.1089/107662902760326896; ARASON VA, 1996, BRIT MED J, V313, P7054; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; BROOK I, 1988, ARCH OTOLARYNGOL, V114, P667; Dimopoulou ID, 2002, ANTIMICROB AGENTS CH, V46, P1602, DOI 10.1128/AAC.46.5.1602-1603.2002; Dimopoulou ID, 2007, J MED MICROBIOL, V56, P838, DOI 10.1099/jmm.0.47125-0; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Feikin DR, 2000, J INFECT DIS, V181, P1501, DOI 10.1086/315382; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Leaves NI, 2000, J ANTIMICROB CHEMOTH, V45, P599, DOI 10.1093/jac/45.5.599; Majeed A, 1999, BRIT J GEN PRACT, V49, P735; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Priest P, 2001, BMJ-BRIT MED J, V323, P1037, DOI 10.1136/bmj.323.7320.1037; SCHEIFELE DW, 1982, ANTIMICROB AGENTS CH, V21, P734, DOI 10.1128/AAC.21.5.734; Sharland M, 2005, BMJ-BRIT MED J, V331, P328, DOI 10.1136/bmj.38503.706887.AE1; Turnidge J, 2005, LANCET, V365, P548	17	100	103	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2007	335	7617					429	431		10.1136/bmj.39274.647465.BE	http://dx.doi.org/10.1136/bmj.39274.647465.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208VF	17656505	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000249346600031
J	Minegishi, Y; Saito, M; Tsuchiya, S; Tsuge, I; Takada, H; Hara, T; Kawamura, N; Ariga, T; Pasic, S; Stojkovic, O; Metin, A; Karasuyama, H				Minegishi, Yoshiyuki; Saito, Masako; Tsuchiya, Shigeru; Tsuge, Ikuya; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Pasic, Srdjan; Stojkovic, Oliver; Metin, Ayse; Karasuyama, Hajime			Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome	NATURE			English	Article							B-CELL DEVELOPMENT; ALLERGIC DISEASE; PATHWAY; INTERLEUKIN-6; ACTIVATION; IMMUNITY; INNATE; ROLES	Hyper-immunoglobulin E syndrome (HIES) is a compound primary immunodeficiency characterized by a highly elevated serum IgE, recurrent staphylococcal skin abscesses and cyst-forming pneumonia, with disproportionately milder inflammatory responses, referred to as cold abscesses, and skeletal abnormalities(1). Although some cases of familial HIES with autosomal dominant or recessive inheritance have been reported, most cases of HIES are sporadic, and their pathogenesis has remained mysterious for a long time. Here we show that dominant-negative mutations in the human signal transducer and activator of transcription 3 (STAT3) gene result in the classical multisystem HIES. We found that eight out of fifteen unrelated non-familial HIES patients had heterozygous STAT3 mutations, but their parents and siblings did not have the mutant STAT3 alleles, suggesting that these were de novo mutations. Five different mutations were found, all of which were located in the STAT3 DNA-binding domain. The patients' peripheral blood cells showed defective responses to cytokines, including interleukin (IL)-6 and IL-10, and the DNA-binding ability of STAT3 in these cells was greatly diminished. All five mutants were non-functional by themselves and showed dominant-negative effects when co-expressed with wild-type STAT3. These results highlight the multiple roles played by STAT3 in humans, and underline the critical involvement of multiple cytokine pathways in the pathogenesis of HIES.	Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138519, Japan; Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 9808575, Japan; Fujita Hlth Univ, Dept Pediat, Aichi 4701192, Japan; Kyushu Univ, Dept Pediat, Fukuoka 8128582, Japan; Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; Mother & Child Hlth Inst Serbia, Belgrade 11070, Serbia; Univ Belgrade, Inst Forens Med, Lab Forens Genet, Belgrade 11070, Serbia; SB Ankara Diskapi Childrens Hosp, Dept Pediat Immunol, TR-06110 Ankara, Turkey	Tokyo Medical & Dental University (TMDU); Tohoku University; Fujita Health University; Kyushu University; Hokkaido University; University of Belgrade; Ankara Children's Hematology Oncology Training & Research Hospital	Minegishi, Y (corresponding author), Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138519, Japan.	yminegishi.mbch@tmd.ac.jp	Ariga, Tadashi/A-4252-2012; Karasuyama, Hajime/A-7966-2011; METIN, AYSE/AAS-2382-2020	Karasuyama, Hajime/0000-0003-0689-0836; METIN, AYSE/0000-0002-0731-5799; Stojkovic, Oliver/0000-0002-4794-1882				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Chapman BLW, 2006, CURR MED IMAGING REV, V2, P131, DOI 10.2174/157340506775541695; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVIS SD, 1966, LANCET, V1, P1013; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Grimbacher B, 2002, ALLERGY, V57, P995, DOI 10.1034/j.1398-9995.2002.02168.x; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	30	719	745	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1058	U10		10.1038/nature06096	http://dx.doi.org/10.1038/nature06096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17676033				2022-12-28	WOS:000249097600040
J	Brumfiel, G				Brumfiel, Geoff			Powerful incentives	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					741	741		10.1038/448741a	http://dx.doi.org/10.1038/448741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700671				2022-12-28	WOS:000248754200011
J	Ourjoumtsev, A; Jeong, H; Tualle-Brouri, R; Grangier, P				Ourjoumtsev, Alexei; Jeong, Hyunseok; Tualle-Brouri, Rosa; Grangier, Philippe			Generation of optical "Schrodinger cats' from photon number states	NATURE			English	Article							COHERENT STATES; DECOHERENCE	Schrodinger's cat(1) is a Gedankenexperiment in quantum physics, in which an atomic decay triggers the death of the cat. Because quantum physics allow atoms to remain in superpositions of states, the classical cat would then be simultaneously dead and alive. By analogy, a 'cat' state of freely propagating light can be defined as a quantum superposition of well separated quasiclassical states(2,3) - it is a classical light wave that simultaneously possesses two opposite phases. Such states play an important role in fundamental tests of quantum theory(4-7) and in many quantum information processing tasks, including quantum computation(8), quantum teleportation(9,10) and precision measurements(11). Recently, optical Schrodinger 'kittens' were prepared(12-14); however, they are too small for most of the aforementioned applications and increasing their size is experimentally challenging. Here we demonstrate, theoretically and experimentally, a protocol that allows the generation of arbitrarily large squeezed Schrodinger cat states, using homodyne detection and photon number states as resources. We implemented this protocol with light pulses containing two photons, producing a squeezed Schrodinger cat state with a negative Wigner function. This state clearly exhibits several quantum phase- space interference fringes between the 'dead' and 'alive' components, and is large enough to become useful for quantum information processing and experimental tests of quantum theory.	Univ Paris 11, CNRS, Lab Charles Fabry, Inst Opt,UMR 8501, F-91127 Palaiseau, France; Univ Queensland, Ctr Quantum Comp Technol, Dept Phys, Brisbane, Qld 4072, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; University of Queensland	Ourjoumtsev, A (corresponding author), Univ Paris 11, CNRS, Lab Charles Fabry, Inst Opt,UMR 8501, F-91127 Palaiseau, France.	alexei.ourjoumtsev@institutoptique.fr		Ourjoumtsev, Alexei/0000-0003-4166-0518; Jeong, Hyunseok/0000-0003-0348-3397				Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Jeong H, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012106; Jeong H, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052308; Jeong H, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033813; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Munro WJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023819; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858; Ourjoumtsev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.213601; Ralph TC, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042319; SANDERS BC, 1992, PHYS REV A, V45, P6811, DOI 10.1103/PhysRevA.45.6811; SCHLEICH W, 1991, PHYS REV A, V44, P2172, DOI 10.1103/PhysRevA.44.2172; Schrodinger E, 1926, NATURWISSENSCHAFTEN, V14, P664, DOI 10.1007/BF01507634; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Serafini A, 2004, J OPT B-QUANTUM S O, V6, pS591, DOI 10.1088/1464-4266/6/6/019; Stobinska M, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052105; Suzuki S, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.042304; van Enk SJ, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022313; Waks E, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/1/004; Wakui K, 2007, OPT EXPRESS, V15, P3568, DOI 10.1364/OE.15.003568; Walls D. F., 1994, QUANTUM OPT; Wenger J, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012105; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749; YOSHIKAWA J, 2007, DEMONSTRATION HIGH F; YURKE B, 1986, PHYS REV LETT, V57, P13, DOI 10.1103/PhysRevLett.57.13; ZUREK WH, 1993, PHYS REV LETT, V70, P1187, DOI 10.1103/PhysRevLett.70.1187	27	489	499	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					784	786		10.1038/nature06054	http://dx.doi.org/10.1038/nature06054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700695				2022-12-28	WOS:000248754200034
J	Grenier, MB; McDonald, DB; Buskirk, SW				Grenier, M. B.; McDonald, D. B.; Buskirk, S. W.			Rapid population growth of a critically endangered carnivore	SCIENCE			English	Article									Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; Wyoming Game & Fish Dept, Lander, WY 82520 USA	University of Wyoming	Grenier, MB (corresponding author), Univ Wyoming, Dept Zool & Physiol, 1000 E Univ Ave, Laramie, WY 82071 USA.	martin.grenier@wgf.state.wy.us	Buskirk, Steven W/K-2871-2016; McDonald, David Bartelle/C-3195-2008	Buskirk, Steven W/0000-0003-0611-6648; McDonald, David Bartelle/0000-0001-8582-3775				Caswell, 2000, MATRIX POPULATION MO; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Lockhart J.M., 2006, RECOVERY BLACK FOOTE, P6; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Wisely SM, 2005, ANIM CONSERV, V8, P321, DOI 10.1017/S1367943005002283; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231	6	28	31	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					779	779		10.1126/science.1144648	http://dx.doi.org/10.1126/science.1144648			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690288	Green Submitted			2022-12-28	WOS:000248624500032
J	Gunanathan, C; Ben-David, Y; Milstein, D				Gunanathan, Chidambaram; Ben-David, Yehoshoa; Milstein, David			Direct synthesis of amides from alcohols and amines with liberation of H-2	SCIENCE			English	Article							CATALYZED N-ALKYLATION; ELECTRON-RICH; RUTHENIUM COMPLEXES; NITRILES; LACTAMS; DEHYDROGENATION; CONVERSION; AMIDATION; ESTERS	Given the widespread importance of amides in biochemical and chemical systems, an efficient synthesis that avoids wasteful use of stoichiometric coupling reagents or corrosive acidic and basic media is highly desirable. We report a reaction in which primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only products) in high yields and high turnover numbers. This reaction is catalyzed by a ruthenium complex based on a dearomatized PNN-type ligand [where PNN is 2-(di-tert-butylphosphinomethyl)-6-(diethylaminomethyl) pyridine], and no base or acid promoters are required. Use of primary diamines in the reaction leads to bis-amides, whereas with a mixed primary-secondary amine substrate, chemoselective acylation of the primary amine group takes place. The proposed mechanism involves dehydrogenation of hemiaminal intermediates formed by the reaction of an aldehyde intermediate with the amine.	Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Milstein, D (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	david.milstein@weizmann.ac.il	Milstein, David/E-9092-2012; Chidambaram, Gunanathan/I-3528-2012	Milstein, David/0000-0002-2320-0262; 				Abbenhuis RATM, 1998, J ORG CHEM, V63, P4282, DOI 10.1021/jo972260d; Ben-Ari E, 2006, J AM CHEM SOC, V128, P15390, DOI 10.1021/ja066411i; Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133; Cassidy MP, 2006, ANGEW CHEM INT EDIT, V45, P3154, DOI 10.1002/anie.200503805; Chan WK, 2006, J AM CHEM SOC, V128, P14796, DOI 10.1021/ja064479s; Cho SH, 2005, J AM CHEM SOC, V127, P16046, DOI 10.1021/ja056399e; Cobley CJ, 2000, TETRAHEDRON LETT, V41, P2467, DOI 10.1016/S0040-4039(00)00181-7; Fujita K, 2004, ORG LETT, V6, P2785, DOI 10.1021/ol0489954; Greenberg A., 2000, AMIDE LINKAGE STRUCT; Hamid MHSA, 2007, CHEM COMMUN, P725, DOI 10.1039/b616859k; Hudlicky M., 1990, ACS MONOGR SER, V186; Larock R.C., 2018, COMPREHENSIVE ORGANI; MURAHASHI SI, 1992, J ORG CHEM, V57, P2521, DOI 10.1021/jo00035a003; MURAHASHI SI, 1986, J AM CHEM SOC, V108, P7846, DOI 10.1021/ja00284a066; NAOTA T, 1991, SYNLETT, P693; Owston NA, 2007, ORG LETT, V9, P73, DOI 10.1021/ol062549u; Rannard SP, 2000, ORG LETT, V2, P2117, DOI 10.1021/ol006020n; Sewald N., 2002, PEPTIDES CHEM BIOL; Smith M. B., 2001, COMPENDIUM ORGANIC S, V9, P100; TAMARU Y, 1983, SYNTHESIS-STUTTGART, P4474; Tillack A, 2001, EUR J ORG CHEM, V2001, P523; WATANABE Y, 1984, J ORG CHEM, V49, P3359, DOI 10.1021/jo00192a021; Zhang J, 2006, ANGEW CHEM INT EDIT, V45, P1113, DOI 10.1002/anie.200503771; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b; Zhang J, 2004, ORGANOMETALLICS, V23, P4026, DOI 10.1021/om049716j; Zhang J, 2007, DALTON T, P107, DOI 10.1039/b613438f	26	1045	1059	13	454	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					790	792		10.1126/science.1145295	http://dx.doi.org/10.1126/science.1145295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	198JN	17690291				2022-12-28	WOS:000248624500036
J	Kim, I; Saunders, TL; Morrison, SJ				Kim, Injune; Saunders, Thomas L.; Morrison, Sean J.			Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells	CELL			English	Article							LONG-TERM; DEFINITIVE HEMATOPOIESIS; BETA-CATENIN; C-MYB; GENE; LEUKEMIA; MOUSE; MAINTENANCE; ENDODERM; PROTEINS	Fetal stem cells differ phenotypically and functionally from adult stem cells in diverse tissues. However, little is known about how these differences are regulated. To address this we compared the gene expression profiles of fetal versus adult hematopoietic stem cells (HSCs) and discovered that the Sox17 transcriptional regulator is specifically expressed in fetal and neonatal but not adult HSCs. Germline deletion of Sox17 led to severe fetal hematopoietic defects, including a lack of detectable definitive HSCs. Conditional deletion of Sox17 from hematopoietic cells led to the loss of fetal and neonatal but not adult HSCs. HSCs stopped expressing Sox17 approximately 4 weeks after birth. During this transition, loss of Sox17 expression correlated with slower proliferation and the acquisition of an adult phenotype by individual HSCs. Sox17 is thus required for the maintenance of fetal and neonatal HSCs and distinguishes their transcriptional regulation from adult HSCs.	Univ Michigan, Dept Internal Med, Inst Life Sci, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Dept Internal Med, Inst Life Sci, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Kim, Injune/C-1710-2011	Kim, Injune/0000-0001-9244-815X; Saunders, Thom/0000-0003-2015-101X; Morrison, Sean/0000-0003-1587-8329	NCI NIH HHS [P30 CA046592, CA46592] Funding Source: Medline; NIAMS NIH HHS [AR20557, 1 P30 AR48310, P30 AR048310] Funding Source: Medline; NIA NIH HHS [R01 AG024945-03, R01 AG024945-04, R01 AG024945-02, R01 AG024945-01, R01 AG024945-05, R01 AG024945-03S1, R01 AG024945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557, P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Harrison DE, 1997, EXP HEMATOL, V25, P293; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kim JY, 2004, EUR J HAEMATOL, V73, P75, DOI 10.1111/j.1600-0609.2004.00268.x; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	60	309	322	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					470	483		10.1016/j.cell.2007.06.011	http://dx.doi.org/10.1016/j.cell.2007.06.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17655922	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000249038100015
J	Joly, P; Mouquet, H; Roujeau, J; D'Incan, M; Gilbert, D; Jacquot, S; Gougeon, M; Bedane, C; Muller, R; Dreno, B; Doutre, M; Delaporte, E; Pauwels, C; Franck, N; Caux, F; Picard, C; Tancrede-Bohin, E; Bernard, P; Tron, F; Hertl, M; Musette, P				Joly, Pascal; Mouquet, Hugo; Roujeau, Jean-Claude; D'Incan, Michel; Gilbert, Daniele; Jacquot, Serge; Gougeon, Marie-Lise; Bedane, Christophe; Muller, Ralf; Dreno, Brigitte; Doutre, Marie-Sylvie; Delaporte, Emmanuel; Pauwels, Christine; Franck, Nathalie; Caux, Frederic; Picard, Catherine; Tancrede-Bohin, Emmanuelle; Bernard, Philippe; Tron, Francois; Hertl, Michael; Musette, Philippe			A single cycle of rituximab for the treatment of severe pemphigus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Joint Meeting of the French-Society-of-Pediatric-Dermatology/French-Society-of-Dermatology/British-Society-of-Pediatric-Dermatology	JAN 12, 2006	Paris, FRANCE	French Soc Pediat Dermatol, French Soc Dermatol, British Soc Pediat Dermatol			MONOCLONAL ANTI-CD20 ANTIBODY; INTRAVENOUS IMMUNOGLOBULIN; ADJUVANT THERAPY; VULGARIS; AUTOANTIBODIES; DESMOGLEIN-3; REMISSION; INFECTION; FOLIACEUS; DISEASES	Background: The combination of multiple cycles of rituximab and intravenous immune globulins has been reported to be effective in patients with severe pemphigus. The aim of this study was to assess the efficacy of a single cycle of rituximab in severe types of pemphigus. Methods: We studied 21 patients with pemphigus whose disease had not responded to an 8-week course of 1.5 mg of prednisone per kilogram of body weight per day (corticosteroid-refractory disease), who had had at least two relapses despite doses of prednisone higher than 20 mg per day (corticosteroid-dependent disease), or who had severe contraindications to corticosteroids. The patients were treated with four weekly infusions of 375 mg of rituximab per square meter of body-surface area. The primary end point was complete remission 3 months after the end of rituximab treatment; complete remission was defined as epithelialization of all skin and mucosal lesions. Results: Eighteen of 21 patients (86%; 95% confidence interval, 64 to 97%) had a complete remission at 3 months. The disease relapsed in nine patients after a mean of 18.9+/-7.9 months. After a median follow-up of 34 months, 18 patients (86%) were free of disease, including 8 who were not receiving corticosteroids; the mean prednisone dose decreased from 94.0+/-10.2 to 12.0+/-7.5 mg per day (P=0.04) in patients with corticosteroid-refractory disease and from 29.1+/-12.4 to 10.9+/-16.5 mg per day (P=0.007) in patients with corticosteroid-dependent disease. Pyelonephritis developed in one patient 12 months after rituximab treatment, and one patient died of septicemia 18 months after rituximab treatment. These patients had a profound decrease in the number of circulating B lymphocytes but normal serum levels of IgG. Conclusions: A single cycle of rituximab is an effective treatment for pemphigus. Because of its potentially severe side effects, its use should be limited to the most severe types of the disease. (ClinicalTrials.gov number, NCT00213512.)	Rouen Univ Hosp, INSERM, Unite 519, Rouen, France; Hop Henri Mondor, F-94010 Creteil, France; Clermont Ferrand Univ Hosp, Clermont Ferrand, France; Inst Pasteur, Paris, France; Limoges Univ Hosp, Limoges, France; Nantes Univ Hosp, Nantes, France; Bordeaux Univ Hosp, Bordeaux, France; Lille Univ Hosp, Lille, France; Poissy St Germain Laye Intercommunal Hosp, St Germain En Laye, France; Univ Paris 05, Paris, France; Paris Univ Hosp 13, Bobigny, France; Hop Xavier Bichat, Paris, France; Paris Univ Hosp 10, Paris, France; Reims Univ Hosp, Reims, France; Univ Marburg, Fac Med, Marburg, Germany	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Clermont Ferrand; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Limoges; Nantes Universite; CHU de Nantes; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU de Reims; Philipps University Marburg	Joly, P (corresponding author), Hop Charles Nicolle, Dermatol Clin, 1 Rue Germont, F-76031 Rouen, France.	Pascal.Joly@chu-rouen.fr	Musette, Philippe/AAY-9916-2021; Mouquet, Hugo/M-2750-2014	Mouquet, Hugo/0000-0002-4230-610X; TANCREDE-BOHIN, Emmanuelle/0000-0002-0412-0806				Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; Ahmed AR, 2004, EXPERT OPIN INV DRUG, V13, P1019, DOI 10.1517/13543784.13.8.1019; Ahmed AR, 2003, ARCH DERMATOL, V139, P1051, DOI 10.1001/archderm.139.8.1051; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1999, BRIT J DERMATOL, V140, P351; Anzai H, 2004, J DERMATOL SCI, V35, P133, DOI 10.1016/j.jdermsci.2004.03.011; Arin MJ, 2005, BRIT J DERMATOL, V153, P620, DOI 10.1111/j.1365-2133.2005.06651.x; Arzoo K, 2002, ANN RHEUM DIS, V61, P922, DOI 10.1136/ard.61.10.922; BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479; Bermudez A, 2000, HAEMATOLOGICA, V85, P894; Bystryn JC, 1996, ARCH DERMATOL, V132, P203, DOI 10.1001/archderm.132.2.203; Dupuy A, 2004, ARCH DERMATOL, V140, P91, DOI 10.1001/archderm.140.1.91; El Tal AK, 2006, J AM ACAD DERMATOL, V55, P449, DOI 10.1016/j.jaad.2006.05.009; Espana A, 2004, J AM ACAD DERMATOL, V50, P974, DOI 10.1016/j.jaad.2003.08.021; Goebeler M, 2003, BRIT J DERMATOL, V149, P899, DOI 10.1046/j.1365-2133.2003.05580.x; Hacker MK, 2002, CLIN IMMUNOL, V105, P64, DOI 10.1006/clim.2002.5259; Herrmann G, 2003, BRIT J DERMATOL, V148, P602, DOI 10.1046/j.1365-2133.2003.05209_10.x; Hoyer BF, 2005, ANN NY ACAD SCI, V1050, P124, DOI 10.1196/annals.1313.014; Kazkaz H, 2004, CURR OPIN PHARMACOL, V4, P398, DOI 10.1016/j.coph.2004.03.006; Kong HH, 2005, PEDIATR DERMATOL, V22, P461, DOI 10.1111/j.1525-1470.2005.00118.x; Lehrnbecher T, 2001, KLIN PADIATR, V213, pA103, DOI 10.1055/s-2001-17506; LEVER WF, 1979, J AM ACAD DERMATOL, V1, P2, DOI 10.1016/S0190-9622(79)80050-X; Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849; LIM A, IN PRESS INT IMMUNOL; Maloney DG, 2002, SEMIN ONCOL, V29, P2, DOI 10.1053/sonc.2002.30156; MCDONALD CJ, 1985, J AM ACAD DERMATOL, V12, P753, DOI 10.1016/S0190-9622(85)70097-7; Morrison LH, 2004, J AM ACAD DERMATOL, V51, P817, DOI 10.1016/j.jaad.2004.06.007; Muller R, 2006, EXP DERMATOL, V15, P606, DOI 10.1111/j.1600-0625.2006.00451.x; Narat S, 2005, HAEMATOLOGICA, V90, P1273; Quartier P, 2003, CLIN INFECT DIS, V36, pE47, DOI 10.1086/345746; Schmidt E, 2005, BRIT J DERMATOL, V153, P449, DOI 10.1111/j.1365-2133.2005.06740.x; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Specks U, 2001, ARTHRITIS RHEUM, V44, P2836, DOI 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W; STANLEY JR, 1993, ADV IMMUNOL, V53, P291, DOI 10.1016/S0065-2776(08)60503-9; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Stasi R, 2002, BLOOD, V99, P3872, DOI 10.1182/blood-2002-02-0392; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; Wenzel Joerg, 2005, Acta Derm Venereol, V85, P185, DOI 10.1080/00015550410024111; Zaja F, 2002, ARTHRITIS RHEUM-US, V46, P2252, DOI 10.1002/art.10345	40	324	335	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					545	552		10.1056/NEJMoa067752	http://dx.doi.org/10.1056/NEJMoa067752			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	197VP	17687130	Bronze			2022-12-28	WOS:000248584900005
J	Lahaye, T; Koch, T; Frohlich, B; Fattori, M; Metz, J; Griesmaier, A; Giovanazzi, S; Pfau, T				Lahaye, Thierry; Koch, Tobias; Froehlich, Bernd; Fattori, Marco; Metz, Jonas; Griesmaier, Axel; Giovanazzi, Stefano; Pfau, Tilman			Strong dipolar effects in a quantum ferrofluid	NATURE			English	Article								Symmetry-breaking interactions have a crucial role in many areas of physics, ranging from classical ferrofluids to superfluid He-3 and d-wave superconductivity. For superfluid quantum gases, a variety of new physical phenomena arising from the symmetry-breaking interaction between electric or magnetic dipoles are expected(1). Novel quantum phases in optical lattices, such as chequerboard or supersolid phases, are predicted for dipolar bosons(2,3). Dipolar interactions can also enrich considerably the physics of quantum gases with internal degrees of freedom(4-6). Arrays of dipolar particles could be used for efficient quantum information processing(7). Here we report the realization of a chromium Bose-Einstein condensate with strong dipolar interactions. By using a Feshbach resonance, we reduce the usual isotropic contact interaction, such that the anisotropic magnetic dipole-dipole interaction between Cr-52 atoms becomes comparable in strength. This induces a change of the aspect ratio of the atom cloud; for strong dipolar interactions, the inversion of ellipticity during expansion (the usual 'smoking gun' evidence for a Bose-Einstein condensate) can be suppressed. These effects are accounted for by taking into account the dipolar interaction in the superfluid hydrodynamic equations governing the dynamics of the gas, in the same way as classical ferrofluids can be described by including dipolar terms in the classical hydrodynamic equations. Our results are a first step in the exploration of the unique properties of quantum ferrofluids.	Univ Stuttgart, Inst Phys 5, Pfaffenwaldring 57, D-70550 Stuttgart, Germany	University of Stuttgart	Lahaye, T (corresponding author), Univ Stuttgart, Inst Phys 5, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	t.lahaye@physik.uni-stuttgart.de; t.pfau@physik.uni-stuttgart.de	Pfau, Tilman/G-1774-2011; Griesmaier, Axel/E-8243-2010; Giovanazzi, Stefano/C-2158-2012; Griesmaier, Axel/ABC-5900-2020; Lahaye, Thierry/E-1551-2017	Pfau, Tilman/0000-0003-3272-3468; Lahaye, Thierry/0000-0002-2260-9859				Baranov M, 2002, PHYS SCRIPTA, VT102, P74, DOI 10.1238/Physica.Topical.102a00074; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Doyle J, 2004, EUR PHYS J D, V31, P149, DOI 10.1140/epjd/e2004-00151-x; Dutta O, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.053604; Giovanazzi S, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013621; Giovanazzi S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.130402; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; Goral K, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.051601; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Griesmaier A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.250402; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kawaguchi Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.080405; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Marinescu M, 1998, PHYS REV LETT, V81, P4596, DOI 10.1103/PhysRevLett.81.4596; Menotti C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.235301; Ospelkaus C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120402; Ronen S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030406; Santos L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190404; Santos L, 2000, PHYS REV LETT, V85, P1791, DOI 10.1103/PhysRevLett.85.1791; Santos L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.250403; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; Stenger J, 1999, PHYS REV LETT, V82, P2422, DOI 10.1103/PhysRevLett.82.2422; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; Werner J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183201; Yi S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.020401	25	388	391	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					672	+		10.1038/nature06036	http://dx.doi.org/10.1038/nature06036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687319	Green Submitted			2022-12-28	WOS:000248598000039
J	Okie, S				Okie, Susan			Immigrants and health care - At the intersection of two broken systems	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPENDITURES											Brown ER, 2007, UNDOCUMENTED RESIDEN; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1774; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1085, DOI 10.1001/jama.297.10.1085; Goldman DP, 2006, HEALTH AFFAIR, V25, P1700, DOI 10.1377/hlthaff.25.6.1700; Mohanty SA, 2005, AM J PUBLIC HEALTH, V95, P1431, DOI 10.2105/AJPH.2004.044602; PEAR R, 2007, NY TIMES        0130, pA1	6	86	86	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					525	529		10.1056/NEJMp078113	http://dx.doi.org/10.1056/NEJMp078113			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197VP	17687126				2022-12-28	WOS:000248584900001
J	Lee, GM; Santoli, JM; Hannan, C; Messonnier, ML; Sabin, JE; Rusinak, D; Gay, C; Lett, SM; Lieu, TA				Lee, Grace M.; Santoli, Jeanne M.; Hannan, Claire; Messonnier, Mark L.; Sabin, James E.; Rusinak, Donna; Gay, Charlene; Lett, Susan M.; Lieu, Tracy A.			Gaps in vaccine financing for underinsured children in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; IMPACT; PROGRAM	Context The number of new vaccines recommended for children and adolescents has nearly doubled during the past 5 years, and the cost of fully vaccinating a child has increased dramatically in the past decade. Anecdotal reports from state policy makers and clinicians suggest that new gaps have arisen in financial coverage of vaccines for children who are underinsured (ie, have private insurance that does not cover all recommended vaccines). In 2000, approximately 14% of children were underinsured for vaccines in the United States. Objectives To describe variation among states in the provision of new vaccines to underinsured children and to identify barriers to state purchase and distribution of new vaccines. Design, Setting, and Participants A 2-phase mixed-methods study of state immunization program managers in the United States. The first phase included 1-hour qualitative telephone interviews conducted from November to December 2005 with 9 program managers chosen to represent different state vaccine financing policies. The second phase incorporated findings from phase 1 to develop a national telephone and paper-based survey of state immunization program managers that was conducted from January to June 2006. Main Outcome Measures Percentage of states in which underinsured children are unable to receive publicly purchased vaccines in the private or public sectors. Results Immunization program managers from 48 states ( 96%) participated in the study. Underinsured children were not eligible to receive publicly purchased meningococcal conjugate or pneumococcal conjugate vaccines in the private sector in 70% and 50% of states, respectively, or in the public sector in 40% and 17% of states, respectively. Due to limited financing for new vaccines, 10 states changed their policies for provision of publicly purchased vaccines between 2004 and early 2006 to restrict access to selected new vaccines for underinsured children. The most commonly cited barriers to implementation in underinsured children were lack of sufficient federal and state funding to purchase vaccines. Conclusions The current vaccine financing system has resulted in gaps for underinsured children in the United States, many of whom are now unable to receive publicly purchased vaccines in either the private or public sectors. Additional strategies are needed to ensure financial coverage for all vaccines, particularly new vaccines, among this vulnerable population.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; Childrens Hosp Boston, Div Gen Pediat, Boston, MA USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; Assoc Immunizat Managers, Rockville, MD USA; Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health	Lee, GM (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	grace_lee@hphc.org			AHRQ HHS [K-08 HS013908-01 A1] Funding Source: Medline; NCIRD CDC HHS [1U01IP000029-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013908] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCIRD CDC HHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; ARNOLD PJ, 1992, AM J DIS CHILD, V146, P728, DOI 10.1001/archpedi.1992.02160180088023; Banthin JS, 2006, JAMA-J AM MED ASSOC, V296, P2712, DOI 10.1001/jama.296.22.2712; *CDCP, ENR PUBL PRIV HEALTH; *CDCP, VFC ACIP VFC VACC RE; *CDCP, VACC IMM PROGR TOOLS; Davis MM, 2003, PEDIATRICS, V112, P521, DOI 10.1542/peds.112.3.521; Davis MM, 2002, AM J PUBLIC HEALTH, V92, P1982, DOI 10.2105/AJPH.92.12.1982; Fairbrother G, 2000, AM J PREV MED, V19, P54, DOI 10.1016/S0749-3797(00)00207-5; Freed GL, 1999, ARCH PEDIAT ADOL MED, V153, P748, DOI 10.1001/archpedi.153.7.748; HIMMELSTEIN DU, 1995, AM J PUBLIC HEALTH, V85, P341, DOI 10.2105/AJPH.85.3.341; *KAIS FAM FDN, EMPL HLTH BEN 2006 S; Maciosek MV, 2006, AM J PREV MED, V31, P90, DOI 10.1016/j.amepre.2006.03.011; McInerny TK, 2007, PEDIATRICS, V119, P622, DOI 10.1542/peds.2006-3687; Miles M., 2013, QUALITATIVE DATA ANA; *QSR INT PTY LTD, 2002, NVIVO VERS 2 0 COMP; Santoli JM, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e15; Stokley S, 2006, AM J PUBLIC HEALTH, V96, P1308, DOI 10.2105/AJPH.2004.057810; 2004, FINANCING VACCINES 2	19	63	65	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					638	643		10.1001/jama.298.6.638	http://dx.doi.org/10.1001/jama.298.6.638			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197RS	17684186	Bronze			2022-12-28	WOS:000248574800024
J	Rubinstein, JL; Vidale, JE; Gomberg, J; Bodin, P; Creager, KC; Malone, SD				Rubinstein, Justin L.; Vidale, John E.; Gomberg, Joan; Bodin, Paul; Creager, Kenneth C.; Malone, Stephen D.			Non-volcanic tremor driven by large transient shear stresses	NATURE			English	Article							CASCADIA SUBDUCTION ZONE; LOW-FREQUENCY TREMORS; SOUTHWEST JAPAN; NORTHERN CASCADIA; EPISODIC TREMOR; EARTHQUAKES; SLIP; DENALI	Non-impulsive seismic radiation or 'tremor' has long been observed at volcanoes(1) and more recently around subduction zones(2). Although the number of observations of non-volcanic tremor is steadily increasing, the causative mechanism remains unclear. Some have attributed non-volcanic tremor to the movement of fluids(2-6), while its coincidence with geodetically observed slow-slip events at regular intervals(7,8) has led others to consider slip on the plate interface as its cause(7-14). Low-frequency earthquakes in Japan, which are believed to make up at least part of non-volcanic tremor(9), have focal mechanisms(10) and locations(11) that are consistent with tremor being generated by shear slip on the subduction interface. In Cascadia, however, tremor locations appear to be more distributed in depth than in Japan(3,4), making them harder to reconcile with a plate interface shear-slip model. Here we identify bursts of tremor that radiated from the Cascadia subduction zone near Vancouver Island, Canada, during the strongest shaking from the moment magnitude M-w=7.8, 2002 Denali, Alaska, earthquake. Tremor occurs when the Love wave displacements are to the southwest (the direction of plate convergence of the overriding plate), implying that the Love waves trigger the tremor. We show that these displacements correspond to shear stresses of approximately 40 kPa on the plate interface, which suggests that the effective stress on the plate interface is very low. These observations indicate that tremor and possibly slow slip can be instantaneously induced by shear stress increases on the subduction interface-effectively a frictional failure response to the driving stress.	Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Washington, US Geol Survey, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Rubinstein, JL (corresponding author), Univ Washington, Dept Earth & Space Sci, Box 351310, Seattle, WA 98195 USA.	justin@ess.washington.edu	Vidale, John/H-4965-2011	Vidale, John/0000-0002-3658-818X; Rubinstein, Justin/0000-0003-1274-6785				Brodsky EE, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003211; Dragert H, 2004, EARTH PLANETS SPACE, V56, P1143, DOI 10.1186/BF03353333; Gomberg J, 2001, NATURE, V411, P462, DOI 10.1038/35078053; Gomberg J, 2004, NATURE, V427, P621, DOI 10.1038/nature02335; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kao H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028430; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; LIU Y, UNPUB J GEOPHYS RES; Mazzotti S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002653; McCausland W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024349; McNutt SR, 2005, ANNU REV EARTH PL SC, V33, P461, DOI 10.1146/annurev.earth.33.092203.122459; Miyazawa M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025087; Miyazawa M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022539; MIYAZAWA M, UNPUB J GEOPHYS RES; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2003, J GEOGR, V112, P837; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Royle GT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027316; Seno T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018349; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Tsuboi S, 2003, PHYS EARTH PLANET IN, V139, P305, DOI 10.1016/j.pepi.2003.09.012	26	183	185	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					579	582		10.1038/nature06017	http://dx.doi.org/10.1038/nature06017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671500				2022-12-28	WOS:000248446700040
J	Milinski, M; Rockenbach, B				Milinski, Manfred; Rockenbach, Bettina			Spying on others evolves	SCIENCE			English	Editorial Material							REGARDING BEHAVIOR; SOCIAL DISTANCE; DICTATOR GAMES; FISH; COOPERATION; BIRDS; CUES; EYE		Max Planck Inst Evolut Biol, Dept Evolut Ecol, D-24306 Plon, Germany; Univ Erfurt, Dept Econ, D-99089 Erfurt, Germany	Max Planck Society; University of Erfurt	Milinski, M (corresponding author), Max Planck Inst Evolut Biol, Dept Evolut Ecol, D-24306 Plon, Germany.	milinski@mpil-ploen.mpg.de; bettina.rockenbach@uni-erfurt.de	Rockenbach, Bettina/AAI-8072-2021; Rockenbach, Bettina/B-5447-2016	Rockenbach, Bettina/0000-0003-2624-1964; Rockenbach, Bettina/0000-0003-2624-1964				Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bohnet I, 1999, AM ECON REV, V89, P335, DOI 10.1257/aer.89.1.335; Bshary R, 2002, P ROY SOC B-BIOL SCI, V269, P2087, DOI 10.1098/rspb.2002.2084; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; GAVISH L, 1981, Z TIERPSYCHOL, V56, P193; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hoffman E, 1996, AM ECON REV, V86, P653; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; SCAIFE M, 1976, ANIM BEHAV, V24, P200, DOI 10.1016/S0003-3472(76)80116-9; Whitfield J, 2002, NATURE, V419, P242, DOI 10.1038/419242a	15	29	30	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					464	465		10.1126/science.1143918	http://dx.doi.org/10.1126/science.1143918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656712				2022-12-28	WOS:000248339800030
J	Kelly, PN; Dakic, A; Adams, JM; Nutt, SL; Strasser, A				Kelly, Priscilla N.; Dakic, Aleksandar; Adams, Jerry M.; Nutt, Stephen L.; Strasser, Andreas			Tumor growth need not be driven by rare cancer stem cells	SCIENCE			English	Article							IDENTIFICATION		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Dakic, Aleksandar/B-8290-2013; Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013	Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637; Adams, Jerry/0000-0002-4360-8628				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128	6	624	671	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					337	337		10.1126/science.1142596	http://dx.doi.org/10.1126/science.1142596			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641192				2022-12-28	WOS:000248150200036
J	Bolen, S; Feldman, L; Vassy, J; Wilson, L; Yeh, HC; Marinopoulos, S; Wiley, C; Selvin, E; Wilson, R; Bass, EB; Brancati, FL				Bolen, Shari; Feldman, Leonard; Vassy, Jason; Wilson, Lisa; Yeh, Hsin-Chieh; Marinopoulos, Spyriclon; Wiley, Crystal; Selvin, Elizabeth; Wilson, Renee; Bass, Eric B.; Brancati, Frederick L.			Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							GLYCEMIC CONTROL; MICROVASCULAR COMPLICATIONS; LACTIC-ACIDOSIS; METAANALYSIS; REPAGLINIDE; ROSIGLITAZONE; GLYBURIDE; RISK; THIAZOLIDINEDIONES; METFORMIN	Background: As newer oral diabetes agents continue to emerge on the market, comparative evidence is urgently required to guide appropriate therapy. Purpose: To summarize the English-language literature on the benefits and harms of oral agents (second-generation sulfonylureas, biguanides, thiazolidinediones, meglitinides, and a-glucosidase inhibitors) in the treatment of adults with type 2 diabetes mellitus. Data Sources: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched from inception through January 2006 for original articles and through November 2005 for systematic reviews. Unpublished U.S. Food and Drug Administration and industry data were also searched. Study Selection: 216 controlled trials and cohort studies and 2 systematic reviews that addressed benefits and harms of oral diabetes drug classes available in the United States. Data Extraction: Using standardized protocols, 2 reviewers serially abstracted data for each article. Data Synthesis: Evidence from clinical trials was inconclusive on major clinical end points, such as cardiovascular mortality, Therefore, the review was limited mainly to studies of intermediate end points. Most oral agents (thiazolidinediones, metformin, and repaglinide) improved glycemic control to the same degree as sulfonylureas (absolute decrease in hemoglobin A(1c) level of about 1 percentage point). Nateglinide and alpha-glucosidase inhibitors may have slightly weaker effects, on the basis of indirect comparisons of placebo-controlled trials. Thiazoliclinediones were the only class that had a beneficial effect on high-density lipoprotein cholesterol levels (mean relative increase, 0.08 to 0.13 mmol/L [3 to 5 mg/dL] but a harmful effect on low-density lipoprotein (LDL) cholesterol levels (mean relative increase, 0.26 mmol/L [10 mg/dL]) compared with other oral agents. Metformin decreased LDL cholesterol levels by about 0.26 mmol/L (10 mg/dL), whereas other oral agents had no obvious effects on LDL cholesterol levels. Most agents other than metformin increased body weight by 1 to 5 kg. Sulfonylureas and repaglinide were associated with greater risk for hypoglycemia, thiazolidinediones with greater risk for heart failure, and metformin with greater risk for gastrointestinal problems compared with other oral agents, Lactic acidosis was no more common in metformin recipients without comorbid conditions than in recipients of other oral diabetes agents. Limitations: Data on major clinical end points were limited. Studies inconsistently reported adverse events other than hypoglycennia, and definitions of adverse events varied across studies. Some harms not assessed in trials or observational studies may have been overlooked. Conclusions: Compared with newer, more expensive agents (thiazolidinediones, a-glucosidase inhibitors, and meglitinides), older agents (second-generation sulfonylureas and metformin) have similar or superior effects on glycemic control, lipids, and other intermediate end points. Large, long-term comparative studies are needed to determine the comparative effects of oral diabetes agents on hard clinical end points.	Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, John Hopkins Bloomberg Sch Publ Hlth, Evidence Based Practice Ctr, Baltimore, MD USA; Washington Univ, Sch Med, St Louis, MO USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL)	Bolen, S (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600,Rm 2-615, Baltimore, MD 21205 USA.	sgolden4@jhmi.edu	Vassy, Jason L./AAC-8220-2019; Marinopoulos, Spyridon/C-4541-2008	Feldman, Leonard/0000-0002-4444-6624; Bass, Eric/0000-0001-9106-527X; Vassy, Jason/0000-0001-6113-5564	NIDDK NIH HHS [5 K24 DK062222-05, K01 DK076595, K01 DK076595-01] Funding Source: Medline; PHS HHS [290-02-0018] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062222, K01DK076595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM ASS CLIN END A, 2007, AM ASS CLIN END MED; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bolen S, 2007, AHRQ PUBLICATION; Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659; Buse JB, 2004, DIABETES OBES METAB, V6, P133, DOI 10.1111/j.1462-8902.2004.00325.x; CHANDLER C, 2005, DRUG CLASS REV ORAL; Chilcott J, 2001, CLIN THER, V23, P1792, DOI 10.1016/S0149-2918(00)80078-8; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB, P56; Damsbo P, 1999, DIABETES CARE, V22, P789, DOI 10.2337/diacare.22.5.789; Deeks J J, 2003, Health Technol Assess, V7, piii; Derosa G, 2003, CLIN THER, V25, P472, DOI 10.1016/S0149-2918(03)80090-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Gaster B, 1998, ARCH INTERN MED, V158, P134, DOI 10.1001/archinte.158.2.134; *GLAXOSMITHKLINE, 2005, COMMUNICATION; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Marbury T, 1999, DIABETES RES CLIN PR, V43, P155, DOI 10.1016/S0168-8227(99)00002-9; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; NORRIS SL, 2006, DRUG CLASS REV THIAZ; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Papa G, 2006, DIABETES CARE, V29, P1918, DOI 10.2337/dc05-2495; Pitale SU, 2000, DIABETES CARE, V23, P1316, DOI 10.2337/diacare.23.9.1316; Qayyum Rehan, 2006, J Clin Hypertens (Greenwich), V8, P19, DOI 10.1111/j.1524-6175.2005.04784.x; Saenz A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002966.pub3; SALPETER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002967.PUB2; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1985, DIABETES, V34, P793; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; van Wijk JPH, 2003, ARTERIOSCL THROM VAS, V23, P1744, DOI 10.1161/01.ATV.0000090521.25968.4D; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; *WHO, 2007, DIAB PROGR FACTS FIG; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x	45	567	599	4	95	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					386	399		10.7326/0003-4819-147-6-200709180-00178	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00178			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17638715				2022-12-28	WOS:000249726200004
J	Baena-Gonzalez, E; Rolland, F; Thevelein, JM; Sheen, J				Baena-Gonzalez, Elena; Rolland, Filip; Thevelein, Johan M.; Sheen, Jen			A central integrator of transcription networks in plant stress and energy signalling	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; NITRATE REDUCTASE; SUCROSE; TRANSDUCTION; IDENTIFICATION; PATHWAYS; LEAVES; METABOLISM	Photosynthetic plants are the principal solar energy converter sustaining life on Earth. Despite its fundamental importance, little is known about how plants sense and adapt to darkness in the daily light-dark cycle, or how they adapt to unpredictable environmental stresses that compromise photosynthesis and respiration and deplete energy supplies. Current models emphasize diverse stress perception and signalling mechanisms(1,2). Using a combination of cellular and systems screens, we show here that the evolutionarily conserved Arabidopsis thaliana protein kinases, KIN10 and KIN11 (also known as AKIN10/At3g01090 and AKIN11/At3g29160, respectively), control convergent reprogramming of transcription in response to seemingly unrelated darkness, sugar and stress conditions. Sensing and signalling deprivation of sugar and energy, KIN10 targets a remarkably broad array of genes that orchestrate transcription networks, promote catabolism and suppress anabolism. Specific bZIP transcription factors partially mediate primary KIN10 signalling. Transgenic KIN10 overexpression confers enhanced starvation tolerance and lifespan extension, and alters architecture and developmental transitions. Significantly, double kin10 kin11 deficiency abrogates the transcriptional switch in darkness and stress signalling, and impairs starch mobilization at night and growth. These studies uncover surprisingly pivotal roles of KIN10/11 in linking stress, sugar and developmental signals to globally regulate plant metabolism, energy balance, growth and survival. In contrast to the prevailing view that sucrose activates plant SnRK1s (Snf1-related protein kinases)(3-6), our functional analyses of Arabidopsis KIN10/11 provide compelling evidence that SnRK1s are inactivated by sugars and share central roles with the orthologous yeast Snf1 and mammalian AMPK in energy signalling.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven	Rolland, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	baena@molbio.mgh.harvard.edu; filip.rolland@bio.kuleuven.be	Baena-González, Elena/G-5811-2013; Baena-González, Elena/AAI-4051-2020; Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Baena-González, Elena/0000-0001-6598-3579; Baena-González, Elena/0000-0001-6598-3579; Thevelein, Johan M./0000-0002-2626-0180; Rolland, Filip/0000-0003-2601-0752				Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cheng SH, 2001, FEBS LETT, V503, P185, DOI 10.1016/S0014-5793(01)02732-6; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gonzali S, 2005, ANN BOT-LONDON, V96, P661, DOI 10.1093/aob/mci218; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huang JZ, 2001, PLANT CELL PHYSIOL, V42, P1079, DOI 10.1093/pcp/pce137; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Radchuk R, 2006, PLANT PHYSIOL, V140, P263, DOI 10.1104/pp.105.071167; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Thelander M, 2004, EMBO J, V23, P1900, DOI 10.1038/sj.emboj.7600182; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang YH, 2001, PLANT J, V28, P431, DOI 10.1046/j.1365-313X.2001.01167.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	45	982	1026	21	365	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2007	448	7156					938	U10		10.1038/nature06069	http://dx.doi.org/10.1038/nature06069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17671505				2022-12-28	WOS:000248912900049
J	Surani, A; Smith, J				Surani, Azim; Smith, Jim			Anne McLaren (1927-2007) - Obituary	NATURE			English	Biographical-Item									Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England		Surani, A (corresponding author), Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jim@gurdon.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Medical Research Council [G0300723B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					764	765		10.1038/448764a	http://dx.doi.org/10.1038/448764a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700691				2022-12-28	WOS:000248754200029
J	Kuhl, CK; Schrading, S; Bieling, HB; Wardelmann, E; Leutner, CC; Koenig, R; Kuhn, W; Schild, HH				Kuhl, Christiane K.; Schrading, Simone; Bieling, Heribert B.; Wardelmann, Eva; Leutner, Claudia C.; Koenig, Roy; Kuhn, Walther; Schild, Hans H.			MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study	LANCET			English	Article							DIFFERENT GENETIC PATHWAYS; HIGH FAMILIAL RISK; BREAST-CANCER; MAMMOGRAPHY; WOMEN; LESIONS; CLASSIFICATION; EVOLUTION; STANDARDIZATION; SURVEILLANCE	Background Diagnosing breast cancer in its intraductal stage might be helpful to prevent the development of invasive cancer. Our aim was to investigate the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI. Methods During a 5-year period, 7319 women who were referred to an academic national breast Centre received MRI in addition to mammography for diagnostic assessment and screening. Mammograms and breast MRI studies were assessed independently by different radiologists. We investigated the sensitivity of each method of detection and compared the biological profiles of mammography-diagnosed DCIS versus DCIS detected by MRI alone. We also compared the risk profiles of women with mammography-detected DCIS with those of MRI-detected DCIS. Findings 193 women received a final surgical pathology diagnosis of pure DCIS. Of those, 167 had undergone both imaging tests preoperatively. 93 (56%) of these cases were diagnosed by mammography and 153 (92%) by MRI (p<0.0001). Of the 89 high-grade DCIS, 43 (48%) were missed by mammography, but diagnosed by MRI alone; all 43 cases missed by mammography were detected by MRI. By contrast, MRI detected 87 (98%) of these lesions; the two cases missed by MRI were detected by mammography. Age, menopausal status, personal or family history of breast cancer or of benign breast disease, and breast density of women with MRI-only diagnosed DCIS did not differ significantly from those of women with mammography-diagnosed DCIS. Interpretation MRI could help improve the ability to diagnose DCIS, especially DICIS with high nuclear grade.	Univ Bonn, Dept Radiol, D-53105 Bonn, Germany; Univ Bonn, Dept Pathol, D-53105 Bonn, Germany; Univ Bonn, Dept Gynaecol Oncol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Kuhl, CK (corresponding author), Univ Bonn, Dept Radiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	kuhl@uni-bonn.de	Kuhl, Christiane K/H-3301-2013; Schrading, Simone/ABI-3051-2020	Kuhl, Christiane K/0000-0001-8696-2363; 				ACR, 2003, ACR BREAST IM REP DA, V5; Alexander F E, 1997, J Med Screen, V4, P152; ALLRED DC, 1994, BREAST CANCER RES TR, V32, P13, DOI 10.1007/BF00666202; American College of Radiology, ACR APPR CRIT BREAST; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Boetes C, 1997, EUR RADIOL, V7, P1231, DOI 10.1007/s003300050281; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B; Douglas-Jones A, 2005, HISTOPATHOLOGY, V47, P202, DOI 10.1111/j.1365-2559.2005.02208.x; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Esserman LJ, 2006, J CLIN ONCOL, V24, P4603, DOI 10.1200/JCO.2005.04.5518; Evans A, 2003, BREAST CANCER RES, V5, P250, DOI 10.1186/bcr621; Farabegoli F, 2002, J PATHOL, V196, P280, DOI 10.1002/path.1048; Fischer U, 1996, ROFO FORTSCHR RONTG, V164, P290, DOI 10.1055/s-2007-1015657; Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y; Furman-Haran E, 2005, CANCER-AM CANCER SOC, V104, P708, DOI 10.1002/cncr.21225; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P167; Ikeda DM, 2001, J MAGN RESON IMAGING, V13, P889, DOI 10.1002/jmri.1127; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Kuhl CK, 2000, EUR RADIOL, V10, P46, DOI 10.1007/s003300050006; LAGIOS MD, 1995, CANCER LETT, V90, P97, DOI 10.1016/0304-3835(94)03683-A; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; May DS, 1998, AM J ROENTGENOL, V170, P97, DOI 10.2214/ajr.170.1.9423608; Menell JH, 2005, BREAST J, V11, P382, DOI 10.1111/j.1075-122X.2005.00121.x; Morakkabati-Spitz N, 2005, EUR RADIOL, V15, P2010, DOI 10.1007/s00330-005-2755-4; Morrow M, 2004, J NATL CANCER I, V96, P424, DOI 10.1093/jnci/djh088; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; Orel SG, 1997, RADIOLOGY, V202, P413, DOI 10.1148/radiology.202.2.9015067; OTTINETTI A, 1988, BREAST CANCER RES TR, V11, P241, DOI 10.1007/BF01807282; REMMELE W, 1987, PATHOLOGE, V8, P138; ROSNER D, 1980, ANN SURG, V192, P139, DOI 10.1097/00000658-198008000-00001; Roylance R, 2002, J PATHOL, V196, P32, DOI 10.1002/path.1006; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schnitt SJ, 1997, HUM PATHOL, V28, P877, DOI 10.1016/S0046-8177(97)90000-9; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; SILVERSTEIN MJ, 1995, LANCET, V345, P1154	44	491	522	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					485	492		10.1016/S0140-6736(07)61232-X	http://dx.doi.org/10.1016/S0140-6736(07)61232-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693177				2022-12-28	WOS:000248717800027
J	Smith, DM; Cusack, S; Colman, AW; Folland, CK; Harris, GR; Murphy, JM				Smith, Doug M.; Cusack, Stephen; Colman, Andrew W.; Folland, Chris K.; Harris, Glen R.; Murphy, James M.			Improved surface temperature prediction for the coming decade from a global climate model	SCIENCE			English	Article							THERMOHALINE CIRCULATION; PREDICTABILITY; ENSEMBLE; SKILL	Previous climate model projections of climate change accounted for external forcing from natural and anthropogenic sources but did not attempt to predict internally generated natural variability. We present a new modeling system that predicts both internal variability and externally forced changes and hence forecasts surface temperature with substantially improved skill throughout a decade, both globally and in many regions. Our system predicts that internal variability will partially offset the anthropogenic global warming signal for the next few years. However, climate will continue to warm, with at least half of the years after 2009 predicted to exceed the warmest year currently on record.	Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre	Smith, DM (corresponding author), Hadley Ctr, Met Off, Fitzroy Rd, Exeter EX1 3PB, Devon, England.	doug.smith@metoffice.gov.uk	Folland, Chris K/I-2524-2013; Smith, Doug/ABD-5204-2021; Harris, Glen/J-5326-2013	Folland, Chris K/0000-0002-3143-5918; 				Boer GJ, 2004, CLIM DYNAM, V23, P29, DOI 10.1007/s00382-004-0419-8; Collins M, 2002, J CLIMATE, V15, P3104, DOI 10.1175/1520-0442(2002)015<3104:ATRROI>2.0.CO;2; Collins M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016504; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; Folland CK, 2001, GEOPHYS RES LETT, V28, P2621, DOI 10.1029/2001GL012877; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Griffies SM, 1997, SCIENCE, V275, P181, DOI 10.1126/science.275.5297.181; Grotzner A, 1999, J CLIMATE, V12, P2607, DOI 10.1175/1520-0442(1999)012<2607:ITDPIA>2.0.CO;2; Harris GR, 2006, CLIM DYNAM, V27, P357, DOI 10.1007/s00382-006-0142-8; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; Lee TCK, 2006, J CLIMATE, V19, P5305, DOI 10.1175/JCLI3912.1; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Palmer TN, 2004, B AM METEOROL SOC, V85, P853, DOI 10.1175/BAMS-85-6-853; Parker DE, 1996, INT J CLIMATOL, V16, P487, DOI 10.1002/(SICI)1097-0088(199605)16:5<487::AID-JOC39>3.0.CO;2-J; Parks D, 2004, CYTOM PART A, V59A, P145; Pohlmann H, 2004, J CLIMATE, V17, P4463, DOI 10.1175/3209.1; POWER SB, 2005, PUBLICATION INT ASS, V301; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; Smith DM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2005JC003172; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Wilson S, 2000, OCEANUS, V42, P17; Zwiers FW, 2002, NATURE, V416, P690, DOI 10.1038/416690a	28	555	575	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					796	799		10.1126/science.1139540	http://dx.doi.org/10.1126/science.1139540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690292				2022-12-28	WOS:000248624500038
J	Cole, AJ; Henson, JW; Roehrl, MHA; Frosch, MP; Harris, NL; Cort, AM				Cole, Andrew J.; Henson, John W.; Roehrl, Michael H. A.; Frosch, Matthew P.; Harris, Nancy Lee; Cort, Alice M.			A 20-year-old pregnant woman with altered mental status - Subacute sclerosing panencephalitis secondary to measles virus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENTRICULAR ALPHA-INTERFERON; CENTRAL NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; ONSET; DISEASE; CSF; ISOPRINOSINE; RUBELLA; PROFILE; COMMON		Massachusetts Gen Hosp, Serv Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Cole, AJ (corresponding author), Massachusetts Gen Hosp, Serv Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021; Roehrl, Michael/AAU-8506-2020	Frosch, Matthew P/0000-0002-3940-9861; Roehrl, Michael/0000-0003-4892-1098				ALEISSA A, 1993, BRIT J CLIN PRACT, V47, P14; Anlar B, 1997, NEUROLOGY, V48, P526, DOI 10.1212/WNL.48.2.526; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Fishman RA., 1992, CEREBROSPINAL FLUID; Gagnon A, 2003, ARCH NEUROL-CHICAGO, V60, P1160, DOI 10.1001/archneur.60.8.1160; GASCON G, 1993, BRAIN DEV-JPN, V15, P346, DOI 10.1016/0387-7604(93)90120-W; Gascon GG, 1998, NEW ENGL J MED, V338, P1448, DOI 10.1056/NEJM199805143382008; Gokcil Z, 1999, J NEUROL SCI, V162, P62, DOI 10.1016/S0022-510X(98)00302-5; HIRANO A, 1993, J VIROL, V67, P1848, DOI 10.1128/JVI.67.4.1848-1853.1993; Honarmand S, 2004, NEUROLOGY, V63, P1489, DOI 10.1212/01.WNL.0000142090.62214.61; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673; NORRBY E, 1975, MED MICROBIOL IMMUN, V162, P63, DOI 10.1007/BF02123578; PANITCH HS, 1986, NEUROLOGY, V36, P562, DOI 10.1212/WNL.36.4.562; Prashanth LK, 2006, J NEUROL NEUROSUR PS, V77, P630, DOI 10.1136/jnnp.2005.085829; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; REIBER H, 1980, J NEUROL, V224, P89, DOI 10.1007/BF00313347; STEINER I, 1989, J CHILD NEUROL, V4, P20, DOI 10.1177/088307388900400103; SWOVELAND PT, 1989, VIRAL DIS, P417; THOMPSON EJ, 1983, J CLIN PATHOL, V36, P312, DOI 10.1136/jcp.36.3.312; TOWNSEND JJ, 1975, NEW ENGL J MED, V292, P990, DOI 10.1056/NEJM197505082921902; UEDA S, 1975, BIKEN J, V18, P113; WEIL ML, 1975, NEW ENGL J MED, V292, P994, DOI 10.1056/NEJM197505082921903; WIRGUIN I, 1988, ARCH NEUROL-CHICAGO, V45, P1324, DOI 10.1001/archneur.1988.00520360042009; WOLINSKY JS, 1989, VIRAL DIS, P405; YALAZ K, 1992, NEUROLOGY, V42, P488, DOI 10.1212/WNL.42.3.488; ZAKI SR, 1997, PATHOLOGY INFECT DIS, P233	29	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					589	600		10.1056/NEJMcpc079018	http://dx.doi.org/10.1056/NEJMcpc079018			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687135				2022-12-28	WOS:000248584900012
J	Lan, F; Collins, RE; De Cegli, R; Alpatov, R; Horton, JR; Shi, XB; Gozani, O; Cheng, XD; Shi, Y				Lan, Fei; Collins, Robert E.; De Cegli, Rossella; Alpatov, Roman; Horton, John R.; Shi, Xiaobing; Gozani, Or; Cheng, Xiaodong; Shi, Yang			Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression	NATURE			English	Article							PHD FINGER; MOLECULAR-BASIS; METHYLATION; CHROMODOMAINS; BINDING; DNMT3L; DOMAIN; DEMETHYLATION; IMPRINTS; H3K4ME3	Histone methylation is crucial for regulating chromatin structure, gene transcription and the epigenetic state of the cell. LSD1 is a lysine-specific histone demethylase that represses transcription by demethylating histone H3 on lysine 4 (ref. 1). The LSD1 complex contains a number of proteins, all of which have been assigned roles in events upstream of LSD1-mediated demethylation(2-4) apart from BHC80 (also known as PHF21A), a plant homeodomain (PHD) finger-containing protein. Here we report that, in contrast to the PHD fingers of the bromodomain PHD finger transcription factor (BPTF) and inhibitor of growth family 2 (ING2), which bind methylated H3K4 (H3K4me3)(5,6), the PHD finger of BHC80 binds unmethylated H3K4 (H3K4me0), and this interaction is specifically abrogated by methylation of H3K4. The crystal structure of the PHD finger of BHC80 bound to an unmodified H3 peptide has revealed the structural basis of the recognition of H3K4me0. Knockdown of BHC80 by RNA inhibition results in the de-repression of LSD1 target genes, and this repression is restored by the reintroduction of wild-type BHC80 but not by a PHD-finger mutant that cannot bind H3. Chromatin immunoprecipitation showed that BHC80 and LSD1 depend reciprocally on one another to associate with chromatin. These findings couple the function of BHC80 to that of LSD1, and indicate that unmodified H3K4 is part of the 'histone code'(7). They further raise the possibility that the generation and recognition of the unmodified state on histone tails in general might be just as crucial as post-translational modifications of histone for chromatin and transcriptional regulation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy	Harvard University; Harvard Medical School; Emory University; Stanford University; University of Naples Federico II	Cheng, XD (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	xcheng@emory.edu; yshi@hms.harvard.edu	Horton, John/F-2375-2010; Gozani, Or P/I-6157-2013; Horton, John R/ABB-4770-2020; De Cegli, Rossella/ABA-4372-2020	Gozani, Or/0000-0002-1365-4463; Horton, John/0000-0001-9749-8068; Shi, Xiaobing/0000-0001-5242-8189; Collins, Robert/0000-0002-4580-5991; De Cegli, Rossella/0000-0002-8526-8692	NIGMS NIH HHS [R01 GM068680, R01 GM068680-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hata K, 2002, DEVELOPMENT, V129, P1983; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui G, 2005, METH MOL B, V309, P205; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	34	322	356	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					718	U14		10.1038/nature06034	http://dx.doi.org/10.1038/nature06034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687328	Green Accepted			2022-12-28	WOS:000248598000050
J	Bosch, X; Guilabert, A; Espinosa, G; Mirapeix, E				Bosch, Xavier; Guilabert, Antonio; Espinosa, Gerard; Mirapeix, Eduard			Treatment of Antineutrophil cytoplasmic antibody-associated vasculitis - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; PULSE CYCLOPHOSPHAMIDE THERAPY; REFRACTORY WEGENERS-GRANULOMATOSIS; PLASMA-EXCHANGE TREATMENT; POLYARTERITIS-NODOSA; MICROSCOPIC POLYANGIITIS; RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; TRIMETHOPRIM-SULFAMETHOXAZOLE	Context Immunosuppressive therapies for antineutrophil cytoplasmic antibody ( ANCA) associated vasculitis have greatly advanced patient survival but have turned ANCA-associated vasculitis (AAV) into chronic, relapsing disorders. Long-term treatment and disease-related morbidity are major threats. The last decade has seen a collaborative international effort to determine effective treatment. Objective To analyze the reported evidence on AAV therapy in order to provide physicians with a rational approach for dealing with various clinical scenarios. Data Sources We searched English-language articles on the medical treatment of AAV published between 1966 and March 2007 using MEDLINE. Articles from the reference lists of the most relevant articles retrieved were also analyzed. Study Selection Studies of current available drug treatments or medical interventions for patients with AAV were included. Duplicate publications, case reports, and uncontrolled trials and series including fewer than 10 patients were excluded. Data Synthesis We included 2 meta-analyses, 20 randomized controlled prospective trials, and 62 uncontrolled trials with more than 10 patients or observational studies. Outcome measures and treatment protocols were heterogeneous across trials. Cotrimoxazole can be used alone or in combination with corticosteroids to induce and maintain remission in cases of isolated upper respiratory tract involvement. To induce remission, methotrexate plus corticosteroids can be used instead of cyclophosphamide for patients with generalized, non-organ-threatening disease. When methotrexate is used as maintenance therapy, the likelihood of relapse is high and rigorous monitoring is mandatory. Pulse cyclophosphamide with corticosteroids can be used to induce remission in patients with generalized organ-threatening disease. The combination of azathioprine and daily prednisone is effective in maintaining remission. Plasma exchange is at present the best complement to immunosuppressants in advanced renal disease. In Churg-Strauss syndrome, treatment can be started with high doses of corticosteroids, tapering them when the clinical situation improves. In patients with a high risk of death, cyclophosphamide should be introduced. Conclusions Although AAV therapies should be tailored to the patient's specific clinical situation, evidence for treatment of several disease states is lacking. There is a need for safer and more effective drugs.	Univ Barcelona, Hosp Clin, IDIBAPS, Dept Internal Med, E-08036 Barcelona, Spain; Univ Barcelona, Hosp Clin, IDIBAPS, Dept Dermatol, E-08036 Barcelona, Spain; Univ Barcelona, Hosp Clin, IDIBAPS, Dept Autoimmune Dis, E-08036 Barcelona, Spain; Univ Barcelona, Hosp Clin, IDIBAPS, Dept Nephrol, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, IDIBAPS, Dept Internal Med, Villarroel 170, E-08036 Barcelona, Spain.	xavbosch@clinic.ub.es	Espinosa, Gerard/J-2603-2016; Espinosa, Gerard/AAV-2751-2020	Espinosa, Gerard/0000-0003-1336-0163; Espinosa, Gerard/0000-0003-1336-0163; Guilabert, Antonio/0000-0002-3520-2169				Aasarod K, 2002, BLOOD PURIFICAT, V20, P167, DOI 10.1159/000047004; Adu D, 1997, QJM-MON J ASSOC PHYS, V90, P401, DOI 10.1093/qjmed/90.6.401; Birck R, 2003, J AM SOC NEPHROL, V14, P440, DOI 10.1097/01.ASN.0000048716.42876.14; Boki KA, 1997, BRIT J RHEUMATOL, V36, P1059; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Booth A, 2004, J AM SOC NEPHROL, V15, P717, DOI 10.1097/01.ASN.0000114554.67106.28; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Bosch X, 1999, ANN RHEUM DIS, V58, P644, DOI 10.1136/ard.58.10.644; Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Bourgarit A, 2005, MEDICINE, V84, P323, DOI 10.1097/01.md.0000180793.80212.17; BRANDWEIN S, 1983, ARCH INTERN MED, V143, P476, DOI 10.1001/archinte.143.3.476; Cotch MF, 1996, ARTHRITIS RHEUM, V39, P87, DOI 10.1002/art.1780390112; de Groot K, 2005, CLIN NEPHROL, V64, P480; de Groot K, 2005, KIDNEY BLOOD PRESS R, V28, P195; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; De Groot K, 1998, J RHEUMATOL, V25, P492; de Groot K, 2001, NEPHROL DIAL TRANSPL, V16, P2018, DOI 10.1093/ndt/16.10.2018; deGroot K, 1996, ARTHRITIS RHEUM, V39, P2052, DOI 10.1002/art.1780391215; DEOLIVIERA J, 1995, AM J KIDNEY DIS, V25, P380, DOI 10.1016/0272-6386(95)90098-5; DEREMEE RA, 1985, MAYO CLIN PROC, V60, P27, DOI 10.1016/S0025-6196(12)65279-3; DEREMEE RA, 1988, ARTHRITIS RHEUM, V31, P1068, DOI 10.1002/art.1780310821; Dhaygude A, 2004, NEPHRON CLIN PRACT, V97, pC154, DOI 10.1159/000079175; DROSOS AA, 1992, J INTERN MED, V232, P279, DOI 10.1111/j.1365-2796.1992.tb00584.x; FALK RJ, 1990, ANN INTERN MED, V113, P656, DOI 10.7326/0003-4819-113-9-656; FAUCI AS, 1973, MEDICINE, V52, P535, DOI 10.1097/00005792-197311000-00002; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Flossmann O, 2006, ANN RHEUM DIS, V65, P841, DOI 10.1136/ard.2005.048900; FRASCA GM, 1992, INT J ARTIF ORGANS, V15, P181, DOI 10.1177/039139889201500308; Frasca GM, 2003, THER APHER DIAL, V7, P540, DOI 10.1046/j.1526-0968.2003.00089.x; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Gayraud M, 1997, BRIT J RHEUMATOL, V36, P1290; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Goek ON, 2005, CURR OPIN RHEUMATOL, V17, P257, DOI 10.1097/01.bor.0000160777.28259.c2; GORDON M, 1993, Q J MED, V86, P779; GUILLEVIN L, 1995, ARTHRITIS RHEUM, V38, P1638, DOI 10.1002/art.1780381116; GUILLEVIN L, 1992, ARTHRITIS RHEUM, V35, P208, DOI 10.1002/art.1780350214; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; GUILLEVIN L, 1991, J RHEUMATOL, V18, P567; Guillevin L, 2003, ARTHRIT RHEUM-ARTHR, V49, P93, DOI 10.1002/art.10922; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Haubitz M, 1998, ARTHRITIS RHEUM, V41, P1835, DOI 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q; HAUBITZ M, 1991, NEPHROL DIAL TRANSPL, V6, P531, DOI 10.1093/ndt/6.8.531; Hellmich B, 2006, CURR OPIN RHEUMATOL, V18, P25, DOI 10.1097/01.bor.0000200369.24793.f5; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; HOFFMAN GS, 1992, ARTHRITIS RHEUM, V35, P1322, DOI 10.1002/art.1780351113; HOFFMAN GS, 1994, MEDICINE, V73, P325, DOI 10.1097/00005792-199411000-00006; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; HOFFMAN GS, 1990, AM J MED, V89, P403, DOI 10.1016/0002-9343(90)90367-M; HOLLANDER D, 1967, ANN INTERN MED, V67, P393, DOI 10.7326/0003-4819-67-2-393; Huong DLT, 1996, CLIN EXP RHEUMATOL, V14, P9; Jayne D, 2006, CLIN EXP RHEUMATOL, V24, pS1; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JAYNE DRW, 1995, QJM-MON J ASSOC PHYS, V88, P127; Jayne DRW, 2000, QJM-INT J MED, V93, P433, DOI 10.1093/qjmed/93.7.433; JAYNE DRW, 1993, ADV EXP MED BIOL, V336, P469; Jayne DRW, 1997, MAYO CLIN PROC, V72, P737; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Klemmer PJ, 2003, AM J KIDNEY DIS, V42, P1149, DOI 10.1053/j.ajkd.2003.08.015; Kokolina E, 2005, ANN NY ACAD SCI, V1051, P597, DOI 10.1196/annals.1361.104; Koldingsnes W, 1998, BRIT J RHEUMATOL, V37, P659; Koukoulaki M, 2006, NEPHRON CLIN PRACT, V102, pC100, DOI 10.1159/000089667; Langford CA, 1999, ARTHRITIS RHEUM, V42, P2666, DOI 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E; Langford CA, 2000, ARTHRITIS RHEUM, V43, P1836, DOI 10.1002/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R; Langford CA, 2004, ARTHRIT RHEUM-ARTHR, V51, P278, DOI 10.1002/art.20240; Langford CA, 2003, AM J MED, V114, P463, DOI 10.1016/S0002-9343(03)00077-9; Lynch JP, 2004, SEMIN RESP CRIT CARE, V25, P491, DOI 10.1055/s-2004-836143; Mahr A, 2001, RHEUMATOLOGY, V40, P492, DOI 10.1093/rheumatology/40.5.492; MAHR A, 2005, KIDNEY BLOOD PRESS R, V28, P194; MartinSuarez I, 1997, ANN RHEUM DIS, V56, P481, DOI 10.1136/ard.56.8.481; Metzler C, 2005, ANN RHEUM DIS, V64, P85; Metzler C, 2004, RHEUMATOLOGY, V43, P315, DOI 10.1093/rheumatology/keh009; Mukhtyar C, 2005, ANN RHEUM DIS, V64, P31, DOI 10.1136/ard.2005.042416; Nowack R, 1999, J AM SOC NEPHROL, V10, P1965; *OXF CTR EV BAS ME, LEV EV GRAD REC; Pagnoux C, 2003, ARTHRITIS RHEUM, V48, pS661; PUSEY CD, 1991, KIDNEY INT, V40, P757, DOI 10.1038/ki.1991.272; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Reinhold-Keller E, 2002, ARTHRIT RHEUM-ARTHR, V47, P326, DOI 10.1002/art.10459; ReinholdKeller E, 1996, QJM-MON J ASSOC PHYS, V89, P15, DOI 10.1093/oxfordjournals.qjmed.a030133; REINHOLDKELLER E, 1994, ARTHRITIS RHEUM, V37, P919, DOI 10.1002/art.1780370622; RICHTER C, 1995, CLIN EXP IMMUNOL, V101, P2; Rosenstiel P, 2005, GUT, V54, P314; Sanders J. S. F., 2005, Kidney & Blood Pressure Research, V28, P195; Sanders JF, 2003, NEW ENGL J MED, V349, P2072; Sarraf Pasha, 2006, Curr Rheumatol Rep, V8, P303, DOI 10.1007/s11926-006-0014-6; SAVAGE COS, 1985, Q J MED, V56, P467; Schmitt WH, 2004, KIDNEY INT, V65, P1440, DOI 10.1111/j.1523-1755.2004.00534.x; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; Sieper J, 2005, SEMIN ARTHRITIS RHEU, V34, P23, DOI 10.1016/j.semarthrit.2005.01.006; Slot MC, 2004, ARTHRIT RHEUM-ARTHR, V51, P269, DOI 10.1002/art.20234; Sneller MC, 2005, ARTHRITIS RHEUM-US, V52, P1, DOI 10.1002/art.20717; SNELLER MC, 1995, ARTHRITIS RHEUM, V38, P608, DOI 10.1002/art.1780380505; Stassen PM, 2007, ANN RHEUM DIS, V66, P798, DOI 10.1136/ard.2006.060301; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stone JH, 2005, NEW ENGL J MED, V352, P351; Stone JH, 1999, J RHEUMATOL, V26, P1134; Stone JH, 2002, CONTROL CLIN TRIALS, V23, P450; TalarWilliams C, 1996, ANN INTERN MED, V124, P477, DOI 10.7326/0003-4819-124-5-199603010-00003; WALTON EW, 1958, BRIT MED J, V2, P265, DOI 10.1136/bmj.2.5091.265; Westman KWA, 1998, J AM SOC NEPHROL, V9, P842; White ES, 2006, DRUGS, V66, P1209, DOI 10.2165/00003495-200666090-00004	104	129	143	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					655	669		10.1001/jama.298.6.655	http://dx.doi.org/10.1001/jama.298.6.655			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684188	Bronze			2022-12-28	WOS:000248574800026
J	Klein, HG; Spahn, DR; Carson, JL				Klein, Harvey G.; Spahn, Donat R.; Carson, Jeffrey L.			Transfusion Medicine 1 - Red blood cell transfusion in clinical practice	LANCET			English	Review							ACUTE NORMOVOLEMIC HEMODILUTION; ACUTE ISOVOLEMIC HEMODILUTION; DEPENDENT OXYGEN-CONSUMPTION; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; CRITICALLY-ILL; AUTOLOGOUS TRANSFUSION; HYPOTENSIVE REACTIONS; METABOLIC-RESPONSE; COGNITIVE FUNCTION	Every year, about 75 million units of blood are collected worldwide. Red blood cell (RBC) transfusion is one of the few treatments that adequately restore tissue oxygenation when oxygen demand exceeds supply. Although the respiratory function of blood has been studied intensively, the trigger for RBC transfusion remains controversial, and doctors rely primarily on clinical experience. Laboratory assays that indicate failing tissue oxygenation would be ideal to guide the need for transfusion, but none has proved easy, reproducible, and sensitive to regional tissue hypoxia. The clinical importance of the RBCs storage lesion (ie, the time-dependent metabolic, biochemical, and molecular changes that stored blood cells undergo) is poorly understood. RBCs can be filtered, washed, frozen, or irradiated for specific indications. Donor screening and testing have dramatically reduced infectious risks in the developed world, but infection remains a major hazard in developing countries, where 13 million units of blood are not tested for HIV or hepatitis viruses. Pathogen inactivation techniques are in clinical trials for RBCs, but none is available for use. Despite serious immunological and non-immunological complications, RBC transfusion holds a therapeutic index that exceeds that of many common medications.	NIH, Dept Transfus Med, Bethesda, MD 20892 USA; Univ Zurich Hosp, Dept Anesthesiol, CH-8091 Zurich, Switzerland; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Gen Internal Med, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; University of Zurich; University Zurich Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Klein, HG (corresponding author), NIH, Dept Transfus Med, Bethesda, MD 20892 USA.	hklein@mail.cc.nih.gov						Adams RC., 1942, SURG GYNECOL OBSTET, V3, P603; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Alvarez GG, 2004, CAN J ANAESTH, V51, P425, DOI 10.1007/BF03018303; *AM ASS BLOOD BANK, 2005, STAND BLOOD BANKS TR; *AM ASS BLOOD BANK, 2005, TECHN MAN; AMATO A, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005033.PUB2; ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; Arnold DM, 2004, TRANSFUSION, V44, P1361, DOI 10.1111/j.0041-1132.2004.04057.x; Beasley R, 2006, LANCET, V367, P1124, DOI 10.1016/S0140-6736(06)68488-2; BEUTLER E, 1988, TRANSFUSION, V28, P353, DOI 10.1046/j.1537-2995.1988.28488265266.x; BEUTLER E, 1969, TRANSFUSION, V9, P109, DOI 10.1111/j.1537-2995.1969.tb05527.x; Bierbaum BE, 1999, J BONE JOINT SURG AM, V81A, P2, DOI 10.2106/00004623-199901000-00002; Blajchman MA, 2005, HEMATOLOGY, V10, P208, DOI 10.1080/10245330512331390447; BLUNDELL J, 1818, MED CHIR T, V10, P310; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; BRITTINGHAM TE, 1957, JAMA-J AM MED ASSOC, V165, P819, DOI 10.1001/jama.1957.02980250053013; Buehler PW, 2004, ANTIOXID REDOX SIGN, V6, P1000, DOI 10.1089/ars.2004.6.1000; BUSCH ORC, 1993, NEW ENGL J MED, V328, P1372, DOI 10.1056/NEJM199305133281902; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; BUTCH SH, 1994, TRANSFUSION, V34, P187, DOI 10.1046/j.1537-2995.1994.34294143958.x; CAIN SM, 1977, J APPL PHYSIOL, V42, P228, DOI 10.1152/jappl.1977.42.2.228; CAPON SM, 1995, TRANSFUSION, V35, P513, DOI 10.1046/j.1537-2995.1995.35695288773.x; Carless PA, 2003, COCHRANE DB SYST REV, V4; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; Casutt M, 1999, CRIT CARE MED, V27, P2194, DOI 10.1097/00003246-199910000-00021; Cazzola M, 1997, TRANSFUSION, V37, P135, DOI 10.1046/j.1537-2995.1997.37297203514.x; CHANUTIN A, 1968, ARCH BIOCHEM BIOPHYS, V123, P163, DOI 10.1016/0003-9861(68)90114-8; CHAPLER CK, 1986, CAN J PHYSIOL PHARM, V64, P7, DOI 10.1139/y86-002; Clewley JP, 2004, J CLIN VIROL, V29, P2, DOI 10.1016/j.jcv.2003.08.002; *COUNC EUR PUBL, 2005, GUID PREP US QUAL AS; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; Davies A, 2006, TRANSFUSION, V46, P352, DOI 10.1111/j.1537-2995.2006.00729.x; DERN RJ, 1967, J LAB CLIN MED, V69, P968; Domen RE, 2003, ARCH PATHOL LAB MED, V127, P316; Dzik Walter H, 2005, Hematology Am Soc Hematol Educ Program, P476; Dzik WH, 2003, VOX SANG, V85, P40, DOI 10.1046/j.1423-0410.2003.00313.x; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; FAN FC, 1980, AM J PHYSIOL, V238, pH545, DOI 10.1152/ajpheart.1980.238.4.H545; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; FRIEDMAN BA, 1980, TRANSFUSION, V20, P179, DOI 10.1046/j.1537-2995.1980.20280169958.x; GABRIO BW, 1954, J CLIN INVEST, V33, P242, DOI 10.1172/JCI102891; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; GIORDANO GF, 1990, HOSP HEALTH SERV ADM, V35, P139; Goldman M, 1997, TRANSFUSION, V37, P523, DOI 10.1046/j.1537-2995.1997.37597293885.x; GREENWALT TJ, 1990, VOX SANG, V58, P90, DOI 10.1111/j.1423-0410.1990.tb02068.x; GREENWALT TJ, 1984, VOX SANG, V47, P261, DOI 10.1111/j.1423-0410.1984.tb01596.x; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Habler OP, 1996, ANESTH ANALG, V83, P451, DOI 10.1097/00000539-199609000-00002; Harmatz P, 2000, BLOOD, V96, P76, DOI 10.1182/blood.V96.1.76.013k22_76_79; Hashmi G, 2005, TRANSFUSION, V45, P680, DOI 10.1111/j.1537-2995.2005.04362.x; HATHAWAY WE, 1965, NEW ENGL J MED, V273, P953, DOI 10.1056/NEJM196510282731803; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2001, CHEST, V119, P1850, DOI 10.1378/chest.119.6.1850; HEISS MM, 1994, J CLIN ONCOL, V12, P1859, DOI 10.1200/JCO.1994.12.9.1859; Henry D A, 2002, Cochrane Database Syst Rev, pCD003602; Hess JR, 2000, TRANSFUSION, V40, P110, DOI 10.1046/j.1537-2995.2000.40010110.x; HILLMAN NM, 1979, TRANSFUSION, V19, P548, DOI 10.1046/j.1537-2995.1979.19580059807.x; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; HOWARTH S, 1947, LANCET, V252, P18; Hsia CCW, 1998, NEW ENGL J MED, V338, P239, DOI 10.1056/NEJM199801223380407; Huber TS, 1997, J VASC SURG, V25, P984, DOI 10.1016/S0741-5214(97)70121-6; Ickx BE, 2000, ANESTHESIOLOGY, V93, P1011, DOI 10.1097/00000542-200010000-00024; Jamnicki M, 2003, J CARDIOTHOR VASC AN, V17, P747, DOI 10.1053/j.jvca.2003.09.018; JAN KM, 1977, AM J PHYSIOL, V233, pH106, DOI 10.1152/ajpheart.1977.233.1.H106; Jensen LS, 2005, LANCET, V365, P681; Johansson PI, 2005, VOX SANG, V89, P92, DOI 10.1111/j.1423-0410.2005.00668.x; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; Klein HG, 2006, CRIT CARE MED, V34, P2013, DOI 10.1097/01.CCM.0000224226.45049.20; Klein HG, 2006, TRANSFUSION, V46, P878, DOI 10.1111/j.1537-2995.2006.00853.x; Klein HG, 2005, J INTERN MED, V257, P224, DOI 10.1111/j.1365-2796.2005.01451.x; Klein HG, 2003, ANESTHESIOLOGY, V98, P807, DOI 10.1097/00000542-200304000-00003; Klein HG, 1999, ANESTHESIOLOGY, V91, P861, DOI 10.1097/00000542-199909000-00040; Klein HG., 2005, MOLLISONS BLOOD TRAN; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; Koda Y, 2000, BLOOD, V95, P1138, DOI 10.1182/blood.V95.4.1138.004k27_1138_1143; KOSHY M, 1988, NEW ENGL J MED, V319, P1447, DOI 10.1056/NEJM198812013192204; KOSHY M, 1995, BLOOD, V86, P3676, DOI 10.1182/blood.V86.10.3676.bloodjournal86103676; KREUZER F, 1970, RESP PHYSIOL, V9, P1, DOI 10.1016/0034-5687(70)90002-2; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Landsteiner K., 1901, WIEN KLIN WSCHR, V14, P1132; Lane TA, 2002, TRANSFUSION, V42, P265, DOI 10.1046/j.1537-2995.2002.00036.x; LATHAM JT, 1982, TRANSFUSION, V22, P158, DOI 10.1046/j.1537-2995.1982.22282177126.x; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Lavee J, 2001, J HEART LUNG TRANSPL, V20, P759, DOI 10.1016/S1053-2498(00)00330-2; LEY TJ, 1983, NEW ENGL J MED, V308, P1422; Licker M, 2005, CRIT CARE MED, V33, P591, DOI 10.1097/01.ccm.0000156446.03285.E0; Licker M, 2004, ANAESTHESIA, V59, P108, DOI 10.1111/j.1365-2044.2004.03571.x; Lieberman JA, 2000, ANESTHESIOLOGY, V92, P407, DOI 10.1097/00000542-200002000-00022; Linden JV, 1997, TRANSFUSION, V37, P455, DOI 10.1046/j.1537-2995.1997.37597293872.x; Linden JV, 2000, TRANSFUSION, V40, P1207, DOI 10.1046/j.1537-2995.2000.40101207.x; LOSTUMBO MM, 1966, NEW ENGL J MED, V275, P141, DOI 10.1056/NEJM196607212750305; Lotke PA, 1999, J ARTHROPLASTY, V14, P647, DOI 10.1016/S0883-5403(99)90216-4; Madjdpour C, 2005, BRIT J ANAESTH, V95, P33, DOI 10.1093/bja/aeh290; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; MCVAY PA, 1990, VOX SANG, V59, P70, DOI 10.1111/j.1423-0410.1990.tb05011.x; MENITOVE JE, 1982, VOX SANG, V42, P318, DOI 10.1111/j.1423-0410.1982.tb01106.x; MEYERS RL, 1991, J DEV PHYSIOL, V15, P189; MOIA M, 1987, LANCET, V2, P1227; Morisaki H, 2004, CRIT CARE CLIN, V20, P213, DOI 10.1016/j.ccc.2003.12.003; Morris KP, 2005, ARCH DIS CHILD, V90, P724, DOI 10.1136/adc.2004.062174; MOSS GS, 1976, SURG GYNECOL OBSTET, V142, P357; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; MURRAY JF, 1972, CARDIOVASC RES, V6, P360, DOI 10.1093/cvr/6.4.360; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; NESS PM, 1990, TRANSFUSION, V30, P688, DOI 10.1046/j.1537-2995.1990.30891020325.x; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Ohto H, 1996, TRANSFUS MED REV, V10, P31, DOI 10.1016/S0887-7963(96)80121-0; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Olsson ML, 2004, TRANSFUS CLIN BIOL, V11, P33, DOI 10.1016/j.tracli.2003.12.002; OPELZ G, 1973, TRANSPLANT P, V5, P253; Pearce FJ, 2005, J APPL PHYSIOL, V99, P814, DOI 10.1152/japplphysiol.00816.2003; Pineda AA, 1999, TRANSFUSION, V39, P1097, DOI 10.1046/j.1537-2995.1999.39101097.x; PINEDA AA, 1975, TRANSFUSION, V15, P10; Popovsky M A, 1996, Immunohematology, V12, P87; POPOVSKY MA, 1985, TRANSFUSION, V25, P444, DOI 10.1046/j.1537-2995.1985.25586020125.x; POPOVSKY MA, 1985, MAYO CLIN PROC, V60, P312, DOI 10.1016/S0025-6196(12)60538-2; POPOVSKY MA, 1995, TRANSFUSION, V35, P734, DOI 10.1046/j.1537-2995.1995.35996029156.x; POPOVSKY MA, 2001, IMMUNOHEMATOL, V17, P157; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Rao MP, 2002, ANAESTHESIA, V57, P530, DOI 10.1046/j.1365-2044.2002.02514.x; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; RASANEN J, 1992, CHEST, V101, P1121, DOI 10.1378/chest.101.4.1121; Rizzo JD, 2002, BLOOD, V100, P2303, DOI 10.1182/blood-2002-06-1767; Robertson O H, 1918, Br Med J, V1, P691; RUMSBY MG, 1977, BIOCHEM SOC T, V5, P126, DOI 10.1042/bst0050126; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Sandler SG, 1996, TRANSFUSION, V36, P256, DOI 10.1046/j.1537-2995.1996.36396182145.x; Schonewille H, 2006, TRANSFUSION, V46, P250, DOI 10.1111/j.1537-2995.2006.00708.x; Segal JB, 2004, TRANSFUSION, V44, P632, DOI 10.1111/j.1537-2995.2004.03353.x; Shapiro MJ, 2003, J TRAUMA, V55, P269, DOI 10.1097/01.TA.0000080530.77566.04; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684; SKILLMAN JJ, 1967, ANN SURG, V166, P865, DOI 10.1097/00000658-196712000-00001; SKILLMAN JJ, 1967, SURG GYNECOL OBSTETR, V125, P983; SPAHN DR, 1994, ANESTH ANALG, V78, P1000; Spahn DR, 2005, CURR PHARM DESIGN, V11, P4099, DOI 10.2174/138161205774913354; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Spahn DR, 1996, ANESTH ANALG, V82, P687, DOI 10.1097/00000539-199604000-00003; Spahn DR, 1996, ANESTH ANALG, V82, P681, DOI 10.1097/00000539-199604000-00002; SPAHN DR, 1993, J THORAC CARDIOV SUR, V105, P694; Spiess BD, 1998, J THORAC CARDIOV SUR, V116, P460, DOI 10.1016/S0022-5223(98)70012-1; STEPHEN CR, 1955, JAMA-J AM MED ASSOC, V158, P525, DOI 10.1001/jama.1955.02960070001001; Strauss RG, 2000, J PEDIATR-US, V136, P215, DOI 10.1016/S0022-3476(00)70104-1; STRUMIA MM, 1962, AM J CLIN PATHOL, V37, P491; Sweeney JD, 1998, TRANSFUSION, V38, P410, DOI 10.1046/j.1537-2995.1998.38498257382.x; TOPLEY E, 1956, BR J CLIN PRACT, V1, P770; TROUWBORST A, 1990, ANESTH ANALG, V70, P523; Tsai AG, 2004, ANTIOXID REDOX SIGN, V6, P1011, DOI 10.1089/1523086042259896; *TSO, 2005, GUID BLOOD TRANSF SE; VALERI CR, 1969, J LAB CLIN MED, V73, P722; Valeri CR, 2001, TRANSFUSION, V41, P977, DOI 10.1046/j.1537-2995.2001.41080977.x; VAN BJ, 2002, ANESTHESIOLOGY, V97, P660; van de Watering LMG, 2001, BRIT J SURG, V88, P267, DOI 10.1046/j.1365-2168.2001.01674.x; Van der Linden P, 1998, BRIT J ANAESTH, V81, P556, DOI 10.1093/bja/81.4.556; Van der Linden P, 2003, ANESTHESIOLOGY, V99, P97, DOI 10.1097/00000542-200307000-00018; VANWOERKENS ECSM, 1992, ANESTH ANALG, V75, P818; VANWOERKENS ECSM, 1992, J APPL PHYSIOL, V72, P760, DOI 10.1152/jappl.1992.72.2.760; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Vichinsky EP, 2001, TRANSFUSION, V41, P1086, DOI 10.1046/j.1537-2995.2001.41091086.x; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; VON F, 1982, AM J MED, V72, P951; Walker RH, 1996, CLIN LAB MED, V16, P895, DOI 10.1016/S0272-2712(18)30245-2; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; WILKERSON DK, 1988, SURGERY, V103, P665; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; [No title captured]	177	270	298	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					415	426		10.1016/S0140-6736(07)61197-0	http://dx.doi.org/10.1016/S0140-6736(07)61197-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679019				2022-12-28	WOS:000248590200032
J	Moran, SL; Bishop, AT				Moran, Steven L.; Bishop, Allen T.			Clinical update: surgical management of rheumatoid hand	LANCET			English	Article							TERM-FOLLOW-UP; ARTHRITIS; SYNOVECTOMY; JOINT; WRIST; ARTHROPLASTY; TENOSYNOVECTOMY; DEFORMITIES; IMPLANTS; RUPTURES		Mayo Clin, Coll Med, Dept Orthoped Surg, Div Plast Surg, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Orthoped Surg, Div Hand Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Moran, SL (corresponding author), Mayo Clin, Coll Med, Dept Orthoped Surg, Div Plast Surg, Rochester, MN 55905 USA.	moran.steven@mayo.edu						Alderman AK, 2003, J RHEUMATOL, V30, P1464; Chung KC, 2006, J HAND SURG-AM, V31A, P289, DOI 10.1016/j.jhsa.2005.10.005; Cook SD, 1999, J BONE JOINT SURG AM, V81A, P635, DOI 10.2106/00004623-199905000-00005; HINDLEY CJ, 1991, J HAND SURG-BRIT EUR, V16B, P275, DOI 10.1016/0266-7681(91)90053-Q; ISHIKAWA H, 1992, J HAND SURG-AM, V17A, P1109, DOI 10.1016/S0363-5023(09)91076-0; Ishikawa H, 2005, J HAND SURG-AM, V30A, P658, DOI 10.1016/j.jhsa.2005.02.005; Jain A, 2001, ARTHRITIS RHEUM, V44, P1754, DOI 10.1002/1529-0131(200108)44:8<1754::AID-ART310>3.0.CO;2-8; Jain A, 2002, J HAND SURG-AM, V27A, P449, DOI 10.1053/jhsu.2002.32958; Mandl LA, 2002, J RHEUMATOL, V29, P2488; MCEWEN C, 1988, J RHEUMATOL, V15, P765; Nakamura H, 2000, INT ORTHOP, V24, P242, DOI 10.1007/s002640000168; NICOLLE FV, 1971, ANN RHEUM DIS, V30, P476, DOI 10.1136/ard.30.5.476; Parker W, 2006, HAND CLIN, V22, P183, DOI 10.1016/j.hcl.2006.02.012; Pereira JA, 2001, J HAND SURG-BRIT EUR, V26, P229, DOI 10.1054/jhsb.2001.0574; Ryu J, 1998, J HAND SURG-BRIT EUR, V23B, P658, DOI 10.1016/S0266-7681(98)80022-3; SWANSON AB, 1972, J BONE JOINT SURG AM, VA 54, P435, DOI 10.2106/00004623-197254030-00001; Tolat AR, 1996, J HAND SURG-BRIT EUR, V21B, P538, DOI 10.1016/S0266-7681(96)80061-1; Trail IA, 2004, J BONE JOINT SURG BR, V86B, P1002, DOI 10.1302/0301-620X.86B7.15061; VAUGHANJACKSON OJ, 1959, P ROY SOC MED, V52, P132; WILDE AH, 1974, J BONE JOINT SURG AM, VA 56, P71, DOI 10.2106/00004623-197456010-00008	20	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					372	374		10.1016/S0140-6736(07)61175-1	http://dx.doi.org/10.1016/S0140-6736(07)61175-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679002				2022-12-28	WOS:000248590200010
J	Silevitch, DM; Bitko, D; Brooke, J; Ghosh, S; Aeppli, G; Rosenbaum, TF				Silevitch, D. M.; Bitko, D.; Brooke, J.; Ghosh, S.; Aeppli, G.; Rosenbaum, T. F.			A ferromagnet in a continuously tunable random field	NATURE			English	Article							CRITICAL-BEHAVIOR; NEUTRON-SCATTERING; ISING FERROMAGNET; DISORDERED MAGNET; PHASE-TRANSITION; MODEL	Most physical and biological systems are disordered, even though the majority of theoretical models treat disorder as a weak perturbation. One particularly simple system is a ferromagnet approaching its Curie temperature, T-C, where all of the spins associated with partially filled atomic shells acquire parallel orientation. With the addition of disorder by way of chemical substitution, the Curie point is suppressed, but no qualitatively new phenomena appear in bulk measurements as long as the disorder is truly random on the atomic scale and not so large as to eliminate ferromagnetism entirely(1). Here we report the discovery that a simply measured magnetic response is singular above the Curie temperature of a model, disordered magnet, and that the associated singularity grows to an anomalous divergence at T-C. The origin of the singular response is the random internal field induced by an external magnetic field transverse to the favoured direction for magnetization(2-4). The fact that ferromagnets can be studied easily and with high precision using bulk susceptibility and a large variety of imaging tools will not only advance fundamental studies of the random field problem, but also suggests a mechanism for tuning the strength of domain wall pinning, the key to applications.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; MPI Res Inc, East Brunswick, NJ 08816 USA; MIT, Lincoln Lab, Lexington, MA 02420 USA; Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA; UCL, London Ctr Nanotechnol, London WC1E 6BT, England; UCL, Dept Phys & Astron, London WC1E 6BT, England	University of Chicago; University of Chicago; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); University of California System; University of California Merced; University of London; University College London; University of London; University College London	Rosenbaum, TF (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	tfr@uchicago.edu			Engineering and Physical Sciences Research Council [EP/D049717/1] Funding Source: researchfish; EPSRC [EP/D049717/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AHARONY A, 1975, PHYS REV LETT, V35, P1308, DOI 10.1103/PhysRevLett.35.1308; AHLERS G, 1975, PHYS REV LETT, V34, P1227, DOI 10.1103/PhysRevLett.34.1227; BELANGER DP, 1983, PHYS REV B, V28, P2522, DOI 10.1103/PhysRevB.28.2522; BELANGER DP, 1991, J MAGN MAGN MATER, V100, P272, DOI 10.1016/0304-8853(91)90825-U; BELANGER DP, 1987, PHYS REV B, V35, P4823, DOI 10.1103/PhysRevB.35.4823; BIRGENEAU RJ, 1983, PHYS REV B, V27, P6747, DOI 10.1103/PhysRevB.27.6747; Bitko D, 1996, PHYS REV LETT, V77, P940, DOI 10.1103/PhysRevLett.77.940; BITKO D, 1997, THESIS U CHICAGO; BREZIN E, 1976, PHYS REV B, V13, P251, DOI 10.1103/PhysRevB.13.251; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; Chakraborty PB, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144411; FERREIRA IB, 1983, PHYS REV B, V28, P5192, DOI 10.1103/PhysRevB.28.5192; FISHMAN S, 1979, J PHYS C SOLID STATE, V12, P729; Ghosh S, 2003, NATURE, V425, P48, DOI 10.1038/nature01888; Ghosh S, 2002, SCIENCE, V296, P2195, DOI 10.1126/science.1070731; Gofman M, 1996, PHYS REV B, V53, P6362, DOI 10.1103/PhysRevB.53.6362; GRIFFITHS RB, 1969, PHYS REV LETT, V23, P17, DOI 10.1103/PhysRevLett.23.17; HANSEN PE, 1975, PHYS REV B, V12, P5315, DOI 10.1103/PhysRevB.12.5315; Ma S. K., 2000, MODERN THEORY CRITIC; REICH DH, 1990, PHYS REV B, V42, P4631, DOI 10.1103/PhysRevB.42.4631; Ronnow HM, 2005, SCIENCE, V308, P389, DOI 10.1126/science.1108317; SCHECHTER M, 2006, LIHOXY1XF4 RANDOM FI; Slanic Z, 1999, PHYS REV LETT, V82, P426, DOI 10.1103/PhysRevLett.82.426; Tabei SMA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237203; WU WH, 1991, PHYS REV LETT, V67, P2076, DOI 10.1103/PhysRevLett.67.2076; YOSHIZAWA H, 1982, PHYS REV LETT, V48, P438, DOI 10.1103/PhysRevLett.48.438	27	56	58	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					567	570		10.1038/nature06050	http://dx.doi.org/10.1038/nature06050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671498	Green Submitted			2022-12-28	WOS:000248446700037
J	Hickey, T				Hickey, Tom			Should we consider a boycott of Israeli academic institutions? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Brighton, Fac Arts & Architecture, Univ & Coll Union, Brighton BN2 1RA, E Sussex, England	University of Brighton	Hickey, T (corresponding author), Univ Brighton, Fac Arts & Architecture, Univ & Coll Union, Brighton BN2 1RA, E Sussex, England.	T.Hickey@bton.ac.uk							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					124	124		10.1136/bmj.39266.495567.AD	http://dx.doi.org/10.1136/bmj.39266.495567.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195RA	17641344	Green Published			2022-12-28	WOS:000248428100028
J	Tarantola, D; Gruskin, S				Tarantola, Daniel; Gruskin, Sofia			New guidance on recommended HIV testing and counselling	LANCET			English	Editorial Material									Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Harvard Univ, Sch Publ Hlth, Program Int Hlth & Human Rights, Boston, MA 02115 USA	University of New South Wales Sydney; Harvard University; Harvard T.H. Chan School of Public Health	Tarantola, D (corresponding author), Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	d.tarantola@unsw.edu.au						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], REV REC HIV TEST AD; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; *HUM RIGHTS WATCH, 2007, COMM WHO UNAIDS DRAF; JURGENS R, 2007, ROUTINIZING HIV TEST; KIPPAX S, 2006, COMMENTS GUIDANCE PR; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; *UNAIDS REF GROUP, 2007, CRIM HIV TRANSM	9	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					202	203		10.1016/S0140-6736(07)61102-7	http://dx.doi.org/10.1016/S0140-6736(07)61102-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MG	17658377				2022-12-28	WOS:000248347900008
J	DeLong, EF				DeLong, Edward F.			Life on the thermodynamic edge	SCIENCE			English	Editorial Material							SYNTROPHUS-ACIDITROPHICUS; METHANE OXIDATION; SEDIMENTS		MIT, Inst Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Inst Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu						Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534	11	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					327	328		10.1126/science.1145970	http://dx.doi.org/10.1126/science.1145970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641187				2022-12-28	WOS:000248150200031
J	Travis, MA; Reizis, B; Melton, AC; Masteller, E; Tang, QZ; Proctor, JM; Wang, YL; Bernstein, X; Huang, XZ; Reichardt, LF; Bluestone, JA; Sheppard, D				Travis, Mark A.; Reizis, Boris; Melton, Andrew C.; Masteller, Emma; Tang, Qizhi; Proctor, John M.; Wang, Yanli; Bernstein, Xin; Huang, Xiaozhu; Reichardt, Louis F.; Bluestone, Jeffrey A.; Sheppard, Dean			Loss of integrin alpha(v)beta(8) on dendritic cells causes autoimmunity and colitis in mice	NATURE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; TGF-BETA-1; DISEASE; HOMEOSTASIS; ACTIVATION; EXPRESSION; INFLAMMATION; MECHANISMS; TOLERANCE	The cytokine transforming growth factor-beta (TGF-beta) is an important negative regulator of adaptive immunity(1-3). TGF-beta is secreted by cells as an inactive precursor that must be activated to exert biological effects(4), but the mechanisms that regulate TGF-beta activation and function in the immune system are poorly understood. Here we show that conditional loss of the TGF-beta-activating integrin alpha(v)beta(8) on leukocytes causes severe inflammatory bowel disease and age-related autoimmunity in mice. This autoimmune phenotype is largely due to lack of alpha(v)beta(8) on dendritic cells, as mice lacking alpha(v)beta(8) principally on dendritic cells develop identical immunological abnormalities as mice lacking alpha(v)beta(8) on all leukocytes, whereas mice lacking alpha(v)beta(8) on T cells alone are phenotypically normal. We further show that dendritic cells lacking alpha(v)beta(8) fail to induce regulatory T cells (T-R cells) in vitro, an effect that depends on TGF-beta activity. Furthermore, mice lacking alpha(v)beta(8) on dendritic cells have reduced proportions of T-R cells in colonic tissue. These results suggest that alpha(v)beta(8)-mediated TGF-beta activation by dendritic cells is essential for preventing immune dysfunction that results in inflammatory bowel disease and autoimmunity, effects that are due, at least in part, to the ability of alpha(v)beta(8) on dendritic cells to induce and/or maintain tissue T-R cells.	Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94158 USA; Columbia Univ, Dept Microbiol, New York, NY 10032 USA; Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Columbia University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sheppard, D (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, 1550 4th St,Room 545, San Francisco, CA 94158 USA.	dean.sheppard@ucsf.edu	Travis, Mark/E-9643-2015	Travis, Mark/0000-0002-8485-2272; Reizis, Boris/0000-0003-1140-7853; Tang, Qizhi/0000-0001-7313-3574	NINDS NIH HHS [R01 NS019090-25, R01 NS019090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bohr URM, 2006, J CLIN MICROBIOL, V44, P738, DOI 10.1128/JCM.44.3.738-742.2006; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEFRANCOIS L, 2001, CURR PROTOCOLS IMMUN; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Taylor NS, 2007, J CLIN MICROBIOL, V45, P2166, DOI 10.1128/JCM.00137-07; Whary MT, 2006, LAB ANIMAL, V35, P25, DOI 10.1038/laban0706-25; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhu JW, 2002, DEVELOPMENT, V129, P2891	30	398	408	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					361	+		10.1038/nature06110	http://dx.doi.org/10.1038/nature06110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17694047	Green Accepted			2022-12-28	WOS:000249557300049
J	Russell, AF; Langmore, NE; Cockburn, A; Astheimer, LB; Kilner, RM				Russell, A. F.; Langmore, N. E.; Cockburn, A.; Astheimer, L. B.; Kilner, R. M.			Reduced egg investment can conceal helper effects in cooperatively breeding birds	SCIENCE			English	Article							EVOLUTION; VERTEBRATES; SELECTION; INCREASE; BEHAVIOR; SIZE; CARE; NEST	Cooperative breeding systems are characterized by nonbreeding helpers that assist breeders in offspring care. However, the benefits to offspring of being fed by parents and helpers in cooperatively breeding birds can be difficult to detect. We offer experimental evidence that helper effects can be obscured by an undocumented maternal tactic. In superb fairy-wrens (Malurus cyaneus), mothers breeding in the presence of helpers lay smaller eggs of lower nutritional content that produce lighter chicks, as compared with those laying eggs in the absence of helpers. Helpers compensate fully for such reductions in investment and allow mothers to benefit through increased survival to the next breeding season. We suggest that failure to consider maternal egg-investment strategies can lead to underestimation of the force of selection acting on helping in avian cooperative breeders.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Macquarie Univ, Ctr Integrat Study Anim Behav, N Ryde, NSW 2109, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; Univ Wollongong, Sch Hlth Sci, Wollongong, NSW 2522, Australia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Sheffield; Macquarie University; Australian National University; National Research Foundation - South Africa; University of Cape Town; University of Wollongong; University of Cambridge	Russell, AF (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	a.f.russell@sheffield.ac.uk	Kilner, Rebecca/B-2867-2012; Langmore, Naomi E/C-9302-2009	Kilner, Rebecca/0000-0003-1159-0758; 				BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Dunn PO, 1996, EVOLUTION, V50, P2542, DOI 10.1111/j.1558-5646.1996.tb03643.x; DUNN PO, 1995, P ROY SOC B-BIOL SCI, V259, P339, DOI 10.1098/rspb.1995.0050; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; JAMIESON IG, 1989, AM NAT, V133, P394, DOI 10.1086/284925; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; MacGregor NA, 2002, ANIM BEHAV, V63, P923, DOI 10.1006/anbe.2001.1991; Russell AF, 2007, P R SOC B, V274, P513, DOI 10.1098/rspb.2006.3698; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Russell AF, 2003, P NATL ACAD SCI USA, V100, P3333, DOI 10.1073/pnas.0636503100; Stacey P.B., 1990, COOPERATIVE BREEDING; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Wright J, 1998, J AVIAN BIOL, V29, P105, DOI 10.2307/3677187	23	158	160	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					941	944		10.1126/science.1146037	http://dx.doi.org/10.1126/science.1146037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702942				2022-12-28	WOS:000248780200038
J	Honer, OP; Wachter, B; East, ML; Streich, WJ; Wilhelm, K; Burke, T; Hofer, H				Hoener, O. P.; Wachter, B.; East, M. L.; Streich, W. J.; Wilhelm, K.; Burke, T.; Hofer, H.			Female mate-choice drives the evolution of male-biased dispersal in a social mammal	NATURE			English	Article							INBREEDING AVOIDANCE; SPOTTED HYENAS; TACTICS; SOCIETY; BIRDS	Dispersal has a significant impact on lifetime reproductive success(1), and is often more prevalent in one sex than the other(2). In group- living mammals, dispersal is normally male- biased and in theory this sexual bias could be a response by males to female mate preferences, competition for access to females or resources, or the result of males avoiding inbreeding(2-7). There is a lack of studies on social mammals that simultaneously assess these factors and measure the fitness consequences of male dispersal decisions. Here we show that male- biased dispersal in the spotted hyaena ( Crocuta crocuta) most probably results from an adaptive response by males to simple female mate- choice rules that have evolved to avoid inbreeding. Microsatellite profiling revealed that females preferred sires that were born into or immigrated into the female's group after the female was born. Furthermore, young females preferred short- tenured sires and older females preferred longer- tenured sires. Males responded to these female mate preferences by initiating their reproductive careers in groups containing the highest number of young females. As a consequence, 11% of males started their reproductive career in their natal group and 89% of males dispersed. Males that started reproduction in groups containing the highest number of young females had a higher long- term reproductive success than males that did not. The female mate- choice rules ensured that females effectively avoided inbreeding without the need to discriminate directly against close kin or males born in their own group, or to favour immigrant males. The extent of male dispersal as a response to such female mate preferences depends on the demographic structure of breeding groups, rather than the genetic relatedness between females and males.	Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Leibniz Institut fur Zoo und Wildtierforschung; University of Sheffield	Honer, OP (corresponding author), Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany.	hoener@izw-berlin.de	Burke, Terry/B-3196-2011; Hofer, Heribert/AAF-7854-2021; Höner, Oliver P./N-3224-2014; Wachter, Bettina/AAJ-9663-2020	Burke, Terry/0000-0003-3848-1244; Hofer, Heribert/0000-0002-2813-7442; Höner, Oliver P./0000-0002-0658-3417; Wachter, Bettina/0000-0002-0414-2298				ALBERT R, 2002, THESIS FREIE U BERLI; ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hofer H., 1995, SERENGETI, P332, DOI DOI 10.1186/1471-2148-9-253; Honer OP, 2005, OIKOS, V108, P544, DOI 10.1111/j.0030-1299.2005.13533.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; KEANE B, 1990, ANIM BEHAV, V40, P143, DOI 10.1016/S0003-3472(05)80674-8; Kokko H, 1998, AM NAT, V152, P354, DOI 10.1086/286174; Kruuk H., 1972, SPOTTED HYENA STUDY; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Manly B., 1993, RESOURCE SELECTION A; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; McFadden D., 1974, CONDITIONAL LOGIT AN, P105, DOI DOI 10.1108/EB028592; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; Parker G.A., 1983, P141; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Pusey A., 1986, PRIMATE SOC, P250; Sherman Paul W., 1997, P69; Smale L, 1997, ADV STUD BEHAV, V26, P181, DOI 10.1016/S0065-3454(08)60380-0; SMITH RH, 1979, HEREDITY, V43, P205, DOI 10.1038/hdy.1979.75; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wilhelm K, 2003, MOL ECOL NOTES, V3, P360, DOI 10.1046/j.1471-8286.2003.00450.x	30	80	80	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					798	U5		10.1038/nature06040	http://dx.doi.org/10.1038/nature06040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700698				2022-12-28	WOS:000248754200038
J	Santamaria, D; Barriere, C; Cerqueira, A; Hunt, S; Tardy, C; Newton, K; Caceres, JF; Dubus, P; Malumbres, M; Barbacid, M				Santamaria, David; Barriere, Cedric; Cerqueira, Antonio; Hunt, Sarah; Tardy, Claudine; Newton, Kathryn; Caceres, Javier F.; Dubus, Pierre; Malumbres, Marcos; Barbacid, Mariano			Cdk1 is sufficient to drive the mammalian cell cycle	NATURE			English	Article							EMBRYONIC LETHALITY; DEPENDENT KINASES; GENE; MICE; DISRUPTION; P27(KIP1); MOUSE	Unicellular organisms such as yeasts require a single cyclin-dependent kinase, Cdk1, to drive cell division(1). In contrast, mammalian cells are thought to require the sequential activation of at least four different cyclin- dependent kinases, Cdk2, Cdk3, Cdk4 and Cdk6, to drive cells through interphase, as well as Cdk1 to proceed through mitosis(2). This model has been challenged by recent genetic evidence that mice survive in the absence of individual interphase Cdks(3-8). Moreover, most mouse cell types proliferate in the absence of two or even three interphase Cdks(8-10). Similar results have been obtained on ablation of some of the activating subunits of Cdks, such as the D- type and E- type cyclins(11-14). Here we show that mouse embryos lacking all interphase Cdks ( Cdk2, Cdk3, Cdk4 and Cdk6) undergo organogenesis and develop to midgestation. In these embryos, Cdk1 binds to all cyclins, resulting in the phosphorylation of the retinoblastoma protein pRb and the expression of genes that are regulated by E2F transcription factors. Mouse embryonic fibroblasts derived from these embryos proliferate in vitro, albeit with an extended cell cycle due to inefficient inactivation of Rb proteins. However, they become immortal on continuous passage. We also report that embryos fail to develop to the morula and blastocyst stages in the absence of Cdk1. These results indicate that Cdk1 is the only essential cell cycle Cdk. Moreover, they show that in the absence of interphase Cdks, Cdk1 can execute all the events that are required to drive cell division.	Ctr Nacl Invest Oncol CNIO, Mol Oncol Programme, E-28029 Madrid, Spain; Univ Bordeaux 2, EA2406, F-33076 Bordeaux, France; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	UDICE-French Research Universities; Universite de Bordeaux; University of Edinburgh	Barbacid, M (corresponding author), Ctr Nacl Invest Oncol CNIO, Mol Oncol Programme, E-28029 Madrid, Spain.	mbarbacid@cnio.es	Santamaria, David/D-3930-2011; Tardy, Claudine/AAE-5026-2019; Caceres, Javier F/D-5260-2013; Tardy, Claudine/G-2737-2017; Malumbres, Marcos/E-8834-2011	Santamaria, David/0000-0002-4711-3569; Tardy, Claudine/0000-0002-5292-0672; Caceres, Javier F/0000-0001-8025-6169; Malumbres, Marcos/0000-0002-0829-6315; Dubus, Pierre/0000-0003-1803-4711	Medical Research Council [MC_U127584479] Funding Source: Medline; MRC [MC_U127584479] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; ROBLES MTS, 1994, MOL CELL BIOL, V14, P2686, DOI 10.1128/MCB.14.4.2686; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	24	707	728	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					811	U8		10.1038/nature06046	http://dx.doi.org/10.1038/nature06046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700700				2022-12-28	WOS:000248754200041
J	Mangin, D; Sweeney, K; Heath, I				Mangin, Dee; Sweeney, Kieran; Heath, Iona			Preventive health care in elderly people needs rethinking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		Univ Otago, Christchurch Sch Med, Christchurch, New Zealand; Royal Devon & Exeter Hosp, Peninsula Med Sch, Exeter EX2 5DW, Devon, England; Caversham Grp Practice, London NW5 2UP, England	University of Otago; University of Exeter	Mangin, D (corresponding author), Univ Otago, Christchurch Sch Med, Christchurch, New Zealand.	derelie.mangin@chmeds.ac.nz		Mangin, Dee/0000-0003-2149-9376				Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bjerre LM, 2001, AM J MED, V110, P716, DOI 10.1016/S0002-9343(01)00705-7; Emslie C, 2001, CORONARY HLTH CARE, V5, P25, DOI DOI 10.1054/CHEC.2000.0109; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Gray Denis Pereira, 2005, J Health Serv Res Policy, V10, P66, DOI 10.1258/1355819053559146; Hippisley-Cox J, 2005, BRIT J GEN PRACT, V55, P369; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lubsen J, 2000, LANCET, V356, P1757, DOI 10.1016/S0140-6736(00)03215-3; *NAT HLTH SERV, NAT SERV FRAM COR HE; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Tsoukas H, 1997, FUTURES, V29, P827, DOI 10.1016/S0016-3287(97)00035-9; Wanless D, 2001, SECURING OUR FUTURE	14	75	78	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2007	335	7614					285	287		10.1136/bmj.39241.630741.BE1	http://dx.doi.org/10.1136/bmj.39241.630741.BE1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	203PV	17690369	Green Published			2022-12-28	WOS:000248987400023
J	Semenkovich, CF; Teitelbaum, SL				Semenkovich, Clay F.; Teitelbaum, Steven L.			Bone weighs in on obesity	CELL			English	Editorial Material							DIABETES-MELLITUS; MINERAL DENSITY; ELDERLY-WOMEN; TURNOVER; FRACTURE	Obesity, insulin resistance, and diabetes are related disorders of energy metabolism for which therapies are suboptimal. In this issue of Cell, Lee et al. ( 2007) demonstrate in mice that bone regulates the insulin/glucose axis and energy metabolism, providing a new framework for approaching common disorders of bioenergetics.	Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA.	csemenko@wustl.edu; teitelbs@wustl.edu		Teitelbaum, Steven/0000-0002-4054-6679; Semenkovich, Clay/0000-0003-1163-1871				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1506, DOI 10.1007/s00198-005-1877-5; Goulding A, 2001, J PEDIATR-US, V139, P509, DOI 10.1067/mpd.2001.116297; Greenspan SL, 2005, J CLIN ENDOCR METAB, V90, P2762, DOI 10.1210/jc.2004-1091; Horiuchi T, 2004, J BONE MINER METAB, V22, P236, DOI 10.1007/s00774-003-0473-z; Inaba M, 2004, J BONE MINER METAB, V22, P287, DOI 10.1007/s00774-004-0501-7; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; LEE NK, 2007, CELL; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Semenkovich CF, 2006, J CLIN INVEST, V116, P1813, DOI 10.1172/JCI29024	10	9	14	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					409	411		10.1016/j.cell.2007.07.031	http://dx.doi.org/10.1016/j.cell.2007.07.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693252	Bronze			2022-12-28	WOS:000249038100010
J	Cohen, JJ; Cruess, S; Davidson, C				Cohen, Jordan J.; Cruess, Sylvia; Davidson, Christopher			Alliance between society and medicine - The public's stake in medical professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MILLENNIUM; CHARTER; CENTERS		Assoc Amer Med Coll, Washington, DC 20037 USA; George Washington Univ, Dept Med, Washington, DC USA; George Washington Univ, Dept Publ Hlth, Washington, DC USA; McGill Univ, Fac Med, Montreal, PQ, Canada; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England	Association of American Medical Colleges; George Washington University; George Washington University; McGill University; University of Brighton	Cohen, JJ (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	jjcohen@aamc.org						Anderson GF, 2006, HEALTH AFFAIR, V25, P819, DOI 10.1377/hlthaff.25.3.819; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Gough J. W., 1957, SOCIAL CONTRACT CRIT; HOWARD P.K., 2007, WALL STREET J; KIRCH D, 2006, AAMC ANN M ADDR OCT; Salsberg E, 2006, ACAD MED, V81, P782, DOI 10.1097/00001888-200609000-00003; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; WENNBERG JE, 2004, HLTH AFF MILLWOOD S	9	48	49	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					670	673		10.1001/jama.298.6.670	http://dx.doi.org/10.1001/jama.298.6.670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684189				2022-12-28	WOS:000248574800027
J	Bag, S; Trikalitis, PN; Chupas, PJ; Armatas, GS; Kanatzidis, MG				Bag, Santanu; Trikalitis, Pantelis N.; Chupas, Peter J.; Armatas, Gerasimos S.; Kanatzidis, Mercouri G.			Porous semiconducting gels and aerogels from chalcogenide clusters	SCIENCE			English	Article							MESOSTRUCTURED SEMICONDUCTORS; METAL	Inorganic porous materials are being developed for use as molecular sieves, ion exchangers, and catalysts, but most are oxides. We show that various sulfide and selenide clusters, when bound to metal ions, yield gels having porous frameworks. These gels are transformed to aerogels after supercritical drying with carbon dioxide. The aerogels have high internal surface area ( up to 327 square meters per gram) and broad pore size distribution, depending on the precursors used. The pores of these sulfide and selenide materials preferentially absorb heavy metals. These materials have narrow energy gaps ( between 0.2 and 2.0 electron volts) and low densities, and they may be useful in optoelectronics, as photocatalysts, or in the removal of heavy metals from water.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	Northwestern University; Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	m-kanatzidis@northwestern.edu	Armatas, Gerasimos/F-4753-2011; Trikalitis, Pantelis N/E-5696-2011	Armatas, Gerasimos/0000-0001-9475-1929; Trikalitis, Pantelis/0000-0002-6286-2955				Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; Brinker C. J., 1990, SOL GEL SCI, V3, P115; Carreon MA, 2005, EUR J INORG CHEM, P27, DOI 10.1002/ejic.200400675; GREGG S. J., 1982, AUFLAGE, V2nd; He X, 2002, ANGEW CHEM INT EDIT, V41, P214, DOI 10.1002/1521-3773(20020118)41:2<214::AID-ANIE214>3.0.CO;2-D; Heibel M, 1996, CHEM MATER, V8, P1504, DOI 10.1021/cm960105u; Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I; Kalebaila KK, 2006, J NON-CRYST SOLIDS, V352, P232, DOI 10.1016/j.jnoncrysol.2005.11.035; Kistler SS, 1932, J PHYS CHEM-US, V36, P52, DOI 10.1021/j150331a003; Korlann SD, 2005, J AM CHEM SOC, V127, P12516, DOI 10.1021/ja045446k; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; Mercier L, 1997, ADV MATER, V9, P500, DOI 10.1002/adma.19970090611; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; PEKALA RW, 1992, J NON-CRYST SOLIDS, V145, P90, DOI 10.1016/S0022-3093(05)80436-3; Trikalitis PN, 2002, J AM CHEM SOC, V124, P2604, DOI 10.1021/ja017245b; Trikalitis PN, 2002, J AM CHEM SOC, V124, P12255, DOI 10.1021/ja026367g; Trikalitis PN, 2001, NATURE, V410, P671, DOI 10.1038/35070533	17	326	329	9	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					490	493		10.1126/science.1142535	http://dx.doi.org/10.1126/science.1142535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656718				2022-12-28	WOS:000248339800038
J	Donsante, A; Miller, DG; Li, Y; Vogler, C; Brunt, EM; Russell, DW; Sands, MS				Donsante, Anthony; Miller, Daniel G.; Li, Yi; Vogler, Carole; Brunt, Elizabeth M.; Russell, David W.; Sands, Mark S.			AAV vector integration sites in mouse hepatocellular carcinoma	SCIENCE			English	Article							LIVER; CELLS; TUMOR		Univ Washington, Dept Med, Seattle, WA 98112 USA; Univ Washington, Dept Biochem, Seattle, WA 98112 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Washington, Dept Pediat, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Mail Stop 357720, Seattle, WA 98112 USA.	drussell@u.washington.edu; msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Miller, Daniel/0000-0002-5700-3048; Donsante, Anthony/0000-0002-7591-7417	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071657] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Embury JE, 2006, MOL THER, V13, pS83, DOI 10.1016/j.ymthe.2006.08.241; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Miller DG, 2005, J VIROL, V79, P11434, DOI 10.1128/JVI.79.17.11434-11442.2005; Nakai H, 2005, J VIROL, V79, P3606, DOI 10.1128/JVI.79.6.3606-3614.2005	8	443	468	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					477	477		10.1126/science.1142658	http://dx.doi.org/10.1126/science.1142658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656716				2022-12-28	WOS:000248339800034
J	Corneli, HM; Zorc, JJ; Majahan, P; Shaw, KN; Holubkov, R; Reeves, SD; Ruddy, RM; Malik, B; Nelson, KA; Bregstein, JS; Brown, KM; Denenberg, MN; Lillis, KA; Cimpello, LB; Tsung, JW; Borgialli, DA; Baskin, MN; Teshome, G; Goldstein, MA; Monroe, D; Dean, JM; Kuppermann, N				Corneli, Howard M.; Zorc, Joseph J.; Majahan, Prashant; Shaw, Kathy N.; Holubkov, Richard; Reeves, Scott D.; Ruddy, Richard M.; Malik, Baqir; Nelson, Kyle A.; Bregstein, Joan S.; Brown, Kathleen M.; Denenberg, Matthew N.; Lillis, Kathleen A.; Cimpello, Lynn Babcock; Tsung, James W.; Borgialli, Dominic A.; Baskin, Marc N.; Teshome, Getachew; Goldstein, Mitchell A.; Monroe, David; Dean, J. Michael; Kuppermann, Nathan		PECARN	A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; NEBULIZED BUDESONIDE; ORAL DEXAMETHASONE; INFANTS; CHILDREN; PLACEBO; PREDNISOLONE; MANAGEMENT; EMERGENCY; CORTICOSTEROIDS	Background: Bronchiolitis, the most common infection of the lower respiratory tract in infants, is a leading cause of hospitalization in childhood. Corticosteroids are commonly used to treat bronchiolitis, but evidence of their effectiveness is limited. Methods: We conducted a double-blind, randomized trial comparing a single dose of oral dexamethasone (1 mg per kilogram of body weight) with placebo in 600 children (age range, 2 to 12 months) with a first episode of wheezing diagnosed in the emergency department as moderate-to-severe bronchiolitis (defined by a Respiratory Distress Assessment Instrument score greater/equal 6). We enrolled patients at 20 emergency departments during the months of November through April over a 3-year period. The primary outcome was hospital admission after 4 hours of emergency department observation. The secondary outcome was the Respiratory Assessment Change Score (RACS). We also evaluated later outcomes: length of hospital stay, later medical visits or admissions, and adverse events. Results: Baseline characteristics were similar in the two groups. The admission rate was 39.7% for children assigned to dexamethasone, as compared with 41.0% for those assigned to placebo (absolute difference, -1.3%; 95% confidence interval [CI], -9.2 to 6.5). Both groups had respiratory improvement during observation; the mean 4-hour RACS was -5.3 for dexamethasone, as compared with -4.8 for placebo (absolute difference, -0.5; 95% CI, -1.3 to 0.3). Multivariate adjustment did not significantly alter the results, nor were differences detected in later outcomes. Conclusions: In infants with acute moderate-to-severe bronchiolitis who were treated in the emergency department, a single dose of 1 mg of oral dexamethasone per kilogram did not significantly alter the rate of hospital admission, the respiratory status after 4 hours of observation, or later outcomes.	Univ Utah, Salt Lake City, UT USA; Cent Data Management & Corrdinating Ctr, Salt Lake City, UT USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Childrens Hosp Michigan, Detroit, MI 48201 USA; Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; Washington Univ, St Louis, MO USA; Columbia Univ, New York, NY USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Devos Childrens Hosp, Grand Rapids, MI USA; Women & Childrens Hosp Buffalo, Buffalo, NY USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Bellevue Hosp Ctr, New York, NY 10016 USA; Hurley Med Ctr, Flint, MI USA; Childrens Hosp, Boston, MA 02115 USA; Univ Maryland, Baltimore, MD 21201 USA; Johns Hopkins Childrens Ctr, Baltimore, MD USA; Howard Cty Gen Hosp, Columbia, MD USA; Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital of Michigan; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Columbia University; Children's National Health System; Women & Children's Hospital of Buffalo; University of Rochester; Bellevue Hospital Center; Harvard University; Boston Children's Hospital; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Davis	Corneli, HM (corresponding author), POB 581289, Salt Lake City, UT 84158 USA.		Tsung, James W/I-6343-2019	Tsung, James/0000-0002-4718-8325	PHS HHS [R40MC042980100, U03MC00001, U03MC00008, U03MC00006, U03MC00007] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agency for Healthcare Research and Quality, 2003, AHRQ PUBL; Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Bentur L, 2005, ACTA PAEDIATR, V94, P866, DOI 10.1080/08035250510028407; BENTUR L, 1992, PEDIATRICS, V89, P133; Berger I, 1998, PEDIATR PULM, V26, P162, DOI 10.1002/(SICI)1099-0496(199809)26:3<162::AID-PPUL2>3.0.CO;2-N; CHOU JW, 2001, CAN J HOSP PHARM, V54, P96; Christakis DA, 2005, PEDIATRICS, V115, P878, DOI 10.1542/peds.2004-1299; Csonka P, 2003, J PEDIATR-US, V143, P725, DOI 10.1067/S0022-3476(03)00498-0; De Boeck K, 1997, J PEDIATR-US, V131, P919, DOI 10.1016/S0022-3476(97)70044-1; ELLULMICALLEF R, 1982, EUR J RESPIR DIS, V63, P118; Garrison MM, 2000, PEDIATRICS, V105, pCP4, DOI 10.1542/peds.105.4.e44; Goebel J, 2000, CLIN PEDIATR, V39, P213, DOI 10.1177/000992280003900404; Hanna CM, 2004, ANN EMERG MED, V43, P699, DOI 10.1016/j.annemergmed.2003.10.002; Johnson DW, 1998, NEW ENGL J MED, V339, P498, DOI 10.1056/NEJM199808203390802; Kellner JD, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001266, DOI 10.1002/14651858.CD001266]; Klassen TP, 1998, JAMA-J AM MED ASSOC, V279, P1629, DOI 10.1001/jama.279.20.1629; Klassen TP, 1997, J PEDIATR-US, V130, P191, DOI 10.1016/S0022-3476(97)70342-1; Kuyucu S, 2004, PEDIATR INT, V46, P539, DOI 10.1111/j.1442-200x.2004.01944.x; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Lin RY, 1999, ANN EMERG MED, V33, P487, DOI 10.1016/S0196-0644(99)70334-3; LOWELL DI, 1987, PEDIATRICS, V79, P939; McBride JT, 2002, J PEDIATR-US, V140, P8, DOI 10.1067/mpd.2002.121691; Patel H., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004878; Rodrigo G, 1998, AM J RESP CRIT CARE, V157, P698, DOI 10.1164/ajrccm.157.3.9704022; Roosevelt G, 1996, LANCET, V348, P292, DOI 10.1016/S0140-6736(96)02285-4; Rowe BH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002178; RUSSELL K, 2004, COCHRANE DB SYST REV, V1; SCARFONE RJ, 1995, ANN EMERG MED, V26, P480, DOI 10.1016/S0196-0644(95)70118-4; SCARFONE RJ, 1993, PEDIATRICS, V92, P513; Schuh S, 2002, J PEDIATR-US, V140, P27, DOI 10.1067/mpd.2002.120271; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; van Woensel JBM, 1997, THORAX, V52, P634, DOI 10.1136/thx.52.7.634; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; Willson DF, 2001, PEDIATRICS, V108, P851, DOI 10.1542/peds.108.4.851	36	195	201	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					331	339		10.1056/NEJMoa071255	http://dx.doi.org/10.1056/NEJMoa071255			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652648				2022-12-28	WOS:000248283500004
J	Bundy, DG; Byerley, JS; Liles, EA; Perrin, EM; Katznelson, J; Rice, HE				Bundy, David G.; Byerley, Julie S.; Liles, E. Allen; Perrin, Eliana M.; Katznelson, Jessica; Rice, Henry E.			Does this child have appendicitis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; ABDOMINAL-PAIN; RECTAL EXAMINATION; SUSPECTED APPENDICITIS; PEDIATRIC APPENDICITIS; NEONATAL APPENDICITIS; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; ALVARADO-SCORE; CELL COUNT	Context Evaluation of abdominal pain in children can be difficult. Rapid, accurate diagnosis of appendicitis in children reduces the morbidity of this common cause of pediatric abdominal pain. Clinical evaluation may help identify ( 1) which children with abdominal pain and a likely diagnosis of appendicitis should undergo immediate surgical consultation for potential appendectomy and ( 2) which children with equivocal presentations of appendicitis should undergo further diagnostic evaluation. Objective To systematically assess the precision and accuracy of symptoms, signs, and basic laboratory test results for evaluating children with possible appendicitis. Data Sources We searched English-language articles in MEDLINE ( January 1966 March 2007) and the Cochrane Database, as well as physical examination textbooks and bibliographies of retrieved articles, yielding 2521 potentially relevant articles. Study Selection Studies were included if they ( 1) provided primary data on children aged 18 years or younger in whom the diagnosis of appendicitis was considered; ( 2) presented medical history data, physical examination findings, or basic laboratory data; and ( 3) confirmed or excluded appendicitis by surgical pathologic findings, clinical observation, or follow-up. Of 256 full-text articles examined, 42 met inclusion criteria. Data Extraction Twenty-five of 42 studies were assigned a quality level of 3 or better. Data from these studies were independently extracted by 2 reviewers. Results In children with abdominal pain, fever was the single most useful sign associated with appendicitis; a fever increases the likelihood of appendicitis ( likelihood ratio [LR], 3.4; 95% confidence interval [CI], 2.4-4.8) and conversely, its absence decreases the chance of appendicitis ( LR, 0.32; 95% CI, 0.16-0.64). In select groups of children, in whom the diagnosis of appendicitis is suspected and evaluation undertaken, rebound tenderness triples the odds of appendicitis ( summary LR, 3.0; 95% CI, 2.3-3.9), while its absence reduces the likelihood ( summary LR, 0.28; 95% CI, 0.14-0.55). Midabdominal pain migrating to the right lower quadrant ( LR range, 1.9-3.1) increases the risk of appendicitis more than right lower quadrant pain itself ( summary LR, 1.2; 95% CI, 1.0-1.5). A white blood cell count of less than 10 000/ mu L decreases the likelihood of appendicitis ( summary LR, 0.22; 95% CI, 0.17-0.30), as does an absolute neutrophil count of 6750/ mu L or lower ( LR, 0.06; 95% CI, 0.03-0.16). Symptoms and signs are most useful in combination, particularly for identifying children who do not require further evaluation or intervention. Conclusions Although the clinical examination does not establish a diagnosis of appendicitis with certainty, it is useful in determining which children with abdominal pain warrant immediate surgical evaluation for consideration of appendectomy and which children may warrant further diagnostic evaluation. More child-specific, age-stratified data are needed to improve the utility of the clinical examination for diagnosing appendicitis in children.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Bundy, DG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, CMSC 1-141,600 N Wolfe St, Baltimore, MD 21287 USA.	dbundy3@jhmi.edu		Liles, Edmund/0000-0001-5490-5233	NICHD NIH HHS [K23 HD051817, K23 HD051817-01A1, 1K23 HD051817-01A1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD051817] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; BANCO L, 1984, AM J DIS CHILD, V138, P976, DOI 10.1001/archpedi.1984.02140480078024; BICKLEY LS, 1999, BATES GUIDE PHYS EXA; BOND GR, 1990, ANN EMERG MED, V19, P1014; BONELLO JC, 1979, DIS COLON RECTUM, V22, P97, DOI 10.1007/BF02586770; Bratton SL, 2000, PEDIATRICS, V106, P75, DOI 10.1542/peds.106.1.75; BRENDER JD, 1985, PEDIATRICS, V76, P301; Craig JV, 2000, BRIT MED J, V320, P1174, DOI 10.1136/bmj.320.7243.1174; Craig JV, 2002, LANCET, V360, P603, DOI 10.1016/S0140-6736(02)09783-0; CURRAN TJ, 1993, J PEDIATR SURG, V28, P204, DOI 10.1016/S0022-3468(05)80276-3; Dado G, 2000, J PEDIATR SURG, V35, P1320, DOI 10.1053/jpsu.2000.9316; DeGowin R. L., 1994, DEGOWIN DEGOWINS DIA; DICKSON AP, 1985, ARCH DIS CHILD, V60, P666, DOI 10.1136/adc.60.7.666; DIXON JM, 1991, BRIT MED J, V302, P386, DOI 10.1136/bmj.302.6773.386; DOLGIN SE, 1992, SURG GYNECOL OBSTET, V175, P320; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Eddy DM, 1992, METAANALYSIS CONFIDE; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; GRAHAM JM, 1980, AM J SURG, V139, P247, DOI 10.1016/0002-9610(80)90265-2; Graneto JW, 1996, PEDIATR EMERG CARE, V12, P183, DOI 10.1097/00006565-199606000-00009; GROSFELD JL, 1973, J PEDIATR SURG, V8, P285, DOI 10.1016/S0022-3468(73)80096-X; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; HARLAND R N L, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P89; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Horwitz JR, 1997, AM J SURG, V173, P80, DOI 10.1016/S0002-9610(96)00417-5; Karaman A, 2003, PEDIATR SURG INT, V19, P707, DOI 10.1007/s00383-003-1030-5; Kharbanda AB, 2005, PEDIATRICS, V116, P709, DOI 10.1542/peds.2005-0094; Lintula H, 2005, LANGENBECK ARCH SURG, V390, P164, DOI 10.1007/s00423-005-0545-8; LUCKMANN R, 1989, AM J EPIDEMIOL, V129, P905, DOI 10.1093/oxfordjournals.aje.a115224; Macklin CP, 1997, ANN ROY COLL SURG, V79, P203; MIKAELSSON C, 1984, ANN CHIR GYNAECOL FE, V73, P281; MISKOWIAK J, 1982, DAN MED BULL, V29, P210; MOLLITT DL, 1988, SOUTHERN MED J, V81, P1477, DOI 10.1097/00007611-198812000-00004; Nance ML, 2000, PEDIATR EMERG CARE, V16, P160, DOI 10.1097/00006565-200006000-00005; Nelson DS, 2000, PEDIATR EMERG CARE, V16, P233, DOI 10.1097/00006565-200008000-00004; O'Shea J S, 1988, Pediatr Emerg Care, V4, P172, DOI 10.1097/00006565-198809000-00002; ODOM NJ, 1982, ANN ROY COLL SURG, V64, P260; Orient JM., 2000, SAPIRAS ART SCI BEDS; OWEN TD, 1992, J ROY SOC MED, V85, P87; Paajanen H, 1997, J AM COLL SURGEONS, V184, P303; Paajanen H, 1996, ACTA PAEDIATR, V85, P459, DOI 10.1111/j.1651-2227.1996.tb14061.x; PEARL RH, 1995, J PEDIATR SURG, V30, P173, DOI 10.1016/0022-3468(95)90556-1; PELTOLA H, 1986, ACTA CHIR SCAND, V152, P55; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; REYNOLDS SL, 1992, PEDIATR EMERG CARE, V8, P126, DOI 10.1097/00006565-199206000-00003; Robinson JL, 1998, J PEDIATR-US, V133, P553, DOI 10.1016/S0022-3476(98)70067-8; Robinson Joan L, 2005, BMC Fam Pract, V6, P3, DOI 10.1186/1471-2296-6-3; Rodriguez-Sanjuan JC, 1999, DIS COLON RECTUM, V42, P1325, DOI 10.1007/BF02234223; ROTHROCK SG, 1991, ANN EMERG MED, V20, P45, DOI 10.1016/S0196-0644(05)81117-5; Rothrock SG, 2000, ANN EMERG MED, V36, P39, DOI 10.1067/mem.2000.105658; Rothrock Steven G., 1995, Journal of Emergency Medicine, V13, P1, DOI 10.1016/0736-4679(94)00104-9; Samuel M, 2002, J PEDIATR SURG, V37, P877, DOI 10.1053/jpsu.2002.32893; Schneider C, 2007, ANN EMERG MED, V49, P778, DOI 10.1016/j.annemergmed.2006.12.016; Scholer SJ, 1996, PEDIATRICS, V98, P680; SCHORLEMMER GR, 1983, SOUTHERN MED J, V76, P536, DOI 10.1097/00007611-198304000-00039; Seidel HM, 1999, MOSBYS GUIDE PHYS EX; Selbst SM, 2005, PEDIATR EMERG CARE, V21, P165; Smink DS, 2005, PEDIATRICS, V115, P920, DOI 10.1542/peds.2004-1363; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Trowbridge RL, 2003, JAMA-J AM MED ASSOC, V289, P80, DOI 10.1001/jama.289.1.80; Turkyilmaz Z, 2006, SCAND J CLIN LAB INV, V66, P723, DOI 10.1080/00365510600975251; van den Broek WT, 2004, J PEDIATR SURG, V39, P570, DOI 10.1016/j.jpedsurg.2003.12.015; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Wu Han-Ping, 2003, Acta Paediatrica Taiwanica, V44, P227; Yen K, 2005, ARCH PEDIAT ADOL MED, V159, P373, DOI 10.1001/archpedi.159.4.373	66	212	219	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					438	451		10.1001/jama.298.4.438	http://dx.doi.org/10.1001/jama.298.4.438			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652298	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000248269100023
J	Srinivasan, G; Whitehouse, MJ; Weber, I; Yamaguchi, A				Srinivasan, G.; Whitehouse, M. J.; Weber, I.; Yamaguchi, A.			The crystallization age of eucrite zircon	SCIENCE			English	Article							EARLY CORE FORMATION; EARLY SOLAR-SYSTEM; PARENT BODY; BASALTIC EUCRITES; ASTEROID-4 VESTA; METAMORPHISM; METEORITES; HF-182-W-182; DIFFERENTIATION; CHRONOLOGY	Eucrites are a group of meteorites that represent the first planetary igneous activity following metal-silicate differentiation on an early planetesimal, similar to Asteroid 4 Vesta, and, thus, help date geophysical processes occurring on such bodies in the early solar system. Using the short-lived radionuclide Hf-182 as a relative chronometer, we demonstrate that eucrite zircon crystallized quickly within 6.8 million years of metal-silicate differentiation. This implies that mantle differentiation on the eucrite parent body occurred during a period when internal heat from the decay of Al-26 and Fe-60 was still available. Later metamorphism of eucrites took place at least 8.9 million years after the zircons crystallized and was likely caused by heating from impacts, or by burial under hot material excavated by impacts, rather than from lava flows. Thus, the timing of eucrite formation and of mantle differentiation is constrained.	Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden; Univ Munster, Inst Planetol, Dept Geosci, D-48149 Munster, Germany; Natl Inst Polar Res, Tokyo 1738515, Japan	University of Toronto; Swedish Museum of Natural History; University of Munster; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Srinivasan, G (corresponding author), Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada.	srini@geology.utoronto.ca	Whitehouse, Martin J/E-1425-2013	Whitehouse, Martin J/0000-0003-2227-577X				Bingen B, 2001, J PETROL, V42, P355, DOI 10.1093/petrology/42.2.355; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; CARLSON RW, 2000, ORIGIN EARTH MOON, P25; DELANEY JS, 1995, LUNAR PLANET SCI, V26, P329; Ghosh A, 1998, ICARUS, V134, P187, DOI 10.1006/icar.1998.5956; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; Kleine T, 2005, EARTH PLANET SC LETT, V231, P41, DOI 10.1016/j.epsl.2004.12.016; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Lee JKW, 1997, NATURE, V390, P159, DOI 10.1038/36554; LINDSLEY DH, 1983, AM MINERAL, V68, P477; LUDWIG KR, 1991, SPECIAL PUBLICATIO A, V1; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; METZLER K, 1995, PLANET SPACE SCI, V43, P499, DOI 10.1016/0032-0633(94)00219-H; Misawa K, 2005, GEOCHIM COSMOCHIM AC, V69, P5847, DOI 10.1016/j.gca.2005.08.009; MIYAMOTO M, 1994, EARTH PLANET SC LETT, V122, P343, DOI 10.1016/0012-821X(94)90007-8; Nyquist LE, 2003, EARTH PLANET SC LETT, V214, P11, DOI 10.1016/S0012-821X(03)00371-6; Palme H., 1981, P LUNAR PLANET SCI, V12B, P949; Quitte G, 2000, EARTH PLANET SC LETT, V184, P83, DOI 10.1016/S0012-821X(00)00303-4; Schoenberg R, 2002, GEOCHIM COSMOCHIM AC, V66, P3151, DOI 10.1016/S0016-7037(02)00911-0; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; SRINIVASAN G, 2002, LUNAR PLANET SCI, V33; STOLPER E, 1977, GEOCHIM COSMOCHIM AC, V41, P587, DOI 10.1016/0016-7037(77)90300-3; Takeda H., 1997, ANTARCTIC METEORITE, V10, P401; Yamaguchi A, 1996, ICARUS, V124, P97, DOI 10.1006/icar.1996.0192; Yamaguchi A, 2001, GEOCHIM COSMOCHIM AC, V65, P3577, DOI 10.1016/S0016-7037(01)00681-0; Yamaguchi A., 1997, ANTARCTIC METEORITE, V10, P415	26	37	37	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					345	347		10.1126/science.1140264	http://dx.doi.org/10.1126/science.1140264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641194				2022-12-28	WOS:000248150200039
J	van den Heuvel, MGL; Dekker, C				van den Heuvel, Martin G. L.; Dekker, Cees			Motor proteins at work for nanotechnology	SCIENCE			English	Review							BIOMOLECULAR MOTOR; MICROTUBULE MOTILITY; MOLECULAR SHUTTLES; DNA-MOLECULES; TRANSPORT; DRIVEN; SURFACES; MACHINES; ACTIN; NANOSTRUCTURES	The biological cell is equipped with a variety of molecular machines that perform complex mechanical tasks such as cell division or intracellular transport. One can envision employing these biological motors in artificial environments. We review the progress that has been made in using motor proteins for powering or manipulating nanoscale components. In particular, kinesin and myosin biomotors that move along linear biofilaments have been widely explored as active components. Currently realized applications are merely proof-of-principle demonstrations. Yet, the sheer availability of an entire ready-to-use toolbox of nanosized biological motors is a great opportunity that calls for exploration.	Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.dekker@tudelft.nl		Dekker, Cees/0000-0001-6273-071X				Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bachand GD, 2004, NANO LETT, V4, P817, DOI 10.1021/nl049811h; Bachand GD, 2006, SMALL, V2, P381, DOI 10.1002/smll.200500262; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bohm KJ, 2001, NANOTECHNOLOGY, V12, P238, DOI 10.1088/0957-4484/12/3/307; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Bull JL, 2005, BIOMED MICRODEVICES, V7, P21, DOI 10.1007/s10544-005-6168-6; Bunk R, 2005, NANOTECHNOLOGY, V16, P710, DOI 10.1088/0957-4484/16/6/014; Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e; Clemmens J, 2003, LANGMUIR, V19, P10967, DOI 10.1021/la035519y; Diez S, 2003, NANO LETT, V3, P1251, DOI 10.1021/nl034504h; Dinu CZ, 2006, SMALL, V2, P1090, DOI 10.1002/smll.200600112; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; Hess H, 2004, CHEM-EUR J, V10, P2110, DOI 10.1002/chem.200305712; Hess H, 2002, NANO LETT, V2, P113, DOI 10.1021/nl015647b; Hess H, 2006, SOFT MATTER, V2, P669, DOI 10.1039/b518281f; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; Hiratsuka Y, 2006, P NATL ACAD SCI USA, V103, P13618, DOI 10.1073/pnas.0604122103; Huang YM, 2005, IEEE T ADV PACKAGING, V28, P564, DOI 10.1109/TADVP.2005.858330; Hutchins BM, 2007, SMALL, V3, P126, DOI 10.1002/smll.200600410; Ionov L, 2006, NANO LETT, V6, P1982, DOI 10.1021/nl0611539; Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r; Limberis L, 2001, NANO LETT, V1, P277, DOI [10.1021/nl0155375, 10.1021/n10155375]; Liu HQ, 2002, NAT MATER, V1, P173, DOI 10.1038/nmat761; Luo TJM, 2005, NAT MATER, V4, P220, DOI 10.1038/nmat1322; Mihajlovic G, 2004, APPL PHYS LETT, V85, P1060, DOI 10.1063/1.1777815; Nicolau DV, 2006, MICROELECTRON ENG, V83, P1582, DOI 10.1016/j.mee.2006.01.198; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; Riveline D, 1998, EUR BIOPHYS J BIOPHY, V27, P403, DOI 10.1007/s002490050147; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Seetharam R, 2006, LAB CHIP, V6, P1239, DOI 10.1039/b601635a; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Stracke R, 2000, NANOTECHNOLOGY, V11, P52, DOI 10.1088/0957-4484/11/2/302; Suzuki H, 1997, BIOPHYS J, V72, P1997, DOI 10.1016/S0006-3495(97)78844-1; Taira S, 2006, BIOTECHNOL BIOENG, V95, P533, DOI 10.1002/bit.21055; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van den Heuvel MGL, 2006, SCIENCE, V312, P910, DOI 10.1126/science.1124258; van den Heuvel MGL, 2005, NANO LETT, V5, P1117, DOI 10.1021/nl0506554; van den Heuvel MGL, 2005, NANO LETT, V5, P235, DOI 10.1021/nl048291n; Wendell DW, 2006, SMALL, V2, P1324, DOI 10.1002/smll.200600019; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Yokokawa R, 2004, J MICROELECTROMECH S, V13, P612, DOI 10.1109/JMEMS.2004.832193; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	48	426	433	8	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					333	336		10.1126/science.1139570	http://dx.doi.org/10.1126/science.1139570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641191				2022-12-28	WOS:000248150200035
J	Amelino-Camelia, G				Amelino-Camelia, Giovanni			Theoretical physics - Walk the Planck	NATURE			English	Editorial Material									Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; Natl Inst Nucl Phys, Sez Roma1, I-00185 Rome, Italy	Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN)	Amelino-Camelia, G (corresponding author), Univ Roma La Sapienza, Dept Phys, Piazzale Moro 2, I-00185 Rome, Italy.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					257	257		10.1038/448257a	http://dx.doi.org/10.1038/448257a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637644	Bronze			2022-12-28	WOS:000248118300032
J	Grimwood, K; Buttery, JP				Grimwood, Keith; Buttery, Jim P.			Clinical update: rotavirus gastroenteritis and its prevention	LANCET			English	Article							UNITED-STATES; VACCINES; INTUSSUSCEPTION; VACCINATION; PROTECTION; INFECTION; EFFICACY; CHILDREN; SAFETY; INFANTS		Univ Otago, Sch Med & Hlth Sci, Dept Paediat & Child Hlth, Wellington 6242, New Zealand; NHMRC Ctr Clin Res Excellence Child & Adolescent, Melbourne, Vic, Australia	University of Otago	Grimwood, K (corresponding author), Univ Otago, Sch Med & Hlth Sci, Dept Paediat & Child Hlth, Wellington 6242, New Zealand.	keith.grimwood@otago.ac.nz	Grimwood, Keith/F-9334-2011	Grimwood, Keith/0000-0003-3174-9834				[Anonymous], 24 ANN M EUR SOC PAE; Banerjee I, 2007, J INFECT DIS, V195, P625, DOI 10.1086/510853; Belongia E., 2007, Morbidity and Mortality Weekly Report, V56, P218; Bines J, 2006, VACCINE, V24, P3772, DOI 10.1016/j.vaccine.2005.07.031; Blutt SE, 2007, CURR OPIN GASTROEN, V23, P39, DOI 10.1097/MOG.0b013e328011829d; Chandran A, 2006, J PEDIATR-US, V149, P441, DOI 10.1016/j.jpeds.2006.04.054; Cunliffe NA, 2001, LANCET, V358, P550, DOI 10.1016/S0140-6736(01)05706-3; Fischer TK, 2007, J INFECT DIS, V195, P1117, DOI 10.1086/512863; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Melliez H, 2007, VACCINE, V25, P298, DOI 10.1016/j.vaccine.2006.07.038; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Soriano-Gabarro M, 2006, PEDIATR INFECT DIS J, V25, pS7, DOI 10.1097/01.inf.0000197622.98559.01; Tai JH, 2006, PEDIATRICS, V118, pE258, DOI 10.1542/peds.2005-2874; Van Damme P, 2007, J INFECT DIS, V195, pS4, DOI 10.1086/516714; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151	20	36	38	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					302	304		10.1016/S0140-6736(07)61142-8	http://dx.doi.org/10.1016/S0140-6736(07)61142-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662867				2022-12-28	WOS:000248426100011
J	de la Rocha, J; Doiron, B; Shea-Brown, E; Josic, K; Reyes, A				de la Rocha, Jaime; Doiron, Brent; Shea-Brown, Eric; Josic, Kresimir; Reyes, Alex			Correlation between neural spike trains increases with firing rate	NATURE			English	Article							PYRAMIDAL NEURONS; VISUAL-CORTEX; DISCHARGE; CELLS; SYNCHRONIZATION; COMPUTATION; POPULATION; MACAQUE; INPUT; WEAK	Populations of neurons in the retina(1-3), olfactory system(4), visual(5) and somatosensory(6) thalamus, and several cortical regions(7-10) show temporal correlation between the discharge times of their action potentials ( spike trains). Correlated firing has been linked to stimulus encoding(9), attention(11), stimulus discrimination(4), and motor behaviour(12). Nevertheless, the mechanisms underlying correlated spiking are poorly understood(2,3,13-20), and its coding implications are still debated(13,16,21,22). It is not clear, for instance, whether correlations between the discharges of two neurons are determined solely by the correlation between their afferent currents, or whether they also depend on the mean and variance of the input. We addressed this question by computing the spike train correlation coefficient of unconnected pairs of in vitro cortical neurons receiving correlated inputs. Notably, even when the input correlation remained fixed, the spike train output correlation increased with the firing rate, but was largely independent of spike train variability. With a combination of analytical techniques and numerical simulations using 'integrate- and- fire' neuron models we show that this relationship between output correlation and firing rate is robust to input heterogeneities. Finally, this overlooked relationship is replicated by a standard threshold- linear model, demonstrating the universality of the result. This connection between the rate and correlation of spiking activity links two fundamental features of the neural code.	NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10012 USA; Univ Houston, Dept Math, Houston, TX 77204 USA	New York University; New York University; University of Houston System; University of Houston	Doiron, B (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jrocha@cns.nyu.edu; bdoiron@cns.nyu.edu	de la Rocha, Jaime/I-2119-2015	de la Rocha, Jaime/0000-0002-3314-9384				Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Binder MD, 2001, J NEUROPHYSIOL, V86, P2266, DOI 10.1152/jn.2001.86.5.2266; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lau D, 2000, J NEUROSCI, V20, P9071; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Svirskis G, 2003, NETWORK-COMP NEURAL, V14, P747, DOI 10.1088/0954-898X/14/4/307; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	30	459	462	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					802	U6		10.1038/nature06028	http://dx.doi.org/10.1038/nature06028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700699				2022-12-28	WOS:000248754200039
J	Burnham, G; Robinson, C				Burnham, Gilbert; Robinson, Courtland			Protecting the rights of those in conflict	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA.	gburnham@jhsph.edu						[Anonymous], 2007, REHABILITATING HLTH; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; *FUND PEAC, 2007, FOREIGN POLICY   JUL; *SPHERE PROJ, 2004, HUM CHART MIN STAND; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Swiss S, 1998, JAMA-J AM MED ASSOC, V279, P625, DOI 10.1001/jama.279.8.625; *UN EC SOC COUNC, 2006, REP SPEC RAPP RIGHT	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					463	464		10.1016/S0140-6736(07)61210-0	http://dx.doi.org/10.1016/S0140-6736(07)61210-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693160				2022-12-28	WOS:000248717800007
J	Lee, DF; Kuo, HP; Chen, CT; Hsu, JM; Chou, CK; Wei, Y; Sun, HL; Li, LY; Ping, B; Huang, WC; He, X; Hung, JY; Lai, CC; Ding, Q; Su, JL; Yang, JY; Sahin, AA; Hortobagyi, GN; Tsai, FJ; Tsai, CH; Hung, MC				Lee, Dung-Fang; Kuo, Hsu-Ping; Chen, Chun-Te; Hsu, Jung-Mao; Chou, Chao-Kai; Wei, Yongkun; Sun, Hui-Lung; Li, Long-Yuan; Ping, Bo; Huang, Wei-Chien; He, Xianghuo; Hung, Jen-Yu; Lai, Chien-Chen; Ding, Qingqing; Su, Jen-Liang; Yang, Jer-Yen; Sahin, Aysegul A.; Hortobagyi, Gabriel N.; Tsai, Fuu-Jen; Tsai, Chang-Hai; Hung, Mien-Chie			IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway	CELL			English	Article							KAPPA-B KINASE; CELL-GROWTH; TUBEROUS SCLEROSIS; BREAST-CANCER; MAMMALIAN TARGET; GENE-EXPRESSION; MOUSE MODEL; PHOSPHORYLATION; ACTIVATION; ALPHA	TNF alpha has recently emerged as a regulator linking inflammation to cancer pathogenesis, but the detailed cellular and molecular mechanisms underlying this link remain to be elucidated. The tuberous sclerosis 1 (TSC1)/TSC2 tumor suppressor complex serves as a repressor of the mTOR pathway, and disruption of TSC1/TSC2 complex function may contribute to tumorigenesis. Here we show that IKK beta, a major downstream kinase in the TNFa signaling pathway, physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1. The IKK beta mediated TSC1 suppression activates them TOR pathway, enhances angiogenesis, and results in tumor development. We further find that expression of activated IKKb is associated with TSC1 Ser511 phosphorylation and VEGF production in multiple tumor types and correlates with poor clinical outcome of breast cancer patients. Our findings identify a pathway that is critical for inflammation-mediated tumor angiogenesis and may provide a target for clinical intervention in human cancer.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA; China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; Asia Univ, Taichung 413, Taiwan; Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	He, Xianghuo/I-1497-2014; Hsu, Jung-Mao/AAC-9527-2019; /AGZ-4617-2022; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/H-3126-2019; Hsu, Jung-Mao/AAP-8045-2020; Huang, Wei-Chien/D-1740-2012; Tsai, Fuu-Jen/J-4140-2015	He, Xianghuo/0000-0001-8872-668X; /0000-0002-7133-8266; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Dung-Fang/0000-0003-2387-597X; CHOU, CHAO-KAI/0000-0001-5231-5264; Li, Long-Yuan/0000-0001-7472-8318	NATIONAL CANCER INSTITUTE [R01CA058880, R01CA109311, P01CA099031, P50CA116199, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058880, R01 CA109311, CA116199, P01 CA099031, CA16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; BINGLE L, 1995, J PATHOL, V377, P441; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Delhase M, 2000, NATURE, V406, P367, DOI 10.1038/35019154; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; El-Hashemite N, 2003, CANCER RES, V63, P5173; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zou YY, 2002, CANCER RES, V62, P8	42	506	534	1	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					440	455		10.1016/j.cell.2007.05.058	http://dx.doi.org/10.1016/j.cell.2007.05.058			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693255	Bronze			2022-12-28	WOS:000249038100013
J	Chong, CR; Sullivan, DJ				Chong, Curtis R.; Sullivan, David J., Jr.			New uses for old drugs	NATURE			English	Editorial Material							INNOVATION; DISCOVERY		Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chong, CR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.							Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sussman GL, 1999, J ALLERGY CLIN IMMUN, V104, P100, DOI 10.1016/S0091-6749(99)70120-X; Voigt JH, 2001, J CHEM INF COMP SCI, V41, P702, DOI 10.1021/ci000150t; Weber WW, 1999, MOL DIAGN, V4, P299, DOI 10.1016/S1084-8592(99)80006-X; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	12	711	734	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					645	646		10.1038/448645a	http://dx.doi.org/10.1038/448645a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687303				2022-12-28	WOS:000248598000020
J	Daneshbod, Y				Daneshbod, Yahya			Asymptomatic bladder stones	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Daneshbod Pathol Lab, Shiraz 71347, Iran		Daneshbod, Y (corresponding author), Daneshbod Pathol Lab, Shiraz 71347, Iran.	daneshbk@yahoo.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					E7	E7		10.1056/NEJMicm064313	http://dx.doi.org/10.1056/NEJMicm064313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687125				2022-12-28	WOS:000248584900011
J	Day, M				Day, Michael			The rise of the doctor-manager	BRITISH MEDICAL JOURNAL			English	Article												miday@f2s.com							0	11	12	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					230	231		10.1136/bmj.39290.740752.BD	http://dx.doi.org/10.1136/bmj.39290.740752.BD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201QC	17673763	Green Published			2022-12-28	WOS:000248846700023
J	Pittock, SJ				Pittock, Sean J.			Interferon beta in multiple sclerosis: how much BENEFIT?	LANCET			English	Editorial Material							STATUS SCALE EDSS; 1ST DEMYELINATING EVENT; DEFINITE; INTERRATER; CONVERSION; DIAGNOSIS; TRIALS; TIME		Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55901 USA; Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN 55901 USA	Mayo Clinic; Mayo Clinic	Pittock, SJ (corresponding author), Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55901 USA.	Pittock.Sean@mayo.edu						Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Compston A., 2005, MCALPINES MULTIPLE S, P729; Frohman EM, 2006, ARCH NEUROL-CHICAGO, V63, P614, DOI 10.1001/archneur.63.4.614; GOODKIN DE, 1992, NEUROLOGY, V42, P859, DOI 10.1212/WNL.42.4.859; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kinkel RP, 2006, NEUROLOGY, V66, P678; KURTZKE JF, 1986, ANN NEUROL, V19, P311, DOI 10.1002/ana.410190402; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; Noseworthy JH, 2006, NEUROLOGY, V67, P930, DOI 10.1212/01.wnl.0000241080.31577.df; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P611, DOI 10.1001/archneur.63.4.611; Pittock SJ, 2004, ANN NEUROL, V56, P303, DOI 10.1002/ana.20197; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe	15	9	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					363	364		10.1016/S0140-6736(07)61170-2	http://dx.doi.org/10.1016/S0140-6736(07)61170-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17678997				2022-12-28	WOS:000248590200004
J	Carmody, RJ; Ruan, QG; Palmer, S; Hilliard, B; Chen, YHH				Carmody, Ruaidhri J.; Ruan, Qingguo; Palmer, Scott; Hilliard, Brendan; Chen, Youhai H.			Negative regulation of Toll-like receptor signaling by NF-kappa B p50 ubiquitination blockade	SCIENCE			English	Article							IMMUNE-RESPONSES; DNA-BINDING; BCL-3; HOMODIMERS; TOLERANCE; SPECIFICITY; ONCOPROTEIN; PROTEINS; SUBUNIT; ENCODES	Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)-3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-kB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3-deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Chen, YHH (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu	Chen, Youhai/AAJ-4031-2021; Carmody, Ruaidhri/H-5396-2019		NIAID NIH HHS [AI50059, AI069289] Funding Source: Medline; NIDDK NIH HHS [DK070691] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069289, R01AI050059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070691] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; INOUE J, 1993, ONCOGENE, V8, P2067; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	24	180	188	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					675	678		10.1126/science.1142953	http://dx.doi.org/10.1126/science.1142953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673665				2022-12-28	WOS:000248494400049
J	Niemann, HH; Jager, V; Butler, PJG; van den Heuvel, J; Schmidt, S; Ferraris, D; Gherardi, E; Heinz, DW				Niemann, Hartmut H.; Jaeger, Volker; Butler, P. Jonathan G.; van den Heuvel, Joop; Schmidt, Sabine; Ferraris, Davide; Gherardi, Ermanno; Heinz, Dirk W.			Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InIB	CELL			English	Article							GROWTH FACTOR/SCATTER FACTOR; HOST-CELL INVASION; SURFACE PROTEIN; L-MONOCYTOGENES; SEMA DOMAIN; GW DOMAINS; INTERNALIN; INLB; ENTRY; SUFFICIENT	The tyrosine kinase Met, the product of the c-met proto-oncogene and the receptor for hepatocyte growth factor/scatter factor (HGF/SF), mediates signals critical for cell survival and migration. The human pathogen Listeria monocytogenes exploits Met signaling for invasion of host cells via its surface protein InlB. We present the crystal structure of the complex between a large fragment of the human Met ectodomain and the Met-binding domain of InlB. The concave face of the InlB leucine-rich repeat region interacts tightly with the first immunoglobulin-like domain of the Met stalk, a domain which does not bind HGF/SF. A second contact between InlB and the Met Sema domain locks the otherwise flexible receptor in a rigid, signaling competent conformation. Full Met activation requires the additional C-terminal domains of InlB which induce heparin-mediated receptor clustering and potent signaling. Thus, although it elicits a similar cellular response, InlB is not a structural mimic of HGF/SF.	Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany; MRC Ctr & Lab Mol Biol, Cambridge CB2 2QH, England	Helmholtz Association; Helmholtz-Center for Infection Research	Gherardi, E (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Inhoffenstr 7, Braunschweig, Germany.	egherard@mrc-lmb.cam.ac.uk; dirk.heinz@helmholtz-hzi.de	Gherardi, Ermanno/AAB-9608-2022; Ferraris, Davide Maria/AAP-7110-2020; Ferraris, Davide Maria/AAO-9743-2020; Niemann, Hartmut/F-7947-2011	Ferraris, Davide Maria/0000-0001-5112-9910; Niemann, Hartmut/0000-0002-8582-0360; GHERARDI, ERMANNO/0000-0002-0016-2945	MRC [G9704528] Funding Source: UKRI; Medical Research Council [G9704528] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BRAUN J, 2000, P SOC PHOTO-OPT INS, V1, P32; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAYES DB, 2006, RASMB SOFTWARE ARCH; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Prat M, 1998, J CELL SCI, V111, P237; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubert WD, 2003, CHEMBIOCHEM, V4, P1285, DOI 10.1002/cbic.200300624; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0	51	123	135	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					235	246		10.1016/j.cell.2007.05.037	http://dx.doi.org/10.1016/j.cell.2007.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662939	Green Submitted, Bronze			2022-12-28	WOS:000248588000014
J	Yan, L; Vatner, DE; O'Connor, JP; Ivessa, A; Ge, H; Chen, W; Hirotani, S; Ishikawa, Y; Sadoshima, J; Vatner, SF				Yan, Lin; Vatner, Dorothy E.; O'Connor, J. Patrick; Ivessa, Andreas; Ge, Hui; Chen, Wei; Hirotani, Shinichi; Ishikawa, Yoshihiro; Sadoshima, Junichi; Vatner, Stephen F.			Type 5 adenylyl cyclase disruption increases longevity and protects against stress	CELL			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; PRESERVES CARDIAC-FUNCTION; LIFE-SPAN; OXIDATIVE STRESS; CALORIC RESTRICTION; CAENORHABDITIS-ELEGANS; HEART-FAILURE; DWARF MOUSE; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE	Mammalian models of longevity are related primarily to caloric restriction and alterations in metabolism. We examined mice in which type 5 adenylyl cyclase (AC5) is knocked out (AC5 KO) and which are resistant to cardiac stress and have increased median lifespan of similar to 30%. AC5 KO mice are protected from reduced bone density and susceptibility to fractures of aging. Old AC5 KO mice are also protected from aging-induced cardiomyopathy, e.g., hypertrophy, apoptosis, fibrosis, and reduced cardiac function. Using a proteomic-based approach, we demonstrate a significant activation of the Raf/MEK/ERK signaling pathway and upregulation of cell protective molecules, including superoxide dismutase. Fibroblasts isolated from AC5 KO mice exhibited ERK-dependent resistance to oxidative stress. These results suggest that AC is a fundamentally important mechanism regulating lifespan and stress resistance.	UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; UMDNJ, Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sadoshju@umdnj.edu; vatnersf@umdnj.edu		Ivessa, Andreas/0000-0002-7578-1337; Sadoshima, Junichi/0000-0003-3724-4132	NHLBI NIH HHS [HL069020, HL033107, HL059139, HL069752, HL65183] Funding Source: Medline; NIA NIH HHS [AG028854, AG023137, AG014121] Funding Source: Medline; NICHD NIH HHS [HD01457] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065183, P01HL069020, R37HL033107, R01HL033107, P01HL059139, T32HL069752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023137, R01AG028854, R01AG014121] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Du XJ, 2000, CARDIOVASC RES, V48, P448, DOI 10.1016/S0008-6363(00)00187-5; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Geng YJ, 1999, CIRC RES, V84, P34; GLOBOCNIK E, 1978, Folia Morphologica (Prague), V26, P1; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Liggett SB, 2000, CIRCULATION, V101, P1707; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lithgow GJ, 1996, BIOESSAYS, V18, P809, DOI 10.1002/bies.950181007; Lorenzini A, 2002, EXP GERONTOL, V37, P1149, DOI 10.1016/S0531-5565(02)00133-X; LOUTIT JF, 1976, J ANAT, V122, P357; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Meloche S, 2000, CYTOGENET CELL GENET, V88, P249, DOI 10.1159/000015530; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB297, DOI 10.1093/gerona/54.7.B297; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Naf D, 2002, CANCER RES, V62, P1235; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRCULATION, V108, P48; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Romanick MA, 2004, MECH AGEING DEV, V125, P269, DOI 10.1016/j.mad.2004.02.001; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 2002, GENETICS, V161, P661; SWYNGHEDAUW B, 1995, AM J CARDIOL, V76, pD2, DOI 10.1016/S0002-9149(99)80484-6; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wolff JE, 2001, DEV MED CHILD NEUROL, V43, P71, DOI 10.1017/S0012162201230114; Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001; Yoon SO, 2002, MECH AGEING DEV, V123, P1597, DOI 10.1016/S0047-6374(02)00095-7; Zhen XC, 1999, J GERONTOL A-BIOL, V54, pB539, DOI 10.1093/gerona/54.12.B539; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071	65	265	272	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					247	258		10.1016/j.cell.2007.05.038	http://dx.doi.org/10.1016/j.cell.2007.05.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662940	Bronze			2022-12-28	WOS:000248588000015
J	Menke, J; Grabbe, E				Menke, Jan; Grabbe, Eckhardt			Metastatic germ-cell cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp, D-37075 Gottingen, Germany	University of Gottingen	Menke, J (corresponding author), Univ Hosp, D-37075 Gottingen, Germany.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					391	391		10.1056/NEJMicm060694	http://dx.doi.org/10.1056/NEJMicm060694			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652654				2022-12-28	WOS:000248283500011
J	Maron, BJ; Spirito, P; Shen, WK; Haas, TS; Formisano, F; Link, MS; Epstein, AE; Almquist, AK; Daubert, JP; Lawrenz, T; Boriani, G; Estes, NAM; Favale, S; Piccininno, M; Winters, SL; Santini, M; Betocchi, S; Arribas, F; Sherrid, MV; Buja, G; Semsarian, C; Bruzzi, P				Maron, Barry J.; Spirito, Paolo; Shen, Win-Kuang; Haas, Tammy S.; Formisano, Francesco; Link, Mark S.; Epstein, Andrew E.; Almquist, Adrian K.; Daubert, James P.; Lawrenz, Thorsten; Boriani, Giuseppe; Estes, N. A. Mark, III; Favale, Stefano; Piccininno, Marco; Winters, Stephen L.; Santini, Massimo; Betocchi, Sandro; Arribas, Fernando; Sherrid, Mark V.; Buja, Gianfranco; Semsarian, Christopher; Bruzzi, Paolo			Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL PROFILE; ABLATION; THERAPY; HEART; RISK	Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved. Objective To study the relationship between clinical risk profile and incidence and efficacy of ICD intervention in HCM. Design, Setting, and Patients Multicenter registry study of ICDs implanted between 1986 and 2003 in 506 unrelated patients with HCM. Patients were judged to be at high risk for sudden death; had received ICDs; underwent evaluation at 42 referral and nonreferral institutions in the United States, Europe, and Australia; and had a mean follow-up of 3.7 (SD, 2.8) years. Measured risk factors for sudden death included family history of sudden death, massive left ventricular hypertrophy, nonsustained ventricular tachycardia on Holter monitoring, and unexplained prior syncope. Main Outcome Measure Appropriate ICD intervention terminating ventricular tachycardia or fibrillation. Results The 506 patients were predominately young ( mean age, 42 [ SD, 17] years) at implantation, and most ( 439 [87%]) had no or only mildly limiting symptoms. ICD interventions appropriately terminated ventricular tachycardia/fibrillation in 103 patients (20%). Intervention rates were 10.6% per year for secondary prevention after cardiac arrest (5-year cumulative probability, 39% [ SD, 5%]), and 3.6% per year for primary prevention (5-year probability, 17% [ SD, 2%]). Time to first appropriate discharge was up to 10 years, with a 27% ( SD, 7%) probability 5 years or more after implantation. For primary prevention, 18 of the 51 patients with appropriate ICD interventions (35%) had undergone implantation for only a single risk factor; likelihood of appropriate discharge was similar in patients with 1, 2, or 3 or more risk markers (3.83, 2.65, and 4.82 per 100 person-years, respectively; P=.77). The single sudden death due to an arrhythmia ( in the absence of advanced heart failure) resulted from ICD malfunction. ICD complications included inappropriate shocks in 136 patients ( 27%). Conclusions In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm. An important proportion of ICD discharges occurred in primary prevention patients who had undergone implantation for a single risk factor. Therefore, a single marker of high risk for sudden death may be sufficient to justify consideration for prophylactic defibrillator implantation in selected patients with HCM.	Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; Ente Osped Osped Galliera, Genoa, Italy; Mayo Clin, Rochester, MN USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Rochester, Med Ctr, Rochester, MN USA; Univ Munster, Acad Teaching Hosp, Bielefeld, Germany; Univ Bologna, Bologna, Italy; Univ Bari, Bari, Italy; Morristown Mem Hosp, Morristown, NJ USA; Osped S Filippo Neri, Rome, Italy; Univ Naples Federico II, Naples, Italy; Hosp 12 Octubre, E-28041 Madrid, Spain; St Lukes Roosevelt Hosp, New York, NY USA; Univ Padua, Padua, Italy; Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; Centenary Inst, Sydney, NSW, Australia; Ist Nazl Ric Canc, I-16132 Genoa, Italy	Minneapolis Heart Institute Foundation; Ente Ospedaliero Ospedali Galliera; Mayo Clinic; Tufts Medical Center; Tufts University; University of Alabama System; University of Alabama Birmingham; University of Rochester; University of Munster; University of Bologna; Universita degli Studi di Bari Aldo Moro; Atlantic Health System; San Filippo Neri Hospital; University of Naples Federico II; Hospital Universitario 12 de Octubre; Mount Sinai St. Luke's; Mount Sinai West; University of Padua; University of Sydney; University of Sydney; Centenary Institute; University of Genoa; IRCCS AOU San Martino IST	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org	Boriani, Giuseppe/A-4852-2015; Bruzzi, Paolo/AAU-3363-2021; Boriani, Giuseppe/AAC-3406-2022; Betocchi, Sandro/N-9647-2013; Arribas, Fernando/Q-9536-2017; Daubert, James P./ABC-1476-2021	Boriani, Giuseppe/0000-0002-9820-4815; Boriani, Giuseppe/0000-0002-9820-4815; Arribas, Fernando/0000-0002-2574-7923; Bruzzi, Paolo/0000-0002-7874-2077; Betocchi, Sandro/0000-0002-8701-2463; Sherrid, Mark/0000-0003-4972-7780				Almquist AK, 2005, HEART RHYTHM, V2, P814, DOI 10.1016/j.hrthm.2005.05.008; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Boriani G, 2004, CIRCULATION, V110, pE438, DOI 10.1161/01.CIR.0000144463.65977.C9; BRAUNWALD E, 1964, CIRCULATION, V30, P1; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Goldenberg I, 2005, ANN NONINVAS ELECTRO, V10, P67, DOI 10.1111/j.1542-474X.2005.00070.x; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Jayatilleke I, 2004, AM J CARDIOL, V93, P1192, DOI 10.1016/j.amjcard.2004.01.057; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Marin F, 2006, REV ESP CARDIOL, V59, P537, DOI 10.1016/S1885-5857(07)60004-8; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Maron BJ, 2003, CIRCULATION, V107, P2872, DOI 10.1161/01.CIR.0000072343.81530.75; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Primo J, 1998, J AM COLL CARDIOL, V31, P1081, DOI 10.1016/S0735-1097(98)00037-0; Seggewiss H, 2000, EUR HEART J, V21, P704, DOI 10.1053/euhj.1999.2019; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Steinbrook R, 2005, NEW ENGL J MED, V353, P221, DOI 10.1056/NEJMp058158; TEARE D, 1958, BRIT HEART J, V20, P1; Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055; WOO A, IN PRESS HEART	35	542	568	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					405	412		10.1001/jama.298.4.405	http://dx.doi.org/10.1001/jama.298.4.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652294	Bronze			2022-12-28	WOS:000248269100019
J	Wiener, RS; Welch, HG				Wiener, Renda Soylemez; Welch, H. Gilbert			Trends in the use of the pulmonary artery catheter in the United States, 1993-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED TRIAL; CARE; HEART	Context Although there is now substantial evidence that pulmonary artery (PA) catheterization does not reduce mortality in critically ill patients, it is unknown whether national utilization has decreased in response. Objective To determine trends in PA catheterization use in the United States. Design, Setting, and Participants A time trend analysis on national estimates of PA catheterization utilization from 1993-2004 using data from all US states contributing to the Nationwide Inpatient Sample. Hospital admissions for those participants aged 18 years or older were assessed, with primary analysis focused on admissions with a medical diagnosis related group and a secondary analysis focused on surgical admissions. PA catheterization was identified by 5 International Classification of Diseases, Ninth Revision procedure codes describing PA or wedge-pressure monitoring, measurement of mixed venous blood gases, or monitoring of cardiac output by oxygen consumption or other technique. Main Outcome Measure Annual PA catheterization use per 1000 medical admissions. Results Between 1993 and 2004, PA catheterization use decreased by 65% from 5.66 to 1.99 per 1000 medical admissions ( risk ratio [RR], 0.35; 95% confidence interval [CI], 0.29-0.42). Among patients who died during hospitalization, a group whose disease severity may be consistent across time, the relative decline was similar, decreasing from 54.7 to 18.1 per 1000 deaths ( RR, 0.33; 95% CI, 0.28-0.38). A significant change in trend occurred following a 1996 study that suggested increased mortality with PA catheterization. The decline in utilization was similar in surgical patients ( RR, 0.37; 95% CI, 0.25-0.49). Among common diagnoses associated with PA catheterization, the decline was most prominent for myocardial infarction, which decreased by 81% ( RR, 0.19; 95% CI, 0.15-0.23), and least prominent for septicemia, which decreased by 54% ( RR, 0.46; 95% CI, 0.38-0.54). Sensitivity analyses suggested findings were not due to artifact of changing procedure coding practice. Conclusion Use of the PA catheter, previously a hallmark of critical care practice, has decreased in the United States during the last decade, possibly due to growing evidence that this invasive procedure does not reduce mortality.	Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Med Sch, Dept Med, Hanover, NH USA; Dartmouth Med Sch, Dept Family & Community Med, Hanover, NH USA	Dartmouth College; Dartmouth College	Wiener, RS (corresponding author), Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, 215 N Main St 111B, White River Jct, VT 05009 USA.	renda.s.wiener@dartmouth.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135				Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; CONNORS AF, 1994, AM J RESP CRIT CARE, V149, pA1073; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; GORE JM, 1987, CHEST, V92, P721, DOI 10.1378/chest.92.4.721; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Guyatt G, 1991, J Intensive Care Med, V6, P91; Harvey S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003408.pub2; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Houchens R., 2006, USING HCUP NATIONWID; Kerr A, 2000, J AHIMA, V71, P81; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lapinsky SE, 2003, CRIT CARE, V7, P101, DOI 10.1186/cc1872; Peters SG, 2003, J CRIT CARE, V18, P166, DOI 10.1016/j.jcrc.2003.08.006; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; ROBIN ED, 1985, ANN INTERN MED, V103, P445, DOI 10.7326/0003-4819-103-3-445; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; ROWLEY KM, 1984, NEW ENGL J MED, V311, P1152, DOI 10.1056/NEJM198411013111804; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	25	207	214	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					423	429		10.1001/jama.298.4.423	http://dx.doi.org/10.1001/jama.298.4.423			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652296				2022-12-28	WOS:000248269100021
J	Ribera, JM; Oriol, A				Ribera, Josep-Maria; Oriol, Albert			A step forward in therapy for ALL in infants	LANCET			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL TRANSPLANTATION; CHILDREN; CHEMOTHERAPY; REMISSION		Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Catala Oncol, Dept Clin Haematol, Badalona 08916, Spain	Autonomous University of Barcelona; Catalan Institute of Oncology; Hospital Germans Trias i Pujol	Ribera, JM (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Catala Oncol, Dept Clin Haematol, Badalona 08916, Spain.	jribera@iconcologia.net	Ribera, JM/B-8181-2009; Oriol, Albert/K-9923-2017	Ribera, JM/0000-0003-1042-6024; Oriol, Albert/0000-0001-6804-2221				Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Inukai T, 2006, LEUKEMIA, V20, P2119, DOI 10.1038/sj.leu.2404429; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Mann G, 2007, LEUKEMIA, V21, P642, DOI 10.1038/sj.leu.2404577; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Ribera JM, 2007, J CLIN ONCOL, V25, P16, DOI 10.1200/JCO.2006.06.8312; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Satwani P, 2007, BIOL BLOOD MARROW TR, V13, P218, DOI 10.1016/j.bbmt.2006.09.013; Stam RW, 2006, BRIT J HAEMATOL, V132, P539, DOI 10.1111/j.1365-2141.2005.05909.x; Thompson PA, 2007, CANCER CHEMOTH PHARM, V59, P847, DOI 10.1007/s00280-006-0388-1	12	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2007	370	9583					198	200		10.1016/S0140-6736(07)61101-5	http://dx.doi.org/10.1016/S0140-6736(07)61101-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658376				2022-12-28	WOS:000248347900006
J	Wong, TY; Liew, G; Mitchell, P				Wong, Tien Y.; Liew, Gerald; Mitchell, Paul			Clinical update: new treatments for age-related macular degeneration	LANCET			English	Article							RANIBIZUMAB; RISK		Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117548, Singapore; Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia	University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Sydney	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014; Liew, Gerald/AAB-6870-2022	Wong, Tien Yin/0000-0002-8448-1264; 				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, BRIT J OPHTHALMOL, V90, P1188, DOI 10.1136/bjo.2005.082255; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598; *GEN, 2007, SAF UPD LUC; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; *MAC AMD STUD GROU, 2007, PEG 1 YEAR SYST SAF, DOI DOI 10.1016/J.OPHTHA.2007.02.021; *NAT EYE I, 2006, NIH STIM DEV TEST NE; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2006, AM J OPHTHALMOL, V142, P141, DOI 10.1016/j.ajo.2006.03.036; *ROYAL COLL OPHTH, 2006, AMD INT GUID ROYAL C; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	18	113	117	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					204	206		10.1016/S0140-6736(07)61104-0	http://dx.doi.org/10.1016/S0140-6736(07)61104-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658379				2022-12-28	WOS:000248347900010
J	Cullen, BR				Cullen, Bryan R.			Outwitted by viral RNAs	SCIENCE			English	Editorial Material							APOPTOSIS; MECHANISM; NKG2D		Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27707 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27707 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27707 USA.	culle002@mc.duke.edu						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Clemens MJ, 2006, INT J BIOCHEM CELL B, V38, P164, DOI 10.1016/j.biocel.2005.09.014; Conrad NK, 2006, COLD SH Q B, V71, P377; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; McSharry BP, 2003, J GEN VIROL, V84, P2511, DOI 10.1099/vir.0.19298-0; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956	11	11	12	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					329	330		10.1126/science.1146077	http://dx.doi.org/10.1126/science.1146077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641188				2022-12-28	WOS:000248150200032
J	Smith, CL				Smith, Chris Llewellyn			How the LHC came to be	NATURE			English	Editorial Material								Approval of a project the size of the Large Hadron Collider is an exercise in politics and high finance.			Smith, CL (corresponding author), UK Atom Energy Author Culham Div, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England.								0	7	7	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					281	284		10.1038/nature06076	http://dx.doi.org/10.1038/nature06076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637657				2022-12-28	WOS:000248118300043
J	Spillane, C; Schmid, KJ; Laoueille-Duprat, S; Pien, S; Escobar-Restrepo, JM; Baroux, C; Gagliardini, V; Page, DR; Wolfe, KH; Grossniklaus, U				Spillane, Charles; Schmid, Karl J.; Laoueille-Duprat, Sylvia; Pien, Stephane; Escobar-Restrepo, Juan-Miguel; Baroux, Celia; Gagliardini, Valeria; Page, Damian R.; Wolfe, Kenneth H.; Grossniklaus, Ueli			Positive darwinian selection at the imprinted MEDEA locus in plants	NATURE			English	Article							POLYCOMB-GROUP GENE; DETECTING MOLECULAR ADAPTATION; SET DOMAIN PROTEINS; ARABIDOPSIS-THALIANA; SEED DEVELOPMENT; ENDOSPERM DEVELOPMENT; EXPRESSION PATTERNS; DNA POLYMORPHISM; EVOLUTION; GENOME	In mammals and seed plants, a subset of genes is regulated by genomic imprinting where an allele's activity depends on its parental origin. The parental conflict theory suggests that genomic imprinting evolved after the emergence of an embryo-nourishing tissue (placenta and endosperm), resulting in an intragenomic parental conflict over the allocation of nutrients from mother to offspring(1,2). It was predicted that imprinted genes, which arose through antagonistic co-evolution driven by a parental conflict, should be subject to positive darwinian selection(3). Here we show that the imprinted plant gene MEDEA (MEA)(4,5), which is essential for seed development, originated during a whole-genome duplication 35 to 85 million years ago. After duplication, MEA underwent positive darwinian selection consistent with neo-functionalization and the parental conflict theory. MEA continues to evolve rapidly in the out-crossing species Arabidopsis lyrata but not in the self-fertilizing species Arabidopsis thaliana, where parental conflicts are reduced. The paralogue of MEA, SWINGER (SWN; also called EZA1)(6), is not imprinted and evolved under strong purifying selection because it probably retained the ancestral function of the common precursor gene. The evolution of MEA suggests a late origin of genomic imprinting within the Brassicaceae, whereas imprinting is thought to have originated early within the mammalian lineage(7).	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; Univ Coll Cork, Genet & Biotechnol Lab, Dept Biochem, Cork, Ireland; Univ Coll Cork, Biosci Inst, Cork, Ireland; Max Planck Inst Chem Ecol, Dept Genet & Evolut, D-07745 Jena, Germany; Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin, Ireland	University of Zurich; University of Zurich; University College Cork; University College Cork; Max Planck Society; Trinity College Dublin	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	c.spillane@ucc.ie; grossnik@botinst.uzh.ch	Wolfe, Kenneth H/B-4653-2009; Grossniklaus, Ueli/E-9995-2016; Baroux, Célia/J-5359-2013; Grossniklaus, Ueli/A-2736-2012; Spillane, Charles/H-3786-2013	Grossniklaus, Ueli/0000-0002-0522-8974; Baroux, Célia/0000-0001-6307-2229; Gagliardini, Valeria/0000-0001-9471-0764; Spillane, Charles/0000-0003-3318-323X; Wolfe, Kenneth/0000-0003-4992-4979				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Fay JC, 2000, GENETICS, V155, P1405; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Huang SR, 1997, PLANT MOL BIOL, V33, P125, DOI 10.1023/A:1005741514764; HUDSON RR, 1987, GENETICS, V116, P153; JACKSON D, 1991, PLANT CELL, V3, P115, DOI 10.1105/tpc.3.2.115; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Mayama T, 2003, PLANT CELL PHYSIOL, V44, P811, DOI 10.1093/pcp/pcg102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GT, 1997, P ROY SOC B-BIOL SCI, V264, P739, DOI 10.1098/rspb.1997.0105; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Springer NM, 2002, PLANT PHYSIOL, V128, P1332, DOI 10.1104/pp.010742; TAJIMA F, 1989, GENETICS, V123, P585; Thakur JK, 2003, GENE, V314, P1, DOI 10.1016/S0378-1119(03)00723-6; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	40	116	118	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					349	U8		10.1038/nature05984	http://dx.doi.org/10.1038/nature05984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637669				2022-12-28	WOS:000248118300057
J	Treasure, T				Treasure, Tom			Minimal access surgery for pneumothorax	LANCET			English	Editorial Material							ASSISTED THORACIC-SURGERY		Guys Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Treasure, T (corresponding author), Guys Hosp, St Thomas St, London SE1 9RT, England.	tom.treasure@gmail.com						Barker A, 2007, LANCET, V370, P329, DOI 10.1016/S0140-6736(07)61163-5; Ben-Nun A, 2006, WORLD J SURG, V30, P285, DOI 10.1007/s00268-005-0235-2; Henry M, 2003, THORAX S2, V58, P39, DOI DOI 10.1136/TH0RAX.58.SUPPL_21I39; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; LEWIS RJ, 1992, ANN THORAC SURG, V54, P421, DOI 10.1016/0003-4975(92)90431-3; Sedrakyan A, 2004, BMJ-BRIT MED J, V329, P1008, DOI 10.1136/bmj.38243.440486.55; Sedrakyan A, 2004, BMJ-BRIT MED J, V329, P1011, DOI 10.1136/bmj.329.7473.1011; TREASURE T, IN PRESS JR SOC MED	8	6	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					294	295		10.1016/S0140-6736(07)61136-2	http://dx.doi.org/10.1016/S0140-6736(07)61136-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662861				2022-12-28	WOS:000248426100005
J	Hvorup, RN; Goetz, BA; Niederer, M; Hollenstein, K; Perozo, E; Locher, KP				Hvorup, Rikki N.; Goetz, Birke A.; Niederer, Martina; Hollenstein, Kaspar; Perozo, Eduardo; Locher, Kaspar P.			Asymmetry in the structure of the ABC transporter-binding protein complex BtuCD-BtuF	SCIENCE			English	Article							ESCHERICHIA-COLI; ATP-BINDING; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; CASSETTE TRANSPORTER; IDENTIFICATION; VITAMIN-B12; MECHANISM; DYNAMICS; SYSTEM	BtuCD is an adenosine triphosphate-binding cassette (ABC) transporter that translocates vitamin B-12 from the periplasmic binding protein BtuF into the cytoplasm of Escherichia coli. The 2.6 angstrom crystal structure of a complex BtuCD-F reveals substantial conformational changes as compared with the previously reported structures of BtuCD and BtuF. The lobes of BtuF are spread apart, and B-12 is displaced from the binding pocket. The transmembrane BtuC subunits reveal two distinct conformations, and the translocation pathway is closed to both sides of the membrane. Electron paramagnetic resonance spectra of spin-labeled cysteine mutants reconstituted in proteoliposomes are consistent with the conformation of BtuCD-F that was observed in the crystal structure. A comparison with BtuCD and the homologous HI1470/71 protein suggests that the structure of BtuCD-F may reflect a posttranslocation intermediate.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA; Univ Chicago, Inst Mol Pediat Sci, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Chicago; University of Chicago; University of Chicago	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, HPK D14-3, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch	Winnen, Brit/B-9223-2008	Hollenstein, Kaspar/0000-0001-7606-4105				Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hustedt EJ, 1999, ANNU REV BIOPH BIOM, V28, P129, DOI 10.1146/annurev.biophys.28.1.129; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	25	227	241	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1387	1390		10.1126/science.1145950	http://dx.doi.org/10.1126/science.1145950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17673622				2022-12-28	WOS:000249377500045
J	Neumann, M; Nyeki, J; Cowan, B; Saunders, J				Neumann, Michael; Nyeki, Jan; Cowan, Brian; Saunders, John			Bilayer He-3: A simple two-dimensional heavy-fermion system with quantum criticality	SCIENCE			English	Article							MULTIPLE-SPIN-EXCHANGE; SOLID HE-3; TRIANGULAR LATTICE; GRAPHITE; LIQUID; METALS; FILMS; TRANSITIONS; FRUSTRATION	Two-dimensional helium-3 (He-3) provides a simple model for the experimental investigation of the emergence of quantum complexity in a strongly correlated Fermi system. We have observed two-dimensional, two-band heavy-fermion behavior in bilayer films of He-3 atoms when adsorbed on the surface of graphite preplated by a solid bilayer of He-4. Thermodynamic measurements on this system showed that the relevant control parameter is the total density of the He-3 film. The He-3 bilayer system can be driven toward a quantum critical point at which the effective mass appears to diverge, interband coupling vanishes, and a local-moment state appears. It opens a new testing ground for theories of quantum criticality in heavy-fermion materials.	Univ London Royal Holloway & Bedford New Coll, Dept Phys, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Saunders, J (corresponding author), Univ London Royal Holloway & Bedford New Coll, Dept Phys, Egham TW20 0EX, Surrey, England.	j.saunders@rhul.ac.uk			Engineering and Physical Sciences Research Council [GR/S20567/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Casey A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.115301; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Fazekas P., 1999, LECT NOTES ELECT COR; Gegenwart P, 2007, SCIENCE, V315, P969, DOI 10.1126/science.1136020; Godfrin H., 1995, PROGR LOW TEMPERATUR, VXIV, P213, DOI DOI 10.1016/S0079-6417(06)80018-1; GREYWALL DS, 1990, PHYS REV B, V41, P1842, DOI 10.1103/PhysRevB.41.1842; HERITIER M, 1979, J PHYS LETT-PARIS, V40, pL451; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Hewson A C, 1993, KONDO PROBLEM HEAVY; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Knebel G, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.114709; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; LUSHER CP, 1991, PHYS REV LETT, V67, P2497, DOI 10.1103/PhysRevLett.67.2497; Misguich G, 1998, PHYS REV LETT, V81, P1098, DOI 10.1103/PhysRevLett.81.1098; Morhard KD, 1996, PHYS REV B, V53, P2658, DOI 10.1103/PhysRevB.53.2658; Pepin C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206401; Pines D, 1966, THEORY QUANTUM LIQUI, V1; Roger M, 1998, PHYS REV LETT, V80, P1308, DOI 10.1103/PhysRevLett.80.1308; ROGER M, 1990, PHYS REV LETT, V64, P297, DOI 10.1103/PhysRevLett.64.297; Roger M, 1998, J LOW TEMP PHYS, V112, P451, DOI 10.1023/A:1022344904078; Sachdev S., 1999, QUANTUM PHASE TRANSI; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; SIQUEIRA M, 1993, PHYS REV LETT, V71, P1407, DOI 10.1103/PhysRevLett.71.1407; Siqueira M, 1997, PHYS REV LETT, V78, P2600, DOI 10.1103/PhysRevLett.78.2600; Tsuji D, 2004, J LOW TEMP PHYS, V134, P31, DOI 10.1023/B:JOLT.0000012530.31728.09; VARMA CM, 1985, PHYS REV LETT, V55, P2723, DOI 10.1103/PhysRevLett.55.2723; ZIOUZIA F, 2004, THESIS U LONDON	31	76	76	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1356	1359		10.1126/science.1143607	http://dx.doi.org/10.1126/science.1143607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17656686				2022-12-28	WOS:000249377500037
J	Cunningham, SA; Kanzow, T; Rayner, D; Baringer, MO; Johns, WE; Marotzke, J; Longworth, HR; Grant, EM; Hirschi, JJM; Beal, LM; Meinen, CS; Bryden, HL				Cunningham, Stuart A.; Kanzow, Torsten; Rayner, Darren; Baringer, Molly O.; Johns, William E.; Marotzke, Jochem; Longworth, Hannah R.; Grant, Elizabeth M.; Hirschi, Joel J. -M.; Beal, Lisa M.; Meinen, Christopher S.; Bryden, Harry L.			Temporal variability of the Atlantic meridional overturning circulation at 26.5 degrees N	SCIENCE			English	Article							NORTH-ATLANTIC; FLORIDA CURRENT; HEAT-FLUX; TRANSPORT; 27-DEGREES-N; DESIGN; OCEAN	The vigor of Atlantic meridional overturning circulation (MOC) is thought to be vulnerable to global warming, but its short-term temporal variability is unknown so changes inferred from sparse observations on the decadal time scale of recent climate change are uncertain. We combine continuous measurements of the MOC (beginning in 2004) using the purposefully designed transatlantic Rapid Climate Change array of moored instruments deployed along 26.5 degrees N, with time series of Gulf Stream transport and surface-layer Ekman transport to quantify its intra-annual variability. The year-long average overturning is 18.7 +/- 5.6 sverdrups (Sv) (range: 4.0 to 34.9 Sv, where 1 Sv = a flow of ocean water of 10(6) cubic meters per second). Interannual changes in the overturning can be monitored with a resolution of 1.5 Sv.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; NOAA, Atlantic Oceanog & Meteorol Lab, Phys Oceanog Div, Miami, FL 33149 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Max Planck Inst Meteorol, D-20146 Hamburg, Germany	NERC National Oceanography Centre; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Max Planck Society	Cunningham, SA (corresponding author), Natl Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.	scu@noc.soton.ac.uk; marotzke@dkrz.de	Hirschi, Joel/F-5631-2013; Baringer, Molly O/D-2277-2012; Meinen, Christopher S/G-1902-2012	Hirschi, Joel/0000-0003-1481-3697; Baringer, Molly O/0000-0002-8503-5194; Meinen, Christopher S/0000-0002-8846-6002; Beal, Lisa/0000-0003-3678-5367; Kanzow, Torsten/0000-0002-5786-3435; Bryden, Harry/0000-0002-8216-6359	NERC [soc010012, soc010007] Funding Source: UKRI; Natural Environment Research Council [NER/T/S/2002/00449, NER/T/S/2002/00481, soc010012, soc010007] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baehr J, 2004, J MAR RES, V62, P283, DOI 10.1357/0022240041446191; Baehr J, 2008, CLIMATIC CHANGE, V91, P11, DOI 10.1007/s10584-006-9153-z; Baringer MO, 2001, GEOPHYS RES LETT, V28, P3179, DOI 10.1029/2001GL013246; Bryden HL, 1996, J CLIMATE, V9, P3162, DOI 10.1175/1520-0442(1996)009<3162:DCIWMC>2.0.CO;2; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Cunningham S. A., 2005, 54 SOUTH OC CTR; CUNNINGHAM SA, 2005, 2 NAT OC CTR; DUNCAN LM, 2004, 1 RAPID ANN SCI M 6; FUGLISTER FC, 1960, ATLANTIC OCEAN ATLAS; Ganachaud A, 2003, J ATMOS OCEAN TECH, V20, P1641, DOI 10.1175/1520-0426(2003)020<1641:EBOIBM>2.0.CO;2; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Hirschi J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016776; Kanzow T, 2007, SCIENCE, V317, P938, DOI 10.1126/science.1141293; LARSEN JC, 1992, PHILOS T R SOC A, V338, P169, DOI 10.1098/rsta.1992.0007; Longworth HR., 2007, THESIS U SOUTHAMPTON; MCTAGGART KE, 1999, PMEL68 NOAA ERL NOAA; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rayner D., 2005, 53 SOUTH OC CTR; ROEMMICH D, 1985, DEEP-SEA RES, V32, P619, DOI 10.1016/0198-0149(85)90070-6; Sturges W, 2001, J PHYS OCEANOGR, V31, P1304, DOI 10.1175/1520-0485(2001)031<1304:GSTVAP>2.0.CO;2	21	601	619	0	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					935	938		10.1126/science.1141304	http://dx.doi.org/10.1126/science.1141304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702940				2022-12-28	WOS:000248780200036
J	Ferrero, S; Remorgida, V				Ferrero, Simone; Remorgida, Valentino			Endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Osped San Martino Genova, I-16132 Genoa, Italy; Univ Genoa, I-16132 Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Ferrero, S (corresponding author), Osped San Martino Genova, I-16132 Genoa, Italy.	dr@simonferrero.com	remorgida, valentino/K-9386-2016	remorgida, valentino/0000-0002-5043-6676; Ferrero, Simone/0000-0003-2225-5568					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					E8	E8		10.1056/NEJMicm066574	http://dx.doi.org/10.1056/NEJMicm066574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699812				2022-12-28	WOS:000248746000010
J	Ding, SW; Voinnet, O				Ding, Shou-Wei; Voinnet, Olivier			Antiviral immunity directed by small RNAs	CELL			English	Review							RETRACTED ARTICLE. SEE; SMALL INTERFERING RNA; DICER-LIKE PROTEINS; ARABIDOPSIS ARGONAUTE1; SILENCING SUPPRESSION; VIRAL SUPPRESSOR; INNATE IMMUNITY; P19 PROTEIN; VIRUS; MICRORNA	Plants and invertebrates can protect themselves from viral infection through RNA silencing. This antiviral immunity involves production of virus-derived small interfering RNAs (viRNAs) and results in specific silencing of viruses by viRNA-guided effector complexes. The proteins required for viRNA production as well as several key downstream components of the antiviral immunity pathway have been identified in plants, flies, and worms. Meanwhile, viral mechanisms to suppress this small RNA-directed immunity by viruses are being elucidated, thereby illuminating an ongoing molecular arms race that likely impacts the evolution of both viral and host genomes.	Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	shou-wei.ding@ucr.edu; olivier.voinnet@ibmp-ulp.u-strasbg.fr	Ding, Shou Wei/AAC-2533-2020	Voinnet, Olivier/0000-0001-6982-9544; Ding, SW/0000-0002-4697-8413	NIAID NIH HHS [R01 AI052447, R01 AI052447-05, R01 AI052447-04, AI052447, R01 AI052447-04S1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bian XY, 2006, MOL PLANT MICROBE IN, V19, P614, DOI 10.1094/MPMI-19-0614; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Ebhardt HA, 2005, P NATL ACAD SCI USA, V102, P13398, DOI 10.1073/pnas.0506597102; Fenner BJ, 2007, J VIROL, V81, P5449, DOI 10.1128/JVI.00009-07; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Hernandez-Pinzon I, 2007, PLANT J, V50, P140, DOI 10.1111/j.1365-313X.2007.03043.x; Ho T, 2006, J VIROL METHODS, V136, P217, DOI 10.1016/j.jviromet.2006.05.016; Imler JL, 2004, J ENDOTOXIN RES, V10, P241, DOI 10.1179/096805104225005887; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li HW, 1999, EMBO J, V18, P2683, DOI 10.1093/emboj/18.10.2683; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Matthews REF., 2002, PLANT VIROLOGY; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Omarov RT, 2007, P NATL ACAD SCI USA, V104, P1714, DOI 10.1073/pnas.0608117104; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; SEGERS GC, 2006, CELL, V5, P896; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ye KQ, 2005, STRUCTURE, V13, P1375, DOI 10.1016/j.str.2005.06.017; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	96	1065	1141	6	227	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					413	426		10.1016/j.cell.2007.07.039	http://dx.doi.org/10.1016/j.cell.2007.07.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693253	Bronze, Green Accepted			2022-12-28	WOS:000249038100011
J	Shuaib, A; Lees, KR; Lyden, P; Grotta, J; Davalos, A; Davis, SM; Diener, H; Ashwood, T; Wasiewski, WW; Emeribe, U				Shuaib, Ashfaq; Lees, Kennedy R.; Lyden, Patrick; Grotta, James; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Ashwood, Tim; Wasiewski, Warren W.; Emeribe, Ugochi		SAINT II Trial Investigators	NXY-059 for the treatment of acute ischemic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMMENDATIONS; THERAPIES; TRIAL	Background: The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke. We sought confirmation of efficacy in a second, larger trial. Methods: We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-hour infusion of intravenous NXY-059 or placebo within 6 hours after the onset of stroke symptoms. Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days. We examined scores on neurologic and activities-of-daily-living scales as secondary end points. We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages. Results: The efficacy analysis was based on 3195 patients. Prognostic factors were well balanced between the treatment groups. Mortality was equal in the two groups, and adverse-event rates were similar. The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P=0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06). Analysis of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 versus 2 to 3 versus 4 to 6 was 0.92 (95% CI, 0.80 to 1.06). There was no evidence of efficacy for any of the secondary end points. Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage. Conclusions: NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 hours after the onset of symptoms. (ClinicalTrials.gov number, NCT00061022.)	Univ Glasgow, Western Infirm, Acute Stroke Unit, Dept Med & Therapeut,Gardiner Inst, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Western Infirm, Cerebrovasc Clin, Dept Med & Therapeut,Gardiner Inst, Glasgow G11 6NT, Lanark, Scotland; Univ Calif San Diego, Stroke Ctr, San Diego, CA 92103 USA; Univ Texas, Dept Neurol, Houston Med Sch, Houston, TX USA; Univ Autonoma Barcelona, Dept Neurosci, Hosp Germans Trias & Pujol, Badalona, Spain; Univ Melbourne, Dept Neurol, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; Univ Duisburg Essen, Dept Neurol, Essen, Germany; AstraZeneca R&D Sodertalje, Med Neurosci, Sodertalje, Sweden; AstraZeneca, Wilmington, DE USA	University of Glasgow; University of Glasgow; University of California System; University of California San Diego; University of Texas System; University of Texas Health Science Center Houston; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Royal Melbourne Hospital; University of Melbourne; University of Duisburg Essen; AstraZeneca; AstraZeneca	Lees, KR (corresponding author), Univ Glasgow, Western Infirm, Acute Stroke Unit, Dept Med & Therapeut,Gardiner Inst, 44 Church St, Glasgow G11 6NT, Lanark, Scotland.	k.r.lees@clinmed.gla.ac.uk	Grotta, James/AAH-7423-2021; Davis, Stephen M/L-5260-2013	Davis, Stephen M/0000-0003-0962-2300				Albers GW, 2001, STROKE, V32, P1598, DOI 10.1161/01.STR.32.7.1598; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Donnan GA, 2006, STROKE, V37, P2521, DOI 10.1161/01.STR.0000239696.61545.4b; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2003, STROKE, V34, P1539, DOI 10.1161/01.STR.0000072983.64326.53; Green AR, 2006, DRUG DISCOV TODAY, V11, P681, DOI 10.1016/j.drudis.2006.06.001; Koch GG, 1988, BIOPHARMACEUTICAL ST, P403; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Lapchak PA, 2002, STROKE, V33, P1665, DOI 10.1161/01.STR.0000017145.22806.AA; Lees KR, 2006, STROKE, V37, P2970, DOI 10.1161/01.STR.0000249410.91473.44; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; MAHONEY F I, 1965, Md State Med J, V14, P61; QUINN TJ, IN PRESS STROKE; Stokes ME, 2000, CATEGORICAL DATA ANA; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	17	524	557	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					562	571		10.1056/NEJMoa070240	http://dx.doi.org/10.1056/NEJMoa070240			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687131				2022-12-28	WOS:000248584900007
J	van der Worp, HB; van Gijn, J				van der Worp, H. Bart; van Gijn, Jan			Acute ischemic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MIDDLE CEREBRAL-ARTERY; COMPUTED-TOMOGRAPHY; POOLED ANALYSIS; INFARCTION; THROMBOEMBOLISM; HYPERGLYCEMIA; THROMBOLYSIS; METAANALYSIS; ASSOCIATION; PROGNOSIS		Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van der Worp, HB (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	h.b.vanderworp@umcutrecht.nl	van Gijn, Jan/A-9444-2008					Adams, 2007, STROKE, V38, pE38, DOI 10.1161/STROKEAHA.106.110011; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Flint AC, 2007, STROKE, V38, P1274, DOI 10.1161/01.STR.0000260187.33864.a7; Francis CW, 2007, NEW ENGL J MED, V356, P1438, DOI 10.1056/NEJMcp067264; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Gray CS, 2004, STROKE, V35, P122, DOI 10.1161/01.STR.0000106916.81680.C0; GUBITZ G, 2004, COCHRANE DB SYST REV, V3; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Hacke W, 2004, LANCET, V363, P768; Halkes PHA, 2006, LANCET, V367, P1665; HANKEY GJ, 1990, BMJ-BRIT MED J, V300, P1485, DOI 10.1136/bmj.300.6738.1485; Hofmeijer J, 2003, CRIT CARE MED, V31, P617, DOI 10.1097/01.CCM.0000050446.16158.80; Holzer M, 2002, NEW ENGL J MED, V346, P549; Johnston SC, 2002, NEW ENGL J MED, V347, P1687, DOI 10.1056/NEJMcp020891; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; Khatri P, 2007, STROKE, V38, P431, DOI 10.1161/01.STR.0000254524.23708.c9; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f; Patel SC, 2001, JAMA-J AM MED ASSOC, V286, P2830, DOI 10.1001/jama.286.22.2830; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sandercock P, 1997, LANCET, V349, P1569; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; *STROK UN TRIAL CO, 2002, COCHRANE DB SYST REV, V1; The ESPRIT Study Group, 2007, LANCET, V369, P274; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Breda Eric J, 2005, BMC Cardiovasc Disord, V5, P24, DOI 10.1186/1471-2261-5-24; VANDERWORP HB, IN PRESS BRAIN; Wahlgren N, 2007, LANCET, V369, P826; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	58	195	207	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					572	579		10.1056/NEJMcp072057	http://dx.doi.org/10.1056/NEJMcp072057			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687132				2022-12-28	WOS:000248584900008
J	Kappos, L; Freedman, MS; Polman, CH; Edan, G; Hartung, HP; Miller, DH; Montalban, X; Barkhof, F; Radu, EW; Bauer, L; Dahms, S; Lanius, V; Pohl, C; Sandbrink, R				Kappos, Ludwig; Freedman, Mark S.; Polman, Chris H.; Edan, Gilles; Hartung, Hans-Peter; Miller, David H.; Montalban, Xavier; Barkhof, Frederik; Radu, Ernst-Wilheim; Bauer, Lars; Dahms, Susanne; Lanius, Vivian; Pohl, Christoph; Sandbrink, Rupert		BENEFIT Study Grp	Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study	LANCET			English	Article							DIAGNOSTIC-CRITERIA; AXONAL DAMAGE; DEFINITE; IMPAIRMENT; GUIDELINES; CONVERSION	Background Several controlled studies provide evidence that treatment with interferon beta in patients with a first event suggestive of multiple sclerosis (MS) delays conversion to clinically definite MS (CDMS). Our aim was to determine whether early initiation of treatment with interferon beta prevents development of confirmed disability in MS. Methods In the initial placebo-controlled phase of the double-blinded BENEFIT study, patients with a first event suggestive of MS and a minimum of two clinically silent lesions in MRI were randomised to receive either interferon beta-1b 250 mu g (n=292) or placebo (n=176) subcutaneously every other day for 2 years, or until diagnosis of CDMS. Patients were then eligible to enter the follow-up phase with open-label interferon beta-1b. In the current prospectively planned analysis 3 years after randomisation, the effects of early interferon beta-1b treatment were compared with those of delayed treatment initiated after diagnosis of CDMS or after 2 years on the study. The primary outcomes of this ITT analysis were time to diagnosis of CDMS, time to confirmed expanded disability status scale (EDSS) progression, and score on a patient-reported functional assessment scale (FAMS-TOI). This trial is registered with ClinicalTrials.gov, number NCT00185211. Findings Of the 468 patients originally randomised, 418 (89%) entered the follow-up phase; 392 (84%) completed 3 years' post-randomisation follow-up. After 3 years, 99 (37%) patients in the early group developed CDMS compared with 85 (51%) patients in the delayed treatment group. Early treatment reduced the risk of CDMS by 41% (hazard ratio 0.59, 95% CI 0.44-0.80; p=0.0011; absolute risk reduction 14%) compared with delayed treatment. Over 3 years, 42 (16%) patients in the early group and 40 (24%) in the delayed group had confirmed EDSS progression; early treatment reduced the risk for progression of disability by 40% compared with delayed treatment (0.60, 0.39-0.92; p=0.022; absolute risk reduction 8%). The FAMS-TOI score was high and stable in both groups over the 3-year period (p=0.31). Interpretation Our data suggest that early initiation of treatment with interferon beta-1b prevents the development of confirmed disability, supporting its use after the first manifestation of relapsing-remitting MS.	Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Ottawa Hosp, Ottawa, ON, Canada; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Ctr Hosp Univ, Rennes, France; Univ Dusseldorf, D-4000 Dusseldorf, Germany; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Hosp Valle De Hebron, Barcelona, Spain; Bayer Schering Pharma AG, Berlin, Germany; Univ Hosp Bonn, Bonn, Germany	University of Basel; University of Ottawa; Ottawa Hospital Research Institute; Vrije Universiteit Amsterdam; CHU Rennes; Heinrich Heine University Dusseldorf; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Hospital Universitari Vall d'Hebron; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Bonn	Kappos, L (corresponding author), Univ Basel Hosp, Dept Res, Petersgraben 4, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch	Macedo, Ana/L-9912-2018; Barkhof, Frederik/AAJ-6226-2020; Montalban, Xavier/J-5938-2016; Edan, Gilles/AAI-5944-2020	Macedo, Ana/0000-0002-6978-8989; Barkhof, Frederik/0000-0003-3543-3706; Montalban, Xavier/0000-0002-0098-9918; 	Multiple Sclerosis Society [748] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Francis G, 2001, NEUROLOGY, V56, P1628; Hoogervorst ELJ, 2001, MULT SCLER, V7, P335; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2003, NEUROLOGY, V61, P1528, DOI 10.1212/01.WNL.0000096175.39831.21; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Pungor E, 1998, J INTERF CYTOK RES, V18, P1025, DOI 10.1089/jir.1998.18.1025; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	23	387	400	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					389	397		10.1016/S0140-6736(07)61194-5	http://dx.doi.org/10.1016/S0140-6736(07)61194-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679016				2022-12-28	WOS:000248590200028
J	Simpson, SJ; Travis, J				Simpson, Stephen J.; Travis, John			Testing our defenses - Introduction	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					611	611		10.1126/science.317.5838.611	http://dx.doi.org/10.1126/science.317.5838.611			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673647				2022-12-28	WOS:000248494400028
J	Townshend, J; Hails, S; Mckean, M				Townshend, J.; Hails, S.; Mckean, M.			Diagnosis of asthma in children	BRITISH MEDICAL JOURNAL			English	Review							PRESCHOOL VIRAL WHEEZE; ADULT MODEL; COUGH; PREVALENCE; ACTIVATION		Royal Victoria Infirm, Paediat Resp Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Mckean, M (corresponding author), Royal Victoria Infirm, Paediat Resp Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	m.c.mckean@ncl.ac.uk						*ASTHM UK, DO WE STAND ASTHM U; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; *BRIT THOR SOC, 2005, SCOTT INT GUID NETW; Bush A, 2002, PULM PHARMACOL THER, V15, P309, DOI 10.1006/pupt.2002.0340; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Chang AB, 2006, CHEST, V129, p260S, DOI 10.1378/chest.129.1_suppl.260S; Faniran AO, 1999, CHEST, V115, P434, DOI 10.1378/chest.115.2.434; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; HAYMANN PW, 2005, PEDIAT INFECT DIS S, V24, pS217; Kilburn S., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002989, DOI 10.1002/14651858.CD002989]; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McKean MC, 2001, THORAX, V56, P81; Mckean MC, 2003, CLIN EXP ALLERGY, V33, P912, DOI 10.1046/j.1365-2222.2003.01715.x; Mochizuki H, 2005, CHEST, V128, P2427, DOI 10.1378/chest.128.4.2427; Oommen A, 2003, THORAX, V58, P876, DOI 10.1136/thorax.58.10.876; Oommen A, 2003, ARCH DIS CHILD, V88, P529, DOI 10.1136/adc.88.6.529; Peat JK, 2001, THORAX, V56, P406, DOI 10.1136/thorax.56.5.406; Silverman M, 2002, CHILDHOOD ASTHMA OTH; SILVERMAN M, 2002, CHILDHOOD ASTHMA OTH, P144; SILVERMAN M, 2002, CHILDHOOD ASTHMA OTH, P1; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; Wensley DC, 2001, THORAX, V56, P183, DOI 10.1136/thorax.56.3.183; [No title captured]	23	21	22	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					198	202		10.1136/bmj.39234.651412.AE	http://dx.doi.org/10.1136/bmj.39234.651412.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17656544	Green Published			2022-12-28	WOS:000248662200032
J	Iwasawa, T; Hooley, RJ; Rebek, J				Iwasawa, Tetsuo; Hooley, Richard J.; Rebek, Julius, Jr.			Stabilization of labile carbonyl addition intermediates by a synthetic receptor	SCIENCE			English	Article							MOLECULAR RECOGNITION; TRIOSEPHOSPHATE ISOMERASE; ENZYME; CATALYSIS; CAVITANDS; MECHANISM; CAGE	Products of unfavorable chemical equilibria are not readily observed because their high energy and increased reactivity result in low concentrations. Biological macromolecules use binding forces to access unfavorable equilibria and stabilize reactive intermediates by isolating them from the medium. In a similar vein, we describe here a synthetic receptor that allows direct observation of labile tetrahedral intermediates: hemiaminals formed in the reaction of an aldehyde carbonyl group with amines. The receptor encapsulates alkyl-substituted primary amines, then orients them toward a covalently tethered aldehyde function. The hemiaminal intermediates appear at high concentration, confined from the bulk solution and observable at ambient temperature by conventional nuclear magnetic resonance spectroscopy.	Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Rebek, J (corresponding author), Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrebek@scripps.edu	Iwasawa, Tetsuo/E-4047-2016	Iwasawa, Tetsuo/0000-0002-5913-5167	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050174] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50174] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Anslyn E. V., 2006, MODERN PHYS ORGANIC; CHUDEK JA, 1985, J CHEM SOC PERK T 2, P1285, DOI 10.1039/p29850001285; Dong VM, 2006, J AM CHEM SOC, V128, P14464, DOI 10.1021/ja0657915; Evans DA, 2002, ANGEW CHEM INT EDIT, V41, P3188, DOI 10.1002/1521-3773(20020902)41:17<3188::AID-ANIE3188>3.0.CO;2-H; Fersht AA, 1984, ENZYME STRUCTURE MEC, P47; Fiedler D, 2004, ANGEW CHEM INT EDIT, V43, P6748, DOI 10.1002/anie.200461776; FLORIANI L, 1984, J CHEM RES, P126; Gottschalk T, 2007, ANGEW CHEM INT EDIT, V46, P260, DOI 10.1002/anie.200603366; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hooley RJ, 2005, J AM CHEM SOC, V127, P11904, DOI 10.1021/ja052910s; Iwasawa T, 2006, J AM CHEM SOC, V128, P9308, DOI 10.1021/ja062768a; Kawano M, 2006, J AM CHEM SOC, V128, P6558, DOI 10.1021/ja0609250; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lin SN, 2005, TETRAHEDRON LETT, V46, P4315, DOI 10.1016/j.tetlet.2005.04.101; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Masel R.I., 2001, CHEM KINETICS CATALY; Purse BW, 2005, J AM CHEM SOC, V127, P11222, DOI 10.1021/ja052877+; Purse BW, 2003, J AM CHEM SOC, V125, P14682, DOI 10.1021/ja036595q; REBEK J, 1979, TETRAHEDRON, V35, P723, DOI 10.1016/0040-4020(79)80087-3; Renslo AR, 2000, ANGEW CHEM INT EDIT, V39, P3281, DOI 10.1002/1521-3773(20000915)39:18<3281::AID-ANIE3281>3.0.CO;2-P; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Rudkevich DM, 1999, EUR J ORG CHEM, V1999, P1991; Yoshizawa M, 2000, J AM CHEM SOC, V122, P6311, DOI 10.1021/ja000779c; Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s; Ziegler M, 2000, ANGEW CHEM INT EDIT, V39, P4119, DOI 10.1002/1521-3773(20001117)39:22<4119::AID-ANIE4119>3.0.CO;2-1	26	220	220	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					493	496		10.1126/science.1143272	http://dx.doi.org/10.1126/science.1143272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	194JD	17656719				2022-12-28	WOS:000248339800039
J	Oh, SD; Lao, JP; Hwang, PYH; Taylor, AF; Smith, GR; Hunter, N				Oh, Steve D.; Lao, Jessica P.; Hwang, Patty Yi-Hwa; Taylor, Andrew F.; Smith, Gerald R.; Hunter, Neil			BLM ortholog, Sgs1, prevents aberrant crossing-over by suppressing formation of multichromatid joint molecules	CELL			English	Article							DOUBLE-STRAND-BREAK; SYNDROME GENE-PRODUCT; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; HOMOLOGOUS RECOMBINATION; HOLLIDAY JUNCTIONS; GENOME STABILITY; RECQ HELICASES; MEIOSIS	Bloom's helicase (BLM) is thought to prevent crossing-over during DNA double-strand-break repair (DSBR) by disassembling double-Holliday junctions (dHJs) or by preventing their formation. We show that the Saccharomyces cerevisiae BLM ortholog, Sgs1, prevents aberrant crossing-over during meiosis by suppressing formation of joint molecules (JMs) comprising three and four interconnected duplexes. Sgs1 and procrossover factors, Msh5 and Mlh3, are antagonistic since Sgs1 prevents dHJ formation in msh5 cells and sgs1 mutation alleviates crossover defects of both msh5 and mlh3 mutants. We propose that differential activity of Sgs1 and procrossover factors at the two DSB ends effects productive formation of dHJs and crossovers and prevents multichromatid JMs and counterproductive crossing-over. Strand invasion of different templates by both DSB ends may be a common feature of DSBR that increases repair efficiency but also the likelihood of associated crossing-over. Thus, by disrupting aberrant JMs, BLM-related helicases maximize repair efficiency while minimizing the risk of deleterious crossing-over.	Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, Davis, CA 95616 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California Davis; Fred Hutchinson Cancer Center	Hunter, N (corresponding author), Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	nhunter@ucdavis.edu		Smith, Gerald/0000-0002-8747-1352	NIGMS NIH HHS [R01 GM031693-25, GM031693, GM074223, R01 GM031693, R56 GM031693, R01 GM074223, R01 GM074223-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; de los Santos T, 2003, GENETICS, V164, P81; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOYON C, 1993, MOL CELL BIOL, V13, P373, DOI 10.1128/MCB.13.1.373; Grushcow JM, 1999, GENETICS, V153, P607; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Hoffmann ER, 2003, GENETICS, V163, P515; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Langland G, 2001, J BIOL CHEM, V276, P30031, DOI 10.1074/jbc.M009664200; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; MAGUIRE MP, 1980, HEREDITY, V45, P127, DOI 10.1038/hdy.1980.56; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Moens PB, 2002, J CELL SCI, V115, P1611; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MULLER K, 2000, GENE FUNCT DIS, V1, P154; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; NILSSON NO, 1995, J THEOR BIOL, V173, P93, DOI 10.1006/jtbi.1995.0046; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; PERKINS DD, 1949, GENETICS, V34, P607; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van Veen JE, 2003, CURR BIOL, V13, pR831, DOI 10.1016/j.cub.2003.10.014; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Watt PM, 1996, GENETICS, V144, P935; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	65	213	216	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					259	272		10.1016/j.cell.2007.05.035	http://dx.doi.org/10.1016/j.cell.2007.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662941	Bronze, Green Accepted			2022-12-28	WOS:000248588000016
J	Dikin, DA; Stankovich, S; Zimney, EJ; Piner, RD; Dommett, GHB; Evmenenko, G; Nguyen, ST; Ruoff, RS				Dikin, Dmitriy A.; Stankovich, Sasha; Zimney, Eric J.; Piner, Richard D.; Dommett, Geoffrey H. B.; Evmenenko, Guennadi; Nguyen, SonBinh T.; Ruoff, Rodney S.			Preparation and characterization of graphene oxide paper	NATURE			English	Article							GRAPHITE OXIDE; MECHANICAL-PROPERTIES; FLEXIBLE GRAPHITE; NANOTUBE SHEETS; FILMS; DISPERSIONS; TENSILE	Free-standing paper-like or foil-like materials are an integral part of our technological society. Their uses include protective layers, chemical filters, components of electrical batteries or supercapacitors, adhesive layers, electronic or optoelectronic components, and molecular storage(1). Inorganic 'paper-like' materials based on nanoscale components such as exfoliated vermiculite or mica platelets have been intensively studied(2,3) and commercialized as protective coatings, high-temperature binders, dielectric barriers and gas-impermeable membranes(4,5). Carbon-based flexible graphite foils(6-8) composed of stacked platelets of expanded graphite have long been used(9,10) in packing and gasketing applications because of their chemical resistivity against most media, superior sealability over a wide temperature range, and impermeability to fluids. The discovery of carbon nanotubes brought about bucky paper(11), which displays excellent mechanical and electrical properties that make it potentially suitable for fuel cell and structural composite applications(12-15). Here we report the preparation and characterization of graphene oxide paper, a free-standing carbon-based membrane material made by flow-directed assembly of individual graphene oxide sheets. This new material outperforms many other paper-like materials in stiffness and strength. Its combination of macroscopic flexibility and stiffness is a result of a unique interlocking-tile arrangement of the nanoscale graphene oxide sheets.	Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Ruoff, RS (corresponding author), Northwestern Univ, Dept Mech Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.	r-ruoff@northwestern.edu	Dikin, Dmitriy/A-1086-2010; Dikin, Dmitriy/B-4649-2014; Piner, Richard/Y-2520-2019; Nguyen, SonBinh/C-1682-2014; Ruoff, Rodney S/B-7605-2009; Ruoff, Rodney/ABE-6532-2020; Dikin, Dmitriy/B-7592-2009	Dikin, Dmitriy/0000-0001-8100-4502; Dikin, Dmitriy/0000-0001-8100-4502; Nguyen, SonBinh/0000-0002-6977-3445; Ruoff, Rodney S/0000-0002-6599-6764; Ruoff, Rodney/0000-0002-6599-6764; Evmenenko, Guennadi/0000-0002-6580-2237				Alava M, 2006, REP PROG PHYS, V69, P669, DOI 10.1088/0034-4885/69/3/R03; BALLARD DGH, 1983, J MATER SCI, V18, P545, DOI 10.1007/BF00560644; BARTRAM SF, 1967, HDB XRAYS; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Berhan L, 2004, J APPL PHYS, V95, P4335, DOI 10.1063/1.1687995; Coleman JN, 2003, APPL PHYS LETT, V82, P1682, DOI 10.1063/1.1559421; DOWELL MB, 1986, CARBON, V24, P311, DOI 10.1016/0008-6223(86)90232-0; *GRAFTECH INT INC, 2005, GRAF; Hennrich F, 2002, PHYS CHEM CHEM PHYS, V4, P2273, DOI 10.1039/b201570f; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; *IS INC US SAM, 2007, SAM; Kellar J.J., 2006, FUNCTIONAL FILLERS N; Leng Y, 1998, CARBON, V36, P875, DOI 10.1016/S0008-6223(97)00196-6; Lerf A, 2006, J PHYS CHEM SOLIDS, V67, P1106, DOI 10.1016/j.jpcs.2006.01.031; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Pitkethly MJ, 2004, MATER TODAY, V7, P20, DOI 10.1016/S1369-7021(04)00627-3; Reynolds RA, 2001, CARBON, V39, P479, DOI 10.1016/S0008-6223(00)00291-8; SCHOLZ W, 1969, Z ANORG ALLG CHEM, V369, P327, DOI 10.1002/zaac.19693690322; SOULE DE, 1968, J APPL PHYS, V39, P5122, DOI 10.1063/1.1655933; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Timoshenko S.P., 1970, THEORY ELASTICITY; Titelman GI, 2005, CARBON, V43, P641, DOI 10.1016/j.carbon.2004.10.035; WARD IM, 1983, MECHANICAL PROPERTIE, P329; Zhang XF, 2004, J PHYS CHEM B, V108, P16435, DOI 10.1021/jp0475988	27	4586	4754	131	6521	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					457	460		10.1038/nature06016	http://dx.doi.org/10.1038/nature06016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653188				2022-12-28	WOS:000248302700043
J	Catovsky, D; Richards, S; Matutes, E; Oscier, D; Dyer, MJS; FBezares, R; Pettitt, AR; Hamblin, T; Milligan, DW; Child, JA; Hamilton, MS; Dearden, CE; Smith, AG; Bosanquet, AG; Davis, Z; Brito-Babapulle, V; Else, M; Wade, R; Hillmen, P				Catovsky, D.; Richards, S.; Matutes, E.; Oscier, D.; Dyer, M. J. S.; FBezares, R.; Pettitt, A. R.; Hamblin, T.; Milligan, D. W.; Child, J. A.; Hamilton, M. S.; Dearden, C. E.; Smith, A. G.; Bosanquet, A. G.; Davis, Z.; Brito-Babapulle, V.; Else, M.; Wade, R.; Hillmen, P.		NCRI Haematological Oncol; NCRI Chronic Lymphocytic	Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial	LANCET			English	Article							GENE MUTATION STATUS; 1ST-LINE THERAPY; REGIMEN; CHEMOIMMUNOTHERAPY; COMBINATION; CLADRIBINE; RITUXIMAB; ZAP-70; CHLORAMBUCIL; MULTICENTER	Background Previous studies of patients with chronic lymphocytic leukaemia reported high response rates to fludarabine combined with cyclophosphamide. We aimed to establish whether this treatment combination provided greater survival benefit than did chlorambucil or fludarabine. Methods 777 patients with chronic lymphocytic leukaemia requiring treatment were randomly assigned to fludarabine (n=194) or fludarabine plus cyclophosphamide (196) for six courses, or chlorambucil (387) for 12 courses. The primary endpoint was overall survival, with secondary endpoints of response rates, progression-free survival, toxic effects, and quality of life. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number NCT 58585610. Findings There was no significant difference in overall survival between patients given fludarabine plus cyclophosphamide, fludarabine, or chlorambucil. Complete and overall response rates were better with fludarabine plus cyclophosphamide than with fludarabine (complete response rate 38% vs 15%, respectively; overall response rate 94% vs 80%, respectively; p < 0.0001 for both comparisons), which were in turn better than with chlorambucil (complete response rate 7%, overall response rate 72%; p=0.006 and 0.04, respectively). Progression-free survival at 5 years was significantly better with fludarabine plus cyclophosphamide (36%) than with fludarabine (10%) or chlorambucil (10%; p < 0.00005). Fludarabine plus cyclophosphamide was the best combination for all ages, including patients older than 70 years, and in prognostic groups defined by immunoglobulin heavy chain gene (V,,) mutation status and cytogenetics, which were tested in 533 and 579 cases, respectively. Patients had more neutropenia and days in hospital with fludarabine plus cyclophosphamide, or fludarabine, than with chlorambucil. There was less haemolytic anaemia with fludarabine plus cyclophosphamide (5%) than with fludarabine (11%) or chlorambucil (12%). Quality of life was better for responders, but preliminary analyses showed no significant difference between treatments. A meta-analysis of these data and those of two published phase III trials showed a consistent benefit for the fludarabine plus cyclophosphamide regimen in terms of progression-free survival. Interpretation Fludarabine plus cyclophosphamide should now become the standard treatment for chronic lymphocytic leukaemia and the basis for new protocols that incorporate monoclonal antibodies.	Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; Clin Trial Serv Unit, Oxford, England; Royal Bournemouth Hosp, Bournemouth, Dorset, England; Leicester Royal Infirm, Leicester, Leics, England; Hosp Alvarez, Buenos Aires, DF, Argentina; Univ Liverpool, Liverpool L69 3BX, Merseyside, England; Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; Southampton Gen Hosp, Southampton SO9 4XY, Hants, England; Bath Canc Res, Bath, Avon, England; Good Hope Hosp, Sutton Coldfield, England	University of London; Institute of Cancer Research - UK; University of Oxford; University of Leicester; University of Liverpool; Heart of England NHS Foundation Trust; University of Birmingham; Leeds General Infirmary; University of Southampton; Heart of England NHS Foundation Trust; Good Hope Hospital	Catovsky, D (corresponding author), Inst Canc Res, Sect Haematooncol, Brookes Lawley Bldg,15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	daniel.catovsky@icr.ac.uk	Dyer, Martin/F-2691-2014	Dyer, Martin/0000-0002-5033-2236; Wade, Rachel/0000-0001-9826-6322	Medical Research Council [MC_U132670597, MC_U137686856] Funding Source: Medline; MRC [MC_U137686856, MC_U132670597] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABE O, 1992, LANCET, V339, P71; [Anonymous], 1999, J Natl Cancer Inst, V91, P861; [Anonymous], 1988, BRIT MED J, V296, P320; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Byrd JC, 2006, J CLIN ONCOL, V24, P437, DOI 10.1200/JCO.2005.03.1021; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; Flinn IW, 2007, J CLIN ONCOL, V25, P793, DOI 10.1200/JCO.2006.08.0762; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hillmen P, 2005, BLOOD, V106, p214A; Johnson S, 1996, Lancet, V347, P1432; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Krober A, 2006, J CLIN ONCOL, V24, P969, DOI 10.1200/JCO.2005.03.7184; Leporrier M, 2001, BLOOD, V98, P2319, DOI 10.1182/blood.V98.8.2319; Lozanski G, 2004, BLOOD, V103, P3278, DOI 10.1182/blood-2003-10-3729; Machin D., 1987, STAT TABLES DESIGN C; Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Brien SM, 2001, J CLIN ONCOL, V19, P1414, DOI 10.1200/JCO.2001.19.5.1414; Oscier DG, 2006, BLOOD, V108, P299; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Osuji NC, 2005, HAEMATOLOGICA, V90, P1435; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pettitt AR, 2006, LEUKEMIA, V20, P1441, DOI 10.1038/sj.leu.2404265; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Robak T, 2000, BLOOD, V96, P2723; Robak T, 2006, BLOOD, V108, P473, DOI 10.1182/blood-2005-12-4828; Robak T, 2005, HAEMATOLOGICA, V90, P994; Steurer M, 2006, CANCER TREAT REV, V32, P377, DOI 10.1016/j.ctrv.2006.05.002; Wierda W, 2005, J CLIN ONCOL, V23, P4070, DOI 10.1200/JCO.2005.12.516; Zhu Q, 2004, LEUKEMIA LYMPHOMA, V45, P2239, DOI 10.1080/10428190412331283260	35	573	601	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					230	239		10.1016/S0140-6736(07)61125-8	http://dx.doi.org/10.1016/S0140-6736(07)61125-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658394				2022-12-28	WOS:000248347900027
J	Rohatgi, R; Milenkovic, L; Scott, MP				Rohatgi, Rajat; Milenkovic, Ljiljana; Scott, Matthew P.			Patched1 regulates Hedgehog signaling at the primary cilium	SCIENCE			English	Article							INTRAFLAGELLAR TRANSPORT; CELLS; TRANSDUCTION; LOCALIZATION	Primary cilia are essential for transduction of the Hedgehog (Hh) signal in mammals. We investigated the role of primary cilia in regulation of Patched1 (Ptc1), the receptor for Sonic Hedgehog (Shh). Ptc1 localized to cilia and inhibited Smoothened (Smo) by preventing its accumulation within cilia. When Shh bound to Ptc1, Ptc1 left the cilia, leading to accumulation of Smo and activation of signaling. Thus, primary cilia sense Shh and transduce signals that play critical roles in development, carcinogenesis, and stem cell function.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	mscott@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA088060] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088060] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	16	1010	1048	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					372	376		10.1126/science.1139740	http://dx.doi.org/10.1126/science.1139740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641202				2022-12-28	WOS:000248150200047
J	Sirajuddin, M; Farkasovsky, M; Hauer, F; Kuhlmann, D; Macara, IG; Weyand, M; Stark, H; Wittinghofer, A				Sirajuddin, Minhajuddin; Farkasovsky, Marian; Hauer, Florian; Kuehlmann, Dorothee; Macara, Ian G.; Weyand, Michael; Stark, Holger; Wittinghofer, Alfred			Structural insight into filament formation by mammalian septins	NATURE			English	Article							GTP-BINDING; YEAST SEPTINS; COMPLEX; PROTEIN; CLASSIFICATION; ORGANIZATION; CHITIN	Septins are GTP-binding proteins that assemble into homo- and hetero-oligomers and filaments. Although they have key roles in various cellular processes, little is known concerning the structure of septin subunits or the organization and polarity of septin complexes. Here we present the structures of the human SEPT2 G domain and the heterotrimeric human SEPT2-SEPT6-SEPT7 complex. The structures reveal a universal bipolar polymer building block, composed of an extended G domain, which forms oligomers and filaments by conserved interactions between adjacent nucleotide-binding sites and/or the amino- and carboxy-terminal extensions. Unexpectedly, X-ray crystallography and electron microscopy showed that the predicted coiled coils are not involved in or required for complex and/or filament formation. The asymmetrical heterotrimers associate head-to-head to form a hexameric unit that is nonpolarized along the filament axis but is rotationally asymmetrical. The architecture of septin filaments differs fundamentally from that of other cytoskeletal structures.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany; Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; University of Virginia; Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Sirajuddin, Minhaj/H-8040-2019	Sirajuddin, Minhaj/0000-0001-5742-2130; Holger, Stark/0000-0002-6161-1118				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Chant J, 1996, CELL, V84, P187, DOI 10.1016/S0092-8674(00)80972-1; DeLano W., 2006, PYMOL MOL GRAPHICS S; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Mitchison TJ, 2002, CURR BIOL, V12, pR788, DOI 10.1016/S0960-9822(02)01295-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TQ, 2000, J CELL SCI, V113, P3825; Oegema K, 1998, METHOD ENZYMOL, V298, P279, DOI 10.1016/S0076-6879(98)98025-9; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; VANHEEL M, 1989, OPTIK, V82, P114; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Vrabioiu AM, 2004, J BIOL CHEM, V279, P3111, DOI 10.1074/jbc.M310941200	46	321	333	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					311	+		10.1038/nature06052	http://dx.doi.org/10.1038/nature06052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17637674				2022-12-28	WOS:000249557300039
J	Abraham, C; Cho, JH				Abraham, Clara; Cho, Judy H.			Bugging of the intestinal mucosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; COLI		Univ Chicago, Dept Med, Chicago, IL 60637 USA; Yale Univ, Sch Med, Dept Med & Genet, New Haven, CT USA	University of Chicago; Yale University	Abraham, C (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Xavier R, 2005, GASTROENTEROLOGY, V128, P1122, DOI 10.1053/j.gastro.2005.02.053	5	19	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					708	710		10.1056/NEJMcibr073420	http://dx.doi.org/10.1056/NEJMcibr073420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699823				2022-12-28	WOS:000248746000014
J	Tung, A				Tung, Avery			The other side	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					722	723		10.1001/jama.298.7.722	http://dx.doi.org/10.1001/jama.298.7.722			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699001				2022-12-28	WOS:000248728800001
J	Malen, CD; Peat, G; Porcheret, M				Malen, Christian David; Peat, George; Porcheret, Mark			Chronic knee pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England	Keele University	Malen, CD (corresponding author), Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England.	c.d.mallen@cphc.keele.ac.uk	Peat, George/AAE-5869-2020	Peat, George/0000-0002-9008-0184; Mallen, Christian/0000-0002-2677-1028	Department of Health [2008 IPF PORCHERET] Funding Source: Medline	Department of Health		CHARD J, OSTEOARTHRITIS KNEE; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742	2	1	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					303	303		10.1136/bmj.39231.735498.94	http://dx.doi.org/10.1136/bmj.39231.735498.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17690372	Green Published			2022-12-28	WOS:000248987400028
J	Arkin, IT; Xu, HF; Jensen, MO; Arbely, E; Bennett, ER; Bowers, KJ; Chow, E; Dror, RO; Eastwood, MP; Flitman-Tene, R; Gregersen, BA; Klepeis, JL; Kolossvary, I; Shan, YB; Shaw, DE				Arkin, Isaiah T.; Xu, Huafeng; Jensen, Morten O.; Arbely, Eyal; Bennett, Estelle R.; Bowers, Kevin J.; Chow, Edmond; Dror, Ron O.; Eastwood, Michael P.; Flitman-Tene, Ravenna; Gregersen, Brent A.; Klepeis, John L.; Kolossvary, Istvan; Shan, Yibing; Shaw, David E.			Mechanism of Na+/H+ antiporting	SCIENCE			English	Article							ESCHERICHIA-COLI; NHAA; PH; HISTIDINE-226; DYNAMICS; DOMAIN; MODEL; PART; ANT	Na+/H+ antiporters are central to cellular salt and pH homeostasis. The structure of Escherichia coli NhaA was recently determined, but its mechanisms of transport and pH regulation remain elusive. We performed molecular dynamics simulations of NhaA that, with existing experimental data, enabled us to propose an atomically detailed model of antiporter function. Three conserved aspartates are key to our proposed mechanism: Asp(164) (D164) is the Na+-binding site, D163 controls the alternating accessibility of this binding site to the cytoplasm or periplasm, and D133 is crucial for pH regulation. Consistent with experimental stoichiometry, two protons are required to transport a single Na+ ion: D163 protonates to reveal the Na+-binding site to the periplasm, and subsequent protonation of D164 releases Na+. Additional mutagenesis experiments further validated the model.	DE Shaw Res, New York, NY 10036 USA; Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Hebrew University of Jerusalem; Columbia University	Shaw, DE (corresponding author), DE Shaw Res, New York, NY 10036 USA.	david@deshaw.com	Arbely, Eyal/G-1530-2013; Arkin, Isaiah/GQA-4328-2022; Kolossvary, Istvan/AHD-3572-2022; Xu, Huafeng/GZK-8527-2022; Xu, Huafeng/V-2206-2019; Bennett, Estelle R/A-5067-2017; Kolossvary, Istvan/CAA-8254-2022	Xu, Huafeng/0000-0001-5447-0452; Dror, Ron/0000-0002-6418-2793; Arkin, Isaiah/0000-0002-7659-1746				Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; Bowers KJ, 2007, J COMPUT PHYS, V221, P303, DOI 10.1016/j.jcp.2006.06.014; BOWERS KJ, 2006, P 2006 ASS COMP MACH; DeLano W.L, PYMOL MOL GRAPHICS S; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; NEEDLEMAN R, 1991, J BIOL CHEM, V266, P11478; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; RIMON A, 1995, J BIOL CHEM, V270, P26813, DOI 10.1074/jbc.270.45.26813; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	28	125	126	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					799	803		10.1126/science.1142824	http://dx.doi.org/10.1126/science.1142824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690293				2022-12-28	WOS:000248624500039
J	Aster, RH; Bougie, DW				Aster, Richard H.; Bougie, Daniel W.			Current concepts - Drug-induced immune thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							QUININE-INDUCED THROMBOCYTOPENIA; DEPENDENT ANTIBODIES; PURPURA; QUINIDINE; PLATELETS; BINDING; SENSITIVITY; ABCIXIMAB; INDIVIDUALS; FEATURES		BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Aster, RH (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	richard.aster@bcw.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R56HL013629, R37HL013629, R01HL013629] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL013629, HL-13629, HL-44612] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Arndt PA, 2005, SEMIN HEMATOL, V42, P137, DOI 10.1053/j.seminhematol.2005.04.004; Arnold J, 1998, LANCET, V352, P618, DOI 10.1016/S0140-6736(98)05194-0; Aster RH, 2005, TOXICOLOGY, V209, P149, DOI 10.1016/j.tox.2004.12.031; Aster RH, 2005, CHEST, V127, p53S, DOI 10.1378/chest.127.2_suppl.53S; Aster RH, 2000, SEMIN HEMATOL, V37, P229; Aster RH, 2007, PLATELETS, 2ND EDITION, P887, DOI 10.1016/B978-012369367-9/50811-9; Asvadi P, 2003, BLOOD, V102, P1670, DOI 10.1182/blood-2002-07-2175; Attassi K, 2002, CLIN INFECT DIS, V34, P695, DOI 10.1086/338403; Azuno Y, 1999, LANCET, V354, P304, DOI 10.1016/S0140-6736(99)01336-7; BELKIN GA, 1967, ANN INTERN MED, V66, P583, DOI 10.7326/0003-4819-66-3-583; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bougie D, 2001, BLOOD, V97, P3846, DOI 10.1182/blood.V97.12.3846; Bougie DW, 2006, BLOOD, V108, P922, DOI 10.1182/blood-2006-01-009803; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; CHRISTIE DJ, 1985, J CLIN INVEST, V75, P310, DOI 10.1172/JCI111691; CHRISTIE DJ, 1984, J LAB CLIN MED, V104, P730; Curtis BR, 2006, AM J HEMATOL, V81, P193, DOI 10.1002/ajh.20516; Curtis BR, 2004, J THROMB HAEMOST, V2, P985, DOI 10.1111/j.1538-7836.2004.00744.x; Curtis BR, 2002, BLOOD, V99, P2054, DOI 10.1182/blood.V99.6.2054; FIREMAN Z, 1981, CHEST, V79, P358, DOI 10.1378/chest.79.3.358; FREIMAN JP, 1990, ANN INTERN MED, V112, P308, DOI 10.7326/0003-4819-112-4-308; Garner SF, 2002, BLOOD, V100, P344, DOI 10.1182/blood.V100.1.344; Garratty George, 1993, Transfusion Medicine Reviews, V7, P255; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; KAUFMAN DW, 1993, BLOOD, V82, P2714; Knower MT, 2003, INTENS CARE MED, V29, P1007, DOI 10.1007/s00134-003-1732-0; Kojouri K, 2001, ANN INTERN MED, V135, P1047, DOI 10.7326/0003-4819-135-12-200112180-00008; LAVY R, 1964, J ALLERGY, V35, P386, DOI 10.1016/0021-8707(64)90065-6; Li XN, 2005, ANN INTERN MED, V142, P474, DOI 10.7326/0003-4819-142-6-200503150-00023; McCorry Roger B, 2006, J Invasive Cardiol, V18, pE173; Mueller-Eckhardt C, 1990, Transfus Med Rev, V4, P69; Neau D, 1998, SCAND J INFECT DIS, V30, P115, DOI 10.1080/003655498750003465; NIEMINEN U, 1993, ACTA PAEDIATR, V82, P267, DOI 10.1111/j.1651-2227.1993.tb12657.x; PARKER CW, 1981, ARTHRITIS RHEUM, V24, P1024, DOI 10.1002/art.1780240808; Pillai S, 2005, IMMUNITY, V23, P242, DOI 10.1016/j.immuni.2005.09.001; POURRAT O, 1994, ANN MED INTERNE, V145, P357; RAY JB, 1990, DICP ANN PHARMAC, V24, P693, DOI 10.1177/106002809002400706; Reddy JC, 2004, ARCH INTERN MED, V164, P218, DOI 10.1001/archinte.164.2.218; REID DM, 1988, ANN INTERN MED, V108, P206, DOI 10.7326/0003-4819-108-2-206; ROSS MP, 1993, CLIN PHARMACOL THER, V53, P661, DOI 10.1038/clpt.1993.87; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; SALAMON DJ, 1984, TRANSFUSION, V24, P395, DOI 10.1046/j.1537-2995.1984.24585017827.x; SCHMITT SK, 1994, ANN INTERN MED, V120, P90, DOI 10.7326/0003-4819-120-1-199401010-00025; Shulman N. Raphael, 1993, Transfusion Medicine Reviews, V7, P215; SHULMAN NR, 1964, ANN INTERN MED, V60, P506, DOI 10.7326/0003-4819-60-3-506; SHULMAN NR, 1958, J EXP MED, V107, P711, DOI 10.1084/jem.107.5.711; SMITH ME, 1987, J CLIN INVEST, V79, P912, DOI 10.1172/JCI112901; Stroncek David F., 1993, Transfusion Medicine Reviews, V7, P268, DOI 10.1016/S0887-7963(93)70146-7; Tcheng JE, 2001, CIRCULATION, V104, P870, DOI 10.1161/hc3301.094533; Trannel TJ, 2001, AM J PSYCHIAT, V158, P128, DOI 10.1176/appi.ajp.158.1.128; van den Bemt PMLA, 2004, DRUG SAFETY, V27, P1243, DOI 10.2165/00002018-200427150-00007; Vipan W., 1865, LANCET, V2, P37; VISENTIN GP, 1991, BLOOD, V77, P2668; Von Drygalski A, 2007, NEW ENGL J MED, V356, P904, DOI 10.1056/NEJMoa065066; VONDEMBORNE AEGK, 1986, BRIT J HAEMATOL, V63, P509; WARKENTIN TE, 2005, HEMATOLOGY BASIC PRI, P2305	57	326	351	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					580	587		10.1056/NEJMra066469	http://dx.doi.org/10.1056/NEJMra066469			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687133				2022-12-28	WOS:000248584900009
J	Schousboe, JT; Taylor, BC; Fink, HA; Kane, RL; Cummings, SR; Orwoll, ES; Melton, LJ; Bauer, DC; Ensrud, KE				Schousboe, John T.; Taylor, Brent C.; Fink, Howard A.; Kane, Robert L.; Cummings, Steven R.; Orwoll, Eric S.; Melton, L. Joseph, III; Bauer, Douglas C.; Ensrud, Kristine E.			Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; EUROPEAN VERTEBRAL OSTEOPOROSIS; FRACTURE INTERVENTION TRIAL; HIP FRACTURE; ELDERLY-WOMEN; POPULATION HEALTH; EXCESS MORTALITY; RISK-FACTORS; BACK-PAIN; ALENDRONATE	Context Osteoporotic fractures are common among elderly men. Objective To evaluate among older men the cost-effectiveness of bone densitometry followed by 5 years of oral bisphosphonate therapy to prevent fractures for those found to have osteoporosis ( femoral neck T score <=-2.5), compared with no intervention. Design, Setting, and Population Computer Markov microsimulation model using a societal perspective and a lifetime horizon. Simulations were performed for hypothetical cohorts of white men aged 65, 70, 75, 80, or 85 years, with or without prior clinical fracture. Data sources for model parameters included the Rochester Epidemiology Project for fracture costs and population-based age-specific fracture rates; the Osteoporotic Fractures in Men (MrOS) study and published meta-analyses for the associations among prior fractures, bone density, and incident fractures; and published studies of fracture disutility. Main Outcome Measures Costs per quality-adjusted life-year ( QALY) gained for the densitometry and follow-up treatment strategy compared with no intervention, calculated from lifetime costs and accumulated QALYs for each strategy. Results Lifetime costs per QALY gained for the densitometry and follow-up treatment strategy were less than $ 50 000 for men aged 65 years or older with a prior clinical fracture and for men aged 80 years or older without a prior fracture. These results were most sensitive to oral bisphosphonate cost and fracture reduction efficacy, the strength of association between bone mineral density and fractures, fracture rates and disutility, and medication adherence. Conclusions Bone densitometry followed by bisphosphonate therapy for those with osteoporosis may be cost-effective for men aged 65 years or older with a self-reported prior clinical fracture and for men aged 80 to 85 years with no prior fracture. This strategy may also be cost-effective for men as young as 70 years without a prior clinical fracture if oral bisphosphonate costs are less than $ 500 per year or if the societal willingness to pay per QALY gained is $ 100 000.	Univ Minnesota, Pk Nicollet Hlth Serv, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Clin Outcomes Res Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Vet Adm Med Ctr, Dept Med, Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Calif San Francisco, San Francisco Coordinating Ctr, Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med & Epidemiol, San Francisco, CA 94143 USA; Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Oregon Health & Science University	Schousboe, JT (corresponding author), Univ Minnesota, Pk Nicollet Hlth Serv, Ctr Chron Dis Outcomes Res, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	john.schousboe@parknicollet.com	Fink, Howard/F-3933-2012; Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Ensrud, Kristine/0000-0002-9069-3036; Orwoll, Eric/0000-0002-8520-7355	NCRR NIH HHS [UL1 RR024140] Funding Source: Medline; NIAMS NIH HHS [U01 AR45583, U01 AR45580, U01 AR45632, U01 AR45614, U01 AR45654, U01 AR45647] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045614, U01AR045647, U01AR045654, U01AR045583, U01AR045580, U01AR045632] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; BLINKLEY N, 2006, J CLIN DENSITOM, V9, P4; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P637, DOI 10.1007/s00198-005-0015-8; Borgstrom F, 2004, BONE, V34, P1064, DOI 10.1016/j.bone.2003.12.028; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; *BUR LAB STAT US C, CPS ANN DEM SURV; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Centers for Medicare and Medicaid Services, 2007, PHYS FEE SCHED SEARC; *CTR MED MED SERV, 5 YEAR REV WORK REL; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P953, DOI 10.1007/s00198-005-1950-0; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Haentjens P, 2003, J BONE JOINT SURG AM, V85A, P1936, DOI 10.2106/00004623-200310000-00011; Hasserius R, 2003, BONE, V32, P180, DOI 10.1016/S8756-3282(02)00951-1; Hasserius R, 2003, OSTEOPOROSIS INT, V14, P61, DOI 10.1007/s00198-002-1316-9; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; Jackson SA, 2000, OSTEOPOROSIS INT, V11, P680, DOI 10.1007/s001980070066; JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147, DOI 10.2105/AJPH.82.8.1147; Joakimsen RM, 2001, OSTEOPOROSIS INT, V12, P1001, DOI 10.1007/s001980170008; Johnell O, 1997, OSTEOPOROSIS INT, V7, P138, DOI 10.1007/BF01623689; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; KELLIE SE, 1990, AM J PUBLIC HEALTH, V80, P326, DOI 10.2105/AJPH.80.3.326; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Macran S, 2003, MED CARE, V41, P218; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; *MED EC CO, 2001, DRUG TOP 2001 RED BO; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 2000, J AM GERIATR SOC, V48, P338, DOI 10.1111/j.1532-5415.2000.tb02658.x; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Mussolino ME, 1998, J BONE MINER RES, V13, P918, DOI 10.1359/jbmr.1998.13.6.918; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; O'Neill TW, 2004, OSTEOPOROSIS INT, V15, P760, DOI 10.1007/s00198-004-1615-4; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Olszynski WP, 2004, CLIN THER, V26, P15, DOI 10.1016/S0149-2918(04)90002-1; ONeill TW, 1996, J BONE MINER RES, V11, P1010; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Papadimitropoulos EA, 1997, CAN MED ASSOC J, V157, P1357; Ringe JD, 2004, RHEUMATOL INT, V24, P110, DOI 10.1007/s00296-003-0388-y; Sawka AM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-39; Schousboe John T, 2007, Curr Rheumatol Rep, V9, P50, DOI 10.1007/s11926-007-0022-1; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; Wright VJ, 2006, J AM ACAD ORTHOP SUR, V14, P347, DOI 10.5435/00124635-200606000-00004	60	117	120	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					629	637		10.1001/jama.298.6.629	http://dx.doi.org/10.1001/jama.298.6.629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684185	Bronze			2022-12-28	WOS:000248574800023
J	Szarewski, A				Szarewski, Anne			Cervical screening by visual inspection with acetic acid	LANCET			English	Editorial Material							CANCER; TRIAL; INDIA		Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Szarewski, A (corresponding author), Wolfson Inst Prevent Med, London EC1M 6BQ, England.	anne.szarewski@cancer.org.uk						Cronje HS, 2005, BEST PRACT RES CL OB, V19, P517, DOI 10.1016/j.bpobgyn.2005.02.005; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Legood R, 2005, INT J CANCER, V117, P981, DOI 10.1002/ijc.21220; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, P54, DOI 10.1016/j.ijgo.2005.01.009; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sherris J, 2003, EFFECTIVENESS SAFETY	8	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					365	366		10.1016/S0140-6736(07)61171-4	http://dx.doi.org/10.1016/S0140-6736(07)61171-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17678998				2022-12-28	WOS:000248590200005
J	Albert, MS				Albert, Marilyn S.			Changing the trajectory of cognitive decline?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; AMYLOID DEPOSITION; TRANSGENIC MICE		Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Albert, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.							Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	5	9	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					502	503		10.1056/NEJMcibr073273	http://dx.doi.org/10.1056/NEJMcibr073273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671260				2022-12-28	WOS:000248436300016
J	Heath, I				Heath, Iona			Only general practice can save the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					183	183		10.1136/bmj.39286.704722.59	http://dx.doi.org/10.1136/bmj.39286.704722.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17656542	Green Published			2022-12-28	WOS:000248662200027
J	Dillin, A; Kelly, JW				Dillin, Andrew; Kelly, Jeffery W.			The yin-yang of sirtuins	SCIENCE			English	Editorial Material							INHIBITORS		Salk Inst Biol Studies, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu; jkelly@scripps.edu						Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Sinclair D, 2005, NAT GENET, V37, P339, DOI 10.1038/ng0405-339; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568	12	31	35	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					461	462		10.1126/science.1146585	http://dx.doi.org/10.1126/science.1146585			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656709				2022-12-28	WOS:000248339800027
J	Gazelle, G				Gazelle, Gail			Understanding hospice - An underutilized option for life's final chapter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		MD Can Help, Boston, MA USA		Gazelle, G (corresponding author), MD Can Help, Boston, MA USA.							Emanuel L L, 2000, J Palliat Med, V3, P419, DOI 10.1089/jpm.2000.3.4.419; National Hospice and Palliative Care Organization, 2006, NHCPOS FACTS FIG 200; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011	5	48	48	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					321	324		10.1056/NEJMp078067	http://dx.doi.org/10.1056/NEJMp078067			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652645				2022-12-28	WOS:000248283500001
J	Griffiths, CEM; Barker, JNWN				Griffiths, Christopher E. M.; Barker, Jonathan N. W. N.			Psoriasis 1 - Pathogenesis and clinical features of psoriasis	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; NATURAL-KILLER RECEPTORS; NECROSIS-FACTOR-ALPHA; T-CELLS; PSYCHOLOGICAL DISTRESS; MOUSE MODEL; SUSCEPTIBILITY LOCUS; GUTTATE PSORIASIS; SKIN INFLAMMATION; ATOPIC-DERMATITIS	Psoriasis, a papulosquamous skin disease, was originally thought of as a disorder primarily of epidermal keratinocytes, but is now recognised as one of the commonest immune-mediated disorders. Tumour necrosis factor a, dendritic cells, and T-cells all contribute substantially to its pathogenesis. In early-onset psoriasis (beginning before age 40 years), carriage of HLA-Cw6 and environmental triggers, such as P-haemolytic streptococcal infections, are major determinants of disease expression. Moreover, at least nine chromosomal psoriasis susceptibility loci have been identified. Several clinical phenotypes of psoriasis are recognised, with chronic plaque (psoriasis vulgaris) accounting for 90% of cases. Comorbidities of psoriasis are attracting interest, and include impairment of quality of life and associated depressive illness, cardiovascular disease, and a seronegative arthritis known as psoriatic arthritis. A more complete understanding of underlying pathomechanisms is leading to new treatments, which will be discussed in the second part of this Series.	Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England; Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England	University of Manchester; University of London; King's College London	Griffiths, CEM (corresponding author), Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England.	christopher.griffiths@manchester.ac.uk	Abed, Saad Raheem/A-6131-2018; Griffiths, Christopher E.M./P-5448-2014	Abed, Saad Raheem/0000-0003-2428-4450; Griffiths, Christopher E.M./0000-0001-5371-4427; Barker, Jonathan/0000-0002-9030-183X				Allen M, 2001, LAB INVEST, V81, P969, DOI 10.1038/labinvest.3780309; Allen MH, 2005, J INVEST DERMATOL, V124, P103, DOI 10.1111/j.0022-202X.2004.23511.x; ANDRESSEN C, 1982, HAUTARZT, V33, P214; Asumalahti K, 2003, J INVEST DERMATOL, V120, P627, DOI 10.1046/j.1523-1747.2003.12094.x; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; BRAATHEN LR, 1989, ACTA DERM-VENEREOL, P5; BRAVERMAN IM, 1974, J INVEST DERMATOL, V62, P493, DOI 10.1111/1523-1747.ep12681007; Capon F, 2004, DERMATOL CLIN, V22, P339, DOI 10.1016/S0733-8635(03)00125-6; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Capon F, 2001, J INVEST DERMATOL, V116, P728, DOI 10.1046/j.1523-1747.2001.01311.x; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Creamer D, 1996, LANCET, V348, P1101, DOI 10.1016/S0140-6736(05)64447-9; Cumberbatch M, 2006, J EXP MED, V203, P953, DOI 10.1084/jem.20052367; Davison SC, 2001, EXP DERMATOL, V10, P280, DOI 10.1034/j.1600-0625.2001.100408.x; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; EEDY DJ, 1990, BRIT MED J, V300, P908, DOI 10.1136/bmj.300.6729.908; Esposito M, 2006, DERMATOLOGY, V212, P123, DOI 10.1159/000090652; FARBER EM, 1974, ARCH DERMATOL, V109, P207, DOI 10.1001/archderm.109.2.207; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FINLAY AY, 1987, CLIN EXP DERMATOL, V12, P8, DOI 10.1111/j.1365-2230.1987.tb01844.x; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; Fortune DG, 2004, BRIT J DERMATOL, V151, P1219, DOI 10.1111/j.1365-2133.2004.06222.x; Fortune DG, 2003, ARCH DERMATOL, V139, P752, DOI 10.1001/archderm.139.6.752; Fortune DG, 2003, J BEHAV MED, V26, P211, DOI 10.1023/A:1023408503807; Fortune DG, 2002, CLIN EXP DERMATOL, V27, P177, DOI 10.1046/j.1365-2230.2002.01055.x; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Griffin TG, 2005, ACM SIGCOMM COMP COM, V35, P1, DOI 10.1145/1090191.1080094; Griffiths CEM, 2007, BRIT J DERMATOL, V156, P258, DOI 10.1111/j.1365-2133.2006.07675.x; Griffiths CEM, 2005, CYTOKINE, V32, P67, DOI 10.1016/j.cyto.2005.07.011; Gupta MA, 2003, AM J CLIN DERMATOL, V4, P833, DOI 10.2165/00128071-200304120-00003; Helliwell PS, 2005, ANN RHEUM DIS, V64, P3, DOI 10.1136/ard.2004.032318; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Ho P, 2005, ARTHRITIS RHEUM-US, V52, P3596, DOI 10.1002/art.21393; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Kuroda K, 2001, J INVEST DERMATOL, V116, P713, DOI 10.1046/j.1523-1747.2001.01316.x; Landgren E, 2006, BRIT J DERMATOL, V154, P332, DOI 10.1111/j.1365-2133.2005.07004.x; LEE FI, 1990, AM J GASTROENTEROL, V85, P962; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; LINDELOF B, 1990, J AM ACAD DERMATOL, V22, P1056, DOI 10.1016/0190-9622(90)70152-8; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038; Martin BA, 1996, ARCH DERMATOL, V132, P717, DOI 10.1001/archderm.1996.03890300147032; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Mossner R, 2005, J INVEST DERMATOL, V124, P282, DOI 10.1111/j.0022-202X.2004.23556.x; Mrowietz U, 2006, ARCH DERMATOL RES, V298, P309, DOI 10.1007/s00403-006-0707-8; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Nickoloff BJ, 2000, J DERMATOL SCI, V24, P212, DOI 10.1016/S0923-1811(00)00120-1; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pitzalis C, 1996, ARTHRITIS RHEUM, V39, P137, DOI 10.1002/art.1780390118; Potter Dennis, 1986, SINGING DETECTIVE; Prinz JC, 1999, EUR J IMMUNOL, V29, P3360, DOI 10.1002/(SICI)1521-4141(199910)29:10<3360::AID-IMMU3360>3.0.CO;2-G; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Richards HL, 2004, BRIT J DERMATOL, V151, P1227, DOI 10.1111/j.1365-2133.2004.06221.x; Richards HL, 2004, J INVEST DERMATOL, V123, P49, DOI 10.1111/j.0022-202X.2004.22703.x; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Suomela S, 2003, J INVEST DERMATOL, V121, P1360, DOI 10.1046/j.1523-1747.2003.12642.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Updike John, 1989, SELF CONSCIOUSNESS M; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Vissers WHPM, 2004, BRIT J DERMATOL, V150, P852, DOI 10.1111/j.1365-2133.2004.05863.x; Wahie S, 2006, BRIT J DERMATOL, V154, P194, DOI 10.1111/j.1365-2133.2005.07026.x; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Willan R., 1808, CUTANEOUS DIS; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Young HS, 2004, J INVEST DERMATOL, V122, P209, DOI 10.1046/j.0022-202X.2003.22107.x; Zachariae H, 2003, AM J CLIN DERMATOL, V4, P441, DOI 10.2165/00128071-200304070-00001; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; 2006, J INVEST DERMATOL, V126, P2194	90	1228	1315	13	137	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					263	271		10.1016/S0140-6736(07)61128-3	http://dx.doi.org/10.1016/S0140-6736(07)61128-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658397				2022-12-28	WOS:000248347900031
J	Schaeffer, J; Burch, N; Bjornsson, Y; Kishimoto, A; Muller, M; Lake, R; Lu, P; Sutphen, S				Schaeffer, Jonathan; Burch, Neil; Bjoernsson, Yngvi; Kishimoto, Akihiro; Mueller, Martin; Lake, Robert; Lu, Paul; Sutphen, Steve			Checkers is solved	SCIENCE			English	Article								The game of checkers has roughly 500 billion billion possible positions (5 x 10(20)). The task of solving the game, determining the final result in a game with no mistakes made by either player, is daunting. Since 1989, almost continuously, dozens of computers have been working on solving checkers, applying state-of-the-art artificial intelligence techniques to the proving process. This paper announces that checkers is now solved: Perfect play by both sides leads to a draw. This is the most challenging popular game to be solved to date, roughly one million times as complex as Connect Four. Artificial intelligence technology has been used to generate strong heuristic-based game-playing programs, such as Deep Blue for chess. Solving a game takes this to the next level by replacing the heuristics with perfection.	Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada	University of Alberta	Schaeffer, J (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada.	jonathan@cs.ualberta.ca						Allis V., 1994, THESIS U LIMBURG MAA; APPEL K, 1977, SCI AM, V237, P108, DOI 10.1038/scientificamerican1077-108; BEAL DF, 1999, THESIS U MAASTRICHT; Buro M, 1999, IEEE INTELL SYST APP, V14, P12; FORTMAN R, BASIC CHECKERS; GASSER R, 1995, THESIS ETH ZURICH SW; Kishimoto A, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P644; Nagai A., 2002, THESIS U TOKYO JAPAN; Romein JW, 2003, COMPUTER, V36, P26, DOI 10.1109/MC.2003.1236468; Schaeffer J., 1997, ONE JUMP AHEAD; SCHAEFFER J, 2003, ADV COMPUTER GAMES M, P193; SCHAEFFER J, SOLVING CHECKERS; Shannon C. E., 1950, PHILOS MAG, V41, P256, DOI DOI 10.1007/978-1-4757-1968-0_1; Sheppard B, 2002, THESIS U MAASTRICHT; van den Herik HJ, 2002, ARTIF INTELL, V134, P277, DOI 10.1016/S0004-3702(01)00152-7	16	216	219	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1518	1522		10.1126/science.1144079	http://dx.doi.org/10.1126/science.1144079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17641166				2022-12-28	WOS:000249467900033
J	Manco-Johnson, MJ; Abshire, TC; Shapiro, AD; Riske, B; Hacker, MR; Kilcoyne, R; Ingram, JD; Manco-Johnson, ML; Funk, S; Jacobson, L; Valentino, LA; Hoots, WK; Buchanan, GR; DiMichele, D; Recht, M; Brown, D; Leissinger, C; Bleak, S; Cohen, A; Mathew, P; Matsunaga, A; Medeiros, D; Nugent, D; Thomas, GA; Thompson, AA; McRedmond, K; Soucie, JM; Austin, H; Evatt, BL				Manco-Johnson, Marilyn J.; Abshire, Thomas C.; Shapiro, Amy D.; Riske, Brenda; Hacker, Michele R.; Kilcoyne, Ray; Ingram, J. David; Manco-Johnson, Michael L.; Funk, Sharon; Jacobson, Linda; Valentino, Leonard A.; Hoots, W. Keith; Buchanan, George R.; DiMichele, Donna; Recht, Michael; Brown, Deborah; Leissinger, Cindy; Bleak, Shirley; Cohen, Alan; Mathew, Prasad; Matsunaga, Alison; Medeiros, Desiree; Nugent, Diane; Thomas, Gregory A.; Thompson, Alexis A.; McRedmond, Kevin; Soucie, J. Michael; Austin, Harlan; Evatt, Bruce L.			Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE EXPECTANCY; CARE; ARTHROPATHY; EXPERIENCE; CHILDREN; THERAPY; SCALE	Background: Effective ways to prevent arthropathy in severe hemophilia are unknown. Methods: We randomly assigned young boys with severe hemophilia A to regular infusions of recombinant factor VIII (prophylaxis) or to an enhanced episodic infusion schedule of at least three doses totaling a minimum of 80 IU of factor VIII per kilogram of body weight at the time of a joint hemorrhage. The primary outcome was the incidence of bone or cartilage damage as detected in index joints (ankles, knees, and elbows) by radiography or magnetic resonance imaging (MRI). Results: Sixty-five boys younger than 30 months of age were randomly assigned to prophylaxis (32 boys) or enhanced episodic therapy (33 boys). When the boys reached 6 years of age, 93% of those in the prophylaxis group and 55% of those in the episodic-therapy group were considered to have normal index-joint structure on MRI (P=0.006). The relative risk of MRI-detected joint damage with episodic therapy as compared with prophylaxis was 6.1 (95% confidence interval, 1.5 to 24.4). The mean annual numbers of joint and total hemorrhages were higher at study exit in the episodic-therapy group than in the prophylaxis group (P<0.001 for both comparisons).High titers of inhibitors of factor VIII developed in two boys who received prophylaxis; three boys in the episodic-therapy group had a life-threatening hemorrhage. Hospitalizations and infections associated with central-catheter placement did not differ significantly between the two groups. Conclusions: Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A. (ClinicalTrials.gov number, NCT00207597.)	Univ Colorado, Denver, CO 80202 USA; Hlth Sci Ctr, Denver, CO USA; Childrens Hosp, Denver, CO 80218 USA; Emory Univ, Atlanta, GA 30322 USA; Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; Rush Childrens Hosp, Chicago, IL USA; Univ Texas, Houston, TX USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Childrens Med Ctr, Dallas, TX 75235 USA; Cornell Univ, Weill Med Coll, New York, NY USA; Phoenix Childrens Hosp, Phoenix, AZ USA; Tulane Univ, New Orleans, LA 70118 USA; Primary Childrens Med Ctr, Salt Lake City, UT USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Childrens Hosp Oakland, Oakland, CA USA; Univ Hawaii, Honolulu, HI 96822 USA; Childrens Hosp Orange Cty, Orange, CA 92668 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Childrens Mem Hosp, Chicago, IL 60614 USA; Northwestern Univ, Chicago, IL 60611 USA; Palmetto Hlth Richland, Columbia, SC USA; Ctr Dis Control & Prevent, Atlanta, GA USA	University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; Emory University; Indiana Hemophilia & Thrombosis Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rush University; University of Texas System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Cornell University; Phoenix Children's Hospital; Tulane University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New Mexico; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Hawaii System; Childrens Hospital of Orange County; Oregon Health & Science University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Centers for Disease Control & Prevention - USA	Manco-Johnson, MJ (corresponding author), Mt States Reg Hemophilia & Thrombosis Ctr, MS F-416,POB 6507, Aurora, CO 80045 USA.	marilyn.manco-johnson@uchsc.edu	Hacker, Michele/ABC-5031-2021; VALENTINO, LEONARD A/W-7818-2019; mathew, prasad/ABG-9590-2021	Hacker, Michele/0000-0003-0217-9991	PHS HHS [R00069, U27/CCU812106] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahlberg A, 1965, ACTA ORTHOP SCAND S, P3, DOI DOI 10.3109/ORT.1965.36.SUPPL-77.01; ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Baker JR, 2005, AM J PUBLIC HEALTH, V95, P1910, DOI 10.2105/AJPH.2004.051318; Blanchette VS, 2003, HAEMOPHILIA, V9, P19, DOI 10.1046/j.1365-2516.9.s1.12.x; *CDCP, 2005, REP UN DAT COLL PROG, V7, P28; CHORBA TL, 1994, AM J HEMATOL, V45, P112, DOI 10.1002/ajh.2830450204; *FOOD DRUG ADM, 1992, FDA B P, V9239; Globe DR, 2004, HAEMOPHILIA, V10, P63, DOI 10.1111/j.1355-0691.2004.00881.x; Hacker MR, 2007, HAEMOPHILIA, V13, P71, DOI 10.1111/j.1365-2516.2006.01387.x; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; HIRSCHMAN RJ, 1970, BLOOD-J HEMATOL, V35, P189, DOI 10.1182/blood.V35.2.189.189; IKKALA E, 1982, BRIT J HAEMATOL, V52, P7, DOI 10.1111/j.1365-2141.1982.tb03856.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kreuz W, 1998, HAEMOPHILIA, V4, P413, DOI 10.1046/j.1365-2516.1998.440413.x; Lusher J, 2005, TXB HEMOPHILIA, P34; Manco-Johnson MJ, 2000, HAEMOPHILIA, V6, P649, DOI 10.1046/j.1365-2516.2000.00439.x; Manco-Johnson MJ, 2003, SEMIN THROMB HEMOST, V29, P585; *MASAC, 1994, MASAC MED B, V193; Mejia-Carvajal C, 2006, J THROMB HAEMOST, V4, P507, DOI 10.1111/j.1538-7836.2006.01776.x; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Nuss R, 2000, HAEMOPHILIA, V6, P162, DOI 10.1046/j.1365-2516.2000.00383.x; PETRINI P, 1991, AM J PEDIAT HEMATOL, V13, P280; PETTERSSON H, 1980, CLIN ORTHOP RELAT R, P153; ROBINSON PM, 1967, CAN MED ASSOC J, V97, P559; SHANBROM E, 1969, J AMER MED ASSOC, V208, P1853, DOI 10.1001/jama.208.10.1853; Smith PS, 1996, J PEDIATR-US, V129, P424, DOI 10.1016/S0022-3476(96)70076-8; Soucie JM, 2004, BLOOD, V103, P2467, DOI 10.1182/blood-2003-05-1457; Stobart K, 2006, COCHRANE DB SYST REV, V2; VANCREVELD S, 1969, ACTA HAEMATOL-BASEL, V41, P206, DOI 10.1159/000208852	29	1349	1409	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					535	544		10.1056/NEJMoa067659	http://dx.doi.org/10.1056/NEJMoa067659			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687129	Bronze			2022-12-28	WOS:000248584900004
J	Ooi, SKT; Qiu, C; Bernstein, E; Li, KQ; Jia, D; Yang, Z; Erdjument-Bromage, H; Tempst, P; Lin, SP; Allis, CD; Cheng, XD; Bestor, TH				Ooi, Steen K. T.; Qiu, Chen; Bernstein, Emily; Li, Keqin; Jia, Da; Yang, Zhe; Erdjument-Bromage, Hediye; Tempst, Paul; Lin, Shau-Ping; Allis, C. David; Cheng, Xiaodong; Bestor, Timothy H.			DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA	NATURE			English	Article							METHYLTRANSFERASE; CELLS	Mammals use DNA methylation for the heritable silencing of retrotransposons and imprinted genes and for the inactivation of the X chromosome in females. The establishment of patterns of DNA methylation during gametogenesis depends in part on DNMT3L, an enzymatically inactive regulatory factor that is related in sequence to the DNA methyltransferases DNMT3A and DNMT3B(1,2). The main proteins that interact in vivo with the product of an epitope-tagged allele of the endogenous Dnmt3L gene were identified by mass spectrometry as DNMT3A2, DNMT3B and the four core histones. Peptide interaction assays showed that DNMT3L specifically interacts with the extreme amino terminus of histone H3; this interaction was strongly inhibited by methylation at lysine 4 of histone H3 but was insensitive to modifications at other positions. Crystallographic studies of human DNMT3L showed that the protein has a carboxy-terminal methyltransferase-like domain and an N-terminal cysteine-rich domain. Cocrystallization of DNMT3L with the tail of histone H3 revealed that the tail bound to the cysteine-rich domain of DNMT3L, and substitution of key residues in the binding site eliminated the H3 tail-DNMT3L interaction. These data indicate that DNMT3L recognizes histone H3 tails that are unmethylated at lysine 4 and induces de novo DNA methylation by recruitment or activation of DNMT3A2.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan	Columbia University; Emory University; Rockefeller University; Memorial Sloan Kettering Cancer Center; National Taiwan University	Cheng, XD (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	XCheng@emory.edu; THB12@columbia.edu	Hu, Ruogu/B-2203-2008	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Jia, Da/0000-0002-2205-1998; Lin, Shau-Ping/0000-0003-3423-991X; Tempst, Paul/0000-0002-6680-3987; Ooi, Steen/0000-0003-4198-9014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM049245, R01 GM049245-14] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei H, 1996, DEVELOPMENT, V122, P3195; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	21	1045	1076	4	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					714	U13		10.1038/nature05987	http://dx.doi.org/10.1038/nature05987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687327	Green Accepted, Green Published			2022-12-28	WOS:000248598000049
J	Rossant, J; Hogan, B				Rossant, Janet; Hogan, Brigid			Anne McLaren (1927-2007) - Retrospective	SCIENCE			English	Biographical-Item									Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Duke Univ, Dept Cell Biol, Durham, NC 27710 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Duke University	Rossant, J (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	janet.rossant@sickkids.ca; b.hogan@cellbio.duke.edu							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					609	609		10.1126/science.1147801	http://dx.doi.org/10.1126/science.1147801			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673646				2022-12-28	WOS:000248494400027
J	Yeh, WW; Saint, S; Weinberger, SE				Yeh, Wendy W.; Saint, Sanjay; Weinberger, Steven E.			A growing problem	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HYDATID-DISEASE; ECHINOCOCCOSIS; ALBENDAZOLE; PRAZIQUANTEL; DIAGNOSIS; CYSTS; LUNG		Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; Amer Coll Physicians, Philadelphia, PA USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; American College of Physicians	Yeh, WW (corresponding author), Brigham & Womens Hosp, Div Infect Dis, PBB-4,75 Francis St, Boston, MA 02115 USA.	wyeh@partners.org	Mills, Tracey A/F-6748-2014; Saint, Sanjay/AAF-5126-2019	Mills, Tracey A/0000-0002-2183-7999; 				Brightling CE, 2006, CHEST, V129, p116S, DOI 10.1378/chest.129.1_suppl.116S; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Frider B, 1999, J HEPATOL, V30, P228, DOI 10.1016/S0168-8278(99)80066-X; Gottstein B, 2002, CLIN CHEST MED, V23, P397, DOI 10.1016/S0272-5231(02)00007-2; Horton RJ, 1997, ACTA TROP, V64, P79, DOI 10.1016/S0001-706X(96)00640-7; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; KAIMAL KP, 1982, AM HEART J, V103, P566, DOI 10.1016/0002-8703(82)90345-3; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; McManus D P, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS151, DOI 10.1016/S0035-9203(02)90068-4; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Mohamed AE, 1998, HEPATO-GASTROENTEROL, V45, P1690; MOSSMAN KL, 1982, OBSTET GYNECOL, V60, P237; PUGATCH RD, 1980, AM J ROENTGENOL, V134, P685, DOI 10.2214/ajr.134.4.685; Salih OK, 1998, CAN J SURG, V41, P131; TAYLOR DH, 1989, BRIT J SURG, V76, P954, DOI 10.1002/bjs.1800760927	15	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					489	494		10.1056/NEJMcps064251	http://dx.doi.org/10.1056/NEJMcps064251			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671258				2022-12-28	WOS:000248436300012
J	Bayer, CP; Klasen, F; Adam, H				Bayer, Christophe Pierre; Klasen, Fionna; Adam, Hubertus			Association of trauma and PTSD symptoms with openness to reconciliation and feelings of revenge among former Ugandan and Congolese child soldiers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Tens of thousands of the estimated 250 000 child soldiers worldwide are abused or have been abused during the last decade in Africa's Great Lakes Region. In the process of rebuilding the war-torn societies, it is important to understand how psychological trauma may shape the former child soldiers' ability to reconcile. Objective To investigate the association of posttraumatic stress disorder ( PTSD) symptoms and openness to reconciliation and feelings of revenge in former Ugandan and Congolese child soldiers. Design, Setting, and Participants Cross-sectional field study of 169 former child soldiers ( aged 11-18 years) in rehabilitation centers in Uganda and the Democratic Republic of the Congo, conducted in 2005. Main Outcome Measures Potentially traumatic war-related experiences assessed via a sample-specific events scale; PTSD symptoms assessed using the Child Posttraumatic Stress Disorder Reaction Index (CPTSD-RI), with a score of 35 or higher indicating clinically important PTSD symptoms; and openness to reconciliation and feelings of revenge assessed via structured questionnaires. Results Children participating in this study were a mean of 15.3 years old. These former child soldiers reported that they had been ( violently) recruited by armed forces at a young age ( mean [ SD], 12.1 [ 2] years), had served a mean of 38 months ( SD, 24 months), and had been demobilized a mean of 2.3 months before data collection ( SD, 2.4 months). The children were exposed to a high level of potentially traumatic events ( mean [ SD], 11.1 [2.99]). The most commonly reported traumatic experiences were having witnessed shooting (92.9%), having witnessed someone wounded (89.9%), and having been seriously beaten (84%). A total of 54.4% reported having killed someone, and 27.8% reported that they were forced to engage in sexual contact. Of the 169 interviewed, 59 (34.9%; 95% confidence interval, 34.4%-35.4%) had a PTSD symptom score higher than 35. Children who showed more PTSD symptoms had significantly less openness to reconciliation (rho=- 0.34, P <. 001) and more feelings of revenge (rho= 0.29, P <. 001). Conclusions PTSD symptoms are associated with less openness to reconciliation and more feelings of revenge among former Ugandan and Congolese child soldiers. The effect of psychological trauma should be considered when these children are rehabilitated and reintegrated into civilian society.	Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, D-20246 Hamburg, Germany; Hosp PSychiat Neurol & Child & Adolescent Psychia, Eberswalde, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Klasen, F (corresponding author), Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, Martinistr 52, D-20246 Hamburg, Germany.	klasen@children-for-tomorrow.de						ADAM H, 2006, MENTAL HLTH REFUGEE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boothby NG, 2000, SCI AM, V282, P60, DOI 10.1038/scientificamerican0600-60; *DEM REP CONG, 2006, DRC CHILDR WAR CREAT; Derluyn I, 2004, LANCET, V363, P861, DOI 10.1016/S0140-6736(04)15734-6; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; *INT LAB ORG, 2003, WOUND CHILDH US CHIL; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; NADER K, 1990, AM J PSYCHIAT, V147, P1526; NADER KO, 1993, BRIT J CLIN PSYCHOL, V32, P407, DOI 10.1111/j.2044-8260.1993.tb01075.x; *OFF SPEC REPR SEC, 2005, REP GEN ASS A 60 335; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; SAVJAK N, 2003, PSIHOLOGIJA ONLINE, V36, P59; Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Weiss DSMC, 1997, ASSESSING PSYCHOL TR; 1989, ARES4425 UN GEN ASS; 2006, AFRICA RES B, V43, DOI UNSP 17043A-17044A	18	186	186	1	40	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					555	559		10.1001/jama.298.5.555	http://dx.doi.org/10.1001/jama.298.5.555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666676	Bronze			2022-12-28	WOS:000248438100023
J	Adachi, K; Oiwa, K; Nishizaka, T; Furuike, S; Noji, H; Itoh, H; Yoshida, M; Kinosita, K				Adachi, Kengo; Oiwa, Kazuhiro; Nishizaka, Takayuki; Furuike, Shou; Noji, Hiroyuki; Itoh, Hiroyasu; Yoshida, Masasuke; Kinosita, Kazuhiko, Jr.			Coupling of rotation and catalysis in F-1-ATPase revealed by single-molecule imaging and manipulation	CELL			English	Article							ATP SYNTHASE; ACTIVITY-COEFFICIENTS; MECHANISM; F1-ATPASE; MOTOR; HYDROLYSIS; RESOLUTION; SUBSTEPS; DISTINCT; PATHWAY	F1-ATPase is a rotary molecular motor that proceeds in 120 degrees steps, each driven by ATP hydrolysis. How the chemical reactions that occur in three catalytic sites are coupled to mechanical rotation is the central question. Here, we show by high-speed imaging of rotation in single molecules of F1 that phosphate release drives the last 40 degrees of the 120 degrees step, and that the 40 degrees rotation accompanies reduction of the affinity for phosphate. We also show, by single-molecule imaging of a fluorescent ATP analog Cy3-ATP while F1 is forced to rotate slowly, that release of Cy3-ADP occurs at similar to 240 degrees after it is bound as Cy3-ATP at 0 degrees. This and other results suggest that the affinity for ADP also decreases with rotation, and thus ADP release contributes part of energy for rotation. Together with previous results, the coupling scheme is now basically complete.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; Natl Inst Informat & Commun Technol, Kobe Adv Res Ctr, Kobe, Hyogo 6512492, Japan; Gakushuin Univ, Dept Phys, Tokyo 1718588, Japan; Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; CREST, Tsukuba, Ibaraki 3002635, Japan; ERATO, ATP Syst Project, Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Waseda University; National Institute of Information & Communications Technology (NICT) - Japan; Gakushuin University; Osaka University; Hamamatsu Photonics; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan.	kazuhiko@waseda.jp	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Cohn EJ, 1927, J AM CHEM SOC, V49, P173, DOI 10.1021/ja01400a021; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; ESTESO MA, 1987, J ELECTROANAL CHEM, V230, P69, DOI 10.1016/0022-0728(87)80132-8; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oiwa K, 2003, BIOPHYS J, V84, P634, DOI 10.1016/S0006-3495(03)74883-8; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sillen L.G., 1964, SPEC PUBL, V17; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1994, J BIOL CHEM, V269, P20462; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	31	298	300	0	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					309	321		10.1016/j.cell.2007.05.020	http://dx.doi.org/10.1016/j.cell.2007.05.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662945	Bronze			2022-12-28	WOS:000248588000020
J	Frederick, KK; Marlow, MS; Valentine, KG; Wand, AJ				Frederick, Kendra King; Marlow, Michael S.; Valentine, Kathleen G.; Wand, A. Joshua			Conformational entropy in molecular recognition by proteins	NATURE			English	Article							CALMODULIN-PEPTIDE COMPLEX; NMR RELAXATION; TEMPERATURE-DEPENDENCE; BACKBONE DYNAMICS; INTERNAL DYNAMICS; STRUCTURAL BASIS; HEAT-CAPACITY; SIDE-CHAINS; BINDING; KINASE	Molecular recognition by proteins is fundamental to almost every biological process, particularly the protein associations underlying cellular signal transduction. Understanding the basis for protein-protein interactions requires the full characterization of the thermodynamics of their association. Historically it has been virtually impossible to experimentally estimate changes in protein conformational entropy, a potentially important component of the free energy of protein association. However, nuclear magnetic resonance spectroscopy has emerged as a powerful tool for characterizing the dynamics of proteins. Here we employ changes in conformational dynamics as a proxy for corresponding changes in conformational entropy. We find that the change in internal dynamics of the protein calmodulin varies significantly on binding a variety of target domains. Surprisingly, the apparent change in the corresponding conformational entropy is linearly related to the change in the overall binding entropy. This indicates that changes in protein conformational entropy can contribute significantly to the free energy of protein-ligand association.	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu		Frederick, Kendra/0000-0002-1656-5167	NIDDK NIH HHS [R01 DK039806] Funding Source: Medline; NIGMS NIH HHS [T32 GM008275] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Best RB, 2005, J MOL BIOL, V349, P185, DOI 10.1016/j.jmb.2005.03.001; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHARBONNEAU H, 1991, BIOCHEMISTRY-US, V30, P7931, DOI 10.1021/bi00246a009; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DELLWO MJ, 1989, J AM CHEM SOC, V111, P4571, DOI 10.1021/ja00195a007; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lee AL, 2002, BIOCHEMISTRY-US, V41, P13814, DOI 10.1021/bi026380d; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; SCOTT D, 1979, BIOMETRIKA, V10, P605; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wintrode PL, 1997, J MOL BIOL, V266, P1050, DOI 10.1006/jmbi.1996.0785; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHANG MJ, 1994, J BIOL CHEM, V269, P981	34	515	520	5	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					325	U3		10.1038/nature05959	http://dx.doi.org/10.1038/nature05959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637663	Green Accepted			2022-12-28	WOS:000248118300051
J	Lee, H; Lee, BP; Messersmith, PB				Lee, Haeshin; Lee, Bruce P.; Messersmith, Phillip B.			A reversible wet/dry adhesive inspired by mussels and geckos	NATURE			English	Article							MYTILUS-EDULIS; FORCE; MICRO; DOPA	The adhesive strategy of the gecko relies on foot pads composed of specialized keratinous foot-hairs called setae, which are subdivided into terminal spatulae of approximately 200 nm (ref.1). Contact between the gecko foot and an opposing surface generates adhesive forces that are sufficient to allow the gecko to cling onto vertical and even inverted surfaces. Although strong, the adhesion is temporary, permitting rapid detachment and reattachment of the gecko foot during locomotion. Researchers have attempted to capture these properties of gecko adhesive in synthetic mimics with nanoscale surface features reminiscent of setae(2-7); however, maintenance of adhesive performance over many cycles has been elusive(2,8), and gecko adhesion is greatly diminished upon full immersion in water(9,10). Here we report a hybrid biologically inspired adhesive consisting of an array of nanofabricated polymer pillars coated with a thin layer of a synthetic polymer that mimics the wet adhesive proteins found in mussel holdfasts. Wet adhesion of the nanostructured polymer pillar arrays increased nearly 15-fold when coated with mussel-mimetic polymer. The system maintains its adhesive performance for over a thousand contact cycles in both dry and wet environments. This hybrid adhesive, which combines the salient design elements of both gecko and mussel adhesives, should be useful for reversible attachment to a variety of surfaces in any environment.	Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Northwestern Univ, Inst Bionanotechnol Med, Evanston, IL 60208 USA; Nerites Corp, Madison, WI 53711 USA	Northwestern University; Northwestern University; Northwestern University	Messersmith, PB (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	philm@northwestern.edu	Lee, Haeshin/C-1720-2011; Messersmith, Phil/B-6695-2009; Lee, Bruce P/H-5233-2011	Lee, Haeshin/0000-0003-3961-9727; Lee, Bruce P/0000-0002-6529-0032; Messersmith, Phillip/0000-0002-1197-333X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE014193] Funding Source: NIH RePORTER; NIDCR NIH HHS [R37 DE014193] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Arzt E, 2006, MAT SCI ENG C-BIO S, V26, P1245, DOI 10.1016/j.msec.2005.08.033; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Crosby AJ, 2005, LANGMUIR, V21, P11738, DOI 10.1021/la051721k; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Frank BP, 2002, BIOTECHNOL PROGR, V18, P580, DOI 10.1021/bp010140s; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102; Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Northen MT, 2006, SENSOR ACTUAT A-PHYS, V130, P583, DOI 10.1016/j.sna.2005.10.032; Northen MT, 2005, NANOTECHNOLOGY, V16, P1159, DOI 10.1088/0957-4484/16/8/030; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Peressadko A, 2004, J ADHESION, V80, P247, DOI 10.1080/00218460490430199; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788; Spolenak R, 2005, ACTA BIOMATER, V1, P5, DOI 10.1016/j.actbio.2004.08.004; Sun WX, 2005, BIOPHYS J, V89, pL14, DOI 10.1529/biophysj.105.065268; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1987, CHEMTECH, V17, P692; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Yurdumakan B, 2005, CHEM COMMUN, P3799, DOI 10.1039/b506047h	30	1508	1580	86	1568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					338	U4		10.1038/nature05968	http://dx.doi.org/10.1038/nature05968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637666				2022-12-28	WOS:000248118300054
J	Wyatt, T				Wyatt, Terry			High-energy colliders and the rise of the standard model	NATURE			English	Review							TOP-QUARK; TRANSVERSE ENERGY; SEARCH; COLLISIONS; ELECTRONS; LEP	Over the past quarter of a century, experiments at high-energy particle colliders have established the standard model as the precise theory of particle interactions up to the 100 GeV scale. A series of important experimental discoveries and measurements have filled in most of the missing pieces and tested the predictions of the standard model with great precision.			Wyatt, T (corresponding author), Univ Manchester, Sch Phys & Astron, Particle Phys Grp, Manchester, Lancs, England.	twyatt@fnal.gov						ABACHI S, 1995, PHYS REV LETT, V74, P2632, DOI 10.1103/PhysRevLett.74.2632; ABACHI S, 1995, PHYS REV D, V52, P4877, DOI 10.1103/PhysRevD.52.4920; ABACHI S, 1994, PHYS REV LETT, V72, P2138, DOI 10.1103/PhysRevLett.72.2143; Abazov VM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.181802; Abbaneo D, 2003, PHYS LETT B, V565, P61, DOI 10.1016/S0370-2693(03)00614-2; ABE F, 1995, PHYS REV LETT, V74, P2626, DOI 10.1103/PhysRevLett.74.2638; ABULENCIA A, OBSERVATION WZ PRODU; ARNISON G, 1983, PHYS LETT B, V126, P398, DOI 10.1016/0370-2693(83)90188-0; ARNISON G, 1983, PHYS LETT B, V122, P103, DOI 10.1016/0370-2693(83)91177-2; BAGNAIA P, 1983, PHYS LETT B, V129, P130, DOI 10.1016/0370-2693(83)90744-X; *CDF COLL, 8775 CDF; Jones RWL, 2006, NUCL PHYS B-PROC SUP, V152, P15, DOI 10.1016/j.nuclphysbps.2005.08.003; Kodama K, 2001, PHYS LETT B, V504, P218, DOI 10.1016/S0370-2693(01)00307-0; Quadt A, 2006, EUR PHYS J C, V48, P835, DOI 10.1140/epjc/s2006-02631-6; Schael S, 2006, PHYS REP, V427, P257, DOI 10.1016/j.physrep.2005.12.006; *TEV EL WORK GROUP, 2007, COMB CDF D EMPT SET	17	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					274	280		10.1038/nature06075	http://dx.doi.org/10.1038/nature06075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637656				2022-12-28	WOS:000248118300042
J	Datta, SD; Sternberg, M; Johnson, RE; Berman, S; Papp, JR; McQuillan, G; Weinstock, H				Datta, S. Deblina; Sternberg, Maya; Johnson, Robert E.; Berman, Stuart; Papp, John R.; McQuillan, Geraldine; Weinstock, Hillard			Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; INFECTION; TRACHOMATIS; PREVALENCE; BEHAVIOR; POLICY; CARE	Background: Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs. Objective: To measure chlamydia and gonorrhea prevalence in the United States. Design: Analysis of sexual history information and urine specimens collected in the National Health and Nutrition Examination Survey (NHANES), 1999-2002. Setting: U.S. civilian noninstitutionalized population as sampled by NHANES, 1999-2002. Participants: 6632 NHANES respondents. Measurements: Urine specimens were tested for chlamydia and gonorrhea. Results were weighted to represent the U.S. civilian, non institutionalized population between 14 and 39 years of age. Results: Prevalence of gonorrheal infection was 0.24% (95% Cl, 0.16% to 0.38%). Prevalence of gonorrheal infection was higher among non-Hispanic black persons (1.2% [Cl, 0.7% to 1.9%]) than among non-Hispanic white persons (0.07% [Cl, 0.02% to 0.24%]). Among those with gonorrheal infection, 46% also had chlamydial infection. Prevalence of chlamyclial infection was 2.2% (Cl, 1.8% to 2.8%) and was similar between males (2.0% [Cl, 1.6% to 2.5%]) and females (2.5% [Cl, 1.8% to 3.4%]). Among females, the highest prevalence was in those age 14 to 19 years, whereas among males, it was highest in those age 14 to 29 years. Prevalence was higher among non-Hispanic black persons (6.4% [Cl, 5.4% to 7.5%]) than non-Hispanic white persons (1.5% [Cl, 1.0% to 2.4%]). Among females with a history of gonorrhea or chlamydia in the previous 12 months, chlamydia prevalence was 16.7% (Cl, 5.5% to 50.7%). Limitations: The specificity of urine-based assays for chlamydia and gonorrhea is limited, and the possible misclassification of sexual experience status may have affected the accuracy of some estimates. Conclusions: The findings support current recommendations to screen sexually active females age 25 years or younger for chlamydia, to retest infected females for chlamyclial infection, and to co-treat individuals with gonorrhea for chlamydia.	Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Datta, SD (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	ddatta@cdc.gov	Papp, John/AAA-3073-2019	Papp, John/0000-0002-7495-5454				*ABB LAB, 1996, ABB LCX PROB SYST CH; *ABB LAB, 1996, ABB LCX PROB SYST NE; Adekoya N., 2005, Morbidity and Mortality Weekly Report, V54, P9; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; *CDCP, 2006, SEX TRANSM DIS SURV; *CDCP NAT CTR DIS, 2005, AN REP GUID NAT HLTH; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; ENG TR, 1997, HIDDEN EPIDEMIC CONF; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; Hollblad-Fadiman K, 2003, AM J PREV MED, V24, P287, DOI 10.1016/S0749-3797(02)00636-0; Hook Er., 1999, SEX TRANSM DIS; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; KOOPMAN JS, 1994, AM J PUBLIC HEALTH, V84, P836, DOI 10.2105/AJPH.84.5.836; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Levine WC, 2004, AM J EPIDEMIOL, V160, P91, DOI 10.1093/aje/kwh162; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; National Committee for Quality Assurance, STAT HLTH CAR QUAL 2; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Skeate RC, 2005, AM J CLIN PATHOL, V123, P809, DOI 10.1309/1LD8LU7YFFW75WQA; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; *US CENS BUR, MONTHL POP EST 2000	30	191	199	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					89	96		10.7326/0003-4819-147-2-200707170-00007	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17638719				2022-12-28	WOS:000248179300003
J	Nash, R				Nash, Robert			Health-care workers in influenza pandemics	LANCET			English	Editorial Material							DUTY		Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England	University of Oxford	Nash, R (corresponding author), Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England.	robertnash@doctors.org.uk	Nash, Robert/AAO-9847-2020	Nash, Robert/0000-0002-7861-3734				*ECDC INFL TEAM, 2005, EURO SURVEILL, V10; Ehrenstein BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-311; Harrod ME, 2006, MED J AUSTRALIA, V185, pS58; Irvin C., 2007, ACAD EMERG MED S1, V14, P13; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Ruderman Carly, 2006, BMC Med Ethics, V7, pE5, DOI 10.1186/1472-6939-7-5; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Yen MY, 2006, J HOSP INFECT, V62, P195, DOI 10.1016/j.jhin.2005.02.011	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					300	301		10.1016/S0140-6736(07)61140-4	http://dx.doi.org/10.1016/S0140-6736(07)61140-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662865	Green Published, Bronze			2022-12-28	WOS:000248426100009
J	Bostick, M; Kim, JK; Esteve, PO; Clark, A; Pradhan, S; Jacobsen, SE				Bostick, Magnolia; Kim, Jong Kyong; Esteve, Pierre-Olivier; Clark, Amander; Pradhan, Sriharsa; Jacobsen, Steven E.			UHRF1 plays a role in maintaining DNA methylation in mammalian cells	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; REPLICATION FOCI; NP95 GENE; S-PHASE; METHYLTRANSFERASE; DOMAIN; DNMT1; EXPRESSION; ICBP90; CYCLE	Epigenetic inheritance in mammals relies in part on robust propagation of DNA methylation patterns throughout development. We show that the protein UHRF1 (ubiquitin-like, containing PHD and RING finger domains 1), also known as NP95 in mouse and ICBP90 in human, is required for maintaining DNA methylation. UHRF1 colocalizes with the maintenance DNA methyltransferase protein DNMT1 throughout S phase. UHRF1 appears to tether DNMT1 to chromatin through its direct interaction with DNMT1. Furthermore UHRF1 contains a methyl DNA binding domain, the SRA (SET and RING associated) domain, that shows strong preferential binding to hemimethylated CG sites, the physiological substrate for DNMT1. These data suggest that UHRF1 may help recruit DNMT1 to hemimethylated DNA to facilitate faithful maintenance of DNA methylation.	New England Biolabs Inc, Ipswich, MA 01938 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	New England Biolabs; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pradhan, S (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	pradhan@neb.com; jacobsen@ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM060398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Miura M, 2001, EXP CELL RES, V263, P202, DOI 10.1006/excr.2000.5115; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Muto M, 1995, CELL PROLIFERAT, V28, P645, DOI 10.1111/j.1365-2184.1995.tb00051.x; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Sakai A, 2003, BIOL PHARM BULL, V26, P347; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Woodcock DM, 1998, GENE, V206, P63, DOI 10.1016/S0378-1119(97)00566-0	29	906	943	11	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1760	1764		10.1126/science.1147939	http://dx.doi.org/10.1126/science.1147939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17673620	Bronze			2022-12-28	WOS:000249585900051
J	Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, MEA; Wang, DN				Zhou, Zheng; Zhen, Juan; Karpowich, Nathan K.; Goetz, Regina M.; Law, Christopher J.; Reith, Maarten E. A.; Wang, Da-Neng			LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake	SCIENCE			English	Article							SENSITIVE DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTERS; MONOAMINE TRANSPORTERS; ION-BINDING; INHIBITORS; SEROTONIN	Tricyclic antidepressants exert their pharmacological effect-inhibiting the reuptake of serotonin, norepinephrine, and dopamine-by directly blocking neurotransmitter transporters (SERT, NET, and DAT, respectively) in the presynaptic membrane. The drug-binding site and the mechanism of this inhibition are poorly understood. We determined the crystal structure at 2.9 angstroms of the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in complex with leucine and the antidepressant desipramine. Desipramine binds at the inner end of the extracellular cavity of the transporter and is held in place by a hairpin loop and by a salt bridge. This binding site is separated from the leucine-binding site by the extracellular gate of the transporter. By directly locking the gate, desipramine prevents conformational changes and blocks substrate transport. Mutagenesis experiments on human SERT and DAT indicate that both the desipramine-binding site and its inhibition mechanism are probably conserved in the human neurotransmitter transporters.	NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Reith, MEA (corresponding author), NYU, Sch Med, Dept Psychiat, 540 1st Ave, New York, NY 10016 USA.	maarten.reith@med.nyu.edu; wang@saturn.med.nyu.edu	Law, Christopher/E-7174-2011; Reith, Maarten E/A-4601-2008; Reith, Maarten E./AAD-2303-2019; Zhen, Juan/E-8593-2016; Goetz, Regina/M-2411-2019	Reith, Maarten E./0000-0002-1900-842X; Zhen, Juan/0000-0002-6111-9692; Goetz, Regina/0000-0003-3681-4703; Wang, Da-Neng/0000-0002-6496-4699	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053973, R21DK060841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R21GM075936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013261, R01DA019676] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA013261, DA013261, R01 DA019676, DA019676] Funding Source: Medline; NIDDK NIH HHS [R21 DK060841, R01 DK053973] Funding Source: Medline; NIGMS NIH HHS [U54 GM095315, R21 GM075936, U54 GM075026, GM075026, GM075936] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brunton L.B., 2005, GOODMAN GILMANS PHAR, V11th ed; Cantu MD, 2005, J CHROMATOGR A, V1068, P99, DOI 10.1016/j.chroma.2004.12.009; Chen Nian-Hang, 2002, P53; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gumnick JF, 2000, J CLIN PSYCHIAT, V61, P5; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Klimek V, 1997, J NEUROSCI, V17, P8451; Mortensen OV, 2006, J NEUROCHEM, V98, P1531, DOI 10.1111/j.1471-4159.2006.04060.x; Nelson N, 1998, J NEUROCHEM, V71, P1785; Olivier B, 2000, Prog Drug Res, V54, P59; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Roubert C, 2001, J BIOL CHEM, V276, P8254, DOI 10.1074/jbc.M009798200; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Schafer WR, 1999, CELL, V98, P551, DOI 10.1016/S0092-8674(00)80042-2; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	26	273	277	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1390	1393		10.1126/science.1147614	http://dx.doi.org/10.1126/science.1147614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690258	Green Accepted			2022-12-28	WOS:000249377500046
J	Ji, HB; Ramsey, MR; Hayes, DN; Fan, C; McNamara, K; Kozlowski, P; Torrice, C; Wu, MC; Shimamura, T; Perera, SA; Liang, MC; Cai, DP; Naumov, GN; Bao, L; Contreras, CM; Li, DN; Chen, L; Krishnamurthy, J; Koivunen, J; Chirieac, LR; Padera, RF; Bronson, RT; Lindeman, NI; Christiani, DC; Lin, XH; Shapiro, GI; Janne, PA; Johnson, BE; Meyerson, M; Kwiatkowski, DJ; Castrillon, DH; Bardeesy, N; Sharpless, NE; Wong, KK				Ji, Hongbin; Ramsey, Matthew R.; Hayes, D. Neil; Fan, Cheng; McNamara, Kate; Kozlowski, Piotr; Torrice, Chad; Wu, Michael C.; Shimamura, Takeshi; Perera, Samanthi A.; Liang, Mei-Chih; Cai, Dongpo; Naumov, George N.; Bao, Lei; Contreras, Cristina M.; Li, Danan; Chen, Liang; Krishnamurthy, Janakiraman; Koivunen, Jussi; Chirieac, Lucian R.; Padera, Robert F.; Bronson, Roderick T.; Lindeman, Neal I.; Christiani, David C.; Lin, Xihong; Shapiro, Geoffrey I.; Jaenne, Pasi A.; Johnson, Bruce E.; Meyerson, Matthew; Kwiatkowski, David J.; Castrillon, Diego H.; Bardeesy, Nabeel; Sharpless, Norman E.; Wong, Kwok-Kin			LKB1 modulates lung cancer differentiation and metastasis	NATURE			English	Article							MOUSE MODEL; CELL; EXPRESSION; ADENOCARCINOMAS; IDENTIFICATION; ACTIVATION; NORMALIZATION; INACTIVATION; P16(INK4A); LKB1/STK11	Germline mutation in serine/ threonine kinase 11 ( STK11, also called LKB1) results in Peutz - Jeghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers(1). Although uncommon in most sporadic cancers(2), inactivating somatic mutations of LKB1 have been reported in primary human lung adenocarcinomas and derivative cell lines(3-5). Here we used a somatically activatable mutant Kras- driven model of mouse lung cancer to compare the role of Lkb1 to other tumour suppressors in lung cancer. Although Kras mutation cooperated with loss of p53 or Ink4a/ Arf ( also known as Cdkn2a) in this system, the strongest cooperation was seen with homozygous inactivation of Lkb1. Lkb1- deficient tumours demonstrated shorter latency, an expanded histological spectrum ( adeno-, squamous and large- cell carcinoma) and more frequent metastasis compared to tumours lacking p53 or Ink4a/ Arf. Pulmonary tumorigenesis was also accelerated by hemizygous inactivation of Lkb1. Consistent with these findings, inactivation of LKB1 was found in 34% and 19% of 144 analysed human lung adenocarcinomas and squamous cell carcinomas, respectively. Expression profiling in human lung cancer cell lines and mouse lung tumours identified a variety of metastasis-promoting genes, such as NEDD9, VEGFC and CD24, as targets of LKB1 repression in lung cancer. These studies establish LKB1 as a critical barrier to pulmonary tumorigenesis, controlling initiation, differentiation and metastasis.	Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biostat, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ludwig Ctr Dana Farber, Harvard Canc Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Translat Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Wong, KK (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	nelbardeesy@partners.org; nes@med.unc.edu; kwong1@partners.org	Chirieac, Lucian R./AAD-2030-2019; Kozlowski, Piotr/I-1860-2019; Wu, Michael/X-5084-2019; Meyerson, Matthew L/E-7123-2012; ji, Hongbin/I-5625-2017	Kozlowski, Piotr/0000-0003-3770-7715; Wu, Michael/0000-0002-3357-6570; ji, Hongbin/0000-0003-0891-6390; Hayes, D. Neil/0000-0001-6203-7771; Sharpless, Norman/0000-0001-7078-9455; wong, kwok kin/0000-0001-6323-235X; Ramsey, Matthew/0000-0003-2402-8502; Chen, Liang/0000-0001-7300-6604; Liang, Mei-Chih/0000-0002-7389-2455; Koivunen, Jussi/0000-0001-6425-1640				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Entius MM, 1997, GUT, V41, P320, DOI 10.1136/gut.41.3.320; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kozlowski P, 2007, HUM GENET, V121, P389, DOI 10.1007/s00439-006-0308-9; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Volikos E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039875; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	36	754	818	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					807	U7		10.1038/nature06030	http://dx.doi.org/10.1038/nature06030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17676035				2022-12-28	WOS:000248754200040
J	Holloway, RG; Quill, TE				Holloway, Robert G.; Quill, Timothy E.			Mortality as a measure of quality - Implications for palliative and end-of-life care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH OUTCOMES; ASSOCIATION; PERFORMANCE		Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Holloway, RG (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	robert_holloway@urmc.rochester.edu						Adams K., 2003, PRIORITY AREAS NATL; *AG HEALTHC RES QU, 2006, HLTH CAR REP CARD CO; [Anonymous], NAT FRAM PREF PRACT; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; *CDCP, MORT TABL 2003; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; *HOSP COMP, QUAL TOOL AD INCL PE; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Kapo J, 2007, J PALLIAT MED, V10, P185, DOI 10.1089/jpm.2006.9989; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; MILLER MG, 1994, JAMA-J AM MED ASSOC, V271, P1493, DOI 10.1001/jama.271.19.1493; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; *NAT HOSP PALL CAR, NHPCOS FACTS FIG 200; National Quality Forum, 2012, SER REP EV HEALTHC 2; O'Connor Annette M, 2004, Health Aff (Millwood), VSuppl Variation, pVAR63; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; WENNBERG DE, 2003, HLTH AFF MILLWOOD S; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	25	52	53	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					802	804		10.1001/jama.298.7.802	http://dx.doi.org/10.1001/jama.298.7.802			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699014				2022-12-28	WOS:000248728800025
J	Dodoo, A; Adjei, S; Couper, M; Hugman, B; Edwards, R				Dodoo, Alexander; Adjei, Sam; Couper, Mary; Hugman, Bruce; Edwards, Ralph			When rumours derail a mass deworming exercise	LANCET			English	Editorial Material							COMMUNITY PERCEPTION		Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana; Ghana Hlth Serv, Accra, Ghana; WHO, PSM QSM, CH-1211 Geneva, Switzerland; Uppsala Monitoring Ctr, Uppsala, Sweden	University of Ghana; Ghana Health Service; World Health Organization	Dodoo, A (corresponding author), Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana.	alexooo@yahoo.com						Brooker S, 2001, TROP MED INT HEALTH, V6, P1075, DOI 10.1046/j.1365-3156.2001.00806.x; *GHANAWEB, 2007, DEW DRUG IS SAF GHS; *GHANAWEB, 2007, DEW SCAR HITS VOLT; *GHANAWEB, 2007, NO PUP HAS DIED DEW; *UGMS CTR PHARM, 2007, MIN HLTH RESP CONC N; Ulukanligil M, 2006, AM J TROP MED HYG, V75, P1063, DOI 10.4269/ajtmh.2006.75.1063; 2007, DAILY GUIDE     0213; 1997, LANCET, V350, P1041; 1998, EFFECTIVE COMMUNICAT	9	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					465	466		10.1016/S0140-6736(07)61211-2	http://dx.doi.org/10.1016/S0140-6736(07)61211-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693161				2022-12-28	WOS:000248717800008
J	Hall, PL				Hall, Peter Lawrence			Health care for refused asylum seekers in the UK	LANCET			English	Editorial Material									Doctors Human Rights, Abbots Langley WD5 0BE, Herts, England		Hall, PL (corresponding author), Doctors Human Rights, Abbots Langley WD5 0BE, Herts, England.	peterhall@doctorsforhumanrights.org						BLAIR T, 2006, GLOBAL ALLIANCE GLOB; Department of Health, 2007, HUM RIGHTS HEALTHC F; *GEN MED COUNC, 2006, GOOD MED PRACT 2006; Hall P, 2006, BRIT MED J, V333, P109, DOI 10.1136/bmj.333.7559.109; HILBERG R, 1993, PERPETRATORS VIC TIM; MANSFIELD M, 2007, INDEPENDENT     0506; *NAT HLTH SERV, 1999, OV VIS EL REC FREE P; *UN, 2002, CONCL OBS COMM EC SO; *UN, 1997, CONCL OBS COMM EC SO	9	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					466	467		10.1016/S0140-6736(07)61212-4	http://dx.doi.org/10.1016/S0140-6736(07)61212-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693162				2022-12-28	WOS:000248717800009
J	Brack, AS; Conboy, MJ; Roy, S; Lee, M; Kuo, CJ; Keller, C; Rando, TA				Brack, Andrew S.; Conboy, Michael J.; Roy, Sudeep; Lee, Mark; Kuo, Calvin J.; Keller, Charles; Rando, Thomas A.			Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis	SCIENCE			English	Article							GENE-EXPRESSION; BETA-CATENIN; PATHWAY; AGE; TRANSCRIPTION; REGENERATION; ACTIVATION; MICE	The regenerative potential of skeletal muscle declines with age, and this impairment is associated with an increase in tissue fibrosis. We show that muscle stem cells (satellite cells) from aged mice tend to convert from a myogenic to a fibrogenic lineage as they begin to proliferate and that this conversion is mediated by factors in the systemic environment of the old animals. We also show that this lineage conversion is associated with an activation of the canonical Wnt signaling pathway in aged myogenic progenitors and can be suppressed by Wnt inhibitors. Furthermore, components of serum from aged mice that bind to the Frizzled family of proteins, which are Wnt receptors, may account for the elevated Wnt signaling in aged cells. These results indicate that the Wnt signaling pathway may play a critical role in tissue-specific stem cell aging and an increase in tissue fibrosis with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; VA Palo Alto Hlth Care Syst, CRECC, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Neurol Serv, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Keller, Charles/0000-0003-2505-7487; Kuo, Calvin/0000-0002-7427-5985; Rando, Thomas/0000-0001-5843-8564	NIA NIH HHS [AG23806] Funding Source: Medline; NIDDK NIH HHS [DK069989] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023806, R37AG023806] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DasGupta R, 1999, DEVELOPMENT, V126, P4557; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	17	1035	1110	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					807	810		10.1126/science.1144090	http://dx.doi.org/10.1126/science.1144090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690295				2022-12-28	WOS:000248624500041
J	Feliciangeli, S; Bendahhou, S; Sandoz, G; Gounon, P; Reichold, M; Warth, R; Lazdunski, M; Barhanin, J; Lesage, F				Feliciangeli, Sylvain; Bendahhou, Said; Sandoz, Guillaume; Gounon, Pierre; Reichold, Markus; Warth, Richard; Lazdunski, Michel; Barhanin, Jacques; Lesage, Florian			Does sumoylation control K2P1/TWIK1 background K+ channels?	CELL			English	Article							POTASSIUM CHANNELS; TWIK-1; PHARMACOLOGY; EXPRESSION; SUMO-1; KIDNEY	A novel model for the regulation of cell excitability has recently been proposed. It originates from the observation that the background K+ channel K2P1 (TWIK1) may be silenced by sumoylation in Xenopus oocytes and that inactivation of the putative sumoylation site ( mutation K274E) gives rise to robust current expression in transfected COS-7 cells. Here, we show that only the mutation K274E, and not K274R, is associated with an increase of K2P1 current density, suggesting a charge effect of K274E. Furthermore, we failed to observe any band shift by western blot analysis that would confirm an eventual sumoylation of K2P1 in COS-7 cells and oocytes.	CNRS, Inst Paul Hamel, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06108 Nice, France; Inst Physiol, D-93053 Regensburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Paul Hamel, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Warth, Richard/N-7119-2014; sandoz, guillaume/AAI-9236-2020; Feliciangeli, Sylvain/Q-1292-2016; Lesage, Florian/D-5097-2011; Reichold, Markus/J-9933-2015; Lesage, Florian/P-9780-2019	Warth, Richard/0000-0001-6084-0659; sandoz, guillaume/0000-0003-1251-0852; Feliciangeli, Sylvain/0000-0003-3358-3719; Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106				Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Nie X, 2005, PFLUG ARCH EUR J PHY, V451, P479, DOI 10.1007/s00424-005-1480-9; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2000, J BIOL CHEM, V275, P28722, DOI 10.1074/jbc.M003755200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; WILSON VG, 2005, STKE 2005	23	66	70	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					563	569		10.1016/j.cell.2007.06.012	http://dx.doi.org/10.1016/j.cell.2007.06.012			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693262	Bronze			2022-12-28	WOS:000249038100022
J	Lee, NK; Sowa, H; Hinoi, E; Ferron, M; Ahn, JD; Confavreux, C; Dacquin, R; Mee, PJ; Mckee, MD; Jung, DY; Zhang, Z; Kim, JK; Mauvais-Jarvis, F; Ducy, P; Karsenty, G				Lee, Na Kyung; Sowa, Hideaki; Hinoi, Eiichi; Ferron, Mathieu; Ahn, Jong Deok; Confavreux, Cyrille; Dacquin, Romain; Mee, Patrick J.; Mckee, Marc D.; Jung, Dae Young; Zhang, Zhiyou; Kim, Jason K.; Mauvais-Jarvis, Franck; Ducy, Patricia; Karsenty, Gerard			Endocrine regulation of energy metabolism by the skeleton	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; INSULIN-RESISTANCE; BONE MASS; DIABETES-MELLITUS; OSTEOBLAST; MICE; ADIPONECTIN; OBESITY; LEPTIN; OSTEOCALCIN	The regulation of bone remodeling by an adipocyte-derived hormone implies that bone may exert a feedback control of energy homeostasis. To test this hypothesis we looked for genes expressed in osteoblasts, encoding signaling molecules and affecting energy metabolism. We show here that mice lacking the protein tyrosine phosphatase OST-PTP are hypoglycemic and are protected from obesity and glucose intolerance because of an increase in beta-cell proliferation, insulin secretion, and insulin sensitivity. In contrast, mice lacking the osteoblast-secreted molecule osteocalcin display decreased beta-cell proliferation, glucose intolerance, and insulin resistance. Removing one Osteocalcin allele from OST-PTP-deficient mice corrects their metabolic phenotype. Ex vivo, osteocalcin can stimulate CyclinD1 and Insulin expression in beta-cells and Adiponectin, an insulin-sensitizing adipokine, in adipocytes; in vivo osteocalcin can improve glucose tolerance. By revealing that the skeleton exerts an endocrine regulation of sugar homeostasis this study expands the biological importance of this organ and our understanding of energy metabolism.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; CHO A Pharm, CHO A Biotechnol Res Inst, Seoul 143701, South Korea; Ecole Normale Super Lyon, Lab Endocrinol Mol & Differenciat Hematopoiet & O, UMR5161, F-69364 Lyon, France; Univ Cambridge, Ctr Stem Cell Res, Cambridge CB2 1TN, England; McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA	Columbia University; Columbia University; Ecole Normale Superieure de Lyon (ENS de LYON); University of Cambridge; McGill University; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwestern University	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	McKee, Marc D/E-2187-2011; Ferron, Mathieu/M-7794-2013	McKee, Marc D/0000-0001-8349-965X; Kim, Jason/0000-0002-7185-042X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR045548, R01 AR045548-08] Funding Source: Medline; NICHD NIH HHS [R01 HD065439] Funding Source: Medline; NIDDK NIH HHS [R01 DK080756] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; BRECHER G, 1965, J EXP MED, V121, P395, DOI 10.1084/jem.121.3.395; Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003; DeGroot LJ., 2001, ENDOCRINOLOGY, V4th ed.; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; MAURO LJ, 1994, J BIOL CHEM, V269, P30659; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Mauvais-Jarvis F, 2000, DIABETES, V49, P2126, DOI 10.2337/diabetes.49.12.2126; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Price P A, 1989, Connect Tissue Res, V21, P51, DOI 10.3109/03008208909049995; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Rosato MT, 1998, CALCIFIED TISSUE INT, V63, P107, DOI 10.1007/s002239900498; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	35	1783	1924	5	156	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					456	469		10.1016/j.cell.2007.05.047	http://dx.doi.org/10.1016/j.cell.2007.05.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693256	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000249038100014
J	Thines, B; Katsir, L; Melotto, M; Niu, Y; Mandaokar, A; Liu, GH; Nomura, K; He, SY; Howe, GA; Browse, J				Thines, Bryan; Katsir, Leron; Melotto, Maeli; Niu, Yajie; Mandaokar, Ajin; Liu, Guanghui; Nomura, Kinya; He, Sheng Yang; Howe, Gregg A.; Browse, John			JAZ repressor proteins are targets of the SCFCO11 complex during jasmonate signalling	NATURE			English	Article							METHYL JASMONATE; DEFENSE RESPONSES; REGULATED DEFENSE; GENE-EXPRESSION; PLANT DEFENSE; MALE-STERILE; ACID; COI1; CORONATINE-INSENSITIVE1; BIOSYNTHESIS	Jasmonate and related signalling compounds have a crucial role in both host immunity and development in plants, but the molecular details of the signalling mechanism are poorly understood. Here we identify members of the jasmonate ZIM-domain (JAZ) protein family as key regulators of jasmonate signalling. JAZ1 protein acts to repress transcription of jasmonate-responsive genes. Jasmonate treatment causes JAZ1 degradation and this degradation is dependent on activities of the SCFCOI1 ubiquitin ligase and the 26S proteasome. Furthermore, the jasmonoyl-isoleucine (JA-Ile) conjugate, but not other jasmonate-derivatives such as jasmonate, 12-oxo-phytodienoic acid, or methyl-jasmonate, promotes physical interaction between COI1 and JAZ1 proteins in the absence of other plant proteins. Our results suggest a model in which jasmonate ligands promote the binding of the SCF COI1 ubiquitin ligase to and subsequent degradation of the JAZ1 repressor protein, and implicate the SCFCOI1-JAZ1 protein complex as a site of perception of the plant hormone JA-Ile.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Washington State University; Michigan State University; Michigan State University; Michigan State University	Browse, J (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jab@wsu.edu	Howe, Gregg A/N-1887-2014	Howe, Gregg A/0000-0002-9218-979X; Melotto, Maeli/0000-0001-6021-9803; Browse, John/0000-0002-2554-2821; He, Sheng Yang/0000-0003-1308-498X				Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; Conconi A, 1996, NATURE, V383, P826, DOI 10.1038/383826a0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Jensen AB, 2002, PLANT J, V29, P595, DOI 10.1046/j.0960-7412.2001.01241.x; KATAGIRI F, 2002, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0039; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kramell R, 1997, FEBS LETT, V414, P197, DOI 10.1016/S0014-5793(97)01005-3; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	37	1613	1748	43	478	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					661	U2		10.1038/nature05960	http://dx.doi.org/10.1038/nature05960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17637677				2022-12-28	WOS:000248598000037
J	McMurray, B				McMurray, Bob			Defusing the childhood vocabulary explosion	SCIENCE			English	Article							SPURT		Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa	McMurray, B (corresponding author), Univ Iowa, Dept Psychol, E11 SSh, Iowa City, IA 52242 USA.	bob-mcmurray@uiowa.edu			NIDCD NIH HHS [DC008089-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008089] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BLOOM L, 1973, 1 WORD TIME USE SING; Ganger J, 2004, DEV PSYCHOL, V40, P621, DOI 10.1037/0012-1649.40.4.621; MARKMAN E. M., 1991, PERSPECTIVES LANGUAG, P72; Nazzi T, 2003, DEVELOPMENTAL SCI, V6, P136, DOI 10.1111/1467-7687.00263; Swingley D, 2007, COGNITIVE PSYCHOL, V54, P99, DOI 10.1016/j.cogpsych.2006.05.001	6	133	134	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					631	631		10.1126/science.1144073	http://dx.doi.org/10.1126/science.1144073			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673655				2022-12-28	WOS:000248494400036
J	Miller-Jensen, K; Janes, KA; Brugge, JS; Lauffenburger, DA				Miller-Jensen, Kathryn; Janes, Kevin A.; Brugge, Joan S.; Lauffenburger, Douglas A.			Common effector processing mediates cell-specific responses to stimuli	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTORS; CANCER; TNF; NETWORKS; INFLAMMATION; INDUCTION; APOPTOSIS	The fundamental components of many signalling pathways are common to all cells(1-3). However, stimulating or perturbing the intracellular network often causes distinct phenotypes that are specific to a given cell type(4,5). This 'cell specificity' presents a challenge in understanding how intracellular networks regulate cell behaviour and an obstacle to developing drugs that treat signalling dysfunctions(6,7). Here we apply a systems-modelling approach(8) to investigate how cell-specific signalling events are integrated through effector proteins to cause cell-specific outcomes. We focus on the synergy between tumour necrosis factor and an adenoviral vector as a therapeutically relevant stimulus that induces cell-specific responses(9-11). By constructing models that estimate how kinase-signalling events are processed into phenotypes through effector substrates, we find that accurate predictions of cell specificity are possible when different cell types share a common 'effector-processing' mechanism. Partial-least-squares regression models based on common effector processing accurately predict cell-specific apoptosis, chemokine release, gene induction, and drug sensitivity across divergent epithelial cell lines. We conclude that cell specificity originates from the differential activation of kinases and other upstream transducers, which together enable different cell types to use common effectors to generate diverse outcomes. The common processing of network signals by downstream effectors points towards an important cell biological principle, which can be applied to the understanding of cell-specific responses to targeted drug therapies(6).	MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lauffenburger, DA (corresponding author), MIT, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu		Miller-Jensen, Kathryn/0000-0002-7233-0100				Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bowen GP, 2002, HUM GENE THER, V13, P367, DOI 10.1089/10430340252792503; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Gerhart J, 1999, TERATOLOGY, V60, P226; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenakin T, 2003, NAT REV DRUG DISCOV, V2, P429, DOI 10.1038/nrd1110; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P118; Liu TC, 2005, GENE THER, V12, P1333, DOI 10.1038/sj.gt.3302555; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; NELSON PJ, 1993, J IMMUNOL, V151, P2601; OHMORI Y, 1994, BIOCHEM BIOPH RES CO, V198, P590, DOI 10.1006/bbrc.1994.1086; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schmitz EK, 2004, APOPTOSIS, V9, P369, DOI 10.1023/B:APPT.0000025814.46962.62; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	34	145	151	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					604	U11		10.1038/nature06001	http://dx.doi.org/10.1038/nature06001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17637676				2022-12-28	WOS:000248446700046
J	Ajdari, A				Ajdari, Armand			Pierre-Gilles de Gennes (1932-2007)	SCIENCE			English	Biographical-Item									ESPCI, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Ajdari, A (corresponding author), ESPCI, 10 Rue Vauquelin, F-75005 Paris, France.	armand.ajdari@saint-gobain.com							0	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					466	466		10.1126/science.1146688	http://dx.doi.org/10.1126/science.1146688			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656713				2022-12-28	WOS:000248339800031
J	Veiga, E; Cossart, P				Veiga, Esteban; Cossart, Pascale			Listeria InIB takes a different route to met	CELL			English	Editorial Material							INVASION PROTEIN; MONOCYTOGENES; RECEPTOR; INLB; DOMAINS; CELLS; HGF	InlB, a surface protein of the human bacterial pathogen Listeria monocytogenes, interacts with the receptor tyrosine kinase Met on host cells to enable bacterial invasion. In this issue, Niemann et al. (2007) provide the first structural evidence that InlB does not compete for the same interaction site on Met as the natural ligand HGF.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; INSERM, U604, F-75015 Paris, France; INRA, USC 2020, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Veiga, E (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	eveiga@pasteur.fr; pcossart@pasteur.fr	veiga, esteban/C-2129-2011	veiga, esteban/0000-0002-7333-2466				Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; NIEMANN HH, 2007, CELL; Prat M, 1998, J CELL SCI, V111, P237; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243	10	9	14	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					218	219		10.1016/j.cell.2007.07.005	http://dx.doi.org/10.1016/j.cell.2007.07.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662936	Bronze			2022-12-28	WOS:000248588000011
J	Dosa, DM				Dosa, David M.			A day in the life of oscar the cat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rhode Isl Hosp, Providence, RI 02902 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Dosa, DM (corresponding author), Rhode Isl Hosp, Providence, RI 02902 USA.								0	20	20	5	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					328	329		10.1056/NEJMp078108	http://dx.doi.org/10.1056/NEJMp078108			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652647				2022-12-28	WOS:000248283500003
J	Bacon, CJ; Hey, EN				Bacon, C. J.; Hey, E. N.			Uncertainty in classification of repeat sudden unexpected infant deaths in Care of the Next Infant programme	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Chrisjbacon@googlemail.com						Arnestad M, 2005, AM J MED GENET A, V134A, P459, DOI 10.1002/ajmg.a.30614; Bacon C, 2005, LANCET, V365, P1137, DOI 10.1016/S0140-6736(05)71872-9; Carpenter RG, 2007, BRIT MED J, V334, P7, DOI 10.1136/bmj.39070.643009.3A; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; *CROWN PROS SERV, 2004, COD CROWN PROS; DENMARK JC, 1966, BRIT J MED PSYCHOL, V39, P117, DOI 10.1111/j.2044-8341.1966.tb01320.x; Di Maio VM, 2005, LANCET, V365, P1137, DOI 10.1016/S0140-6736(05)71873-0; DORRIES C, 2004, CORONERS COURTS GUID, P272; Emery JL, 2000, BRIT MED J, V320, P310, DOI 10.1136/bmj.320.7230.310; EMERY JL, 1986, LANCET, V1, P313; EMERY JL, 1993, AM J DIS CHILD, V147, P1097, DOI 10.1001/archpedi.1993.02160340083019; Gornall J, 2006, BRIT MED J, V333, P1165, DOI 10.1136/bmj.39031.590914.68; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KRUGMAN RD, 1994, PEDIATRICS, V94, P124; Limerick SR, 2004, J CLIN PATHOL, V57, P309, DOI 10.1136/jcp.2003.013052; Maguire S, 2006, CHILD ABUSE NEGLECT, V30, P739, DOI 10.1016/j.chiabu.2005.12.007; WOLKIND S, 1993, ACTA PAEDIATR, V82, P873, DOI 10.1111/j.1651-2227.1993.tb12583.x	18	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2007	335	7611					129	131		10.1136/bmj.39203.430984.AD	http://dx.doi.org/10.1136/bmj.39203.430984.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641347	Green Published			2022-12-28	WOS:000248428100032
J	Feuillet, L; Dufour, H; Pelletier, J				Feuillet, Lionel; Dufour, Henry; Pelletier, Jean			Brain of a white-collar worker	LANCET			English	Editorial Material									Univ Aix Marseille 2, Assistance Publ Hop Marseille, Hop Timone, Fac Med Marseille,Dept Neurol, Marseille, France; Univ Aix Marseille 2, Assistance Publ Hop Marseille, Hop Timone, Fac Med Marseille,Dept Neurosurg, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Feuillet, L (corresponding author), Univ Aix Marseille 2, Assistance Publ Hop Marseille, Hop Timone, Fac Med Marseille,Dept Neurol, Marseille, France.	lionel.feufllet@mail.ap-hm.fr							0	60	63	2	30	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2007	370	9583					262	262		10.1016/S0140-6736(07)61127-1	http://dx.doi.org/10.1016/S0140-6736(07)61127-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658396				2022-12-28	WOS:000248347900030
J	Rosebrock, TR; Zeng, LR; Brady, JJ; Abramovitch, RB; Xiao, FM; Martin, GB				Rosebrock, Tracy R.; Zeng, Lirong; Brady, Jennifer J.; Abramovitch, Robert B.; Xiao, Fangming; Martin, Gregory B.			A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity	NATURE			English	Article							PROGRAMMED CELL-DEATH; PATHOGEN PSEUDOMONAS-SYRINGAE; III EFFECTORS; DISEASE RESISTANCE; INNATE IMMUNITY; BASAL DEFENSE; GENE FAMILY; TOMATO; PTO; ARABIDOPSIS	Many bacterial pathogens of plants and animals use a type III secretion system to deliver diverse virulence-associated 'effector' proteins into the host cell(1). The mechanisms by which these effectors act are mostly unknown; however, they often promote disease by suppressing host immunity(2). One type III effector, AvrPtoB, expressed by the plant pathogen Pseudomonas syringae pv. tomato, has a carboxy-terminal domain that is an E3 ubiquitin ligase(3). Deletion of this domain allows an amino-terminal region of AvrPtoB (AvrPtoB(1-387)) to be detected by certain tomato varieties leading to immunity-associated programmed cell death(4). Here we show that a host kinase, Fen, physically interacts with AvrPtoB(1-387) and is responsible for activating the plant immune response. The AvrPtoB E3 ligase specifically ubiquitinates Fen and promotes its degradation in a proteasome-dependent manner. This degradation leads to disease susceptibility in Fen-expressing tomato lines. Various wild species of tomato were found to exhibit immunity in response to AvrPtoB(1-387) and not to full-length AvrPtoB. Thus, by acquiring an E3 ligase domain, AvrPtoB has thwarted a highly conserved host resistance mechanism.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Abramovitch, Robert/O-6798-2019; Martin, Gregory B/F-6262-2011; Abramovitch, Robert B/A-5324-2013	Abramovitch, Robert/0000-0002-4119-4169; Martin, Gregory B/0000-0003-0044-6830; Zeng, Lirong/0000-0001-8802-4872; Rosebrock, Tracy/0000-0001-6339-6661	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078021] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078021-02, R01 GM078021] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jia YL, 1997, PLANT CELL, V9, P61, DOI 10.1105/tpc.9.1.61; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Lin NC, 2006, APPL ENVIRON MICROB, V72, P702, DOI 10.1128/AEM.72.1.702-712.2006; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; PASCUZZI PE, 2006, THESIS CORNELL U; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Xing T, 2001, PLANT MOL BIOL, V46, P109, DOI 10.1023/A:1010633215445; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	32	235	244	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					370	U13		10.1038/nature05966	http://dx.doi.org/10.1038/nature05966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637671	Green Accepted			2022-12-28	WOS:000248118300062
J	Behnia, K; Balicas, L; Kopelevich, Y				Behnia, Kamran; Balicas, Luis; Kopelevich, Yakov			Signatures of electron fractionalization in ultraquantum bismuth	SCIENCE			English	Article							MAGNETIC-FIELDS; QUANTUM; MAGNETORESISTANCE	Because of the long Fermi wavelength of itinerant electrons, the quantum limit of elemental bismuth (unlike most metals) can be attained with a moderate magnetic field. The quantized orbits of electrons shrink with increasing magnetic field. Beyond the quantum limit, the circumference of these orbits becomes shorter than the Fermi wavelength. We studied transport coefficients of a single crystal of bismuth up to 33 tesla, which is deep in this ultraquantum limit. The Nernst coefficient presents three unexpected maxima that are concomitant with quasi-plateaus in the Hall coefficient. The results suggest that this bulk element may host an exotic quantum fluid reminiscent of the one associated with the fractional quantum Hall effect and raise the issue of electron fractionalization in a three-dimensional metal.	Ecole Super Phys & Chim Ind Ville Paris, Lab Photons & Mat, CNRS UPR5, F-75231 Paris, France; Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083970 Campinas, SP, Brazil; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universidade Estadual de Campinas; State University System of Florida; Florida State University	Behnia, K (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, Lab Photons & Mat, CNRS UPR5, 10 Rue Vauquelin, F-75231 Paris, France.	kamran.behnia@espci.fr	Balicas, Luis/A-3110-2008; KOPELEVITCH, IAKOV/AAW-4539-2020; Behnia, Kamran/AHC-5765-2022	KOPELEVICH, YAKOV/0000-0002-0831-6769; Behnia, Kamran/0000-0001-8997-5645				Abrikosov AA, 2003, J PHYS A-MATH GEN, V36, P9119, DOI 10.1088/0305-4470/36/35/301; Balents L, 1996, PHYS REV LETT, V76, P2782, DOI 10.1103/PhysRevLett.76.2782; Behnia K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166602; Biagini C, 2001, EUROPHYS LETT, V55, P383, DOI 10.1209/epl/i2001-00426-2; Bompadre SG, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.073103; de Haas WJ, 1930, P K AKAD WET-AMSTERD, V33, P1106; EDELMAN VS, 1976, ADV PHYS, V25, P555, DOI 10.1080/00018737600101452; FALKOVSK.LA, 1968, SOV PHYS USPEKHI, V11, P1, DOI 10.1070/PU1968v011n01ABEH003721; Hengsberger M, 2000, EUR PHYS J B, V17, P603, DOI 10.1007/s100510070097; HIRUMA K, 1983, J PHYS SOC JPN, V52, P2118, DOI 10.1143/JPSJ.52.2118; Hofmann P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.195413; ISSI JP, 1979, AUST J PHYS, V32, P585, DOI 10.1071/PH790585; Kapitza P, 1928, P R SOC LOND A-CONTA, V119, P358, DOI 10.1098/rspa.1928.0103; Murakami S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236805; Nakamura H, 2005, SOLID STATE COMMUN, V135, P510, DOI 10.1016/j.ssc.2005.05.036; PIPPARD AB, 1952, P PHYS SOC LOND A, V65, P955, DOI 10.1088/0370-1298/65/11/117; Shoenberg D, 1939, PROC R SOC LON SER-A, V170, P0341, DOI 10.1098/rspa.1939.0036; SHOENBERG D, 1984, MAGNETIC OSCILLATION, P228; SHUBNIKOV L, 1930, COMM PHYS LAB U LEID; SMITH GE, 1964, PHYS REV, V135, P1118, DOI 10.1103/PhysRev.135.A1118; STORMER HL, 1986, PHYS REV LETT, V56, P85, DOI 10.1103/PhysRevLett.56.85; Yang FY, 2000, PHYS REV B, V61, P6631, DOI 10.1103/PhysRevB.61.6631; Yoshioka D., 2002, QUANTUM HALL EFFECT	25	135	135	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1729	1731		10.1126/science.1146509	http://dx.doi.org/10.1126/science.1146509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17702909	Green Submitted			2022-12-28	WOS:000249585900042
J	Alley, RB				Alley, Richard B.			Geochemistry - "C" ing Arctic Climate with Black Ice	SCIENCE			English	Editorial Material									Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	rba6@psu.edu						Bengtsson L, 2004, J CLIMATE, V17, P4045, DOI 10.1175/1520-0442(2004)017<4045:TETWIT>2.0.CO;2; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Jenk TM, 2006, ATMOS CHEM PHYS, V6, P5381; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; McConnell JR, 2007, SCIENCE, V317, P1381, DOI 10.1126/science.1144856; Solomon S., 2007, PHYS SCI BASIS WORKI	8	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1333	1334		10.1126/science.1147470	http://dx.doi.org/10.1126/science.1147470			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690263				2022-12-28	WOS:000249377500027
J	Roberts, TE; Robinson, S; Barton, PM; Bryan, S; McCarthy, A; Macleod, J; Egger, M; Low, N				Roberts, Tracy E.; Robinson, Suzanne; Barton, Pelham M.; Bryan, Stirling; McCarthy, Anne; Macleod, John; Egger, Matthias; Low, Nicola			Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project	BRITISH MEDICAL JOURNAL			English	Article							INFECTION; PROGRAMS; PREVALENCE; DISEASE; CARE	Objective To investigate the cost effectiveness of screening for Chlamydia trachomatis compared with a policy of no organised screening in the United Kingdom. Design Economic evaluation using a transmission dynamic mathematical model. Setting Central and southwest England. Participants Hypothetical population of 50 000 men and women, in which all those aged 16-24 years were invited to be screened each year. Main outcome measures Cost effectiveness based on major outcomes averted, defined as pelvic inflammatory disease, ectopic pregnancy, infertility, or neonatal complications. Results The incremental cost per major outcome averted for a programme of screening women only (assuming eight years of screening) was 22 pound 300 (is an element of 33 000; $45 000) compared with no organised screening. For a programme screening both men and women, the incremental cost effectiveness ratio was approximately 28 pound 900. Pelvic inflammatory disease leading to hospital admission was the most frequently averted major outcome. The model was highly sensitive to the incidence of major outcomes and to uptake of screening. When both were increased the cost effectiveness ratio fell to 6200 pound per major outcome averted for screening women only. Conclusions Proactive register based screening for chlamydia is not cost effective if the uptake of screening and incidence of complications are based on contemporary empirical studies, which show lower rates than commonly assumed. These data are relevant to discussions about the cost effectiveness of the opportunistic model of chlamydia screening being introduced in England.	Univ Birmingham, HSMC, Hlth Econ Facil, Birmingham B15 2RT, W Midlands, England; Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland	University of Birmingham; University of Bristol; University of Birmingham; University of Bern	Roberts, TE (corresponding author), Univ Birmingham, HSMC, Hlth Econ Facil, Birmingham B15 2RT, W Midlands, England.	T.E.Roberts@bham.ac.uk	Roberts, Tracy/AAO-4610-2021; Low, Nicola/H-4718-2019; Robinson, Suzanne/B-6604-2013	Roberts, Tracy/0000-0002-0624-0537; Low, Nicola/0000-0003-4817-8986; Egger, Matthias/0000-0001-7462-5132; Robinson, Suzanne/0000-0001-5703-6475				Adams EJ, 2006, SEX TRANSM INFECT, V82, P201, DOI 10.1136/sti.2005.018960; Adams EJ, 2004, SEX TRANSM INFECT, V80, P363, DOI 10.1136/sti.2004.009654; ADAMS EJ, 2007, SEX TRANSM INFECT; Andersen B, 2006, SEX TRANSM DIS, V33, P407, DOI 10.1097/01.olq.0000200609.77577.3f; Chen MY, 2006, INT J STD AIDS, V17, P384, DOI 10.1258/095646206777323436; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; de Vries R, 2006, VALUE HEALTH, V9, P1, DOI 10.1111/j.1524-4733.2006.00075.x; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Honey E, 2002, SEX TRANSM INFECT, V78, P406, DOI 10.1136/sti.78.6.406; *I MED, 2000, VACC 21 CENT TOOL DE; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N, 2006, BRIT MED J, V332, P14, DOI 10.1136/bmj.38678.405370.7C; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; LOW N, 2007, HLTH TECHNOL ASSESS, V11; Low N, 2007, BMJ-BRIT MED J, V334, P725, DOI 10.1136/bmj.39154.378079.BE; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; *NAT CHLAM SCREEN, 2006, NEW FRONT ANN REP NA; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Roberts T, 2004, SEX TRANSM INFECT, V80, P324, DOI 10.1136/sti.2003.008458; Roberts TE, 2006, SEX TRANSM INFECT, V82, P193, DOI 10.1136/sti.2005.017517; ROBINSON S, 2007, SEX TRANSM INFECT; Salisbury C, 2006, BRIT J GEN PRACT, V56, P99; Turner KME, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-3; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; Welte R, 2005, SEX TRANSM DIS, V32, P474, DOI 10.1097/01.olq.0000161181.48687.cf	29	31	33	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					291	294A		10.1136/bmj.39262.683345.AE	http://dx.doi.org/10.1136/bmj.39262.683345.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17656504	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000248987400025
J	Bennett, EJ; Shaler, TA; Woodman, B; Ryu, KY; Zaitseva, TS; Becker, CH; Bates, GP; Schulman, H; Kopito, RR				Bennett, Eric J.; Shaler, Thomas A.; Woodman, Ben; Ryu, Kwon-Yul; Zaitseva, Tatiana S.; Becker, Christopher H.; Bates, Gillian P.; Schulman, Howard; Kopito, Ron R.			Global changes to the ubiquitin system in Huntington's disease	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; IN MOUSE MODEL; PROTEASOME SYSTEM; PARKINSONS-DISEASE; DYSFUNCTION; IMPAIRMENT; NUCLEAR; QUANTIFICATION; AGGREGATION; DEGRADATION	Huntington's disease (HD) is a dominantly inherited neuro-degenerative disorder caused by expansion of CAG triplet repeats in the huntingtin (HTT) gene (also called HD) and characterized by accumulation of aggregated fragments of polyglutamine-expanded HTT protein in affected neurons(1,2). Abnormal enrichment of HD inclusion bodies with ubiquitin, a diagnostic characteristic of HD and many other neurodegenerative disorders including Alzheimer's and Parkinson's diseases(3,4), has suggested that dysfunction in ubiquitin metabolism may contribute to the pathogenesis of these diseases(5,6). Because modification of proteins with polyubiquitin chains regulates many essential cellular processes including protein degradation, cell cycle, transcription, DNA repair and membrane trafficking(7), disrupted ubiquitin signalling is likely to have broad consequences for neuronal function and survival. Although ubiquitin-dependent protein degradation is impaired in cell-culture models of HD8-11 and of other neurodegenerative diseases(12,13), it has not been possible to evaluate the function of the ubiquitin-proteasome system (UPS) in HD patients or in animal models of the disease, and a functional role for UPS impairment in neurodegenerative disease pathogenesis remains controversial(14-16). Here we exploit a mass-spectrometry-based method to quantify polyubiquitin chains(17) and demonstrate that the abundance of these chains is a faithful endogenous biomarker of UPS function. Lys 48-linked polyubiquitin chains accumulate early in pathogenesis in brains from the R6/2 transgenic mouse model of HD, from a knock-in model of HD and from human HD patients, establishing that UPS dysfunction is a consistent feature of HD pathology. Lys 63- and Lys 11-linked polyubiquitin chains, which are not typically associated with proteasomal targeting, also accumulate in the R6/2 mouse brain. Thus, HD is linked to global changes in the ubiquitin system to a much greater extent than previously recognized.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; PPD Biomarker Discovery Inc, Menlo Pk, CA 94025 USA; Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England	Stanford University; University of London; King's College London	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	kopito@stanford.edu	Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Ryu, Kwon-Yul/0000-0001-6104-8575	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Barr JR, 1996, CLIN CHEM, V42, P1676; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; DASS C, 1989, INT J PEPT PROT RES, V34, P81; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang HL, 2007, CELL SIGNAL, V19, P573, DOI 10.1016/j.cellsig.2006.08.006; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	28	408	412	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					704	U11		10.1038/nature06022	http://dx.doi.org/10.1038/nature06022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687326				2022-12-28	WOS:000248598000047
J	Shortell, SM; Rundall, TG; Hsu, J				Shortell, Stephen M.; Rundall, Thomas G.; Hsu, John			Improving patient care by linking evidence-based medicine and evidence-based management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PAY-FOR-PERFORMANCE; HEALTH-CARE; HIGH-RELIABILITY; QUALITY		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Kaiser Permanente Med Care Program, Div Res, Inst Hlth Policy, Oakland, CA 94611 USA	University of California System; University of California Berkeley; Kaiser Permanente	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 140 Warren Hall, Berkeley, CA 94720 USA.	short-ell@berkeley.edu						[Anonymous], 2005, BUILDING BETTER DELI; Berwick DM, 2005, QUAL SAF HEALTH CARE, V14, P315, DOI 10.1136/qshc.2005.015669; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Bush RW, 2007, JAMA-J AM MED ASSOC, V297, P871, DOI 10.1001/jama.297.8.871; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Chan KS, 2004, AM J MANAG CARE, V10, P806; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Frankel AS, 2006, HEALTH SERV RES, V41, P1690, DOI 10.1111/j.1475-6773.2006.00572.x; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; *I MED, 2006, MED QUAL IMPR ORG PR; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Kravitz RL, 2006, MILBANK Q, V84, P759; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; PFEFFER J, 2006, HARDFACTS DANGEROUS; Pronovost P, 2006, CRIT CARE MED, V34, P1988, DOI 10.1097/01.CCM.0000226412.12612.B6; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Shortell SM, 2004, MED CARE, V42, P1040, DOI 10.1097/00005650-200411000-00002; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Walshe K, 2001, MILBANK Q, V79, P429, DOI 10.1111/1468-0009.00214	26	116	140	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					673	676		10.1001/jama.298.6.673	http://dx.doi.org/10.1001/jama.298.6.673			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684190				2022-12-28	WOS:000248574800028
J	Peltecu, G				Peltecu, Gheorghe			Cellulitis after treatment for breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Carol Davila Univ Med, Bucharest 010455, Romania	Carol Davila University of Medicine & Pharmacy	Peltecu, G (corresponding author), Carol Davila Univ Med, Bucharest 010455, Romania.	peltecu@dnt.ro							0	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					488	488		10.1056/NEJMicm065836	http://dx.doi.org/10.1056/NEJMicm065836			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671257				2022-12-28	WOS:000248436300010
J	Forstemann, K; Horwich, MD; Wee, L; Tomari, Y; Zamore, PD				Foerstemann, Klaus; Horwich, Michael D.; Wee, LiangMeng; Tomari, Yukihide; Zamore, Phillip D.			Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by Dicer-1	CELL			English	Article							RNA-INTERFERENCE; CRYSTAL-STRUCTURE; PASSENGER-STRAND; STRUCTURAL BASIS; MESSENGER-RNAS; ENZYME DICER; SIRNA; RECOGNITION; CLEAVAGE; SLICER	Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide distinct classes of RNA-induced silencing complexes (RISCs) to repress mRNA expression in biological processes ranging from development to antiviral defense. In Drosophila, separate but conceptually similar endonucleolytic pathways produce siRNAs and miRNAs. Here, we show that despite their distinct biogenesis, double-stranded miRNAs and siRNAs participate in a common sorting step that partitions them into Ago1- or Ago2-containing effector complexes. These distinct complexes silence their target RNAs by different mechanisms. miRNA-loaded Ago2-RISC mediates RNAi, but only Ago1 is able to repress an mRNA with central mismatches in its miRNA-binding sites. Conversely, Ago1 cannot mediate RNAi, because it is an inefficient nuclease whose catalytic rate is limited by the dissociation of its reaction products. Thus, the two members of the Drosophila Ago subclade of Argonaute proteins are functionally specialized, but specific small RNA classes are not restricted to associate with Ago1 or Ago2.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, CiPS, D-81377 Munich, Germany; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawagoe, Saitama 3320012, Japan	University of Munich; University of Munich; University of Tokyo; Japan Science & Technology Agency (JST)	Zamore, PD (corresponding author), Univ Munich, Gene Ctr, Foedor Lynen Str 25, D-81377 Munich, Germany.	phillip.zamore@umassmed.edu	Tomari, Yukihide/A-8009-2009; Zamore, Phillip D/A-8941-2013; Wee, Liang Meng/U-2188-2017	Tomari, Yukihide/0000-0001-8442-0851; Wee, Liang Meng/0000-0003-3870-8568; Zamore, Phillip/0000-0002-4505-9618	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [P30 DK032520-259007, P30 DK032520, 5 P30 DK032520] Funding Source: Medline; NIGMS NIH HHS [R01 GM062862, R01 GM065236, R01 GM065236-07, R01 GM062862-08, GM62862, GM65236, R37 GM062862] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Davis AC, 2001, J HIGH ENERGY PHYS; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Preall JB, 2006, CURR BIOL, V16, P530, DOI 10.1016/j.cub.2006.01.061; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	83	298	316	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					287	297		10.1016/j.cell.2007.05.056	http://dx.doi.org/10.1016/j.cell.2007.05.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662943	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000248588000018
J	Lacour, J; Linder, D				Lacour, Jerome; Linder, David			A counterion strategy	SCIENCE			English	Editorial Material							ORGANOMETALLIC CHEMISTRY; GOLD CATALYSIS		Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland	University of Geneva	Lacour, J (corresponding author), Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland.	jerome.lacour@chiorg.unige.ch	Lacour, Jerome/G-3352-2015	Lacour, Jerome/0000-0001-6247-8059; Linder, David/0000-0002-5587-1458				Appelhans LN, 2005, J AM CHEM SOC, V127, P16299, DOI 10.1021/ja055317j; Eliel EL., 1994, STEREOCHEMISTRY ORGA; Gausepohl R, 2006, ANGEW CHEM INT EDIT, V45, P3689, DOI 10.1002/anie.200600327; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Jimenez-Nunez E, 2007, CHEM COMMUN, P333, DOI 10.1039/b612008c; Lacour J, 2003, CHEM SOC REV, V32, P373, DOI 10.1039/b205251m; LaLonde RL, 2007, J AM CHEM SOC, V129, P2452, DOI 10.1021/ja068819l; Macchioni A, 2005, CHEM REV, V105, P2039, DOI 10.1021/cr0300439; Maruoka K, 2003, CHEM REV, V103, P3013, DOI 10.1021/cr020020e; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Monchaud D, 2002, ANGEW CHEM INT EDIT, V41, P2317, DOI 10.1002/1521-3773(20020703)41:13<2317::AID-ANIE2317>3.0.CO;2-W; Pregosin PS, 2005, CHEM REV, V105, P2977, DOI 10.1021/cr0406716	13	43	43	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					462	463		10.1126/science.1146922	http://dx.doi.org/10.1126/science.1146922			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656710				2022-12-28	WOS:000248339800028
J	Anderlini, M; Lee, PJ; Brown, BL; Sebby-Strabley, J; Phillips, WD; Porto, JV				Anderlini, Marco; Lee, Patricia J.; Brown, Benjamin L.; Sebby-Strabley, Jennifer; Phillips, William D.; Porto, J. V.			Controlled exchange interaction between pairs of neutral atoms in an optical lattice	NATURE			English	Article							QUANTUM COMPUTATION; CONTROLLED COLLISIONS; ENTANGLEMENT; MANIPULATION; DYNAMICS; GATES; DOTS	Ultracold atoms trapped by light offer robust quantum coherence and controllability, providing an attractive system for quantum information processing and for the simulation of complex problems in condensed matter physics. Many quantum information processing schemes require the manipulation and deterministic entanglement of individual qubits; this would typically be accomplished using controlled, state-dependent, coherent interactions among qubits. Recent experiments have made progress towards this goal by demonstrating entanglement among an ensemble of atoms(1) confined in an optical lattice. Until now, however, there has been no demonstration of a key operation: controlled entanglement between atoms in isolated pairs. Here we use an optical lattice of double-well potentials(2,3) to isolate and manipulate arrays of paired Rb-87 atoms, inducing controlled entangling interactions within each pair. Our experiment realizes proposals to use controlled exchange coupling(4) in a system of neutral atoms(5). Although Rb-87 atoms have nearly state-independent interactions, when we force two atoms into the same physical location, the wavefunction exchange symmetry of these identical bosons leads to state-dependent dynamics. We observe repeated interchange of spin between atoms occupying different vibrational levels, with a coherence time of more than ten milliseconds. This observation demonstrates the essential component of a neutral atom quantum SWAP gate ( which interchanges the state of two qubits). Its 'half-implementation', the root SWAP gate, is entangling, and together with single-qubit rotations it forms a set of universal gates for quantum computation(4).	Univ Maryland, Natl Inst Stand & Technol, Joint Quantum Inst, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Porto, JV (corresponding author), Univ Maryland, Natl Inst Stand & Technol, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	trey@nist.gov	Lee, Patricia/B-6146-2012; Porto, Trey/AAH-2101-2021	Brown, Benjamin/0000-0002-4873-6362; Porto, James/0000-0002-6290-7535				Altman E, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/113; Anderlini M, 2006, J PHYS B-AT MOL OPT, V39, pS199, DOI 10.1088/0953-4075/39/10/S19; Batrouni GG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.117203; Brennen GK, 1999, PHYS REV LETT, V82, P1060, DOI 10.1103/PhysRevLett.82.1060; Calarco T, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.012306; DiVincenzo DP, 2000, NATURE, V408, P339, DOI 10.1038/35042541; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Hayes D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070501; Isacsson A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053604; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Jane E, 2003, QUANTUM INF COMPUT, V3, P15; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; KASTBERG A, 1995, PHYS REV LETT, V74, P1542, DOI 10.1103/PhysRevLett.74.1542; LEE PJ, IN PRESS PHYS REV LE; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Matthews MR, 1998, PHYS REV LETT, V81, P243, DOI 10.1103/PhysRevLett.81.243; PETHICK CJ, 2002, BOSE EINSTEIN CONDEN, pCH5; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Scarola VW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033003; Sebby-Strabley J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200405; Sebby-Strabley J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033605; Sorensen A, 1999, PHYS REV LETT, V83, P2274, DOI 10.1103/PhysRevLett.83.2274; Widera A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190405; Zhang CW, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042316	29	323	325	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					452	456		10.1038/nature06011	http://dx.doi.org/10.1038/nature06011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653187	Green Submitted			2022-12-28	WOS:000248302700042
J	Gotzsche, PC; Hrobjartsson, A; Maric, K; Tendal, B				Gotzsche, Peter C.; Hrobjartsson, Asbjorn; Maric, Katja; Tendal, Britta			Data extraction errors in meta-analyses that use standardized mean differences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; CLINICAL ANALGESIC TRIALS; BONE-MINERAL DENSITY; DOUBLE-BLIND; GRADED-EXERCISE; PLACEBO; EFFICACY; STROKE; OSTEOARTHRITIS	Context Meta-analysis of trials that have used different continuous or rating scales to record outcomes of a similar nature requires sophisticated data handling and data transformation to a uniform scale, the standardized mean difference (SMD). It is not known how reliable such meta-analyses are. Objective To study whether SMDs in meta-analyses are accurate. Data Sources Systematic review of meta-analyses published in 2004 that reported a result as an SMD, with no language restrictions. Two trials were randomly selected from each meta-analysis. We attempted to replicate the results in each meta-analysis by independently calculating SMD using Hedges adjusted g. Data Extraction Our primary outcome was the proportion of meta-analyses for which our result differed from that of the authors by 0.1 or more, either for the point estimate or for its confidence interval, for at least 1 of the 2 selected trials. We chose 0.1 as cut point because many commonly used treatments have an effect of 0.1 to 0.5, compared with placebo. Results Of the 27 meta-analyses included in this study, we could not replicate the result for at least 1 of the 2 trials within 0.1 in 10 of the meta-analyses (37%), and in 4 cases, the discrepancy was 0.6 or more for the point estimate. Common problems were erroneous number of patients, means, standard deviations, and sign for the effect estimate. In total, 17 meta-analyses (63%) had errors for at least 1 of the 2 trials examined. For the 10 meta-analyses with errors of at least 0.1, we checked the data from all the trials and conducted our own meta-analysis, using the authors' methods. Seven of these 10 meta-analyses were erroneous (70%); 1 was subsequently retracted, and in 2 a significant difference disappeared or appeared. Conclusions The high proportion of meta-analyses based on SMDs that show errors indicates that although the statistical process is ostensibly simple, data extraction is particularly liable to errors that can negate or even reverse the findings of the study. This has implications for researchers and implies that all readers, including journal reviewers and policy makers, should approach such meta-analyses with caution.	Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk						Abul-Ainine A, 2002, ARCH DIS CHILD, V86, P276, DOI 10.1136/adc.86.4.276; Adams NP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003135.pub3; Alam NH, 1999, LANCET, V354, P296, DOI 10.1016/S0140-6736(98)09332-5; [Anonymous], 2006, COMPR MET; BARDAYGODDARD R, 2004, COCHRANE DB SYST REV; Barlow J, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002020.PUB2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brady-Fryer B, 2004, Cochrane Database Syst Rev, pCD004217, DOI 10.1002/14651858.CD004217.pub2; Brosseau L, 2004, COCHRANE DB SYST REV, V3; BULOW PM, 1994, SCAND J REHABIL MED, V26, P155; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Castro-Rodriguez JA, 2004, J PEDIATR-US, V145, P172, DOI 10.1016/j.jpeds.2004.04.007; CHEN J, 2004, COCHRANE DB SYST REV, V3; CHENG L, 1993, EUR J CLIN NUTR, V47, P88; Deery C, 2004, J DENT, V32, P197, DOI 10.1016/j.jdent.2003.11.006; Den Boer PCAM, 2004, PSYCHOL MED, V34, P959, DOI 10.1017/S003329170300179X; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Ekeland E, 2004, Cochrane Database Syst Rev.; Frisina PG, 2004, J NERV MENT DIS, V192, P629, DOI 10.1097/01.nmd.0000138317.30764.63; Goebel J, 2000, CLIN PEDIATR, V39, P213, DOI 10.1177/000992280003900404; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; GRIFFITHS PD, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002214.PUB2; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HARKAPAA K, 1990, SCAND J REHABIL MED, V22, P181; Hartling L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003123.pub2, DOI 10.1002/14651858.CD003123.PUB2]; Hrobjartsson A, 2006, J CLIN EPIDEMIOL, V59, P336, DOI 10.1016/j.jclinepi.2005.05.011; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Kool J, 2004, J REHABIL MED, V36, P49, DOI 10.1080/16501970310020104; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; LANDER J, 1997, JAMA-J AM MED ASSOC, V278, P217; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MANAGER R, 2003, REV MANAGER VERSION; Merry S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003380.PUB2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moncrieff J., 2004, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD003012.PUB2; Murphy C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003754.PUB2; Murray E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004274.pub4; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521; Partridge C, 2000, Physiother Res Int, V5, P230, DOI 10.1002/pri.203; Patel H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004878; Perrott DA, 2004, ARCH PEDIAT ADOL MED, V158, P521, DOI 10.1001/archpedi.158.6.521; Powell H, 2004, COCHRANE DB SYST REV; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Price DD, 2003, PAIN, V104, P715, DOI 10.1016/S0304-3959(03)00165-9; Ramakrishnan U, 2004, J NUTR, V134, P2592, DOI 10.1093/jn/134.10.2592; Richards JM, 2000, J ABNORM PSYCHOL, V109, P156, DOI 10.1037/0021-843X.109.1.156; Richy F, 2004, OSTEOPOROSIS INT, V15, P301, DOI 10.1007/s00198-003-1570-5; Rosner R, 1999, Z KLIN PSYCHOL-FORSC, V28, P112, DOI 10.1026//0084-5345.28.2.112; Roychowdhury B, 2002, RHEUMATOLOGY, V41, P1330, DOI 10.1093/rheumatology/41.11.1330; Rozenberg S, 2002, SPINE, V27, P1487, DOI 10.1097/00007632-200207150-00002; Sackley CM, 1997, DISABIL REHABIL, V19, P536, DOI 10.3109/09638289709166047; Sato Y, 1997, STROKE, V28, P736, DOI 10.1161/01.STR.28.4.736; Steiner A, 2001, BRIT MED J, V322, P453, DOI 10.1136/bmj.322.7284.453; STELIAN J, 1992, J AM GERIATR SOC, V40, P23, DOI 10.1111/j.1532-5415.1992.tb01824.x; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Tuunainen A, 2004, Cochrane Database Syst Rev, pCD004050, DOI 10.1002/14651858.CD004050.pub2; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485; Wulff H. R., 2000, RATIONAL DIAGNOSIS T, V3rd; [No title captured], DOI DOI 10.1002/14651858.CD001187.PUB2	63	138	141	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					430	437		10.1001/jama.298.4.430	http://dx.doi.org/10.1001/jama.298.4.430			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652297				2022-12-28	WOS:000248269100022
J	't Hooft, G				't Hooft, Gerard			The making of the standard model	NATURE			English	Editorial Material								The standard model of particle physics is more than a model. It is a detailed theory that encompasses nearly all that is known about the subatomic particles and forces in a concise set of principles and equations. The extensive research that culminated in this model includes numerous small and large triumphs. Extremely delicate experiments, as well as tedious theoretical calculations - demanding the utmost of human ingenuity - have been essential to achieve this success.	Univ Utrecht, Inst Theoret Phys, NL-3508 TD Utrecht, Netherlands; Univ Utrecht, Spinoza Inst, NL-3508 TD Utrecht, Netherlands	Utrecht University; Utrecht University	't Hooft, G (corresponding author), Univ Utrecht, Inst Theoret Phys, POB 80-195, NL-3508 TD Utrecht, Netherlands.	g.thooft@phys.uu.nl						YANG CN, 1954, PHYS REV, V96, P191, DOI 10.1103/PhysRev.96.191	1	5	5	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					271	273		10.1038/nature06074	http://dx.doi.org/10.1038/nature06074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637655				2022-12-28	WOS:000248118300041
J	Ortlund, EA; Bridgham, JT; Redinbo, MR; Thornton, JW				Ortlund, Eric A.; Bridgham, Jamie T.; Redinbo, Matthew R.; Thornton, Joseph W.			Crystal structure of an ancient protein: Evolution by conformational epistasis	SCIENCE			English	Article							MINERALOCORTICOID RECEPTOR; COMPENSATORY EVOLUTION; HORMONE-RECEPTOR; ADAPTATION; ARCHITECTURE; LANDSCAPE; STABILITY	The structural mechanisms by which proteins have evolved new functions are known only indirectly. We report x-ray crystal structures of a resurrected ancestral protein-the similar to 450 million-year-old precursor of vertebrate glucocorticoid (GR) and mineralocorticoid (MR) receptors. Using structural, phylogenetic, and functional analysis, we identify the specific set of historical mutations that recapitulate the evolution of GR's hormone specificity from an MR-like ancestor. These substitutions repositioned crucial residues to create new receptor-ligand and intraprotein contacts. Strong epistatic interactions occur because one substitution changes the conformational position of another site. "Permissive" mutations-substitutions of no immediate consequence, which stabilize specific elements of the protein and allow it to tolerate subsequent function-switching changes-played a major role in determining GR's evolutionary trajectory.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Oregon	Thornton, JW (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	joet@uoregon.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019; Thornton, Joseph/GSN-4190-2022	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081592, F32GM074398] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK622229] Funding Source: Medline; NIGMS NIH HHS [R01 GM081592, R01 GM081592-01, F32-GM074398, R01-GM081592, F32 GM074398, R01 GM081592-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley P., 1998, COMP VERTEBRATE ENDO; Benton M.J., 2005, VERTEBRATE PALAEONTO; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Campbell-Valois FX, 2006, J MOL BIOL, V362, P151, DOI 10.1016/j.jmb.2006.06.061; CHARLESWORTH B, 1990, EVOLUTIONARY INNOVATIONS, P47; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Gould S. J., 1989, WONDERFUL LIFE BURGE; Haag ES, 2005, EVOLUTION, V59, P1620, DOI 10.1111/j.0014-3820.2005.tb01813.x; Hedstrom L, 1996, BIOL CHEM, V377, P465; Janvier P., 1996, EARLY VERTEBRATES; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; Provine, 1971, ORIGINS THEORETICAL; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Turner JM, 2006, P NATL ACAD SCI USA, V103, P6483, DOI 10.1073/pnas.0601756103; Vatzaki EH, 1999, EUR J BIOCHEM, V260, P176, DOI 10.1046/j.1432-1327.1999.00142.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125	32	302	306	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1544	1548		10.1126/science.1142819	http://dx.doi.org/10.1126/science.1142819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17702911	Green Accepted, Green Submitted			2022-12-28	WOS:000249467900040
J	Reyren, N; Thiel, S; Caviglia, AD; Kourkoutis, LF; Hammerl, G; Richter, C; Schneider, CW; Kopp, T; Ruetschi, AS; Jaccard, D; Gabay, M; Muller, DA; Triscone, JM; Mannhart, J				Reyren, N.; Thiel, S.; Caviglia, A. D.; Kourkoutis, L. Fitting; Hammerl, G.; Richter, C.; Schneider, C. W.; Kopp, T.; Ruetschi, A.-S.; Jaccard, D.; Gabay, M.; Muller, D. A.; Triscone, J.-M.; Mannhart, J.			Superconducting interfaces between insulating oxides	SCIENCE			English	Article							LONG-RANGE ORDER; TRANSITION	At interfaces between complex oxides, electronic systems with unusual electronic properties can be generated. We report on superconductivity in the electron gas formed at the interface between two insulating dielectric perovskite oxides, LaAlO3 and SrTiO3. The behavior of the electron gas is that of a two-dimensional superconductor, confined to a thin sheet at the interface. The superconducting transition temperature of congruent to 200 millikelvin provides a strict upper limit to the thickness of the superconducting layer of congruent to 10 nanometers.	Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany; Univ Geneva, Dept Phys Mat Condensee, CH-1211 Geneva, Switzerland; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Univ Paris Sud 11, Phys Solides Lab, F-91405 Orsay, France	University of Augsburg; University of Geneva; Cornell University; UDICE-French Research Universities; Universite Paris Saclay	Mannhart, J (corresponding author), Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany.	jochen.mannhart@physik.uni-augsburg.de	Reyren, Nicolas/AAA-4984-2022; Hammerl, German/E-9358-2017; Schneider, Christof W/I-5857-2014; Schneider, Christof/AAC-9106-2020; Caviglia, Andrea/B-4443-2009; Caviglia, Andrea/HHZ-9774-2022; Muller, David/A-7745-2010; Richter, Christoph/A-6172-2013; Kourkoutis, Lena/B-4229-2010	Reyren, Nicolas/0000-0002-7745-7282; Schneider, Christof W/0000-0002-4292-8574; Schneider, Christof/0000-0002-4292-8574; Caviglia, Andrea/0000-0001-9650-3371; Caviglia, Andrea/0000-0001-9650-3371; Muller, David/0000-0003-4129-0473; Richter, Christoph/0000-0002-6591-1118; Mannhart, Jochen/0000-0001-6331-2640; Hammerl, German/0000-0002-2010-5163; Kourkoutis, Lena/0000-0002-1303-1362				ALTIERI S, 2001, THIN SOLID FILMS, V9, P400; BEASLEY MR, 1979, PHYS REV LETT, V42, P1165, DOI 10.1103/PhysRevLett.42.1165; Berezinskii V. L., 1971, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V61, P1144; BEREZINSKII VL, 1972, SOV PHYS JETP-USSR, V34, P610; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; GABAY M, 1993, PHYS REV LETT, V71, P2138, DOI 10.1103/PhysRevLett.71.2138; GURVITCH M, 1986, P S S, P47; Herranz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216803; Huijben M, 2006, NAT MATER, V5, P556, DOI 10.1038/nmat1675; Koerting V, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104510; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; KOSTERLI.JM, 1972, J PHYS PART C SOLID, V5, pL124, DOI 10.1088/0022-3719/5/11/002; Mannhart J., 2005, MULTIFUNCT THIN FILM, P251; Maurice JL, 2006, PHYS STATUS SOLIDI A, V203, P2209, DOI 10.1002/pssa.200566033; Medvedyeva K, 2000, PHYS REV B, V62, P14531, DOI 10.1103/PhysRevB.62.14531; Muller DA, 2004, NATURE, V430, P657, DOI 10.1038/nature02756; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Pavlenko N, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174516; Pentcheva R, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035112; Schneider CW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354422; Siemons W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196802; Takahashi KS, 2006, NATURE, V441, P195, DOI 10.1038/nature04731; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; TREACY MMJ, 1986, J VAC SCI TECHNOL B, V4, P1458, DOI 10.1116/1.583473; UENO K, 2003, THESIS U TOKYO	28	2102	2119	35	1029	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1196	1199		10.1126/science.1146006	http://dx.doi.org/10.1126/science.1146006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17673621	Green Submitted			2022-12-28	WOS:000249126800033
J	Hafler, DA; Compston, A; Sawcer, S; Lander, ES; Daly, MJ; De Jager, PL; de Bakker, PIW; Gabriel, SB; Mirel, DB; Ivinson, AJ; Pericak-Vance, MA; Gregory, SG; Rioux, JD; McCauley, JL; Haines, JL; Barcellos, LF; Cree, B; Oksenberg, JR; Hauser, SL				Hafler, David A.; Compston, Alastair; Sawcer, Stephen; Lander, Eric S.; Daly, Mark J.; De Jager, Philip L.; de Bakker, Paul I. W.; Gabriel, Stacey B.; Mirel, Daniel B.; Ivinson, Adrian J.; Pericak-Vance, Margaret A.; Gregory, Simon G.; Rioux, John D.; McCauley, Jacob L.; Haines, Jonathan L.; Barcellos, Lisa F.; Cree, Bruce; Oksenberg, Jorge R.; Hauser, Stephen L.		Int Multiple Sclerosis Genetics Co	Risk alleles for multiple sclerosis identified by a genomewide study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; LYMPHOID TYROSINE PHOSPHATASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; INTERLEUKIN-7 RECEPTOR-ALPHA; TYPE-1 DIABETES LOCUS; WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; SUSCEPTIBILITY LOCI	Background: Multiple sclerosis has a clinically significant heritable component. We conducted a genomewide association study to identify alleles associated with the risk of multiple sclerosis. Methods: We used DNA microarray technology to identify common DNA sequence variants in 931 family trios (consisting of an affected child and both parents) and tested them for association. For replication, we genotyped another 609 family trios, 2322 case subjects, and 789 control subjects and used genotyping data from two external control data sets. A joint analysis of data from 12,360 subjects was performed to estimate the overall significance and effect size of associations between alleles and the risk of multiple sclerosis. Results: A transmission disequilibrium test of 334,923 single-nucleotide polymorphisms (SNPs) in 931 family trios revealed 49 SNPs having an association with multiple sclerosis (P<1 x 10(sup -4)); of these SNPs, 38 were selected for the second-stage analysis. A comparison between the 931 case subjects from the family trios and 2431 control subjects identified an additional nonoverlapping 32 SNPs (P<0.001). An additional 40 SNPs with less stringent P values (<0.01) were also selected, for a total of 110 SNPs for the second-stage analysis. Of these SNPs, two within the interleukin-2 receptor (alpha) gene (IL2RA) were strongly associated with multiple sclerosis (P=2.96 x 10(sup -8)), as were a nonsynonymous SNP in the interleukin-7 receptor (alpha) gene (IL7RA) (P=2.94 x 10(sup -7)) and multiple SNPs in the HLA-DRA locus (P=8.94 x 10(sup -81)). Conclusions: Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Broad Inst, Boston, MA USA; MIT, Cambridge, MA 02139 USA; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; Harvard Partners Ctr Genet & Genom, Boston, MA USA; Harvard Univ, Sch Med, Harvard Ctr Neurodgenerat & Repair, Boston, MA USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Miami, Sch Med, Miami, FL USA; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Duke University; University of Miami; Universite de Montreal; Vanderbilt University; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Ivinson, AJ (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, 75 Francis St, Boston, MA 02115 USA.		Haines, Jonathan/C-3374-2012; Hauser, Stephen L/J-2978-2016; Cree, Bruce C/AAV-6109-2020; de Bakker, Paul IW/B-8730-2009; Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015	Haines, Jonathan/0000-0002-4351-4728; Cree, Bruce C/0000-0001-7689-2533; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Gregory, Simon/0000-0002-7805-1743	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477, R01NS032830] Funding Source: NIH RePORTER; NCRR NIH HHS [U54-RR020278-1] Funding Source: Medline; NIAID NIH HHS [U19 AI067152, AI067152, P01-AI039671] Funding Source: Medline; NINDS NIH HHS [NS26799, NS032830, NS2427, NS049477] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P17565, DOI 10.1073/pnas.0404694101; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 1999, J NEUROIMMUNOL, V100, P115, DOI 10.1016/S0165-5728(99)00200-3; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; COMPSTON A, 2005, MCALPINES MULTIPLE S, P113; Criswell LA, 2005, RHEUMATOLOGY, V44, P9, DOI 10.1093/rheumatology/kei054; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2006, EUR J HUM GENET, V14, P317, DOI 10.1038/sj.ejhg.5201548; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300; GREGORY SG, IN PRESS NAT GENET; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Kyogoku C, 2004, ARTHRITIS RHEUM, V50, P671, DOI 10.1002/art.20029; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PRINEAS JW, 1978, LAB INVEST, V38, P409; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	64	1278	1308	1	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					851	862		10.1056/NEJMoa073493	http://dx.doi.org/10.1056/NEJMoa073493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17660530				2022-12-28	WOS:000249065700004
J	Singh, SK; Yamashita, A; Gouaux, E				Singh, Satinder K.; Yamashita, Atsuko; Gouaux, Eric			Antidepressant binding site in a bacterial homologue of neurotransmitter transporters	NATURE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; HUMAN SEROTONIN TRANSPORTERS; NOREPINEPHRINE TRANSPORTER; INHIBITION; COTRANSPORTER; MUTATIONS; RECEPTORS; MECHANISM; DRUGS; MODEL	Sodium-coupled transporters are ubiquitous pumps that harness pre-existing sodium gradients to catalyse the thermodynamically unfavourable uptake of essential nutrients, neurotransmitters and inorganic ions across the lipid bilayer(1). Dysfunction of these integral membrane proteins has been implicated in glucose/galactose malabsorption(2), congenital hypothyroidism(3), Bartter's syndrome(4), epilepsy(5), depression(6), autism(7) and obsessive-compulsive disorder(8). Sodium-coupled transporters are blocked by a number of therapeutically important compounds, including diuretics(9), anticonvulsants(10) and antidepressants(11), many of which have also become indispensable tools in biochemical experiments designed to probe antagonist binding sites and to elucidate transport mechanisms. Steady-state kinetic data have revealed that both competitive(12,13) and noncompetitive(14,15) modes of inhibition exist. Antagonist dissociation experiments on the serotonin transporter (SERT) have also unveiled the existence of a low-affinity allosteric site that slows the dissociation of inhibitors from a separate high-affinity site(16). Despite these strides, atomic-level insights into inhibitor action have remained elusive. Here we screen a panel of molecules for their ability to inhibit LeuT, a prokaryotic homologue of mammalian neurotransmitter sodium symporters, and show that the tricyclic antidepressant (TCA) clomipramine noncompetitively inhibits substrate uptake. Cocrystal structures show that clomipramine, along with two other TCAs, binds in an extracellular-facing vestibule about 11 angstrom above the substrate and two sodium ions, apparently stabilizing the extracellular gate in a closed conformation. Off-rate assays establish that clomipramine reduces the rate at which leucine dissociates from LeuT and reinforce our contention that this TCA inhibits LeuT by slowing substrate release. Our results represent a molecular view into noncompetitive inhibition of a sodium-coupled transporter and define principles for the rational design of new inhibitors.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Columbia University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360				Barker Eric L., 1995, P321; BEAUMONT K, 1988, P NATL ACAD SCI USA, V85, P2311, DOI 10.1073/pnas.85.7.2311; Cantu MD, 2005, J CHROMATOGR A, V1068, P99, DOI 10.1016/j.chroma.2004.12.009; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Paczkowski FA, 2007, J BIOL CHEM, V282, P17837, DOI 10.1074/jbc.M610813200; Pohlenz J, 1999, BIOCHIMIE, V81, P469, DOI 10.1016/S0300-9084(99)80097-2; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SMART L, 1981, EUR J PHARMACOL, V75, P265, DOI 10.1016/0014-2999(81)90553-7; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Uryu K, 2000, ANESTH ANALG, V91, P546, DOI 10.1213/00000539-200009000-00008; Vroye L, 1998, PFLUG ARCH EUR J PHY, V435, P259; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	30	331	339	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					952	956		10.1038/nature06038	http://dx.doi.org/10.1038/nature06038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17687333				2022-12-28	WOS:000248912900052
J	Jallepalli, PV; Pellman, D				Jallepalli, Prasad V.; Pellman, David			Aneuploidy in the balance	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; CANCER-CELLS; INSTABILITY; POLYPLOIDY; EVOLUTION; DIPLOIDY; YEAST		Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Jallepalli, PV (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	jallepap@mskcc.org; david_pellman@dfci.harvard.edu			NCI NIH HHS [CA107342, CA098537] Funding Source: Medline; NIGMS NIH HHS [GM061345] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098537, R01CA107342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN M, 1991, COLD SH Q B, V56, P359; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; ORR HA, 1995, GENETICS, V139, P1441; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Waghmare SK, 2005, YEAST, V22, P625, DOI 10.1002/yea.1226; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zang YH, 2002, YEAST, V19, P553, DOI 10.1002/yea.859	18	11	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					904	905		10.1126/science.1146857	http://dx.doi.org/10.1126/science.1146857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702931				2022-12-28	WOS:000248780200025
J	Virk, J; Zhang, J; Olsen, J				Virk, Jasveer; Zhang, Jun; Olsen, Jorn			Medical abortion and the risk of subsequent adverse pregnancy outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE INDUCED ABORTIONS; LOW-BIRTH-WEIGHT; ECTOPIC PREGNANCY; MIFEPRISTONE; MISCARRIAGE; TRIMESTER; FRANCE	Background: The long-term safety of surgical abortion in the first trimester is well established. Despite the increasing use of medical abortion (abortion by means of medication), limited information is available regarding the effects of this procedure on subsequent pregnancies. Methods: We identified all women living in Denmark who had undergone an abortion for nonmedical reasons between 1999 and 2004 and obtained information regarding subsequent pregnancies from national registries. Risks of ectopic pregnancy, spontaneous abortion, preterm birth (at < 37 weeks of gestation), and low birth weight (< 2500 g) in the first subsequent pregnancy in women who had had a first-trimester medical abortion were compared with risks in women who had had a first-trimester surgical abortion. Results: Among 11,814 pregnancies in women who had had a previous first-trimester medical abortion (2710 women) or surgical abortion (9104 women), there were 274 ectopic pregnancies (respective incidence rates, 2.4% and 2.3%), 1426 spontaneous abortions (12.2% and 12.7%), 552 preterm births (5.4% and 6.7%), and 478 births with low birth weight (4.0% and 5.1%). After adjustment for maternal age, interval between pregnancies, gestational age at abortion, parity, cohabitation status, and urban or nonurban residence, medical abortion was not associated with a significantly increased risk of ectopic pregnancy (relative risk, 1.04; 95% confidence interval [CI], 0.76 to 1.41), spontaneous abortion (relative risk, 0.87; 95% CI, 0.72 to 1.05), preterm birth (relative risk, 0.88; 95% CI, 0.66 to 1.18), or low birth weight (relative risk, 0.82; 95% CI, 0.61 to 1.11). Gestational age at medical abortion was not significantly associated with any of these adverse outcomes. Conclusions: We found no evidence that a previous medical abortion, as compared with a previous surgical abortion, increases the risk of spontaneous abortion, ectopic pregnancy, preterm birth, or low birth weight.	NICHHD, Epidemiol Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; Aarhus Univ, Inst Publ Hlth, Aarhus, Denmark	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; Aarhus University	Zhang, J (corresponding author), NICHHD, Epidemiol Branch, NIH, Bldg 6100,Rm 7B03, Bethesda, MD 20892 USA.	zhangj@mail.nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ATRASH HK, 1990, BAILLIERE CLIN OB GY, V4, P391, DOI 10.1016/S0950-3552(05)80234-2; Atrash HK, 1997, OBSTET GYNECOL, V89, P512, DOI 10.1016/S0029-7844(97)00050-1; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; *CDCP, 1995, CURR TRENDS ECT PREG; Che Y, 2001, J Obstet Gynaecol, V21, P270, DOI 10.1080/01443610120046396; Chen AM, 2004, AM J EPIDEMIOL, V160, P110, DOI 10.1093/aje/kwh182; CHOW WH, 1987, EPIDEMIOL REV, V9, P70, DOI 10.1093/oxfordjournals.epirev.a036309; CHRISTENSEN K, 1995, NEW ENGL J MED, V333, P161, DOI 10.1056/NEJM199507203330305; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; FRANK PI, 1991, BRIT J OBSTET GYNAEC, V98, P1015, DOI 10.1111/j.1471-0528.1991.tb15340.x; Grimes DA, 2005, CONTRACEPTION, V71, P161, DOI 10.1016/j.contraception.2004.12.001; InfanteRivard C, 1996, EPIDEMIOLOGY, V7, P540, DOI 10.1097/00001648-199609000-00017; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P154, DOI 10.2307/3097714; KALANDIDI A, 1991, BRIT J OBSTET GYNAEC, V98, P207, DOI 10.1111/j.1471-0528.1991.tb13370.x; Knudsen UB, 2001, CONTRACEPTION, V63, P247, DOI 10.1016/S0010-7824(01)00196-2; Kruse Beth, 2000, American Journal of Obstetrics and Gynecology, V183, pS65; MANDELSON MT, 1992, AM J PUBLIC HEALTH, V82, P391, DOI 10.2105/AJPH.82.3.391; Newhall Elizabeth Pirruccello, 2000, American Journal of Obstetrics and Gynecology, V183, pS44; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; PARAZZINI F, 1995, HUM REPROD, V10, P1841, DOI 10.1093/oxfordjournals.humrep.a136188; Parazzini F, 1998, BRIT J OBSTET GYNAEC, V105, P418, DOI 10.1111/j.1471-0528.1998.tb10127.x; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, P59; Skjeldestad FE, 1997, ACTA OBSTET GYN SCAN, V76, P151, DOI 10.3109/00016349709050072; Skjeldestad FE, 1997, ACTA OBSTET GYN SCAN, V76, P691, DOI 10.3109/00016349709024612; STENCHEVER MA, 2001, COMPREHENSIVE GYNECO, P413; Sun YL, 2003, INT J EPIDEMIOL, V32, P449, DOI 10.1093/ije/dyg093; Tharaux-Deneux C, 1998, AM J PUBLIC HEALTH, V88, P401, DOI 10.2105/AJPH.88.3.401; *WHO, INT CLASS DIS ICD ON; World Health Organization, 2001, ACTA OBSTET GYN SCAN, V80, P447; Zhou W., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P49; Zhou WJ, 1999, OBSTET GYNECOL, V94, P948, DOI 10.1016/S0029-7844(99)00440-8; Zhou WJ, 2000, INT J EPIDEMIOL, V29, P100, DOI 10.1093/ije/29.1.100	32	59	64	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					648	653		10.1056/NEJMoa070445	http://dx.doi.org/10.1056/NEJMoa070445			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699814	Bronze			2022-12-28	WOS:000248746000004
J	Brown, H				Brown, Hannah			For richer for poorer	BRITISH MEDICAL JOURNAL			English	Article							COUNTRIES	Five years ago, the world's biggest publishing houses committed themselves to letting researchers in developing countries have free access to the content of their journals. Beset by technical problems and language difficulties, is HINARI succeeding in what it set out to do?.				hannah@two-cultures.com						Godlee F, 2000, BRIT MED J, V321, P776, DOI 10.1136/bmj.321.7264.776; Smith H, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-72	2	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					280	283		10.1136/bmj.39293.711088.DE	http://dx.doi.org/10.1136/bmj.39293.711088.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17690367	Green Published			2022-12-28	WOS:000248987400021
J	Hawkes, N				Hawkes, Nigel			How not to win friends and influence people	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					284	284		10.1136/bmj.39297.609421.94	http://dx.doi.org/10.1136/bmj.39297.609421.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	203PV	17690368	Green Published			2022-12-28	WOS:000248987400022
J	Leo, M; Pinchera, A; Fiore, E; Giustarini, E; Giani, C				Leo, Marenza; Pinchera, Aldo; Fiore, Emilio; Giustarini, Elisa; Giani, Claudio			A swollen, red scar	LANCET			English	Editorial Material									Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy	University of Pisa	Fiore, E (corresponding author), Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy.	e.fiore@ao-pisa.toscana.it						DICKINSON JA, 1969, ARCH DERMATOL, V100, P315, DOI 10.1001/archderm.100.3.315; Morhenn V B, 1998, J Cutan Med Surg, V3, P46; Sorabjee JS, 2005, POSTGRAD MED J, V81, P60, DOI 10.1136/pgmj.2004.018796; Tchernev G, 2006, AM J CLIN DERMATOL, V7, P375, DOI 10.2165/00128071-200607060-00006	4	0	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					456	456		10.1016/S0140-6736(07)61201-X	http://dx.doi.org/10.1016/S0140-6736(07)61201-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679023				2022-12-28	WOS:000248590200036
J	Chen, GK; Zhuchenko, O; Kuspa, A				Chen, Guokai; Zhuchenko, Olga; Kuspa, Adam			Immune-like phagocyte activity in the social amoeba	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; LEGIONELLA-PNEUMOPHILA; INNATE IMMUNITY; SIGNALING PATHWAYS; PATTERN-FORMATION; PATHOGEN; RECOGNITION; RECEPTORS; EVOLUTION; ANIMALS	Social amoebae feed on bacteria in the soil but aggregate when starved to form a migrating slug. We describe a previously unknown cell type in the social amoeba, which appears to provide detoxification and immune-like functions and which we term sentinel ( S) cells. S cells were observed to engulf bacteria and sequester toxins while circulating within the slug, eventually being sloughed off. A Toll/ interleukin-1 receptor (TIR) domain protein, TirA, was also required for some S cell functions and for vegetative amoebae to feed on live bacteria. This apparent innate immune function in social amoebae, and the use of TirA for bacterial feeding, suggest an ancient cellular foraging mechanism that may have been adapted to defense functions well before the diversification of the animals.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kuspa, A (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	akuspa@bcm.tmc.edu		Kuspa, Adam/0000-0002-9156-149X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052359] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD039691-06, P01 HD039691-05, P01 HD039691-03, P01 HD039691, HD39691, P01 HD039691-07, P01 HD039691-08, P01 HD039691-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM052359-10, R01 GM052359-12, R01 GM052359-11, R01 GM052359, GM52359, R01 GM052359-13] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Casademunt E, 2002, DIFFERENTIATION, V70, P23, DOI 10.1046/j.1432-0436.2002.700103.x; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shuman HA, 1998, CURR TOP MICROBIOL, V225, P99; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Song J, 2005, PLOS COMPUT BIOL, V1, P579, DOI 10.1371/journal.pcbi.0010071; STERNFELD J, 1981, DIFFERENTIATION, V20, P10, DOI 10.1111/j.1432-0436.1981.tb01150.x; Strassmann JE, 2004, ASM NEWS, V70, P526; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; WILLIAMS J, 1997, DICTYOSTELIUM MODEL, P293; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	33	131	138	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					678	681		10.1126/science.1143991	http://dx.doi.org/10.1126/science.1143991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673666	Green Accepted			2022-12-28	WOS:000248494400050
J	Rouse, DJ; Caritis, SN; Peaceman, AM; Sciscione, A; Thom, EA; Spong, CY; Varner, M; Malone, F; Iams, JD; Mercer, BM; Thorp, J; Sorokin, Y; Carpenter, M; Lo, J; Ramin, S; Harper, M; Anderson, G; Andrews, WW; Northen, A; Sheppard, J; Tillinghast, J; Allard, D; Milluzzi, C; Heggie, C; Ehrenberg, H; Stetzer, B; Merlino, A; Berkowitz, R; Bousleiman, S; South, S; Paley, L; Carmona, V; Wapner, R; Hoffman, M; Talucci, M; Wilson, S; Tocci, C; Lake, M; Boggess, K; Dorman, K; Timlin, S; Grobman, W; Mallett, G; Dinsmoor, M; Simon, P; Huntley, M; Ramos, M; Johnson, F; Landon, M; Latimer, C; Simhan, H; Cotroneo, M; Daugherty, E; Soebbing-Cross, D; Martinez, J; Glenn-Cole, B; Gilstrap, L; Leveno, K; Moseley, L; Anderson, K; Porter, F; Jolley, C; Quinn, S; Guzman, A; Meis, P; Swain, M; Johnson, K; Lanier, K; Leftwich, C; Norman, G; Sudz, C; Blackwell, S; Momirova, V; Braga, A; Cardenas, E; Leuchtenburg, L; Pagliaro, S				Rouse, Dwight J.; Caritis, Steve N.; Peaceman, Alan M.; Sciscione, Anthony; Thom, Elizabeth A.; Spong, Catherine Y.; Varner, Michael; Malone, Fergal; Iams, Jay D.; Mercer, Brian M.; Thorp, John; Sorokin, Yoram; Carpenter, Marshall; Lo, Julie; Ramin, Susan; Harper, Margaret; Anderson, Garland; Andrews, W. W.; Northen, A.; Sheppard, J.; Tillinghast, J.; Allard, D.; Milluzzi, C.; Heggie, C.; Ehrenberg, H.; Stetzer, B.; Merlino, A.; Berkowitz, R.; Bousleiman, S.; South, S.; Paley, L.; Carmona, V.; Wapner, R.; Hoffman, M.; Talucci, M.; Wilson, S.; Tocci, C.; Lake, M.; Boggess, K.; Dorman, K.; Timlin, S.; Grobman, W.; Mallett, G.; Dinsmoor, M.; Simon, P.; Huntley, M.; Ramos, M.; Johnson, F.; Landon, M.; Latimer, C.; Simhan, H.; Cotroneo, M.; Daugherty, E.; Soebbing-Cross, D.; Martinez, J.; Glenn-Cole, B.; Gilstrap, L.; Leveno, K.; Moseley, L.; Anderson, K.; Porter, F.; Jolley, C.; Quinn, S.; Guzman, A.; Meis, P.; Swain, M.; Johnson, K.; Lanier, K.; Leftwich, C.; Norman, G.; Sudz, C.; Blackwell, S.; Momirova, V.; Braga, A.; Cardenas, E.; Leuchtenburg, L.; Pagliaro, S.		Natl Inst Child Hlth Human Dev Mat	A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRETERM BIRTH; WOMEN; RISK; PROGESTERONE	Background: In singleton gestations, 17 alpha-hydroxyprogesterone caproate (17P) has been shown to reduce the rate of recurrent preterm birth. This study was undertaken to evaluate whether 17P would reduce the rate of preterm birth in twin gestations. Methods: We performed a randomized, double-blind, placebo-controlled trial in 14 centers. Healthy women with twin gestations were assigned to weekly intramuscular injections of 250 mg of 17P or matching placebo, starting at 16 to 20 weeks of gestation and ending at 35 weeks. The primary study outcome was delivery or fetal death before 35 weeks of gestation. Results: Six hundred sixty-one women were randomly assigned to treatment. Baseline demographic data were similar in the two study groups. Six women were lost to follow-up; data from 655 were analyzed (325 in the 17P group and 330 in the placebo group). Delivery or fetal death before 35 weeks occurred in 41.5% of pregnancies in the 17P group and 37.3% of those in the placebo group (relative risk, 1.1; 95% confidence interval [CI], 0.9 to 1.3). The rate of the prespecified composite outcome of serious adverse fetal or neonatal events was 20.2% in the 17P group and 18.0% in the placebo group (relative risk, 1.1; 95% CI, 0.9 to 1.5). Side effects of the injections were frequent in both groups, occurring in 65.9% and 64.4% of subjects, respectively (P=0.69), but were generally mild and limited to the injection site. Conclusions: Treatment with 17 alpha-hydroxyprogesterone caproate did not reduce the rate of preterm birth in women with twin gestations. (ClinicalTrials.gov number, NCT00099164.).	Univ Alabama Birmingham, Dept Obstet & Gynecol, Ctr Womens Reprod Hlth, Birmingham, AL 35249 USA; Univ Pittsburgh, Pittsburgh, PA USA; Northwestern Univ, Chicago, IL 60611 USA; Drexel Univ, Philadelphia, PA 19104 USA; George Washington Univ, Ctr Biostat, Washington, DC USA; NICHHD, Bethesda, MD 20892 USA; Univ Utah, Salt Lake City, UT USA; Columbia Univ, New York, NY USA; Ohio State Univ, Columbus, OH 43210 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ N Carolina, Chapel Hill, NC USA; Wayne State Univ, Detroit, MI USA; Brown Univ, Providence, RI 02912 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Univ Texas, Houston, TX USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Univ Texas, Med Branch, Galveston, TX 77550 USA	University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Drexel University; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Columbia University; University System of Ohio; Ohio State University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; Wayne State University; Brown University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; Wake Forest University; University of Texas System; University of Texas Medical Branch Galveston	Rouse, DJ (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Ctr Womens Reprod Hlth, 619 19th St S, Birmingham, AL 35249 USA.	drouse@uab.edu	Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973; caritis, steve/0000-0002-2169-0712; Peaceman, Alan/0000-0002-4515-4850	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NICHD NIH HHS [HD27915, HD27917, HD40544, HD40545, HD40512, HD27860, HD34136, HD40485, HD40560, HD27869, HD21410, HD34116, HD36801, HD40500, HD34208] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD027915, U10HD027869, U10HD027915, UG1HD034208, U10HD040512, U10HD034208, UG1HD040544, UG1HD027869, U10HD027917, U10HD040485, UG1HD040545, U10HD040500, U10HD036801, U10HD040545, U10HD021410, UG1HD040512, UG1HD034116, U10HD034116, UG1HD040560, U10HD040544, UG1HD040485, U10HD040560, UG1HD040500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027860, U01HD021410, U01HD036801, U10HD034136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1047, DOI 10.1016/S0002-9378(96)80051-2; HARTIKAINENSORRI AL, 1980, OBSTET GYNECOL, V56, P692; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mackenzie R, 2006, AM J OBSTET GYNECOL, V194, P1234, DOI 10.1016/j.ajog.2005.06.049; MARTIN JA, 2006, NATL STAT REPORTS, V55; MATHEWS TJ, 2006, NAT VITAL STAT REPOR, V54; Meis PJ, 2003, NEW ENGL J MED, V349, P1087; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; WEI LJ, 1989, CONTROL CLIN TRIALS, V10, P127	15	261	269	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					454	461		10.1056/NEJMoa070641	http://dx.doi.org/10.1056/NEJMoa070641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671253				2022-12-28	WOS:000248436300006
J	Ahmed, AT				Ahmed, Ameena T.			Bearing witness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ameena.t.ahmed@gmail.com						*HUM RIGHTS WATCH, 1992, ENDL TORM 1991 UPR I	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					494	495		10.1001/jama.298.5.494	http://dx.doi.org/10.1001/jama.298.5.494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666663				2022-12-28	WOS:000248438100001
J	Daum, RS				Daum, Robert S.			Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANTON-VALENTINE LEUKOCIDIN; NASAL CARRIAGE; NECROTIZING PNEUMONIA; CLINDAMYCIN TREATMENT; TREATMENT FAILURE; UNITED-STATES; RISK-FACTORS; CHILDREN; ENDOCARDITIS; COLONIZATION		Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago	Daum, RS (corresponding author), Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA.				NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000384, R01CI000373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067584, R01AI040481] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01AI067584, R01AI40481] Funding Source: Medline; PHS HHS [R01CCR 523379] Funding Source: Medline; NCPDCID CDC HHS [R01CI000373, U01-CI000384] Funding Source: Medline	NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NCPDCID CDC HHS		Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Aiello AE, 2006, LANCET INFECT DIS, V6, P335, DOI 10.1016/S1473-3099(06)70491-1; Ben Mansour EH, 2003, EUR J CLIN MICROBIOL, V22, P372, DOI 10.1007/s10096-003-0959-6; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P6223, DOI 10.1128/JCM.43.12.6223.2005; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Castrodale L J, 2004, Alaska Med, V46, P88; *CDCP, VISA VRSA VANC INT R; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; *CLIN LAB STAND I, 2007, M100S17 CLIN LAB STA, P52; Corne P, 2005, SCAND J INFECT DIS, V37, P946, DOI 10.1080/00365540500263110; Crawford SE, 2007, EMERG INFECT, V7, P153; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dietrich DW, 2004, PEDIATRICS, V113, pE347, DOI 10.1542/peds.113.4.e347; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Frank AL, 2002, PEDIATR INFECT DIS J, V21, P530, DOI 10.1097/00006454-200206000-00010; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gentry DR, 2007, ANTIMICROB AGENTS CH, V51, P2048, DOI 10.1128/AAC.01066-06; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; GOLAN Y, 2006, 44 ANN M INF DIS SOC, pLB11; Gonzalez BE, 2006, PEDIATRICS, V117, P1673, DOI 10.1542/peds.2005-2009; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Iyer S, 2004, J AM ACAD DERMATOL, V50, P854, DOI 10.1016/j.jaad.2003.12.043; Jones RN, 2006, DIAGN MICR INFEC DIS, V54, P63, DOI 10.1016/j.diagmicrobio.2005.08.009; KAPADIA M, 2005, 45 INT C ANT AG CHEM; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kravitz GR, 2005, CLIN INFECT DIS, V40, P941, DOI 10.1086/428573; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lee NE, 2005, CLIN INFECT DIS, V41, P135; Lee NE, 2005, CLIN INFECT DIS, V40, P1529, DOI 10.1086/429827; LEONARD FC, IN PRESS VET J; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; MARKOWITZ N, 1992, ANN INTERN MED, V117, P390, DOI 10.7326/0003-4819-117-5-390; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2007, CLIN INFECT DIS, V44, P471, DOI 10.1086/511033; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Moore MR, 2003, ANTIMICROB AGENTS CH, V47, P1262, DOI 10.1128/AAC.47.4.1262-1266.2003; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Peeters MJ, 2005, AM J MED SCI, V330, P102, DOI 10.1097/00000441-200508000-00007; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Ruhe JJ, 2005, CLIN INFECT DIS, V40, P1429, DOI 10.1086/429628; Shahin R, 1999, ARCH PEDIAT ADOL MED, V153, P864, DOI 10.1001/archpedi.153.8.864; Silverman JA, 2005, J INFECT DIS, V191, P2149, DOI 10.1086/430352; Skiest DJ, 2007, J INFECTION, V54, P427, DOI 10.1016/j.jinf.2006.09.012; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; STRAUSBAUGH LJ, 1992, INFECT CONT HOSP EP, V13, P151, DOI 10.1086/646499; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang GQ, 2006, J CLIN MICROBIOL, V44, P3883, DOI 10.1128/JCM.01388-06; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Young DM, 2004, ARCH SURG-CHICAGO, V139, P947, DOI 10.1001/archsurg.139.9.947	68	305	310	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					380	390		10.1056/NEJMcp070747	http://dx.doi.org/10.1056/NEJMcp070747			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652653				2022-12-28	WOS:000248283500009
J	Lizarralde, D; Axen, GJ; Brown, HE; Fletcher, JM; Gonzalez-Fernandez, A; Harding, AJ; Holbrook, WS; Kent, GM; Paramo, P; Sutherland, F; Umhoefer, PJ				Lizarralde, Daniel; Axen, Gary J.; Brown, Hillary E.; Fletcher, John M.; Gonzalez-Fernandez, Antonio; Harding, Alistair J.; Holbrook, W. Steven; Kent, Graham M.; Paramo, Pedro; Sutherland, Fiona; Umhoefer, Paul J.			Variation in styles of rifting in the Gulf of California	NATURE			English	Article							PLATE; EXTENSION; EVOLUTION; MOTION	Constraints on the structure of rifted continental margins and the magmatism resulting from such rifting can help refine our understanding of the strength of the lithosphere, the state of the underlying mantle and the transition from rifting to seafloor spreading. An important structural classification of rifts is by width(1), with narrow rifts thought to form as necking instabilities(2) ( where extension rates outpace thermal diffusion(3)) and wide rifts thought to require a mechanism to inhibit localization, such as lower-crustal flow in high heat-flow settings(1,4). Observations of the magmatism that results from rifting range from volcanic margins with two to three times the magmatism predicted from melting models(5) to non-volcanic margins with almost no rift or post-rift magmatism. Such variations in magmatic activity are commonly attributed to variations in mantle temperature. Here we describe results from the PESCADOR seismic experiment in the southern Gulf of California and present crustal-scale images across three rift segments. Over short lateral distances, we observe large differences in rifting style and magmatism - from wide rifting with minor synchronous magmatism to narrow rifting in magmatically robust segments. But many of the factors believed to control structural evolution and magmatism during rifting ( extension rate, mantle potential temperature and heat flow) tend to vary over larger length scales. We conclude instead that mantle depletion, rather than low mantle temperature, accounts for the observed wide, magma-poor margins, and that mantle fertility and possibly sedimentary insulation, rather than high mantle temperature, account for the observed robust rift and post-rift magmatism.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Ctr Invest Cient & Educ Ensenada, Dept Geol, Ensenada 22860, Baja California, Mexico; Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92037 USA; No Arizona Univ, Dept Geol, Flagstaff, AZ 86011 USA; BP Explorat Operating Co Ltd, Sunbury On Thames TW16 7LN, Middx, England	Woods Hole Oceanographic Institution; New Mexico Institute of Mining Technology; University of Wyoming; University of California System; University of California San Diego; Scripps Institution of Oceanography; Northern Arizona University; BP	Lizarralde, D (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	danl@whoi.edu	Holbrook, Steven/G-9800-2011; Gonzalez-Fernandez, Antonio/J-5032-2016	Holbrook, Steven/0000-0003-0065-8841; Gonzalez-Fernandez, Antonio/0000-0002-0910-8240; Lizarralde, Daniel/0000-0001-6152-6039; Fletcher, John M./0000-0003-2473-1740				Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; BATIZA R, 1978, GEOL SOC AM BULL, V89, P1309, DOI 10.1130/0016-7606(1978)89<1309:GPAGOI>2.0.CO;2; BOWN JW, 1995, J GEOPHYS RES-SOL EA, V100, P18011, DOI 10.1029/94JB01478; BRAUN J, 1987, MEM CAN SOC PET GEOL, V12, P241; BRWON HE, 2006, EOS S, V87; Buck WR, 2006, GEOL SOC SPEC PUBL, V259, P43, DOI 10.1144/GSL.SP.2006.259.01.05; Buck WR, 1999, PHILOS T R SOC A, V357, P671, DOI 10.1098/rsta.1999.0348; Castillo PR, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000666; DeMets C, 1999, GEOPHYS RES LETT, V26, P1921, DOI 10.1029/1999GL900405; EINSELE G, 1980, NATURE, V283, P441, DOI 10.1038/283441a0; ENGLAND P, 1983, J GEOPHYS RES, V88, P1145, DOI 10.1029/JB088iB02p01145; Ferrari Luca, 2005, Bol. Soc. Geol. Mex, V57, P343, DOI 10.18268/bsgm2005v57n3a5; Gonzalez-Fernandez A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2003JB002941; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hopper JR, 1996, J GEOPHYS RES-SOL EA, V101, P20175, DOI 10.1029/96JB01644; Humphreys E, 2003, INT GEOL REV, V45, P575, DOI 10.2747/0020-6814.45.7.575; Johnson HP, 2003, EARTH PLANET SC LETT, V216, P565, DOI 10.1016/S0012-821X(03)00545-4; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3345, DOI 10.1130/0016-7606(1972)83[3345:BMAAPT]2.0.CO;2; Lonsdale P., 1989, E PACIFIC OCEAN HAWA, VN, P499, DOI [DOI 10.1130/DNAG-GNA-N.499, 10.1130/DNAG-GNA-N.499]; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MENARD HW, 1978, J GEOL, V86, P99, DOI 10.1086/649658; Michaud F, 2006, GEOLOGY, V34, P13, DOI 10.1130/G22050.1; Oskin M, 2001, GEOLOGY, V29, P459, DOI 10.1130/0091-7613(2001)029<0459:RLOPNA>2.0.CO;2; PARAMO P, 2006, THESIS U WYOMING; Phillips R. P., 1964, MARINE GEOLOGY GULF, V3, P90; STOCK JM, 1994, TECTONICS, V13, P1472, DOI 10.1029/94TC01808; Sutherland, 2006, THESIS U CALIFORNIA; WHITE RS, 1992, J GEOPHYS RES-SOL EA, V97, P19683, DOI 10.1029/92JB01749; ZELT CA, 1992, GEOPHYS J INT, V108, P16, DOI 10.1111/j.1365-246X.1992.tb00836.x	29	221	224	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					466	469		10.1038/nature06035	http://dx.doi.org/10.1038/nature06035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653189	Green Submitted			2022-12-28	WOS:000248302700045
J	Pieters, R; Schrappe, M; De Lorenzo, P; Hann, I; De Rossi, G; Felice, M; Hovi, L; LeBlanc, T; Szczepanski, T; Ferster, A; Janka, G; Rubnitz, J; Silverman, L; Stary, J; Campbell, M; Li, CK; Mann, G; Suppiah, R; Biondi, A; Vora, A; Valsecchi, MG				Pieters, Rob; Schrappe, Martin; De Lorenzo, Paola; Hann, Ian; De Rossi, Giulio; Felice, Maria; Hovi, Liisa; LeBlanc, Thierry; Szczepanski, Tomasz; Ferster, Alice; Janka, Gritta; Rubnitz, Jeffrey; Silverman, Lewis; Stary, Jan; Campbell, Myriam; Li, Chi-Kong; Mann, Georg; Suppiah, Ram; Biondi, Andrea; Vora, Ajay; Valsecchi, Maria Grazia			A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial	LANCET			English	Article							MLL GENE; CYTOSINE-ARABINOSIDE; PROGNOSTIC-FACTORS; CHEMOTHERAPY; THERAPY; REARRANGEMENTS; EXPERIENCE; SURVIVAL	Background Acute lymphoblastic leukaemia in infants younger than 1 year is rare, and infants with the disease have worse outcomes than do older children. We initiated an international study to investigate the effects of a new hybrid treatment protocol with elements designed to treat both acute lymphoblastic: leukaemia and acute myeloid leukaemia, and to identify any prognostic factors for outcome in infants. We also did a randomised trial to establish the value of a late intensification course. Methods Patients aged 0-12 months were enrolled by 17 study groups in 22 countries between 1999 and 2005. Eligible patients were stratified for risk according to their peripheral blood response to a 7-day prednisone prophase, and then given a hybrid regimen based on the standard protocol for acute lymphoblastic leukaemia, with some elements designed for treatment of acute myeloid leukaemia. Before the maintenance phase, a subset of patients in complete remission were randomly assigned to receive either standard treatment or a more intensive chemotherapy course with high-dose cytarabine and methotrexate. The primary outcomes were event-free survival (EFS) for the initial cohort of patients and disease-free survival (DFS) for the patients randomly assigned to a treatment group. Data were analysed on an intention-to-treat basis. This trial was registered with ClinicalTrials.gov, number NCT 00015873, and at controlled-trials.com, number ISRCTN24251487. Findings In the 482 enrolled patients who underwent hybrid treatment, 260 (58%) were in complete remission at a median follow-up of 38 (range 1-78) months, and EFS at 4 years was 47.0% (SE 2.6, 95% CI 41.9-52.1). Of 445 patients in complete remission after 5 weeks of induction treatment, 191 were randomised: 95 patients to receive a late intensification course, and 96 to a control group. At a median follow-up of 42 (range 1-73) months, 60 patients in the treatment group and 57 controls were disease-free. DFS at 4 years did not differ between the two groups (60.9% [SE 5.2] for treatment group vs 57.0% [5.5] for controls; p=0.81). During the intensification phase, of 71 patients randomly assigned to the treatment group, and for whom toxicity data were available, 35 (49%) had infections, 21 (30%) patients had mucositis, 22 (31%) patients had toxic effects on the liver, and 2 (3%) had neurotoxicity. All types of rearrangements in the (mixed lineage leukaemia) MLL gene, very high white blood cell count, age of younger than 6 months, and a poor response to the prednisone prophase were independently associated with inferior outcomes. Interpretation Patients treated with our hybrid protocol, and especially those who responded poorly to prednisone, had higher EFS than most reported outcomes for treatment of infant ALL. Delayed intensification of chemotherapy did not benefit patients.	Sophia Childrens Univ Hosp, Erasmus MC, Dept Paediat Oncol & Haematol, NL-3015 GJ Rotterdam, Netherlands; Univ Med Ctr Schleswig Holstein, Kiel, Germany; Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; Univ Milano Bicocca, San Gerardo Hosp, Monza, Italy; Children Hosp Bambino Gesu, Rome, Italy; Argentina Hosp Pediat, Buenos Aires, DF, Argentina; Univ Helsinki, Helsinki, Finland; Hop St Louis, Paris, France; Med Univ Silesia, Zabrze, Poland; Hop Univ Enfants Reine Fabiola, Brussels, Belgium; Univ Hosp Hamburg Eppendorf, Hamburg, Germany; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Charles Univ Prague, Sch Med 2, Prague, Czech Republic; Univ Hosp Motol, Prague, Czech Republic; Hosp Roberto del Rio, Santiago, Chile; Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; St Anna Childrens Hosp, A-1090 Vienna, Austria; Womens & Childrens Hosp, Adelaide, SA, Australia	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Milano-Bicocca; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Bambino Gesu; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University Silesia; University of Hamburg; University Medical Center Hamburg-Eppendorf; St Jude Children's Research Hospital; Harvard University; Dana-Farber Cancer Institute; Charles University Prague; Motol University Hospital; Universidad de Chile; Chinese University of Hong Kong; Prince of Wales Hospital; Saint Anna Children's Hospital; Womens & Childrens Hospital Australia	Pieters, R (corresponding author), Sophia Childrens Univ Hosp, Erasmus MC, Dept Paediat Oncol & Haematol, Dr Molewaterpl 60, NL-3015 GJ Rotterdam, Netherlands.	rob.picters@erasmusmc.nl	Li, Chi-kong/J-8456-2013; Schrappe, Martin/A-8109-2010; Schrappe, Martin/ABA-6144-2020; Valsecchi, Maria Grazia/K-8891-2016; Stary, Jan/AAB-9635-2020; Biondi, Andrea/AAX-1865-2020; Rubnitz, Jeffrey E/N-2619-2018; Biondi, Andrea/K-9997-2016	Li, Chi-kong/0000-0002-2810-5758; Valsecchi, Maria Grazia/0000-0001-5574-3504; Biondi, Andrea/0000-0002-6757-6173; Rubnitz, Jeffrey E/0000-0001-9885-3527; Szczepanski, Tomasz/0000-0001-5336-261X	Medical Research Council [G0300130] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Biondi A, 2006, HAEMATOLOGICA, V91, P534; Chessells JM, 2002, BRIT J HAEMATOL, V117, P306, DOI 10.1046/j.1365-2141.2002.03442.x; Creutzig U, 2005, LEUKEMIA, V19, P2030, DOI 10.1038/sj.leu.2403920; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Fayers PM, 1997, STAT MED, V16, P1413, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U; FERSTER A, 1994, BRIT J HAEMATOL, V86, P284, DOI 10.1111/j.1365-2141.1994.tb04727.x; Frankel LS, 1997, J PEDIAT HEMATOL ONC, V19, P35, DOI 10.1097/00043426-199701000-00005; Heerema NA, 1999, LEUKEMIA, V13, P679, DOI 10.1038/sj.leu.2401413; Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Lauer SJ, 1998, J PEDIAT HEMATOL ONC, V20, P229, DOI 10.1097/00043426-199805000-00008; Leung W, 2000, LEUKEMIA, V14, P1185, DOI 10.1038/sj.leu.2401818; Ludwig WD, 1998, BLOOD, V92, P1898; Marco F, 2000, J CLIN ONCOL, V18, P3256, DOI 10.1200/JCO.2000.18.18.3256; MARUBINI E, 1995, ANAL SURVIVAL DATA C, P171; Nagayama J, 2006, BLOOD, V107, P4663, DOI 10.1182/blood-2005-11-4728; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Pieters R., 2003, CONTEMPORARY CLIN NE, P61; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reaman GH, 1999, J CLIN ONCOL, V17, P445, DOI 10.1200/JCO.1999.17.2.445; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Silverman LB, 1997, CANCER-AM CANCER SOC, V80, P2285; Stam RW, 2006, BRIT J HAEMATOL, V132, P539, DOI 10.1111/j.1365-2141.2005.05909.x; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; WHITE JC, 1987, J CLIN INVEST, V79, P380, DOI 10.1172/JCI112823; WILEY JS, 1982, J CLIN INVEST, V69, P479, DOI 10.1172/JCI110472	31	411	434	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					240	250		10.1016/S0140-6736(07)61126-X	http://dx.doi.org/10.1016/S0140-6736(07)61126-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658395				2022-12-28	WOS:000248347900028
J	Denchi, EL; de Lange, T				Denchi, Eros Lazzerini; de lange, Titia			Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1	NATURE			English	Article							CELL-CYCLE ARREST; DNA-DAMAGE; DYSFUNCTIONAL TELOMERES; HOMOLOGOUS RECOMBINATION; ATAXIA-TELANGIECTASIA; CHECKPOINT; COMPLEX; END; MAINTENANCE; SENESCENCE	When telomeres are rendered dysfunctional through replicative attrition of the telomeric DNA or by inhibition of shelterin(1), cells show the hallmarks of ataxia telangiectasia mutated (ATM) kinase signalling(2-4). In addition, dysfunctional telomeres might induce an ATM-independent pathway, such as ataxia telangiectasia and Rad3-related (ATR) kinase signalling, as indicated by the phosphorylation of the ATR target CHK1 in senescent cells(2,5) and the response of ATM-deficient cells to telomere dysfunction(6,7). However, because telomere attrition is accompanied by secondary DNA damage, it has remained unclear whether there is an ATM-independent pathway for the detection of damaged telomeres. Here we show that damaged mammalian telomeres can activate both ATM and ATR and address the mechanism by which the shelterin complex represses these two important DNA damage signalling pathways. We analysed the telomere damage response on depletion of either or both of the shelterin proteins telomeric repeat binding factor 2 (TRF2) and protection of telomeres 1 (POT1) from cells lacking ATM and/or ATR kinase signalling. The data indicate that TRF2 and POT1 act independently to repress these two DNA damage response pathways. TRF2 represses ATM, whereas POT1 prevents activation of ATR. Unexpectedly, we found that either ATM or ATR signalling is required for efficient non-homologous end-joining of dysfunctional telomeres. The results reveal how mammalian telomeres use multiple mechanisms to avoid DNA damage surveillance and provide an explanation for the induction of replicative senescence and genome instability by shortened telomeres.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	Denchi, Eros Lazzerini/AAD-8208-2020; de Lange, Titia/B-8263-2011; lazzerini denchi, eros/F-7913-2010	de Lange, Titia/0000-0002-9267-367X; lazzerini denchi, eros/0000-0001-5378-4644				Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; HOCKEMEYER D, 2007, NATURE STRUCT MOL BI; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Qi L, 2003, CANCER RES, V63, P8188; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	611	641	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1068	1071		10.1038/nature06065	http://dx.doi.org/10.1038/nature06065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17687332				2022-12-28	WOS:000249097600042
J	Dunckley, T; Huentelman, MJ; Craig, DW; Pearson, JV; Szelinger, S; Joshipura, K; Halperin, RF; Stamper, C; Jensen, KR; Letizia, D; Hesterlee, SE; Pestronk, A; Levine, T; Bertorini, T; Graves, MC; Mozaffar, T; Jackson, CE; Bosch, P; McVey, A; Dick, A; Barohn, R; Lomen-Hoerth, C; Rosenfeld, J; O'Connor, DT; Zhang, KX; Crook, R; Ryberg, H; Hutton, M; Katz, J; Simpson, EP; Mitsumoto, H; Bowser, R; Miller, RG; Appel, SH; Stephan, DA				Dunckley, Travis; Huentelman, Matthew J.; Craig, David W.; Pearson, John V.; Szelinger, Szabolcs; Joshipura, Keta; Halperin, Rebecca F.; Stamper, Chelsea; Jensen, Kendall R.; Letizia, David; Hesterlee, Sharon E.; Pestronk, Alan; Levine, Todd; Bertorini, Tulio; Graves, Michael C.; Mozaffar, Tahseen; Jackson, Carlayne E.; Bosch, Peter; McVey, April; Dick, Arthur; Barohn, Richard; Lomen-Hoerth, Catherine; Rosenfeld, Jeffrey; O'Connor, Daniel T.; Zhang, Kuixing; Crook, Richard; Ryberg, Henrik; Hutton, Michael; Katz, Jonathan; Simpson, Ericka P.; Mitsumoto, Hiroshi; Bowser, Robert; Miller, Robert G.; Appel, Stanley H.; Stephan, Dietrich A.			Whole-genome analysis of sporadic amyotrophic lateral sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOTOR-NEURON DEGENERATION	Background: Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have the sporadic form, which may be caused by the interaction of multiple environmental factors and previously unknown genes. Methods: We performed a genomewide association analysis using 766,955 single-nucleotide polymorphisms (SNPs) found in 386 white patients with sporadic ALS and 542 neurologically normal white controls (the discovery series). Associations of SNPs with sporadic ALS were confirmed in two independent replication populations: replication series 1, with 766 case patients with the disease and 750 neurologically normal controls, and replication series 2, with 135 case patients and 275 controls. Results: We identified 10 genetic loci that are significantly associated (P<0.05) with sporadic ALS in three independent series of case patients and controls and an additional 41 loci that had significant associations in two of the three series. The most significant association with disease in white case patients as compared with controls was found for a SNP near an uncharacterized gene known as FLJ10986 (P=3.0 x 10(sup -4); odds ratio for having the genotype in patients vs. controls, 1.35; 95% confidence interval, 1.13 to 1.62). The FLJ10986 protein was found to be expressed in the spinal cord and cerebrospinal fluid of patients and of controls. Specific SNPs seem to be associated with sex, age at onset, and site of onset of sporadic ALS. Conclusions: Variants of FLJ10986 may confer susceptibility to sporadic ALS. FLJ10986 and 50 other candidate loci warrant further investigation for their potential role in conferring susceptibility to the disease.	Translat Genom Res Inst, Phoenix, AZ 85004 USA; Muscular Dystrophy Assoc, Tucson, AZ USA; Washington Univ, Sch Med, St Louis, MO USA; Phoenix Neurol Assoc, Phoenix, AZ USA; Univ Tennessee, Memphis, TN USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif Irvine, Irvine, CA USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Mayo Clin, Scottsdale, AZ USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Carolinas Med Ctr, Charlotte, NC 28203 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Mayo Clin, Coll Med, Jacksonville, FL 32224 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Calif Pacific Med Ctr, San Francisco, CA USA; Methodist Neurol Inst, Houston, TX USA; Columbia Univ, Med Ctr, New York, NY USA	Translational Genomics Research Institute; Washington University (WUSTL); University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; Mayo Clinic; Mayo Clinic Phoenix; University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; Carolinas Medical Center; University of California System; University of California San Diego; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Pacific Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Columbia University	Stephan, DA (corresponding author), Translat Genom Res Inst, 445 N 5th St, Phoenix, AZ 85004 USA.	dstephan@tgen.org	Craig, David Wesley/K-6961-2019; Pearson, John/AAT-4211-2020; Mozaffar, Tahseen/AAE-6971-2020; Ryberg, Henrik/AFT-8978-2022; Pearson, John V/F-2249-2011	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Ryberg, Henrik/0000-0002-2652-6612				Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Frey D, 2000, J NEUROSCI, V20, P2534; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Wang W, 2004, J BIOL CHEM, V279, P53491, DOI 10.1074/jbc.M410370200; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103	16	190	199	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					775	788		10.1056/NEJMoa070174	http://dx.doi.org/10.1056/NEJMoa070174			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202MU	17671248	Bronze			2022-12-28	WOS:000248906700006
J	Xu, XD; Sun, B; Berman, PR; Steel, DG; Bracker, AS; Gammon, D; Sham, LJ				Xu, Xiaodong; Sun, Bo; Berman, Paul R.; Steel, Duncan G.; Bracker, Allan S.; Gammon, Dan; Sham, L. J.			Coherent optical spectroscopy of a strongly driven quantum dot	SCIENCE			English	Article							SYSTEM; ABSORPTION; RESONANCE; EMISSION; CAVITY	Quantum dots are typically formed from large groupings of atoms and thus may be expected to have appreciable many-body behavior under intense optical excitation. Nonetheless, they are known to exhibit discrete energy levels due to quantum confinement effects. We show that, like single-atom or single-molecule two- and three-level quantum systems, single semiconductor quantum dots can also exhibit interference phenomena when driven simultaneously by two optical fields. Probe absorption spectra are obtained that exhibit Autler-Townes splitting when the optical fields drive coupled transitions and complex Mollow-related structure, including gain without population inversion, when they drive the same transition. Our results open the way for the demonstration of numerous quantum level-based applications, such as quantum dot lasers, optical modulators, and quantum logic devices.	Univ Michigan, Harrison M Randall Lab Phys, Ann Arbor, MI 48109 USA; USN, Res Lab, Washington, DC 20375 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; United States Department of Defense; United States Navy; Naval Research Laboratory; University of California System; University of California San Diego	Steel, DG (corresponding author), Univ Michigan, Harrison M Randall Lab Phys, Ann Arbor, MI 48109 USA.	dst@umich.edu	xu, xiaodong/C-4316-2008	Sham, Lu/0000-0001-5718-2077				AUTLER SH, 1955, PHYS REV, V100, P703, DOI 10.1103/PhysRev.100.703; AXT VM, 1994, Z PHYS B CON MAT, V93, P195, DOI 10.1007/BF01316963; BAKLANOV EV, 1972, SOV PHYS JETP-USSR, V34, P490; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Carter SG, 2005, SCIENCE, V310, P651, DOI 10.1126/science.1116195; DUPONTROC J, 1998, ATOM PHOTON INTERACT; Gammon D, 2002, PHYS TODAY, V55, P36, DOI 10.1063/1.1522165; Gammon D, 1996, PHYS REV LETT, V76, P3005, DOI 10.1103/PhysRevLett.76.3005; GRUNEISEN MT, 1988, J OPT SOC AM B, V5, P123, DOI 10.1364/JOSAB.5.000123; HAROCHE S, 1972, PHYS REV A, V6, P1280, DOI 10.1103/PhysRevA.6.1280; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hogele A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.217401; Htoon H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.087401; Kamada H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.246401; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MEYSTRE P, 1998, ELEMENTS QUANTUM OPT, pCH9; Mollow B. R., 1969, Physical Review, V188, P1969, DOI 10.1103/PhysRev.188.1969; MOLLOW BR, 1972, PHYS REV A, V5, P2217, DOI 10.1103/PhysRevA.5.2217; NING L, 1991, PHYS REV A, V44, P5965, DOI 10.1103/PhysRevA.44.5965; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; SANCHEZMONDRAGON JJ, 1983, PHYS REV LETT, V51, P550, DOI 10.1103/PhysRevLett.51.550; Scully M.O., 1997, QUANTUM OPT; SHAM LJ, 1966, PHYS REV, V144, P708, DOI 10.1103/PhysRev.144.708; Stievater TH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133603; Thranhardt A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035327; WU FY, 1977, PHYS REV LETT, V38, P1077, DOI 10.1103/PhysRevLett.38.1077; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	29	297	303	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					929	932		10.1126/science.1142979	http://dx.doi.org/10.1126/science.1142979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702938				2022-12-28	WOS:000248780200034
J	Trampuz, A; Piper, KE; Jacobson, MJ; Hanssen, AD; Unni, KK; Osmon, DR; Mandrekar, JN; Cockerill, FR; Steckelberg, JM; Greenleaf, JF; Patel, R				Trampuz, Andrej; Piper, Kerryl E.; Jacobson, Melissa J.; Hanssen, Arlen D.; Unni, Krishnan K.; Osmon, Douglas R.; Mandrekar, Jayawant N.; Cockerill, Franklin R.; Steckelberg, James M.; Greenleaf, James F.; Patel, Robin			Sonication of removed hip and knee prostheses for diagnosis of infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JOINT INFECTION; REVISION ARTHROPLASTY; SYNOVIAL-FLUID; ULTRASOUND; RISK	Background: Culturing of samples of periprosthetic tissue is the standard method used for the microbiologic diagnosis of prosthetic-joint infection, but this method is neither sensitive nor specific. In prosthetic-joint infection, microorganisms are typically present in a biofilm on the surface of the prosthesis. We hypothesized that culturing of samples obtained from the prosthesis would improve the microbiologic diagnosis of prosthetic-joint infection. Methods: We performed a prospective trial comparing culture of samples obtained by sonication of explanted hip and knee prostheses to dislodge adherent bacteria from the prosthesis with conventional culture of periprosthetic tissue for the microbiologic diagnosis of prosthetic-joint infection among patients undergoing hip or knee revision or resection arthroplasty. Results: We studied 331 patients with total knee prostheses (207 patients) or hip prostheses (124 patients); 252 patients had aseptic failure, and 79 had prosthetic-joint infection. With the use of standardized nonmicrobiologic criteria to define prosthetic-joint infection, the sensitivities of periprosthetic-tissue and sonicate-fluid cultures were 60.8% and 78.5% (P < 0.001), respectively, and the specificities were 99.2% and 98.8%, respectively. Fourteen cases of prosthetic-joint infection were detected by sonicate-fluid culture but not by prosthetic-tissue culture. In patients receiving antimicrobial therapy within 14 days before surgery, the sensitivities of periprosthetic tissue and sonicate-fluid culture were 45.0% and 75.0% (P < 0.001), respectively. Conclusions: In this study, culture of samples obtained by sonication of prostheses was more sensitive than conventional periprosthetic-tissue culture for the microbiologic diagnosis of prosthetic hip and knee infection, especially in patients who had received antimicrobial therapy within 14 days before surgery.	Mayo Clin, Coll Med, Div Infect Dis, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Anat Pathol, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Ultrasound Res Lab, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Coll Med, Div Infect Dis, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Trampuz, Andrej/K-9633-2013					Anguita-Alonso Paloma, 2005, Expert Rev Anti Infect Ther, V3, P797, DOI 10.1586/14787210.3.5.797; Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Bernard L, 2004, SCAND J INFECT DIS, V36, P410, DOI 10.1080/00365540410015240; DEFRANCES DJ, 2005, 359 NAT CTR HLTH STA; Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29; Ensing GT, 2005, J BIOMED MATER RES B, V75B, P1, DOI 10.1002/jbm.b.30140; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hughes JG, 2001, J CLIN MICROBIOL, V39, P4468, DOI 10.1128/JCM.39.12.4468-4471.2001; Lutz MF, 2005, EUR J CLIN MICROBIOL, V24, P739, DOI 10.1007/s10096-005-0040-8; NIH Consensus Statement, 1994, TOT HIP REPL, V12, P1; Pitt WG, 2003, BIOTECHNOL PROGR, V19, P1038, DOI 10.1021/bp0340685; Trampuz A, 2006, J CLIN MICROBIOL, V44, P628, DOI 10.1128/JCM.44.2.628-631.2006; Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473; WOODWARD M, 1999, EPIDEMIOLOGY STUDY S; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	18	876	927	4	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					654	663		10.1056/NEJMoa061588	http://dx.doi.org/10.1056/NEJMoa061588			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699815				2022-12-28	WOS:000248746000005
J	Weis, K				Weis, Karsten			The nuclear pore complex: Oily spaghetti or gummy bear?	CELL			English	Editorial Material							NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOPORINS; TRANSLOCATION	In this issue, Frey and Gorlich (2007) provide new insight into the selective barrier that controls protein traffic through the nuclear pore complex. They show that a single protein domain of the nuclear pore protein Nsp1 can form a hydrogel that allows highly selective access of nuclear transport receptors and their cargos, but rejects other proteins of similar size.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	kweis@berkeley.edu	Weis, Karsten/F-5719-2011	Weis, Karsten/0000-0001-7224-925X	NIGMS NIH HHS [R01 GM058065] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058065] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; FREY S, 2007, CELL; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	12	60	62	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					405	407		10.1016/j.cell.2007.07.029	http://dx.doi.org/10.1016/j.cell.2007.07.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693250	Bronze			2022-12-28	WOS:000249038100008
J	Yang, ZY; Wei, CJ; Kong, WP; Wu, L; Xu, L; Smith, DF; Nabel, GJ				Yang, Zhi-Yong; Wei, Chih-Jen; Kong, Wing-Pui; Wu, Lan; Xu, Ling; Smith, David F.; Nabel, Gary J.			Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity	SCIENCE			English	Article							VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; PANDEMIC INFLUENZA; ESCAPE MUTANTS; A VIRUSES; GLYCOPROTEIN; CORONAVIRUS; SITES; ENTRY	Influenza virus entry is mediated by the receptor binding domain (RBD) of its spike, the hemagglutinin (HA). Adaptation of avian viruses to humans is associated with HA specificity for alpha 2,6- rather than alpha 2,3-linked sialic acid (SA) receptors. Here, we define mutations in influenza A subtype H5N1 (avian) HA that alter its specificity for SA either by decreasing alpha 2,3- or increasing alpha 2,6- SA recognition. RBD mutants were used to develop vaccines and monoclonal antibodies that neutralized new variants. Structure-based modification of HA specificity can guide the development of preemptive vaccines and therapeutic monoclonal antibodies that can be evaluated before the emergence of human-adapted H5N1 strains.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,Mailstop Code MSC-3005,40 Conve, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022; Yang, Ziheng/C-1358-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005003] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ilyushina N, 2004, VIROLOGY, V329, P33, DOI 10.1016/j.virol.2004.08.002; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Laeeq S, 1997, J VIROL, V71, P2600, DOI 10.1128/JVI.71.4.2600-2605.1997; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MURPHY BR, 1996, FIELDS VIROLOGY, P1403; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; PAULSON JC, 1987, METHOD ENZYMOL, V138, P162; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034	24	180	216	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					825	828		10.1126/science.1135165	http://dx.doi.org/10.1126/science.1135165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690300	Green Accepted			2022-12-28	WOS:000248624500047
J	Chini, A; Fonseca, S; Fernandez, G; Adie, B; Chico, JM; Lorenzo, O; Garcia-Casado, G; Lopez-Vidriero, I; Lozano, FM; Ponce, MR; Micol, JL; Solano, R				Chini, Andrea; Fonseca, S.; Fernandez, G.; Adie, B.; Chico, J. M.; Lorenzo, O.; Garcia-Casado, G.; Lopez-Vidriero, I.; Lozano, F. M.; Ponce, M. R.; Micol, J. L.; Solano, R.			The JAZ family of repressors is the missing link in jasmonate signalling	NATURE			English	Article							BOX PROTEIN TIR1; PHYTOTOXIN CORONATINE; REGULATED DEFENSE; METHYL JASMONATE; PLANT-RESPONSES; GENE; ACID; TRANSFORMATION; BIOSYNTHESIS; RESISTANCE	Jasmonates are essential phytohormones for plant development and survival. However, the molecular details of their signalling pathway remain largely unknown. The identification more than a decade ago of COI1 as an F-box protein suggested the existence of a repressor of jasmonate responses that is targeted by the SCFCOI1 complex for proteasome degradation in response to jasmonate. Here we report the identification of JASMONATE-INSENSITIVE 3 (JAI3) and a family of related proteins named JAZ (jasmonate ZIM-domain), in Arabidopsis thaliana. Our results demonstrate that JAI3 and other JAZs are direct targets of the SCFCOI1 E3 ubiquitin ligase and jasmonate treatment induces their proteasome degradation. Moreover, JAI3 negatively regulates the key transcriptional activator of jasmonate responses, MYC2. The JAZ family therefore represents the molecular link between the two previously known steps in the jasmonate pathway. Furthermore, we demonstrate the existence of a regulatory feed-back loop involving MYC2 and JAZ proteins, which provides a mechanistic explanation for the pulsed response to jasmonate and the subsequent desensitization of the cell.	CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma, Madrid 28049, Spain; CSIC, Ctr Nacl Biotecnol, Unidad Genom, Madrid 28049, Spain; Univ Miguel Hernandez, Div Genet, Elche 03202, Spain; Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Solano, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma, Madrid 28049, Spain.	rsolano@cnb.uam.es	Ponce, María Rosa/C-8203-2014; Chini, Andrea/D-1336-2009; Solano, Roberto/O-5908-2017; Micol, José Luis/B-4832-2010; Lorenzo, Oscar/K-8170-2014; Fonseca, Sandra/AAB-3639-2019	Ponce, María Rosa/0000-0003-0770-4230; Solano, Roberto/0000-0001-5459-2417; Micol, José Luis/0000-0002-0396-1750; Lorenzo, Oscar/0000-0001-9523-0789; Fonseca, Sandra/0000-0002-2021-4482; Chini, Andrea/0000-0001-5841-0254				Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; AXEL M, 2004, J PLANT GROWTH REGUL, V23, P170; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chini A, 2005, PLANTA, V221, P597, DOI 10.1007/s00425-005-1499-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; DEMOLE E, 1962, HELV CHIM ACTA, V45, P675, DOI 10.1002/hlca.19620450233; Devoto A, 2003, ANN BOT-LONDON, V92, P329, DOI 10.1093/aob/mcg151; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Farber K, 2003, PHYTOCHEMISTRY, V62, P491, DOI 10.1016/S0031-9422(02)00562-9; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Flescher E, 2005, ANTI-CANCER DRUG, V16, P911, DOI 10.1097/01.cad.0000176501.63680.80; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; LIECHTI R, 2006, SCI STKE, V203, pCM18; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MITA S, 1995, PLANT PHYSIOL, V107, P895, DOI 10.1104/pp.107.3.895; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	46	1550	1674	43	528	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					666	+		10.1038/nature06006	http://dx.doi.org/10.1038/nature06006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17637675				2022-12-28	WOS:000248598000038
J	Sun, YG; Chen, ZF				Sun, Yan-Gang; Chen, Zhou-Feng			A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord	NATURE			English	Article							PROTEINASE-ACTIVATED RECEPTOR; BOMBESIN-LIKE PEPTIDES; SCRATCHING BEHAVIOR; HUMAN SKIN; MICE; PRURITUS; AGONISTS; PATHWAY; BRAIN	Itching, or pruritus, is defined as an unpleasant cutaneous sensation that serves as a physiological self-protective mechanism to prevent the body from being hurt by harmful external agents. Chronic itch represents a significant clinical problem resulting from renal diseases and liver diseases, as well as several serious skin diseases such as atopic dermatitis(1-3). The identity of the itch-specific mediator in the central nervous system, however, remains elusive. Here we describe that the gastrin-releasing peptide receptor (GRPR) plays an important part in mediating itch sensation in the dorsal spinal cord. We found that gastrin-releasing peptide is specifically expressed in a small subset of peptidergic dorsal root ganglion neurons, whereas expression of its receptor GRPR is restricted to lamina I of the dorsal spinal cord. GRPR mutant mice showed comparable thermal, mechanical, inflammatory and neuropathic pain responses relative to wild-type mice. In contrast, induction of scratching behaviour was significantly reduced in GRPR mutant mice in response to pruritogenic stimuli, whereas normal responses were evoked by painful stimuli. Moreover, direct spinal cerebrospinal fluid injection of a GRPR antagonist significantly inhibited scratching behaviour in three independent itch models. These data demonstrate that GRPR is required for mediating the itch sensation rather than pain, at the spinal level. Our results thus indicate that GRPR may represent the first molecule that is dedicated to mediating the itch sensation in the dorsal horn of the spinal cord, and thus may provide a central therapeutic target for antipruritic drug development.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	chenz@wustl.edu						Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; BATTEY J, 1991, TRENDS NEUROSCI, V14, P524, DOI 10.1016/0166-2236(91)90005-F; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; COWAN A, 1985, LIFE SCI, V37, P135, DOI 10.1016/0024-3205(85)90416-3; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; GMEREK DE, 1983, PEPTIDES, V4, P907, DOI 10.1016/0196-9781(83)90089-X; GREAVES MW, 2005, DERMATOL THER, V1, P323; Green AD, 2006, PAIN, V124, P50, DOI 10.1016/j.pain.2006.03.023; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Inan S, 2004, EUR J PHARMACOL, V502, P233, DOI 10.1016/j.ejphar.2004.09.010; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Moody TW, 2004, PEPTIDES, V25, P511, DOI 10.1016/j.peptides.2004.02.012; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; ODONOHUE TL, 1984, J NEUROSCI, V4, P2956; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Roesler R., 2006, CNS & Neurological Disorders-Drug Targets, V5, P197, DOI 10.2174/187152706776359673; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; SOWUNMI A, 1989, LANCET, V2, P213; Stander S, 2006, EUR J PAIN, V10, P473, DOI 10.1016/j.ejpain.2006.03.005; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; WANG LH, 1990, J BIOL CHEM, V265, P15695; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006	30	529	550	7	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					700	U10		10.1038/nature06029	http://dx.doi.org/10.1038/nature06029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17653196				2022-12-28	WOS:000248598000046
J	Kim, SK				Kim, Stuart K.			Cell biology - Proteins that promote long life	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; DAF-16; METABOLISM; DIAPAUSE; GENES; SPAN		Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu			NIA NIH HHS [R01 AG025941] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723	7	0	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					603	604		10.1126/science.1146805	http://dx.doi.org/10.1126/science.1146805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673641				2022-12-28	WOS:000248494400022
J	Reiner, SL; Sallusto, F; Lanzavecchia, A				Reiner, Steven L.; Sallusto, Federica; Lanzavecchia, Antonio			Perspective - Division of labor with a workforce of one: Challenges in specifying effector and memory T cell fate	SCIENCE			English	Editorial Material							DIFFERENTIATION; T(H)1	In the course of the immune response against microbes, naive T cells proliferate and generate varied classes of effector cells, as well as memory cells with distinct properties and functions. Owing to recent technological advances, some of the most imposing questions regarding effector and memory T cell differentiation are now becoming experimentally soluble: How many classes of antigen-specific T cells exist, and how malleable are they in their fate and in their functional state? How might a spectrum of cell fates be imparted to the clonal descendants of a single lymphocyte? Where, when, and how does pathogen-associated information refine the instruction, selection, and direction of newly activated T cells as they perform their tasks in different locations and times? Some surprising new glimpses ahead on these subjects and other yet-unanswered questions are discussed.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Inst Res Biomed, CH-6500 Bellinzona, Switzerland	University of Pennsylvania; Pennsylvania Medicine; Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu; federica.sallusto@irb.unisi.ch; lanzavecchia@irb.unisi.ch						Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714	23	83	84	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					622	625		10.1126/science.1143775	http://dx.doi.org/10.1126/science.1143775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673652				2022-12-28	WOS:000248494400033
J	Christensen, ST; Ott, CM				Christensen, Soren Tvorup; Ott, Carolyn Marie			A ciliary signaling switch	SCIENCE			English	Editorial Material							INTRAFLAGELLAR TRANSPORT; SONIC HEDGEHOG; PRIMARY CILIUM		Univ Copenhagen, Dept Mol Biol, DK-2100 Copenhagen, Denmark; NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	University of Copenhagen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Christensen, ST (corresponding author), Univ Copenhagen, Dept Mol Biol, DK-2100 Copenhagen, Denmark.	stchristensen@aki.ku.dk; ottcarol@mail.nih.gov	Christensen, Søren Tvorup/ABG-6089-2020; Christensen, Søren/N-3049-2014	Christensen, Søren Tvorup/0000-0001-5004-304X; Christensen, Søren/0000-0001-5004-304X				Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005	12	36	37	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					330	331		10.1126/science.1146180	http://dx.doi.org/10.1126/science.1146180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641189				2022-12-28	WOS:000248150200033
J	Malo, JL; Gautrin, D				Malo, Jean-Luc; Gautrin, Denyse			From asthma in the workplace to occupational asthma	LANCET			English	Editorial Material							DIAGNOSIS		Hop Sacre Coeur, Ctr Asthma Workpl, Dept Chest Med, Montreal, PQ H4J 1C5, Canada	Universite de Montreal	Malo, JL (corresponding author), Hop Sacre Coeur, Ctr Asthma Workpl, Dept Chest Med, Montreal, PQ H4J 1C5, Canada.	malojl@meddir.umontreal.ca						Bernstein I. L., 2006, ASTHMA WORKPLACE, V3, P1; Blanc PD, 1999, AM J MED, V107, P580, DOI 10.1016/S0002-9343(99)00307-1; BURGE PS, 1979, THORAX, V34, P317, DOI 10.1136/thx.34.3.317; Gautrin D, 2006, ASTHMA WORKPLACE, P579; Karjalainen A, 2000, AM J IND MED, V37, P451, DOI 10.1002/(SICI)1097-0274(200005)37:5&lt;451::AID-AJIM1&gt;3.0.CO;2-U; Kennedy SM, 2000, OCCUP ENVIRON MED, V57, P635, DOI 10.1136/oem.57.9.635; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Koskela H, 2003, CHEST, V124, P383, DOI 10.1378/chest.124.1.383; Malo JL, 2006, ALLERGY, V61, P1200, DOI 10.1111/j.1398-9995.2006.01198.x; MALO JL, 1990, AM REV RESPIR DIS, V142, P1359, DOI 10.1164/ajrccm/142.6_Pt_1.1359; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; Walusiak J, 2004, ALLERGY, V59, P442, DOI 10.1111/j.1398-9995.2003.00418.x	12	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2007	370	9584					295	297		10.1016/S0140-6736(07)61137-4	http://dx.doi.org/10.1016/S0140-6736(07)61137-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662862				2022-12-28	WOS:000248426100006
J	Fitzmaurice, DA; Hobbs, FDR; Jowett, S; Mant, J; Murray, ET; Holder, R; Raftery, JP; Bryan, S; Davies, M; Lip, GYH; Allan, TF				Fitzmaurice, David A.; Hobbs, F. D. Richard; Jowett, Sue; Mant, Jonathon; Murray, Ellen T.; Holder, Roger; Raftery, J. P.; Bryan, S.; Davies, Michael; Lip, Gregory Y. H.; Allan, T. F.			Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE	Objectives To assess whether screening improves the detection of atrial fibrillation (cluster randomisation) and to compare systematic and opportunistic screening. Design Multicentre cluster randomised controlled trial, with subsidiary trial embedded within the intervention arm. Setting 50 primary care centres in England, with further individual randomisation of patients in the intervention practices. Participants 14 802 patients aged 65 or over in 25 intervention and 25 control practices. Interventions Patients in intervention practices were randomly allocated to systematic screening (invitation for electrocardiography) or opportunistic screening (pulse taking and invitation for electrocardiography if the pulse was irregular). Screening took place over 12 months in each practice from October 2001 to February 2003. No active screening took place in control practices. Main outcome measure Newly identified atrial fibrillation. Results The detection rate of new cases of atrial fibrillation was 1.63% a year in the intervention practices and 1.04% in control practices (difference 0.59%, 95% confidence interval 0.20% to 0.98%). Systematic and opportunistic screening detected similar numbers of new cases (1.62% v 1.64%, difference 0.02%, -0.5% to 0.5%). Conclusion Active screening for atrial fibrillation detects additional cases over current practice. The preferred method of screening in patients aged 65 or over in primary care is opportunistic pulse taking with follow-up electrocardiography. Trial registration Current Controlled Trials ISRCTN19633732.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO9 5NH, Hants, England; Univ Birmingham, Hlth Econ Facil, Birmingham B15 2TT, W Midlands, England; Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England; City Hosp, Univ Dept Med, Birmingham, W Midlands, England; City Univ London, St Bartholomews Sch Nursing & Midwifery, Hlth Care Res Unit, London, England	University of Birmingham; University of Southampton; University of Birmingham; University of Birmingham; City University London	Hobbs, FDR (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.acuk	Jowett, Sue/AAO-4198-2021	Jowett, Sue/0000-0001-8936-3745; hobbs, richard/0000-0001-7976-7172; Mant, Jonathan/0000-0002-9531-0268				Jungner Gunnar, 1968, PRINCIPLES PRACTICE, P34; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Marjoram J, 1996, BRIT J GEN PRACT, V46, P283; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Somerville S, 2000, BRIT J GEN PRACT, V50, P727; Wheeldon NM, 1998, HEART, V79, P50, DOI 10.1136/hrt.79.1.50	6	263	264	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 25	2007	335	7616					383	386		10.1136/bmj.39280.660567.55	http://dx.doi.org/10.1136/bmj.39280.660567.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206VC	17673732	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000249210000027
J	Righelato, R; Spracklen, DV				Righelato, Renton; Spracklen, Dominick V.			Environment - Carbon mitigation by biofuels or by saving and restoring forests?	SCIENCE			English	Editorial Material									World Land Trust, Halesworth IP19 8AB, Suffolk, England; Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	University of Leeds	Righelato, R (corresponding author), World Land Trust, Halesworth IP19 8AB, Suffolk, England.	renton@worldlandtrust.org	Spracklen, Dominick V/B-4890-2014; Spracklen, Dominick/AAA-6257-2019					Elsayed MA, 2003, CARBON ENERGY BALANC; *EUCAR JRC CONCAWE, 2006, WELL TO WHEELS AN FU; *INT EN AUTH, 2004, BIOF TRANSP INT PERS, pCH6; Kirschbaum MUF, 2003, BIOMASS BIOENERG, V24, P297, DOI 10.1016/S0961-9534(02)00171-X; Larson E, 2005, SCI TECHN ADV PAN GL; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; WATSON RT, 2001, LAND USE LAND USE CH, P184	8	242	252	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					902	902		10.1126/science.1141361	http://dx.doi.org/10.1126/science.1141361			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702929				2022-12-28	WOS:000248780200023
J	Moore, DE; Rymer, MJ				Moore, Diane E.; Rymer, Michael J.			Talc-bearing serpentinite and the creeping section of the San Andreas fault	NATURE			English	Article							2004 PARKFIELD; HEAT-FLOW; CALIFORNIA; STRESS; SYSTEM; SLIP; EARTHQUAKE; BEHAVIOR; STATE; ZONE	The section of the San Andreas fault located between Cholame Valley and San Juan Bautista in central California creeps at a rate as high as 28 mm yr(-1) ( ref. 1), and it is also the segment that yields the best evidence for being a weak fault embedded in a strong crust(2-5). Serpentinized ultramafic rocks have been associated with creeping faults in central and northern California(6-8), and serpentinite is commonly invoked as the cause of the creep and the low strength of this section of the San Andreas fault. However, the frictional strengths of serpentine minerals are too high to satisfy the limitations on fault strength, and these minerals also have the potential for unstable slip under some conditions(9,10). Here we report the discovery of talc in cuttings of serpentinite collected from the probable active trace of the San Andreas fault that was intersected during drilling of the San Andreas Fault Observatory at Depth ( SAFOD) main hole in 2005. We infer that the talc is forming as a result of the reaction of serpentine minerals with silica- saturated hydrothermal fluids that migrate up the fault zone, and the talc commonly occurs in sheared serpentinite. This discovery is significant, as the frictional strength of talc at elevated temperatures is sufficiently low to meet the constraints on the shear strength of the fault, and its inherently stable sliding behaviour is consistent with fault creep(11). Talc may therefore provide the connection between serpentinite and creep in the San Andreas fault, if shear at depth can become localized along a talc- rich principal- slip surface within serpentinite entrained in the fault zone.	US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Moore, DE (corresponding author), US Geol Survey, 345 Middlefield Rd,Mail Stop 977, Menlo Pk, CA 94025 USA.	dmoore@usgs.gov						ALLEN CR, 1968, STANFORD U PUBL GEOL, V11, P70; BLANPIED ML, 1995, J GEOPHYS RES-SOL EA, V100, P13045, DOI 10.1029/95JB00862; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; Chery J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019521; Chester FM, 1998, TECTONOPHYSICS, V295, P199, DOI 10.1016/S0040-1951(98)00121-8; COLEMAN RG, 1971, GEOL SOC AM BULL, V82, P897, DOI 10.1130/0016-7606(1971)82[897:PAGNOS]2.0.CO;2; DICKINSO.WR, 1966, GEOL SOC AM BULL, V77, P451, DOI 10.1130/0016-7606(1966)77[451:TMSEIC]2.0.CO;2; EVANS BW, 1988, REV MINERAL, V19, P225; Galehouse JS, 2003, B SEISMOL SOC AM, V93, P2415, DOI 10.1785/0120020226; Hickman S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020043; INOUE A, 1991, AM MINERAL, V76, P628; IRWIN WP, 1975, GEOLOGY, V3, P713, DOI 10.1130/0091-7613(1975)3<713:EOGSAM>2.0.CO;2; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; McPhee DK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019363; Moore D. E., 2004, GEOLOGICAL SOC AM IN, V8, P525; Moore DE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002582; Moore DE, 1997, J GEOPHYS RES-SOL EA, V102, P14787, DOI 10.1029/97JB00995; Moore DE, 2007, INT GEOL REV, V49, P401, DOI 10.2747/0020-6814.49.5.401; MOUNT VS, 1987, GEOLOGY, V15, P1143, DOI 10.1130/0091-7613(1987)15<1143:SOSNTS>2.0.CO;2; Provost AS, 2001, J GEOPHYS RES-SOL EA, V106, P11373, DOI 10.1029/2001JB900007; Rymer MJ, 2006, B SEISMOL SOC AM, V96, pS11, DOI 10.1785/0120050830; RYMER MJ, 1981, 811173 US GEOL SURV; Solum JG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027285; Titus SJ, 2006, B SEISMOL SOC AM, V96, pS250, DOI 10.1785/0120050811; Williams CF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019352; WILLIAMS CF, 2006, EOS S, V87; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105; ZOBACK MD, 2005, EOS S, V86	28	312	321	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					795	797		10.1038/nature06064	http://dx.doi.org/10.1038/nature06064			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700697				2022-12-28	WOS:000248754200037
J	Meyerhardt, JA; Niedzwiecki, D; Hollis, D; Saltz, LB; Hu, FB; Mayer, RJ; Nelson, H; Whittom, R; Hantel, A; Thomas, J; Fuchs, CS				Meyerhardt, Jeffrey A.; Niedzwiecki, Donna; Hollis, Donna; Saltz, Leonard B.; Hu, Frank B.; Mayer, Robert J.; Nelson, Heidi; Whittom, Renaud; Hantel, Alexander; Thomas, James; Fuchs, Charles S.			Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; TOTAL-ENERGY-INTAKE; IOWA WOMENS HEALTH; COLORECTAL-CANCER; MEAT CONSUMPTION; LIFE-STYLE; VITAMIN-D; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY	Context Dietary factors have been associated with the risk of developing colon cancer but the influence of diet on patients with established disease is unknown. Objective To determine the association of dietary patterns with cancer recurrences and mortality of colon cancer survivors. Design, Setting, and Patients Prospective observational study of 1009 patients with stage III colon cancer who were enrolled in a randomized adjuvant chemotherapy trial (CALGB 89803) between April 1999 and May 2001. Patients reported on dietary intake using a semiquantitative food frequency questionnaire during and 6 months after adjuvant chemotherapy. We identified 2 major dietary patterns, prudent and Western, by factor analysis. The prudent pattern was characterized by high intakes of fruits and vegetables, poultry, and fish; the Western pattern was characterized by high intakes of meat, fat, refined grains, and dessert. Patients were followed up for cancer recurrence or death. Main Outcome Measures Disease-free survival, recurrence-free survival, and overall survival by dietary pattern. Results During a median follow-up of 5.3 years for the overall cohort, 324 patients had cancer recurrence, 223 patients died with cancer recurrence, and 28 died without documented cancer recurrence. A higher intake of a Western dietary pattern after cancer diagnosis was associated with a significantly worse disease-free survival (colon cancer recurrences or death). Compared with patients in the lowest quintile of Western dietary pattern, those in the highest quintile experienced an adjusted hazard ratio (AHR) for disease-free survival of 3.25 (95% confidence interval [CI], 2.04-5.19; P for trend < .001). The Western dietary pattern was associated with a similar detriment in recurrence-free survival (AHR, 2.85; 95% CI, 1.75-4.63) and overall survival (AHR, 2.32; 95% CI, 1.36-3.96]), comparing highest to lowest quintiles (both with P for trend < .001). The reduction in disease-free survival with a Western dietary pattern was not significantly modified by sex, age, nodal stage, body mass index, physical activity level, baseline performance status, or treatment group. In contrast, the prudent dietary pattern was not significantly associated with cancer recurrence or mortality. Conclusions Higher intake of a Western dietary pattern may be associated with a higher risk of recurrence and mortality among patients with stage III colon cancer treated with surgery and adjuvant chemotherapy. Further studies are needed to delineate which components of such a diet show the strongest association.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Duke Univ, Med Ctr, CALGB Stat Ctr, Durham, NC USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Brigham & Womens Hosp, Harvard Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Mayo Clin Fdn, Rochester, MN USA; Hop Sacre Coeur, Dept Med, Montreal, PQ H4J 1C5, Canada; Loyola Univ, Stritch Sch Med, Div Hematol & Oncol, Maywood, IL 60153 USA; Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA	Harvard University; Dana-Farber Cancer Institute; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Mayo Clinic; Universite de Montreal; Loyola University Chicago; University System of Ohio; Ohio State University	Meyerhardt, JA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	jmeyerhardt@partners.org		Saltz, Leonard/0000-0001-8353-4670; Niedzwiecki, Donna/0000-0002-3566-0450	NCI NIH HHS [CA33601, CA31946, K07CA097992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA033601, U10CA031946, K07CA097992] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adeyemo D, 2001, CANCER LETT, V164, P77, DOI 10.1016/S0304-3835(00)00720-5; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; BOSTICK RM, 1993, CANCER RES, V53, P4230; BOSTICK RM, 1993, AM J EPIDEMIOL, V137, P1302, DOI 10.1093/oxfordjournals.aje.a116640; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; CHLEBOWSKI RT, 2005, P AN M AM SOC CLIN, V23, P10; COX DR, 1972, J R STAT SOC B, V34, P187; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Dray X, 2003, GUT, V52, P868, DOI 10.1136/gut.52.6.868; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2002, GASTROENTEROL CLIN N, V31, P925, DOI 10.1016/S0889-8553(02)00057-2; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GLYNN SA, 1994, NUTR CANCER, V22, P101, DOI 10.1080/01635589409514336; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kesse E, 2006, AM J EPIDEMIOL, V164, P1085, DOI 10.1093/aje/kwj324; Kim MK, 2005, INT J CANCER, V115, P790, DOI 10.1002/ijc.20943; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee MM, 2000, J NATL CANCER I, V92, P42, DOI 10.1093/jnci/92.1.42; Martinez ME, 2005, RECENT RESULTS CANC, V166, P177; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; Meyerhardt JA, 2005, J CLIN ONCOL, V23, P8453, DOI 10.1200/JCO.2005.02.5460; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Michaud DS, 2005, J NATL CANCER I, V97, P518, DOI 10.1093/jnci/dji094; Patterson RE, 2002, J ALTERN COMPLEM MED, V8, P477, DOI 10.1089/107555302760253676; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; RANDALL E, 1992, NUTR CANCER, V18, P265, DOI 10.1080/01635589209514227; SALTZ LB, IN PRESS J CLIN ONCO; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Satia JA, 2004, CANCER EPIDEM BIOMAR, V13, P1022; Schulze MB, 2001, BRIT J NUTR, V85, P363, DOI 10.1079/BJN2000254; Slattery ML, 1997, NUTR CANCER, V28, P52, DOI 10.1080/01635589709514553; SLATTERY ML, 1989, INT J EPIDEMIOL, V18, P792, DOI 10.1093/ije/18.4.792; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143; US Department of Agriculture (USDA) Agricultural Research Service, 2007, USDA NUTR DAT STAND; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu K, 2004, CANCER CAUSE CONTROL, V15, P853, DOI 10.1007/s10552-004-1809-2; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P1298; Wu K, 2002, JNCI-J NATL CANCER I, V94, P437, DOI 10.1093/jnci/94.6.437; Zubrod C.G., 1960, J CHRON DIS, V11, P7	56	293	300	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					754	764		10.1001/jama.298.7.754	http://dx.doi.org/10.1001/jama.298.7.754			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699009	Bronze			2022-12-28	WOS:000248728800020
J	Rajasekaran, NS; Connell, P; Christians, ES; Yan, LJ; Taylor, RP; Orosz, A; Zhang, XQ; Stevenson, TJ; Peshock, RM; Leopold, JA; Barry, WH; Loscalzo, J; Odelberg, SJ; Benjamin, IJ				Rajasekaran, Namakkal S.; Connell, Patrice; Christians, Elisabeth S.; Yan, Liang-Jun; Taylor, Ryan P.; Orosz, Andras; Zhang, Xiu Q.; Stevenson, Tamara J.; Peshock, Ronald M.; Leopold, Jane A.; Barry, William H.; Loscalzo, Joseph; Odelberg, Shannon J.; Benjamin, Ivor J.			Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice	CELL			English	Article							HEAT-SHOCK-PROTEIN; DESMIN-RELATED CARDIOMYOPATHY; OXIDATIVE STRESS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; MOLECULAR CHAPERONES; SKELETAL MYOPATHY; OXIDANT STRESS; GLUTATHIONE; APOPTOSIS; REGULATORS	The autosomal dominant mutation in the human alpha B-crystallin gene inducing a R120G amino acid exchange causes a multisystem, protein aggregation disease including cardiomyopathy. The pathogenesis of cardiomyopathy in this mutant (hR120GCryAB) is poorly understood. Here, we show that transgenic mice overexpressing cardiac-specific hR120GCryAB recapitulate the cardiomyopathy in humans and find that the mice are under reductive stress. The myopathic hearts show an increased recycling of oxidized glutathione ( GSSG) to reduced glutathione (GSH), which is due to the augmented expression and enzymatic activities of glucose-6-phosphate dehydrogenase (G6PD), glutathione reductase, and glutathione peroxidase. The intercross of hR120GCryAB cardiomyopathic animals with mice with reduced G6PD levels rescues the progeny from cardiac hypertrophy and protein aggregation. These findings demonstrate that dysregulation of G6PD activity is necessary and sufficient for maladaptive reductive stress and suggest a novel therapeutic target for abrogating R120GCryAB cardiomyopathy and heart failure in humans.	Univ Utah, Sch Med, Dept Internal Med, Div Cardiol,Ctr Cardiovasc Translat Biomed, Salt Lake City, UT 84132 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Ctr Dev Biol, UMR5547, F-31062 Toulouse, France; Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75390 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Med Div, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Benjamin, IJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Cardiol,Ctr Cardiovasc Translat Biomed, 30 N 1900 E,Room 4A100, Salt Lake City, UT 84132 USA.	ivor.benjamin@hsc.utah.edu	Loscalzo, Joseph/ABD-8980-2021; peshock, ron/Q-6381-2019	Yan, Liang-Jun/0000-0002-5815-5430; peshock, ron/0000-0003-3217-1966	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063834] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063834-01A1, R01 HL063834, 5R01 HL63874] Funding Source: Medline; NIH HHS [DP1 OD006438] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baek SH, 2000, J CELL PHYSIOL, V183, P100, DOI 10.1002/(SICI)1097-4652(200004)183:1<100::AID-JCP12>3.0.CO;2-F; Benjamin IJ, 2005, J CLIN INVEST, V115, P495, DOI 10.1172/JCI200524477; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; FARDEAU M, 1978, J AM STAT ASSOC, V88, P920; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; Handy DE, 2006, J BIOL CHEM, V281, P3382, DOI 10.1074/jbc.M511295200; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HOCHMAN JH, 1982, P NATL ACAD SCI-BIOL, V79, P6866, DOI 10.1073/pnas.79.22.6866; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Kumar MS, 2005, BIOCHEM J, V391, P335, DOI 10.1042/BJ20050506; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2001, FASEB J, V15, P1771, DOI 10.1096/fj.00-0893fje; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Tome ME, 2006, ANTIOXID REDOX SIGN, V8, P1315, DOI 10.1089/ars.2006.8.1315; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Xiao XZ, 1999, AM J HUM GENET, V64, P685, DOI 10.1086/302305; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528	45	344	359	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					427	439		10.1016/j.cell.2007.06.044	http://dx.doi.org/10.1016/j.cell.2007.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693254	Green Accepted, Bronze			2022-12-28	WOS:000249038100012
J	van der Vlies, CH; Busch, ORC				van der Vlies, Cornelis H.; Busch, Olivier R. C.			An intraabdominal cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van der Vlies, CH (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.h.vandervlies@amc.uva.nl	Busch, Olivier/AAC-3650-2020						0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					E6	E6		10.1056/NEJMicm063646	http://dx.doi.org/10.1056/NEJMicm063646			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671250				2022-12-28	WOS:000248436300011
J	Henzinger, M				Henzinger, Monika			Search technologies for the Internet	SCIENCE			English	Review							WEB	About 20% of the world's population uses the Web, and a large majority thereof uses Web search engines to find information. As a result, many Web researchers are devoting much effort to improving the speed and capability of search technology.	Google Switzerland, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Google Incorporated; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Henzinger, M (corresponding author), Google Switzerland, CH-1015 Lausanne, Switzerland.	monika.henzinger@epfl.ch						Amer-Yahia S, 2005, SIGMOD RECORD, V34, P71; Anick P, 2003, P 26 ANN INT ACM SIG, P88, DOI DOI 10.1145/860435.860453; BECCHETTI L, 2006, P 2 INT WORKSH ADV I, P1; Bergman MK, 2001, J ELECT PUB, V7; Berkhin P, 2005, INTERNET MATH, V2, P73, DOI 10.1080/15427951.2005.10129098; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Broder A., 2002, SIGIR Forum, V36, P3, DOI 10.1145/792550.792552; Broder AZ, 1997, COMPUT NETWORKS ISDN, V29, P1157, DOI 10.1016/S0169-7552(97)00031-7; Carmel D, 2003, P 26 ANN INT ACM SIG, P151, DOI DOI 10.1002/ASI.10060; Chen H., 2006, SIGIR, DOI DOI 10.1145/1148170.1148245; Etzioni O, 2005, ARTIF INTELL, V165, P91, DOI 10.1016/j.artint.2005.03.001; Fetterly D, 2003, FIRST LATIN AMERICAN WEB CONGRESS, PROCEEDINGS, P37, DOI 10.1109/LAWEB.2003.1250280; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Ghemawat S., 2003, Operating Systems Review, V37, P29, DOI 10.1145/1165389.945450; Girju R, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P80; Granka L. A., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P478, DOI 10.1145/1008992.1009079; Gyongyi Z, 2005, COMPUTER, V38, P28, DOI 10.1109/MC.2005.352; Henzinger M., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P284, DOI 10.1145/1148170.1148222; Jeh G., 2003, P 12 INT C WORLD WID, P271, DOI DOI 10.1145/775152.775191; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Langville A. N., 2004, INTERNET MATH, V1, P335; Ntoulas A, 2005, ACM-IEEE J CONF DIG, P100, DOI 10.1145/1065385.1065407; Ntoulas Alexandros, 2006, P 15 INT C WORLD WID, P83, DOI DOI 10.1145/1135777.1135794; Sahami M, 2004, LECT NOTES ARTIF INT, V3157, P3; Shen X., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P43, DOI 10.1145/1076034.1076045; TAN B, 2006, P 12 ACM SIGKDD INT, P718, DOI DOI 10.1145/1150402.1150493; Teevan J., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P449, DOI 10.1145/1076034.1076111; TEEVAN J, 2005, P 1 INT WORKSH NEW T; WANG L, 2005, P 28 ANN INT ACM SIG, P424; WU W, 2006, P 22 INT C DAT ENG, P44	31	39	39	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					468	471		10.1126/science.1126557	http://dx.doi.org/10.1126/science.1126557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656714				2022-12-28	WOS:000248339800032
J	Baum, M				Baum, Michael			Should we consider a boycott of Israeli academic institutions? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6AU, England	University of London; University College London	Baum, M (corresponding author), UCL, London WC1E 6AU, England.	michael@mbaum.freeserve.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					125	125		10.1136/bmj.39266.509016.AD	http://dx.doi.org/10.1136/bmj.39266.509016.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195RA	17641345	Green Published			2022-12-28	WOS:000248428100029
J	Jack, A				Jack, Andrew			No cure no cost	BRITISH MEDICAL JOURNAL			English	Article												Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*DEP HLTH, HSC 2002 004 COST EF	1	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					122	123		10.1136/bmj.39267.432153.94	http://dx.doi.org/10.1136/bmj.39267.432153.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641343	Green Published			2022-12-28	WOS:000248428100027
J	Gupta, S; Collier, JS; Palmer-Felgate, A; Potter, G				Gupta, Sanjeev; Collier, Jenny S.; Palmer-Felgate, Andy; Potter, Graeme			Catastrophic flooding origin of shelf valley systems in the English Channel	NATURE			English	Article							PLEISTOCENE RIVERS; EUROPEAN RIVERS; HISTORY; BRITAIN; REGION; EARTH	Megaflood events involving sudden discharges of exceptionally large volumes of water are rare, but can significantly affect landscape evolution, continental-scale drainage patterns and climate change(1). It has been proposed that a significant flood event eroded a network of large ancient valleys on the floor of the English Channel - the narrow seaway between England and France(2-4). This hypothesis has remained untested through lack of direct evidence, and alternative non-catastrophist ideas have been entertained for valley formation(5,6). Here we analyse a new regional bathymetric map of part of the English Channel derived from high-resolution sonar data, which shows the morphology of the valley in unprecedented detail. We observe a large bedrock-floored valley that contains a distinct assemblage of landforms, including streamlined islands and longitudinal erosional grooves, which are indicative of large-scale subaerial erosion by high-magnitude water discharges. Our observations support the megaflood model, in which breaching of a rock dam at the Dover Strait instigated catastrophic drainage of a large pro-glacial lake in the southern North Sea basin(2). We suggest that megaflooding provides an explanation for the permanent isolation of Britain from mainland Europe during interglacial high-sea-level stands(7), and consequently for patterns of early human colonisation of Britain together with the large-scale reorganization of palaeodrainage in northwest Europe(4).	Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; UK Hydrog Off, Taunton TA1 2DN, Somerset, England	Imperial College London; NERC National Oceanography Centre	Gupta, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	s.gupta@imperial.ac.uk		Gupta, Sanjeev/0000-0001-6415-1332; Collier, Jennifer/0000-0003-0453-1928				Antoine P, 2003, J QUATERNARY SCI, V18, P227, DOI 10.1002/jqs.762; Ashton N, 2002, ANTIQUITY, V76, P388, DOI 10.1017/S0003598X00090505; AUFFRET JP, 1980, ANN I OCEANOGR PARIS, V56, P21; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; Baker V. R., 1978, CHANNELED SCABLAND G; Baker VR, 2002, SCIENCE, V295, P2379, DOI 10.1126/science.1068448; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Broecker WS, 2006, SCIENCE, V312, P1146, DOI 10.1126/science.1123253; Chow V.T., 1959, OPEN CHANNEL HYDRAUL; DESTOMBES JP, 1975, PHILOS T R SOC A, V279, P243, DOI 10.1098/rsta.1975.0056; DINGWALL RG, 1975, PHILOS T R SOC A, V279, P233, DOI 10.1098/rsta.1975.0055; EHLERS J, 2004, QUATERNARY GLACIAT 1, P251; Gibbard P.L., 1995, ISLAND BRITAIN QUATE, V96, P15, DOI DOI 10.1144/GSL.SP.1995.096.01.03; GIBBARD PL, 1988, PHILOS T ROY SOC B, V318, P559, DOI 10.1098/rstb.1988.0024; Hamblin R.J.O., 1992, UK OFFSHORE REGIONAL; HAMILTON D, 1972, MEM BUR RECH GEOL MI, V79, P59; KEEN DH, 1995, ISLAND BRITAIN QUATE, P63; KELLAWAY GA, 1975, PHILOS T R SOC A, V279, P189, DOI 10.1098/rsta.1975.0051; KOMAR PD, 1983, GEOLOGY, V11, P651, DOI 10.1130/0091-7613(1983)11<651:SOSIOE>2.0.CO;2; Lericolais G, 2003, J QUATERNARY SCI, V18, P245, DOI 10.1002/jqs.759; Manning R., 1889, T I CIVIL ENG IRELAN, V20, P161, DOI DOI 10.1680/IMOTP.1891.20563; MEIJER T, 1995, ISLAND BRITAIN QUATE, V96, P89, DOI DOI 10.1144/GSL.SP.1995.096.01.08; Menot G, 2006, SCIENCE, V313, P1623, DOI 10.1126/science.1130511; O'Connor JE, 2002, WATER SCI APPL, V5, P359; Parfitt SA, 2005, NATURE, V438, P1008, DOI 10.1038/nature04227; PREECE RG, 1995, ISLAND BRITAIN QUATE; ROEP TB, 1975, PALAEOGEOGR PALAEOCL, V17, P289, DOI 10.1016/0031-0182(75)90003-6; SMITH AJ, 1985, MAR GEOL, V64, P65, DOI 10.1016/0025-3227(85)90160-4; SUTCLIFFE A, 1995, ISLAND BRITAIN QUATE, P127; White M.J., 2000, P PREHIST SOC, V66, P1, DOI [10.1017/S0079497X00001742, DOI 10.1017/S0079497X00001742]]; White M, 2006, J QUATERNARY SCI, V21, P525, DOI 10.1002/jqs.1034	31	183	187	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					342	U5		10.1038/nature06018	http://dx.doi.org/10.1038/nature06018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637667				2022-12-28	WOS:000248118300055
J	Finkel, T; Serrano, M; Blasco, MA				Finkel, Toren; Serrano, Manuel; Blasco, Maria A.			The common biology of cancer and ageing	NATURE			English	Review							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; LIFE-SPAN; TELOMERE LENGTH; C-ELEGANS; HUMAN FIBROBLASTS; OXIDATIVE STRESS; HUMAN-CELLS; SUCCINATE-DEHYDROGENASE; GENOMIC INSTABILITY	At first glance, cancer and ageing would seem to be unlikely bedfellows. Yet the origins for this improbable union can actually be traced back to a sequence of tragic - and some say unethical - events that unfolded more than half a century ago. Here we review the series of key observations that has led to a complex but growing convergence between our understanding of the biology of ageing and the mechanisms that underlie cancer.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Centro Nacional de Investigaciones Oncologicas (CNIO)	Finkel, T (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10,CRC 5-3330,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	Blasco, Maria A./M-1694-2014; Serrano, Manuel/H-2634-2015	Blasco, Maria A./0000-0002-4211-233X; Serrano, Manuel/0000-0001-7177-9312	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; CURTIS HJ, 1963, SCIENCE, V141, P686, DOI 10.1126/science.141.3582.686; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez-Suarez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hara E, 1996, MOL CELL BIOL, V16, P859; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MELZER D, 2007, MECH AGEING DEV 0327, DOI DOI 10.1016/J.MAD.2007.03.005; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Roninson IB, 2003, CANCER RES, V63, P2705; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	101	754	798	3	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					767	774		10.1038/nature05985	http://dx.doi.org/10.1038/nature05985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700693	Green Published			2022-12-28	WOS:000248754200031
J	Singh, IM; Shishehbor, MH; Ansell, BJ				Singh, Inder M.; Shishehbor, Mehdi H.; Ansell, Benjamin J.			High-density lipoprotein as a therapeutic target - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ESTER TRANSFER PROTEIN; CORONARY-HEART-DISEASE; COLESTIPOL-NIACIN THERAPY; INTIMA-MEDIA THICKNESS; APOLIPOPROTEIN-A-I; EXTENDED-RELEASE NIACIN; CHOLESTEROL LEVELS; RISK-FACTORS; SECONDARY PREVENTION; ARTERY-DISEASE	Context High-density lipoprotein cholesterol (HDL-C) is a cardiovascular risk factor that is gaining substantial interest as a therapeutic target. Objectives To review the current and emerging strategies that modify high-density lipoproteins (HDLs). Data Sources Systematic search of English-language literature (1965-May 2007) in MEDLINE and the Cochrane database, using the key words HDL-C and apolipoprotein A-I and the subheadings reverse cholesterol transport, CVD [cardiovascular disease] prevention and control, drug therapy, and therapy; review of presentations made at major cardiovascular meetings from 2003-2007; and review of ongoing trials from ClinicalTrials.gov and current guidelines from major cardiovascular societies. Study Selection and Data Extraction Study selection was prioritized to identify randomized controlled trials over meta-analyses over mechanistic studies; identified studies also included proof-of-concept studies and key phase 1 through 3 trials of novel agents. Study eligibility was assessed by 2 authors; disagreements were resolved by consensus with the third. Data Synthesis Of 754 studies identified, 31 randomized controlled trials met the inclusion criteria. Currently available therapeutic and lifestyle strategies, when optimized, increase HDL-C levels by 20% to 30%. While basic and small pilot studies have shown promise, proof that increasing HDL-C levels confers a reduction in major cardiovascular outcomes independent of changes in levels of low-density lipoprotein cholesterol or triglycerides has been more elusive. Some novel therapeutic agents in human studies appear to effectively increase HDL-C levels, whereas other novel strategies that target HDL metabolism or function may have minimal effect on HDL-C levels. Conclusions At present there is modest evidence to support aggressively increasing HDL-C levels in addition to what is achieved by lifestyle modification alone. Ongoing clinical trials that target specific pathways in HDL metabolism may help expand cardiovascular treatment options.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Indiana Univ, Med Ctr, Dept Cardiovasc Med, Krannert Inst Cardiol, Indianapolis, IN USA; Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA	Cleveland Clinic Foundation; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shishehbor, MH (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,JJ40, Cleveland, OH 44195 USA.	shishem@gmail.com			NCRR NIH HHS [KL2 RR024990] Funding Source: Medline; NICHD NIH HHS [K12 HD049091] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD049091] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*ACCORD, NCT00000620 ACCORD; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Ansell Benjamin J, 2006, Curr Atheroscler Rep, V8, P405, DOI 10.1007/s11883-006-0038-4; Ansell Benjamin J, 2005, Curr Atheroscler Rep, V7, P29, DOI 10.1007/s11883-005-0072-7; Ansell BJ, 2005, J AM COLL CARDIOL, V46, P1792, DOI 10.1016/j.jacc.2005.06.080; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Asztalos BF, 2002, ATHEROSCLEROSIS, V164, P361, DOI 10.1016/S0021-9150(02)00149-1; Asztalos BF, 2005, ARTERIOSCL THROM VAS, V25, P2185, DOI 10.1161/01.ATV.0000183727.90611.4f; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bavirti Surekha, 2003, Endocr Pract, V9, P487; BLANKENHORN DH, 1993, CIRCULATION, V88, P20, DOI 10.1161/01.CIR.88.1.20; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BLANKENHORN DH, 1991, CIRCULATION, V83, P438, DOI 10.1161/01.CIR.83.2.438; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Burke V, 2007, J CLIN EPIDEMIOL, V60, P133, DOI 10.1016/j.jclinepi.2006.05.012; Buse JB, 2005, CLIN THER, V27, P1181, DOI 10.1016/j.clinthera.2005.08.005; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CARLSON LA, 1988, ACTA MED SCAND, V223, P405; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; Chapman MJ, 2004, CURR MED RES OPIN, V20, P1253, DOI 10.1185/030079904125004402; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Csaszar A., 2005, Acta Physiologica Hungarica, V92, P109, DOI 10.1556/APhysiol.92.2005.2.2; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; Deakin S, 2003, ARTERIOSCL THROM VAS, V23, P2083, DOI 10.1161/01.ATV.0000096207.01487.36; Despres JP, 2004, DRUGS, V64, P2177, DOI 10.2165/00003495-200464190-00003; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; Ericsson CG, 1996, LANCET, V347, P849, DOI 10.1016/S0140-6736(96)91343-4; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Forrester JS, 2006, AM J CARDIOL, V98, P1542, DOI 10.1016/j.amjcard.2006.06.059; Frick MH, 1997, CIRCULATION, V96, P2137; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Grundy SM, 2002, ARCH INTERN MED, V162, P1568, DOI 10.1001/archinte.162.14.1568; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HAFFNER SM, 2004, DIABETES CARE S, V1, pS68; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; Huang ZP, 2002, CLIN SCI, V103, P587, DOI 10.1042/cs1030587; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kashyap ML, 2002, AM J CARDIOL, V89, P672, DOI 10.1016/S0002-9149(01)02338-4; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Khurana M, 2000, J Assoc Physicians India, V48, P895; Klerkx AHEM, 2004, EUR J CLIN INVEST, V34, P21, DOI 10.1111/j.1365-2362.2004.01281.x; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kuivenhoven JA, 2005, AM J CARDIOL, V95, P1085, DOI 10.1016/j.amjcard.2004.12.064; Kuwabara K, 2004, J PHARMACOL EXP THER, V309, P970, DOI 10.1124/jpet.103.064659; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Meyers CD, 2004, CURR OPIN CARDIOL, V19, P366, DOI 10.1097/01.hco.0000126582.27767.87; Morehouse LA, 2007, J LIPID RES, V48, P1263, DOI 10.1194/jlr.M600332-JLR200; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2003, CIRCULATION, V108, P1735, DOI 10.1161/01.CIR.0000089375.60050.35; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; *NCT, NCT99JLULO9; *NCT, NCT00158899; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Nissen SE, 2007, JAMA-J AM MED ASSOC, V297, P1362, DOI 10.1001/jama.297.12.1362; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; OLIVER MF, 1984, LANCET, V2, P600; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; RADER DJ, 2006, CIRCULATION S, V114, P288; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Rimm EB, 2007, ANN EPIDEMIOL, V17, pS3, DOI 10.1016/j.annepidem.2007.01.002; Roberts CK, 2006, J APPL PHYSIOL, V101, P1727, DOI 10.1152/japplphysiol.00345.2006; Rodrigueza WV, 1998, BBA-BIOMEMBRANES, V1368, P306, DOI 10.1016/S0005-2736(97)00198-3; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Shah PK, 2001, CIRCULATION, V104, P2376, DOI 10.1161/hc4401.098467; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Skrumsager BK, 2003, J CLIN PHARMACOL, V43, P1244, DOI 10.1177/0091270003257230; Slyper A, 2005, AM J CLIN NUTR, V81, P376; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Steiner G, 2001, LANCET, V357, P905; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; TALL AR, 1993, J LIPID RES, V34, P1255; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Valmadrid CT, 1999, JAMA-J AM MED ASSOC, V282, P239, DOI 10.1001/jama.282.3.239; WEISWEILER P, 1987, J CLIN ENDOCR METAB, V65, P969, DOI 10.1210/jcem-65-5-969; Whitney EJ, 2005, ANN INTERN MED, V142, P95, DOI 10.7326/0003-4819-142-2-200501180-00008; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; 1971, BR MED J, V4, P767	124	367	389	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					786	798		10.1001/jama.298.7.786	http://dx.doi.org/10.1001/jama.298.7.786			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699012				2022-12-28	WOS:000248728800023
J	Boetes, C; Mann, RM				Boetes, Carla; Mann, Ritse M.			Ductal carcinoma in situ and breast MRI	LANCET			English	Editorial Material							CONTRALATERAL BREAST; CANCER; MAMMOGRAPHY		Radboud Univ Nijmegen Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Boetes, C (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands.	c.boetes@rad.umcn.nl	Mann, R.M./L-4502-2015	Mann, R.M./0000-0001-8111-1930				Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Cao Y, 2004, ARCH PATHOL LAB MED, V128, P893; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; IKEDA DM, 1989, RADIOLOGY, V172, P661, DOI 10.1148/radiology.172.3.2549563; Kuhl CK, 2007, LANCET, V370, P485, DOI 10.1016/S0140-6736(07)61232-X; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Pediconi F, 2007, RADIOLOGY, V243, P670, DOI 10.1148/radiol.2433060838; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014	12	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					459	460		10.1016/S0140-6736(07)61207-0	http://dx.doi.org/10.1016/S0140-6736(07)61207-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693157				2022-12-28	WOS:000248717800004
J	Chen, HC; McCaffery, JM; Chan, DC				Chen, Hsiuchen; McCaffery, J. Michael; Chan, David C.			Mitochondrial fusion protects against neurodegeneration in the cerebellum	CELL			English	Article							DOMINANT OPTIC ATROPHY; CRE RECOMBINASE EXPRESSION; MARIE-TOOTH-DISEASE; AXONAL-TRANSPORT; PURKINJE-CELLS; CYTOCHROME-C; OPA1; MOUSE; GTPASE; MUTATIONS	Mutations in the mitochondrial fusion gene Mfn2 cause the human neurodegenerative disease Charcot-Marie-Tooth type 2A. However, the cellular basis underlying this relationship is poorly understood. By removing Mfn2 from the cerebellum, we established a model for neurodegeneration caused by loss of mitochondrial fusion. During development and after maturity, Purkinje cells require Mfn2 but not Mfn1 for dendritic outgrowth, spine formation, and cell survival. In vivo, cell culture, and electron microscopy studies indicate that mutant Purkinje cells have aberrant mitochondrial distribution, ultrastructure, and electron transport chain activity. In fibroblasts lacking mitochondrial fusion, the majority of mitochondria lack mitochondrial DNA nucleoids. This deficiency provides a molecular mechanism for the dependence of respiratory activity on mitochondrial fusion. Our results show that exchange of mitochondrial contents is important for mitochondrial function as well as organelle distribution in neurons and have important implications for understanding the mechanisms of neurodegeneration due to perturbations in mitochondrial fusion.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu			NCRR NIH HHS [S10 RR023454, S10 RR021023-01, S10 RR019409-01, S10 RR022588-01, S10 RR022588, S10 RR023454-01] Funding Source: Medline; NIGMS NIH HHS [GM062967] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023454, S10RR019409, S10RR021023, S10RR022588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Aller MI, 2003, GENESIS, V36, P97, DOI 10.1002/gene.10204; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Kimmel RA, 2000, GENE DEV, V14, P1377; LAINE J, 1994, J COMP NEUROL, V339, P159, DOI 10.1002/cne.903390202; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	649	664	4	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					548	562		10.1016/j.cell.2007.06.026	http://dx.doi.org/10.1016/j.cell.2007.06.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693261	Bronze			2022-12-28	WOS:000249038100021
J	Huang, L; Treisman, A; Pashler, H				Huang, Liqiang; Treisman, Anne; Pashler, Harold			Characterizing the limits of human visual awareness	SCIENCE			English	Article							FEATURE-INTEGRATION-THEORY; ATTENTION; SEARCH	Momentary awareness of a visual scene is very limited; however, this limitation has not been formally characterized. We test the hypothesis that awareness reflects a surprisingly impoverished data structure called a labeled Boolean map, defined as a linkage of just one feature value per dimension (for example, the color is green and the motion is rightward) with a spatial pattern. Features compete with each other, whereas multiple locations form a spatial pattern and thus do not compete. Perception of the colors of two objects was significantly improved by successive compared with simultaneous presentation, whereas perception of their locations was not. Moreover, advance information about which objects are relevant aided perception of colors much more than perception of locations. Both results support the Boolean map hypothesis.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	Princeton University; University of California System; University of California San Diego	Huang, L (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	lqhuang@psy.cuhk.edu.hk	Huang, Liqiang/A-3228-2008	Huang, Liqiang/0000-0002-0007-9375	NIMH NIH HHS [2004 2RO1 MH 058383-, R01-MH45584] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058383, R01MH045584] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; DUNCAN J, 1980, COGNITIVE PSYCHOL, V12, P75, DOI 10.1016/0010-0285(80)90004-3; Huang LQ, 2007, PSYCHOL REV, V114, P599, DOI 10.1037/0033-295X.114.3.599; Huang LQ, 2002, VISION RES, V42, P1421, DOI 10.1016/S0042-6989(02)00059-7; Morales D, 1999, NATURE, V399, P115, DOI 10.1038/20103; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Quinlan PT, 2003, PSYCHOL BULL, V129, P643, DOI 10.1037/0033-2909.129.5.643; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	15	93	95	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					823	825		10.1126/science.1143515	http://dx.doi.org/10.1126/science.1143515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690299				2022-12-28	WOS:000248624500046
J	Rodriguez, JP; Taber, AB; Daszak, P; Sukumar, R; Valladares-Padua, C; Padua, S; Aguirre, LF; Medellin, RA; Acosta, M; Aguirre, AA; Bonacic, C; Bordino, P; Bruschini, J; Buchori, D; Gonzalez, S; Mathew, T; Mendez, M; Mugica, L; Pacheco, LF; Dobson, AP; Pearl, M				Rodriguez, J. P.; Taber, A. B.; Daszak, P.; Sukumar, R.; Valladares-Padua, C.; Padua, S.; Aguirre, L. F.; Medellin, R. A.; Acosta, M.; Aguirre, A. A.; Bonacic, C.; Bordino, P.; Bruschini, J.; Buchori, D.; Gonzalez, S.; Mathew, T.; Mendez, M.; Mugica, L.; Pacheco, L. F.; Dobson, A. P.; Pearl, M.			Environment - Globalization of conservation: a view from the south	SCIENCE			English	Editorial Material							BIODIVERSITY; HOTSPOTS		Wildlife Trust, New York, NY USA; Inst Venezolano Invest Cient, Caracas, Venezuela; PROVITA, Caracas, Venezuela; Consortium Conservat Med, New York, NY USA; Indian Inst Sci, Bangalore 560012, Karnataka, India; Asian Nat Conservat Fdn, Bangalore, Karnataka, India; IPE, Sao Paulo, Brazil; Univ Mayor San Simon, Ctr Biodivers & Genet, Cochabamba, Bolivia; BIOTA, Ctr Estudios Biol Teor & Aplicada, La Paz, Bolivia; Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; Univ La Habana, Havana, Cuba; Fauna Australis, Santiago, Chile; Pontificia Univ Catolica Chile, Santiago, Chile; AquaMarina, Ctr Estudios Ciencias Marinas, Pinamar, Argentina; Bogor Agr Univ, Bogor, Indonesia; PEKA Indonesia Fdn, Bogor, Indonesia; Univ Republica, Fac Ciencias, IIBCE, Montevideo, Uruguay; Columbia Univ, New York, NY USA; Univ Mayor San Andres, La Paz, Bolivia; Princeton Univ, Princeton, NJ 08544 USA	Venezuelan Institute Science Research; Indian Institute of Science (IISC) - Bangalore; Universidad Nacional Autonoma de Mexico; Universidad de la Habana; Pontificia Universidad Catolica de Chile; Bogor Agricultural University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Columbia University; Universidad Mayor de San Andres; Princeton University	Taber, AB (corresponding author), Wildlife Trust, New York, NY USA.	taber@wildlifetrust.org	Buchori, Damayanti/L-5878-2017; Aguirre, Luis F./AAE-9255-2019; Rodriguez, Jon P/G-7224-2012; González, Susana/AAC-7053-2021; Bonacic, Cristian/O-2558-2014; Raman, Sukumar/C-9809-2013; Rodriguez, Jon P/A-1491-2009; daszak, peter/U-4588-2017; Gonzalez, Susana A/F-1300-2017; Pacheco, F.A.L./H-6400-2013	Buchori, Damayanti/0000-0002-2843-0737; Aguirre, Luis F./0000-0002-4194-1523; González, Susana/0000-0001-6470-6182; Bonacic, Cristian/0000-0003-2175-076X; Rodriguez, Jon P/0000-0001-5019-2870; daszak, peter/0000-0002-2046-5695; Pacheco, F.A.L./0000-0002-2399-5261				Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Castro G., 2000, MAPPING CONSERVATION; Chapman B, 2004, PHYS WORLD, V17, P17; Easterly W., 2006, WHITE MANS BURDEN WH; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Herrera Amilcar O., 1976, CATASTROPHE NEW SOC; Hulme D., 2001, African wildlife and livelihoods: the promise and performance of community conservation; MEADOWS D H, 1972, P205; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers RA., 2005, MARINE CONSERVATION, P126; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PEREDO B, 2007, MOTION MAGAZINE 0610; RANSOM D, 2005, NEW INT, V383, P2; Rodriguez JP, 2005, CONSERV BIOL, V19, P969, DOI 10.1111/j.1523-1739.2005.00555.x; Ruiz R. M., 2003, Journal of Sustainable Forestry, V17, P7, DOI 10.1300/J091v17n01_02; Saberwal V., 2003, BATTLES NATURE SCI P; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; SILVIUS KM, 2004, PEOPLE NATURE; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; 2007, ECONOMIST, V383, P67	25	92	98	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					755	756		10.1126/science.1145560	http://dx.doi.org/10.1126/science.1145560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690278				2022-12-28	WOS:000248624500022
J	Wang, ZH; Carter, JA; Lagutchev, A; Koh, YK; Seong, NH; Cahill, DG; Dlott, DD				Wang, Zhaohui; Carter, Jeffrey A.; Lagutchev, Alexei; Koh, Yee Kan; Seong, Nak-Hyun; Cahill, David G.; Dlott, Dana D.			Ultrafast flash thermal conductance of molecular chains	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SHOCK COMPRESSION; TRANSPORT; SPECTROSCOPY; DESORPTION; DYNAMICS; AU(111); FILMS; GOLD	At the level of individual molecules, familiar concepts of heat transport no longer apply. When large amounts of heat are transported through a molecule, a crucial process in molecular electronic devices, energy is carried by discrete molecular vibrational excitations. We studied heat transport through self-assembled monolayers of long-chain hydrocarbon molecules anchored to a gold substrate by ultrafast heating of the gold with a femtosecond laser pulse. When the heat reached the methyl groups at the chain ends, a nonlinear coherent vibrational spectroscopy technique detected the resulting thermally induced disorder. The flow of heat into the chains was limited by the interface conductance. The leading edge of the heat burst traveled ballistically along the chains at a velocity of 1 kilometer per second. The molecular conductance per chain was 50 picowatts per kelvin.	Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Fredrick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dlott, DD (corresponding author), Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.	dlott@scs.uiuc.edu	Koh, Yee Kan/A-8893-2010; Cahill, David G./B-3495-2014	Koh, Yee Kan/0000-0002-4156-6209; Dlott, Dana/0000-0001-8719-7093				BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; BAIN CD, 1991, LANGMUIR, V7, P1563, DOI 10.1021/la00056a003; BRORSON SD, 1987, PHYS REV LETT, V59, P1962, DOI 10.1103/PhysRevLett.59.1962; Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; Chen S, 2006, ANGEW CHEM INT EDIT, V45, P5154, DOI 10.1002/anie.200601778; Galperin M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/10/103201; Ge ZB, 2004, J PHYS CHEM B, V108, P18870, DOI 10.1021/jp048375k; Ge ZB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186101; Kondoh H, 1999, J CHEM PHYS, V111, P1175, DOI 10.1063/1.479302; Lagutchev AS, 2005, J PHYS CHEM B, V109, P5033, DOI 10.1021/jp0450742; Lyeo HK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144301; Nishida N, 1996, JPN J APPL PHYS 1, V35, P5866, DOI 10.1143/JJAP.35.5866; Patterson JE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.015501; Patterson JE, 2005, J PHYS CHEM B, V109, P5045, DOI 10.1021/jp045075u; Richter LJ, 1998, OPT LETT, V23, P1594, DOI 10.1364/OL.23.001594; Segal D, 2003, J CHEM PHYS, V119, P6840, DOI 10.1063/1.1603211; Wang RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358856	18	373	377	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					787	790		10.1126/science.1145220	http://dx.doi.org/10.1126/science.1145220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690290				2022-12-28	WOS:000248624500035
J	Ali, B; Zafari, AM				Ali, Bakhtiar; Zafari, A. Maziar			Narrative review: Cardiopulmonary resuscitation and emergency cardiovascular care: Review of the current guidelines	ANNALS OF INTERNAL MEDICINE			English	Review							HOSPITAL CARDIAC-ARREST; PUBLIC-ACCESS DEFIBRILLATION; CHEST COMPRESSION DEVICE; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; WAVE-FORM; CIRCULATION TIMES; EPINEPHRINE; VASOPRESSIN; SURVIVAL	Sudden cardiac death is a major clinical problem, causing 300 000 to 400000 deaths annually and 63% of all cardiac deaths. Despite the overall decrease in cardiovascular mortality, the proportion of cardiovascular death from sudden cardiac death has remained constant. Survival rates among patients who have out-of-hospital cardiac arrest vary from 5% to 18%, depending on the presenting rhythm. The latest guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care published by the American Heart Association include substantial changes to the algorithms for basic life support and advanced cardiovascular life support. For unwitnessed cardiac arrest, immediate defibrillation of the patient is no longer recommended. Rather, 2 minutes of CPR before defibrillation is now recommended. People in cardiac arrest should no longer receive stacked shocks. The compression-ventilation ratio has been changed from 15:2 to 30:2. This article is a contemporary review of the management of CPR and emergency cardiovascular care. It examines current practice and data supporting use of CPR, along with changes in the management of sudden cardiac death.	Atlanta Vet Affairs Med Ctr, Decatur, GA USA; Emory Univ, Sch Med, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Zafari, AM (corresponding author), Emory Univ, Div Cardiol, Woodruff Mem Res Bldg, Room 322,1639 Pierce Dr, Atlanta, GA 30332 USA.	azafari@emory.edu	Zafari, Abarmard/GRF-6849-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL079156] Funding Source: NIH RePORTER; NHLBI NIH HHS [1U01HL079156] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; *AM HEART ASS, 2003, CURR OPIN CARDIOL, V18, P14; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; AUBLE TE, 1995, ANN EMERG MED, V25, P642, DOI 10.1016/S0196-0644(95)70178-8; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BARSAN WG, 1981, ANN EMERG MED, V10, P73, DOI 10.1016/S0196-0644(81)80339-3; Berg MD, 2005, RESUSCITATION, V64, P287, DOI 10.1016/j.resuscitation.2004.07.017; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; BROWN DC, 1979, JACEP-J AM COLL EMER, V8, P448, DOI 10.1016/S0361-1124(79)80058-1; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Carpenter J, 2003, RESUSCITATION, V59, P189, DOI 10.1016/S0300-9572(03)00183-7; CHANDRASTROBOS N, 2004, HURSTS HEART, P1030; CHOUX C, 1995, RESUSCITATION, V29, P3, DOI 10.1016/0300-9572(94)00810-3; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; COON GA, 1981, ANN EMERG MED, V10, P462, DOI 10.1016/S0196-0644(81)80277-6; Crile G, 1906, J EXP MED, V8, P713, DOI 10.1084/jem.8.6.713; CUMMINS RO, 1995, ANN EMERG MED, V25, P833; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; DEVRIES W, 2004, NEW ENGL J MED, V351, P637; DITCHEY RV, 1988, CIRCULATION, V78, P382, DOI 10.1161/01.CIR.78.2.382; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; EMERMAN CL, 1988, CRIT CARE MED, V16, P1138, DOI 10.1097/00003246-198811000-00011; *EUR RES COUNC VAS, 2004, NEW ENGL J MED, V350, P105; Gliner BE, 1999, RESUSCITATION, V41, P133, DOI 10.1016/S0300-9572(99)00040-4; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Guyette FX, 2004, RESUSCITATION, V63, P277, DOI 10.1016/j.resuscitation.2004.05.007; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Heidenreich JW, 2004, RESUSCITATION, V62, P283, DOI 10.1016/j.resuscitation.2004.05.013; Holmberg M, 1998, RESUSCITATION, V36, P29, DOI 10.1016/S0300-9572(97)00089-0; Holmberg M, 2001, EUR HEART J, V22, P511, DOI 10.1053/euhj.2000.2421; HORNCHEN U, 1987, CRIT CARE MED, V15, P1037; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jacobs Ian G, 2005, Emerg Med Australas, V17, P39, DOI 10.1111/j.1742-6723.2005.00694.x; KERN KB, 1990, RESUSCITATION, V20, P221, DOI 10.1016/0300-9572(90)90005-Y; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Kudenchuk PJ, 2006, CIRCULATION, V114, P2010, DOI 10.1161/CIRCULATIONAHA.106.636506; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; KUHN GJ, 1981, ANN EMERG MED, V10, P417, DOI 10.1016/S0196-0644(81)80308-3; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Martens PR, 2001, RESUSCITATION, V49, P233, DOI 10.1016/S0300-9572(01)00321-5; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Niemann JT, 2002, RESUSCITATION, V53, P153, DOI 10.1016/S0300-9572(02)00004-7; Ong MEH, 2006, JAMA-J AM MED ASSOC, V295, P2629, DOI 10.1001/jama.295.22.2629; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Schneider T, 2000, CIRCULATION, V102, P1780; Schwarz B, 2003, ANESTHESIOLOGY, V98, P1063, DOI 10.1097/00000542-200305000-00007; *STEER COMM CTR VA, 2005, RESUSCITATION, V66, P149; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; Stiell IG, 2001, LANCET, V358, P105, DOI 10.1016/S0140-6736(01)05328-4; STUEVEN HA, 1984, ANN EMERG MED, V13, P815, DOI 10.1016/S0196-0644(84)80447-3; TZIVONI D, 1988, CIRCULATION, V77, P392, DOI 10.1161/01.CIR.77.2.392; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; van Alem AP, 2003, RESUSCITATION, V58, P17, DOI 10.1016/S0300-9572(03)00106-0; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Waalewijn RA, 2001, RESUSCITATION, V50, P273, DOI 10.1016/S0300-9572(01)00354-9; WEAVER WD, 1982, NEW ENGL J MED, V307, P1101, DOI 10.1056/NEJM198210283071801; WEAVER WD, 1976, CIRCULATION, V54, P895, DOI 10.1161/01.CIR.54.6.895; WEISFELDT ML, 1995, CIRCULATION, V92, P2763, DOI 10.1161/01.CIR.92.9.2763; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; WEISFELDT ML, 1995, CIRCULATION, V92, P2740, DOI 10.1161/01.CIR.92.9.2740; Wenzel V, 1999, CIRCULATION, V99, P1379, DOI 10.1161/01.CIR.99.10.1379; Wenzel V, 2006, CRIT CARE, V10, DOI 10.1186/cc4846; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018; White RD, 2002, RESUSCITATION, V55, P17, DOI 10.1016/S0300-9572(02)00194-6; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; YAKAITIS RW, 1979, CRIT CARE MED, V7, P293, DOI 10.1097/00003246-197907000-00001; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E; Zafari AM, 2004, J AM COLL CARDIOL, V44, P846, DOI 10.1016/j.jacc.2004.04.054; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; 2005, CIRCULATION S, V112, P35; 2004, AM J CARDIOL, V93, P576; 2002, AM J CARDIOL, V90, P853; 2005, CIRCULATION, V122; 2005, CIRCULATION S, V112, P58	87	48	49	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					171	179		10.7326/0003-4819-147-3-200708070-00006	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17679705				2022-12-28	WOS:000248454700004
J	Hunt, P				Hunt, Paul			Right to the highest attainable standard of health	LANCET			English	Editorial Material									Univ Essex, Colchester CO4 3SQ, Essex, England	University of Essex	Hunt, P (corresponding author), Univ Essex, Colchester CO4 3SQ, Essex, England.	paulhunt28@yahoo.co.uk						ASHER J, 2004, RIGHT HLTH RESOURCE; British Medical Association (BMA), 2001, MED PROF HUM RIGHTS; Freedman LP, 2003, INT J GYNECOL OBSTET, V82, P111, DOI 10.1016/S0020-7292(03)00147-4; Kinney ED, 2004, CORNELL INT LAW J, V37, P285; *UN EC SOC COUNC, 2005, MISS ROM; *UN EC SOC COUNC, 2005, MISS PER; *UN EC SOC COUNC, REP SPEC RAPP RIGHT; *UN EC SOC COUNC, 2003, RIGHT EV ENJ HIGH AT; *UN EC SOC COUNC, 2006, MISS LEB ISR; *UN EC SOC COUNC, 2006, MISS UG; United Nations Economic and Social Council, 2006, SIT DET GUANT BAY; Yamin AE, 2005, HUM RIGHTS QUART, V27, P1200, DOI 10.1353/hrq.2005.0056	12	22	23	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					369	371		10.1016/S0140-6736(07)61173-8	http://dx.doi.org/10.1016/S0140-6736(07)61173-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197XL	17679000				2022-12-28	WOS:000248590200008
J	McGaugh, S				McGaugh, Stacy			Astronomy - Seeing through dark matter	SCIENCE			English	Editorial Material							SURFACE BRIGHTNESS GALAXIES; MODIFIED NEWTONIAN DYNAMICS; MASS; HYPOTHESIS		Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	McGaugh, S (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ssm@astro.umd.edu	McGaugh, Stacy/AAC-2757-2022	McGaugh, Stacy/0000-0002-9762-0980				Bekenstein JD, 2006, CONTEMP PHYS, V47, P387, DOI 10.1080/00107510701244055; Bekenstein JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.083509; Bournaud F, 2007, SCIENCE, V316, P1166, DOI 10.1126/science.1142114; CARIGNAN C, 1990, ASTRON ASTROPHYS, V234, P43; Clowe D, 2004, ASTROPHYS J, V604, P596, DOI 10.1086/381970; De Naray RK, 2006, ASTROPHYS J SUPPL S, V165, P461, DOI 10.1086/505345; FABER SM, 1979, ANNU REV ASTRON ASTR, V17, P135, DOI 10.1146/annurev.aa.17.090179.001031; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; McGaugh SS, 1998, ASTROPHYS J, V499, P66, DOI 10.1086/305629; McGaugh SS, 1998, ASTROPHYS J, V499, P41, DOI 10.1086/305612; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Portinari L, 2004, MON NOT R ASTRON SOC, V347, P691, DOI 10.1111/j.1365-2966.2004.07207.x; Sanders RH, 2003, MON NOT R ASTRON SOC, V342, P901, DOI 10.1046/j.1365-8711.2003.06596.x; Sanders RH, 2002, ANNU REV ASTRON ASTR, V40, P263, DOI 10.1146/annurev.astro.40.060401.093923	15	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					607	608		10.1126/science.1144534	http://dx.doi.org/10.1126/science.1144534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673645				2022-12-28	WOS:000248494400026
J	Tomlins, SA; Laxman, B; Dhanasekaran, SM; Helgeson, BE; Cao, XH; Morris, DS; Menon, A; Jing, XJ; Cao, Q; Han, B; Yu, JD; Wang, L; Montie, JE; Rubin, MA; Pienta, KJ; Roulston, D; Shah, RB; Varambally, S; Mehra, R; Chinnaiyan, AM				Tomlins, Scott A.; Laxman, Bharathi; Dhanasekaran, Saravana M.; Helgeson, Beth E.; Cao, Xuhong; Morris, David S.; Menon, Anjana; Jing, Xiaojun; Cao, Qi; Han, Bo; Yu, Jindan; Wang, Lei; Montie, James E.; Rubin, Mark A.; Pienta, Kenneth J.; Roulston, Diane; Shah, Rajal B.; Varambally, Sooryanarayana; Mehra, Rohit; Chinnaiyan, Arul M.			Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer	NATURE			English	Article							HIGH-FREQUENCY; EXPRESSION; TMPRSS2-ERG; TRANSLOCATIONS; IDENTIFICATION; MECHANISMS; RELEVANT; PATHWAYS; 3Q21	Recently, we identified recurrent gene fusions involving the 59 untranslated region of the androgen-regulated gene TMPRSS2 and the ETS (E26 transformation-specific) family genes ERG, ETV1 or ETV4 in most prostate cancers(1,2). Whereas TMPRSS2 ERG fusions are predominant, fewer TMPRSS2-ETV1 cases have been identified than expected on the basis of the frequency of high (outlier) expression of ETV1 (refs 3-13). Here we explore the mechanism of ETV1 outlier expression in human prostate tumours and prostate cancer cell lines. We identified previously unknown 59 fusion partners in prostate tumours with ETV1 outlier expression, including untranslated regions from a prostate-specific androgen-induced gene (SLC45A3) and an endogenous retroviral element (HERV-K_22q11.23), a prostate-specific androgen-repressed gene (C15orf21), and a strongly expressed housekeeping gene (HNRPA2B1). To study aberrant activation of ETV1, we identified two prostate cancer cell lines, LNCaP and MDA-PCa 2B, that had ETV1 outlier expression. Through distinct mechanisms, the entire ETV1 locus (7p21) is rearranged to a 1.5-megabase prostate-specific region at 14q13.3-14q21.1 in both LNCaP cells (cryptic insertion) and MDA- PCa 2B cells (balanced translocation). Because the common factor of these rearrangements is aberrant ETV1 overexpression, we recapitulated this event in vitro and in vivo, demonstrating that ETV1 overexpression in benign prostate cells and in the mouse prostate confers neoplastic phenotypes. Identification of distinct classes of ETS gene rearrangements demonstrates that dormant oncogenes can be activated in prostate cancer by juxtaposition to tissue-specific or ubiquitously active genomic loci. Subversion of active genomic regulatory elements may serve as a more generalized mechanism for carcinoma development. Furthermore, the identification of androgen-repressed and insensitive 59 fusion partners may have implications for the anti-androgen treatment of advanced prostate cancer.	Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Pienta, Kenneth/E-7679-2015	Cao, Qi/0000-0002-5140-3681; Tomlins, Scott/0000-0001-8661-9821; Pienta, Kenneth/0000-0002-4138-2186; Varambally, Sooryanarayana/0000-0002-2277-1127; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Rubin, Mark/0000-0002-8321-9950				Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; DEMICHELIS F, 2007, ONCOGENE        0122, DOI DOI 10.1038/SJ.ONC.1210237; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Korenchuk S, 2001, IN VIVO, V15, P163; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; MEHRA R, 2007, MODERN PATHOL, V6, P1177; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Stauffer Yves, 2004, Cancer Immun, V4, P2; SUZUKAWA K, 1994, BLOOD, V84, P2681; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van Bokhoven A, 2003, PROSTATE, V57, P226, DOI 10.1002/pros.10291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiemels JL, 1999, CANCER RES, V59, P4075; Wieser R, 2002, LEUKEMIA LYMPHOMA, V43, P59, DOI 10.1080/10428190210196; Winnes M, 2007, ONCOL REP, V17, P1033; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	34	601	643	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					595	U9		10.1038/nature06024	http://dx.doi.org/10.1038/nature06024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671502	Green Published			2022-12-28	WOS:000248446700044
J	MacLennan, CA; Liu, MKP; White, SA; van Osterhout, JJG; Simukonda, F; Bwanali, J; Moore, MJ; Zijlstra, EE; Drayson, MT; Molyneux, ME				MacLennan, Caman A.; Liu, Michael K. P.; White, Sarah A.; van Osterhout, Joep J. G.; Simukonda, Felanji; Bwanali, Joseph; Moore, Michael J.; Zijlstra, Eduard E.; Drayson, Mark T.; Molyneux, Malcolm E.			Diagnostic accuracy and clinical utility of a simplified low cos method of counting CD4 cells with flow cytometry in Malawi diagnostic accuracy study	BRITISH MEDICAL JOURNAL			English	Article							QUALITY ASSESSMENT; HIV; ENUMERATION; NUMBERS; UGANDA; BLOOD	Objectives To assess the diagnostic accuracy and clinical utility of a simplified low cost method for measuring absolute and percentage CD4 counts with flow cytometry. Design A CD4 counting method (Blantyre count) using a CD4 and CD45 antibody combination with reduced blood and reagent volumes. Diagnostic accuracy was assessed by measuring agreement of the index test with two other assays (TruCount and FACSCount). Clinical utility was investigated by comparing CD4 counts with the new assay with WHO clinical staging in patients with HIV. Setting Research laboratories and antiretroviral therapy clinic at a medical school and large government hospital in southern Malawi. Participants Assay comparisons were performed on consecutive blood samples sent for CD4 counting from 129 patients with HIV. Comparison of CD4 count with staging was conducted on 253 consecutive new patients attending the antiretroviral therapy clinic. Main outcome measures Limits of agreement with 95% confidence intervals between index test and reference standards. Results The limits of agreement for Blantyre count and TruCount were excellent (cell count -48.9 to 27.0 x 10(9)/l for absolute counts in the CD4 range <400 x 10(9)/l and -2.42% to 2.37% for CD4 percentage). The assay was affordable with reagent costs per test of $0.44 (0.22 pound, --E0.33) for both absolute count and CD4 percentage, an( $0.11 for CD4 percentage atone. Of 193 patients with clinical stage 1 or 11 disease, who were ineligible for antiretroviral therapy by clinical staging criteria, 73 (38% had CD4 counts <200 x 10(9)/l. By contrast, 12 (200/6) of 60 patients with stage III or IV disease had CD4 counts >350 x 10(9)/l. Conclusions This simplified method of counting CD4 cell. with flow cytometry has good agreement with established commercial assays, is affordable for routine clinical use in Africa, and could improve clinical decision making in patients with HIV.	Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre 3, Malawi; Univ Birmingham, Med Res Council Ctr Immune Regulat, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England; Univ Malawi, Dept Med, Coll Med, Blantyre 3, Malawi	University of Malawi; University of Birmingham; University of Malawi	MacLennan, CA (corresponding author), Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, POB 30096, Blantyre 3, Malawi.	c.maclennan@bham.ac.uk	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846; Drayson, Mark/0000-0002-1528-7564	Wellcome Trust [067902/Z/02/Z, 067902, 074124/Z/04/Z] Funding Source: Medline; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Brando B, 2000, CYTOMETRY, V42, P327, DOI 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F; BRANSON BM, POINT OF CARE RAPID; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Downing RG, 1998, J ACQ IMMUN DEF SYND, V18, P384, DOI 10.1097/00042560-199808010-00011; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Mandy F, 2002, CYTOMETRY, V50, P111, DOI 10.1002/cyto.10088; McKenna SL, 1997, AIDS, V11, pS103; NSO ICF, 2005, MAL DEM HLTH SURV 20; Schnizlein-Bick CT, 2000, CLIN DIAGN LAB IMMUN, V7, P336, DOI 10.1128/CDLI.7.3.336-343.2000; SCHOOF M, 2004, WALL STREET J   0114; *UNICEF UNAIDS MSF, SOURC PRIC SEL MED D; Whitby L, 2002, CYTOMETRY, V50, P102, DOI 10.1002/cyto.10094; *WHO, 2005, CD4 T CELL ENUMERATI; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	16	18	19	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					190	194		10.1136/bmj.39268.719780.BE	http://dx.doi.org/10.1136/bmj.39268.719780.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17638858	Green Submitted, Green Published			2022-12-28	WOS:000248662200030
J	Talarico, EF; Prather, AD				Talarico, Ernest F., Jr.; Prather, Andrew D.			Connecting the dots to make a difference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPEROSTOSIS-FRONTALIS-INTERNA					etalaric@iun.edu						Hershkovitz I, 1999, AM J PHYS ANTHROPOL, V109, P303, DOI 10.1002/(SICI)1096-8644(199907)109:3<303::AID-AJPA3>3.0.CO;2-I; MORGAGNI G, 1769, SED CAUS MORB SEATS; Ruhli FJ, 2004, HOMO, V55, P91, DOI 10.1016/j.jchb.2004.04.003; Sohmiya M, 2001, Nihon Ronen Igakkai Zasshi, V38, P218	4	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					381	382		10.1001/jama.298.4.381	http://dx.doi.org/10.1001/jama.298.4.381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652284				2022-12-28	WOS:000248269100001
J	Birkenhaeger, WH; Staessen, JA				Birkenhaeger, Willem H.; Staessen, Jan A.			Dual inhibition of the renin system by aliskiren and valsartan	LANCET			English	Editorial Material							CONVERTING-ENZYME-INHIBITORS; RECEPTOR BLOCKERS; ANGIOTENSIN; COMBINATION; THERAPY; DISEASE		Univ Leuven, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, BE-3000 Louvain, Belgium; Erasmus Univ, Rotterdam, Netherlands	KU Leuven; Erasmus University Rotterdam	Staessen, JA (corresponding author), Univ Leuven, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, BE-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637				Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; HIGGINS B, 2006, MANAGEMENT HYPERTENS; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Oparil S, 2007, LANCET, V370, P221, DOI 10.1016/S0140-6736(07)61124-6; Raebel MA, 2007, PHARMACOEPIDEM DR S, V16, P55, DOI 10.1002/pds.1217; STAESSEN J, 1981, J ENDOCRINOL, V91, P457, DOI 10.1677/joe.0.0910457; Staessen JA, 2006, LANCET, V368, P1449, DOI 10.1016/S0140-6736(06)69442-7; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Tigerstedt R., 1898, SKAND ARCH PHYSIOL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5	12	18	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2007	370	9583					195	196		10.1016/S0140-6736(07)61099-X	http://dx.doi.org/10.1016/S0140-6736(07)61099-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658374				2022-12-28	WOS:000248347900004
J	Xu, GY; Broholm, C; Soh, YA; Aeppli, G; DiTusa, JF; Chen, Y; Kenzelmann, M; Frost, CD; Ito, T; Oka, K; Takagi, H				Xu, Guangyong; Broholm, C.; Soh, Yeong-Ah; Aeppli, G.; DiTusa, J. F.; Chen, Ying; Kenzelmann, M.; Frost, C. D.; Ito, T.; Oka, K.; Takagi, H.			Mesoscopic phase coherence in a quantum spin fluid	SCIENCE			English	Article							NEUTRON-SCATTERING; HEISENBERG ANTIFERROMAGNETS; MAGNETIC EXCITATIONS; HALDANE-GAP; CHAIN; DYNAMICS; Y2BANIO5	Mesoscopic quantum phase coherence is important because it improves the prospects for handling quantum degrees of freedom in technology. Here we show that the development of such coherence can be monitored using magnetic neutron scattering from a one-dimensional spin chain of an oxide of nickel (Y2BaNiO5), a quantum spin fluid in which no classical static magnetic order is present. In the cleanest samples, the quantum coherence length is 20 nanometers, which is almost an order of magnitude larger than the classical antiferromagnetic correlation length of 3 nanometers. We also demonstrate that the coherence length can be modified by static and thermally activated defects in a quantitatively predictable manner.	Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; UCL, London Ctr Nanotechnol, London WC1H OAH, England; UCL, Dept Phys & Astrophys, London WC1H OAH, England; Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Chiba 2778561, Japan	Johns Hopkins University; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institute of Standards & Technology (NIST) - USA; Dartmouth College; University of London; University College London; University of London; University College London; Louisiana State University System; Louisiana State University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Xu, GY (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	gxu@bnl.gov	Broholm, Collin Leslie/E-8228-2011; Xu, Guangyong/A-8707-2010; TAKAGI, HIDENORI/Q-1041-2019; Takagi, Hidenori/B-2935-2010; Ito, Toshimitsu/K-8543-2012; Oka, Kunihiko/L-6888-2018; Kenzelmann, Michel/A-8438-2008; Kenzelmann, Michel/ABE-1645-2020	Broholm, Collin Leslie/0000-0002-1569-9892; Xu, Guangyong/0000-0003-1441-8275; TAKAGI, HIDENORI/0000-0001-5700-3761; Ito, Toshimitsu/0000-0003-2094-2807; Oka, Kunihiko/0000-0002-0159-124X; Kenzelmann, Michel/0000-0001-7913-4826; 				Altshuler BL, 2006, NUCL PHYS B, V739, P311, DOI 10.1016/j.nuclphysb.2006.01.022; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; BUYERS WJL, 1986, PHYS REV LETT, V56, P371, DOI 10.1103/PhysRevLett.56.371; Damle K, 1998, PHYS REV B, V57, P8307, DOI 10.1103/PhysRevB.57.8307; DENNIJS M, 1989, PHYS REV B, V40, P4709, DOI 10.1103/PhysRevB.40.4709; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; HUTCHINGS MT, 1972, PHYS REV B-SOLID ST, V5, P1999, DOI 10.1103/PhysRevB.5.1999; Ioffe LB, 2002, NATURE, V415, P503, DOI 10.1038/415503a; ITOH S, 1995, PHYS REV LETT, V74, P2375, DOI 10.1103/PhysRevLett.74.2375; JOSEPHSON BD, 1962, PHYS LETT, V1, P2511; Kellogg M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036801; Kenzelmann M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087202; Kenzelmann M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.134417; Kordonis K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.115901; NIGHTINGALE MP, 1986, PHYS REV B, V33, P659, DOI 10.1103/PhysRevB.33.659; RAMIREZ AP, 1994, PHYS REV LETT, V72, P3108, DOI 10.1103/PhysRevLett.72.3108; REGNAULT LP, 1994, PHYS REV B, V50, P9174, DOI 10.1103/PhysRevB.50.9174; RENARD JP, 1988, J APPL PHYS, V63, P3538, DOI 10.1063/1.340736; Sakaguchi T, 1996, J PHYS SOC JPN, V65, P3025, DOI 10.1143/JPSJ.65.3025; Schollwock U, 1996, PHYS REV B, V53, P3304, DOI 10.1103/PhysRevB.53.3304; Skalyo J, 1970, PHYS REV B-SOLID ST, V2, P4632, DOI 10.1103/PhysRevB.2.4632; Sologubenko AV, 2007, J LOW TEMP PHYS, V147, P387, DOI 10.1007/s10909-007-9317-x; Xu GY, 2000, SCIENCE, V289, P419, DOI 10.1126/science.289.5478.419; Xu GY, 1996, PHYS REV B, V54, pR6827, DOI 10.1103/PhysRevB.54.R6827; Yoshida M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117202; Zheludev A, 1996, PHYS REV B, V53, P15004, DOI 10.1103/PhysRevB.53.15004	28	32	32	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1049	1052		10.1126/science.1143831	http://dx.doi.org/10.1126/science.1143831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17656685	Green Submitted			2022-12-28	WOS:000248946700035
J	Donahoe, SM; Stewart, GC; McCabe, CH; Mohanavelu, S; Murphy, SA; Cannon, CP; Antman, EM				Donahoe, Sean M.; Stewart, Garrick C.; McCabe, Carolyn H.; Mohanavelu, Satishkumar; Murphy, Sabina A.; Cannon, Christopher P.; Antman, Elliott M.			Diabetes and mortality following acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; TIMI RISK SCORE; CARDIOVASCULAR-DISEASES; FASTING GLUCOSE; BLOOD-GLUCOSE; MELLITUS; PREVALENCE; THERAPY; INTERVENTION	Context The worldwide epidemic of diabetes mellitus is increasing the burden of cardiovascular disease, the leading cause of death among persons with diabetes. The independent effect of diabetes on mortality following acute coronary syndromes (ACS) is uncertain. Objective To evaluate the influence of diabetes on mortality following ACS using a large database spanning the full spectrum of ACS. Design, Setting, and Patients A subgroup analysis of patients with diabetes enrolled in randomized clinical trials that evaluated ACS therapies. Patients with ACS in 11 independent Thrombolysis in Myocardial Infarction (TIMI) Study Group clinical trials from 1997 to 2006 were pooled, including 62 036 patients (46 577 with ST-segment elevation myocardial infarction [STEMI] and 15 459 with unstable angina/non-STEMI [UA/NSTEMI]), of whom 10 613 (17.1%) had diabetes. A multivariable model was constructed to adjust for baseline characteristics, aspects of ACS presentation, and treatments for the ACS event. Main Outcome Measures Mortality at 30 days and 1 year following ACS among patients with diabetes vs patients without diabetes. Results Mortality at 30 days was significantly higher among patients with diabetes than without diabetes presenting with UA/NSTEMI (2.1% vs 1.1%, P < .001) and STEMI (8.5% vs 5.4%, P < .001). After adjusting for baseline characteristics and features and management of the ACS event, diabetes was independently associated with higher 30-day mortality after UA/NSTEMI (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.24-2.56) or STEMI (OR, 1.40; 95% CI, 1.24-1.57). Diabetes at presentation with ACS was associated with significantly higher mortality 1 year after UA/NSTEMI (hazard ratio [HR], 1.65; 95% CI, 1.30-2.10) or STEMI (HR, 1.22; 95% CI, 1.08-1.38). By 1 year following ACS, patients with diabetes presenting with UA/NSTEMI had a risk of death that approached patients without diabetes presenting with STEMI (7.2% vs 8.1%). Conclusion Despite modern therapies for ACS, diabetes confers a significant adverse prognosis, which highlights the importance of aggressive strategies to manage this high-risk population with unstable ischemic heart disease.	Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div,Dept Med, Boston, MA 02115 USA; Cornell Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	Antman, EM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div,Dept Med, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				[Anonymous], 2005, DIABETES CARE, V28, pS4; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Antman EM, 2002, CIRCULATION, V105, P1642, DOI 10.1161/01.CIR.0000013402.34759.46; Braunwald E, 2000, EUR HEART J, V21, P2005; Brooks MM, 2006, AM J CARDIOL, V97, p9G, DOI 10.1016/j.amjcard.2006.02.023; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS1; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Franklin K, 2004, ARCH INTERN MED, V164, P1457, DOI 10.1001/archinte.164.13.1457; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giugliano RP, 2003, J AM COLL CARDIOL, V41, P1251, DOI 10.1016/S0735-1097(03)00123-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kim SH, 2006, J AM COLL CARDIOL, V48, P293, DOI 10.1016/j.jacc.2006.03.043; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Ohman EM, 2005, AM HEART J, V150, P79, DOI 10.1016/j.ahj.2005.01.007; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; COMP 2 TREATMENTS MU	49	491	514	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					765	775		10.1001/jama.298.7.765	http://dx.doi.org/10.1001/jama.298.7.765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699010	Bronze			2022-12-28	WOS:000248728800021
J	Levi, SK; Glick, BS				Levi, Stephanie K.; Glick, Benjamin S.			GRAsPing unconventional secretion	CELL			English	Editorial Material							PROTEIN; PATHWAY; CELLS	GRASP proteins associate with the Golgi apparatus and have been implicated in the stacking of Golgi cisternae, vesicle tethering, and mitotic progression, but their specific functions are unclear. In this issue, Kinseth et al. ( 2007) show unexpectedly that a GRASP homolog is required for an unconventional secretory pathway that bypasses the usual route for Golgi-dependent membrane traffic.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Glick, BS (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	bsglick@uchicago.edu						Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; KINSETH MA, 2007, IN PRESS CELL; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317	10	19	19	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					407	409		10.1016/j.cell.2007.07.030	http://dx.doi.org/10.1016/j.cell.2007.07.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693251	Bronze			2022-12-28	WOS:000249038100009
J	Rousseau, P				Rousseau, Paul			Chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com						Ferrell BR, 2006, ONCOL NURS FORUM, V33, P922, DOI 10.1188/06.ONF.922-930	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					604	604		10.1001/jama.298.6.604	http://dx.doi.org/10.1001/jama.298.6.604			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684174				2022-12-28	WOS:000248574800001
J	Junge, W; Rutherford, AW				Junge, Wolfgang; Rutherford, A. William			Horst Tobias Witt (1922-2007) - Obituary	NATURE			English	Biographical-Item									Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany; CEA Saclay, iBiTec S, F-91191 Gif Sur Yvette, France	University Osnabruck; CEA; UDICE-French Research Universities; Universite Paris Saclay	Junge, W (corresponding author), Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany.	junge@uos.de; alfred.rutherford@cea.fr	Rutherford, Alfred W/A-7831-2019	Rutherford, Alfred W/0000-0002-3124-154X					0	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					425	425		10.1038/448425a	http://dx.doi.org/10.1038/448425a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653184	Bronze			2022-12-28	WOS:000248302700037
J	Kerr, DJ; Dunn, JA; Langman, MJ; Smith, JL; Midgley, RSJ; Stanley, A; Stokes, JC; Julier, P; Iveson, C; Duvvuri, R; McConkey, CC				Kerr, David J.; Dunn, Janet A.; Langman, Michael J.; Smith, Justine L.; Midgley, Rachel S. J.; Stanley, Andrew; Stokes, Joanne C.; Julier, Patrick; Iveson, Claire; Duvvuri, Ravi; McConkey, Christopher C.		VICTOR Trial Grp	Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYOCARDIAL-INFARCTION; ASPIRIN USE; RISK; INHIBITORS; ADENOMA; CHEMOPREVENTION; CELECOXIB	Background: Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal cancer. Methods: All serious adverse events that were cardiovascular thrombotic events were reviewed in 2434 patients with stage II or III colorectal cancer participating in a randomized, placebo-controlled trial of rofecoxib, 25 mg daily, started after potentially curative tumor resection and chemotherapy or radiotherapy as indicated. The trial was terminated prematurely owing to worldwide withdrawal of rofecoxib. To examine possible persistent risks, we examined cardiovascular thrombotic events reported up to 24 months after the trial was closed. Results: The median duration of active treatment was 7.4 months. The 1167 patients receiving rofecoxib and the 1160 patients receiving placebo were well matched, with a median follow-up period of 33.0 months (interquartile range, 27.6 to 40.1) and 33.4 months (27.7 to 40.4), respectively. Of the 23 confirmed cardiovascular thrombotic events, 16 occurred in the rofecoxib group during or within 14 days after the treatment period, with an estimated relative risk of 2.66 (from the Cox proportional-hazards model; 95% confidence interval [CI], 1.03 to 6.86; P=0.04). Analysis of the Antiplatelet Trialists' Collaboration end point (the combined incidence of death from cardiovascular, hemorrhagic, and unknown causes; of nonfatal myocardial infarction; and of nonfatal ischemic and hemorrhagic stroke) gave an unadjusted relative risk of 1.60 (95% CI, 0.57 to 4.51; P=0.37). Fourteen more cardiovascular thrombotic events, six in the rofecoxib group, were reported within the 2 years after trial closure, with an overall unadjusted relative risk of 1.50 (95% CI, 0.76 to 2.94; P=0.24). Four patients in the rofecoxib group and two in the placebo group died from thrombotic causes during or within 14 days after the treatment period, and during the follow-up period, one patient in the rofecoxib group and five patients in the placebo group died from cardiovascular causes. Conclusions: Rofecoxib therapy was associated with an increased frequency of adverse cardiovascular events among patients with a median study treatment of 7.4 months' duration.	Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oncol Clin Trials Off, Oxford OX2 6HA, England; Univ Warwick, Warwick Med Sch, Ctr Stat, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; City Hosp, Birmingham, W Midlands, England	Radcliffe Infirmary; University of Oxford; University of Warwick; University of Birmingham	Kerr, DJ (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oncol Clin Trials Off, Woodstock Rd, Oxford OX2 6HA, England.	david.kerr@clinpharm.ox.ac.uk		Dunn, Janet/0000-0001-7313-4446; Kerr, Rachel/0000-0002-7240-3269				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; European Medicines Agency E, 2006, PUBLIC CHMP ASS REP; Fenwick SW, 2003, GASTROENTEROLOGY, V125, P716, DOI 10.1016/S0016-5085(03)01061-8; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Gray RG, 2000, LANCET, V355, P1588; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Lagakos SW, 2006, NEW ENGL J MED, V355, P113, DOI 10.1056/NEJMp068137; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Midgley RSJ, 2000, BRIT MED J, V321, P1208, DOI 10.1136/bmj.321.7270.1208; Moussa O, 2005, CANCER RES, V65, P11581, DOI 10.1158/0008-5472.CAN-05-1622; Oshima M, 2001, CANCER RES, V61, P1733; *QUASAR COLL, 2004, JCLIN ONCOL S14, V22, pA3501; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; SHEEHAN KM, 2000, JAMA-J AM MED ASSOC, V283, P1427; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; THUN MJ, 1993, CANCER RES, V53, P1322	25	96	102	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					360	369		10.1056/NEJMoa071841	http://dx.doi.org/10.1056/NEJMoa071841			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652651	Green Published, Bronze			2022-12-28	WOS:000248283500007
J	Mulholland, K				Mulholland, Kim			Childhood pneumonia mortality - a permanent global emergency	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; SERIOUSLY ILL CHILDREN; DISEASE; MALARIA; HEALTH; IMPACT; DEATH; CARE		Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Mulholland, K (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	kim.mulholland@lshtm.ac.uk						BARROS FC, 1992, PEDIATRICS, V90, P238; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cohen R, 2006, PEDIATR INFECT DIS J, V25, P1001, DOI 10.1097/01.inf.0000243163.85163.a8; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Duke T, 2004, LANCET, V363, P1922, DOI 10.1016/S0140-6736(04)16438-6; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Dyson T., 1997, INFANT CHILD MORTALI, P109; GARENNE M, 2000, CAUSES CIRCONSTANCES; *GAVI ALL, COUNTR SUPP; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Hambidge KM, 2006, AM J CLIN NUTR, V83, P991, DOI 10.1093/ajcn/83.5.991; Hetzel Alice, 1968, VITAL STAT RATES US; HOLT LE, 1913, ARCH PEDIATR, V30, P885; Kersting M, 2006, BRIT J NUTR, V95, P1229, DOI 10.1079/BJN20061768; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; MINUJIN A, 2003, EQUALITY MATTERS WOR; Mulholland EK, 2005, NEW ENGL J MED, V352, P75, DOI 10.1056/NEJMe048306; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Pio A, 2003, B WORLD HEALTH ORGAN, V81, P298; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Preston S. H., 1991, FATAL YEARS CHILD MO; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Smith KR, 2006, EPIDEMIOLOGY, V17, pS45, DOI 10.1097/00001648-200611001-00079; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Weber MW, 1999, J PEDIATR-US, V135, P683, DOI 10.1016/S0022-3476(99)70085-5; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; 1999, WHOCHSCAH9912	36	73	76	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					285	289		10.1016/S0140-6736(07)61130-1	http://dx.doi.org/10.1016/S0140-6736(07)61130-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658399				2022-12-28	WOS:000248347900033
J	Glinoer, D; Abalovich, M				Glinoer, Daniel; Abalovich, Marcos			Unresolved questions in managing hypothyroidism during pregnancy	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL THYROID-DEFICIENCY; SUBCLINICAL HYPOTHYROIDISM; WOMEN; COMPLICATIONS; DISEASE; CHILD		Hop Univ St Pierre, Dept Internal Med, Div Endocrinol, B-1000 Brussels, Belgium; Carlos Durand Hosp, Div Endocrinol, Buenos Aires, DF, Argentina	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Glinoer, D (corresponding author), Hop Univ St Pierre, Dept Internal Med, Div Endocrinol, B-1000 Brussels, Belgium.	dglinoer@ulb.ac.be						Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; Caixas A, 1999, J CLIN ENDOCR METAB, V84, P4000, DOI 10.1210/jc.84.11.4000; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; KAPLAN MM, 1992, THYROID, V2, P147, DOI 10.1089/thy.1992.2.147; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Poppe K, 2007, CLIN ENDOCRINOL, V66, P309, DOI 10.1111/j.1365-2265.2007.02752.x	10	24	28	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					300	302		10.1136/bmj.39189.513935.BE	http://dx.doi.org/10.1136/bmj.39189.513935.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17690371	Green Published			2022-12-28	WOS:000248987400027
J	Bucksbaum, PH				Bucksbaum, Philip H.			The future of attosecond Spectroscopy	SCIENCE			English	Review							HARMONIC-GENERATION; OPTICAL PULSES; LASER; COMPRESSION; IONIZATION; INTENSITY; GASES; FIELD	Attoscience is the study of physical processes that occur in less than a fraction of a cycle of visible light, in times less than a quadrillionth of a second. The motion of electrons inside atoms and molecules that are undergoing photoionization or chemical change falls within this time scale, as does the plasma motion that causes the reflectivity of metals. The techniques to study motion on this scale are based on careful control of strong-field laser-atom interactions. These techniques and new research opportunities in attosecond spectroscopy are reviewed.	Stanford Univ, Stanford Linear Accelerator Ctr, PULSE, Menlo Pk, CA 94025 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Bucksbaum, PH (corresponding author), Stanford Univ, Stanford Linear Accelerator Ctr, PULSE, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	phb@slac.stanford.edu		Bucksbaum, Philip/0000-0003-1258-5571				AUGST S, 1989, PHYS REV LETT, V63, P2212, DOI 10.1103/PhysRevLett.63.2212; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; FORK RL, 1987, OPT LETT, V12, P483, DOI 10.1364/OL.12.000483; Hauri CP, 2004, APPL PHYS B-LASERS O, V79, P673, DOI 10.1007/s00340-004-1650-z; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; KRAUSE JL, 1992, PHYS REV A, V45, P4998, DOI 10.1103/PhysRevA.45.4998; Lein M, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023805; LI XF, 1989, PHYS REV A, V39, P5751, DOI 10.1103/PhysRevA.39.5751; Lopez-Martens R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033001; Matsubara E, 2007, J OPT SOC AM B, V24, P985, DOI 10.1364/JOSAB.24.000985; Naumova NM, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1880032; Nisoli M, 1996, APPL PHYS LETT, V68, P2793, DOI 10.1063/1.116609; Schafer KJ, 1997, PHYS REV LETT, V78, P638, DOI 10.1103/PhysRevLett.78.638; SPENCE DE, 1991, OPT LETT, V16, P42, DOI 10.1364/OL.16.000042; Yao WM, 2006, J PHYS G NUCL PARTIC, V33, P1, DOI 10.1088/0954-3899/33/1/001; Zholents AA, 2005, PHYS REV SPEC TOP-AC, V8, DOI 10.1103/PhysRevSTAB.8.050704	18	109	109	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					766	769		10.1126/science.1142135	http://dx.doi.org/10.1126/science.1142135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690285				2022-12-28	WOS:000248624500029
J	Dimmeler, S; Zeiher, AM				Dimmeler, Stefanie; Zeiher, Andreas M.			A "reductionist" view of cardiomyopathy	CELL			English	Editorial Material								Oxidative stress due to the generation of reactive oxygen species has been implicated in many diseases. Rajasekaran et al. ( 2007) now make the surprising discovery that its counterpart "reductive stress," caused by an increase in reduced glutathione, contributes to cardiomyopathy triggered by protein aggregation.	Univ Frankfurt, Dept Internal Med 3, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Dept Internal Med 3, D-6000 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de		Dimmeler, Stefanie/0000-0002-1045-2436				Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Matsui R, 2006, ARTERIOSCL THROM VAS, V26, P910, DOI 10.1161/01.ATV.0000205850.49390.3b; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; RAJASEKARAN NS, 2007, CELL; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782	8	26	27	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					401	402		10.1016/j.cell.2007.07.028	http://dx.doi.org/10.1016/j.cell.2007.07.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693248	Bronze			2022-12-28	WOS:000249038100006
J	Nitzan, A				Nitzan, Abraham			Chemistry - Molecules take the heat	SCIENCE			English	Editorial Material							THERMAL CONDUCTANCE		Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nitzan, A (corresponding author), Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel.	nitzan@post.tau.ac.il						Chang CW, 2006, SCIENCE, V314, P1121, DOI 10.1126/science.1132898; Galperin M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/10/103201; Ge ZB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186101; Huang ZF, 2006, NANO LETT, V6, P1240, DOI 10.1021/nl0608285; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; Paulsson M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241403; Reddy P, 2007, SCIENCE, V315, P1568, DOI 10.1126/science.1137149; Saira OP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027203; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Schwarzer D, 2004, J CHEM PHYS, V121, P1754, DOI 10.1063/1.1765092; Segal D, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165426; Segal D, 2003, J CHEM PHYS, V119, P6840, DOI 10.1063/1.1603211; Wang RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358856; Wang ZH, 2007, SCIENCE, V317, P787, DOI 10.1126/science.1145220	15	48	49	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					759	760		10.1126/science.1147011	http://dx.doi.org/10.1126/science.1147011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690281				2022-12-28	WOS:000248624500025
J	Janssen, BJC; Read, RJ; Brunger, AT; Gros, P				Janssen, Bert J. C.; Read, Randy J.; Bruenger, Axel T.; Gros, Piet			Crystallography - Crystallographic evidence for deviating C3b structure?	NATURE			English	Letter							COMPLEMENT ACTIVATION; CRYSTAL-STRUCTURES; INSIGHTS		Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA	Utrecht University; University of Cambridge; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Janssen, BJC (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Gros, Piet/AAD-6452-2019; Janssen, Bert/I-3338-2016; Gros, Piet/I-5569-2016; Read, Randy J/L-1418-2013	Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Gros, Piet/0000-0002-7782-2585; Read, Randy J/0000-0001-8273-0047; Brunger, Axel/0000-0001-5121-2036	Wellcome Trust [050211] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; HUBBRD SJ, 1993, NACCESS COMPUTER PRO; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P2773, DOI 10.1073/pnas.88.7.2773; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	13	33	34	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					E1	E2		10.1038/nature06102	http://dx.doi.org/10.1038/nature06102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687277	Green Accepted, Green Submitted			2022-12-28	WOS:000248598000035
J	Stroncek, DF; Rebulla, P				Stroncek, David F.; Rebulla, Paolo			Transfusion Medicine 2 - Platelet transfusions	LANCET			English	Review							ACUTE LUNG INJURY; RANDOMIZED CONTROLLED-TRIAL; WHITE CELL-REDUCTION; SERONEGATIVE BLOOD-PRODUCTS; MOLECULARLY BASED ALGORITHM; BACTERIAL-CONTAMINATION; PATHOGEN INACTIVATION; IN-VITRO; ACUTE-LEUKEMIA; HISTOCOMPATIBILITY DETERMINATION	Ever since platelet transfusions were shown to reduce mortality from haemorrhage in patients with acute leukaemia in the 1950s, the use of this therapy has steadily grown to become an essential part of the treatment of cancer, haematological malignancies, marrow failure, and haematopoietic stem cell transplantation. Today, more than 1.5 million platelet products are transfused in the USA each year, 2.9 million products in Europe. However, platelet transfusion can transmit infections and trigger serious immune reactions and they can be rendered ineffective by alloimmunisation. There are several types of platelet components and all can be modified to reduce the chances of many of the complications of platelet transfusion. Transfusion practices, including indications for transfusion, dose of platelets transfused, and methods of treating alloimmunised recipients vary between countries, and even within countries. We review commonly used platelet components, product modifications, transfusion practices, and adverse consequences of platelet transfusions.	NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; Fdn Osped Maggiore Policlin Mangiagalli & Regina, Dept Regenerat Med, Ctr Transfus Med Cellular Therapy & Cryobiol, Milan, Italy	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); IRCCS Ca Granda Ospedale Maggiore Policlinico	Stroncek, DF (corresponding author), NIH, Dept Transfus Med, Ctr Clin, ID Ctr Dr,MSC 1184, Bethesda, MD 20892 USA.	dstroncek@cc.nih.gov	Rebulla, Paolo/I-7684-2015	Rebulla, Paolo/0000-0002-3875-5754				*AABB, 2004, STAND BLOOD BANKS TR; Ackerman SJ, 2000, TRANSFUSION, V40, P1457, DOI 10.1046/j.1537-2995.2000.40121457.x; Ancliff PJ, 1998, BLOOD REV, V12, P234, DOI 10.1016/S0268-960X(98)90004-2; ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; AuBuchon JP, 2005, TRANSFUSION, V45, P1356, DOI 10.1111/j.1537-2995.2005.00217.x; Balduini CL, 2001, LEUKEMIA, V15, P1885, DOI 10.1038/sj.leu.2402307; BERNSTEIN MJ, 1987, JAMA-J AM MED ASSOC, V257, P1777; BISHOP JF, 1992, TRANSFUSION MED, V2, P35, DOI 10.1111/j.1365-3148.1992.tb00132.x; BISHOP JF, 1991, TRANSFUSION, V31, P392, DOI 10.1046/j.1537-2995.1991.31591263191.x; Bock M, 1996, TRANSFUSION, V36, P952, DOI 10.1046/j.1537-2995.1996.36111297091736.x; Bode AP, 2000, TRANSFUS SCI, V22, P99, DOI 10.1016/S0955-3886(00)00028-X; BOLGIANO DC, 1989, TRANSFUSION, V29, P306, DOI 10.1046/j.1537-2995.1989.29489242795.x; BOWDEN RA, 1986, NEW ENGL J MED, V314, P1006, DOI 10.1056/NEJM198604173141602; BOWDEN RA, 1995, BLOOD, V86, P3598, DOI 10.1182/blood.V86.9.3598.bloodjournal8693598; Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005; Brecher ME, 2001, TRANSFUSION, V41, P477, DOI 10.1046/j.1537-2995.2001.41040477.x; BRECHER ME, 1994, TRANSFUSION, V34, P750, DOI 10.1046/j.1537-2995.1994.34994378273.x; BRITTINGHAM T E, 1957, Vox Sang, V2, P242; BRUGGERS CS, 1991, AM J PEDIAT HEMATOL, V13, P300; BUCHHOLZ DH, 1983, TRANSFUSION, V23, P190, DOI 10.1046/j.1537-2995.1983.23383224893.x; Burgstaler EA, 1997, J CLIN APHERESIS, V12, P55, DOI 10.1002/(SICI)1098-1101(1997)12:2<55::AID-JCA1>3.0.CO;2-8; Burstain JM, 1997, TRANSFUSION, V37, P255, DOI 10.1046/j.1537-2995.1997.37397240205.x; CARR JM, 1986, AM J MED, V80, P1051, DOI 10.1016/0002-9343(86)90664-9; Castro E, 1998, BRIT J HAEMATOL, V100, P245; CHRISTIE DJ, 1993, TRANSFUSION, V33, P234, DOI 10.1046/j.1537-2995.1993.33393174450.x; Cook RJ, 2004, TRANSFUSION, V44, P1135, DOI 10.1111/j.1537-2995.2004.03231.x; *COUNC EUR PUBL, 2006, GUID PREP US QUAL AS; de la Rubia J, 2002, TRANSFUSION, V42, P1384, DOI 10.1046/j.1537-2995.2002.00260.x; Densmore TL, 1999, TRANSFUSION, V39, P103, DOI 10.1046/j.1537-2995.1999.39199116901.x; DOUGHTY HA, 1994, VOX SANG, V66, P200, DOI 10.1111/j.1423-0410.1994.tb00310.x; DUNSTAN RA, 1984, TRANSFUSION, V24, P243, DOI 10.1046/j.1537-2995.1984.24384225031.x; Duquesnoy RJ, 2002, HUM IMMUNOL, V63, P353, DOI 10.1016/S0198-8859(02)00381-6; Duquesnoy RJ, 2002, HUM IMMUNOL, V63, P339, DOI 10.1016/S0198-8859(02)00382-8; DUQUESNOY RJ, 1977, AM J HEMATOL, V2, P219, DOI 10.1002/ajh.2830020303; DZIK WH, 1992, TRANSFUSION, V32, P334, DOI 10.1046/j.1537-2995.1992.32492263447.x; FORD JM, 1976, LANCET, V2, P1167; Fournel JJ, 1997, TRANSFUSION, V37, P487, DOI 10.1046/j.1537-2995.1997.37597293878.x; Freireich EJ, 2000, BRIT J HAEMATOL, V111, P68, DOI 10.1046/j.1365-2141.2000.02144.x; GilFernandez JJ, 1996, BONE MARROW TRANSPL, V18, P931; GMUR J, 1991, LANCET, V338, P1223, DOI 10.1016/0140-6736(91)92098-M; GOLDFINGER D, 1971, NEW ENGL J MED, V284, P942, DOI 10.1056/NEJM197104292841704; Goldman M, 2005, TRANSFUS MED REV, V19, P2, DOI 10.1016/j.tmrv.2004.10.001; Goodnough LT, 2001, BLOOD, V98, P1346, DOI 10.1182/blood.V98.5.1346; GORDON LI, 1987, SEMIN HEMATOL, V24, P194; Haimowitz MD, 2005, LANCET, V365, P1596, DOI 10.1016/S0140-6736(05)66462-8; Hanseler E, 1996, AM J CLIN PATHOL, V105, P782; HANSON SR, 1985, BLOOD, V66, P1105; HARDING SA, 1975, J THORAC CARDIOV SUR, V70, P350; HEAL JM, 1986, TRANSFUSION, V26, P388, DOI 10.1046/j.1537-2995.1986.26486262751.x; Heaton WAL, 1997, TRANSFUS MED REV, V11, P116, DOI 10.1053/tm.1997.0110116; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Heddle NM, 2006, TRANSFUSION, V46, P903, DOI 10.1111/j.1537-2995.2006.00822.x; Heddle NM, 2002, TRANSFUSION, V42, P556, DOI 10.1046/j.1537-2995.2002.00094.x; Heddle NM, 1999, TRANSFUSION, V39, P231, DOI 10.1046/j.1537-2995.1999.39399219278.x; HEDDLE NM, 1994, NEW ENGL J MED, V331, P625, DOI 10.1056/NEJM199409083311001; HEIM MU, 1992, VOX SANG, V62, P165, DOI 10.1111/j.1423-0410.1992.tb01191.x; HERSH EM, 1965, J AMER MED ASSOC, V193, P105, DOI 10.1001/jama.1965.03090020019005; Hiippala S, 1998, VOX SANG, V74, P399, DOI 10.1111/j.1423-0410.1998.tb05449.x; Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hogman CF, 1997, TRANSFUS SCI, V18, P3, DOI 10.1016/S0955-3886(97)87108-1; HOWARD JE, 1978, TRANSFUSION, V18, P496, DOI 10.1046/j.1537-2995.1978.18478251250.x; Jafari M, 2002, NEW ENGL J MED, V347, P1075, DOI 10.1056/NEJMoa021050; KATZ AJ, 1981, TRANSFUSION, V21, P560, DOI 10.1046/j.1537-2995.1981.21582040820.x; KEEGAN T, 1992, TRANSFUSION, V32, P113, DOI 10.1046/j.1537-2995.1992.32292180138.x; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kerkhoffs JLH, 2006, BLOOD, V108, P3210, DOI 10.1182/blood-2006-04-020131; Klein HG, 2005, J INTERN MED, V257, P224, DOI 10.1111/j.1365-2796.2005.01451.x; Klumpp TR, 1996, BONE MARROW TRANSPL, V17, P1035; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; KURTZBERG J, 1987, AM J MED, V83, P30, DOI 10.1016/0002-9343(87)90548-1; Kuter DJ, 2001, BLOOD, V98, P1339, DOI 10.1182/blood.V98.5.1339; Laundy GJ, 2004, TRANSFUSION, V44, P814, DOI 10.1111/j.1537-2995.2004.03387.x; Lawrence JB, 2001, LEUKEMIA LYMPHOMA, V41, P67, DOI 10.3109/10428190109057955; Lee D, 1999, TRANSFUSION MED, V9, P93; LEE EJ, 1989, TRANSFUSION, V29, P384, DOI 10.1046/j.1537-2995.1989.29589284135.x; Legler TJ, 1997, ANN HEMATOL, V74, P185, DOI 10.1007/s002770050280; LEITMAN SF, 1985, TRANSFUSION, V25, P293, DOI 10.1046/j.1537-2995.1985.25485273804.x; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; LICHTIGER B, 1986, HAEMATOLOGIA, V19, P81; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; LIND SE, 1987, ANN INTERN MED, V106, P478, DOI 10.7326/0003-4819-106-3-478_1; Lozano M, 2005, TRANSFUSION, V45, P1984, DOI 10.1111/j.1537-2995.2005.00656.x; Maniatis A, 2005, BLOOD TRANSFUSION EU, P205; Mascaretti L, 2004, TRANSFUSION MED, V14, P105, DOI 10.1111/j.1365-3148.2004.0487.x; McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443; McFarland J, 1997, NEW ENGL J MED, V337, P1861; MCLEOD BC, 1982, SCAND J HAEMATOL, V28, P193; MOROFF G, 1992, TRANSFUSION, V32, P633, DOI 10.1046/j.1537-2995.1992.32792391036.x; Murphy S, 1996, TRANSFUSION, V36, P751, DOI 10.1046/j.1537-2995.1996.36896374382.x; Murphy S, 2005, TRANSFUSION, V45, P634, DOI 10.1111/j.0041-1132.2005.04467.x; MURPHY S, 1982, BLOOD, V60, P194; Murray NA, 2004, ARCH DIS CHILD-FETAL, V89, P101, DOI 10.1136/adc.2002.019760; Nambiar A, 2006, BLOOD, V107, P1680, DOI 10.1182/blood-2004-10-4080; Norol F, 1998, BLOOD, V92, P1448, DOI 10.1182/blood.V92.4.1448.416k10_1448_1453; NOVOTNY VMJ, 1995, BLOOD, V85, P1736, DOI 10.1182/blood.V85.7.1736.bloodjournal8571736; Novotny VMJ, 1996, TRANSFUSION, V36, P438, DOI 10.1046/j.1537-2995.1996.36596282588.x; OCONNELL B, 1988, TRANSFUSION, V28, P66, DOI 10.1046/j.1537-2995.1988.28188127957.x; Ortolano GA, 2003, TRANSFUSION, V43, P1276, DOI 10.1046/j.1537-2995.2003.00487.x; PIERCE RN, 1985, TRANSFUSION, V25, P60, DOI 10.1046/j.1537-2995.1985.25185116506.x; PIETERSZ RNI, 1985, VOX SANG, V49, P81, DOI 10.1111/j.1423-0410.1985.tb00773.x; Pineda A, 2006, TRANSFUSION, V46, P562, DOI 10.1111/j.1537-2995.2006.00761.x; POPOVSKY MA, 1983, AM REV RESPIR DIS, V128, P185, DOI 10.1164/arrd.1983.128.1.185; PORRETTI L, 1994, VOX SANG, V67, P52, DOI 10.1111/j.1423-0410.1994.tb05038.x; Quillen K, 2000, NEW ENGL J MED, V343, P1422, DOI 10.1056/NEJM200011093431918; REBULLA P, 1993, TRANSFUSION MED, V3, P91, DOI 10.1111/j.1365-3148.1993.tb00108.x; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Rebulla P, 2005, HAEMATOLOGICA, V90, P247; Rebulla P, 2004, BRIT J HAEMATOL, V125, P83, DOI 10.1111/j.1365-2141.2004.04865.x; Rebulla P, 1998, VOX SANG, V74, P217, DOI 10.1111/j.1423-0410.1998.tb05423.x; RHAME FS, 1973, ANN INTERN MED, V78, P633, DOI 10.7326/0003-4819-78-5-633; Roberts I, 2003, ARCH DIS CHILD-FETAL, V88, pF359, DOI 10.1136/fn.88.5.F359; Rock G, 2004, TRANSFUSION, V44, P337, DOI 10.1111/j.1537-2995.2003.00670.x; Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744; Salama ME, 2004, TRANSFUS APHER SCI, V30, P93, DOI 10.1016/j.transci.2003.10.005; Sandler SG, 2006, TRANSFUSION, V46, P10, DOI 10.1111/j.1537-2995.2006.00686.x; Sanz C, 2001, TRANSFUSION, V41, P762, DOI 10.1046/j.1537-2995.2001.41060762.x; Satake M, 2004, INT J HEMATOL, V80, P306, DOI 10.1532/IJH97.04118; Schaefer-Eckart K, 2006, BLOOD, V108, p174A, DOI 10.1182/blood.V108.11.577.577; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; SCHIFFER CA, 1986, BLOOD, V67, P1591; Schnaidt M, 1996, TRANSFUSION MED, V6, P111, DOI 10.1046/j.1365-3148.1996.d01-58.x; Seftel MD, 2004, BLOOD, V103, P333, DOI 10.1182/blood-2003-03-0940; Sensebe L, 2005, BLOOD, V105, P862, DOI 10.1182/blood-2004-05-1841; Silliman CC, 2006, BLOOD REV, V20, P139, DOI 10.1016/j.blre.2005.11.001; SIMON TL, 1984, ANN THORAC SURG, V37, P359, DOI 10.1016/S0003-4975(10)60755-2; Slichter SJ, 2006, BLOOD, V108, p175A, DOI 10.1182/blood.V108.11.580.580; SLICHTER SJ, 1976, BRIT J HAEMATOL, V34, P403, DOI 10.1111/j.1365-2141.1976.tb03587.x; Slichter SJ, 2005, BLOOD, V105, P4106, DOI 10.1182/blood-2003-08-2724; SLICHTER SJ, 1978, BRIT J HAEMATOL, V38, P131, DOI 10.1111/j.1365-2141.1978.tb07115.x; Stanworth SJ, 2005, BRIT J HAEMATOL, V131, P588, DOI 10.1111/j.1365-2141.2005.05769.x; STANWORTH SJ, 2004, COCHRANE DB SYST REV, V2; Strauss RG, 2005, CURR OPIN HEMATOL, V12, P499; Strauss RG, 2004, TRANSFUSION, V44, P1680, DOI 10.1111/j.0041-1132.2004.04378.x; Sullivan MT, 2005, TRANSFUSION, V45, P141, DOI 10.1111/j.1537-2995.2004.03288.x; Sweeney J, 2006, TRANSFUSION, V46, P835, DOI 10.1111/j.1537-2995.2006.00804.x; TAKAHASHI K, 1987, TRANSFUSION, V27, P394, DOI 10.1046/j.1537-2995.1987.27587320531.x; TILLY H, 1990, AM J HEMATOL, V34, P75, DOI 10.1002/ajh.2830340118; Tinmouth A, 2004, TRANSFUSION, V44, P1711, DOI 10.1111/j.0041-1132.2004.04118.x; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; TURNER VS, 1994, J CLIN APHERESIS, V9, P189, DOI 10.1002/jca.2920090309; Vamvakas EC, 2005, TRANSFUS MED REV, V19, P181, DOI 10.1016/j.tmrv.2005.02.002; van der Meer PF, 2005, VOX SANG, V88, P227, DOI 10.1111/j.1423-0410.2005.00621.x; Vassallo R R, 2004, Immunohematology, V20, P226; Wagner SJ, 1996, TRANSFUSION, V36, P989, DOI 10.1046/j.1537-2995.1996.36111297091744.x; Wagner SJ, 1998, TRANSFUSION, V38, P674, DOI 10.1046/j.1537-2995.1998.38798346637.x; WALTER CW, 1952, SURG GYNECOL OBSTET, V94, P687; Wandt H, 2006, BONE MARROW TRANSPL, V37, P387, DOI 10.1038/sj.bmt.1705246; Wandt H, 1998, BLOOD, V91, P3601; WOODMAN RC, 1990, BLOOD, V76, P1680; YAMAMOTO M, 1990, AM J HEMATOL, V33, P220, DOI 10.1002/ajh.2830330312; YOMTOVIAN R, 1993, TRANSFUSION, V33, P902, DOI 10.1046/j.1537-2995.1993.331194082380.x; ZEIGLER ZR, 1987, BLOOD, V70, P1433; 1996, BCSH BLOOD TRANSFUSI, V6, P261	155	210	226	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					427	438		10.1016/S0140-6736(07)61198-2	http://dx.doi.org/10.1016/S0140-6736(07)61198-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679020	Green Submitted			2022-12-28	WOS:000248590200033
J	Auffray, C; Fogg, D; Garfa, M; Elain, G; Join-Lambert, O; Kayal, S; Sarnacki, S; Cumano, A; Lauvau, G; Geissmann, F				Auffray, Cedric; Fogg, Darin; Garfa, Meriem; Elain, Gaelle; Join-Lambert, Olivier; Kayal, Samer; Sarnacki, Sabine; Cumano, Ana; Lauvau, Gregoire; Geissmann, Frederic			Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior	SCIENCE			English	Article							DENDRITIC CELLS; IN-VIVO; FRACTALKINE; ADHESION; IDENTIFICATION; CHEMOKINE; DISTINCT; RECRUITMENT; MACROPHAGES; EMIGRATION	The cellular immune response to tissue damage and infection requires the recruitment of blood leukocytes. This process is mediated through a classical multistep mechanism, which involves transient rolling on the endothelium and recognition of inflammation followed by extravasation. We have shown, by direct examination of blood monocyte functions in vivo, that a subset of monocytes patrols healthy tissues through long-range crawling on the resting endothelium. This patrolling behavior depended on the integrin LFA-1 and the chemokine receptor CX(3)CR1 and was required for rapid tissue invasion at the site of an infection by this "resident" monocyte population, which initiated an early immune response and differentiated into macrophages.	Inst Federat Rech Necker Enfants Malades, INSERM, Lab Biol Mononucl Phagocyte Syst, U838, Paris, France; Inst Federat Rech Necker Enfants Malades, INSERM, Cellular & Mol Imaging Core Facil, U838, Paris, France; Univ Paris 05, Paris, France; Hop Necker Enfants Malad, AP HP, Paris, France; Inst Pasteur, INSERM, Unite Dev Lymphocytes, U668, Paris, France; Inst Pharmacol Mol & Cellulaire, INSERM, E03 44, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Geissmann, F (corresponding author), Inst Federat Rech Necker Enfants Malades, INSERM, Lab Biol Mononucl Phagocyte Syst, U838, Paris, France.	geissmann@necker.fr	VOUGNY, Marie-Christine/K-8938-2017; Sarnacki, Sabine/I-2692-2017; Join-Lambert, Olivier/AAE-5205-2019; Auffray, Cedric/M-3225-2017	Sarnacki, Sabine/0000-0003-4304-5578; GARFA TRAORE, Meriem/0000-0001-8597-6472; Cumano, Ana/0000-0002-4578-959X; geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fischer A, 1988, Immunodefic Rev, V1, P39; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steppich B, 2000, AM J PHYSIOL-CELL PH, V279, pC578, DOI 10.1152/ajpcell.2000.279.3.C578; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011	27	1313	1347	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					666	670		10.1126/science.1142883	http://dx.doi.org/10.1126/science.1142883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673663				2022-12-28	WOS:000248494400047
J	Lowrance, WW; Collins, FS				Lowrance, William W.; Collins, Francis S.			Ethics - Identifiability in genomic research	SCIENCE			English	Editorial Material							PRIVACY		NHGRI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lowrance, WW (corresponding author), 72 Rue St Jean, CH-1201 Geneva, Switzerland.	lowrance@iprolink.ch; francisc@mail.nih.gov						Butler J. M., 2005, FORENSIC DNA TYPING; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; *C RES SERV, 2005, FED PROT HUM RES SUB; *DEP HHS, MED PRIV NAT STAND P; *EUR COMM, DAT PROT EUR UN EU; Kohane IS, 2007, SCIENCE, V316, P836, DOI 10.1126/science.1135489; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lin Z, 2006, SCIENCE, V313, P441; LOWRANCE WILLIAM W., 2006, ACCESS COLLECTIONS D; LOWRANCE WW, 2002, LEARNING EXPERIENCE, P32; Malin B, 2000, J AM MED INFORM ASSN, P537; Malin BA, 2005, J AM MED INFORM ASSN, V12, P28, DOI 10.1197/jamia.M1603; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; National Human Genome Research Institute, 2003, REAFF EXT NHGRI RAP; *NIH, PROT PERS HLTH INF R; *NIH, 2006, CERT CONF KIOSK; Wellcome Trust, POL DAT MAN SHAR	17	129	132	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					600	602		10.1126/science.1147699	http://dx.doi.org/10.1126/science.1147699			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673640				2022-12-28	WOS:000248494400021
J	Simhan, HN; Caritis, SN				Simhan, Hyagriv N.; Caritis, Steve N.			Drug therapy: Prevention of preterm delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PATENT DUCTUS-ARTERIOSUS; MAGNESIUM-SULFATE; DOUBLE-BLIND; CONTROLLED-TRIAL; NITRIC-OXIDE; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; CYCLOOXYGENASE-2 INHIBITOR; CALCIUM-CONCENTRATION; UTERINE CONTRACTIONS; ANTAGONIST ATOSIBAN		Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Simhan, HN (corresponding author), 300 Halket St, Pittsburgh, PA 15213 USA.	hsimhan@mail.magee.edu		caritis, steve/0000-0002-2169-0712	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Andrews WW, 2003, OBSTET GYNECOL, V101, P847, DOI 10.1016/S0029-7844(03)00172-8; [Anonymous], 2003, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD002255; Anotayanonth S, 2004, COCHRANE DB SYST REV, V4; Bailit JL, 2007, AM J OBSTET GYNECOL, V196, P219, DOI 10.1016/j.ajog.2006.12.021; Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berghella V, 2005, OBSTET GYN CLIN N AM, V32, P383, DOI 10.1016/j.ogc.2005.04.007; Bisits A, 2004, AM J OBSTET GYNECOL, V191, P683, DOI 10.1016/j.ajog.2004.02.019; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; CARITIS SN, 1979, AM J OBSTET GYNECOL, V133, P557, DOI 10.1016/0002-9378(79)90292-8; CARITIS SN, 1987, AM J PHYSIOL, V253, pE410, DOI 10.1152/ajpendo.1987.253.4.E410; CARITIS SN, 1991, AM J OBSTET GYNECOL, V164, P1005, DOI 10.1016/0002-9378(91)90574-B; Challis JRG, 2002, REPRODUCTION, V124, P1; Cordero L, 2007, J PERINATOL, V27, P158, DOI 10.1038/sj.jp.7211659; COX SM, 1990, AM J OBSTET GYNECOL, V163, P767, DOI 10.1016/0002-9378(90)91065-K; CREASY RK, 1980, OBSTET GYNECOL, V55, P692; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Crowther CA, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001060; CUNZE T, 1995, INT J GYNECOL OBSTET, V48, P9, DOI 10.1016/0020-7292(94)02217-8; DARBY MJ, 1989, OBSTET GYNECOL, V74, P88; DUDLEY DKL, 1985, AM J OBSTET GYNECOL, V151, P181, DOI 10.1016/0002-9378(85)90008-0; El-Sayed YY, 1999, OBSTET GYNECOL, V93, P79, DOI 10.1016/S0029-7844(98)00337-8; Elder H A, 1967, Antimicrob Agents Chemother (Bethesda), V7, P101; FERGUSON JE, 1989, AM J OBSTET GYNECOL, V161, P788, DOI 10.1016/0002-9378(89)90403-1; Fomin VP, 2006, AM J OBSTET GYNECOL, V194, P1384, DOI 10.1016/j.ajog.2005.11.045; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FORMAN A, 1986, ACTA PHARMACOL TOX, V58, P183; FOULON W, 1986, OBSTET GYNECOL, V68, P280; Gibler WB, 2005, CIRCULATION, V111, P2699, DOI 10.1161/01.CIR.0000165556.44271.BE; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2001, AM J OBSTET GYNECOL, V185, P643, DOI 10.1067/mob.2001.116752; Gomez, 2005, AM J OBSTET GYNECOL, V193, P308; Gomez R, 2005, AM J OBSTET GYNECOL, V192, P350, DOI 10.1016/j.ajog.2004.09.034; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; GOODWIN TM, 1994, AM J OBSTET GYNECOL, V170, P474, DOI 10.1016/S0002-9378(94)70214-4; Goodwin TM, 1996, AM J PERINAT, V13, P143, DOI 10.1055/s-2007-994312; GORDON MC, 1995, CLIN OBSTET GYNECOL, V38, P697, DOI 10.1097/00003081-199538040-00004; Grimes DA, 2006, OBSTET GYNECOL, V108, P986, DOI 10.1097/01.AOG.0000236445.18265.93; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; Hammerman C, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e56; Hartmann K, 1999, OBSTET GYNECOL, V93, P504, DOI 10.1016/S0029-7844(98)00497-9; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Hoyert DL, 2006, PEDIATRICS, V117, P2338, DOI 10.1524/peds.2006-1079; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 1998, PRENAT NEONAT MED, V3, P138; KAMINSKI M, 1974, J PERINAT MED, V2, P37, DOI 10.1515/jpme.1974.2.1.37; KEIRSE MJNC, 1990, BRIT J OBSTET GYNAEC, V97, P149, DOI 10.1111/j.1471-0528.1990.tb01740.x; King J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub2; KING JF, 1988, BRIT J OBSTET GYNAEC, V95, P211, DOI 10.1111/j.1471-0528.1988.tb06860.x; Klein LL, 2004, AM J OBSTET GYNECOL, V190, P1493, DOI 10.1016/j.ajog.2004.03.014; KUMAR D, 1963, AM J OBSTET GYNECOL, V86, P1036, DOI 10.1016/S0002-9378(16)35290-5; KURTZMAN JL, 1993, AM J PERINAT, V10, P450; Lamont RF, 2000, BRIT J OBSTET GYNAEC, V107, P439, DOI 10.1111/j.1471-0528.2000.tb13259.x; Ledingham MA, 2000, BRIT J OBSTET GYNAEC, V107, P581, DOI 10.1111/j.1471-0528.2000.tb13297.x; Lees CC, 1999, OBSTET GYNECOL, V94, P403, DOI 10.1016/S0029-7844(99)00296-3; Lemancewicz A, 2000, HUM REPROD, V15, P2018, DOI 10.1093/humrep/15.9.2018; LIGGINS GC, 1972, PEDIATRICS, V50, P515; LIGGINS GC, 1969, J ENDOCRINOL, V45, P515, DOI 10.1677/joe.0.0450515; Lockwood CJ, 2005, AM J PATHOL, V167, P1443, DOI 10.1016/S0002-9440(10)61230-8; Lockwood CJ, 1999, J PERINAT MED, V27, P5, DOI 10.1515/JPM.1999.001; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; MAIN DM, 1987, OBSTET GYNECOL, V69, P61; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Meis PJ, 2003, NEW ENGL J MED, V349, P1087; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mittendorf R, 2002, AM J OBSTET GYNECOL, V186, P1111, DOI 10.1067/mob.2002.123544; MIZUKI J, 1993, AM J OBSTET GYNECOL, V169, P134, DOI 10.1016/0002-9378(93)90147-B; MORALES WJ, 1993, AM J OBSTET GYNECOL, V169, P97, DOI 10.1016/0002-9378(93)90138-9; Moutquin JM, 2000, AM J OBSTET GYNECOL, V182, P1191, DOI 10.1067/mob.2000.104950; NIEBYL JR, 1986, AM J OBSTET GYNECOL, V155, P747, DOI 10.1016/S0002-9378(86)80012-6; NIEBYL JR, 1980, AM J OBSTET GYNECOL, V136, P1014, DOI 10.1016/0002-9378(80)90629-8; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Papatsonis D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub2; Papatsonis DNM, 1997, OBSTET GYNECOL, V90, P230, DOI 10.1016/S0029-7844(97)00182-8; PAPIERNIK E, 1984, CLIN OBSTET GYNAECOL, V11, P315; PAPIERNIK E, 1974, J PERINAT MED, V2, P30, DOI 10.1515/jpme.1974.2.1.30; PERRY KG, 1995, AM J OBSTET GYNECOL, V173, P1273, DOI 10.1016/0002-9378(95)91369-6; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; PHANEUF S, 1994, AM J OBSTET GYNECOL, V171, P1627, DOI 10.1016/0002-9378(94)90414-6; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Romero R, 2000, AM J OBSTET GYNECOL, V182, P1173, DOI 10.1067/mob.2000.95834; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Rosen T, 2002, J Matern Fetal Neonatal Med, V11, P11, DOI 10.1080/713605444; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Sadovsky Y, 2000, AM J OBSTET GYNECOL, V182, P370, DOI 10.1016/S0002-9378(00)70226-2; Sakai M, 2001, MOL HUM REPROD, V7, P595, DOI 10.1093/molehr/7.6.595; SAWAYA GF, 1992, AM J OBSTET GYNECOL, V167, P512, DOI 10.1016/S0002-9378(11)91443-4; Sawdy R, 1997, LANCET, V350, P265, DOI 10.1016/S0140-6736(05)62229-5; Smith GN, 1999, BRIT J OBSTET GYNAEC, V106, P736, DOI 10.1111/j.1471-0528.1999.tb08376.x; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; SNYDER SW, 1989, AM J OBSTET GYNECOL, V161, P35, DOI 10.1016/0002-9378(89)90226-3; Souter D, 1998, AUST NZ J OBSTET GYN, V38, P11, DOI 10.1111/j.1479-828X.1998.tb02949.x; Suarez VR, 2002, AM J OBSTET GYNECOL, V187, P886, DOI 10.1067/mob.2002.127464; THORP JM, 1990, AM J OBSTET GYNECOL, V163, P655, DOI 10.1016/0002-9378(90)91218-2; Watson JE, 1996, J PEDIATR PSYCHOL, V21, P419, DOI 10.1093/jpepsy/21.3.419; WOODS D L, 1986, Pediatric Pathology, V6, P81; Wray S, 2003, J SOC GYNECOL INVEST, V10, P252, DOI 10.1016/S1071-5576(03)00089-3; Yallampalli C, 1998, J SOC GYNECOL INVEST, V5, P58, DOI 10.1016/S1071-5576(97)00106-8; Yousif MH, 1998, J PHARM PHARMACOL, V50, P681, DOI 10.1111/j.2042-7158.1998.tb06905.x; ZUCKERMAN H, 1984, J PERINAT MED, V12, P25, DOI 10.1515/jpme.1984.12.1.25	104	193	209	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					477	487		10.1056/NEJMra050435	http://dx.doi.org/10.1056/NEJMra050435			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671256				2022-12-28	WOS:000248436300009
J	Tonks, A				Tonks, Alison			A spoonful of antigen	BRITISH MEDICAL JOURNAL			English	Article							PLANT-DERIVED VACCINES; EDIBLE VACCINE; IMMUNOGENICITY; HUMANS					atonks@bmj.com						Arntzen C, 2005, VACCINE, V23, P1753, DOI 10.1016/j.vaccine.2005.01.090; Castle D, 2005, VACCINE, V23, P1881, DOI 10.1016/j.vaccine.2004.11.022; *DOW AGR SCI, 2006, DOW AGR SCI ACH WORL; HOYLE B, 2006, MICROBE, V1, P311; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Tacket CO, 2000, J INFECT DIS, V182, P302, DOI 10.1086/315653; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Thanavala Y, 2005, P NATL ACAD SCI USA, V102, P3378, DOI 10.1073/pnas.0409899102; VANDERLAAN JW, 2005, WHO INFORMAL CONSULT; Webster DE, 2002, MED J AUSTRALIA, V176, P434	10	1	3	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					180	182		10.1136/bmj.39275.480000.AD	http://dx.doi.org/10.1136/bmj.39275.480000.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17656541	Green Published			2022-12-28	WOS:000248662200026
J	Kerszberg, M; Wolpert, L				Kerszberg, Michel; Wolpert, Lewis			Specifying positional information in the embryo: Looking beyond morphogens	CELL			English	Article							GRADIENT FORMATION; SONIC HEDGEHOG; CELL POLARITY; TRANSPORT; PATTERN; ESTABLISHMENT; XENOPUS	Concentration gradients of small diffusible molecules called morphogens are key regulators of development, specifying position during pattern formation in the embryo. It is now becoming clear that additional or alternative mechanisms involving interactions among cells are also crucial for positional specification.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Paris 06, UMR 7138, CNRS, Paris, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Kerszberg, M (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	mkersz@ccr.jussieu.fr; profwolpert@yahoo.com						Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MEINHARDT H, 1978, J THEOR BIOL, V74, P307, DOI 10.1016/0022-5193(78)90078-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WOLPERT L, 2006, PRINCIPLES DEV, P24; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	37	109	110	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					205	209		10.1016/j.cell.2007.06.038	http://dx.doi.org/10.1016/j.cell.2007.06.038			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662932	Bronze			2022-12-28	WOS:000248588000007
J	Shiomi, D; Margolin, W				Shiomi, Daisuke; Margolin, William			A sweet sensor for size-conscious bacteria	CELL			English	Editorial Material								Bacteria, like eukaryotic cells, regulate their size by coordinating cell growth and division, growing faster and becoming larger when nutrients are more plentiful. Weart et al. (2007) now identify an enzyme in a glucolipid pathway that inhibits assembly of the key cell division protein FtsZ, but only during high nutrient conditions. Delaying cell division during rapid growth allows bacterial cells to become larger.	Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System	Margolin, W (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	william.margolin@uth.tmc.edu		Shiomi, Daisuke/0000-0002-8558-7175	NIGMS NIH HHS [R01 GM061074] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061074] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; WEART RB, 2007, CELL	9	9	9	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					216	218		10.1016/j.cell.2007.07.011	http://dx.doi.org/10.1016/j.cell.2007.07.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662935	Bronze			2022-12-28	WOS:000248588000010
J	Cayley, WE				Cayley, William E.			Preventing deep vein thrombosis in hospital inpatients	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; UNFRACTIONATED HEPARIN; METAANALYSIS; PROPHYLAXIS; SURGERY; RISK				Cayley, WE (corresponding author), Univ Wisconsin, Dept Family Med, Augusta Rural Training Site,Eau Claire Family Med, Augusta, WI 54701 USA.	bcayley@yahoo.com						Agnelli G, 2005, BRIT J SURG, V92, P1212, DOI 10.1002/bjs.5154; *AM COLL OBSTET GY, 2000, ACOG PRACT B, V21; AMARAGIRI SV, 2000, COCHRANE DATABASE SY, V0003; [Anonymous], 2007, VEN THROMB RED RISK; Brookenthal KR, 2001, J ARTHROPLASTY, V16, P293, DOI 10.1054/arth.2001.21499; Fitzmaurice DA, 2007, BMJ-BRIT MED J, V334, P1017, DOI 10.1136/bmj.39210.496505.BE; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Handoll HH., 2002, COCHRANE DB SYST REV, V4, pCD000305, DOI [10.1002/14651858.CD000305, DOI 10.1002/14651858.CD000305]; Hill J, 2007, BMJ-BRIT MED J, V334, P1053, DOI 10.1136/bmj.39174.678032.AD; Hull RD, 1999, ARCH INTERN MED, V159, P137, DOI 10.1001/archinte.159.2.137; *I CLIN SYST IMPR, 2005, VEN THROMB PROPH; Koch A, 2001, THROMB RES, V102, P295, DOI 10.1016/S0049-3848(01)00251-1; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Mismetti P, 2004, J THROMB HAEMOST, V2, P1058, DOI 10.1111/j.1538-7836.2004.00757.x; Mismetti P, 2001, BRIT J SURG, V88, P913, DOI 10.1046/j.0007-1323.2001.01800.x; O'Brien J, 2000, LANCET, V355, P1295; Oates-Whitehead RM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003679.pub2; Palmer AJ, 1997, HAEMOSTASIS, V27, P65; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Rasmussen MS., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001217, DOI 10.1002/14651858.CD001217]; Roderick P, 2005, HEALTH TECHNOL ASSES, V9, P1; *SCOTT INT GUID NE, 2002, PROPH VEN THROMB NAT; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99; Vanek VW, 1998, AM SURGEON, V64, P1050; Westrich GH, 2000, J BONE JOINT SURG BR, V82B, P795, DOI 10.1302/0301-620X.82B6.9869; Zufferey P, 2003, THROMB HAEMOSTASIS, V90, P654, DOI 10.1160/TH03-02-0086	26	26	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2007	335	7611					147	151		10.1136/bmj.39247.542477.AE	http://dx.doi.org/10.1136/bmj.39247.542477.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641348	Green Published			2022-12-28	WOS:000248428100036
J	Nordentoft, M; Hjorthoj, C				Nordentoft, Merete; Hjorthoj, Carsten			Cannabis use and risk of psychosis in later life	LANCET			English	Editorial Material							SCHIZOPHRENIA; COGNITION		Copenhagen Univ Hosp, Bispebjerg Hosp, Dept Psychiat, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Nordentoft, M (corresponding author), Copenhagen Univ Hosp, Bispebjerg Hosp, Dept Psychiat, DK-2400 Copenhagen, Denmark.	mn@dadlnet.dk	Nordentoft, Merete/AAH-3253-2019	Nordentoft, Merete/0000-0003-4895-7023; Hjorthoj, Carsten/0000-0002-6943-4785				Armitage P., 1987, STAT METHODS MED RES; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; European Monitoring Centre for Drugs and Drug Addiction, 2006, STAT B; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Solowij N, 2007, J PSYCHIATR NEUROSCI, V32, P30; Thorup A, 2007, PSYCHOL MED, V37, P479, DOI 10.1017/S0033291707009944; *UN OFF DRUGS CRIM, 2007, WORLD DRUG REP 2007	9	13	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					293	294		10.1016/S0140-6736(07)61135-0	http://dx.doi.org/10.1016/S0140-6736(07)61135-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662860				2022-12-28	WOS:000248426100004
J	Palinkas, LA; Suedfeld, P				Palinkas, Lawrence A.; Suedfeld, Peter			Psychological effects of polar expeditions	LANCET			English	Review							SEASONAL AFFECTIVE-DISORDER; PROLONGED ANTARCTIC RESIDENCE; EXTREME ENVIRONMENTS; PERSONALITY-CHARACTERISTICS; CIRCADIAN-RHYTHMS; SLEEP PATTERNS; PERFORMANCE; WINTER; BEHAVIOR; ADJUSTMENT	Polar expeditions include treks and stays at summer camps or year-round research stations. People on such expeditions generally undergo psychological changes resulting from exposure to long periods of isolation and confinement, and the extreme physical environment. Symptoms include disturbed sleep, impaired cognitive ability, negative affect, and interpersonal tension and conflict. Seasonal occurrence of these symptoms suggests the existence of three overlapping syndromes: the winter-over syndrome, the polar T3 syndrome, and subsyndromal seasonal affective disorder. About 5% of people on expeditions meet DSM-lV or ICD criteria for psychiatric disorders. However, they also experience positive or so-called salutogenic outcomes resulting from successfully coping with stress and enhanced self-sufficiency, improved health, and personal growth. Prevention of pathogenic psychological outcomes is best accomplished by psychological and psychiatric screening procedures to select out unsuitable candidates, and by providing access to psychological support, including telephone counselling. Promotion of salutogenic experiences is best accomplished by screening for suitable personality traits, and training participants in individual coping strategies, group interaction, and team leadership.	[Palinkas, Lawrence A.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA; [Suedfeld, Peter] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	University of Southern California; University of British Columbia	Palinkas, LA (corresponding author), Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA.	palinkas@usc.edu						ALEXANDER D, 1994, MIL MED, V159, P595, DOI 10.1093/milmed/159.9.595; ANGUS RG, 1979, AVIAT SPACE ENVIR MD, V50, P692; [Anonymous], 2002, HDB POSITIVE PSYCHOL; Antonovsky A., 1987, UNRAVELING MYSTERY H; Arendt J, 2005, J BIOL RHYTHM, V20, P291, DOI 10.1177/0748730405277492; ATLIS MM, 2001, ENVIRON BEHAV, V36, P402; BARABASZ AF, 1980, INT J CLIN EXP HYP, V28, P63, DOI 10.1080/00207148008409829; BARABASZ M, 1983, INT J CLIN EXP HYP, V31, P235, DOI 10.1080/00207148308406617; Bechtel R.B., 1991, ANTARCTICA OUTER SPA, P261, DOI DOI 10.1007/978-1-4612-3012-0_24; Behrendt John C., 1957, INNOCENTS ICE MEMOIR; Bhargava R, 2000, ENVIRON BEHAV, V32, P111, DOI 10.1177/00139160021972450; BIERSNER RJ, 1984, J RES PERS, V18, P491, DOI 10.1016/0092-6566(84)90007-2; BOGOSLOV.MM, 1974, LANCET, V1, P503, DOI 10.1016/S0140-6736(74)92803-7; BOUTON K, 1981, NEW YORKER, P42; BRAINARD CG, 1993, LIGHT BIOL RHYTHMS M, P29; BRAINARD GC, 1988, BRAIN RES, V454, P212, DOI 10.1016/0006-8993(88)90820-7; Broadway J W, 1988, Arctic Med Res, V47 Suppl 1, P201; BUGUET A, 1987, SLEEP, V10, P374, DOI 10.1093/sleep/10.4.374; CARVER CS, 1994, J PERS SOC PSYCHOL, V66, P184, DOI 10.1037/0022-3514.66.1.184; Cattermole T J, 2001, Int J Circumpolar Health, V60, P72; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; CONNOR S, 2005, INDEPENDENT     0916, P1; COOK FA, 1 ANTARCTIC NIGHT 18; Cooke FJ, 2000, J TRAVEL MED, V7, P205; Dahlstrom W., 1975, MMPI HDB; DEFAYOLLE M, 1985, J HUM STRESS, V11, P157, DOI 10.1080/0097840X.1985.9936753; GANDER PH, 1991, AVIAT SPACE ENVIR MD, V62, P1019; GUENTER CA, 1970, ARCH INTERN MED, V125, P630, DOI 10.1001/archinte.125.4.630; Gunderson E.K.E., 1974, HUMAN ADAPTABILITY A, P115, DOI DOI 10.1029/AR022P0115; GUNDERSON EK, 1966, BRIT J PSYCHIAT, V112, P405, DOI 10.1192/bjp.112.485.405; GUNDERSON EK, 1963, ARCH GEN PSYCHIAT, V9, P362; GUTHRIDGE LF, 2000, GHOSTS CAPE SABINE H; Haggarty JM, 2002, ACTA PSYCHIAT SCAND, V105, P378, DOI 10.1034/j.1600-0447.2002.1o185.x; Harinath K, 2005, WILD ENVIRON MED, V16, P81, DOI 10.1580/PR30-04.1; Harrison A., 1991, ANTARCTICA OUTER SPA, P1; Hassi J, 2000, Int J Circumpolar Health, V59, P92; Hodgdon J A, 1991, Arctic Med Res, V50 Suppl 6, P132; HOLAHAN CJ, 1987, J PERS SOC PSYCHOL, V52, P946, DOI 10.1037/0022-3514.52.5.946; *I MED, 2005, BIOASTR ROADM RISK R; Ikegawa M, 1998, AVIAT SPACE ENVIR MD, V69, P452; Jacka F., 1988, MAWSONS ANTARCTIC DI; JOERN AT, 1970, ARCH INTERN MED, V125, P649, DOI 10.1001/archinte.125.4.649; Johnson JC, 2003, J MATH SOCIOL, V27, P89, DOI 10.1080/00222500305890; Johnson P.J., 1996, HIST FAMILY, V1, P41, DOI [10.1016/S1081-602X(96)90019-6, DOI 10.1016/S1081-602X(96)90019-6]; Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6; KAHN PM, 1994, ENVIRON BEHAV, V26, P669, DOI 10.1177/0013916594265004; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LAW P, 1960, Med J Aust, V47(1), P273; Leon GR, 2005, AVIAT SPACE ENVIR MD, V76, pB84; Leon GR, 2003, ACTA ASTRONAUT, V53, P259, DOI 10.1016/S0094-5765(03)80003-6; Leon GR, 2002, ENVIRON BEHAV, V34, P672, DOI 10.1177/0013916502034005006; LEON GR, 1989, J RES PERS, V23, P162, DOI 10.1016/0092-6566(89)90021-4; LEON GR, 1991, ENVIRON BEHAV, V23, P723, DOI 10.1177/0013916591236005; Leppaluoto J, 2005, ACTA PHYSIOL SCAND, V184, P255, DOI 10.1111/j.1365-201X.2005.01464.x; Leppaluoto J, 2003, J PINEAL RES, V35, P158, DOI 10.1034/j.1600-079X.2003.00069.x; LeScanff C, 1997, AVIAT SPACE ENVIR MD, V68, P1144; LEWY AJ, 1985, CIBA F SYMP, V117, P231; Magnusson A, 2005, CNS SPECTRUMS, V10, P625, DOI 10.1017/S1092852900019593; MCGUIRE F, 1961, J MENT SCI, V107, P954, DOI 10.1192/bjp.107.450.954; McKay, 1991, ANTARCTICA OUTER SPA, P217, DOI DOI 10.1007/978-1-4612-3012-0_20; McNair DM., 1992, EDITS MANUAL PROFILE; Mear Roger., 1987, FOOTSTEPS SCOTT; MOCELLIN JS, 1991, J ENVIRON PSYCHOL, V11, P265, DOI 10.1016/S0272-4944(05)80187-2; MOCELLIN JSP, 1991, ENVIRON BEHAV, V23, P704, DOI 10.1177/0013916591236004; MULLER HK, 1995, IMMUNOL CELL BIOL, V73, P316, DOI 10.1038/icb.1995.48; MULLIN CS, 1960, AM J PSYCHIAT, V117, P323, DOI 10.1176/ajp.117.4.323; NARDINI JE, 1962, AM J PSYCHIAT, V119, P97, DOI 10.1176/ajp.119.2.97; NATANI K, 1970, ARCH INTERN MED, V125, P655, DOI 10.1001/archinte.125.4.655; Natani K., 1974, HUMAN ADAPTABILITY A, P89, DOI [10.1029/AR022p0089, DOI 10.1029/AR022P0089]; Nilssen O, 1997, ACTA PSYCHIAT SCAND, V95, P44, DOI 10.1111/j.1600-0447.1997.tb00372.x; NORMAN JN, 1991, ARCTIC MED RES, V50, P719; O'Brien C, 2003, WILD ENVIRON MED, V14, P112, DOI 10.1580/1080-6032(2003)014[0112:PRTCCS]2.0.CO;2; Palinkas L A, 2000, Int J Circumpolar Health, V59, P63; Palinkas L A, 1989, Med Anthropol, V10, P235; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, P619; Palinkas LA, 2004, AVIAT SPACE ENVIR MD, V75, P973; Palinkas LA, 2003, AM PSYCHOL, V58, P353, DOI 10.1037/0003-066X.58.5.353; PALINKAS LA, 1986, AVIAT SPACE ENVIR MD, V57, P954; PALINKAS LA, 1995, J APPL SOC PSYCHOL, V25, P557, DOI 10.1111/j.1559-1816.1995.tb01599.x; Palinkas LA, 1998, AVIAT SPACE ENVIR MD, V69, P73; PALINKAS LA, 1992, SOC SCI MED, V35, P651, DOI 10.1016/0277-9536(92)90004-A; PALINKAS LA, 1995, ACTA PSYCHIAT SCAND, V91, P423, DOI 10.1111/j.1600-0447.1995.tb09803.x; Palinkas LA, 2000, ENVIRON BEHAV, V32, P128, DOI 10.1177/00139160021972469; PALINKAS LA, 1991, ENVIRON BEHAV, V23, P782, DOI 10.1177/0013916591236008; PALINKAS LA, 1995, AVIAT SPACE ENVIR MD, V66, P943; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; Palinkas LA, 2001, PSYCHONEUROENDOCRINO, V26, P421, DOI 10.1016/S0306-4530(00)00064-0; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, pA29; Palinkas Lawrence A, 2004, Int J Circumpolar Health, V63, P157; PALMAI G, 1963, BRIT J PSYCHIAT, V109, P364, DOI 10.1192/bjp.109.460.364; PATERSON RA, 1975, LANCET, V1, P468, DOI 10.1016/S0140-6736(75)91552-4; Peri A, 2000, ENVIRON BEHAV, V32, P72, DOI 10.1177/00139160021972432; POPE FE, 1968, J NERV MENT DIS, V146, P433, DOI 10.1097/00005053-196806000-00002; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; REED HL, 1986, CLIN ENDOCRINOL, V25, P55, DOI 10.1111/j.1365-2265.1986.tb03595.x; Reed HL, 2001, J CLIN ENDOCR METAB, V86, P110, DOI 10.1210/jc.86.1.110; RIVOLIER J, 1997, HOMME ESPACE APPROCH; Rosen LN, 2002, MIL MED, V167, P581; Rosnet E, 2004, AVIAT SPACE ENVIR MD, V75, pC10; Rosnet E, 2000, ENVIRON BEHAV, V32, P18, DOI 10.1177/00139160021972414; Sandal GM, 1996, AVIAT SPACE ENVIR MD, V67, P227; Sandal GM, 2000, AVIAT SPACE ENVIR MD, V71, pA37; Sandbaek Gunnar, 1997, Tidsskrift for den Norske Laegeforening, V117, P1104; Schmidt LL, 2004, AVIAT SPACE ENVIR MD, V75, P681; Selye H., 1974, STRESS DISTRESS; Shearer WT, 2002, J ALLERGY CLIN IMMUN, V109, P854, DOI 10.1067/mai.2002.123873; SHURLEY JT, 1970, ARCH GEN PSYCHIAT, V22, P385; SPROULE J, 1991, ARCTIC MED RES S, V50, P489; STEEGER W, 1987, N POLE; Steel GD, 2000, ENVIRON BEHAV, V32, P796, DOI 10.1177/00139160021972801; STEEL GD, 1995, BIOL RHYTHM RES, V26, P582, DOI 10.1080/09291019509360360; Steel GD, 1997, ENVIRON BEHAV, V29, P324, DOI 10.1177/001391659702900302; Steine Kjetil, 2003, Tidsskr Nor Laegeforen, V123, P3529; Steine Siri, 2003, Tidsskr Nor Laegeforen, V123, P3524; STRANGE RE, 1971, ANTARCT J US, V6, P255; Stuster J, 2000, AVIAT SPACE ENVIR MD, V71, pA17; Stuster J.W., 2011, BOLD ENDEAVORS LESSO; Suedfeld P, 2005, AVIAT SPACE ENVIR MD, V76, pB61; Suedfeld P., 2002, HUMAN PERFORMANCE EX, V6, P21; Taylor A.J., 1987, ANTARCTIC PSYCHOL; TAYLOR AJW, 1998, INT J CIRCUMPOL HEAL, V57, P58; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Usui A, 2000, PSYCHIAT CLIN NEUROS, V54, P361, DOI 10.1046/j.1440-1819.2000.00715.x; Weiss K, 2000, ENVIRON BEHAV, V32, P142, DOI 10.1177/00139160021972478; WIRZJUSTICE A, 1993, LIGHT BIOL RHYTHMS M, P385; Wood H, 2005, NAT REV NEUROSCI, V6, P89, DOI 10.1038/nrn1614; Wood J, 2005, AVIAT SPACE ENVIR MD, V76, pB89; Wood J, 2000, ENVIRON BEHAV, V32, P84, DOI 10.1177/00139160021972441; Xu Chengli, 2003, Int J Circumpolar Health, V62, P255; Xue Z H, 1994, ANTARCTIC RES, V5, P27; Yoneyama S, 1999, AM J PHYSIOL-REG I, V277, pR1091, DOI 10.1152/ajpregu.1999.277.4.R1091	134	152	169	1	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					153	163		10.1016/S0140-6736(07)61056-3	http://dx.doi.org/10.1016/S0140-6736(07)61056-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	252ND	17655924				2022-12-28	WOS:000252452300030
J	Bibring, JP; Arvidson, RE; Gendrin, A; Gondet, B; Langevin, Y; Le Mouelic, S; Mangold, N; Morris, RV; Mustard, JF; Poulet, F; Quantin, C; Sotin, C				Bibring, J.-P.; Arvidson, R. E.; Gendrin, A.; Gondet, B.; Langevin, Y.; Le Mouelic, S.; Mangold, N.; Morris, R. V.; Mustard, J. F.; Poulet, F.; Quantin, C.; Sotin, C.			Coupled ferric oxides and sulfates on the Martian surface	SCIENCE			English	Article							MERIDIANI-PLANUM; BURNS FORMATION; REFLECTIVITY SPECTRA; TERRESTRIAL ANALOG; HEMATITE; MARS; GOETHITE; SYSTEM; REGION	The Mars Exploration Rover ( MER), Opportunity, showed that layered sulfate deposits in Meridiani Planum formed during a period of rising acidic ground water. Crystalline hematite spherules formed in the deposits as a consequence of aqueous alteration and were concentrated on the surface as a lag deposit as wind eroded the softer sulfate rocks. On the basis of Mars Express Observatoire pour la Mineralogie, l'Eau, les Glaces et l'Activite ( OMEGA) orbital data, we demonstrate that crystalline hematite deposits are associated with layered sulfates in other areas on Mars, implying that Meridiani-like ground water systems were indeed widespread and representative of an extensive acid sulfate aqueous system.	Inst Astrophys Spatiale, F-91405 Orsay, France; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Univ Nantes, F-44322 Nantes 03, France; Interact & Dynam Environm Surface, F-91405 Orsay, France; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Brown Univ, Providence, RI 02912 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Washington University (WUSTL); Nantes Universite; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brown University	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	bibring@ias.fr	Quantin, Cathy/H-1516-2014	Le Mouelic, Stephane/0000-0001-5260-1367				ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Arvidson RE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002728; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Chan MA, 2004, NATURE, V429, P731, DOI 10.1038/nature02600; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; Crowley JK., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; GEISSLER PE, 1993, ICARUS, V106, P380, DOI 10.1006/icar.1993.1179; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; MORRIS RV, 1990, J GEOPHYS RES-SOLID, V95, P5101, DOI 10.1029/JB095iB04p05101; Morris RV, 2005, EARTH PLANET SC LETT, V240, P168, DOI 10.1016/j.epsl.2005.09.044; Morris RV, 1997, J GEOPHYS RES-PLANET, V102, P9125, DOI 10.1029/96JE03993; Morris RV, 1998, ICARUS, V134, P1, DOI 10.1006/icar.1998.5939; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1985, J GEOPHYS RES-SOLID, V90, P3126, DOI 10.1029/JB090iB04p03126; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Nordstrom DK, 1999, GEOCHEMISTRY OF THE EARTH'S SURFACE, P139; SHERMAN DM, 1982, J GEOPHYS RES, V87, P169, DOI 10.1029/JB087iB12p10169; Smith AB, 2003, ORG LETT, V5, P1, DOI 10.1021/ol0202520; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; SUNSHINE JM, 1990, J GEOPHYS RES-SOLID, V95, P6955, DOI 10.1029/JB095iB05p06955; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042	29	135	136	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1206	1210		10.1126/science.1144174	http://dx.doi.org/10.1126/science.1144174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17673623				2022-12-28	WOS:000249126800036
J	Fellay, J; Shianna, KV; Ge, DL; Colombo, S; Ledergerber, B; Weale, M; Zhang, KL; Gumbs, C; Castagna, A; Cossarizza, A; Cozzi-Lepri, A; De Luca, A; Easterbrook, P; Francioli, P; Mallal, S; Martinez-Picado, J; Miro, JM; Obel, N; Smith, JP; Wyniger, J; Descombes, P; Antonarakis, SE; Letvin, NL; McMichael, AJ; Haynes, BF; Telenti, A; Goldstein, DB				Fellay, Jacques; Shianna, Kevin V.; Ge, Dongliang; Colombo, Sara; Ledergerber, Bruno; Weale, Mike; Zhang, Kunlin; Gumbs, Curtis; Castagna, Antonella; Cossarizza, Andrea; Cozzi-Lepri, Alessandro; De Luca, Andrea; Easterbrook, Philippa; Francioli, Patrick; Mallal, Simon; Martinez-Picado, Javier; Miro, Jose M.; Obel, Niels; Smith, Jason P.; Wyniger, Josiane; Descombes, Patrick; Antonarakis, Stylianos E.; Letvin, Norman L.; McMichael, Andrew J.; Haynes, Barton F.; Telenti, Amalio; Goldstein, David B.			A whole-genome association study of major determinants for host control of HIV-1	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MULTICOPY GENE FAMILY; ESCAPE MUTATIONS; INFECTION; AIDS; RESPONSES; SEQUENCE; MHC	Understanding why some people establish and maintain effective control of HIV-1 and others do not is a priority in the effort to develop new treatments for HIV/AIDS. Using a whole-genome association strategy, we identified polymorphisms that explain nearly 15% of the variation among individuals in viral load during the asymptomatic set-point period of infection. One of these is found within an endogenous retroviral element and is associated with major histocompatibility allele human leukocyte antigen (HLA)-B*5701, whereas a second is located near the HLA-C gene. An additional analysis of the time to HIV disease progression implicated two genes, one of which encodes an RNA polymerase I subunit. These findings emphasize the importance of studying human genetic variation as a guide to combating infectious agents.	Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; Univ Lausanne, CH-1011 Lausanne, Switzerland; Duke Univ, Ctr Populat Genom & Pharmacogenet, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; Univ Milan, Osped San Raffaele, Clin Infect Dis, Ist Ricovero & Cura Carattere Sci, I-20127 Milan, Italy; Univ Modena & Reggio Emilia, Sch Med, Dept Biomed Sci, Sect Gen Pathol, I-41100 Modena, Italy; UCL, Dept Primary Care & Populat Sci, Royal Free & Univ Coll Med Sch, London NW3 2PF, England; Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy; Kings Coll London, Guys Hosp, Acad Dept HIV & Genitourinary Med, London SE5 9RJ, England; Kings Coll London, Kings Hosp, Acad Dept HIV & Genitourinary Med, London SE5 9RJ, England; Kings Coll London, St Thomas Hosp, Acad Dept HIV & Genitourinary Med, London SE5 9RJ, England; Univ Hosp Ctr, Infect Dis Serv, Dept Med, CH-1011 Lausanne, Switzerland; Univ Hosp Ctr, Serv Hosp Prevent Med, CH-1011 Lausanne, Switzerland; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Perth, WA 6000, Australia; Irsicaixa Fdn, Badalona 08916, Spain; Hosp Badalona Germans Trias & Pujol, Badalona 08916, Spain; Inst Catalana Recerca & Estud Avancats, Barcelona, Spain; Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Med, Div Viral Pathogenesis, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; John Radcliffe Hosp, Med Res Council Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	University of Lausanne; Duke University; University of Zurich; University Zurich Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Royal Perth Hospital; University of Western Australia; Murdoch University; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Rigshospitalet; University of Copenhagen; University of Geneva; University of Geneva; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford; Duke University	Telenti, A (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.	amalio.telenti@chuv.ch; d.goldstein@duke.edu	Telenti, Amalio/AAY-1674-2021; Easterbrook, Philippa J/A-3937-2009; De Luca, Andrea/G-8810-2011; Mallal, Simon Alexander/HDM-9561-2022; Ge, Dongliang/A-2073-2010; Martinez-Picado, Javier/G-5507-2012; Castagna, Antonella/K-3280-2018; Fellay, Jacques/A-6681-2009; Weale, Michael E/F-2587-2010; Goldstein, David/AAY-8125-2020; VALLET, Yannick/F-9979-2011; Ledergerber, Bruno/B-5656-2009; Antonarakis, Stylianos E/N-8866-2014	De Luca, Andrea/0000-0002-9561-9193; Mallal, Simon Alexander/0000-0002-7036-1309; Martinez-Picado, Javier/0000-0002-4916-2129; Castagna, Antonella/0000-0002-8338-9714; Fellay, Jacques/0000-0002-8240-939X; Weale, Michael E/0000-0003-4593-1186; Ledergerber, Bruno/0000-0002-6881-4401; Antonarakis, Stylianos E/0000-0001-8907-5823; Cossarizza, Andrea/0000-0002-5381-1558; Easterbrook, Philippa/0000-0002-2603-5418; Ge, David/0000-0002-9732-8170	ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER; MRC [MC_U137884177, G0200585] Funding Source: UKRI; Medical Research Council [G0200585, MC_U137884177] Funding Source: Medline; NIAID NIH HHS [U19 AI067854-03, U19 AI067854] Funding Source: Medline	ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adnan S, 2006, BLOOD, V108, P3414, DOI 10.1182/blood-2006-06-030668; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bleiber G, 2005, J VIROL, V79, P12674, DOI 10.1128/JVI.79.20.12674-12680.2005; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; DUNDR M, 1995, J CELL SCI, V108, P2811; Goulder PJR, 1997, AIDS, V11, P1884, DOI 10.1097/00002030-199715000-00016; Kulski JK, 1999, IMMUNOGENETICS, V49, P404, DOI 10.1007/s002510050513; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Nelson GW, 2006, JAIDS-J ACQ IMM DEF, V42, P347, DOI 10.1097/01.qai.0000219786.88786.d8; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Telenti A, 2006, FUTURE VIROL, V1, P55, DOI 10.2217/17460794.1.1.55; VERNET C, 1993, IMMUNOGENETICS, V38, P47, DOI 10.1007/BF00216390	23	965	988	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					944	947		10.1126/science.1143767	http://dx.doi.org/10.1126/science.1143767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17641165	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000248780200039
J	Kanzow, T; Cunningham, SA; Rayner, D; Hirschi, JJM; Johns, WE; Baringer, MO; Bryden, HL; Beal, LM; Meinen, CS; Marotzke, J				Kanzow, Torsten; Cunningham, Stuart A.; Rayner, Darren; Hirschi, Joel J. -M.; Johns, William E.; Baringer, Molly O.; Bryden, Harry L.; Beal, Lisa M.; Meinen, Christopher S.; Marotzke, Jochem			Observed flow compensation associated with the MOC at 26.5 degrees N in the Atlantic	SCIENCE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; OCEAN HEAT-TRANSPORT; NORTH-ATLANTIC; VARIABILITY; WATER	The Atlantic meridional overturning circulation (MOC), which provides one-quarter of the global meridional heat transport, is composed of a number of separate flow components. How changes in the strength of each of those components may affect that of the others has been unclear because of a lack of adequate data. We continuously observed the MOC at 26.5 degrees N for 1 year using end-point measurements of density, bottom pressure, and ocean currents; cable measurements across the Straits of Florida; and wind stress. The different transport components largely compensate for each other, thus confirming the validity of our monitoring approach. The MOC varied over the period of observation by +/- 5.7 x 10(6) cubic meters per second, with density-inferred and wind-driven transports contributing equally to it. We find evidence for depth-independent compensation for the wind-driven surface flow.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; Max Planck Inst Meteorol, D-20146 Hamburg, Germany	NERC National Oceanography Centre; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); Max Planck Society	Kanzow, T (corresponding author), Natl Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.	tok@noc.soton.ac.uk; jochem.marotzke@zmaw.de	Baringer, Molly O/D-2277-2012; Hirschi, Joel/F-5631-2013; Meinen, Christopher S/G-1902-2012	Baringer, Molly O/0000-0002-8503-5194; Hirschi, Joel/0000-0003-1481-3697; Meinen, Christopher S/0000-0002-8846-6002; Kanzow, Torsten/0000-0002-5786-3435; Bryden, Harry/0000-0002-8216-6359; Beal, Lisa/0000-0003-3678-5367	Natural Environment Research Council [soc010007, soc010012, NER/T/S/2002/00481] Funding Source: researchfish; NERC [soc010007, soc010012] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BROWN W, 1975, J PHYS OCEANOGR, V5, P75, DOI 10.1175/1520-0485(1975)005<0075:MBE>2.0.CO;2; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; CUNNINGHAM SA, 2004, 53 NAT OC CTR; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Dong BW, 2001, GEOPHYS RES LETT, V28, P2445, DOI 10.1029/2000GL012531; Ganachaud A, 2003, J CLIMATE, V16, P696, DOI 10.1175/1520-0442(2003)016<0696:LSOHAF>2.0.CO;2; Graf J, 1998, ACTA ASTRONAUT, V43, P397, DOI 10.1016/S0094-5765(97)00180-X; Hirose N, 2001, GEOPHYS RES LETT, V28, P2441, DOI 10.1029/2001GL012907; Hirschi JJM, 2007, J PHYS OCEANOGR, V37, P1246, DOI 10.1175/JPO3049.1; Jayne SR, 2001, REV GEOPHYS, V39, P385, DOI 10.1029/2000RG000084; Johns WE, 2005, DEEP-SEA RES PT I, V52, P1542, DOI 10.1016/j.dsr.2005.02.002; Kanzow T, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002772; Kanzow T, 2006, DEEP-SEA RES PT I, V53, P528, DOI 10.1016/j.dsr.2005.12.007; LARSEN JC, 1985, SCIENCE, V227, P302, DOI 10.1126/science.227.4684.302; MAROTZKE J, 2002, MONITORING ATLANTIC; Meinen CS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026965; Meinen CS, 2001, DEEP-SEA RES PT I, V48, P1553, DOI 10.1016/S0967-0637(00)00103-5; Rahmstorf S, 2003, NATURE, V421, P699, DOI 10.1038/421699a; ROACH AT, 1995, J GEOPHYS RES-OCEANS, V100, P18443, DOI 10.1029/95JC01673; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; WHITWORTH T, 1983, J PHYS OCEANOGR, V13, P2045, DOI 10.1175/1520-0485(1983)013<2045:MTTOTA>2.0.CO;2	22	171	172	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					938	941		10.1126/science.1141293	http://dx.doi.org/10.1126/science.1141293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702941				2022-12-28	WOS:000248780200037
J	Rieseberg, LH; Willis, JH				Rieseberg, Loren H.; Willis, John H.			Plant speciation	SCIENCE			English	Review							HYBRID INCOMPATIBILITY; REPRODUCTIVE ISOLATION; LOCAL ADAPTATION; FLORAL TRAITS; GENE-FLOW; EVOLUTION; POPULATIONS; STERILITY; DIVERSIFICATION; DIFFERENTIATION	Like the formation of animal species, plant speciation is characterized by the evolution of barriers to genetic exchange between previously interbreeding populations. Prezygotic barriers, which impede mating or fertilization between species, typically contribute more to total reproductive isolation in plants than do postzygotic barriers, in which hybrid offspring are selected against. Adaptive divergence in response to ecological factors such as pollinators and habitat commonly drives the evolution of prezygotic barriers, but the evolutionary forces responsible for the development of intrinsic postzygotic barriers are virtually unknown and frequently result in polymorphism of incompatibility factors within species. Polyploid speciation, in which the entire genome is duplicated, is particularly frequent in plants, perhaps because polyploid plants often exhibit ecological differentiation, local dispersal, high fecundity, perennial life history, and self-fertilization or asexual reproduction. Finally, species richness in plants is correlated with many biological and geohistorical factors, most of which increase ecological opportunities.	Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA	University of British Columbia; Indiana University System; Indiana University Bloomington; Duke University	Rieseberg, LH (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	Lriesebe@interchange.ubc.ca	Rieseberg, Loren H/B-3591-2013	Rieseberg, Loren H/0000-0002-2712-2417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059065] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059065-07] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baack EJ, 2005, HEREDITY, V94, P538, DOI 10.1038/sj.hdy.6800656; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; CHRISTIE P, 1987, EVOLUTION, V41, P571, DOI 10.1111/j.1558-5646.1987.tb05827.x; Coyne J.A., 2004, SPECIATION; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Gillman JD, 2007, PLANT J, V49, P217, DOI 10.1111/j.1365-313X.2006.02953.x; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Grundt HH, 2006, P NATL ACAD SCI USA, V103, P972, DOI 10.1073/pnas.0510270103; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lai Z, 2005, GENETICS, V171, P291, DOI 10.1534/genetics.105.042242; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; McDaniel SF, 2005, MOL ECOL, V14, P1121, DOI 10.1111/j.1365-294X.2005.02484.x; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Nagy ES, 1997, EVOLUTION, V51, P1079, DOI 10.1111/j.1558-5646.1997.tb03955.x; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orr HA, 1998, GENETICS, V149, P2099; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Rausch JH, 2005, EVOLUTION, V59, P1867; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2004, NEW PHYTOL, V161, P59, DOI 10.1046/j.1469-8137.2003.00933.x; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rodriguez DJ, 1996, AM NAT, V147, P33, DOI 10.1086/285838; Sargent RD, 2006, AM NAT, V167, P67, DOI 10.1086/498433; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; STEBBINS GL, 1950, VARIATION EVOLUTION; Sweigart AL, 2007, EVOLUTION, V61, P141, DOI 10.1111/j.1558-5646.2007.00011.x; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Whitlock MC, 2003, GENETICS, V164, P767	54	807	847	8	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2007	317	5840					910	914		10.1126/science.1137729	http://dx.doi.org/10.1126/science.1137729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702935	Green Accepted			2022-12-28	WOS:000248780200029
J	Chapman, HN; Hau-Riege, SP; Bogan, MJ; Bajt, S; Barty, A; Boutet, S; Marchesini, S; Frank, M; Woods, BW; Benner, WH; London, RA; Rohner, U; Szoke, A; Spiller, E; Moller, T; Bostedt, C; Shapiro, DA; Kuhlmann, M; Treusch, R; Plonjes, E; Burmeister, F; Bergh, M; Caleman, C; Huldt, G; Seibert, MM; Hajdu, J				Chapman, Henry N.; Hau-Riege, Stefan P.; Bogan, Michael J.; Bajt, Sasa; Barty, Anton; Boutet, Sebastien; Marchesini, Stefano; Frank, Matthias; Woods, Bruce W.; Benner, W. Henry; London, Richard A.; Rohner, Urs; Szoeke, Abraham; Spiller, Eberhard; Moeller, Thomas; Bostedt, Christoph; Shapiro, David A.; Kuhlmann, Marion; Treusch, Rolf; Ploenjes, Elke; Burmeister, Florian; Bergh, Magnus; Caleman, Carl; Huldt, Goesta; Seibert, M. Marvin; Hajdu, Janos			Femtosecond time-delay X-ray holography	NATURE			English	Article							FREE-ELECTRON LASER; PULSES; GENERATION; LIGHT; SCATTERING; RADIATION; DYNAMICS	Extremely intense and ultrafast X-ray pulses from free-electron lasers offer unique opportunities to study fundamental aspects of complex transient phenomena in materials. Ultrafast time-resolved methods usually require highly synchronized pulses to initiate a transition and then probe it after a precisely defined time delay. In the X-ray regime, these methods are challenging because they require complex optical systems and diagnostics. Here we propose and apply a simple holographic measurement scheme, inspired by Newton's 'dusty mirror' experiment(1), to monitor the X-ray-induced explosion of microscopic objects. The sample is placed near an X-ray mirror; after the pulse traverses the sample, triggering the reaction, it is reflected back onto the sample by the mirror to probe this reaction. The delay is encoded in the resulting diffraction pattern to an accuracy of one femtosecond, and the structural change is holographically recorded with high resolution. We apply the technique to monitor the dynamics of polystyrene spheres in intense free-electron-laser pulses, and observe an explosion occurring well after the initial pulse. Our results support the notion that X-ray flash imaging(2,3) can be used to achieve high resolution, beyond radiation damage limits for biological samples(4). With upcoming ultrafast X-ray sources we will be able to explore the three-dimensional dynamics of materials at the time-scale of atomic motion.	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; DESY, D-22607 Hamburg, Germany	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Uppsala University; Technical University of Berlin; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Chapman, HN (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	henry.chapman@llnl.gov	Marchesini, Stefano/A-6795-2009; Bajt, Sasa/G-2228-2010; FRS, Henry N Chapman/G-2153-2010; Treusch, Rolf/P-4876-2019; Bajt, Sasa/O-4695-2019; Frank, Matthias/O-9055-2014; Bogan, Mike/I-6962-2012; Marchesini, Stefano/GYR-1409-2022; Barty, Anton/K-5137-2014; Treusch, Rolf/C-3935-2015	Marchesini, Stefano/0000-0002-6798-2913; FRS, Henry N Chapman/0000-0002-4655-1743; Treusch, Rolf/0000-0001-8479-8862; Bajt, Sasa/0000-0002-7163-7602; Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Frank, Matthias/0000-0002-5244-0791; Seibert, Mark Marvin/0000-0003-0251-0744				Ayvazyan V, 2006, EUR PHYS J D, V37, P297, DOI 10.1140/epjd/e2005-00308-1; Bartels RA, 2002, SCIENCE, V297, P376, DOI 10.1126/science.1071718; Bergh M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051904; BOGAN MJ, UNPUB J AEROSOL SCI; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; Cavalieri AL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.114801; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; DEWITTE AJ, 1967, AM J PHYS, V35, P301, DOI 10.1119/1.1974069; FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118; GAUR U, 1982, J PHYS CHEM REF DATA, V11, P313, DOI 10.1063/1.555663; Goodman JW., 1996, INTRO FOURIER OPTICS; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; Hau-Riege SP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.145502; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; HOWELLS MR, 2005, IN PRESS J ELECT SPE; Jurek Z, 2004, EUR PHYS J D, V29, P217, DOI 10.1140/epjd/e2004-00033-3; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Lee RW, 2003, J OPT SOC AM B, V20, P770, DOI 10.1364/JOSAB.20.000770; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; NEWTON I, 1952, OPTICKS BOOK 4, V2; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; SOLEM JC, 1982, SCIENCE, V218, P229, DOI 10.1126/science.218.4569.229; Sorokin AA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397561; Temnov VV, 2006, J OPT SOC AM B, V23, P1954, DOI 10.1364/JOSAB.23.001954; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004; ZIMMERMAN GB, 1980, J QUANT SPECTROSC RA, V23, P517, DOI 10.1016/0022-4073(80)90055-2	32	199	200	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					676	679		10.1038/nature06049	http://dx.doi.org/10.1038/nature06049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687320	Green Published, Green Submitted			2022-12-28	WOS:000248598000040
J	Qiu, J				Qiu, Jane			China tightens up	NATURE			English	News Item																		Cyranoski D, 2007, NATURE, V446, P598, DOI 10.1038/446598a	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					636	637		10.1038/448636a	http://dx.doi.org/10.1038/448636a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687294				2022-12-28	WOS:000248598000011
J	Wharam, JF; Daniels, N				Wharam, J. Frank; Daniels, Norman			Toward evidence-based policy making and standardized assessment of health policy reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-CARE; EMERGENCY-DEPARTMENT USE; UNINTENDED CONSEQUENCES; PERFORMANCE; PLANS; DISPARITIES; ACCESS; SYSTEM		Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@partners.org		Wharam, James/0000-0003-2053-0757				Altman SH, 2006, NEW ENGL J MED, V354, P2093, DOI 10.1056/NEJMp068103; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BULLEN B, ETHICS HLTH CARE REF; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Daniels N, 2002, SETTING LIMITS FAIRL; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V297, P2131, DOI 10.1001/jama.297.19.2131; Epstein AM, 2007, NEW ENGL J MED, V356, P515, DOI 10.1056/NEJMe078002; FINEGOLD K, SNAPSHOTS AM FAMILIE; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Fontanarosa PB, 2007, JAMA-J AM MED ASSOC, V297, P1128, DOI 10.1001/jama.297.10.1128; Grudzen CR, 2007, JAMA-J AM MED ASSOC, V297, P1126, DOI 10.1001/jama.297.10.1126; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; Lurie N, 2007, JAMA-J AM MED ASSOC, V297, P1118, DOI 10.1001/jama.297.10.1118; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Rosenthal M, 2006, J HEALTH POLIT POLIC, V31, P671, DOI 10.1215/03616878-2005-013; Shen YJ, 2003, HEALTH SERV RES, V38, P535, DOI 10.1111/1475-6773.00132; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SULMASY DP, 1992, ANN INTERN MED, V116, P920, DOI 10.7326/0003-4819-116-11-920; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; *US GEN ACC OFF, MED SAV ACC RES SURV; Van Herten LM, 2000, HEALTH POLICY, V53, P13, DOI 10.1016/S0168-8510(00)00082-8; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093	25	16	16	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					676	679		10.1001/jama.298.6.676	http://dx.doi.org/10.1001/jama.298.6.676			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684191				2022-12-28	WOS:000248574800029
J	Kioussis, D; Georgopoulos, K				Kioussis, Dimitris; Georgopoulos, Katia			Perspective - Epigenetic flexibility underlying lineage choices in the adaptive immune system	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; B-CELLS; CHROMATIN; LYMPHOCYTE; EXPRESSION; COMPLEXES; DIVISION; IKAROS; GENES; CD4	Although fundamental models have emerged in recent years describing how chromatin and transcription regulation interface with one another in the developing immune system, the order of events and their biological impact are still being resolved. Recent advances have provided a flexible, rather than static, view of chromatin regulation to reveal how both positive and negative forces work concomitantly to establish specific chromatin structures and regulate gene expression. The challenge will now be to explore new epigenetic models and validate them during lymphocyte development, with the ultimate goal of unraveling the long-sought mechanisms that support the emerging complexity of the adaptive immune response.	Natl Inst Med Res, MRC, London NW7 1AA, England; Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02129 USA	MRC National Institute for Medical Research; Harvard University; Massachusetts General Hospital	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk			MRC [MC_U117512796] Funding Source: UKRI; Medical Research Council [MC_U117512796] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	31	20	20	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					620	622		10.1126/science.1143777	http://dx.doi.org/10.1126/science.1143777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673651				2022-12-28	WOS:000248494400032
J	Laing, CM; Roberts, R; Lightstone, L; Graham, A; Cook, TH; Summers, S; Pusey, CD				Laing, Chris M.; Roberts, Rhys; Lightstone, Liz; Graham, Alison; Cook, Terry H.; Summers, Shaun; Pusey, Charles D.			A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Coll Hosp, Dept Med, London NW1 2BU, England; Hammersmith Hosp, Dept Med, London W12 0HS, England; Hammersmith Hosp, W London Renal & Transplant Ctr, London W12 0NN, England; Hammersmith Hosp, Dept Radiol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Div Invest Med, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England	University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Laing, CM (corresponding author), Univ Coll Hosp, Dept Med, London NW1 2BU, England.	christopher.laing@mac.com	Lightstone, Liz/M-4331-2014	Lightstone, Liz/0000-0002-4603-4076; Roberts, Rhys/0000-0003-0008-4649					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					205	206		10.1136/bmj.39239.479560.80	http://dx.doi.org/10.1136/bmj.39239.479560.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17656546	Green Published			2022-12-28	WOS:000248662200034
J	Pilling, S; Strang, J; Gerada, C				Pilling, Stephen; Strang, John; Gerada, Clare		Guideline Dev Grp	Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England; Kings Coll London, Natl Addict Ctr, Inst Psychiat, London SE5 8AF, England; Hurley Clin, London SE11 4HJ, England	University of London; University College London; University of London; King's College London	Pilling, S (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England.	s.pilting@uct.ac.uk	Gerada, Clare/O-8264-2019; Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				*NAT I HLTH CLIN E, 2007, DRUG MIS OP DET; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT; Strang J, 2005, BRIT J GEN PRACT, V55, P444	3	38	39	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					203	205		10.1136/bmj.39265.639641.AD	http://dx.doi.org/10.1136/bmj.39265.639641.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	198YA	17656545	Green Submitted, Green Published			2022-12-28	WOS:000248662200033
J	Ortega-Martinez, O; Pernas, M; Carol, RJ; Dolan, L				Ortega-Martinez, Olga; Pernas, Monica; Carol, Rachel J.; Dolan, Liam			Ethylene modulates stem cell division in the Arabidopsis thaliana root	SCIENCE			English	Article							AUXIN; PROTEIN; DIFFERENTIATION; BIOSYNTHESIS; MUTANTS; GROWTH; NICHE; FATE; ETO1	The construction of multicellular organisms depends on stem cells-cells that can both regenerate and produce daughter cells that undergo differentiation. Here, we show that the gaseous messenger ethylene modulates cell division in the cells of the quiescent center, which act as a source of stem cells in the seedling root. The cells formed through these ethylene-induced divisions express quiescent center-specific genes and can repress differentiation of surrounding initial cells, showing that quiescence is not required for these cells to signal to adjacent stem cells. We propose that ethylene is part of a signaling pathway that modulates cell division in the quiescent center in the stem cell niche during the postembryonic development of the root system.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Pernas, Monica/G-3485-2015	Pernas, Monica/0000-0002-6521-9164; Dolan, Liam/0000-0003-1206-7096; Carol, Rachel/0000-0002-6193-5163	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; van den Berg C, 1998, PLANTA, V205, P483, DOI 10.1007/s004250050347; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	18	170	177	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					507	510		10.1126/science.1143409	http://dx.doi.org/10.1126/science.1143409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656722				2022-12-28	WOS:000248339800043
J	Sadler, PM; Tai, RH				Sadler, Philip M.; Tai, Robert H.			Transitions - The two high-school pillars supporting college science	SCIENCE			English	Editorial Material							PHYSICS; EDUCATION; GRADES		Harvard Smithsonian Ctr Astrophys, Dept Sci Educ, Cambridge, MA 02138 USA; Univ Virginia, Curry Sch Educ, Charlottesville, VA 22904 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Virginia	Sadler, PM (corresponding author), Harvard Smithsonian Ctr Astrophys, Dept Sci Educ, 60 Garden St, Cambridge, MA 02138 USA.	psadler@cfa.harvard.edu		Sadler, Philip/0000-0001-7578-4047				Bardeen MG, 1998, SCIENCE, V281, P178, DOI 10.1126/science.281.5374.178; Dexter K.M., 2006, HIGH SCH J, V89, P22, DOI [10.1353/hsj.2006.0007, DOI 10.1353/HSJ.2006.0007]; Dorans N. J., 1999, CORRES ACT SAT 1 SCO; EWALD G, 2005, PHYS TEACH, V43, P319; Kuncel NR, 2005, REV EDUC RES, V75, P63, DOI 10.3102/00346543075001063; Lederman L, 2001, PHYS TODAY, V54, P11, DOI 10.1063/1.1420496; LEDERMAN L, 1999, ED WEEK, V18, P56; Mason DS, 2002, J CHEM EDUC, V79, P1393, DOI 10.1021/ed079p1393; Pike GR, 2002, RES HIGH EDUC, V43, P187, DOI 10.1023/A:1014419724092; RICHARDS R, TEACHING PHYS 1 TEAC; SAWYER R, 1989, COLL UNIV, V64, P288; TAI R, 2006, J COLL SCI TEACH, V35, P56; Tai RH, 2005, J RES SCI TEACH, V42, P987, DOI 10.1002/tea.20082; Tai RH, 2001, INT J SCI EDUC, V23, P1017, DOI 10.1080/09500690010025067; Thorndike R. M., 1996, MEASUREMENT EVALUATI	15	72	72	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					457	458		10.1126/science.1144214	http://dx.doi.org/10.1126/science.1144214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194JD	17656706				2022-12-28	WOS:000248339800024
J	Duggan, CP; Westra, SJ; Rosenberg, AE; Grinspan, ZM; Harris, NL; Whelan, JP; Seashore, C; Rosenberg, AE				Duggan, Christopher P.; Westra, Sjirk J.; Rosenberg, Andrew E.; Grinspan, Zachary M.; Harris, Nancy Lee; Whelan, J. Patrick; Seashore, Carl; Rosenberg, Andrew E.			A boy with bone pain, rash, and gingival hypertrophy - Scurvy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT MULTIFOCAL OSTEOMYELITIS; PERVASIVE DEVELOPMENTAL DISORDER; VITAMIN-A; CHILDREN; AUTISM; POPULATION; SECRETIN		Childrens Hosp, Dept Med, Div Gastroenterol & Nutr, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Duggan, CP (corresponding author), Childrens Hosp, Dept Med, Div Gastroenterol & Nutr, Boston, MA 02115 USA.							ASPERGER H, 1961, ANN PAEDIATR-BASEL, V197, P346; BAKER EM, 1971, AM J CLIN NUTR, V24, P444; CLARK JH, 1993, JPEN-PARENTER ENTER, V17, P284, DOI 10.1177/0148607193017003284; DENARDO BA, 1994, J RHEUMATOL, V21, P1553; HODGES RE, 1969, AM J CLIN NUTR, V22, P535; Horvath K, 1998, J Assoc Acad Minor Phys, V9, P9; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huber AM, 2002, J PEDIATR-US, V141, P198, DOI 10.1067/mpd.2002.126457; Jacob RA., 1999, MODERN NUTR HLTH DIS, V9th edn, P467; Jurik AG, 1997, SKELETAL RADIOL, V26, P230, DOI 10.1007/s002560050227; Lighdale JR, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e90; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Monks George, 2002, J Drugs Dermatol, V1, P67; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Robertson LP, 2001, ANN RHEUM DIS, V60, P828; Sandler AD, 1999, NEW ENGL J MED, V341, P1801, DOI 10.1056/NEJM199912093412404; Steinemann TL, 1998, ARCH OPHTHALMOL-CHIC, V116, P392, DOI 10.1001/archopht.116.3.392; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Weinstein M, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e55	19	50	50	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					392	400		10.1056/NEJMcpc079017	http://dx.doi.org/10.1056/NEJMcpc079017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652655				2022-12-28	WOS:000248283500013
J	Wiesner, T; Leinweber, B; Quasthoff, S; Unger, B; Kamericki, P; Hoedl, S; Kerl, H				Wiesner, Thomas; Leinweber, Bernd; Quasthoff, Stefan; Unger, Baerbel; Kamericki, Peter; Hoedl, Stefan; Kerl, Helmut			Itch, skin lesions - and a stiff neck	LANCET			English	Editorial Material							PRURITUS		Med Univ Graz, Dept Dermatol, A-8036 Graz, Austria; Med Univ Graz, Dept Neurol, Graz, Austria; Med Univ Graz, Dept Radiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Wiesner, T (corresponding author), Med Univ Graz, Dept Dermatol, Auenbruggerpl 8, A-8036 Graz, Austria.	th.wiesner@meduni-graz.at		Wiesner, Thomas/0000-0001-5877-2992				Cohen AD, 2005, J AM ACAD DERMATOL, V52, P61, DOI 10.1016/j.jaad.2004.04.039; Kavak A, 2002, J AM ACAD DERMATOL, V46, P437, DOI 10.1067/mjd.2002.113674; RONGIOLETTI F, 1992, LANCET, V339, P55, DOI 10.1016/0140-6736(92)90177-5; Savk O, 2005, J AM ACAD DERMATOL, V52, P1085, DOI 10.1016/j.jaad.2005.01.138; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2007	370	9583					290	290		10.1016/S0140-6736(07)61131-3	http://dx.doi.org/10.1016/S0140-6736(07)61131-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658400				2022-12-28	WOS:000248347900034
J	Haynes, G; Anderson, DG; Ferring, CR; Fiedel, SJ; Grayson, DK; Haynes, CV; Holliday, VT; Huckell, BB; Kornfeld, M; Meltzer, DJ; Morrow, J; Surovell, T; Waguespack, NM; Wigand, P; Yohe, RM				Haynes, Gary; Anderson, David G.; Ferring, C. Reid; Fiedel, Stuart J.; Grayson, Donald K.; Haynes, C. Vance, Jr.; Holliday, Vance T.; Huckell, Bruce B.; Kornfeld, Marcel; Meltzer, David J.; Morrow, Julie; Surovell, Todd; Waguespack, Nicole M.; Wigand, Peter; Yohe, Robert M., II			Comment on "Redefining the age of Clovis: Implications for the peopling of the Americas"	SCIENCE			English	Editorial Material									Univ Nevada, Dept Anthropol, Reno, NV 89557 USA; Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; Univ N Texas, Dept Geog, Denton, TX 76203 USA; Louis Berger Grp, Richmond, VA 23219 USA; Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Univ New Mexico, Maxwell Museum Anthropol, Albuquerque, NM 87131 USA; Univ Wyoming, Dept Anthropol, Laramie, WY 82071 USA; So Methodist Univ, Dept Anthropol, Dallas, TX 75205 USA; Arkansas Archeol Survey, State College, AR 72467 USA; Calif State Univ, Dept Sociol & Anthropol, Bakersfield, CA 93311 USA; Univ Nevada, Dept Geog, Reno, NV 89557 USA; Calif State Univ, Dept Geol, Bakersfield, CA 93311 USA; Nevada State Museum, Carson City, NV 89701 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Tennessee System; University of Tennessee Knoxville; University of North Texas System; University of North Texas Denton; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona; University of New Mexico; University of Wyoming; Southern Methodist University; California State University System; California State University Bakersfield; Nevada System of Higher Education (NSHE); University of Nevada Reno; California State University System; California State University Bakersfield	Haynes, G (corresponding author), Univ Nevada, Dept Anthropol, Reno, NV 89557 USA.	gahaynes@unr.edu		Meltzer, David/0000-0001-8084-9802; Surovell, Todd/0000-0001-6587-8621				DONAHUE J, 2001, CURR RES PLEISTOCENE, V18, P20; FRISON G, 1996, MILL IRON SITE, pCH1; Kornfeld M., 1999, GEOARCHAEOLOGY, V14, P655; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166	4	68	70	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836								10.1126/science.1141960	http://dx.doi.org/10.1126/science.1141960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641183				2022-12-28	WOS:000248150200024
J	Stiffler, MA; Chen, JR; Grantcharova, VP; Lei, Y; Fuchs, D; Allen, JE; Zaslavskaia, LA; MacBeath, G				Stiffler, Michael A.; Chen, Jiunn R.; Grantcharova, Viara P.; Lei, Ying; Fuchs, Daniel; Allen, John E.; Zaslavskaia, Lioudmila A.; MacBeath, Gavin			PDZ domain binding selectivity is optimized across the mouse proteome	SCIENCE			English	Article							INTERACTION NETWORK; LIGAND RECOGNITION; ERBIN; SPECIFICITY; MICROARRAYS; MOTIFS	PDZ domains have long been thought to cluster into discrete functional classes defined by their peptide-binding preferences. We used protein microarrays and quantitative fluorescence polarization to characterize the binding selectivity of 157 mouse PDZ domains with respect to 217 genome-encoded peptides. We then trained a multidomain selectivity model to predict PDZ domain-peptide interactions across the mouse proteome with an accuracy that exceeds many large-scale, experimental investigations of protein-protein interactions. Contrary to the current paradigm, PDZ domains do not fall into discrete classes; instead, they are evenly distributed throughout selectivity space, which suggests that they have been optimized across the proteome to minimize cross-reactivity. We predict that focusing on families of interaction domains, which facilitates the integration of experimentation and modeling, will play an increasingly important role in future investigations of protein function.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	macbeath@chemistry.harvard.edu		Allen, John/0000-0001-5005-5139; MacBeath, Gavin/0000-0003-2585-6772	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM072872] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072872, R01 GM072872-04, 5 T32 GM07598-25, 1 RO1 GM072872-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Tropsha A, 2006, ANN REP COMP CHEM, V2, P113, DOI 10.1016/S1574-1400(06)02007-X; Van Dongen SM, 2000, THESIS U UTRECHT NET; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	24	305	312	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					364	369		10.1126/science.1144592	http://dx.doi.org/10.1126/science.1144592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641200	Green Accepted			2022-12-28	WOS:000248150200045
J	Sutcliffe, AG; Ludwig, M				Sutcliffe, Alastair G.; Ludwig, Michael			Outcome of assisted reproduction	LANCET			English	Review							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; BECKWITH-WIEDEMANN-SYNDROME; SINGLE-EMBRYO-TRANSFER; CHILDREN BORN; OVARIAN STIMULATION; INCREASED RISK; SPONTANEOUS-ABORTION; MENTAL-DEVELOPMENT; BIRTH-DEFECTS	In-vitro fertilisation has been done for nearly 30 years; in developed countries at least 1% of births are from assisted reproductive therapies (ART). These children now represent a substantial proportion of the population but little is known about their health. Some of the morbidity associated with ART does not result from the techniques but from the underlying health risks of being subfertile. Much of the amplified risk associated with ART is related to high birth order. However, risk of intrauterine and subsequent perinatal complications is enhanced after ART, and urogenital malformations can be present in boys, even in singleton infants. No increase in discord or other difficulties within families has been recorded. Long-term follow-up of children born after ART to reproductive age and beyond is necessary.	UCL, Inst Child Hlth, Dept Paediat, London WC1N 1EH, England; Endokrinologikum Hamburg, Hamburg, Germany	University of London; University College London	Sutcliffe, AG (corresponding author), UCL, Inst Child Hlth, Dept Paediat, London WC1N 1EH, England.	a.sutcliffe@medsch.ucl.ac.uk		Sutcliffe, Alastair/0000-0001-8542-6155				Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Aynsley-Green A, 2000, BRIT MED J, V321, P229, DOI 10.1136/bmj.321.7255.229; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Barnes J, 2004, HUM REPROD, V19, P1480, DOI 10.1093/humrep/deh239; Basso O, 2003, AM J EPIDEMIOL, V157, P195, DOI 10.1093/aje/kwf194; Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Bhattacharya S, 2000, NEW ENGL J MED, V343, P58, DOI 10.1056/NEJM200007063430110; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Bonduelle M, 2005, HUM REPROD, V20, P413, DOI 10.1093/humrep/deh592; Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; Bonduelle M, 2002, HUM REPROD, V17, P2600, DOI 10.1093/humrep/17.10.2600; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; BRADSHAW J, 2001, FAMILY SECRETS WHAT; Brinton LA, 2004, FERTIL STERIL, V81, P1083, DOI 10.1016/j.fertnstert.2003.08.042; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Calogero A E, 2003, Reprod Biomed Online, V6, P310; Colpin H, 1995, J CHILD PSYCHOL PSYC, V36, P1429, DOI 10.1111/j.1469-7610.1995.tb01673.x; De Sutter P, 2005, HUM REPROD, V20, P1642, DOI 10.1093/humrep/deh807; Doyle P, 1998, LANCET, V352, P452, DOI 10.1016/S0140-6736(05)79186-8; Draper ES, 1999, LANCET, V353, P1746, DOI 10.1016/S0140-6736(98)08500-6; EDWARDS RG, 1970, NATURE, V227, P1307, DOI 10.1038/2271307a0; Edwards Robert G, 2003, Reprod Biomed Online, V7, P131; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Engel W, 1996, HUM REPROD, V11, P2359; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Ertzeid G, 2001, HUM REPROD, V16, P221, DOI 10.1093/humrep/16.2.221; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; FISHEL S, 1986, IN VITRO FERTILIZATI; Foresta C, 2005, J CLIN ENDOCR METAB, V90, P152, DOI 10.1210/jc.2004-1469; Gaudoin M, 2003, AM J OBSTET GYNECOL, V188, P611, DOI 10.1067/mob.2003.5; GEISTHOVEL F, 2004, J REPROD ENDOKRINOLO, V1, P299; GHAZI HA, 1991, FERTIL STERIL, V55, P726; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Glinianaia SV, 2002, ARCH DIS CHILD-FETAL, V86, pF9, DOI 10.1136/fn.86.1.F9; Golombok S, 2001, CHILD DEV, V72, P599, DOI 10.1111/1467-8624.00299; Gordts S, 2005, REPROD BIOMED ONLINE, V10, P436, DOI 10.1016/S1472-6483(10)60818-8; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Heape W, 1891, P R SOC LONDON, V48, P457; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; Horsthemke B, 2005, HUM REPROD UPDATE, V11, P473, DOI 10.1093/humupd/dmi022; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jones Howard W Jr, 2003, Reprod Biomed Online, V6, P375; Katalinic A, 2004, FERTIL STERIL, V81, P1604, DOI 10.1016/j.fertnstert.2003.10.053; Keizer M, 2004, FERTIL STERIL, V82, pS48; Klemetti R, 2002, HUM REPROD, V17, P2192, DOI 10.1093/humrep/17.8.2192; Koivurova S, 2003, HUM REPROD, V18, P2328, DOI 10.1093/humrep/deg445; Lerner-Geva L, 2000, CANCER, V88, P2845, DOI 10.1002/1097-0142(20000615)88:12<2845::AID-CNCR26>3.0.CO;2-E; Leslie GI, 2003, HUM REPROD, V18, P2067, DOI 10.1093/humrep/deg408; Leslie GI, 1998, HUM REPROD, V13, P2055, DOI 10.1093/humrep/13.8.2055; Lidegaard O, 2005, HUM REPROD, V20, P950, DOI 10.1093/humrep/deh714; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyh363; Ludwig M, 2005, REPROD BIOMED ONLINE, V10, P83; Ludwig M, 2005, J MED GENET, V42, P289, DOI 10.1136/jmg.2004.026930; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Mitwally MF, 2004, FERTIL STERIL, V82, pS50, DOI 10.1016/j.fertnstert.2004.07.131; Nawroth F, 2003, J AM ASSOC GYN LAP, V10, P396, DOI 10.1016/S1074-3804(05)60271-X; Nuojua-Huttunen S, 1999, HUM REPROD, V14, P2110, DOI 10.1093/humrep/14.8.2110; Olivennes F, 2001, HUM REPROD, V16, P1588, DOI 10.1093/humrep/16.8.1588; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Pandian Z, 2001, HUM REPROD, V16, P2593, DOI 10.1093/humrep/16.12.2593; Peters C, 2005, FERTIL STERIL, V83, P914, DOI 10.1016/j.fertnstert.2004.12.019; Pezeshki K, 2000, FERTIL STERIL, V74, P504, DOI 10.1016/S0015-0282(00)00707-X; Pharoah POD, 2000, LANCET, V355, P1597, DOI 10.1016/S0140-6736(00)02215-7; Pinborg A, 2005, HUM REPROD, V20, P2821, DOI 10.1093/humrep/dei142; Place I, 2003, FERTIL STERIL, V80, P1388, DOI 10.1016/j.fertnstert.2003.06.004; Ponjaert-Kristoffersen I, 2004, HUM REPROD, V19, P2791, DOI 10.1093/humrep/deh511; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Raber W, 2003, HUM REPROD, V18, P707, DOI 10.1093/humrep/deg142; Rimm AA, 2004, J ASSIST REPROD GEN, V21, P437, DOI 10.1007/s10815-004-8760-8; ROBERT EDWARDS AND PATRICK STEPTOE, 1980, MATTER LIFE; Saunders K, 1996, PEDIATRICS, V97, P688; Schenk SL, 1878, MITT EMBRYOL I KK U, V1, P107; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; STEPTOE PC, 1978, LANCET, V2, P366; Strandell A, 1999, HUM REPROD, V14, P2762, DOI 10.1093/humrep/14.11.2762; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; Sutcliffe AG, 2006, HUM REPROD, V21, P1009, DOI 10.1093/humrep/dei405; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; Sutcliffe AG, 1998, LANCET, V352, P578, DOI 10.1016/S0140-6736(05)79291-6; SUTCLIFFE AG, 1995, ARCH DIS CHILD, V72, P290, DOI 10.1136/adc.72.4.290; Sutcliffe AG, 2006, HLTH WELFARE ART CHI; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; TROUNSON AO, 1990, BRIT MED BULL, V46, P695, DOI 10.1093/oxfordjournals.bmb.a072425; Van Royen E, 1999, HUM REPROD, V14, P2345, DOI 10.1093/humrep/14.9.2345; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; vanBalen F, 1996, J CHILD PSYCHOL PSYC, V37, P687; Wang JX, 2004, HUM REPROD, V19, P272, DOI 10.1093/humrep/deh078; Wennerholm UB, 1998, LANCET, V351, P1085, DOI 10.1016/S0140-6736(97)08247-0; WILLIAMS MA, 1991, FERTIL STERIL, V56, P668; WILMUT I, 1972, LIFE SCI 2-BIOCH GEN, V11, P1071, DOI 10.1016/0024-3205(72)90215-9; 2005, RESMI GAZETE TU 0209; [No title captured]	103	208	228	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					351	359		10.1016/S0140-6736(07)60456-5	http://dx.doi.org/10.1016/S0140-6736(07)60456-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195QG	17662884				2022-12-28	WOS:000248426100033
J	Su, LL; Chong, YS; Chan, YH; Chan, YS; Fok, D; Tun, KT; Ng, FSP; Rauff, M				Su, Lin-Lin; Chong, Yap-Seng; Chan, Yiong-Huak; Chan, Yah-Shih; Fok, Doris; Tun, Kay-Thwe; Ng, Faith S. P.; Rauff, Mary			Antenatal education and postnatal support strategies for improving rates of exclusive breast feeding: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LACTATION CONSULTANT INTERVENTION; HEALTH-CARE; INFANT; PROMOTION; MOTHERS; COUNSELORS; DURATION; ILLNESS	Objective To investigate whether antenatal breast feeding education alone or postnatal lactation support alone improves rates of exclusive breast feeding compared with routine hospital care. Design Randomised controlled trial. Setting A tertiary hospital in Singapore. Participants 450 women with uncomplicated pregnancies. Main outcome measures Primary outcomes were rates of exclusive breast feeding at discharge from hospital and two weeks, six weeks, three months, and six months after delivery. Secondary outcomes were rates of any breast feeding. Results Compared with women who received routine care, women in the postnatal support group were more likely to breastfeed exclusively at two weeks (relative risk 1.82, 95% confidence interval 1.14 to 2.90), six weeks (1.85, 1.11 to 3.09), three months (1.87, 1.03 to 3.41), and six months (2.12, 1.03 to 4.37) postnatally. Women receiving antenatal education were more likely to breast feed exclusively at six weeks (1.73, 1.04 to 2.90), three months (1.92, 1.07 to 3.48), and six months (2.16, 1.05 to 4.43) postnatally. The numbers needed to treat to achieve one woman exclusively breast feeding at six months were 11 (6 to 80) for postnatal support and 10 (6 to 60) for antenatal education. Women who received postnatal support were more likely to exclusively or predominantly breast feed two weeks after delivery compared with women who received antenatal education (1.53, 1.01 to 2.31). The rate of any breastfeeding six weeks after delivery was also higher in the postnatal support group compared with women who received routine care (1.16, 1.02 to 1.31). Conclusions Antenatal breast feeding education and postnatal lactation support, as single interventions based in hospital both significantly improve rates of exclusive breast feeding up to six months after delivery. Postnatal support was marginally more effective than antenatal education.	Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Clin Trials & Epidemiol Res Unit, Singapore 1699039, Singapore; Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119074, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Chong, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore.	obgcys@nus.edu.sg	CHAN, YAH SHIH/R-7423-2019	Chong, Yap Seng/0000-0002-7232-8473				[Anonymous], 2002, INFANT FEEDING 2000; Ball TM, 1999, PEDIATRICS, V103, P870; Bartington S, 2006, INT J EPIDEMIOL, V35, P1178, DOI 10.1093/ije/dyl155; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bonuck KA, 2005, PEDIATRICS, V116, P1413, DOI 10.1542/peds.2005-0435; Bonuck KA, 2006, ARCH PEDIAT ADOL MED, V160, P953, DOI 10.1001/archpedi.160.9.953; Cattaneo A, 2006, ACTA PAEDIATR, V95, P540, DOI 10.1080/08035250500447936; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; DANNER S, 1998, NURSING YOUR BABY 1; Dyson L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001688.pub2; Dyson L., 2006, PROMOTION BREASTFEED, P242; Fok D, 1998, Breastfeed Rev, V6, P5; Foo LL, 2005, HEALTH PROMOT INT, V20, P229, DOI 10.1093/heapro/dai002; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; HAMLYN B, 2002, INFANT FEEDIGN 2000; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; Hoddinott P, 1999, BRIT MED J, V318, P30, DOI 10.1136/bmj.318.7175.30; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; Mattar CN, 2007, OBSTET GYNECOL, V109, P73, DOI 10.1097/01.AOG.0000249613.15466.26; Memmott MM, 2006, MATERN CHILD NUTR, V2, P40, DOI 10.1111/j.1740-8709.2006.00040.x; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; *NAT U HOSP, 2002, BREASTF NAT IS BEST; *NICE, 2006, 37 NICE; Oddy WH, 2003, ARCH DIS CHILD, V88, P224, DOI 10.1136/adc.88.3.224; Radford A, 1998, BRIT MED J, V317, P1385, DOI 10.1136/bmj.317.7169.1385; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sikorski J, 2002, COCHRANE DB SYST REV, pCD001141; WEIMER J, 2001, 13120 USDA EC RES SE; WEIMER J, 2001, 13 USDA FOOD RUR EC, P1; World Health Organization, 2001, OPT DUR EXCL BREASTF	33	108	113	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2007	335	7620					596	599		10.1136/bmj.39279.656343.55	http://dx.doi.org/10.1136/bmj.39279.656343.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17670909	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000249832400033
J	Tang, CL; Toomajian, C; Sherman-Broyles, S; Plagnol, V; Guo, YL; Hu, TT; Clark, RM; Nasrallah, JB; Weigel, D; Nordborg, M				Tang, Chunlao; Toomajian, Christopher; Sherman-Broyles, Susan; Plagnol, Vincent; Guo, Ya-Long; Hu, Tina T.; Clark, Richard M.; Nasrallah, June B.; Weigel, Detlef; Nordborg, Magnus			The evolution of selfing in Arabidopsis thaliana	SCIENCE			English	Article							S-LOCUS; INCOMPATIBILITY	Unlike most of its close relatives, Arabidopsis thaliana is capable of self-pollination. In other members of the mustard family, outcrossing is ensured by the complex self-incompatibility (S) locus, which harbors multiple diverged specificity haplotypes that effectively prevent selfing. We investigated the role of the S locus in the evolution of and transition to selfing in A. thaliana. We found that the S locus of A. thaliana harbored considerable diversity, which is an apparent remnant of polymorphism in the outcrossing ancestor. Thus, the fixation of a single inactivated S-locus allele cannot have been a key step in the transition to selfing. An analysis of the genome-wide pattern of linkage disequilibrium suggests that selfing most likely evolved roughly a million years ago or more.	Univ So Calif, Los Angeles, CA 90089 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Univ Cambridge, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 2XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; Cornell University; University of Cambridge; Max Planck Society; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Weigel, Detlef/AAR-3312-2021; Tang, Chunlao/F-9203-2010; Weigel, Detlef/GSJ-0799-2022; Toomajian, Christopher/ABA-2615-2021; Plagnol, Vincent/A-5667-2011; Weigel, Detlef/C-1418-2008; Guo, Yalong/G-4742-2011	Weigel, Detlef/0000-0002-2114-7963; Toomajian, Christopher/0000-0002-6763-0678; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748; Guo, Yalong/0000-0002-4643-4889; Plagnol, Vincent/0000-0002-5597-9215	NHGRI NIH HHS [P50 HG002790] Funding Source: Medline; NIGMS NIH HHS [GM62932, R01 GM062932] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Charlesworth D, 2005, BIOESSAYS, V27, P472, DOI 10.1002/bies.20231; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; KAPLAN NL, 1989, GENETICS, V123, P887; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2000, GENETICS, V154, P923; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776	18	122	138	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1070	1072		10.1126/science.1143153	http://dx.doi.org/10.1126/science.1143153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17656687				2022-12-28	WOS:000248946700041
J	Shojania, KG; Sampson, M; Ansari, MT; Ji, J; Doucette, S; Moher, D				Shojania, Kaveh G.; Sampson, Margaret; Ansari, Mohammed T.; Ji, Jun; Doucette, Steve; Moher, David			How quickly do systematic reviews go out of date? A survival analysis	ANNALS OF INTERNAL MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; METAANALYSIS; STROKE; ACETYLCYSTEINE; IMMUNOTHERAPY; NEPHROPATHY; METFORMIN; CALCIUM; TRIALS	Background: Systematic reviews are often advocated as the best source of evidence to guide clinical decisions and health care policy, yet we know little about the extent to which they require updating. Objective: To estimate the average time to changes in evidence that are sufficiently important to warrant updating systematic reviews. Design: Survival analysis of 100 quantitative systematic reviews Sample: Systematic reviews published from 1995 to 2005 and indexed in ACP Journal Club. Eligible reviews evaluated a specific drug or class of drug, device, or procedure and included only randomized or quasi-randomized, controlled trials. Measurements: Quantitative signals for updating were changes in statistical significance or relative changes in effect magnitude of at least 50% involving 1 of the primary outcomes of the original systematic review or any mortality outcome. Qualitative signals included substantial differences in characterizations of effectiveness, new information about harm, and caveats about the previously reported findings that would affect clinical decision making. Results: The cohort of 100 systematic reviews included a median of 13 studies and 2663 participants per review. A qualitative or quantitative signal for updating occurred for 57% of reviews (95% Cl, 47% to 67%). Median duration of survival free of a signal for updating was 5.5 years (Cl, 4.6 to 7.6 years). However, a signal occurred within 2 years for 23% of reviews and within 1 year for 15%. In 7%, a signal had already occurred at the time of publication. Only 4% of reviews had a signal within 1 year of the end of the reported search period; 11% had a signal within 2 years of the search. Shorter survival was associated with cardiovascular topics (hazard ratio, 2.70 [Cl, 1.36 to 5.34]) and heterogeneity in the original review (hazard ratio, 2.15 [Cl, 1.12 to 4.11]). Limitation: Judgments of the need for updating were made without involving content experts. Conclusion: In a cohort of high-quality systematic reviews directly relevant to clinical practice, signals for updating occurred frequently and within a relatively short time.	Ottawa Civic Hosp, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Chalmers Res Grp, Ottawa, ON, Canada; Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Shojania, KG (corresponding author), Ottawa Civic Hosp, Civic Campus 1053 Carling Ave,Room C403,Box 693, Ottawa, ON K1Y 4E9, Canada.	kshojania@ohri.ca; sdoucette@ohri.ca	Sampson, Margaret/A-9128-2011	Sampson, Margaret/0000-0003-2550-9893; Moher, David/0000-0003-2434-4206	PHS HHS [290-02-0021] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Bucher HC, 1996, JAMA-J AM MED ASSOC, V275, P1113, DOI 10.1001/jama.275.14.1113; Bucher HC, 1998, ANN INTERN MED, V128, P89, DOI 10.7326/0003-4819-128-2-199801150-00002; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Cheng Eric, 2007, ACP J Club, V146, P7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Finfer S, 2004, NEW ENGL J MED, V350, P2247; French Simon D, 2005, BMC Med Res Methodol, V5, P33, DOI 10.1186/1471-2288-5-33; Halkes PHA, 2006, LANCET, V367, P1665; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kent DM, 2006, NEW ENGL J MED, V355, P613, DOI 10.1056/NEJMe068146; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; MOHER D, IN PRESS J CLIN EPID; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; Nallamothu BK, 2004, AM J MED, V117, P938, DOI 10.1016/j.amjmed.2004.06.046; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Shojania K G, 2001, Eff Clin Pract, V4, P157; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; [No title captured], DOI DOI 10.1002/14651858.CD001208	32	455	476	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2007	147	4					224	233		10.7326/0003-4819-147-4-200708210-00179	http://dx.doi.org/10.7326/0003-4819-147-4-200708210-00179			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201AP	17638714				2022-12-28	WOS:000248804200002
J	Katzman, S; Kern, AD; Bejerano, G; Fewell, G; Fulton, L; Wilson, RK; Salama, SR; Haussler, D				Katzman, Sol; Kern, Andrew D.; Bejerano, Gill; Fewell, Ginger; Fulton, Lucinda; Wilson, Richard K.; Salama, Sofie R.; Haussler, David			Human genome ultraconserved elements are ultraselected	SCIENCE			English	Article							REGIONS		Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Haussler, D (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Salama, Sofie/K-6412-2019; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Salama, Sofie/0000-0001-6999-7193				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295	6	187	194	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					915	915		10.1126/science.1142430	http://dx.doi.org/10.1126/science.1142430			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702936				2022-12-28	WOS:000248780200030
J	Tommassen, J				Tommassen, Jan			Getting into and through the outer membrane	SCIENCE			English	Editorial Material							PERTUSSIS FILAMENTOUS HEMAGGLUTININ; ESCHERICHIA-COLI; PROTEINS; FHAC; ARCHITECTURE; BIOGENESIS; SECRETION; COMPONENT; COMPLEX		Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.	j.p.m.tommassen@uu.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Guedin S, 2000, J BIOL CHEM, V275, P30202, DOI 10.1074/jbc.M005515200; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Surana NK, 2004, P NATL ACAD SCI USA, V101, P14497, DOI 10.1073/pnas.0404679101; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	11	20	20	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					903	904		10.1126/science.1146518	http://dx.doi.org/10.1126/science.1146518			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702930				2022-12-28	WOS:000248780200024
J	Fortin, PD; Walsh, CT; Magarvey, NA				Fortin, Pascal D.; Walsh, Christopher T.; Magarvey, Nathan A.			A transglutaminase homologue as a condensation catalyst in antibiotic assembly lines	NATURE			English	Article							HETEROLOGOUS EXPRESSION; BIOSYNTHESIS; GENE; IDENTIFICATION; INACTIVATION; AMINOMUTASE; POLYKETIDE; BACTERIUM	The unrelenting emergence of antibiotic- resistant bacterial pathogens demands the investigation of antibiotics with new modes of action. The pseudopeptide antibiotic andrimid is a nanomolar inhibitor of the bacterial acetyl- CoA carboxylase that catalyses the first committed step in prokaryotic fatty acid biosynthesis(1). Recently, the andrimid ( adm) biosynthetic gene cluster was isolated and heterologously expressed in Escherichia coli(2). This establishes a heterologous biological host in which to rapidly probe features of andrimid formation and to use biosynthetic engineering to make unnatural variants of this important and promising new class of antibiotics. Bioinformatic analysis of the adm cluster revealed a dissociated biosynthetic assembly system lacking canonical amide synthases between the first three carrier protein domains. Here we report that AdmF, a transglutaminase ( TGase) homologue, catalyses the formation of the first amide bond, an N-acyl-beta-peptide link, in andrimid biosynthesis. Hence, AdmF is a newly discovered biosynthetic enzyme that acts as a stand- alone amide synthase between protein- bound, thiotemplated substrates in an antibiotic enzymatic assembly line. TGases ( enzyme class ( EC) 2.3.2.13) normally catalyse the cross- linking of ( poly) peptides by creating isopeptidic bonds between the gamma-carboxamide group of a glutamine side chain of one protein and various amine donors, including lysine side chains(3). To the best of our knowledge, the present study constitutes the first report of a TGase- like enzyme recruited for the assembly of an antibiotic. Moreover, genome mining using the AdmF sequence yielded additional TGases in unassigned natural product biosynthetic pathways. With many more microbial genomes being sequenced, such a strategy could potentially unearth biosynthetic pathways producing new classes of antibiotics.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Fortin, Pascal/0000-0001-9796-791X				Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FREDENHAGEN A, 1987, J AM CHEM SOC, V109, P4409, DOI 10.1021/ja00248a055; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Jin M, 2006, J AM CHEM SOC, V128, P10660, DOI 10.1021/ja063194c; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Molnar-Perl I, 2001, J CHROMATOGR A, V913, P283, DOI 10.1016/S0021-9673(00)01200-0; NEEDHAM J, 1994, J ORG CHEM, V59, P2058, DOI 10.1021/jo00087a020; OCLARIT JM, 1994, MICROBIOS, V78, P7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; SAMPSON BA, 1989, GENETICS, V122, P491; STAAB HA, 1962, CHEM BER-RECL, V95, P1275, DOI 10.1002/cber.19620950526; Tonge PJ, 1995, BIOSPECTROSCOPY, V1, P387, DOI 10.1002/bspy.350010604; Walker KD, 2004, J BIOL CHEM, V279, P53947, DOI 10.1074/jbc.M411215200; Walsh C., 2006, POSTTRANSLATIONAL MO; Xiang LK, 2002, J BIOL CHEM, V277, P32505, DOI 10.1074/jbc.M204171200; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	19	49	51	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					824	U11		10.1038/nature06068	http://dx.doi.org/10.1038/nature06068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653193				2022-12-28	WOS:000248754200044
J	Slotman, B; Faivre-Finn, C; Kramer, G; Rankin, E; Snee, M; Hatton, M; Postmus, P; Collette, L; Musat, E; Senan, S				Slotman, Ben; Faivre-Finn, Corinne; Kramer, Gijs; Rankin, Elaine; Snee, Michael; Hatton, Matthew; Postmus, Pieter; Collette, Laurence; Musat, Elena; Senan, Suresh		EORTC Rad Oncology Grp; Lung Canc Grp	Prophylactic cranial irradiation in extensive small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-BRAIN RADIOTHERAPY; PHASE-III; NEUROLOGIC DISORDERS; CONSECUTIVE PATIENTS; METASTASES; ETOPOSIDE; SURVEILLANCE; CHEMOTHERAPY; METAANALYSIS; TENIPOSIDE	Background: We conducted a randomized trial of prophylactic cranial irradiation in patients with extensive small-cell lung cancer who had had a response to chemotherapy. Methods: Patients between the ages of 18 and 75 years with extensive small-cell lung cancer were randomly assigned to undergo prophylactic cranial irradiation (irradiation group) or receive no further therapy (control group). The primary end point was the time to symptomatic brain metastases. Computed tomography or magnetic resonance imaging of the brain was performed when any predefined key symptom suggestive of brain metastases was present. Results: The two groups (each with 143 patients) were well balanced regarding baseline characteristics. Patients in the irradiation group had a lower risk of symptomatic brain metastases (hazard ratio, 0.27; 95% confidence interval [CI], 0.16 to 0.44; P < 0.001). The cumulative risk of brain metastases within 1 year was 14.6% in the irradiation group (95% CI, 8.3 to 20.9) and 40.4% in the control group (95% CI, 32.1 to 48.6). Irradiation was associated with an increase in median disease-free survival from 12.0 weeks to 14.7 weeks and in median overall survival from 5.4 months to 6.7 months after randomization. The 1-year survival rate was 27.1% (95% CI, 19.4 to 35.5) in the irradiation group and 13.3% (95% CI, 8.1 to 19.9) in the control group. Irradiation had side effects but did not have a clinically significant effect on global health status. Conclusions: Prophylactic cranial irradiation reduces the incidence of symptomatic brain metastases and prolongs disease-free and overall survival.	Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, NL-1081 HV Amsterdam, Netherlands; Arnhems Radiotherapeut Inst, Arnhem, Netherlands; Christie Hosp & Holt Radium Inst, Manchester M20 9BX, Lancs, England; Univ Dundee, Ninewells Hosp, Dundee, Scotland; Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England; Weston Pk Hosp, Sheffield, S Yorkshire, England; European Org Res Treatment Canc, Dept Stat, Brussels, Belgium; European Org Res Treatment Canc, Dept Med Res, Brussels, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Christie NHS Foundation Trust; Christie Hospital; University of Dundee; Cookridge Hospital; Weston Park Hospital; European Organisation for Research & Treatment of Cancer; European Organisation for Research & Treatment of Cancer	Slotman, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	bj.slotman@vumc.nl	Senan, Suresh/P-5790-2019	Senan, Suresh/0000-0003-3995-2204; Collette, Laurence/0000-0003-2518-7281; postmus, pieter/0000-0002-7774-2868; Faivre-Finn, Corinne/0000-0001-5617-9781; Slotman, Ben/0000-0002-9902-4592	NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER; NCI NIH HHS [5U10-CA11488-34, 5U10-CA11488-35, 5U10-CA11488-36, 5U10-CA11488-37, 5U10-CA11488-33, 5U10-CA11488-32, 5U10-CA11488-31, 5U10-CA11488-30, 5U10-CA11488-29] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arriagada R, 1995, EUR J CANCER, V31A, P83; ARRIAGADA R, 1995, JNCI-J NATL CANCER I, V87, P183, DOI 10.1093/jnci/87.3.183; Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Chute JP, 1999, J CLIN ONCOL, V17, P1794, DOI 10.1200/JCO.1999.17.6.1794; FELLETTI R, 1985, RADIOTHER ONCOL, V4, P335, DOI 10.1016/S0167-8140(85)80121-3; FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759; Glantz MJ, 1997, SEMIN ONCOL, V24, P477; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gregor A, 1997, EUR J CANCER, V33, P1752, DOI 10.1016/S0959-8049(97)00135-4; GROEN HJM, 1993, EUR J CANCER, V29A, P1696, DOI 10.1016/0959-8049(93)90107-Q; HARDY J, 1990, BRIT J CANCER, V62, P684, DOI 10.1038/bjc.1990.357; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kotalik J, 2001, INT J RADIAT ONCOL, V50, P309, DOI 10.1016/S0360-3016(01)01448-1; KRISTENSEN CA, 1992, J CLIN ONCOL, V10, P1498, DOI 10.1200/JCO.1992.10.9.1498; Lee JJ, 2006, J CLIN ONCOL, V24, P3597, DOI 10.1200/JCO.2006.06.0632; Meert AP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-5; NUGENT JL, 1979, CANCER, V44, P1885, DOI 10.1002/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Postmus PE, 1998, RADIOTHER ONCOL, V46, P29, DOI 10.1016/S0167-8140(97)00149-7; POSTMUS PE, 1995, J CLIN ONCOL, V13, P660, DOI 10.1200/JCO.1995.13.3.660; POSTMUS PE, 1989, BRIT J CANCER, V59, P254, DOI 10.1038/bjc.1989.52; Postmus PE, 2000, J CLIN ONCOL, V18, P3400, DOI 10.1200/JCO.2000.18.19.3400; Schiller JH, 2001, J CLIN ONCOL, V19, P2114, DOI 10.1200/JCO.2001.19.8.2114; Seute T, 2006, J CLIN ONCOL, V24, P2079, DOI 10.1200/JCO.2005.03.2946; Seute T, 2004, CANCER-AM CANCER SOC, V100, P801, DOI 10.1002/cncr.20043; Sundstrom S, 2005, LUNG CANCER, V48, P251, DOI 10.1016/j.lungcan.2004.10.016; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; Suwinski R, 1998, INT J RADIAT ONCOL, V40, P797, DOI 10.1016/S0360-3016(97)00856-0; Thatcher N, 2005, ANN ONCOL, V16, P235, DOI 10.1093/annonc/mdi700; vanOosterhout AGM, 1996, CANCER, V77, P1434, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1434::AID-CNCR3>3.0.CO;2-C	31	749	791	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					664	672		10.1056/NEJMoa071780	http://dx.doi.org/10.1056/NEJMoa071780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699816				2022-12-28	WOS:000248746000006
J	Detsky, AS; Baker, MA				Detsky, Allan S.; Baker, Michael A.			How to run a successful academic practice plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL-CENTER; FACULTY; COMPENSATION; PRODUCTIVITY; SYSTEM; MODEL		Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Detsky, AS (corresponding author), Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, 600 Univ Ave,Rm 427, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca						Bowman MA, 2007, JAMA-J AM MED ASSOC, V297, P2521, DOI 10.1001/jama.297.22.2521; Brandt TL, 2002, ANN INTERN MED, V137, P738, DOI 10.7326/0003-4819-137-9-200211050-00009; BUNCH WH, 1987, J MED EDUC, V62, P799; Ceriani P J, 1992, J Ambul Care Manage, V15, P69; Coleman DL, 2003, ACAD MED, V78, P682, DOI 10.1097/00001888-200307000-00007; Guss DA, 2002, ACAD EMERG MED, V9, P654, DOI 10.1197/aemj.9.6.654; Longnecker DE, 2003, ACAD MED, V78, P1130, DOI 10.1097/00001888-200311000-00010; SCHMIDT CW, 1981, NEW ENGL J MED, V304, P263, DOI 10.1056/NEJM198101293040504; Sussman AJ, 2001, ACAD MED, V76, P693, DOI 10.1097/00001888-200107000-00009; Willis DR, 2004, FAM MED, V36, P270	10	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					799	801		10.1001/jama.298.7.799	http://dx.doi.org/10.1001/jama.298.7.799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699013				2022-12-28	WOS:000248728800024
J	Masmanidis, SC; Karabalin, RB; De Vlaminck, I; Borghs, G; Freeman, MR; Roukes, ML				Masmanidis, Sotiris C.; Karabalin, Rassul B.; De Vlaminck, Iwijn; Borghs, Gustaaf; Freeman, Mark R.; Roukes, Michael L.			Multifunctional nanomechanical systems via tunably coupled piezoelectric actuation	SCIENCE			English	Article							NANOELECTROMECHANICAL SYSTEMS; NANOSCALE	Efficient actuation is crucial to obtaining optimal performance from nanoelectromechanical systems (NEMS). We employed epitaxial piezoelectric semiconductors to obtain efficient and fully integrated NEMS actuation, which is based on exploitation of the interaction between piezoelectric strain and built-in charge depletion. The underlying actuation mechanism in these depletion-mediated NEMS becomes important only for devices with dimensions approaching semiconductor depletion lengths. The induced actuation forces are controlled electrically, and resonant excitation approaching single-electron efficiency is demonstrated. The fundamental electromechanical coupling itself can be programmed by heterostructure band engineering, externally controllable charge depletion, and crystallographic orientation. These attributes are combined to realize a prototype, mechanically based, exclusive- or logic element.	CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; IMEC, B-3001 Heverlee, Belgium; Univ Alberta, Dept Phys, Edmonton, AB, Canada; Natl Inst Nanotechnol, Edmonton, AB, Canada	California Institute of Technology; IMEC; University of Alberta; National Research Council Canada	Roukes, ML (corresponding author), CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA.	roukes@caltech.edu	Freeman, Mark R/E-4609-2013; De Vlaminck, Iwijn/P-6479-2015; Roukes, Michael L/E-9787-2010; Karabalin, Rassul/F-6358-2012	Freeman, Mark R/0000-0002-6607-6521; De Vlaminck, Iwijn/0000-0001-6085-7311; 				Bargatin I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709620; Beck RG, 1996, APPL PHYS LETT, V68, P3763, DOI 10.1063/1.115999; Carr DW, 1997, J VAC SCI TECHNOL B, V15, P2760, DOI 10.1116/1.589722; Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373; Curie J., 1880, B SOC MIN FRANCE, V3, P90, DOI DOI 10.3406/BULMI.1880.1564; DeVoe DL, 2001, SENSOR ACTUAT A-PHYS, V88, P263, DOI 10.1016/S0924-4247(00)00518-5; Ekinci KL, 2005, SMALL, V1, P786, DOI 10.1002/smll.200500077; Fon WC, 2005, NANO LETT, V5, P1968, DOI 10.1021/nl051345o; FRICKE K, 1991, J APPL PHYS, V70, P914, DOI 10.1063/1.349598; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Jun SC, 2006, NANOTECHNOLOGY, V17, P1506, DOI 10.1088/0957-4484/17/5/057; Knobel R, 2002, APPL PHYS LETT, V81, P2258, DOI 10.1063/1.1507616; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Piekarski B, 2001, SENSOR ACTUAT A-PHYS, V91, P313, DOI 10.1016/S0924-4247(01)00601-X; Roukes M, 2001, PHYS WORLD, V14, P25; Roukes ML, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P539, DOI 10.1109/IEDM.2004.1419213; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; RUGAR D, 1991, PHYS REV LETT, V67, P699, DOI 10.1103/PhysRevLett.67.699; Timoshenko SP., 1974, VIBRATION PROBLEMS E; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m; Zhang Y, 2002, J APPL PHYS, V92, P7550, DOI 10.1063/1.1521790	23	227	233	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					780	783		10.1126/science.1144793	http://dx.doi.org/10.1126/science.1144793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690289				2022-12-28	WOS:000248624500033
J	Sankaranarayanan, R; Esmy, PO; Rajkumar, R; Muwonge, R; Swaminathan, R; Shanthakumari, S; Fayette, JM; Cherian, J				Sankaranarayanan, Rengaswamy; Esmy, Pulikkottil Okkuru; Rajkumar, Rajamanickam; Muwonge, Richard; Swaminathan, Rajaraman; Shanthakumari, Sivanadam; Fayette, Jean-Marie; Cherian, Jacob			Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial	LANCET			English	Article							LOW-RESOURCE SETTINGS; INSPECTION; STRATEGIES; BENEFITS; PATTERNS; TRENDS	Background Cervical cancer is the most common cancer among women in developing countries. We assessed the effect of screening using visual inspection with 4% acetic acid (VIA) on cervical cancer incidence and mortality in a cluster randomised controlled trial in India. Methods Of the 114 study clusters in Dindigul district, India, 57 were randomised to one round of VIA by trained nurses, and 57 to a control group. Healthy women aged 30 to 59 years were eligible for the study. Screen-positive women had colposcopy, directed biopsies, and, where appropriate, cryotherapy by nurses during the screening visit. Those with larger precancerous lesions or invasive cancers were referred for appropriate investigations and treatment. Cervical cancer incidence and mortality in the study groups were analysed and compared using Cox regression taking the cluster design into account, and analysis was by intention to treat. The primary outcome measures were cervical cancer incidence and mortality. Results Of the 49311 eligible women in the intervention group, 31343 (63.6%) were screened during 2000-03; 30958 control women received the standard care. Of the 3088 (9.9%) screened positive, 3052 had colposcopy, and 2539 directed biopsy. Of the 1874 women with precancerous lesions in the intervention group, 72% received treatment. In the intervention group, 274 430 person years, 167 cervical cancer cases, and 83 cervical cancer deaths were accrued compared with 178 781 person-years, 158 cases, and 92 deaths and in the control group during 2000-06 (incidence hazard ratio 0.75 [95% CI 0.55-0.95] and mortality hazard ratio 0.65 [0.47-0.89]). Interpretation VIA screening, in the presence of good training and sustained quality assurance, is an effective method to prevent cervical cancer in developing countries.	Int Agcy Res Canc, Screening Grp, F-69372 Lyon 08, France; Christian Fellowship Community Hlth Ctr, Ambillikai, Tamil Nadu, India; PSG Inst Med Sci & Res, Dept Prevent Med, Coimbatore, Tamil Nadu, India; Canc Inst WIA, Div Epidemiol, Madras, Tamil Nadu, India; Canc Inst WIA, Canc Registry, Madras, Tamil Nadu, India; PSG Inst Med Sci & Res, Dept Pathol, Coimbatore, Tamil Nadu, India	World Health Organization; International Agency for Research on Cancer (IARC)	Sankaranarayanan, R (corresponding author), Int Agcy Res Canc, Screening Grp, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	sankar@iarc.fr	Muwonge, Richard/P-6375-2015; Rajkumar, Rajamanickam/D-7350-2016	Rajkumar, Rajamanickam/0000-0003-4904-8884				[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P607; Belinson JL, 2001, OBSTET GYNECOL, V98, P441, DOI 10.1016/S0029-7844(01)01454-5; BLUMENTHAL P, 2005, INT J GYNAECOL OB S2, V89, pS4; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; FERLAY J, 2004, 5 IARC; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Gaffikin L, 1999, LANCET, V353, P869; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; HERMANEK P, 1987, INT UNION CANC TNM C, P13; Jensen OM, 1991, IARC SCI PUBLICATION, V95; Kyndi M, 2006, ACTA OBSTET GYN SCAN, V85, P106, DOI 10.1080/00016340500324423; LAARA E, 1987, LANCET, V1, P1247; Liu S, 2001, INT J GYNECOL CANCER, V11, P24, DOI 10.1046/j.1525-1438.2001.011001024.x; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Mathers Lawrence J, 2005, J Low Genit Tract Dis, V9, P232, DOI 10.1097/01.lgt.0000179864.59951.91; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; Percy C., 1990, INT CLASSIFICATION D; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Rajkumar R, 2000, CANCER CAUSE CONTROL, V11, P433, DOI 10.1023/A:1008900425151; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2004, INT J CANCER, V109, P461, DOI 10.1002/ijc.11726; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; SELLORS J, 2003, COLPSCOPY TREATMENT; Sigurdsson K, 2006, ACTA OBSTET GYN SCAN, V85, P343, DOI 10.1080/00016340500432457; Wesley RS, 2003, IARC TECHNICAL PUBLI, V41; World Health Organization, 1992, INT CLASS DIS REL HL; 2004, IARC HDB CANC PREVEN, V10	35	347	363	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					398	406		10.1016/S0140-6736(07)61195-7	http://dx.doi.org/10.1016/S0140-6736(07)61195-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679017				2022-12-28	WOS:000248590200029
J	Underhill, K; Montgomery, P; Operario, D				Underhill, Kristen; Montgomery, Paul; Operario, Don			Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK-REDUCTION INTERVENTIONS; TEENAGE PREGNANCY; ADOLESCENTS; EDUCATION; BEHAVIOR; HEALTH; TRIALS; METAANALYSIS; DESIGN; IMPACT	Objective To assess the effects of sexual abstinence only programmes for HIV prevention among participants in high income countries. Design Systematic review. Data sources 30 electronic databases without linguistic or geographical restrictions to February 2007, contacts with experts, hand searching, and cross referencing. Review methods Two reviewers independently applied inclusion criteria and extracted data, resolving disagreements by consensus and referral to a third reviewer. Randomised and quasirandomised controlled trials of abstinence only programmes in any high income country were included. Programmes aimed to prevent HIV only or both pregnancy and HIV. Trials evaluated biological outcomes (incidence of HIV, sexually transmitted infection, pregnancy) or behavioural outcomes (incidence or frequency of unprotected vaginal, anal, or oral sex; incidence or frequency of any vaginal, anal, or oral sex; number of partners; condom use; sexual initiation). Results The search identified 13 trials enrolling about 15 940 US youths. All outcomes were self reported. Compared with various controls, no programme affected incidence of unprotected vaginal sex, number of partners, condom use, or sexual initiation. One trial observed adverse effects at short term follow-up (sexually transmitted infections, frequency of sex) and long term follow-up (sexually transmitted infections, pregnancy) compared with usual care, but findings were offset by trials with non-significant results. Another trial observed a protective effect on incidence of vaginal sex compared with usual care, but this was limited to short term follow-up and countered by trials with non-significant findings. Heterogeneity prevented meta-analysis. Conclusion Programmes that exclusively encourage abstinence from sex do not seem to affect the risk of HIV infection in high income countries, as measured by self reported biological and behavioural outcomes.	Univ Oxford, Ctr Evidence Based Intervent, Oxford OX1 2ER, England	University of Oxford	Underhill, K (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford OX1 2ER, England.	kristen.underhill@socres.ox.ac.uk		Montgomery, Paul/0000-0001-8008-1370				[Anonymous], 2002, LANCET, V360, P97; [Anonymous], 2006, LANCET, V367, P1213; Bennett SE, 2005, J ADOLESCENT HEALTH, V36, P72, DOI 10.1016/j.jadohealth.2003.11.097; BERLIN J, 1997, ONLINE J CURR CLIN T; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BERNE L, 1999, EUROPEAN APPROACHES; Brener ND, 2004, J ADOLESCENT HEALTH, V35, P91, DOI 10.1016/j.jadohealth.2003.08.013; Chavkin W, 2001, AM J PUBLIC HEALTH, V91, P1739, DOI 10.2105/AJPH.91.11.1739; Chinnock P, 2005, PLOS MED, V2, P367, DOI 10.1371/journal.pmed.0020107; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; DiClemente RJ, 1998, JAMA-J AM MED ASSOC, V279, P1574, DOI 10.1001/jama.279.19.1574; DICLEMENTE RJ, 1990, J ADOLESCENT RES, V5, P7, DOI DOI 10.1177/074355489051003; Eagly A. H., 1993, PSYCHOL ATTITUDES; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Goodson P, 2003, J SCHOOL HEALTH, V73, P91, DOI 10.1111/j.1746-1561.2003.tb03579.x; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P243, DOI 10.1136/bmj.315.7102.243; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Haglund K, 2003, J NURS SCHOLARSHIP, V35, P231, DOI 10.1111/j.1547-5069.2003.00231.x; Haskins R, 1997, CHILD YOUTH SERV REV, V19, P465, DOI 10.1016/S0190-7409(97)00028-5; Higgins J., 2005, COCHRANE HDB SYSTEMA; *HUM RIGHTS WATCH, 2002, IGN ONL HIV AIDS HUM; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaffe H, 2004, SCIENCE, V305, P1243, DOI 10.1126/science.1101136; Jemmott JB, 2000, AIDS, V14, pS40; Johnson WD, 2002, J ACQ IMMUN DEF SYND, V30, pS62, DOI 10.1097/01.QAI.0000018888.47949.1B; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP; JONES EF, 1985, FAM PLANN PERSPECT, V17, P53, DOI 10.2307/2135261; Kirby D, 1997, CHILD YOUTH SERV REV, V19, P415, DOI 10.1016/S0190-7409(97)00025-X; Kirby D, 2002, J SEX RES, V39, P27, DOI 10.1080/00224490209552116; KIRBY D, 1985, J SCHOOL HEALTH, V55, P421, DOI 10.1111/j.1746-1561.1985.tb01169.x; KIRBY D, 2006, IMPACT SEX HIV ED PR; Kirby D., 2001, EMERGING ANSWERS RES; Kirby D., 2002, DO ABSTINENCE ONLY P; Lauritsen JL, 1997, FAM PLANN PERSPECT, V29, P215, DOI 10.2307/2953398; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moore KA, 1997, CHILD YOUTH SERV REV, V19, P485, DOI 10.1016/S0190-7409(97)00029-7; Mullen PD, 2002, J ACQ IMMUN DEF SYND, V30, pS94, DOI 10.1097/01.QAI.0000019980.12814.DF; Newcomer S.., 1988, J ADOLESCENT RES, V3, P419, DOI [10.1177/074355488833014, DOI 10.1177/074355488833014]; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; *OFF MAN BUDG, 2006, BUDG US GOV FY 2007; OLeary A, 1997, AIDS EDUC PREV, V9, P1; OREILLY KR, 2006, SYSTEMATIC REV IMPAC; OREILLY KR, 2005, SYSTEMATIC REV IMPAC; Pedlow CT, 2003, BEHAV MODIF, V27, P135, DOI 10.1177/0145445503251562; Peterman TA, 2000, SEX TRANSM DIS, V27, P446, DOI 10.1097/00007435-200009000-00004; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; RECTOR R, 2002, EFFECTIVENESS AB STI; Remez L, 2000, FAM PLANN PERSPECT, V32, P298, DOI 10.2307/2648199; RIVERS K, 2000, HIV PREVENTION HDB; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; Rosenbaum JE, 2006, AM J PUBLIC HEALTH, V96, P1098, DOI 10.2105/AJPH.2005.063305; Rotheram-Borus M J, 2000, Prev Sci, V1, P15, DOI 10.1023/A:1010071932238; Sanders SA, 1999, JAMA-J AM MED ASSOC, V281, P275, DOI 10.1001/jama.281.3.275; Santelli JS, 2007, AM J PUBLIC HEALTH, V97, P150, DOI 10.2105/AJPH.2006.089169; SHOVELLER J, 2002, AIDS BEHAV, V6, P123; SIEGFRIED N, 2007, METHODOLOGICAL QUALI; SIEGFRIED N, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003362; Silva M, 2002, HEALTH EDUC RES, V17, P471, DOI 10.1093/her/17.4.471; Smoak ND, 2006, JAIDS-J ACQ IMM DEF, V41, P374, DOI 10.1097/01.qai.0000185575.36591.fc; Sonfield A, 2001, FAM PLANN PERSPECT, V33, P166, DOI 10.2307/2673720; STAMMERS T, 2007, BMJ-BRIT MED J; Stephenson J, 1998, BMJ-BRIT MED J, V316, P611, DOI 10.1136/bmj.316.7131.611; TANNE J, 2006, BMJ-BRIT MED J, V332, P748, DOI DOI 10.1136/BMJ.332.7544.748; Tanne JH, 2005, BRIT MED J, V331, P471, DOI 10.1136/bmj.331.7515.471; Thomas MH, 2000, J ADOLESCENT HEALTH, V26, P5, DOI 10.1016/S1054-139X(98)00126-8; Trenholm, 2002, EVALUATION ABSTINENC; UNDERHILL K, 2006, 14 COCHR COLL C; Underhill K, 2007, COCHRANE DB SYST REV, V17, DOI DOI 10.1002/14651858; Underhill K, 2007, AIDS, V21, P266, DOI 10.1097/QAD.0b013e32801199fe; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P2494, DOI 10.1001/jama.287.19.2494; Walgate R, 2004, BRIT MED J, V329, P192, DOI 10.1136/bmj.329.7459.192-a; *WORLD BANK, 2007, COUNTR GROUPS INC HI; ZABIN LS, 1984, FAM PLANN PERSPECT, V16, P181, DOI 10.2307/2134899; 2004, LANCET, V364, P303	76	108	108	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2007	335	7613					248	252		10.1136/bmj.39245.446586.BE	http://dx.doi.org/10.1136/bmj.39245.446586.BE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201QC	17656503	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000248846700029
J	Bainbridge, WS				Bainbridge, William Sims			The scientific research potential of virtual worlds	SCIENCE			English	Review							ONLINE; GAMES	Online virtual worlds, electronic environments where people can work and interact in a somewhat realistic manner, have great potential as sites for research in the social, behavioral, and economic sciences, as well as in human-centered computer science. This article uses Second Life and World of Warcraft as two very different examples of current virtual worlds that foreshadow future developments, introducing a number of research methodologies that scientists are now exploring, including formal experimentation, observational ethnography, and quantitative analysis of economic markets or social networks.	Natl Sci Fdn, Div Informat & Intelligent Syst, Arlington, VA 22230 USA	National Science Foundation (NSF); NSF - Directorate for Computer & Information Science & Engineering (CISE); NSF - Division of Information & Intelligent Systems (IIS)	Bainbridge, WS (corresponding author), Natl Sci Fdn, Div Informat & Intelligent Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.							Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bainbridge W. S., 2006, GOD MACHINE ARTIFICI; Bainbridge WS, 1992, SOCIAL RES METHODS S; BAINBRIDGE WS, IN PRESS REV RELIG R; BARAB S, IN PRESS ED DESIGN U; BARDZELL J, 2006, P 4 NORD C HUM COMP, P433; Bartle RA., 2004, DESIGNING VIRTUAL WO; Bell M, 2006, P SIGCHI C HUM FACT, P417, DOI DOI 10.1145/1124772.1124835; Benford Steve, 2006, P SIGCHI C HUMAN FAC, P427, DOI [10.1145/1124772.1124836, DOI 10.1145/1124772.1124836]; Bloom P., 2004, DESCARTES BABY; BRADLEY C, 2004, NYL SCH L REV, V49, P103; CASTRONOVA E, 2005, CESIFO WORKING PAPER, V1621; Castronova Edward, 2005, SYNTHETIC WORLDS BUS; CHEN KT, 2006, P ACE06; Clarke AC, 1956, CITY STARS; Claypool M, 2006, COMMUN ACM, V49, P40, DOI 10.1145/1167838.1167860; Damer B., 1998, AVATARS EXPLORING BU; DIETERLE E, IN PRESS ENCY MULTIM; Ducheneaut N, 2006, GAMES CULT, V1, P281, DOI DOI 10.1177/1555412006292613; Ducheneaut N, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P839; Eckel CC, 2006, EXP ECON, V9, P53, DOI 10.1007/s10683-006-4307-4; Erikson E.H., 1968, IDENTITY YOUTH CRISI; FESTINGER L, 1956, PROPHENCY FOILS; FOO CY, 2004, P ACE04; Gilbert N., 2005, SIMULATION SOCIAL SC; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Grimes SM, 2006, NEW MEDIA SOC, V8, P969, DOI 10.1177/1461444806069651; GUSTAFSSON A, 2006, P ACE 2006 ACE06; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Holt CharlesA., 2007, MARKETS GAMES STRATE; Hung AA, 2001, AM ECON REV, V91, P1508, DOI 10.1257/aer.91.5.1508; Kafai Y. B., 2007, P 3 INT C COMM TECHN; KIMPPA KK, 2005, ETHICS NEW INFORM TE, P259; KLASTRUP L, 2006, P INT C ADV COMP ENT; Kollock P., 1999, COMMUNITIES CYBERSPA, P221; Kot B, 2005, P 6 ACM SIGCHI NZ CH, P53, DOI DOI 10.1145/1073943.1073954; LUMMIS M, 2006, WORLD WARCRAFT MASTE; LUMMIS M, 2007, WORLD WARCRAFT BURNI; MAHER ML, 2006, COMPUTATIONAL COGNIT, V6, P111; Mayo MJ, 2007, COMMUN ACM, V50, P30, DOI 10.1145/1272516.1272536; MCGREGOR GL, 2006, P INT C GAM RES, P75; MERRICK K, 2006, P ACE06; NARDI BA, 2007, IN PRESS P HAW INT C; NARDI BA, 2006, P CSCW 2006, P1; ONDREJKA C, 2006, GAMES CULT, V1, P111; Pargman D, 2005, Communities and Technologies 2005, P95, DOI 10.1007/1-4020-3591-8_6; ROSSI P, 1980, MONEY WORK CRIME; Rymaszewski M., 2007, 2 LIFE OFFICIAL GUID; Seay AF, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P829; Steinkuehler C., 2006, P 7 INT C LEARN SCI, P723; Taylor T. L, 2006, PLAY WORLDS EXPLORIN; Teasley S, 2001, SCIENCE, V292, P2254, DOI 10.1126/science.1061619; Turkle S., 1984, 2 SELF; Tychsen A., 2006, P 3 AUSTR C INT ENT, P75; Willer D., 1999, Journal of Knowledge Management, V3, P276, DOI 10.1108/13673279910304023; Willer David, 2007, BUILDING EXPT TESTIN; Williams D., 2006, GAMES CULT, V1, P338, DOI DOI 10.1177/1555412006292616; Williams D., 2006, GAMES CULTURE, V1, P13, DOI DOI 10.1177/1555412005281774; Yee N, 2007, CYBERPSYCHOL BEHAV, V10, P115, DOI 10.1089/cpb.2006.9984; Yee N, 2006, PRESENCE-VIRTUAL AUG, V15, P309, DOI 10.1162/pres.15.3.309; Zyda M, 2007, COMMUN ACM, V50, P26, DOI 10.1145/1272516.1272535	61	483	498	19	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					472	476		10.1126/science.1146930	http://dx.doi.org/10.1126/science.1146930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656715	Green Submitted			2022-12-28	WOS:000248339800033
J	Webster, M				Webster, Mark			A Cambrian peak in morphological variation within trilobite species	SCIENCE			English	Article							EVOLUTION; PATTERNS; LINES	Morphological variation within species is a raw material subject to natural selection. However, temporal change in morphological diversity has usually been studied in terms of variation among rather than within species. The distribution of polymorphic traits in cladistic character-taxon matrices reveals that the frequency and extent of morphological variation in 982 trilobite species are greatest early in the evolution of the group: Stratigraphically old and/or phylogenetically basal taxa are significantly more variable than younger and/or more derived taxa. Through its influence on evolutionary tempo, high intraspecific variation may have played a major role in the pronounced Cambrian diversification of trilobites.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Webster, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	mwebster@geosci.uchicago.edu						Adrain J.M, 2006, GEOL SOC AM ABSTR, V38, P207; Adrain JM, 1998, SCIENCE, V280, P1922, DOI 10.1126/science.280.5371.1922; [Anonymous], 1994, ACTA PALAEONTOL POL; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; Cotton TJ, 2005, CRUSTACEAN ISS, V16, P95, DOI 10.1201/9781420037548.ch5; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1991, PALAEONTOLOGY, V34, P461; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fortey R.A., 1990, P121; Fortey RA, 2001, J PALEONTOL, V75, P1141, DOI 10.1666/0022-3360(2001)075<1141:TSTLY>2.0.CO;2; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1987, SCIENCE, V236, P1437, DOI 10.1126/science.236.4807.1437; Hughes NC, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P139; Hughes NC, 1999, EVOL DEV, V1, P24, DOI 10.1046/j.1525-142x.1999.99005.x; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; JAANUSSON V, 1975, Fossils and Strata, V4, P209; Jablonski D, 2007, PALAEONTOLOGY, V50, P87, DOI 10.1111/j.1475-4983.2006.00615.x; MCNAMARA KJ, 1986, BIOL REV, V61, P121, DOI 10.1111/j.1469-185X.1986.tb00464.x; Naimark EB, 2006, PALEONTOL J+, V40, P541, DOI 10.1134/S003103010605008X; RAMSKOLD L, 1991, T ROY SOC EDIN-EARTH, V82, P143, DOI 10.1017/S0263593300007616; Renaud S, 2006, EVOLUTION, V60, P1701; Riedl R., 1978, ORDER LIVING ORGANIS; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; VALENTINE JW, 1995, PALAIOS, V10, P190, DOI 10.2307/3515182; Wagner GP, 2004, J EXP ZOOL PART B, V302B, P92, DOI 10.1002/jez.b.20005; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi	31	77	79	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					499	502		10.1126/science.1142964	http://dx.doi.org/10.1126/science.1142964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656721				2022-12-28	WOS:000248339800041
J	Teh, OK; Moore, I				Teh, Ooi-kock; Moore, Ian			An ARF-GEF acting at the Golgi and in selective endocytosis in polarized plant cells	NATURE			English	Article							REGULATES VESICLE TRAFFICKING; NUCLEOTIDE-EXCHANGE FACTORS; ENDOPLASMIC-RETICULUM; BREFELDIN-A; PLASMA-MEMBRANE; AUXIN TRANSPORT; H+-ATPASE; ARABIDOPSIS; PROTEIN; GTPASE	Circumstantial evidence suggests that intracellular membrane trafficking pathways diversified independently in the plant kingdom(1-10), but documented examples are rare(6,11,12). ARF-GEFs (guanine-nucleotide exchange factors for ADP-ribosylation factor GTPases) are essential for vesicular trafficking in all eukaryotic kingdoms, but of the eight ARF-GEF families, only the ancestral BIG and GBF types are found in plants(1,2). Whereas fungal and animal GBF proteins perform conserved functions at the Golgi, the Arabidopsis thaliana GBF protein GNOM is thought to act in only the process of recycling from endosomes(3-5). We now show that the related Arabidopsis GBF protein GNOM-LIKE1 (GNL1) has an ancestral function at the Golgi but is also required for selective internalization from the plasma membrane in the presence of brefeldin A (BFA). We identified gnl1 mutants that accumulated biosynthetic and recycling endoplasmic reticulum markers in enlarged internal compartments. Notably, in the absence of functional GNL1, Golgi stacks were rendered sensitive to the selective ARF-GEF inhibitor BFA, which caused them to fuse with the endoplasmic reticulum. Furthermore, in BFA-treated gnl1 roots, the internalization of a polar plasma-membrane marker, the auxin efflux carrier PIN2, was selectively inhibited. Thus, GNL1 is a BFA-resistant GBF protein that functions with a BFA-sensitive ARF-GEF both at the Golgi and in selective endocytosis, but not in recycling from endosomes. We propose that the evolution of endocytic trafficking in plants was accompanied by neo-functionalization within the GBF family, whereas in other kingdoms it occurred independently by elaboration of additional ARF-GEF families.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Moore, I (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	ian.moore@plants.ox.ac.uk	Teh, Ooi-kock/ABF-6401-2021	Teh, Ooi-kock/0000-0001-6800-2748	Biotechnology and Biological Sciences Research Council [REI20537, BBS/B/09562] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Geldner N, 2004, PLANTA, V219, P547, DOI 10.1007/s00425-004-1302-x; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Hawes C, 2005, NEW PHYTOL, V165, P29, DOI 10.1111/j.1469-8137.2004.01218.x; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Samalova M, 2006, TRAFFIC, V7, P1701, DOI 10.1111/j.1600-0854.2006.00502.x; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	35	198	204	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					493	496		10.1038/nature06023	http://dx.doi.org/10.1038/nature06023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653191				2022-12-28	WOS:000248302700051
J	Moore, THM; Zammit, S; Lingford-Hughes, A; Barnes, TRE; Jones, PB; Burke, M; Lewis, G				Moore, Theresa H. M.; Zammit, Stanley; Lingford-Hughes, Anne; Barnes, Thomas R. E.; Jones, Peter B.; Burke, Margaret; Lewis, Glyn			Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review	LANCET			English	Review							ILLICIT DRUG-USE; YOUNG-PEOPLE; PSYCHOSOCIAL ADJUSTMENT; SWEDISH CONSCRIPTS; GENERAL-POPULATION; ADULT PSYCHOSIS; DOPAMINE LEVELS; SUBSTANCE USE; ADOLESCENT; SYMPTOMS	Background Whether cannabis can cause psychotic or affective symptoms that persist beyond transient intoxication is unclear. We systematically reviewed the evidence pertaining to cannabis use and occurrence of psychotic or affective mental health outcomes. Methods We searched Medline, Embase, CINAHL, PsycINFO, ISI Web of Knowledge, ISI Proceedings, ZETOC, BIOSIS, LILACS, and MEDCARIB from their inception to September, 2006, searched reference lists of studies selected for inclusion, and contacted experts. Studies were included if longitudinal and population based. 35 studies from 4804 references were included. Data extraction and quality assessment were done independently and in duplicate. Findings There was an increased risk of any psychotic outcome in individuals who had ever used cannabis (pooled adjusted odds ratio=1.41, 95% Cl 1.20-1.65). Findings were consistent with a dose-response effect, with greater risk in people who used cannabis most frequently (2.09, 1.54-2.84). Results of analyses restricted to studies of more clinically relevant psychotic disorders were similar. Depression, suicidal thoughts, and anxiety outcomes were examined separately. Findings for these outcomes were less consistent, and fewer attempts were made to address non-causal explanations, than for psychosis. A substantial confounding effect was present for both psychotic and affective outcomes. Interpretation The evidence is consistent with the view that cannabis increases risk of psychotic outcomes independently of confounding and transient intoxication effects, although evidence for affective outcomes is less strong. The uncertainty about whether cannabis causes psychosis is unlikely to be resolved by further longitudinal studies such as those reviewed here. However, we conclude that there is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life.	Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Cardiff Univ, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London, England; Univ Cambridge, Dept Psychiat, Cambridge, England	University of Bristol; University of Bristol; Cardiff University; Imperial College London; University of Cambridge	Zammit, S (corresponding author), Cardiff Univ, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales.	zammits@cardiff.ac.uk	Young, Alexander/A-1523-2009; Moore, Theresa/GWZ-8151-2022; Lewis, Glyn/E-9944-2012	Young, Alexander/0000-0002-9367-9213; Lewis, Glyn/0000-0001-5205-8245; Jones, Peter Brian/0000-0002-0387-880X; Zammit, Stanley/0000-0002-2647-9211; Moore, Theresa/0000-0003-3719-6361				Allott K, 2006, J NERV MENT DIS, V194, P958, DOI 10.1097/01.nmd.0000243761.52104.91; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Arseneault L, 2002, BRIT MED J, V325, P1212, DOI 10.1136/bmj.325.7374.1212; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Beard JR, 2006, AUST NZ J PSYCHIAT, V40, P674, DOI 10.1111/j.1440-1614.2006.01867.x; BLOCK JH, 1991, J PERS SOC PSYCHOL, V60, P726, DOI 10.1037/0022-3514.60.5.726; Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485; Bovasso GB, 2001, AM J PSYCHIAT, V158, P2033, DOI 10.1176/appi.ajp.158.12.2033; Brook DW, 2002, ARCH GEN PSYCHIAT, V59, P1039, DOI 10.1001/archpsyc.59.11.1039; Brook JS, 1998, J AM ACAD CHILD PSY, V37, P322, DOI 10.1097/00004583-199803000-00018; BROOK JS, 2001, NYS PSYCHOL, V13, P35; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; CHEN JP, 1993, BRAIN RES, V621, P65, DOI 10.1016/0006-8993(93)90298-2; CRUM RM, 1993, DRUG ALCOHOL DEPEN, V31, P281, DOI 10.1016/0376-8716(93)90010-N; D'Souza DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1558, DOI 10.1038/sj.npp.1300496; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2005, STAT DRUGS PROBL EUR; Fergusson DM, 2002, ADDICTION, V97, P1123, DOI 10.1046/j.1360-0443.2002.00103.x; Fergusson DM, 2005, ADDICTION, V100, P354, DOI 10.1111/j.1360-0443.2005.01001.x; Fergusson DM, 1996, J ABNORM CHILD PSYCH, V24, P499, DOI 10.1007/BF01441571; Fergusson DM, 2000, NEW ZEAL MED J, V113, P156; Fergusson DM, 1997, ADDICTION, V92, P279; Fergusson DM, 2003, PSYCHOL MED, V33, P15, DOI 10.1017/S0033291702006402; Fischer EH, 2001, J NERV MENT DIS, V189, P49, DOI 10.1097/00005053-200101000-00009; Henquet C, 2005, SCHIZOPHRENIA BULL, V31, P608, DOI 10.1093/schbul/sbi027; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; HERESCOLEVY U, 2002, BIOL PSYCHIAT, P587; Hickman M, 2007, ADDICTION, V102, P597, DOI 10.1111/j.1360-0443.2006.01710.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; ISBELL H, 1967, PSYCHOPHARMACOLOGIA, V11, P184, DOI 10.1007/BF00401256; Juon HS, 1997, J CHILD PSYCHOL PSYC, V38, P553, DOI 10.1111/j.1469-7610.1997.tb01542.x; KANDEL DB, 1986, ARCH GEN PSYCHIAT, V43, P255; KEELER MH, 1968, DIS NERV SYST, V29, P314; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; McGee R, 2000, ADDICTION, V95, P491, DOI 10.1046/j.1360-0443.2000.9544912.x; MELGES FT, 1974, ARCH GEN PSYCHIAT, V30, P855; Newcomb MD, 1999, J COMMUNITY PSYCHOL, V27, P405, DOI 10.1002/(SICI)1520-6629(199907)27:4<405::AID-JCOP4>3.0.CO;2-2; Newcomb MD, 1993, EXP CLIN PSYCHOPHARM, V1, P215, DOI 10.1037/1064-1297.1.1-4.215; NSDUH, 2005, RES 2004 NAT SURV DR; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; PATON S, 1977, J GENET PSYCHOL, V131, P267, DOI 10.1080/00221325.1977.10533299; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Pistis M, 2002, BRAIN RES, V948, P155, DOI 10.1016/S0006-8993(02)03055-X; *RCP, 2005, CANN CANN BAS MED; RENAULT PF, 1974, ARCH GEN PSYCHIAT, V31, P95; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Semple DM, 2005, J PSYCHOPHARMACOL, V19, P187, DOI 10.1177/0269881105049040; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Smith NT, 2002, ADDICTION, V97, P621, DOI 10.1046/j.1360-0443.2002.00026.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TART CT, 1970, NATURE, V226, P701, DOI 10.1038/226701a0; Thomas H, 1996, DRUG ALCOHOL DEPEN, V42, P201, DOI 10.1016/S0376-8716(96)01277-X; TIEN AY, 1990, J NERV MENT DIS, V178, P473, DOI 10.1097/00005053-199017880-00001; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; Wade TJ, 2005, CAN J CRIMINOL CRIM, V47, P619, DOI 10.3138/cjccj.47.4.619; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Webb E, 1996, LANCET, V348, P922, DOI 10.1016/S0140-6736(96)03410-1; WILCOX HC, 2003, THESIS JOHN HOPKINS; Wiles NJ, 2006, BRIT J PSYCHIAT, V188, P519, DOI 10.1192/bjp.bp.105.012179; Windle M, 2004, DEV PSYCHOPATHOL, V16, P1007, DOI 10.1017/S0954579404040118; World Health Organization, 1997, CANN HLTH PERSP RES; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199; ZAMMIT S, 2004, THESIS CARDIFF U	69	1445	1464	15	629	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					319	328		10.1016/S0140-6736(07)61162-3	http://dx.doi.org/10.1016/S0140-6736(07)61162-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662880				2022-12-28	WOS:000248426100029
J	Xing, W; Zou, Y; Liu, Q; Liu, JN; Luo, X; Huang, QQ; Chen, S; Zhu, LH; Bi, RC; Hao, Q; Wu, JW; Zhou, JM; Chai, JJ				Xing, Weiman; Zou, Yan; Liu, Qun; Liu, Jianing; Luo, Xi; Huang, Qingqiu; Chen, She; Zhu, Lihuang; Bi, Ruchang; Hao, Quan; Wu, Jia-Wei; Zhou, Jian-Min; Chai, Jijie			The structural basis for activation of plant immunity by bacterial effector protein AvrPto	NATURE			English	Article							TOMATO PTO KINASE; DISEASE RESISTANCE; RECOGNITION SPECIFICITY; HYPERSENSITIVE RESPONSE; MOLECULAR-BASIS; SPECK DISEASE; SECRETION; MECHANISM; PATHOGENS; PRF	Pathogenic microbes use effectors to enhance susceptibility in host plants. However, plants have evolved a sophisticated immune system to detect these effectors using cognate disease resistance proteins(1), a recognition that is highly specific, often elicits rapid and localized cell death, known as a hypersensitive response, and thus potentially limits pathogen growth(2-5). Despite numerous genetic and biochemical studies on the interactions between pathogen effector proteins and plant resistance proteins, the structural bases for such interactions remain elusive. The direct interaction between the tomato protein kinase Pto and the Pseudomonas syringae effector protein AvrPto is known to trigger disease resistance and programmed cell death(6,7) through the nucleotide-binding site/leucine-rich repeat (NBS-LRR) class of disease resistance protein Prf(8). Here we present the crystal structure of an AvrPto-Pto complex. Contrary to the widely held hypothesis that AvrPto activates Pto kinase activity, our structural and biochemical analyses demonstrated that AvrPto is an inhibitor of Pto kinase in vitro. The AvrPto-Pto interaction is mediated by the phosphorylation-stabilized P+1 loop and a second loop in Pto, both of which negatively regulate the Prf-mediated defences in the absence of AvrPto in tomato plants. Together, our results show that AvrPto derepresses host defences by interacting with the two defence-inhibition loops of Pto.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; Cornell University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chai, JJ (corresponding author), Natl Inst Biol Sci, No 7 Sci Pk Rd, Beijing 102206, Peoples R China.	chaijijie@nibs.ac.cn	Hao, Quan/C-4304-2009; Liu, Qun/A-8757-2011; Zhou, Jian-Min/A-3140-2013; Zou, Yan/AAR-2564-2020; Luo, Xi/AAC-9973-2021; Xing, Weiman/G-5697-2010	Liu, Qun/0000-0002-1179-290X; Zhou, Jian-Min/0000-0002-9943-2975; Zou, Yan/0000-0002-4743-4995; Chai, Jijie/0000-0001-7591-3873; Hao, Quan/0000-0002-9642-0514; Xing, Weiman/0000-0002-6238-0075				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Innes RW, 2004, PLANT PHYSIOL, V135, P695, DOI 10.1104/pp.104.040410; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Wulf' J, 2004, STRUCTURE, V12, P1257, DOI 10.1016/j.str.2004.04.017	29	140	155	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					243	U11		10.1038/nature06109	http://dx.doi.org/10.1038/nature06109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17694048				2022-12-28	WOS:000249394500055
J	D'Angelo, G; Polishchuk, E; Di Tullio, G; Santoro, M; Di Campli, A; Godi, A; West, G; Bielawski, J; Chuang, CC; van der Spoel, AC; Platt, FM; Hannun, YA; Polishchuk, R; Mattjus, P; De Matteis, MA				D'Angelo, Giovanni; Polishchuk, Elena; Di Tullio, Giuseppe; Santoro, Michele; Di Campli, Antonella; Godi, Anna; West, Gun; Bielawski, Jacek; Chuang, Chia-Chen; van der Spoel, Aarnoud C.; Platt, Frances M.; Hannun, Yusuf A.; Polishchuk, Roman; Mattjus, Peter; De Matteis, Maria Antonietta			Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; GOLGI-COMPLEX; MEMBRANE TRAFFICKING; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; ADP-RIBOSYLATION; CELL-SURFACE; BREFELDIN-A; MDCK CELLS; TRANSPORT	The molecular machinery responsible for the generation of transport carriers moving from the Golgi complex to the plasma membrane relies on a tight interplay between proteins and lipids. Among the lipid-binding proteins of this machinery, we previously identified the four-phosphate adaptor protein FAPP2, the pleckstrin homology domain of which binds phosphatidylinositol 4-phosphate and the small GTPase ARF1. FAPP2 also possesses a glycolipid-transfer-protein homology domain. Here we show that human FAPP2 is a glucosylceramide-transfer protein that has a pivotal role in the synthesis of complex glycosphingolipids, key structural and signalling components of the plasma membrane. The requirement for FAPP2 makes the whole glycosphingolipid synthetic pathway sensitive to regulation by phosphatidylinositol 4-phosphate and ARF1. Thus, by coupling the synthesis of glycosphingolipids with their export to the cell surface, FAPP2 emerges as crucial in determining the lipid identity and composition of the plasma membrane.	Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; Abo Akad Univ, Dept Biochem & Pharm, FI-20520 Turku, Finland; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Abo Akademi University; Medical University of South Carolina; University of Oxford	De Matteis, MA (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Via Nazl 8-A, I-66030 Chieti, Italy.	dematteis@negrisud.it	Platt, Frances/G-1004-2010; Mattjus, Peter/ABE-3596-2021; De Matteis, Maria Antonietta/AHE-5161-2022; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; De Matteis, Maria Antonietta/0000-0003-0053-3061; DI CAMPLI, ANTONELLA/0000-0003-4504-5942; van der Spoel, Aarnoud/0000-0002-2338-5316; Platt, Frances/0000-0001-7614-0403; DANGELO, GIOVANNI/0000-0001-5466-8709; Polishchuk, Roman/0000-0002-7698-1955; D'Angelo, Giovanni/0000-0002-0734-4127	Telethon [GGP06166] Funding Source: Medline	Telethon(Fondazione Telethon)		Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boldin SA, 2000, J BIOL CHEM, V275, P9905, DOI 10.1074/jbc.275.14.9905; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brade L, 2000, GLYCOBIOLOGY, V10, P629, DOI 10.1093/glycob/10.6.629; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; De Matteis MA, 2004, BBA-BIOMEMBRANES, V1666, P264, DOI 10.1016/j.bbamem.2004.07.002; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; Drecktrah D, 1999, MOL BIOL CELL, V10, P4021, DOI 10.1091/mbc.10.12.4021; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; Luini A, 2005, CURR OPIN CELL BIOL, V17, P353, DOI 10.1016/j.ceb.2005.06.012; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Millar CA, 2000, TRAFFIC, V1, P141, DOI 10.1034/j.1600-0854.2000.010206.x; Mironov AA, 2004, EUR J CELL BIOL, V83, P263, DOI 10.1078/0171-9335-00377; Nylund M, 2006, BBA-BIOMEMBRANES, V1758, P807, DOI 10.1016/j.bbamem.2006.04.023; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Sala G, 2002, PEDIATR RES, V52, P645, DOI 10.1203/01.PDR.0000032383.67029.F7; Schwarz A, 1997, J NEUROSCI, V17, P2929; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Vieira OV, 2005, J CELL BIOL, V170, P521, DOI 10.1083/jcb.200503078; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Wing DR, 2001, ANAL BIOCHEM, V298, P207, DOI 10.1006/abio.2001.5393; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	46	307	314	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					62	U43		10.1038/nature06097	http://dx.doi.org/10.1038/nature06097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17687330				2022-12-28	WOS:000249233500035
J	Perkins, S; de Wit, M				Perkins, Sarah; de Wit, Melanie			The African private sector steps in to fill the drug gap	LANCET			English	Editorial Material									Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Toronto	Perkins, S (corresponding author), Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada.	s.perkins@utoronto.ca						*GLOB FUND FIGHT A, LIST COUNTR BEL ICH; *GOV CAN, REV CAN ACC MED REG; HEMS J, 2007, CAMR CONSULTATION PA; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *W AFR HLTH ORG, REP EXTR ASS WAHO HL	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					722	723		10.1016/S0140-6736(07)61094-0	http://dx.doi.org/10.1016/S0140-6736(07)61094-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17658595				2022-12-28	WOS:000249209300009
J	Lydeard, JR; Jain, S; Yamaguchi, M; Haber, JE				Lydeard, John R.; Jain, Suvi; Yamaguchi, Miyuki; Haber, James E.			Break-induced replication and telomerase-independent telomere maintenance require Pol32	NATURE			English	Article							DNA-POLYMERASE-DELTA; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GENE CONVERSION; BYPASS PATHWAY; RECOMBINATION; YEAST; REPAIR; CHECKPOINT	Break- induced replication ( BIR) is an efficient homologous recombination process to initiate DNA replication when only one end of a chromosome double- strand break shares homology with a template(1-5). BIR is thought to re- establish replication at stalled and broken replication forks and to act at eroding telomeres in cells that lack telomerase in pathways known as ' alternative lengthening of telomeres' ( reviewed in refs 2, 6). Here we show that, in haploid budding yeast, Rad51- dependent BIR induced by HO endonuclease requires the lagging strand DNA Pol alpha- primase complex as well as Pol delta to initiate new DNA synthesis. Pol epsilon is not required for the initial primer extension step of BIR but is required to complete 30 kb of new DNA synthesis. Initiation of BIR also requires the nonessential DNA Pol delta subunit Pol32 primarily through its interaction with another Pol delta subunit, Pol31. HO-induced gene conversion, in which both ends of a double- strand break engage in homologous recombination, does not require Pol32. Pol32 is also required for the recovery of both Rad51-dependent and Rad51- independent survivors in yeast strains lacking telomerase. These results strongly suggest that both types of telomere maintenance pathways occur by recombination-dependent DNA replication. Thus Pol32, dispensable for replication and for gene conversion, is uniquely required for BIR; this finding provides an opening into understanding how DNA replication re- start mechanisms operate in eukaryotes. We also note that Pol32 homologues have been identified both in fission yeast and in metazoans where telomerase- independent survivors with alternative telomere maintenance have also been identified(2,6,7).	Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr, MS029, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, T32GM007122, R01GM020056] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076020-01A1, T32 GM007122, R01 GM076020-03, R01 GM076020-02, R01 GM020056, R01 GM020056-32, R01 GM076020, R01 GM020056-33] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUDD ME, 1993, MOL CELL BIOL, V13, P496, DOI 10.1128/MCB.13.1.496; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Corrette-Bennett SE, 2004, NUCLEIC ACIDS RES, V32, P6268, DOI 10.1093/nar/gkh965; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Giot L, 1997, GENETICS, V146, P1239; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Huang ME, 2002, GENETICS, V160, P1409; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Le S, 1999, GENETICS, V152, P143; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Morrow DM, 1997, GENETICS, V147, P371; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004	32	356	364	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					820	U10		10.1038/nature06047	http://dx.doi.org/10.1038/nature06047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17671506				2022-12-28	WOS:000248754200043
J	Sitch, S; Cox, PM; Collins, WJ; Huntingford, C				Sitch, S.; Cox, P. M.; Collins, W. J.; Huntingford, C.			Indirect radiative forcing of climate change through ozone effects on the land-carbon sink	NATURE			English	Article							SURFACE OZONE; RESPONSES; TROPOSPHERE; EMISSIONS; EXPOSURE; IMPACT; TREES; CO2	The evolution of the Earth's climate over the twenty- first century depends on the rate at which anthropogenic carbon dioxide emissions are removed from the atmosphere by the ocean and land carbon cycles(1). Coupled climate - carbon cycle models suggest that global warming will act to limit the land- carbon sink(2), but these first generation models neglected the impacts of changing atmospheric chemistry. Emissions associated with fossil fuel and biomass burning have acted to approximately double the global mean tropospheric ozone concentration(3), and further increases are expected over the twenty- first century(4). Tropospheric ozone is known to damage plants, reducing plant primary productivity and crop yields(5), yet increasing atmospheric carbon dioxide concentrations are thought to stimulate plant primary productivity(6). Increased carbon dioxide and ozone levels can both lead to stomatal closure, which reduces the uptake of either gas, and in turn limits the damaging effect of ozone and the carbon dioxide fertilization of photosynthesis(6). Here we estimate the impact of projected changes in ozone levels on the land- carbon sink, using a global land carbon cycle model modified to include the effect of ozone deposition on photosynthesis and to account for interactions between ozone and carbon dioxide through stomatal closure(7). For a range of sensitivity parameters based on manipulative field experiments, we find a significant suppression of the global land- carbon sink as increases in ozone concentrations affect plant productivity. In consequence, more carbon dioxide accumulates in the atmosphere. We suggest that the resulting indirect radiative forcing by ozone effects on plants could contribute more to global warming than the direct radiative forcing due to tropospheric ozone increases.	Hadley Ctr Climate Predict & Res JCHMR, Met Off, Wallingford OX10 8BB, Oxon, England; Ctr Ecol & Hydrol Wallingford, Wallingford OX10 8BB, Oxon, England; Univ Exeter, Sch Engn Comp Sci & Math, Exeter ES4 4QF, Devon, England; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); University of Exeter; Met Office - UK; Hadley Centre	Sitch, S (corresponding author), Hadley Ctr Climate Predict & Res JCHMR, Met Off, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	stephen.sitch@metoffice.gov.uk	Cox, Peter Michae;/B-3299-2012; Collins, William/A-5895-2010; Huntingford, Christopher/A-4307-2008; Sitch, Stephen A/F-8034-2015	Cox, Peter Michae;/0000-0002-0679-2219; Collins, William/0000-0002-7419-0850; Huntingford, Christopher/0000-0002-5941-7770; Sitch, Stephen A/0000-0003-1821-8561	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Berntsen TK, 2000, J GEOPHYS RES-ATMOS, V105, P8915, DOI 10.1029/1999JD901139; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Essery RLH, 2003, J HYDROMETEOROL, V4, P530, DOI 10.1175/1525-7541(2003)004<0530:EROSHI>2.0.CO;2; Felzer B, 2005, CLIMATIC CHANGE, V73, P345, DOI 10.1007/s10584-005-6776-4; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gauss M, 2006, ATMOS CHEM PHYS, V6, P575, DOI 10.5194/acp-6-575-2006; Gauss M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002624; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Karlsson PE, 2004, ATMOS ENVIRON, V38, P2283, DOI 10.1016/j.atmosenv.2004.01.027; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nussbaum S, 2000, ENVIRON POLLUT, V109, P463, DOI 10.1016/S0269-7491(00)00049-X; Percy KE, 2007, ENVIRON POLLUT, V147, P554, DOI 10.1016/j.envpol.2006.10.009; Pleijel H, 2004, ATMOS ENVIRON, V38, P2259, DOI 10.1016/j.atmosenv.2003.09.076; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanderson MG, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017642; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; van der Werf GR, 2003, GLOBAL CHANGE BIOL, V9, P547, DOI 10.1046/j.1365-2486.2003.00604.x; Volk M, 2006, GLOBAL CHANGE BIOL, V12, P74, DOI 10.1111/j.1365-2486.2005.01083.x; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067	30	655	706	20	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					791	U4		10.1038/nature06059	http://dx.doi.org/10.1038/nature06059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653194				2022-12-28	WOS:000248754200036
J	Lautenschlager, S; Wulf, HC; Pittelkow, MR				Lautenschlager, Stephan; Wulf, Hans Christian; Pittelkow, Mark R.			Photoprotection	LANCET			English	Review							MICROFINE ZINC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; BROAD-SPECTRUM SUNSCREEN; SQUAMOUS-CELL CARCINOMAS; UVA PROTECTION FACTORS; IN-VIVO ESTROGENICITY; PIGMENT DARKENING PPD; SUN PROTECTION; ULTRAVIOLET-RADIATION; RISK-FACTORS	Sun exposure is the main cause of photocarcinogenesis, photoageing, and photosensitivity; thus, photoprotection is an important issue. In a skin cancer prevention strategy, behavioural measures-eg, wearing sun protective clothes and a hat and reducing sun exposure to a minimum-should be preferred to sunscreens. Often this solution is deemed to be unacceptable in our global, outdoor society, and sunscreens could become the predominant mode of sun protection for various societal reasons (eg, healthiness of a tan, relaxation in the sun). The application of a liberal quantity of sunscreen has been shown to be by far the most important factor for effectiveness of the sunscreen, followed by the uniformity of application and the specific absorption spectrum of the agent used. The sunscreen market-crowded by numerous products-shows various differences worldwide. Nevertheless, sunscreens should not be abused in an attempt to increase time in the sun to a maximum. Controversies about safety of sunscreens and clinical recommendations are discussed.	Triemli Hosp, Outpatient Clin Dermatol, CH-8004 Zurich, Switzerland; Copenhagen Univ Hosp, Dept Dermatol, Bispebjerg, Denmark; Mayo Clin, Dept Dermatol, Rochester, MN USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Triemli Hospital; University of Copenhagen; Mayo Clinic; Mayo Clinic	Lautenschlager, S (corresponding author), Triemli Hosp, Outpatient Clin Dermatol, Herman Gruelich Str 70, CH-8004 Zurich, Switzerland.	stephan.lautenschlager@triemli.stzh.ch						Abarca JF, 2002, J AM ACAD DERMATOL, V46, P193, DOI 10.1067/mjd.2002.118556; Adam J, 1998, J Cutan Med Surg, V3, P50; Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; Ashby J, 2001, REGUL TOXICOL PHARM, V34, P287, DOI 10.1006/rtph.2001.1511; Australian/New Zealand Standard, 26041998 ASNZ; Autier P, 2000, BRIT J CANCER, V83, P1243, DOI 10.1054/bjoc.2000.1429; Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; Azizi E, 2000, MELANOMA RES, V10, P491, DOI 10.1097/00008390-200010000-00012; Bauer A, 2005, AM J EPIDEMIOL, V161, P620, DOI 10.1093/aje/kwi086; BECHTHOMSEN N, 1993, PHOTODERMATOL PHOTO, V9, P242; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Bolt HM, 2001, ENVIRON HEALTH PERSP, V109, pA358, DOI 10.2307/3454799; BOYD AS, 1995, J AM ACAD DERMATOL, V33, P941, DOI 10.1016/0190-9622(95)90284-8; *CEN, 1999, 13758 CEN PREN; Chatelain E, 2001, PHOTOCHEM PHOTOBIOL, V74, P401, DOI 10.1562/0031-8655(2001)074<0401:POBMAA>2.0.CO;2; COLE C, 1994, J AM ACAD DERMATOL, V30, P729, DOI 10.1016/S0190-9622(08)81503-4; *COLIPA, 1994, COLIPA REF; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Darlington S, 2003, ARCH DERMATOL, V139, P451, DOI 10.1001/archderm.139.4.451; Darvay A, 2001, BRIT J DERMATOL, V145, P597, DOI 10.1046/j.1365-2133.2001.04458.x; Davis S, 1997, INT J DERMATOL, V36, P374, DOI 10.1046/j.1365-4362.1997.00046.x; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; de Gruijl FR, 2003, PHOTOCH PHOTOBIO SCI, V2, P16, DOI 10.1039/b211156j; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Diffey BL, 2005, BRIT J DERMATOL, V153, P378, DOI 10.1111/j.1365-2133.2005.06729.x; Diffey BL, 2002, BRIT J DERMATOL, V146, P659, DOI 10.1046/j.1365-2133.2002.04589.x; Diffey BL, 2001, J AM ACAD DERMATOL, V45, P882, DOI 10.1067/mjd.2001.117385; DIFFEY BL, 2001, COMP PHOTO, V3, P521; Draelos ZD, 2006, DERMATOL CLIN, V24, P101, DOI 10.1016/j.det.2005.09.001; Dumaz N, 1997, CARCINOGENESIS, V18, P897, DOI 10.1093/carcin/18.5.897; Dupuy A, 2005, ARCH DERMATOL, V141, P950, DOI 10.1001/archderm.141.8.950; Edlich Richard F, 2004, J Long Term Eff Med Implants, V14, P95, DOI 10.1615/JLongTermEffMedImplants.v14.i2.30; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; Farrerons J, 1998, BRIT J DERMATOL, V139, P422; Farrerons J, 2001, DERMATOLOGY, V202, P27, DOI 10.1159/000051580; Faurschou A, 2004, PHOTODERMATOL PHOTO, V20, P239, DOI 10.1111/j.1600-0781.2004.00118.x; Faurschou A, 2004, ARCH DERMATOL, V140, P886, DOI 10.1001/archderm.140.7.886; FDA, 1999, FED REG RULES REGULA, V64, P27666; FOLEY P, 1993, BRIT J DERMATOL, V128, P512, DOI 10.1111/j.1365-2133.1993.tb00227.x; Gallagher RDP, 2000, JAMA-J AM MED ASSOC, V283, P2955, DOI 10.1001/jama.283.22.2955; Gambichler T, 2002, RECENT RESULTS CANC, V160, P15; Gambichler T, 2002, PHOTODERMATOL PHOTO, V18, P29, DOI 10.1034/j.1600-0781.2002.180105.x; Gambichler T, 2001, BMC Dermatol, V1, P6, DOI 10.1186/1471-5945-1-6; Gambichler T, 2001, BRIT J DERMATOL, V144, P484, DOI 10.1046/j.1365-2133.2001.04072.x; Gamer AO, 2006, TOXICOL IN VITRO, V20, P301, DOI 10.1016/j.tiv.2005.08.008; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gasparro FP, 1998, PHOTOCHEM PHOTOBIOL, V68, P243, DOI 10.1111/j.1751-1097.1998.tb09677.x; Gelis C, 2003, PHOTODERMATOL PHOTO, V19, P242, DOI 10.1034/j.1600-0781.2003.00045.x; Georgouras K E, 1997, Australas J Dermatol, V38 Suppl 1, pS79; GIES HP, 1994, HEALTH PHYS, V67, P131, DOI 10.1097/00004032-199408000-00003; Gies PH, 1998, MUTAT RES-FUND MOL M, V422, P15, DOI 10.1016/S0027-5107(98)00181-X; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P1867, DOI 10.1002/cncr.10427; Grant WB, 2005, PHOTOCHEM PHOTOBIOL, V81, P1276, DOI 10.1562/2005-01-24-RA-424; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Harrison SL, 2005, AM J EPIDEMIOL, V161, P536, DOI 10.1093/aje/kwi081; Heneweer M, 2005, TOXICOL APPL PHARM, V208, P170, DOI 10.1016/j.taap.2005.02.006; Hoffmann K, 1998, J EUR ACAD DERMATOL, V10, P137, DOI 10.1111/j.1468-3083.1998.tb00787.x; Hoffmann K, 2001, ARCH DERMATOL, V137, P1089; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Janjua NR, 2004, J INVEST DERMATOL, V123, P57, DOI 10.1111/j.0022-202X.2004.22725.x; KAIDBEY KH, 1990, J AM ACAD DERMATOL, V22, P449, DOI 10.1016/0190-9622(90)70063-N; KAIDBEY KH, 1991, J AM ACAD DERMATOL, V25, P262, DOI 10.1016/0190-9622(91)70193-6; KRIPKE ML, 1988, J DERMATOL SURG ONC, V14, P853, DOI 10.1111/j.1524-4725.1988.tb03589.x; KROMANN N, 1986, PHOTODERMATOLOGY, V3, P73; Kullavanijaya P, 2005, J AM ACAD DERMATOL, V52, P937, DOI 10.1016/j.jaad.2004.07.063; Lademann J, 2000, SKIN PHARMACOL APPL, V13, P258, DOI 10.1159/000029931; Lademann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854112; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Lange-Asschenfeldt B, 2005, ACTA DERM-VENEREOL, V85, P280, DOI 10.1080/00015550510026677; Laperre J, 2003, PHOTODERMATOL PHOTO, V19, P11, DOI 10.1034/j.1600-0781.2003.00014.x; Lee TK, 2005, J AM ACAD DERMATOL, V52, P786, DOI 10.1016/j.jaad.2004.12.009; Ley RD, 1997, PHOTOCHEM PHOTOBIOL, V65, P1007, DOI 10.1111/j.1751-1097.1997.tb07961.x; Lim HW, 2001, J AM ACAD DERMATOL, V44, P505, DOI 10.1067/mjd.2001.112913; Loria D, 2001, INT J DERMATOL, V40, P108, DOI 10.1046/j.1365-4362.2001.01132.x; Ma RS, 2003, TOXICOL SCI, V74, P43, DOI 10.1093/toxsci/kfg102; Madan V, 2006, BRIT J DERMATOL, V154, P5, DOI 10.1111/j.1365-2133.2006.07229.x; MARKS R, 1995, ARCH DERMATOL, V131, P462; McHugh PJ, 1997, PHOTOCHEM PHOTOBIOL, V66, P276, DOI 10.1111/j.1751-1097.1997.tb08655.x; MENZIES SW, 1991, PHOTODERMATOL PHOTO, V8, P157; Mitchnick MA, 1999, J AM ACAD DERMATOL, V40, P85, DOI 10.1016/S0190-9622(99)70532-3; Moise AF, 1999, INT J BIOMETEOROL, V43, P128, DOI 10.1007/s004840050128; Morison WL, 2004, NEW ENGL J MED, V350, P1111, DOI 10.1056/NEJMcp022558; Moseley H, 2001, BRIT J DERMATOL, V145, P789, DOI 10.1046/j.1365-2133.2001.04429.x; Moyal D, 2000, PHOTODERMATOL PHOTO, V16, P245, DOI 10.1034/j.1600-0781.2000.160602.x; Moyal D, 2000, PHOTODERMATOL PHOTO, V16, P250, DOI 10.1034/j.1600-0781.2000.160603.x; Moyal D, 2004, PHOTODERMATOL PHOTO, V20, P243, DOI 10.1111/j.1600-0781.2004.00111.x; Nash JF, 2006, DERMATOL CLIN, V24, P35, DOI 10.1016/j.det.2005.09.006; Naylor MF, 1997, ARCH DERMATOL, V133, P1146, DOI 10.1001/archderm.133.9.1146; NAYLOR MF, 1995, ARCH DERMATOL, V131, P170, DOI 10.1001/archderm.131.2.170; Osborne JE, 2002, BRIT J DERMATOL, V147, P197, DOI 10.1046/j.1365-2133.2002.04960.x; PARRISH JA, 1982, PHOTOCHEM PHOTOBIOL, V36, P187, DOI 10.1111/j.1751-1097.1982.tb04362.x; Petersen AB, 2003, MUTAT RES-GEN TOX EN, V542, P129, DOI 10.1016/j.mrgentox.2003.09.003; Pinnell SR, 2000, DERMATOL SURG, V26, P309, DOI 10.1046/j.1524-4725.2000.99237.x; REBUT D, 1990, SUNSCREENS DEV EVALU, P161; Rigel DS, 1999, J AM ACAD DERMATOL, V40, P114, DOI 10.1016/S0190-9622(99)70542-6; Roberts LK, 1996, PHOTOCHEM PHOTOBIOL, V63, P874, DOI 10.1111/j.1751-1097.1996.tb09645.x; Robinson JK, 2005, JAMA-J AM MED ASSOC, V294, P1541, DOI 10.1001/jama.294.12.1541; Robinson JK, 1998, ARCH PEDIAT ADOL MED, V152, P466; Roelandts R, 1998, CLIN EXP DERMATOL, V23, P147; Schauder S, 1997, CONTACT DERMATITIS, V37, P221, DOI 10.1111/j.1600-0536.1997.tb02439.x; Schlumpf M, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.1289/ehp.01109239; Seite S, 2000, PHOTODERMATOL PHOTO, V16, P147, DOI 10.1034/j.1600-0781.2000.160401.x; SHAW AA, 1992, PHOTOCHEM PHOTOBIOL, V55, P657; Sinclair SA, 1997, BRIT J DERMATOL, V136, P239; STANFORD DG, 1995, MED J AUSTRALIA, V162, P422, DOI 10.5694/j.1326-5377.1995.tb139972.x; *THER GOODS ADM, AUSTR REG GUID OTC M; Thieden E, 2005, ARCH DERMATOL, V141, P967, DOI 10.1001/archderm.141.8.967; Thieden E, 2004, ARCH DERMATOL, V140, P197, DOI 10.1001/archderm.140.2.197; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; Urbach F, 2001, J PHOTOCH PHOTOBIO B, V64, P99, DOI 10.1016/S1011-1344(01)00202-0; van der Molen RG, 1998, J PHOTOCH PHOTOBIO B, V44, P143, DOI 10.1016/S1011-1344(98)00137-7; van Kranen HJ, 2005, MUTAT RES-FUND MOL M, V571, P81, DOI 10.1016/j.mrfmmm.2004.07.018; Wachsmuth RC, 2005, J INVEST DERMATOL, V124, P56, DOI 10.1111/j.0022-202X.2004.23548.x; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P767, DOI 10.1067/mjd.2001.112384; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P837, DOI 10.1067/mjd.2001.114594; Westerdahl J, 2000, INT J CANCER, V87, P145, DOI 10.1002/1097-0215(20000701)87:1<145::AID-IJC22>3.0.CO;2-3; Wright AL, 1998, LANCET, V351, P1706, DOI 10.1016/S0140-6736(05)77745-X; Wulf HC, 2006, ACTA DERM-VENEREOL, V86, P25, DOI 10.1080/00015550510042868; WULF HC, 1982, J AM ACAD DERMATOL, V7, P194, DOI 10.1016/S0190-9622(82)70108-2; Wulf HC, 1997, PHOTODERMATOL PHOTO, V13, P129, DOI 10.1111/j.1600-0781.1997.tb00215.x; Wulf HC, 2004, MICRON, V35, P185, DOI 10.1016/j.micron.2003.11.005; Youl P, 2002, INT J CANCER, V98, P92, DOI 10.1002/ijc.10117; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	126	214	225	4	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					528	537		10.1016/S0140-6736(07)60638-2	http://dx.doi.org/10.1016/S0140-6736(07)60638-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693182				2022-12-28	WOS:000248717800032
J	Pey, AL; Martinez, A				Pey, Angel L.; Martinez, Aurora			Tetrahydrobiopterin for patients with phenylketonuria	LANCET			English	Editorial Material							PHENYLALANINE-HYDROXYLASE DEFICIENCY; WILD-TYPE; IN-VIVO; BINDING; CELLS		Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no	Martinez, Aurora/M-3088-2019	Martinez, Aurora/0000-0003-1643-6506; Pey, Angel Luis/0000-0001-7706-3243				Aguado C, 2006, FEBS LETT, V580, P1697, DOI 10.1016/j.febslet.2006.02.005; Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Levy HL, 2007, LANCET, V370, P504, DOI 10.1016/S0140-6736(07)61234-3; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, J AM CHEM SOC, V126, P13670, DOI 10.1021/ja047713s; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; Teigen K, 2003, J BIOMOL STRUCT DYN, V20, P733, DOI 10.1080/07391102.2003.10506889; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056	13	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					462	463		10.1016/S0140-6736(07)61209-4	http://dx.doi.org/10.1016/S0140-6736(07)61209-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693159				2022-12-28	WOS:000248717800006
J	Kapteyn, H; Cohen, O; Christov, I; Murnane, M				Kapteyn, Henry; Cohen, Oren; Christov, Ivan; Murnane, Margaret			Harnessing attosecond science in the quest for coherent X-rays	SCIENCE			English	Review							HIGH-HARMONIC-GENERATION; TIME-SCALE; RARE-GASES; LIGHT; PULSES; RADIATION; EMISSION; DYNAMICS; REGIME; LASERS	Modern laser technology has revolutionized the sensitivity and precision of spectroscopy by providing coherent light in a spectrum spanning the infrared, visible, and ultraviolet wavelength regimes. However, the generation of shorter-wavelength coherent pulses in the x-ray region has proven much more challenging. The recent emergence of high harmonic generation techniques opens the door to this possibility. Here we review the new science that is enabled by an ability to manipulate and control electrons on attosecond time scales, ranging from new tabletop sources of coherent x-rays to an ability to follow complex electron dynamics in molecules and materials. We also explore the implications of these advances for the future of molecular structural characterization schemes that currently rely so heavily on scattering from incoherent x-ray sources.	Univ Colorado, JILA, Boulder, CO 80309 USA; Univ Colorado, Natl Sci Fdn Ctr Extreme Ultraviolet Sci & Techno, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Science Foundation (NSF); University of Colorado System; University of Colorado Boulder	Murnane, M (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	murnane@jila.colorado.edu	Christov, Ivan P/D-4446-2014; Kapteyn, Henry C/H-6559-2011	Christov, Ivan P/0000-0002-9146-6708; Kapteyn, Henry C/0000-0001-8386-6317; Cohen, Oren/0000-0002-1592-6530				Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Balcou P, 1997, PHYS REV A, V55, P3204, DOI 10.1103/PhysRevA.55.3204; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Bartels RA, 2002, SCIENCE, V297, P376, DOI 10.1126/science.1071718; Bauer M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.025501; Chang Z, 1998, PHYS REV A, V58, pR30, DOI 10.1103/PhysRevA.58.R30; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Christov IP, 2001, PHYS REV LETT, V86, P5458, DOI 10.1103/PhysRevLett86.5458; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Cohen O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.053902; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; CORKUM PB, 1994, PHYS REV A, V149, P2117; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kapteyn HC, 2005, PHYS TODAY, V58, P39, DOI 10.1063/1.1897563; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Miaja-Avila L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113604; Paul A, 2003, NATURE, V421, P51, DOI 10.1038/nature01222; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; PEATROSS J, 1995, J OPT SOC AM B, V12, P863, DOI 10.1364/JOSAB.12.000863; Rocca JJ, 1999, REV SCI INSTRUM, V70, P3799, DOI 10.1063/1.1150041; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Tobey RI, 2007, OPT LETT, V32, P286, DOI 10.1364/OL.32.000286; Velotta R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.183901; Wagner NL, 2006, P NATL ACAD SCI USA, V103, P13279, DOI 10.1073/pnas.0605178103; Zhang XH, 2007, NAT PHYS, V3, P270, DOI 10.1038/nphys541	29	135	137	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					775	778		10.1126/science.1143679	http://dx.doi.org/10.1126/science.1143679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690287				2022-12-28	WOS:000248624500031
J	Mondaini, N; Bartoletti, R				Mondaini, Nicola; Bartoletti, Riccardo			Intravesical foreign body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Florence, Florence, Italy	University of Florence	Mondaini, N (corresponding author), Univ Florence, Florence, Italy.	mondatre@hotmail.com	Bartoletti, Riccardo/HGA-5650-2022; Ruiz, Xavier/M-3367-2014	Bartoletti, Riccardo/0000-0002-0021-0302; Ruiz, Xavier/0000-0003-2135-3860					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					588	588		10.1056/NEJMicm067085	http://dx.doi.org/10.1056/NEJMicm067085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17687134				2022-12-28	WOS:000248584900010
J	Novotny, V; Miller, SE; Hulcr, J; Drew, RAI; Basset, Y; Janda, M; Setliff, GP; Darrow, K; Stewart, AJA; Auga, J; Isua, B; Molem, K; Manumbor, M; Tamtiai, E; Mogia, M; Weiblen, GD				Novotny, Vojtech; Miller, Scott E.; Hulcr, Jiri; Drew, Richard A. I.; Basset, Yves; Janda, Milan; Setliff, Gregory P.; Darrow, Karolyn; Stewart, Alan J. A.; Auga, John; Isua, Brus; Molem, Kenneth; Manumbor, Markus; Tamtiai, Elvis; Mogia, Martin; Weiblen, George D.			Low beta diversity of herbivorous insects in tropical forests	NATURE			English	Article							HOST-SPECIFICITY; NEW-GUINEA; SPECIES RICHNESS; RAIN-FOREST; LEPIDOPTERA; ASSEMBLAGES; DIPTERA; PLANTS; AGRICULTURE; TEPHRITIDAE	Recent advances in understanding insect communities in tropical forests(1,2) have contributed little to our knowledge of large-scale patterns of insect diversity, because incomplete taxonomic knowledge of many tropical species hinders the mapping of their distribution records(3). This impedes an understanding of global biodiversity patterns and explains why tropical insects are under-represented in conservation biology. Our study of approximately 500 species from three herbivorous guilds feeding on foliage (caterpillars, Lepidoptera), wood (ambrosia beetles, Coleoptera) and fruit (fruitflies, Diptera) found a low rate of change in species composition (beta diversity) across 75,000 square kilometres of contiguous lowland rainforest in Papua New Guinea, as most species were widely distributed. For caterpillars feeding on large plant genera, most species fed on multiple host species, so that even locally restricted plant species did not support endemic herbivores. Large plant genera represented a continuously distributed resource easily colonized by moths and butterflies over hundreds of kilometres. Low beta diversity was also documented in groups with differing host specificity (fruitflies and ambrosia beetles), suggesting that dispersal limitation does not have a substantial role in shaping the distribution of insect species in New Guinea lowland rainforests. Similar patterns of low beta diversity can be expected in other tropical lowland rainforests, as they are typically situated in the extensive low basins of major tropical rivers similar to the Sepik-Ramu region of New Guinea studied here.	Acad Sci Czech Republ, Ctr Biol, Ceske Budejovice 37005, Czech Republic; Acad Sci Czech Republ, Sch Biol Sci, Ceske Budejovice 37005, Czech Republic; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; Griffith Univ, Australian Sch Environm Studies, Brisbane, Qld 4111, Australia; Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; New Guinea Binatang Res Ctr, Madang, Papua N Guinea; Univ Minnesota, Bell Museum Nat Hist, Biol Sci Ctr 250, St Paul, MN 55108 USA; Univ Minnesota, Dept Plant Biol, Biol Sci Ctr 250, St Paul, MN 55108 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; Griffith University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Sussex; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Novotny, V (corresponding author), Acad Sci Czech Republ, Ctr Biol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	novotny@entu.cas.cz	Novotny, Vojtech/G-9434-2014; Janda, Milan/H-7216-2014; Basset, Yves F/B-6642-2014; Hulcr, Jiri/AAE-4210-2019	Novotny, Vojtech/0000-0001-7918-8023; Janda, Milan/0000-0003-3038-0107; Basset, Yves F/0000-0002-1942-5717; Hulcr, Jiri/0000-0002-8706-4618; Miller, Scott/0000-0002-4138-1378; Stewart, Alan/0000-0001-7878-8879; Setliff, Gregory/0000-0002-1853-0232				ABBOTT LD, 1995, J SOUTHE ASIAN EARTH, V11, P33, DOI 10.1016/0743-9547(94)00032-A; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Beaver R.A., 1989, P121; BEAVER RA, 1979, NATURE, V281, P139, DOI 10.1038/281139a0; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; Brown Keith S. Jr, 2005, P166; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clarke AR, 2004, AUST J ENTOMOL, V43, P148, DOI 10.1111/j.1440-6055.2004.00395.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Davies HL, 1997, GEM 97: PNG GEOLOGY EXPLORATION AND MINING CONFERENCE, PROCEEDINGS, P61; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Erwin T. L., 2004, FOREST CANOPIES, P259; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Fletcher BS, 1998, AUST J ENTOMOL, V37, P315, DOI 10.1111/j.1440-6055.1998.tb01589.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GASTON KJ, 1993, J TROP ECOL, V9, P491, DOI 10.1017/S0266467400007550; Hall JPW, 2002, EVOLUTION, V56, P1489; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HOFT R, 1992, DICT GENERA FAMILIES, V13; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hubell SP, 2001, UNIFIED NEUTRAL THEO; Hulcr J, 2007, MOL ECOL NOTES, V7, P549, DOI 10.1111/j.1471-8286.2007.01786.x; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Miller SE, 2003, P ENTOMOL SOC WASH, V105, P1034; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; NIX HA, 1972, BRIDGE BARRIER NATUR, P61; Novotny V, 2005, ANN ZOOL FENN, V42, P463; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2005, J TROP ECOL, V21, P67, DOI 10.1017/S0266467404002044; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2000, P ROY SOC B-BIOL SCI, V267, P947, DOI 10.1098/rspb.2000.1095; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, SCIENCE, V315, DOI 10.1126/science.1139702; Odegaard F, 2006, BIODIVERS CONSERV, V15, P83, DOI 10.1007/s10531-004-3106-5; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Orr AG, 1996, MONOG BIOL, V74, P125; Paijmans K., 1976, NEW GUINEA VEGETATIO; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; REINER EJ, 1964, GEOGR REV, V54, P20, DOI 10.2307/213028; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Ruokolainen K, 2002, J TROP ECOL, V18, P935, DOI 10.1017/S0266467402002614; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; Swadling P, 1997, WORLD ARCHAEOL, V29, P1; Wood A.W., 1982, BIOGEOGRAPHY ECOLOGY, VVol. 42, P73, DOI 10.1007/978-94-009-8632-9_5; Wurm S. A., 1981, LANGUAGE ATLAS PACIF	54	198	211	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					692	U8		10.1038/nature06021	http://dx.doi.org/10.1038/nature06021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687324				2022-12-28	WOS:000248598000044
J	Johnson, CP; Tang, HY; Carag, C; Speicher, DW; Discher, DE				Johnson, Colin P.; Tang, Hsin-Yao; Carag, Christine; Speicher, David W.; Discher, Dennis E.			Forced unfolding of proteins within cells	SCIENCE			English	Article							SPECTRIN REPEATS; IMMUNOGLOBULIN DOMAINS; MECHANICAL-PROPERTIES; MOLECULAR-STRUCTURE; ERYTHROID SPECTRIN; ELASTICITY; ADHESION; TITIN; SPECTROSCOPY; FIBRONECTIN	To identify cytoskeletal proteins that change conformation or assembly within stressed cells, in situ labeling of sterically shielded cysteines with fluorophores was analyzed by fluorescence imaging, quantitative mass spectrometry, and sequential two-dye labeling. Within red blood cells, shotgun labeling showed that shielded cysteines in the two isoforms of the cytoskeletal protein spectrin were increasingly labeled as a function of shear stress and time, indicative of forced unfolding of specific domains. Within mesenchymal stem cells-as a prototypical adherent cell-nonmuscle myosin IIA and vimentin are just two of the cytoskeletal proteins identified that show differential labeling in tensed versus drug-relaxed cells. Cysteine labeling of proteins within live cells can thus be used to fluorescently map out sites of molecular-scale deformation, and the results also suggest means to colocalize signaling events such as phosphorylation with forced unfolding.	Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Discher, DE (corresponding author), Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Krieger, Christine/AAX-6822-2021	Krieger, Christine/0000-0002-1856-415X; Tang, Hsin-Yao/0000-0003-1838-018X; Johnson, Colin/0000-0002-6783-2835; discher, dennis/0000-0001-6163-2229	NCRR NIH HHS [S10 RR022575, S10 RR022575-01A1] Funding Source: Medline; NHLBI NIH HHS [R01 HL062352, R01 HL062352-09A1] Funding Source: Medline; NIAMS NIH HHS [R21 AR056128-02, R21 AR056128-01A1, R21 AR056128] Funding Source: Medline; NIBIB NIH HHS [R01 EB007049-03, R01 EB007049-01, R01 EB007049-02, R01 EB007049] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; CHIANCONE E, 1970, J BIOL CHEM, V245, P4105; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; EVANS EA, 1980, MECH THERMODYNAMICS, P190; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ortiz V, 2005, J MOL BIOL, V349, P638, DOI 10.1016/j.jmb.2005.03.086; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Randles LG, 2007, BIOPHYS J, V92, P571, DOI 10.1529/biophysj.106.093690; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun SJ, 1997, MOL BIOL CELL, V8, P421, DOI 10.1091/mbc.8.3.421; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	38	276	286	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					663	666		10.1126/science.1139857	http://dx.doi.org/10.1126/science.1139857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673662	Green Accepted			2022-12-28	WOS:000248494400046
J	Brock, SL				Brock, Stephanie L.			Filling a void	SCIENCE			English	Editorial Material							AEROGELS; SEMICONDUCTOR; CLUSTERS		Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Brock, SL (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	sbrock@chem.wayne.edu	Brock, Stephanie/AAS-5974-2021					Arachchige IU, 2007, J AM CHEM SOC, V129, P1840, DOI 10.1021/ja066749c; Bag S, 2007, SCIENCE, V317, P490, DOI 10.1126/science.1142535; Brock SL, 2006, COMMENT INORG CHEM, V27, P103, DOI 10.1080/02603590601084434; Kistler SS, 1932, J PHYS CHEM-US, V36, P52, DOI 10.1021/j150331a003; Korlann SD, 2005, J AM CHEM SOC, V127, P12516, DOI 10.1021/ja045446k; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; Mercier L, 1997, ADV MATER, V9, P500, DOI 10.1002/adma.19970090611; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; Trikalitis PN, 2002, J AM CHEM SOC, V124, P2604, DOI 10.1021/ja017245b; Trikalitis PN, 2001, NATURE, V410, P671, DOI 10.1038/35070533; Zheng N, 2005, ANGEW CHEM INT EDIT, V44, P5299, DOI 10.1002/anie.200500346	12	11	11	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					460	461		10.1126/science.1146517	http://dx.doi.org/10.1126/science.1146517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656708				2022-12-28	WOS:000248339800026
J	Bruning, O; Collier, P				Bruening, Oliver; Collier, Paul			Building a behemoth	NATURE			English	Review								The Large Hadron Collider makes extensive use of existing CERN infrastructure but is in many respects an unprecedented undertaking. It is a proton-proton collider; therefore, it requires two separate accelerator rings with magnetic fields of opposite polarity to guide the two beams in opposite directions around its 27-km circumference. In addition, the extraordinary energies and collision rates that it has been designed to attain pose huge challenges for controlling the beam and protecting the accelerator.	CERN, Accelerators & Beams Dept, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN)	Collier, P (corresponding author), CERN, Accelerators & Beams Dept, CH-1211 Geneva 23, Switzerland.	paul.collier@cern.ch						Alessandro B, 2006, J PHYS G NUCL PARTIC, V32, P1295, DOI 10.1088/0954-3899/32/10/001; AMATO S, 1998, 984 CERN LHSS; [Anonymous], 1984, LEP DES REP; ARMSTRONG WW, ATLAS TECHNICAL PROP; Benedikt M., 2004, LHC DESIGN REPORT, VIII; Berardi V., 2004, TOTAL CROSS SECTION; Bottura L, 2000, IEEE T APPL SUPERCON, V10, P1054, DOI 10.1109/77.828413; Bruning O.S., 2001, LHC DESIGN REPORT; CHRISTOFILOS NC, 1966, DEV HIGH ENERGY ACCE; COLE FT, 1888 FERM; Cortese P, 2004, J PHYS G NUCL PARTIC, V30, P1517, DOI 10.1088/0954-3899/30/11/001; COURANT ED, 1958, ANN PHYS-NEW YORK, V3, P1, DOI 10.1016/0003-4916(58)90012-5; DELLANEGRA M, 2006, CMS PHYS TECHNICAL D, V1; *DESY, 1981, HERA PROP LARG EL PR; Leroy D, 2006, IEEE T APPL SUPERCON, V16, P1152, DOI 10.1109/TASC.2005.864273; MUKARI Y, 2006, LHCF EXPT TECHNICAL; Wilson Martin N., 1983, SUPERCONDUCTING MAGN	17	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					285	289		10.1038/nature06077	http://dx.doi.org/10.1038/nature06077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637658				2022-12-28	WOS:000248118300044
J	Mendillo, M; Laurent, S; Wilson, J; Baumgardner, J; Konrad, J; Karl, WC				Mendillo, Michael; Laurent, Sophie; Wilson, Jody; Baumgardner, Jeffrey; Konrad, Janusz; Karl, W. Clem			The sources of sodium escaping from Io revealed by spectral high definition imaging	NATURE			English	Article							SIMULATION; CHLORINE; FEATURES; MODEL	On Jupiter's moon Io, volcanic plumes and evaporating lava flows provide hot gases to form an atmosphere that is subsequently ionized. Some of Io's plasma is captured by the planet's strong magnetic field to form a co-rotating torus at Io's distance; the remaining ions and electrons form Io's ionosphere. The torus and ionosphere are also depleted by three time-variable processes that produce a banana-shaped cloud orbiting with Io(1), a giant nebula extending out to about 500 Jupiter radii(2-5), and a jet close to Io(6-9). No spatial constraints exist for the sources of the first two; they have been inferred only from modelling the patterns seen in the trace gas sodium observed far from Io. Here we report observations that reveal a spatially confined stream that ejects sodium only from the wake of the Io-torus interaction, together with a visually distinct, spherically symmetrical outflow region arising from atmospheric sputtering. The spatial extent of the ionospheric wake that feeds the stream is more than twice that observed by the Galileo spacecraft and modelled successfully. This implies considerable variability, and therefore the need for additional modelling of volcanically-driven, episodic states of the great jovian nebula.	Boston Univ, Ctr Space Phys, Boston, MA 02215 USA; Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Boston University; Boston University	Mendillo, M (corresponding author), Boston Univ, Ctr Space Phys, Boston, MA 02215 USA.	mendillo@bu.edu	Mendillo, Michael/H-4397-2014					Baumgardner J, 2000, ASTRON J, V119, P2458, DOI 10.1086/301323; Burger MH, 1999, GEOPHYS RES LETT, V26, P3333, DOI 10.1029/1999GL003654; Burger MH, 2001, ASTROPHYS J, V563, P1063, DOI 10.1086/323944; Combi MR, 1998, J GEOPHYS RES-SPACE, V103, P9071, DOI 10.1029/98JA00073; Frank LA, 1996, SCIENCE, V274, P394, DOI 10.1126/science.274.5286.394; FRIED DL, 1978, J OPT SOC AM, V68, P1651, DOI 10.1364/JOSA.68.001651; GOLDBERG BA, 1984, SCIENCE, V226, P512, DOI 10.1126/science.226.4674.512; Hinson DP, 1998, J GEOPHYS RES-SPACE, V103, P29343, DOI 10.1029/98JA02659; Kabin K, 2001, PLANET SPACE SCI, V49, P337, DOI 10.1016/S0032-0633(00)00155-0; Kuppers M, 2000, GEOPHYS RES LETT, V27, P513, DOI 10.1029/1999GL010718; Laurent S, 2004, P SOC PHOTO-OPT INS, V5558, P676, DOI 10.1117/12.581739; LAURENT S, 2004, THESIS BOSTON U BOST; Lellouch E, 2003, NATURE, V421, P45, DOI 10.1038/nature01292; LINKER JA, 1991, J GEOPHYS RES-SPACE, V96, P21037, DOI 10.1029/91JA02132; Mendillo M, 2004, ICARUS, V170, P430, DOI 10.1016/j.icarus.2004.03.009; MENDILLO M, 1990, NATURE, V348, P312, DOI 10.1038/348312a0; Mendillo M, 2001, PLANET SPACE SCI, V49, P1501, DOI 10.1016/S0032-0633(01)00088-5; Moses JI, 2002, ICARUS, V156, P107, DOI 10.1006/icar.2001.6759; PILCHER CB, 1984, ASTROPHYS J, V287, P427, DOI 10.1086/162702; Saur J, 1999, J GEOPHYS RES-SPACE, V104, P25105, DOI 10.1029/1999JA900304; SCHNEIDER NM, 1991, SCIENCE, V253, P1394, DOI 10.1126/science.253.5026.1394; SMYTH WH, 1988, ASTROPHYS J, V328, P888, DOI 10.1086/166346; Warell J, 2001, PLANET SPACE SCI, V49, P1531, DOI 10.1016/S0032-0633(01)00091-5; Wilson JE, 1999, J GEOPHYS RES-PLANET, V104, P16567, DOI 10.1029/1999JE900017; Wilson JK, 2002, ICARUS, V157, P476, DOI 10.1006/icar.2002.6821; WILSON JK, 2001, EOS, V82, pS255; Zolotov MY, 2000, GEOPHYS RES LETT, V27, P2789, DOI 10.1029/2000GL011608	27	14	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					330	332		10.1038/nature06000	http://dx.doi.org/10.1038/nature06000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637664				2022-12-28	WOS:000248118300052
J	Nolet, G				Nolet, Guust			F. Anthony Dahlen (1942-2007) - Pioneering and versatile theoretical geophysicist. Obituary	NATURE			English	Biographical-Item									Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Nolet, G (corresponding author), Princeton Univ, Dept Geosci, 320 Guyot Hall, Princeton, NJ 08544 USA.	nolet@princeton.edu	Nolet, Guust/F-3142-2013	Nolet, Guust/0000-0002-2709-1518					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					268	268		10.1038/448268a	http://dx.doi.org/10.1038/448268a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637652				2022-12-28	WOS:000248118300039
J	Riedel-Kruse, IH; Muller, C; Oates, AC				Riedel-Kruse, Ingmar H.; Mueller, Claudia; Oates, Andrew C.			Synchrony dynamics during initiation, failure, and rescue of the segmentation clock	SCIENCE			English	Article							ZEBRAFISH SOMITOGENESIS; SOMITE SEGMENTATION; EXPRESSION; OSCILLATOR; GENES; HER1; BOUNDARIES; MECHANISM; PATHWAY; EMBRYO	The "segmentation clock" is thought to coordinate sequential segmentation of the body axis in vertebrate embryos. This clock comprises a multicellular genetic network of synchronized oscillators, coupled by intercellular Delta-Notch signaling. How this synchrony is established and how its loss determines the position of segmentation defects in Delta and Notch mutants are unknown. We analyzed the clock's synchrony dynamics by varying strength and timing of Notch coupling in zebrafish embryos with techniques for quantitative perturbation of gene function. We developed a physical theory based on coupled phase oscillators explaining the observed onset and rescue of segmentation defects, the clock's robustness against developmental noise, and a critical point beyond which synchrony decays. We conclude that synchrony among these genetic oscillators can be established by simultaneous initiation and self-organization and that the segmentation defect position is determined by the difference between coupling strength and noise.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Riedel-Kruse, IH (corresponding author), CALTECH, Div Biol, MC 139-74, Pasadena, CA 91125 USA.	ingmar@caltech.edu; oates@mpi-cbg.de	Riedel-Kruse, Ingmar/B-8818-2008	Riedel-Kruse, Ingmar/0000-0002-6068-5561				Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Holley SA, 2006, GENE DEV, V20, P1831, DOI 10.1101/gad.1453706; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2002, DEVELOPMENT, V129, P1107; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Muller M, 1996, DEVELOPMENT, V122, P2071; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pourquie O, 2001, CLIN GENET, V60, P409, DOI 10.1034/j.1399-0004.2001.600602.x; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Winfree AT, 2002, SCIENCE, V298, P2336, DOI 10.1126/science.1072560	32	183	186	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1911	1915		10.1126/science.1142538	http://dx.doi.org/10.1126/science.1142538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17702912	Green Submitted			2022-12-28	WOS:000249764300037
J	Torres, EM; Sokolsky, T; Tucker, CM; Chan, LY; Boselli, M; Dunham, MJ; Amon, A				Torres, Eduardo M.; Sokolsky, Tanya; Tucker, Cheryl M.; Chan, Leon Y.; Boselli, Monica; Dunham, Maitreya J.; Amon, Angelika			Effects of aneuploidy on cellular physiology and cell division in haploid yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; EXPRESSION; CANCER; RESISTANCE; GENOME; KINASE; GENES; CYCLE; WHI5	Aneuploidy is a condition frequently found in tumor cells, but its effect on cellular physiology is not known. We have characterized one aspect of aneuploidy: the gain of extra chromosomes. We created a collection of haploid yeast strains that each bear an extra copy of one or more of almost all of the yeast chromosomes. Their characterization revealed that aneuploid strains share a number of phenotypes, including defects in cell cycle progression, increased glucose uptake, and increased sensitivity to conditions interfering with protein synthesis and protein folding. These phenotypes were observed only in strains carrying additional yeast genes, which indicates that they reflect the consequences of additional protein production as well as the resulting imbalances in cellular protein composition. We conclude that aneuploidy causes not only a proliferative disadvantage but also a set of phenotypes that is independent of the identity of the individual extra chromosomes.	MIT, Canc Res Ctr, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Princeton University	Amon, A (corresponding author), MIT, Canc Res Ctr, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Dunham, Maitreya/0000-0001-9944-2666; Amon, Angelika/0000-0001-9837-0314	NIGMS NIH HHS [GM56800, GM071508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, P50GM071508, R01GM056800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALZI E, 1994, J BIOL CHEM, V269, P2206; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartwell LW, 1982, RECENT ADV YEAST MOL, V1, P28; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; KATZ W, 1990, MOL CELL BIOL, V10, P5286, DOI 10.1128/MCB.10.10.5286; Lehninger A., 1993, PRINCIPLES BIOCH; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LINDSLEY DL, 1972, GENETICS, V71, P157; NILSSONTILLGREN T, 1980, CARLSBERG RES COMMUN, V45, P113, DOI 10.1007/BF02906512; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; ROSENSTRAUS MJ, 1978, GENETICS, V90, P735; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H	29	623	631	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					916	924		10.1126/science.1142210	http://dx.doi.org/10.1126/science.1142210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702937				2022-12-28	WOS:000248780200031
J	Avorn, J				Avorn, Jerry			Keeping science on top in drug evaluation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Avorn J, 2005, POWERFUL MED BENEFIT; *CTR DRUG EV RES, 2007, 21888 NDA CTR DRUG E; *FDA ARTHR ADV COM, 2007, ARC ET; Harris G., 2005, NY TIMES 0225, pA1	4	15	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					633	635		10.1056/NEJMp078134	http://dx.doi.org/10.1056/NEJMp078134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699813				2022-12-28	WOS:000248746000001
J	Borneman, AR; Gianoulis, TA; Zhang, ZDD; Yu, HY; Rozowsky, J; Seringhaus, MR; Wang, LY; Gerstein, M; Snyder, M				Borneman, Anthony R.; Gianoulis, Tara A.; Zhang, Zhengdong D.; Yu, Haiyuan; Rozowsky, Joel; Seringhaus, Michael R.; Wang, Lu Yong; Gerstein, Mark; Snyder, Michael			Divergence of transcription factor binding sites across related yeast species	SCIENCE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENES; GENOME; SEQUENCE; GROWTH; FILAMENTATION; PROTEINS; ELEMENTS	Characterization of interspecies differences in gene regulation is crucial for understanding the molecular basis of both phenotypic diversity and evolution. By means of chromatin immunoprecipitation and DNA microarray analysis, the divergence in the binding sites of the pseudohyphal regulators Ste12 and Tec1 was determined in the yeasts Saccharomyces cerevisiae, S. mikatae, and S. bayanus under pseudohyphal conditions. We have shown that most of these sites have diverged across these species, far exceeding the interspecies variation in orthologous genes. A group of Ste12 targets was shown to be bound only in S. mikatae and S. bayanus under pseudohyphal conditions. Many of these genes are targets of Ste12 during mating in S. cerevisiae, indicating that specialization between the two pathways has occurred in this species. Transcription factor binding sites have therefore diverged substantially faster than ortholog content. Thus, gene regulation resulting from transcription factor binding is likely to be a major cause of divergence between related species.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Yale Univ, Program Computat Biol, New Haven, CT 06511 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Siemens Corp Res, Integrated Data Syst Dept, Princeton, NJ 08540 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Siemens AG; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	michael.snyder@yale.edu		Borneman, Anthony/0000-0001-8491-7235; Snyder, Michael/0000-0003-0784-7987; Rozowsky, Joel/0000-0002-3565-0762				Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; BORNEMAN AR, IN PRESS FUNCT INTEG; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; FIELDS S, 1985, CELL, V42, P923, DOI 10.1016/0092-8674(85)90288-0; Gavrias V, 1996, MOL MICROBIOL, V19, P1255, DOI 10.1111/j.1365-2958.1996.tb02470.x; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Prinz S, 2004, GENOME RES, V14, P380, DOI 10.1101/gr.2020604; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sanchez-Martinez C, 2001, CURR OPIN MICROBIOL, V4, P214, DOI 10.1016/S1369-5274(00)00191-0; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	27	279	285	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					815	819		10.1126/science.1140748	http://dx.doi.org/10.1126/science.1140748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690298				2022-12-28	WOS:000248624500044
J	Jang, YY; Sharkis, SJ				Jang, Yoon-Young; Sharkis, Saul J.			Fetal to adult stem cell transition: Knocking Sox17 off	CELL			English	Editorial Material							ENDODERM	What controls the inherent differences between fetal and adult hematopoietic stem cells(HSCs)? In this issue of Cell, Kim et al. ( 2007) demonstrate in mice that the endodermal transcription factor Sox17 is required for the maintenance of fetal and neonatal but not adult HSCs.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Jang, YY (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	yjang3@jhmi.edu; ssharkis@jhmi.edu						Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; KIM I, 2007, CELL; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; YODER MC, 1994, BLOOD, V83, P2436	10	11	11	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					403	404		10.1016/j.cell.2007.07.027	http://dx.doi.org/10.1016/j.cell.2007.07.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693249	Bronze			2022-12-28	WOS:000249038100007
J	Cui, HG; Chen, ZY; Zhong, S; Wooley, KL; Pochan, DJ				Cui, Honggang; Chen, Zhiyun; Zhong, Sheng; Wooley, Karen L.; Pochan, Darrin J.			Block copolymer assembly via kinetic control	SCIENCE			English	Article							TRIBLOCK COPOLYMERS; MORPHOLOGY; MICELLES; SURFACTANTS; POLYMERS; EXCHANGE; CELLS; WATER; DNA	Block copolymers consist of two or more chemically different polymer segments, or blocks, connected by a covalent linkage. In solution, amphiphilic blocks can self-assemble as a result of energetic repulsion effects between blocks. The degree of repulsion, the lengths of the block segments, and the selectivity of the solvent primarily control the resultant assembled morphology. In an ideal situation, one would like to be able to alter the morphology that forms without having to change the chemistry of the block copolymer. Through the kinetic manipulation of charged, amphiphilic block copolymers in solution, we are able to generate different nanoscale structures with simple block copolymer chemistry. The technique relies on divalent organic counter ions and solvent mixtures to drive the organization of the block copolymers down specific pathways into complex one-dimensional structures. Block copolymers are increasingly used as templating materials; thus, the ability to control the formation of specific patterns and structures is of growing interest and applicability.	Washington Univ, Ctr Mat Innovat, Dept Chem, St Louis, MO 63130 USA; Washington Univ, Ctr Mat Innovat, Dept Radiol, St Louis, MO 63130 USA; Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA	Washington University (WUSTL); Washington University (WUSTL); University of Delaware; University of Delaware	Wooley, KL (corresponding author), Washington Univ, Ctr Mat Innovat, Dept Chem, St Louis, MO 63130 USA.	klwooley@artsci.wustl.edu; Pochan@udel.edu	Cui, Honggang/E-8012-2010; Cui, Honggang/C-6550-2008; Wooley, Karen L/D-4399-2015; Wooley, Karen/AAX-2259-2020	Wooley, Karen L/0000-0003-4086-384X; Wooley, Karen/0000-0003-4086-384X				Chen ZY, 2005, J AM CHEM SOC, V127, P8592, DOI 10.1021/ja050290p; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Cui HG, 2006, MACROMOLECULES, V39, P6599, DOI 10.1021/ma0609026; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Dormidontova EE, 1999, MACROMOLECULES, V32, P7630, DOI 10.1021/ma9809029; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Jain S, 2004, MACROMOLECULES, V37, P1511, DOI 10.1021/ma035467j; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Kahn O, 1998, SCIENCE, V279, P44, DOI 10.1126/science.279.5347.44; Li ZB, 2005, LANGMUIR, V21, P7533, DOI 10.1021/la051020n; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073; Lund R, 2006, MACROMOLECULES, V39, P4566, DOI 10.1021/ma060328y; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Ouyang M, 2003, SCIENCE, V301, P1074, DOI 10.1126/science.1086963; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866; Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Safran S. A., 1994, STAT THERMODYNAMICS; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tlusty T, 2000, SCIENCE, V290, P1328, DOI 10.1126/science.290.5495.1328; Won YY, 2003, MACROMOLECULES, V36, P953, DOI 10.1021/ma021439+; ZANA R, 1993, NATURE, V362, P228, DOI 10.1038/362228a0; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zheng RH, 2005, J AM CHEM SOC, V127, P15358, DOI 10.1021/ja054937h	30	886	911	16	599	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					647	650		10.1126/science.1141768	http://dx.doi.org/10.1126/science.1141768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673657				2022-12-28	WOS:000248494400041
J	Crosby, SS; Apovian, CM; Grodin, MA				Crosby, Sondra S.; Apovian, Caroline M.; Grodin, Michael A.			Hunger strikes, force-feeding, and physicians' responsibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA USA	Boston University; Boston University; Boston University	Crosby, SS (corresponding author), Boston Med Ctr, Sect Gen Internal Med ACC5, 850 Harrison Ave, Boston, MA 02118 USA.	scrosby@bu.edu		Apovian, Caroline/0000-0002-8029-1922; Grodin, Michael/0000-0002-0929-8929; Crosby, Sondra/0000-0002-1672-5407				Altun G, 2004, FORENSIC SCI INT, V146, P35, DOI 10.1016/j.forsciint.2004.03.022; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; APOVIAN CM, 1990, CRIT CARE MED, V18, P1030, DOI 10.1097/00003246-199009000-00021; Cahill GF, 1998, AM J CLIN NUTR, V68, P1; Crook MA, 2001, NUTRITION, V17, P632, DOI 10.1016/S0899-9007(01)00542-1; FELIG P, 1970, NEW ENGL J MED, V282, P166; Fessler DMT, 2003, J MED ETHICS, V29, P243, DOI 10.1136/jme.29.4.243; GOLDEN T, 2007, NY TIMES        0409, pA12; Golden Tim, 2006, N Y Times Web, pA20; *J WEIR FDN HLTH H, 1995, ASS HUNG STRIK MAN P; KALK WJ, 1991, LANCET, V337, P660, DOI 10.1016/0140-6736(91)92465-E; KERNDT PR, 1982, WESTERN J MED, V137, P379; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; OCONNOR A, 1988, MED SCI LAW, V28, P62, DOI 10.1177/002580248802800115; Peel M, 1997, BRIT MED J, V315, P829, DOI 10.1136/bmj.315.7112.829	15	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					563	566		10.1001/jama.298.5.563	http://dx.doi.org/10.1001/jama.298.5.563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666678				2022-12-28	WOS:000248438100025
J	Hunt, G				Hunt, Gene			Paleontology - Variation and early evolution	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Hunt, G (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA.	hunte@si.edu	Hunt, Gene/B-3783-2010	Hunt, Gene/0000-0001-6430-5020				[Anonymous], 1994, ACTA PALAEONTOL POL; Hughes NC, 1995, LETHAIA, V28, P333, DOI 10.1111/j.1502-3931.1995.tb01824.x; JABLONSKI D, 1990, EVOLUTIONARY INNOVATIONS, P253; MCNAMARA KJ, 1986, BIOL REV, V61, P121, DOI 10.1111/j.1469-185X.1986.tb00464.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; VALENTINE JW, 1995, PALAIOS, V10, P190, DOI 10.2307/3515182; Webster M, 2007, SCIENCE, V317, P499, DOI 10.1126/science.1142964	8	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					459	460		10.1126/science.1145550	http://dx.doi.org/10.1126/science.1145550			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656707				2022-12-28	WOS:000248339800025
J	Braun-Munzinger, P; Stachel, J				Braun-Munzinger, Peter; Stachel, Johanna			The quest for the quark-gluon plasma	NATURE			English	Review							NUCLEUS-NUCLEUS COLLISIONS; DENSE PARTONIC MATTER; RADIATIVE ENERGY-LOSS; ELLIPTIC FLOW; PERSPECTIVE; J/PSI	High-energy collisions between heavy nuclei have in the past 20 years provided multiple indications of a deconfined phase of matter that exists at phenomenally high temperatures and pressures. This 'quark-gluon plasma' is thought to have permeated the first microseconds of the Universe. Experiments at the Large Hadron Collider should consolidate the evidence for this exotic medium's existence, and allow its properties to be characterized.	Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Gesell Schwerionenforsch mbH, D-64291 Darmstadt, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Stachel, J (corresponding author), Heidelberg Univ, Inst Phys, Philosophenweg 12, D-69120 Heidelberg, Germany.	stachel@physi.uni-heidelberg.de						Abreu MC, 2001, PHYS LETT B, V499, P85, DOI 10.1016/S0370-2693(01)00019-3; Adamova D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.022301; Adams J, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.014904; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; ADARE A, 2006, ENERGY LOSS FLOW HEA; Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086; ADIL A, 2006, COLLISIONAL ENERGY L; ADLER SS, 2006, DETAILED STUDY HIGH; Akiba Y, 2006, NUCL PHYS A, V774, P403, DOI 10.1016/j.nuclphysa.2006.06.060; ALLTON CR, 2002, QCD THERMAL PHASE TR; Andronic A, 2006, NUCL PHYS A, V772, P167, DOI 10.1016/j.nuclphysa.2006.03.012; ANDRONIC A, 2007, PHYS LETT B; ANDRONIC A, NUCL PHYS A; Aoki Y, 2006, PHYS LETT B, V643, P46, DOI 10.1016/j.physletb.2006.10.021; Aoki Y, 2006, NATURE, V443, P675, DOI 10.1038/nature05120; Arsene I, 2005, NUCL PHYS A, V757, P1, DOI 10.1016/j.nuclphysa.2005.02.130; Back BB, 2005, NUCL PHYS A, V757, P28, DOI 10.1016/j.nuclphysa.2005.03.084; Baier R, 1997, NUCL PHYS B, V483, P291, DOI 10.1016/S0550-3213(96)00553-6; Baier R, 1997, NUCL PHYS B, V484, P265, DOI 10.1016/S0550-3213(96)00581-0; BAIER R, 2006, CAUSAL VISCOUS HYDRO; BARRETTE J, 1994, PHYS REV LETT, V73, P2532, DOI 10.1103/PhysRevLett.73.2532; Becattini F, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.024905; Bhalerao RS, 2005, PHYS LETT B, V627, P49, DOI 10.1016/j.physletb.2005.08.131; Bjorken J.D., 1982, FERMILABPUB8259THY; BJORKEN JD, 1983, PHYS REV D, V27, P140, DOI 10.1103/PhysRevD.27.140; Braun-Munzinger P, 2000, PHYS LETT B, V490, P196, DOI 10.1016/S0370-2693(00)00991-6; Braun-Munzinger P, 2001, NUCL PHYS A, V690, p119C, DOI 10.1016/S0375-9474(01)00936-8; Braun-Munzinger P., 2004, QUARK GLUON PLASMA, P491, DOI DOI 10.1142/9789812795533_0008; BraunMunzinger P, 1996, NUCL PHYS A, V606, P320, DOI 10.1016/0375-9474(96)00198-4; CABIBBO N, 1975, PHYS LETT B, V59, P67, DOI 10.1016/0370-2693(75)90158-6; Capella A, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.054908; CASALDERREYSOLA.J, 2004, CONICAL FLOW INDUCED; *CERN, 2000, NEW STAT MATT CREAT; COLLINS JC, 1975, PHYS REV LETT, V34, P1353, DOI 10.1103/PhysRevLett.34.1353; CSORGO T, 2006, NUCL PHYS A, V774, P1; DENTERRIA D, 2004, QUANTUM CHROMO MANY; EJIRI S, 2003, STUDY QCD THERMODYNA; Fodor Z, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/04/050; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Gyulassy M, 2005, NUCL PHYS A, V750, P30, DOI 10.1016/j.nuclphysa.2004.10.034; HAGEDORN R, 1965, NUOVO CIMENTO, V3, P147; Heinz U, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.034904; Heinz U, 1998, NUCL PHYS A, V638, p357C, DOI 10.1016/S0375-9474(98)00380-7; Heinz U., 2000, EVIDENCE NEW STATE M; Huovinen P, 2001, PHYS LETT B, V503, P58, DOI 10.1016/S0370-2693(01)00219-2; KOLB P, 2004, QUARK GLUON PLASMA, V3, P1; Kolb P. F., 2004, QUARK GLUON PLASMA, P634; MATSUI T, 1986, PHYS LETT B, V178, P416, DOI 10.1016/0370-2693(86)91404-8; MISCHKE A, 2006, HIGH P T HADRON PROD; PLOSKON M, 2007, 2 PARTICLE AZIMUTHAL; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Poskanzer AM, 1998, PHYS REV C, V58, P1671, DOI 10.1103/PhysRevC.58.1671; ROMATSCHKE P, 2007, CAUSAL VISCOUS HYDRO; Stock R, 1999, PHYS LETT B, V456, P277, DOI 10.1016/S0370-2693(99)00482-7; Stocker H, 2005, NUCL PHYS A, V750, P121, DOI 10.1016/j.nuclphysa.2004.12.074; TEANEY D, 2001, HYDRODYNAMIC DESCRIP; VITEV I, 2003, CONTRIBUTION CERN YE; VITEV I, 2005, J PHYS G; VOLOSHIN S, 2007, Z PHYS C, V70, P665; WANG XN, 1992, PHYS REV LETT, V68, P1480, DOI 10.1103/PhysRevLett.68.1480; Zapp K, 2006, PHYS LETT B, V637, P179, DOI 10.1016/j.physletb.2006.03.080; Zhang Y, 2006, MOL SIMULAT, V32, P29, DOI 10.1080/08927020500517223	64	131	133	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					302	309		10.1038/nature06080	http://dx.doi.org/10.1038/nature06080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637661				2022-12-28	WOS:000248118300047
J	Rosen, CJ				Rosen, Clifford J.			The rosiglitazone story - Lessons from an FDA advisory committee meeting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Joseph Hosp, Maine Ctr Osteoporosis, Bangor, ME 04401 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Rosen, CJ (corresponding author), St Joseph Hosp, Maine Ctr Osteoporosis, Bangor, ME 04401 USA.							Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063	7	157	158	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					844	846		10.1056/NEJMp078167	http://dx.doi.org/10.1056/NEJMp078167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17687124	Bronze			2022-12-28	WOS:000249065700002
J	Kubota, Y; Watanabe, K; Tsuda, O; Taniguchi, T				Kubota, Yoichi; Watanabe, Kenji; Tsuda, Osamu; Taniguchi, Takashi			Deep ultraviolet light-emitting hexagonal boron nitride synthesized at atmospheric pressure	SCIENCE			English	Article							SINGLE-CRYSTALS; GROWTH; TEMPERATURE; SOLVENT; WAVELENGTH; DEPOSITION; NICKEL; BN	Materials emitting light in the deep ultraviolet region around 200 nanometers are essential in a wide-range of applications, such as information storage technology, environmental protection, and medical treatment. Hexagonal boron nitride (hBN), which was recently found to be a promising deep ultraviolet light emitter, has traditionally been synthesized under high pressure and at high temperature. We successfully synthesized high-purity hBN crystals at atmospheric pressure by using a nickel-molybdenum solvent. The obtained hBN crystals emitted intense 215-nanometer luminescence at room temperature. This study demonstrates an easier way to grow high-quality hBN crystals, through their liquid-phase deposition on a substrate at atmospheric pressure.	NIMS, Tsukuba, Ibaraki 3050044, Japan	National Institute for Materials Science	Kubota, Y (corresponding author), NIMS, Tsukuba, Ibaraki 3050044, Japan.	kubota.yoichi@nims.go.jp	WATANABE, Kenji/H-2825-2011; TANIGUCHI, Takashi/H-2718-2011	WATANABE, Kenji/0000-0003-3701-8119; 				Akasaki I, 1997, JPN J APPL PHYS 1, V36, P5393, DOI 10.1143/JJAP.36.5393; Arnaud B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026402; ENDO T, 1979, J MATER SCI, V14, P1375, DOI 10.1007/BF00549311; Fleischer J.F., 1972, J CRYST GROWTH, V13/14, P88, DOI [10.1016/0022-0248(72)90068-1, DOI 10.1016/0022-0248(72)90068-1]; GEICK R, 1966, PHYS REV, V146, P543, DOI 10.1103/PhysRev.146.543; ISHII T, 1983, J CRYST GROWTH, V61, P689, DOI 10.1016/0022-0248(83)90199-9; Kowanda C, 2003, SCRIPTA MATER, V48, P1073, DOI 10.1016/S1359-6462(02)00628-0; Kubota Y, 2007, JPN J APPL PHYS 1, V46, P311, DOI 10.1143/JJAP.46.311; Liao P. K., 1990, BINARY ALLOY PHASE D, V1, P508; Massalski T. B., 1990, BINARY ALLOY PHASE D, V1, P861; Mishima O., 2000, ELECT REFRACTORY MAT; SAITO H, 1970, YOGYO-KYOKAI-SHI, V78, P1; Silly MG, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085205; SINGLETON MF, 1990, BINARY ALLOY PHASE D, V1, P866; TAKAHASHI T, 1979, J CRYST GROWTH, V47, P245, DOI 10.1016/0022-0248(79)90248-3; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Taniguchi T, 2004, PHYS STATUS SOLIDI A, V201, P2573, DOI 10.1002/pssa.200405191; Taniguchi T, 2004, NEW DIAM FRONT C TEC, V14, P289; Taniyasu Y, 2006, NATURE, V441, P325, DOI 10.1038/nature04760; Tsuda O, 2007, JPN J APPL PHYS 2, V46, pL287, DOI 10.1143/JJAP.46.L287; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Watanabe K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358314; WENTORF RH, 1961, J CHEM PHYS, V34, P809, DOI 10.1063/1.1731679; Yang PC, 2005, J ELECTRON MATER, V34, P1558, DOI 10.1007/s11664-005-0165-7; Yano M, 2000, JPN J APPL PHYS 2, V39, pL300, DOI 10.1143/JJAP.39.L300	25	929	945	16	426	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					932	934		10.1126/science.1144216	http://dx.doi.org/10.1126/science.1144216			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702939				2022-12-28	WOS:000248780200035
J	Shema, R; Sacktor, TC; Dudai, Y				Shema, Reut; Sacktor, Todd Charlton; Dudai, Yadin			Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKM zeta	SCIENCE			English	Article							CONDITIONED TASTE-AVERSION; RAT INSULAR CORTEX; KINASE M-ZETA; GUSTATORY CORTEX; BEHAVING RAT; RECONSOLIDATION; CONSOLIDATION; NEUROBIOLOGY; MAINTENANCE; ACTIVATION	Little is known about the neuronal mechanisms that subserve long-term memory persistence in the brain. The components of the remodeled synaptic machinery, and how they sustain the new synaptic or cellwide configuration over time, are yet to be elucidated. In the rat cortex, long-term associative memories vanished rapidly after local application of an inhibitor of the protein kinase C isoform, protein kinase M zeta (PKM zeta). The effect was observed for at least several weeks after encoding and may be irreversible. In the neocortex, which is assumed to be the repository of multiple types of long-term memory, persistence of memory is thus dependent on ongoing activity of a protein kinase long after that memory is considered to have consolidated into a long-term stable form.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il			NIMH NIH HHS [R01 MH53576, MH57068] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053576, R01MH057068] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Balleine BW, 2000, J NEUROSCI, V20, P8954; BARTLETT EC, 1932, REMEMBERING STUDY EX; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Berman DE, 1998, J NEUROSCI, V18, P10037; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BURESOVA O, 1980, BEHAV BRAIN RES, V1, P299; BUXBAUM JD, 1989, J BIOL CHEM, V264, P9344; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; DUDAI Y, 2002, MEMORY A Z KEYWORDS; DUVILLARD XD, 1981, CHEM SENSES, V6, P143, DOI 10.1093/chemse/6.2.143; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Koh MT, 2003, BEHAV NEUROSCI, V117, P1416, DOI 10.1037/0735-7044.117.6.1416; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2006, LEARN MEMORY, V13, P530, DOI 10.1101/lm.350906; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Stone ME, 2005, LEARN MEMORY, V12, P579, DOI 10.1101/lm.32305; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3; Yefet K, 2006, EUR J NEUROSCI, V24, P1434, DOI 10.1111/j.1460-9568.2006.05009.x	30	283	297	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					951	953		10.1126/science.1144334	http://dx.doi.org/10.1126/science.1144334			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702943				2022-12-28	WOS:000248780200041
J	Ingelsson, E; Schaefer, EJ; Contois, JH; McNamara, JR; Sullivan, L; Keyes, MJ; Pencina, MJ; Schoonmaker, C; Wilson, PWF; D'Agostino, RB; Vasan, RS				Ingelsson, Erik; Schaefer, Ernst J.; Contois, John H.; McNamara, Judith R.; Sullivan, Lisa; Keyes, Michelle J.; Pencina, Michael J.; Schoonmaker, Christopher; Wilson, Peter W. F.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Clinical utility of different lipid measures for prediction of coronary heart disease in men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REFERENCE INTERVALS; BETA-BLOCKERS; RISK-FACTORS; PLASMA; PREVENTION; PARAMETERS	Context Evidence is conflicting regarding the performance of apolipoproteins vs traditional lipids for predicting coronary heart disease (CHD) risk. Objectives To compare performance of different lipid measures for CHD prediction using discrimination and calibration characteristics and reclassification of risk categories; to assess incremental utility of apolipoproteins over traditional lipids for CHD prediction. Design, Setting, and Participants Population-based, prospective cohort from, Framingham, Massachusetts. We evaluated serum total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), non HDL-C, apolipoprotein (apo) A-I and apo B, and 3 lipid ratios ( total cholesterol: HDL-C, LDL-C: HDL-C, and apo B: apo A-I) in 3322 middle-aged white participants who attended the fourth offspring examination cycle (1987-1991) and were without cardiovascular disease. Fifty-three percent of the participants were women. Main Outcome Measure Incidence of first CHD event (recognized or unrecognized myocardial infarction, angina pectoris, coronary insufficiency, or coronary heart disease death). Results After a median follow-up of 15.0 years, 291 participants, 198 of whom were men, developed CHD. In multivariate models adjusting for nonlipid risk factors, the apo B: apo A-I ratio predicted CHD (hazard ratio [HR] per SD increment, 1.39; 95% confidence interval [CI], 1.23-1.58 in men and HR, 1.40; 95% CI, 1.16-1.67 in women), but risk ratios were similar for total cholesterol: HDL-C (HR, 1.39; 95% CI, 1.22-1.58 in men and HR, 1.39; 95% CI, 1.17-1.66 in women) and for LDL-C: HDL-C (HR, 1.35; 95% CI, 1.18-1.54 in men and HR, 1.36; 95% CI 1.14-1.63 in women). In both sexes, models using the apo B: apo A-I ratio demonstrated performance characteristics comparable with but not better than that for other lipid ratios. The apo B: apo A-I ratio did not predict CHD risk in a model containing all components of the Framingham risk score including total cholesterol: HDL-C (P = .12 in men; P = .58 in women). Conclusions In this large, population-based cohort, the overall performance of apo B: apo A-I ratio for prediction of CHD was comparable with that of traditional lipid ratios but did not offer incremental utility over total cholesterol: HDL-C. These data do not support measurement of apo B or apo A-I in clinical practice when total cholesterol and HDL-C measurements are available.	Boston Univ, Sch Med, Framingham Study, Framingham, MA USA; Tufts Univ, Lipid Metab Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Boston Univ, Dept Biostat, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Boston Univ, Dept Math & Stat, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Boston Univ, Dept Prevent Med, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Boston University; Tufts University; United States Department of Agriculture (USDA); Boston University; Boston University; Boston University; Emory University	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	应, 宁宁/G-9472-2011; Ramachandran, Vasan/Y-2527-2019; Wilson, Peter W.F./J-2455-2016	Ramachandran, Vasan/0000-0001-7357-5970; Sullivan, Lisa/0000-0003-0726-7149; Pencina, Michael/0000-0001-5798-8855	NHLBI NIH HHS [2K24HL04334, N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBERS JJ, 1978, CLIN CHEM, V24, P853; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Benn M, 2007, ARTERIOSCL THROM VAS, V27, P661, DOI 10.1161/01.ATV.0000255580.73689.8e; BIELMANN P, 1982, INT J CLIN PHARM TH, V20, P259; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Contois JH, 1996, CLIN CHEM, V42, P515; Contois JH, 1996, CLIN CHEM, V42, P507; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; D'Agostino RB, 2004, HDB STAT, V23; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Denke MA, 2005, CIRCULATION, V112, P3368, DOI 10.1161/CIRCULATIONAHA.105.588178; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARVENGT C, 1987, J CLIN PHARMACOL, V27, P475, DOI 10.1002/j.1552-4604.1987.tb03052.x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Schweitzer M, 2002, ATHEROSCLEROSIS, V162, P201, DOI 10.1016/S0021-9150(01)00700-6; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	441	447	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					776	785		10.1001/jama.298.7.776	http://dx.doi.org/10.1001/jama.298.7.776			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699011	Bronze			2022-12-28	WOS:000248728800022
J	Garcia, D; Hylek, E				Garcia, David; Hylek, Elaine			Stroke prevention in elderly patients with atrial fibrillation	LANCET			English	Editorial Material							WARFARIN; THERAPY		Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; Boston Univ, Dept Internal Med, Boston, MA 02215 USA	University of New Mexico; Boston University	Garcia, D (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.	davgarcia@salud.unm.edu		Hylek, Elaine/0000-0001-8263-8304				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1	9	19	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					460	461		10.1016/S0140-6736(07)61208-2	http://dx.doi.org/10.1016/S0140-6736(07)61208-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693158				2022-12-28	WOS:000248717800005
J	Levy, HL; Milanowski, A; Chakrapani, A; Cleary, M; Lee, P; Trefz, FK; Whitley, CB; Feillet, F; Feigenbaum, AS; Bebchuk, JD; Christ-Schmidt, H; Dorenbaum, A				Levy, Harvey L.; Milanowski, Andrzej; Chakrapani, Anupam; Cleary, Maureen; Lee, Philip; Trefz, Friedrich K.; Whitley, Chester B.; Feillet, Francois; Feigenbaum, Annette S.; Bebchuk, Judith D.; Christ-Schmidt, Heidi; Dorenbaum, Alex		Sapropterin Res Grp	Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study	LANCET			English	Article							LONG-TERM TREATMENT; TREATED PHENYLKETONURIA; RESPONSIVE PHENYLKETONURIA; FOLLOW-UP; CHILDREN; DIAGNOSIS; MILD; INTELLIGENCE; ADOLESCENTS; ADULTHOOD	Background Early and strict dietary management of phenylketonuria is the only option to prevent mental retardation. We aimed to test the efficacy of sapropterin, a synthetic form of tetrahydrobiopterin (BH4), for reduction of blood phenylalanine concentration. Methods We enrolled 89 patients with phenylketonuria in a Phase III, multicentre, randomised, double-blind, placebo-controlled trial. We randomly assigned 42 patients to receive oral doses of sapropterin (10 mg/kg) and 47 patients to receive placebo, once daily for 6 weeks. The primary endpoint was mean change from baseline in concentration of phenylalanine in blood after 6 weeks. Analysis was on an intention-to-treat basis. The study is registered with ClinicalTrials.gov, number NCT00104247. Findings 88 of 89 enrolled patients received at least one dose of study drug, and 87 attended the week 6 visit. Mean age was 20 (SD 9.7) years. At baseline, mean concentration of phenylalanine in blood was 843 (300) mu mol/L in patients assigned to receive sapropterin, and 888 (323) mu mol/L in controls. After 6 weeks of treatment, patients given sapropterin had a decrease in mean blood phenylalanine of 236 (257) mu mol/L, compared with a 3 (240) mu mol/L increase in the placebo group (p<0.0001). After 6 weeks, 18/41 (44%) patients (95% CI 28-60) in the sapropterin group and 4/47 (9%) controls (95% CI 2-20) had a reduction in blood phenylalanine concentration of 30% or greater from baseline. Blood phenylalanine concentrations fell by about 200 mu mol/L after 1 week in the sapropterin group and this reduction persisted for the remaining 5 weeks of the study (p<0.0001). 11/47 (23%) patients in the sapropterin group and 8/41 (20%) in the placebo group experienced adverse events that might have been drug-related (p=0.80). Upper respiratory tract infections were the most common disorder. Interpretation In some patients with phenylketonuria who are responsive to BH4, sapropterin treatment to reduce blood phenylalanine could he used as an adjunct to a restrictive low-phenylalanine diet, and might even replace the diet in some instances.	Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Inst Matki & Dziecka, Warsaw, Poland; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Great Ormond St Hosp Sick Children, London, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Klin Kinder & Jugendmed Reutlingen, Reutlingen, Germany; Univ Minnesota, Minneapolis, MN USA; Hop Enfants, CHU Brabois, Vandoeuvre Les Nancy, France; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Stat Collaborat, Washington, DC USA; BioMarin Pharmaceut, Novato, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Mother & Child Institute; Polish Mother's Memorial Hospital - Research Institute; University of Birmingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Minnesota System; University of Minnesota Twin Cities; CHU de Nancy; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BioMarin Pharmaceutical Inc.	Levy, HL (corresponding author), Childrens Hosp Boston, Div Genet, 1 Autumn St, Boston, MA 02115 USA.	harvey.levy@childrens.harvard.edu	Feillet, Francois/A-3648-2017; Feillet, Francois/A-2871-2015	Feillet, Francois/0000-0002-8717-469X; 	NCRR NIH HHS [M01-RR00400, M01-RR02172] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400, M01RR002172] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antshel KM, 2003, NEUROPSYCHOLOGY, V17, P458, DOI 10.1037/0894-4105.17.3.458; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Blau N, BIOPKU INT DATABASE; Bowersox J, 2001, PEDIATRICS, V108, P972; Burgard P, 1999, EUR J PEDIATR, V158, P46, DOI 10.1007/s004310051008; BURTON BK, IN PRESS J INHERIT M; Cerone R, 2004, MOL GENET METAB, V81, P137, DOI 10.1016/j.ymgme.2003.11.008; COCKBURN F, 1993, BRIT MED J, V306, P115; DONLON J, 2004, METABOLIC MOL BASES, pCH77; Fiege B, 2005, MOL GENET METAB, V86, pS91, DOI 10.1016/j.ymgme.2005.09.014; Fiori L, 2005, MOL GENET METAB, V86, pS67, DOI 10.1016/j.ymgme.2005.06.017; Griffiths P, 1998, J INHERIT METAB DIS, V21, P125, DOI 10.1023/A:1005339524847; Griffiths P, 1998, J INHERIT METAB DIS, V21, P29, DOI 10.1023/A:1005307229813; Hennermann JB, 2005, MOL GENET METAB, V86, pS86, DOI 10.1016/j.ymgme.2005.05.013; Huijbregts SCJ, 2002, J INHERIT METAB DIS, V25, P419, DOI 10.1023/A:1021205713674; *IFPMA, 2007, MED DICT REG ACT; JONSSON JJ, 1995, AM J HUM GENET, V56, P597; Koch R, 2002, J INHERIT METAB DIS, V25, P333, DOI 10.1023/A:1020158631102; KOCH R, 1984, J INHERIT METAB DIS, V7, P86, DOI 10.1007/BF01805813; KRAUSE W, 1985, J CLIN INVEST, V75, P40, DOI 10.1172/JCI111695; Lambruschini N, 2005, MOL GENET METAB, V86, pS54, DOI 10.1016/j.ymgme.2005.05.014; Landolt MA, 2002, J PEDIATR-US, V140, P516, DOI 10.1067/mpd.2002.123663; Leuzzi V, 2006, J INHERIT METAB DIS, V29, P38, DOI 10.1007/s10545-006-0096-3; LEVY HL, 1994, ACTA PAEDIATR, V83, P92, DOI 10.1111/j.1651-2227.1994.tb13463.x; Matalon R, 2005, MOL GENET METAB, V86, pS17, DOI 10.1016/j.ymgme.2005.06.024; Mitchell JJ, 2005, MOL GENET METAB, V86, pS81, DOI 10.1016/j.ymgme.2005.06.008; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; PIETZ J, 1993, DEV MED CHILD NEUROL, V35, P54; SCHMIDT E, 1994, J CLIN EXP NEUROPSYC, V16, P681, DOI 10.1080/01688639408402681; Schmidt H, 1996, EUR J PEDIATR, V155, pS97, DOI 10.1007/PL00014262; SCRIVER CR, 1980, NEW ENGL J MED, V303, P1394, DOI 10.1056/NEJM198012113032404; SCRIVER CR, 1980, NEW ENGL J MED, V303, P1336, DOI 10.1056/NEJM198012043032305; Shintaku H, 2004, PEDIATR RES, V55, P425, DOI 10.1203/01.PDR.0000111283.91564.7E; Steinfeld R, 2004, J INHERIT METAB DIS, V27, P449, DOI 10.1023/B:BOLI.0000037351.10132.99; Trefz FK, 2005, MOL GENET METAB, V86, pS75, DOI 10.1016/j.ymgme.2005.06.026; WAISBREN SE, 1991, J INHERIT METAB DIS, V14, P755, DOI 10.1007/BF01799946; WAISBREN SE, 2006, 56 ANN M AM SOC HUM; Walter John H, 2004, Int J Adolesc Med Health, V16, P41	38	228	239	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					504	510		10.1016/S0140-6736(07)61234-3	http://dx.doi.org/10.1016/S0140-6736(07)61234-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693179				2022-12-28	WOS:000248717800029
J	Sanders, G; Kingsnorth, AN				Sanders, Grant; Kingsnorth, Andrew N.			Gallstones	BRITISH MEDICAL JOURNAL			English	Review							LAPAROSCOPIC CHOLECYSTECTOMY; MINILAPAROTOMY CHOLECYSTECTOMY; GALLBLADDER SURGERY; DISEASE; TRIAL		Derriford Hosp, Dept Upper Gastrointestinal Surg, Plymouth PL6 8DH, Devon, England	Derriford Hospital	Sanders, G (corresponding author), Derriford Hosp, Dept Upper Gastrointestinal Surg, Plymouth PL6 8DH, Devon, England.	gsanders@doctors.org.uk						Cheruvu CVN, 2002, ANN ROY COLL SURG, V84, P20; Glasgow RE, 2000, ARCH SURG-CHICAGO, V135, P1021, DOI 10.1001/archsurg.135.9.1021; Gurusamy KS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub2; Halldestam I, 2004, BRIT J SURG, V91, P734, DOI 10.1002/bjs.4547; Harju J, 2006, SURG ENDOSC, V20, P583, DOI 10.1007/s00464-004-2280-6; Johansson M, 2006, BRIT J SURG, V93, P40, DOI 10.1002/bjs.5241; KARANI J, 2003, TXB RADIOLOGY IMAGIN, P715; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Keus F, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006231; Keus F, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006229; Leeder PC, 2004, BRIT J SURG, V91, P312, DOI 10.1002/bjs.4409; Mercer SJ, 2004, BRIT J SURG, V91, P504, DOI 10.1002/bjs.4458; Miller K, 2003, ANN SURG, V238, P697, DOI 10.1097/01.sla.0000094305.77843.cf; NHS Institute for Innovation and Improvement, 2006, FOC CHOL GUID COMM; Park PO, 2005, GASTROINTEST ENDOSC, V61, P601, DOI 10.1016/S0016-5107(04)02774-9; Rattner D, 2006, SURG ENDOSC, V20, P329, DOI 10.1007/s00464-005-3006-0; Ros A, 2004, SCAND J GASTROENTERO, V39, P773, DOI 10.1080/00365520410005540; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Spira RM, 2002, AM J SURG, V183, P62, DOI 10.1016/S0002-9610(01)00849-2; Venneman NG, 2005, AM J GASTROENTEROL, V100, P2540, DOI 10.1111/j.1572-0241.2005.00317.x; Venneman NG, 2006, HEPATOLOGY, V43, P1276, DOI 10.1002/hep.21182	21	82	83	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 11	2007	335	7614					295	299		10.1136/bmj.39267.452257.AD	http://dx.doi.org/10.1136/bmj.39267.452257.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17690370	Green Published			2022-12-28	WOS:000248987400026
J	Singh, JA; Govender, M; Mills, EJ				Singh, Jerome Amir; Govender, Michelle; Mills, Edward J.			Health and human rights 2 - Do human rights matter to health?	LANCET			English	Article							PRINCIPLES	Legal instruments and litigation as a way to enforce the rights to life and to health is a relatively new strategy that is increasingly common. We show how legal measures have been used to attain health and human rights with case examples from India and South Africa that resulted in large public-health benefits.	British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Ctr AIDS Programme Res S Africa, Durban, South Africa; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Ctr Bone & Joint, Joint Ctr Bioeth, Toronto, ON, Canada; Univ KwaZulu Natal, Howard Coll Sch Law, Durban, South Africa; AIDS Law Project S Africa, Braamfontein, South Africa	B.C. Centre for Excellence in HIV/AIDS; University of Toronto; University of Toronto; University of Kwazulu Natal	Mills, EJ (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	emills@cihhrs.org	Singh, Jerome Amir/ABG-1573-2021					ABRAMOVICH V, 2003, CTR HOUSING RIGHTS E; Burris S, 2001, LANCET, V358, P1901; BYRNE I, 2005, COMM LAW C LOND SEPT; CHIRWA DM, OVERVIEW IMPACT INT; *DEP HLTH S AFR, 1999, HLTH SECT STRAT FRAM, pCH2; Department of Health South Africa, 2003, OP PLAN COMPR HIV AI; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; GOYER KC, HIV AIDS PRISON TREA; Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; MATHIHARAN K, 2003, INDIAN J MED ETHICS, V11, P4; MELDRUM A, 2006, GUARDIAN ONLINE 1027; PAO M, 2006, QUESTIONS ANSWERS AC; *SABC NEWS, 2006, CORR SERV CHALL ARV; Singh Jerome A., 2005, GEORGETOWN J POVERTY, V12, P355; *TREATM ACT CAMP, GOV LEAD HIV AIDS IR; *UN, 1996, INT COV EC SOC EC RI; UNAIDS, 2006, REP GLOB AIDS EP; *WHO, COUNTR REP IND; 2005, HUMAN RIGHTS NE 0421; [No title captured]; 2006, HUMAN RIGHTS WA 0223	22	26	26	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					521	527		10.1016/S0140-6736(07)61236-7	http://dx.doi.org/10.1016/S0140-6736(07)61236-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693181				2022-12-28	WOS:000248717800031
J	Zimmermann, MB; Hurrell, RF				Zimmermann, Michael B.; Hurrell, Richard F.			Nutritional iron deficiency	LANCET			English	Review							SOLUBLE TRANSFERRIN RECEPTOR; ROUTINE PROPHYLACTIC SUPPLEMENTATION; HELICOBACTER-PYLORI INFECTION; FOLIC-ACID SUPPLEMENTATION; FERRIC PYROPHOSPHATE; DOUBLE-BLIND; FERROUS SULFATE; ELEMENTAL IRON; VITAMIN-A; MICRONUTRIENT STATUS	Iron deficiency is one of the leading risk factors for disability and death worldwide, affecting an estimated 2 billion people. Nutritional iron deficiency arises when physiological requirements cannot be met by iron absorption from diet. Dietary iron bioavailability is low in populations consuming monotonous plant-based diets. The high prevalence of iron deficiency in the developing world has substantial health and economic costs, including poor pregnancy outcome, impaired school performance, and decreased productivity. Recent studies have reported how the body regulates iron absorption and metabolism in response to changing iron status by upregulation or downregulation of key intestinal and hepatic proteins. Targeted iron supplementation, iron fortification of foods, or both, can control iron deficiency in populations. Although technical challenges limit the amount of bioavailable iron compounds that can be used in food fortification, studies show that iron fortification can be an effective strategy against nutritional iron deficiency. Specific laboratory measures of iron status should be used to assess the need for fortification and to monitor these interventions. Selective plant breeding and genetic engineering are promising new approaches to improve dietary iron nutritional quality.	Swiss Fed Inst Technol, Lab Human Nutr, CH-8092 Zurich, Switzerland; Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research	Zimmermann, MB (corresponding author), Swiss Fed Inst Technol, Lab Human Nutr, Schmelzbergstr 7,LFVE19, CH-8092 Zurich, Switzerland.	michael.zimmermann@ilw.agrl.ethz.ch	Zimmermann, Michael B/C-3062-2016; Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				Allen L, 2006, GUIDELINES FOOD FORT; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; ATUKORALA TMS, 1994, AM J CLIN NUTR, V60, P286, DOI 10.1093/ajcn/60.2.286; Baillie FJ, 2003, CLIN LAB HAEMATOL, V25, P353, DOI 10.1046/j.0141-9854.2003.00548.x; BALLOT DE, 1989, AM J CLIN NUTR, V49, P162, DOI 10.1093/ajcn/49.1.162; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Bothwell T.H., 1979, IRON METABOLISM MAN; Bothwell TH, 2004, INT J VITAM NUTR RES, V74, P421, DOI 10.1024/0300-9831.74.6.421; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Briend Andre, 2003, Food and Nutrition Bulletin, V24, pS34; Brownlie T, 2002, AM J CLIN NUTR, V75, P734, DOI 10.1093/ajcn/75.4.734; Brutsaert TD, 2003, AM J CLIN NUTR, V77, P441, DOI 10.1093/ajcn/77.2.441; Bungiro R, 2004, CURR OPIN INFECT DIS, V17, P421, DOI 10.1097/00001432-200410000-00006; Cardenas VM, 2006, AM J EPIDEMIOL, V163, P127, DOI 10.1093/aje/kwj018; Carter JY, 2005, AM J TROP MED HYG, V73, P166, DOI 10.4269/ajtmh.2005.73.166; Cavalli-Sforza T, 2005, NUTR REV, V63, pS152; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P897; Champagne E T, 1989, Adv Exp Med Biol, V249, P173; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; Collins JF, 2006, BIOL RES, V39, P25, DOI 10.4067/S0716-97602006000100004; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; COOPER ES, 1987, BAILLIERE CLIN TROP, V3, P629; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; de Silva A, 2003, AM J CLIN NUTR, V77, P234, DOI 10.1093/ajcn/77.1.234; DEMAEYER E, 1985, WORLD HLTH STAT Q, V38, P303; Donangelo CM, 2003, J AGR FOOD CHEM, V51, P5137, DOI 10.1021/jf030151w; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; English M, 2006, LANCET, V367, P90, DOI 10.1016/S0140-6736(06)67939-7; Faber M, 2005, AM J CLIN NUTR, V82, P1032, DOI 10.1093/ajcn/82.5.1032; Fidler MC, 2004, BRIT J NUTR, V91, P107, DOI 10.1079/BJN20041018; FINCH CA, 1986, WESTERN J MED, V145, P657; *FLOUR FORT IN, 2004, INT TECHN WORKSH DEC; Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;861::AID-JSFA601&gt;3.0.CO;2-P; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Genc Y, 2005, J TRACE ELEM MED BIO, V18, P319, DOI 10.1016/j.jtemb.2005.02.005; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hallberg L, 2002, BLOOD CELL MOL DIS, V29, P562, DOI 10.1006/bcmd.2002.0603; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Heath ALM, 2002, BEST PRACT RES CL HA, V15, P225, DOI 10.1053/beha.2002.0208; Hercberg S, 2001, Public Health Nutr, V4, P537; Hertrampf E, 2002, NUTR REV, V60, pS22, DOI 10.1301/002966402320285056; HERTRAMPF E, 2001, INT NUTR AN CONS GRO, P49; Hess SY, 2002, J NUTR, V132, P1951, DOI 10.1093/jn/132.7.1951; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Horton S, 2001, J NUTR, V131, p691S, DOI 10.1093/jn/131.2.691S; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Huo JS, 2002, ASIA PAC J CLIN NUTR, V11, P123, DOI 10.1046/j.1440-6047.2002.00277.x; Hurrell R, 2002, NUTR REV, V60, P391, DOI 10.1301/002966402320964061; Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137; Hurrell RF, 2004, INT J VITAM NUTR RES, V74, P387, DOI 10.1024/0300-9831.74.6.387; Hurrell RF, 1999, BRIT J NUTR, V81, P289, DOI 10.1017/S0007114599000537; IOM (Institute of Medicine), 2001, DIET REF INT VIT A V, P290; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Larocque R, 2005, AM J TROP MED HYG, V73, P783, DOI 10.4269/ajtmh.2005.73.783; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Lonnerdal B, 2003, J NUTR, V133, p1490S, DOI 10.1093/jn/133.5.1490S; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 2003, PEDIATRICS, V112, P846; Lucca P, 2001, THEOR APPL GENET, V102, P392, DOI 10.1007/s001220051659; Lynch SR, 2005, BEST PRACT RES CL HA, V18, P333, DOI 10.1016/j.beha.2004.09.003; Mast AE, 2002, BLOOD, V99, P1489, DOI 10.1182/blood.V99.4.1489; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mei ZG, 2005, J NUTR, V135, P1974, DOI 10.1093/jn/135.8.1974; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Metzgeroth G, 2005, EUR J HAEMATOL, V75, P309, DOI 10.1111/j.1600-0609.2005.00515.x; Milman N, 2003, EUR J HAEMATOL, V71, P51, DOI 10.1034/j.1600-0609.2003.00090.x; Milman N, 2002, EUR J HAEMATOL, V68, P332, DOI 10.1034/j.1600-0609.2002.01668.x; Moretti D, 2006, AM J CLIN NUTR, V84, P822, DOI 10.1093/ajcn/84.4.822; Moy RJD, 2006, CLIN LAB HAEMATOL, V28, P291, DOI 10.1111/j.1365-2257.2006.00793.x; Munoz EC, 2000, AM J CLIN NUTR, V71, P789, DOI 10.1093/ajcn/71.3.789; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Nestel P, 2004, INT J VITAM NUTR RES, V74, P35, DOI 10.1024/0300-9831.74.1.35; Nestel P, 2003, J PEDIATR GASTR NUTR, V36, P316, DOI 10.1097/00005176-200303000-00005; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Olsson KS, 1997, EUR J CLIN NUTR, V51, P782, DOI 10.1038/sj.ejcn.1600488; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Owen AL, 1997, J AM DIET ASSOC, V97, P777, DOI 10.1016/S0002-8223(97)00191-0; Perez-Exposito AB, 2005, J NUTR, V135, P64, DOI 10.1093/jn/135.1.64; PIZARRO F, 1991, J PEDIATR-US, V118, P687, DOI 10.1016/S0022-3476(05)80027-7; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Raboy Victor, 2000, Food and Nutrition Bulletin, V21, P423; Rashid M, 2005, PEDIATRICS, V116, pE754, DOI 10.1542/peds.2005-0904; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Sachdev HPS, 2006, PUBLIC HEALTH NUTR, V9, P904, DOI 10.1017/PHN2005918; Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677; Samuelsen AI, 1998, PLANT PHYSIOL, V118, P51, DOI 10.1104/pp.118.1.51; Sarker SA, 2004, AM J CLIN NUTR, V80, P149; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; SKIKNE BS, 1990, BLOOD, V75, P1870; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Swain JH, 2003, J NUTR, V133, P3546, DOI 10.1093/jn/133.11.3546; Thuy PV, 2003, AM J CLIN NUTR, V78, P284, DOI 10.1093/ajcn/78.2.284; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Torlesse H, 2000, LANCET, V356, P1083, DOI 10.1016/S0140-6736(00)02738-0; TUNTAWIROON M, 1990, EUR J CLIN NUTR, V44, P489; Ullrich C, 2005, JAMA-J AM MED ASSOC, V294, P924, DOI 10.1001/jama.294.8.924; Umbreit J, 2005, AM J HEMATOL, V78, P225, DOI 10.1002/ajh.20249; van Stuijvenberg ME, 2006, BRIT J NUTR, V95, P532, DOI 10.1079/BJN20051669; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; VITERI FE, 1978, AM J CLIN NUTR, V31, P961, DOI 10.1093/ajcn/31.6.961; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wegmuller R, 2006, J NUTR, V136, P1814, DOI 10.1093/jn/136.7.1814; Welch RM, 2000, J AGR FOOD CHEM, V48, P3576, DOI 10.1021/jf0000981; White KC, 2005, PEDIATRICS, V115, P315, DOI 10.1542/peds.2004-1488; WHO, 2003, DIET NUTR PREVENTION, V916; *WHO, 2007, WHO STAT IR SUPPL YO; *WHO, 1996, WHOCTDSIP961; *WHO INT PROGR CHE, 1999, JOINT FAO WHO EXP CO; Wieringa FT, 2003, AM J CLIN NUTR, V77, P651, DOI 10.1093/ajcn/77.3.651; Wieringa FT, 2002, J NUTR, V132, P3061, DOI 10.1093/jn/131.10.3061; World Health Organization, 2001, IR DEF AN ASS PREV C; YIP R, 1987, JAMA-J AM MED ASSOC, V258, P1619, DOI 10.1001/jama.258.12.1619; Zimmermann M, 2000, AM J CLIN NUTR, V71, P88; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P1276, DOI 10.1093/ajcn/82.6.1276; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115; Zimmermann MB, 2004, AM J CLIN NUTR, V80, P952, DOI 10.1093/ajcn/80.4.952; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P425, DOI 10.1093/ajcn/77.2.425; Zimmermann MB, 2006, PEDIATRICS, V117, P2014, DOI 10.1542/peds.2005-2440; Zlotkin S, 2003, J NUTR, V133, P1075, DOI 10.1093/jn/133.4.1075; [No title captured]	146	840	878	7	194	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					511	520		10.1016/S0140-6736(07)61235-5	http://dx.doi.org/10.1016/S0140-6736(07)61235-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693180				2022-12-28	WOS:000248717800030
J	Donald, PF; Sanderson, FJ; Burfield, IJ; Bierman, SM; Gregory, RD; Waliczky, Z				Donald, Paul F.; Sanderson, Fiona J.; Burfield, Ian J.; Bierman, Stijn M.; Gregory, Richard D.; Waliczky, Zoltan			International conservation policy delivers benefits for birds in Europe	SCIENCE			English	Article							AGRICULTURAL INTENSIFICATION; BIODIVERSITY; POPULATION; STATE	Conservation of the planet's biodiversity will depend on international policy intervention, yet evidence-based assessment of the success of such intervention is lacking. Poor understanding of the effectiveness of international policy instruments exposes them to criticism or abandonment and reduces opportunities to improve them. Comparative analyses of population trends provide strong evidence for a positive impact of one such instrument, the European Union's Birds Directive, and we identify positive associations between the rate of provision of certain conservation measures through the directive and the response of bird populations. The results suggest that supranational conservation policy can bring measurable conservation benefits, although future assessments will require the setting of quantitative objectives and an increase in the availability of data from monitoring schemes.	Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Birdlife Int, Cambridge CB3 0NA, England; Univ Edinburgh, Edinburgh EH9 3JZ, Midlothian, Scotland	Royal Society for Protection of Birds; BirdLife International; University of Edinburgh	Donald, PF (corresponding author), Royal Soc Protect Birds, Lodge, Sandy SG19 2DL, Beds, England.	paul.donald@rspb.org.uk	Bierman, Stijn M/F-8281-2010	Donald, Paul F./0000-0003-0023-6200; Sanderson, Fiona/0000-0003-4726-4145; Gregory, Richard/0000-0002-7419-5053				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; *BIRDL INT EUR BIR, 2000, BIRDL CONS SER, V10; BirdLife International, 2004, BIRDS EUR POP EST TR, V12; Boere GC, 2002, CONSERV BIOL SER, V7, P246; Cahill AJ, 2006, ORYX, V40, P161, DOI 10.1017/S0030605306000366; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; ROHLF DJ, 1991, CONSERV BIOL, V5, P273, DOI 10.1111/j.1523-1739.1991.tb00139.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; STEWARTOATEN A, 1986, COTROL IMPACT PAIR; Stokstad E, 2005, SCIENCE, V309, P2150, DOI 10.1126/science.309.5744.2150; Tucker G. M., 1994, BIRDLIFE CONSERVATIO, V3; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001	22	237	250	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					810	813		10.1126/science.1146002	http://dx.doi.org/10.1126/science.1146002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690296				2022-12-28	WOS:000248624500042
J	St Laurent, LC; Thurnherr, AM				St Laurent, Louis C.; Thurnherr, Andreas M.			Intense mixing of lower thermocline water on the crest of the Mid-Atlantic Ridge	NATURE			English	Article							RIFT-VALLEY; OCEAN; STRAIT; HYDROGRAPHY; OVERFLOW; CANYON; FLOW	Buoyancy exchange between the deep and the upper ocean, which is essential for maintaining global ocean circulation, mainly occurs through turbulent mixing(1,2). This mixing is thought to result primarily from instability of the oceanic internal wave field(3), but internal waves tend to radiate energy away from the regions in which they are generated rather than dissipate it locally as turbulence(4) and the resulting distribution of turbulent mixing remains unknown. Another, more direct, mixing mechanism involves the generation of turbulence as strong flows pass through narrow passages in topography, but the amount of turbulence generated at such locations remains poorly quantified owing to a lack of direct measurements. Here we present observations from the crest of the Mid-Atlantic Ridge in the subtropical North Atlantic Ocean that suggest that passages in rift valleys and ridge-flank canyons provide the most energetic sites for oceanic turbulence. Our measurements show that diffusivities as large as 0.03 m(2) s(-1) characterize the mixing downstream of a sill in a well-stratified boundary layer, with mixing levels remaining of the order of 10(-4) m(2) s(-1) at the base of the main thermocline. These mixing rates are significantly higher than the diffusivities of the order of 10(-5) m(2) s(-1) that characterize much of the global thermocline and the abyssal ocean(5). Our estimates suggest that overflows associated with narrow passages on the Mid-Atlantic Ridge in the North Atlantic Ocean produce as much buoyancy flux as has previously been estimated for the entire Romanche fracture zone(6,7), a large strait in the Mid-Atlantic Ridge that connects the North and South Atlantic basins. This flux is equivalent to the interior mixing that occurs in the entire North Atlantic basin at the depth of the passages, suggesting that turbulence generated in narrow passages on mid-ocean ridges may be important for buoyancy flux at the global scale.	Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Lamont Doherty Earth Observ, Div Ocean & Climate Phys, Palisades, NY 10964 USA	State University System of Florida; Florida State University; Columbia University	St Laurent, LC (corresponding author), Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA.	stlaurent@ocean.fsu.edu		Thurnherr, Andreas/0000-0002-1977-7122				Bryden HL, 2003, J PHYS OCEANOGR, V33, P1870, DOI 10.1175/1520-0485(2003)033<1870:EOSMOO>2.0.CO;2; Cannat M, 1999, EARTH PLANET SC LETT, V173, P257, DOI 10.1016/S0012-821X(99)00234-4; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; ESCARTIN J, 2006, MONITORING MID ATLAN; FARMER DM, 1988, PROG OCEANOGR, V21, P1, DOI 10.1016/0079-6611(88)90055-9; Girton JB, 2003, J PHYS OCEANOGR, V33, P1351, DOI 10.1175/1520-0485(2003)033<1351:DAMOTO>2.0.CO;2; Gregg MC, 1999, J ATMOS OCEAN TECH, V16, P1483, DOI 10.1175/1520-0426(1999)016<1483:UALIMA>2.0.CO;2; Hogg N, 1982, J MAR RES, V40, P231; JOYCE C, 1994, WHP 90 1 REQUIREMENT; KELLER GH, 1975, CAN J EARTH SCI, V12, P703, DOI 10.1139/e75-061; Kunze E, 1996, J PHYS OCEANOGR, V26, P2286, DOI 10.1175/1520-0485(1996)026<2286:AMWIIN>2.0.CO;2; Lueck RG, 2002, J OCEANOGR, V58, P153, DOI 10.1023/A:1015837020019; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Munk W.H., 1981, EVOLUTION PHYS OCEAN, P264, DOI DOI 10.1121/1.3425741; MUNK WH, 1966, DEEP-SEA RES, V13, P207; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Polzin KL, 1996, NATURE, V380, P54, DOI 10.1038/380054a0; *ROCKL SCI INT, 2006, MICR INSTR VMP 5500; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; St Laurent L, 2002, J PHYS OCEANOGR, V32, P2882, DOI 10.1175/1520-0485(2002)032<2882:TROITI>2.0.CO;2; St Laurent L, 2006, J CLIMATE, V19, P4877, DOI 10.1175/JCLI3887.1; Thurnherr AM, 2006, DEEP-SEA RES PT II, V53, P194, DOI 10.1016/j.dsr2.2005.10.020; Thurnherr AM, 2005, J PHYS OCEANOGR, V35, P1370, DOI 10.1175/JPO2773.1; Thurnherr AM, 2002, J PHYS OCEANOGR, V32, P1763, DOI 10.1175/1520-0485(2002)032<1763:FAMITR>2.0.CO;2; Thurnherr AM, 2001, J GEOPHYS RES-OCEANS, V106, P9411, DOI 10.1029/2000JC900164; Visbeck M, 2002, J ATMOS OCEAN TECH, V19, P794, DOI 10.1175/1520-0426(2002)019<0794:DVPULA>2.0.CO;2; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; WILSON C, 1995, J GEOPHYS RES-OCEANS, V100, P20555, DOI 10.1029/95JC02281	28	64	64	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					680	683		10.1038/nature06043	http://dx.doi.org/10.1038/nature06043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687321				2022-12-28	WOS:000248598000041
J	Markel, H; Lipman, HB; Navarro, JA; Sloan, A; Michalsen, JR; Stern, AM; Cetron, MS				Markel, Howard; Lipman, Harvey B.; Navarro, J. Alexander; Sloan, Alexandra; Michalsen, Joseph R.; Stern, Alexandra Minna; Cetron, Martin S.			Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STRATEGIES; DISEASE; VIRUS	Context A critical question in pandemic influenza planning is the role nonpharmaceutical interventions might play in delaying the temporal effects of a pandemic, reducing the overall and peak attack rate, and reducing the number of cumulative deaths. Such measures could potentially provide valuable time for pandemic-strain vaccine and antiviral medication production and distribution. Optimally, appropriate implementation of nonpharmaceutical interventions would decrease the burden on health care services and critical infrastructure. Objectives To examine the implementation of nonpharmaceutical interventions for epidemic mitigation in 43 cities in the continental United States from September 8, 1918, through February 22, 1919, and to determine whether city-to-city variation in mortality was associated with the timing, duration, and combination of nonpharmaceutical interventions; altered population susceptibility associated with prior pandemic waves; age and sex distribution; and population size and density. Design and Setting Historical archival research, and statistical and epidemiological analyses. Nonpharmaceutical interventions were grouped into 3 major categories: school closure; cancellation of public gatherings; and isolation and quarantine. Main Outcome Measures Weekly excess death rate (EDR); time from the activation of nonpharmaceutical interventions to the first peak EDR; the first peak weekly EDR; and cumulative EDR during the entire 24-week study period. Results There were 115 340 excess pneumonia and influenza deaths ( EDR, 500/ 100 000 population) in the 43 cities during the 24 weeks analyzed. Every city adopted at least 1 of the 3 major categories of nonpharmaceutical interventions. School closure and public gathering bans activated concurrently represented the most common combination implemented in 34 cities (79%); this combination had a median duration of 4 weeks ( range, 1-10 weeks) and was significantly associated with reductions in weekly EDR. The cities that implemented nonpharmaceutical interventions earlier had greater delays in reaching peak mortality ( Spearman r=- 0.74, P <. 001), lower peak mortality rates ( Spearman r= 0.31, P=. 02), and lower total mortality ( Spearman r= 0.37, P=. 008). There was a statistically significant association between increased duration of nonpharmaceutical interventions and a reduced total mortality burden ( Spearman r=- 0.39, P=. 005). Conclusions These findings demonstrate a strong association between early, sustained, and layered application of nonpharmaceutical interventions and mitigating the consequences of the 1918-1919 influenza pandemic in the United States. In planning for future severe influenza pandemics, nonpharmaceutical interventions should be considered for inclusion as companion measures to developing effective vaccines and medications for prophylaxis and treatment.	Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan	Cetron, MS (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 1600 Clifton Rd,Mailstop E-03, Atlanta, GA 30333 USA.	mcetron@cdc.gov			PHS HHS [200-2006-16894] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALEDORT JE, 2006, WORKING PAPER NONPHA; [Anonymous], 1993, HIST PUBLIC HLTH; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; *BERM I BIOETH JOH, BELL M SOC JUST INFL; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Byerly Carol R, 2005, FEVER WAR INFLUENZA; Collins SD, 1930, PUBLIC HEALTH REP, V45, P2277, DOI 10.2307/4579795; Crosby AW, 2003, AMERICAS FORGOTTEN P, V2nd; *DEP HLTH CIT NEW, 1918, DEP HLTH M AUG 10 TH; Eichel Otto M., 1923, SPECIAL REPORT MORTA; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Frost WH, 1919, PUBL HLTH REP, V34, P1823; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Gostin L, 2006, JAMA-J AM MED ASSOC, V295, P1700, DOI 10.1001/jama.295.14.1700; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; *I MED BOARD GLOB, 2007, ETH LEG CONS MIT PAN; Inglesby TV, 2006, BIOSECUR BIOTERROR, V4, P366, DOI 10.1089/bsp.2006.4.366; Jordan EO., 1927, EPIDEMIC INFLUENZA S; KLOTZ O, 1919, STUDIES EPIDEMIC INF, P207; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lyon MW, 1919, J AMER MED ASSOC, V72, P924, DOI 10.1001/jama.1919.02610130018006; MARKEL H, 1999, QUARANTINEL E EUROPE; Markel Howard, 2004, GERMS TRAVEL 6 MAJOR; MCLAUGHLIN AJ, 1920, BOSTON MED SURG J, V183, P1; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; *MIN HLTH, 1920, 4 MIN HLTH; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Sydenstricker E., 1918, PUBLIC HLTH REPORTS, V33, P2305, DOI [10.2307/4574973, DOI 10.2307/4574973]; Sydenstricker E, 1921, PUBLIC HEALTH REP, V36, P2201, DOI 10.2307/4576118; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; *US BUR CENS, WEEKL HLTH IND; *US CDCP, 2007, INT PREP PLANN GUID; Vaughan Warren Taylor, 1921, AM J HYGIENE MONOGRA	41	410	421	6	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					644	654		10.1001/jama.298.6.644	http://dx.doi.org/10.1001/jama.298.6.644			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684187	Bronze			2022-12-28	WOS:000248574800025
J	Godlee, F				Godlee, Fiona			Academic boycott of Israel: follow-up to the BMJ's debate	BRITISH MEDICAL JOURNAL			English	Editorial Material												fgodlee@bmj.com						Hickey T, 2007, BRIT MED J, V335, P124, DOI 10.1136/bmj.39266.495567.AD; Sheikh A, 2007, BRIT MED J, V334, P74, DOI 10.1136/bmj.39072.347720.68	2	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					234	235		10.1136/bmj.39294.443264.59	http://dx.doi.org/10.1136/bmj.39294.443264.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201QC	17673766	Green Published			2022-12-28	WOS:000248846700025
J	Sakaguchi, S; Powrie, F				Sakaguchi, Shimon; Powrie, Fiona			Perspective - Emerging challenges in regulatory T cell function and biology	SCIENCE			English	Editorial Material							TARGET GENES; TGF-BETA; FOXP3; SELF; INTERLEUKIN-2; DIFFERENTIATION; SUPPRESSION; INDUCTION; T(H)17	Much progress has been made in understanding how the immune system is regulated, with a great deal of recent interest in naturally occurring CD4(+) regulatory T cells that actively engage in the maintenance of immunological self-tolerance and immune homeostasis. The challenge ahead for immunologists is the further elucidation of the molecular and cellular processes that govern the development and function of these cells. From this, exciting possibilities are emerging for the manipulation of regulatory T cell pathways in treating immunological diseases and suppressing or augmenting physiological immune responses.	Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Kyoto University; University of Oxford	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.		Sakaguchi, Shimon/C-9535-2009		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; COOMBES JL, IN PRESS J EXP MED; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; SUN CM, IN PRESS J EXP MED; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YAMAGUCHI T, IN PRESS IMMUNITY; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	37	185	206	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					627	629		10.1126/science.1142331	http://dx.doi.org/10.1126/science.1142331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673654				2022-12-28	WOS:000248494400035
J	Carapetis, JR				Carapetis, Jonathan R.			Focus on research: Rheumatic heart disease in developing countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FEVER		Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia	Charles Darwin University; Menzies School of Health Research	Carapetis, JR (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia.		Carapetis, Jonathan R/H-8933-2014	Carapetis, Jonathan R/0000-0002-1182-9792				Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; STOLLERMAN GH, 1955, NEW ENGL J MED, V252, P787, DOI 10.1056/NEJM195505122521901; van Alken WG, 2004, WHO TECH REP SER, V926, P1	5	174	177	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					439	441		10.1056/NEJMp078039	http://dx.doi.org/10.1056/NEJMp078039			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671252				2022-12-28	WOS:000248436300004
J	Park, CB; Asin-Cayuela, J; Camara, Y; Shi, YH; Pellegrini, M; Gaspari, M; Wibom, R; Hultenby, K; Erdjument-Bromage, H; Tempst, P; Falkenberg, M; Gustafsson, CM; Larsson, NG				Park, Chan Bae; Asin-Cayuela, Jorge; Camara, Yolanda; Shi, Yonghong; Pellegrini, Mina; Gaspari, Martina; Wibom, Rolf; Hultenby, Kjell; Erdjument-Bromage, Hediye; Tempst, Paul; Falkenberg, Maria; Gustafsson, Claes M.; Larsson, Nils-Goran			MTERF3 is a negative regulator of mammalian mtDNA transcription	CELL			English	Article							MITOCHONDRIAL-DNA POLYMERASE; TERMINATION FACTOR MTERF; GENE-EXPRESSION; ATP PRODUCTION; RIBOSOMAL-RNA; IN-VITRO; MICE; PROTEIN; FAMILY; CELLS	Regulation of mammalian mtDNA gene expression is critical for altering oxidative phosphorylation capacity in response to physiological demands and disease processes. The basal machinery for initiation of mtDNA transcription has been molecularly defined, but the mechanisms regulating its activity are poorly understood. In this study, we show that MTERF3 is a negative regulator of mtDNA transcription initiation. The MTERF3 gene is essential because homozygous knockout mouse embryos die in midgestation. Tissue-specific inactivation of MTERF3 in the heart causes aberrant mtDNA transcription and severe respiratory chain deficiency. MTERF3 binds the mtDNA promoter region and depletion of MTERF3 increases transcription initiation on both mtDNA strands. This increased transcription initiation leads to decreased expression of critical promoter-distal tRNA genes, which is possibly explained by transcriptional collision on the circular mtDNA molecule. To our knowledge, MTERF3 is the first example of a mitochondrial protein that acts as a specific repressor of mammalian mtDNA transcription initiation in vivo.	Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Karolinska Institutet; Memorial Sloan Kettering Cancer Center	Gustafsson, CM (corresponding author), Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden.	claes.gustafsson@ki.se; nils-goran.larsson@ki.se	Cámara, Yolanda/P-2540-2019; Larsson, Nils-Göran/GVS-5578-2022; shi, yonghong/E-8254-2017; Cámara, Yolanda/K-4597-2014	Larsson, Nils-Göran/0000-0001-5100-996X; shi, yonghong/0000-0002-5265-7982; Cámara, Yolanda/0000-0003-2458-6942; Gustafsson, Claes/0000-0003-3531-8468; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Asin-Cayuela J, 2005, J BIOL CHEM, V280, P25499, DOI 10.1074/jbc.M501145200; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; CAREY J, 1991, METHOD ENZYMOL, V208, P103; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Enriquez J A, 1996, Methods Enzymol, V264, P50, DOI 10.1016/S0076-6879(96)64008-7; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HEDDI A, 1993, J BIOL CHEM, V268, P12156; Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Micol V, 1996, Methods Enzymol, V264, P158, DOI 10.1016/S0076-6879(96)64017-8; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHANG J, 1994, J BIOL CHEM, V269, P29112; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	40	176	191	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					273	285		10.1016/j.cell.2007.05.046	http://dx.doi.org/10.1016/j.cell.2007.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662942	Bronze			2022-12-28	WOS:000248588000017
J	Wadman, M				Wadman, Meredith			The pain game	NATURE			English	News Item																		Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	4	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					400	401		10.1038/448400a	http://dx.doi.org/10.1038/448400a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653159				2022-12-28	WOS:000248302700014
J	Light, DW				Light, Donald W.			Is G8 putting pro-fits before the world's poorest children?	LANCET			English	Editorial Material									Ctr Bioeth, Princeton, NJ 08540 USA		Light, DW (corresponding author), Ctr Bioeth, Princeton, NJ 08540 USA.	dlight@princeton.edu						BARDER O, 2006, 80 CTR GLOB DEV; *CTR GLOB DEV, 2005, MAK MARK VACC ID ACT; FARLOW A, 2005, INNOVATION STRATEGY, V1, P66; *GAVI ALL WORLD BA, 2007, Q A ADV MARK COMM AM; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; Kremer M, 2004, STRONG MED CREATING; LEVINE O, 2006, GAVI ALLIANCE INVEST; Light DW, 2005, PLOS MED, V2, P934, DOI 10.1371/journal.pmed.0020271; ROSENTHAL E, 2007, NY TIMES        0210; Tremonti G., 2005, ADV MARKET COMMITMEN; 2006, AMC PILOT PROPOSAL	11	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					297	298		10.1016/S0140-6736(07)61138-6	http://dx.doi.org/10.1016/S0140-6736(07)61138-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662863				2022-12-28	WOS:000248426100007
